>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 1; Drug: OSU6162 10 然 Apo 50 然
bRhbRobLsbRgbRsbRobLgbLsbLoRsbLgbLoLsmbRsbRgbLgbLcbLobRsbLobLjbRibLobR
obRobLgRsbRebRobRebLobLobLcbLcbLoRsRsmbRsbRhbRcLsbRhbRobLoRsbLhLsbLcbL
sbLobRsbLibLebLibLibLsLsmbLibLgbLsbRsbRsRsmbLsLsLsmmbRsbLsRsbLgbRsbLgL
sbLcLsmbLsLsmbRibLcbRobLgbLobLeRsbRgRsmbLhLsbsbsbRjbLsRcbLiLsbRoRsmbLs
bRibRhbRsbRsLsbLsLsmbLsbLjLsmbLibLibLgbRsbRgbRgbRobLsbRgbRiRsmbRsbRhLs
LsmbsbRsbRibLsbLebRobRsbRibLsbRgRsmbRgbRibRsRsmbRibRsbRcbLsbLsbLgbLibL
ibLiLsbLsbRjbLcbsbLcbLsRsbLgbRgRsRgRsmmbLgbLibLgbLibLgbLiRsLsbLibLsLsm
bsbRgbLibRcbRcbLsbRsRhbLibRgRsmbRgbRgbLjbLjbLibRoLsbLgLsbLoLsLsRsmmbLg
LgbLgbLgLsbRobLsRsbRgbRibLsbRgbRsbRgRsmbLsbRcRsmbRiLsbLhbLgbLib

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 2; Drug: OSU6162 10 然 Apo 50 然
bLcbLeLsbRibRjbRhbRsLsbRsbRhbRsbRsbRsbRcbLsbRsbLsbRcbLsbRcbLsLsmbLsbRs
bLoRsbLsbLsRjbRcbRibRcRsmbRsRsmbRsbLebLibLgbRobLsbLhLsbLgbLgRsbLsbLgLs
bLsbLsbLibLsbLsRsbRobRsbRcbRsbRsbLjLsmbLebReRsmbRibRgbReLsLsLsmmbLsbRh
bRsbLsbsbsbsbLsRsLsbLsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 3; Drug: OSU6162 10 然 Apo 50 然
bRgbLebLobLsRsbRgbsbLsbLgbRibLcbLobLcbLcbRebLobRsbsbRsLsRgbLjbLsbRsLgb
LjLgbRgbsbRjRgbLjbLgRjbRcbsbLsLsmbRoLsLsLsmmbsbsbLoRsbRsbLsbLjbRgRsmbL
ibRibLsRsbRgRobLebsbRsbRgLsbLcLoRsbLsbLobRsbRibRibLebLgbRsbRjbLgbsbsbR
sbsbLobRhbLibRcbRcbLsbLobLiRsbRsbLobLibRsLsbLsbLsbsbRsbLobRgbLsbsbRcbR
cbsbsbLgbsbLsbsbsbsbLsbRcRsmbLiLcbLobLgRgbRgbsbRobLsbRebsbLgbLebRsbRsR
smbLsRsRsmbLsbRgLsbLsbRsLsbRcbRcbLoRsbLcbLgbLsbRsbsbsbLhRsbLhbRobsbRhR
ibRsbRsbRcLsLgbLhbLiLsbLsbLgbLsbLsLsmbLsbLgRsbLsbLoRsbLsbsbLibLobRgbRo
bRiLsbRibLebRebRebRsbsbRjbRobLobLcLgbRgbRsbRsRsLsRsRcmbsbRsbRiLsbRiRsm
bRcbLcbLcbsbLiLsbLibLjbRgRsLsmbRsLsbRibLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 4; Drug: OSU6162 10 然 Apo 50 然
bLibRoRsmbRgbRgRsmbLsbRcbRcbLsbLsLsmbLgbLiLsbLiRsLsbRsRsmbRsbLiLsbLibL
sLsmbLgbLsbLsbLgbLibLibRsbRgbLhbLsbLgbLoLsmbRsbLsbLobsbLsbLiLsbLsbLsbL
sbLgbLgbLgbLsbLibLcbLgbRsbLibLgbLgbLgbLgLsbLsbLibLsRsbLiLibLgLiLeLiLsL
iLebRsbLsbRjbRsLibsbLobLjLsmbLhbLjbsbLjbLibLobLcbLiLsbLgbRcbLebRsLsLhb
LebLcbLjbLoLsmbRhbLcLsRsLcmbRgbLibLhbRgLsbRgbLsbLibLebRgbRibRcbLsbLsbL
cbLhLsbLcLsmbLcbRgbLcbLsbLiLsLsmbLibLibRsbLcLsLsmmbRsbLcbLjLgLsbLiLsbR
sbRoRsmbRcLsbRcRibRcbLibLibRsbLgbLibLibLhRsbLobLhbLgLsbLsbLhRsbRsbLsLs
mbLibLiLsbRsbLibLsbLiRsbRibRcbLsLsmbRibLcLsmbLiLsbRsbLcRgLsbLibLibLgLs
bRcbRebRsbRiLsbRhRsmbLgbRiRsmbRgRsmbLsbLcbRobLsLsmbRsRobRibLgRsbLsbLib
LibRsbLiRsbRsbLiLsbLgbLgbLgbLgbLibRiLsbRcbRibRgbRsbRhbLsbRibLsbRgbRsRs
mbRgbRsRsmbRgLsbRgbRibLebLebLgbLcbLsbRsbRsbRobsbRgbLsbRgRibRgbRsLsbRgL
sb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 5; Drug: OSU6162 10 然 Apo 50 然
bRibRgbLgbRibRgbRgbRgRsLsmbRsbRgRgRsmbRgbsbRibLsRsbRibRgbLibLobLgbLgbR
sbLgbRsbLibLibLgbLsbLoRsbRsbsbLiLsbsbsbRgbLiRsRsRsmmbsbLsbLcLsmbLsbLsb
sbsbsbsbLgbLiLsLsmbLgbLgLsbLgbLgbLsbLsLsmbLgbLsbLsbLgLsRsbLgLsbRcbRgbR
gbRsbRiRsmbRsbRibLsbsbsbRsbsbRsbRsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 6; Drug: OSU6162 10 然 Apo 50 然
bLsLibRobRjRcbLsbLcRcbRibRjRhbLsLjbRebLjbLcbRoRsmbRcbRcbLobLcbLcbLcbLs
LcbLcbRibRcbRcbRcRsmbRebLebRsbLsLsmbsbRcbLcbLebsbRcbRcbRsbRoRsmbLcRsbL
cLsmbRcbRiRsmbLsbLsbRibRibRibLsbRgbLsbRsRhbRiRsmbRibLsLsmbLsLsmbRobRsb
RhbRgRsmbRgRsmbRsbRsbRgbRibLsRibRibRcbRebRcRsmbRcbLjLcbLgbLsbLoLsLsmmb
LsLsmbLibLcbLsbLobRsbLobRhbRhbRgbRsbRsbRiRsmbLcLcbLhbLcLsmbLjbLcbLsbLo
bLibLhbLsbLibRgbRsbLsbRibRgbRgRsmbRjbRgRgbRgbRgbRgbLobLibLgbLgbLsbRcRs
mbRgRsmbRebRhLsbRcbRjbRgRsmbRgbLcbRsbRibRsLsbRibRsRjbRsRsmbRgRgLsRhRgb
RibsbRgRsmbRibLsbRsRgbRjbLcbsbLibLobLsbLgbLiLsbLibLgbLebLgLsbLibLsLsRs
LsLsmmbLhbLcbLgbLibRcbRsRibRiRsmbRibRobLhLsbLjbLcbLsLsmbLibLgLsbRsLgbL
obRsbRjbLcbLibLsbLibRcbRsbRhbRcLsbRsLsbRhbLsbRoRsmbRibRibRgbRiRsmbRibR
sLcbLibLgbLibLgRsbsbLhbRobRjbLhbLcbLiLsbLhbRsRsmbRiRsmbRgRsmbRcbRcbRsb
RcbRsbRibRibRibRsbLjRsbLibLibLhRsbRibLsbRcbRoLgLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 7; Drug: OSU6162 3 然 Apo 50 然
bLhbRiRjbRcRsmbLsbRiRsmbRibRobLsbLcLsmbRsRgRsRsmmbLoRsRsmbRsbsbLobRgRs
mbRsbLcbLcbRsbLgbLsbLibLibLsLsmbLsbLcbLhRsbRsLsbRsbLobLibRsbLobRsRsmbL
ibLcLsmbRsRsmbRcbLgbRsbsbLobLsRsbLibLsbLiLgbRsRsmbRgRgbLobLibRsRsLsmbL
sbLcLsmbLibRsbReLsbLobLibLibLcLsmbLsbRsbRibRcLsbLgbLobLgbLgbRsRsmbLoLs
mbLibLsbRibLobLibRsbLgbLhbLibLiLsLsmbLhRsbLsLsLsmmbLoRsLsbLsbRgbRsbRgb
RcbLhbRcbRgbRiLsbLsbLsRsbRsLibLobsbLhLsbRsLsbRgbLoRsbLibLcRsbRcbLsbLob
RsbLgbLsbLsbLgbLsLsLsLsmmmbLsbLsbLsbRcbLsbLibLgbRsbRcbRjbLeRsbLsLsRsmb
LgbLsRsbLjbLibLibLibLgbLsbLcbRsRsLsmbLiRsbRibRcbRibRgbRjbRibLsbLiRsbRc
bRibLsRsLsbRgbRsRsmbRibRsbRobRgbRibRibRgbRsRsmbRiLsbRsbRsbRsRsmbRgbsbR
sbRgbRsbRsbRsbRgbRsbRgRsmbRsRgbRsRsmbRgbRhbLsbLoRsbLcbLcLgbLibRgbLhbLs
bLgRsbLsLsmbLsLsmbLobRgbLibLibLibRsbRsLsbLibLibLhRsbRgbRgRsmbRgbLobLgL
sbLgRsbLgbLgbLiRsbRsLsbRhbRhbLsbRcbRhbLsbRsbRcbRsbRibRsLsbRebRgbRgbRsb
RgRsRgRgmbRsLsbRsbRsbRsbRgbLgbRibLgbRcLsbLibLhbLhbLgLgbLgbLobLibLgbLib
LgbLgbLsLsmbLgLsbLibRsbLcbLcLsmbLgbRsbRcbRiLsbLibRoLsbRsbRibRsbRgbRsRs
mbRgbRsbRobsbRiLsbRibRibRiLsbLsRsLsbRsbRgbRsLsbRsbRgbRgbsbRsRsmbRgbRsb
RsbLjbLibLibLgbLgbLgRsbRsbRsbLgbLiLibLibRgbRibLjbLsbLcbRsbLsbLgbLgbLsb
LgRsbRsbLibLiLiRsbLsbLsRsbRgLsbRcbRgLsbRibRibRsbRibRibRcbRgbLsbRobRsbR
eRsmbRgbRgbRgLsbRhb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 8; Drug: OSU6162 3 然 Apo 50 然
bRsbRsbRjbRibRibRibRsbRsbRobRsbRsbLsbRebRcbRjbRibRjbRhbRsbRjbRcbLobLob
RebRhbRjbRcbLsbRcbRjbRibRsbRibLsbRcbRsbRjbRhbRsbLgbLcbRsbRsbLebRsbLsbR
obRsbLsbLobRsbLcbLibLibRsbRgbRibRsbRibRsbRsbLjLsmbLobLgRsbRibRobLcbLob
RsbLsbLcbRibLobRsbRhbRcbLhbRobRjRsmbRibRsbRsRibRibsbLsbLgbLsLebLsbRibR
sbRobLsbRibLsbRsbRcbLsbReLsbRsbRsbRsbLhbLcbLgbLgbLsbLsbLsLsmbLgbLsbRob
RhbRgbLsbLebRcbRcbRsbRsbRgbLsbRibRibRiLsbLsbLcbLgbLibLoRsbRsbRcbRsRibL
sbRibLibLcbLiLsbRsbLhbLiRsbRibRsbLebRibsbRobLsbLgbRcbLgbRobRsRsmbLjbLi
RsbLhRsbLgbLgbLobRgbRibRebLsbLibLcLibRebLcbLibRgbLgbRcRcRsmbLsbRebsbLi
bLcLibLgRsbRsbLoRsRgbRgbRhbRsbLhbLcbLibLoLsmbLgbRcbRibReRsmbRsbLebLcLs
mbLgbRsLsbRsbLoLsmbRhbLcbRibRebRhLsbRgbsbRhRsmbRsReRsmbRibLibLgbRibLsb
LobLcLsmbLgbLgbLgbRsLibRgRsmbLcbLibRsbRjRsmbRcbLjbLhbLiLoRsRgbRiRsmbRe
bLsRiRsmbRibLsLsmbLibRoRsmbRsbLsbLibLhbRhbLgbLsLcbLgbLobRiRsmbRsbRjRsm
bRhbReb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 9; Drug: OSU6162 3 然 Apo 50 然
bRsbLobLcbRsbLobLcbRsbRgbRcbRcbRcbRsbRsbLcLsmbLcbRgbLhbLcbLsbLsbLcLsmb
LiLsbLhbLibLcbLsbLsbLiLsbRsLsbLsbRebRcRsmbRiLcLsLsmmbLibRgLsbLsbLibLsL
smbLsbLhbLcbLibRgbRibRsbLgbLsbRibLcbLibLsbLgbLgbLibLibRsbRoLsbLgbRobRi
RsmbRsRgbRibRsbRgRsmbRgbRgbLobLibLcbRgbRsLsLsmbRsbLcbLsbRcbRhbRhRsmbRh
RsmbLgbLiLsbLgbLsLgbRsRsmbRsLsbLsbLibLobLhbRibRsLsbRibLebLibLsbLgbRsLs
bRcbLjbLebLhRsbLgRgbRsRsmbLcbRcbLibRoRsLsmbRcbLhbRhRsmbRsbLsbLsbLcbLcb
LhbLiLsbLiLsRsbLjbLgLsbLobRgbLgLsLsmbLcbRcbLcbLcLsLimbLhbLcbLsbRsbLgbL
ibLsbLcbRsLiLsbLibLibLcbLobLsbLibRsbLebLgLsbLhbLcLsmbLiLsbLsbLebLibLcL
smbLhRsbLcbLsbRhbRhbRebRcbRsbRibLjLsLsmmbLcbRsbLjbLhbRgbLoLsmbLiLsbLgb
LsbLcbLcbRsbRsbLcbLgbLsRsbLibLsbLsbLcbRsLsbRsRsmbLcbLibRsbLgbLgbLcbRiL
sbRjbRhbRsbRibRibRhbRsbRcLsbRgbRibRgbRgbLcbRibsbLobLibRsbLsbRhbRjbRibR
cbLjLgbRcbRibRebRgbRcLsbRibRsbLibLobRsbRibLcbLibLsbLibLgbLsbRsbLgbLobR
sbRsbRibRgbRsbRobLgLsbRjRcbsbRebRcbRhbRibRsbRhRsmbRhbRiRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 10; Drug: OSU6162 3 然 Apo 50 然
bRibRoRsmbRobRiRsmbRibRibLebLgbRsLsbLcbLsbLsbLhLsbRibLobLsbLgbRcbsbsbs
bsbRcbRcbLsbLsRsLsbRsbRobRhbRibLsLsmbLibRiLsRsRsmbLibLoRsbLibLibLgbReb
RobRgbRcbRibRibLgbRibLobLibLcbLcbRibLibLibLibRgbLcbLcbLcbLibLjbRjbRibR
sbRibRgRsmbLibRcbRhbRgLsbRcbRibsbLsbRcbRjLsbRjLsbRhbLibLcLsmbLiRsbLhbL
ibLibLcbLibsbRcbRcbRibRjbRibLibLhbLhbRgbLcbLibLibLibLhbRsbsbsbRjbLcbLg
bLibLgbLhbRgbLibLibRsbLgbLhbLibLsbLibLgbLcbLsbLibLsLiLsbRibRibRsbsbRgR
sRsmmbRsbLgbsbLcbRcbRsbRsbsbsbRiRsmbLibLhbLibRsbLibLibRsbLibLibLiLsbLc
bRsbLibLgbLgbLiRsRsmbRibLcLibLgbLgRsbLsbLibLibLcbLiLsRsbLibRsbLibLibRj
RgbRcbRsLsbRibRiLsbLgbRibRcbLhRsbLsLsmbsbLhbsbRjbRcbRjbRcbRobRcbRibRsR
hLsbLgbRcbRiRsmbRgRgbRsbLhbRibRsbRjbRhRsRsmmbRibRebLsbRibLsbRhbRgbRiLs
bRjRiLsbRsbRgbRsRibRcbLsbRhbRibRiRsmbRgbRgbLjbLcbRcbRcbLjbLsbRcbRcbRib
RhbRgbLjbLcbLibLgbLsbLgLsLgLgbLibLsbLiLsbRcbReRgbRiRsmbRibRgbRgbRgbLsb
Lcb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 11; Drug: OSU6162 3 然 Apo 50 然
bLobLibRsLoLsmbRsbRsbRgbLsRobRgbRgbRsbLibLgbLgbLobRobRcRsmbLjbLcbLobRo
bLibLobLobLcbLhbLcbRcbRsbRobRobRebLsbRcbLsLcbRebRsbLobLsbRsbLobRsbLsbR
gbRebRsbRgbRjRgbRjRsmbRibLhbLjLsmbLsLsmbLcLsmbLsbRgbLobLsbRjbRcbRcbRgR
smbLcbRcbRgbRjbRibRcRsmbRiRsmbRgbRgbRsbRgbRibLsbsbLibRsRebRhbRibRgbLsb
RoLsbRgbRsbRcbRsbRsbRsbLobLsbLiRsLsbLsbLsLsmbLgbLibLsbRsbRsbRobRgbRsbR
iRsmbRgRsmbRsbRgRsmbRgbRobLiRsbLobRsbsbRibLcbRcbRgbLsbLgbLiLsLsmbLsbLg
bLgLsbLsbLibLsLsmbsbsbLgbLibLgbLgbRcbRcbLsbLoLsmbLibRcbRibRsRiRsLsmbRg
bRsRsmbRsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 12; Drug: OSU6162 3 然 Apo 50 然
bRibRgLsRsbRgbRgbRsRsmbRgbRsbsbRgRsmbRsbRgbRsbRgbRgRsLsmbRgbRgRoLgRsbR
ibRgbRgbRgRsmbRsbRgbRgbRgbRsLsbRgbRsbRsRcRsmbLsLsRgmbRibRgbRgbRgbRiLsb
LsbRsLsbRibRgbRgRsmbRsbRgbRgbRgbRgLsbRgbRgbRgbRgRsmbRgbRgbRgLsbLsbRgbL
sbRibLjbRibRibRibLsbLsbLsbRibRibLsRsbRcbRsLsbRgbRgbLibRhbRgbRgbLsbLgbR
ibRgbRgbLsbRcbRgbLsLsmbRibRibLsbRibLjbRibRoLsbRibsbRgbRjbRiLsbLjbRsLsb
sbsbRgbRgbRsRsmbRibRsRibRgbLcbLhLsRsbRsRsmbRsbsbLobLsbLhbLibLsLsLsmmbL
cLsLimbLgbLibRiRsmbRgbRsbRsbRsbRsRsmbRgbRgbRsbLsLsmbLcbRgbLiRsRsmbRgbR
hbRibLsbRiRsmbRgbLsbRgbLebLhbLibLsbRibLsbRibRsbLsLsmbRgbRhbRsbRgbLsLsm
bLcbLgRsbLcbLsbLsLsLsLsmmmbLibLsbLibLgLsbLgbLgbLgbLgbLsbLgbLsbLgLsbLgb
LhLsRgbLgbLiRsbLgLsbLibRsbRsbLsLsmbLsbLgLsbLsLgbLoRsbRgLsbRiLsbRsbRgbR
gbLcbLibLibRsbRsLsbLsbLgbLsbLgLsbLgbLgbLgbLsbLgbLgbLgbLsbLgbLgbLgbLsbL
ibLgbLiLsbLsLibLgbLgbLgbLgbLsLgbLsbLgRsbLgLsLibLibLgbLgbLgbLsLsmbLgbLg
bLgbLeLibLgbLgbLgLsLeLgLsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 13; Drug: OSU6162 1 然 Apo 50 然
bRcbRgRsmbRsbRcRsmbRgbLgbLsbRobRcbLsbRgLsbRibRsbRgbRsRsmbRiLsbRsRsmbLs
bRiRsmbRgbLsbRiLsbRhLsbLgbRcLsbLcbRoLsbLibRibRcbLcbRcbRcbLcbLjRsbLcLsm
bLibRcbRcbRjLsbRcbLibLsbRcbRhbLibRibRcbLsbRsRcbLjbRobLsbRcbLjbRcbLjbRh
bRcbLhbRcRsmbRhbRoLsbLcbLcbLjbLcRsbLhbLibRgbRcbRiLsbRsLsbLgbRoLsLsmbLg
bRsbLjbLoLsmbRsLsbLsbLsbRobRcbLsLsmbLibLcbLibLsbLoRsbLsbRsbRcbLcbLebLg
LsbLsRsbLibLiRsbLsbLgbRcbRsbRcRsmbLgLsbLcbLsbLibLsbLiRsbRsbLibLibLsbRo
RsmbLebLibLibRgRjbRcRsmbRiRsmbRsbsbLobLibLsbLibLibLsLsmbLsRsbLsbLsLhbL
ibLhbLgbRsLsbRgbLibLgbLgLsbLoLsRembLsLsmbRgbRgbRiRsLsmbRsbRhRibRgbLhLs
bRgbRebRsbLcbLiLsbRsbLibLsbLgLsbLgbLgbLhRsbLcLsmbRgRsmbLgbLibLibLsbLgL
sbRibLiLsbLcRsbLsbRjbLsRibLobLgLsbLsLsLsmmbLgbLsbLibLiRsbLoLsmbRcbRibR
ibRcRsmbRsbLsRiLsbLgbRsbLobLiLsbLcLsRsmbRgbRhbRsbRcRsmbRcbLjbLsbRhRsmb
LgbRcbLibRibLcLsLimbRsLiLsbLibLgbRibRcbRibRgbRhbRibRibRhLsRsbRgbRibRcL
sbLgbRsbLiLsbLiRsbLsRsbLibRsbRebRibRgbRiRgbRgRsmbRgbRgbRsbRgLsbLsLjRsb
LobLsbLcbLibLhbLcbLgbLiLsRsbLoLsRsRsRsRsmmmmbLcLsmbRobRcRgbRsbLgbLjbLs
LsLsmmbRsbRebRhLsRsbRcbRsbRgbRjbRcbRcbRgbRebRsRsmbsbRibRgbRibRibRsbRiR
sLsmbRibLsbRsbLebLhbLibLiRsbLsbRcRsmbLsbRgRjbLcbLgbLcbLjbLebLgbLobLsbL
eLsbLgbLgbLsbLgbLibRsbRsRsmbLibRgbLcLsmbRebRcbLcbLibLsLsLsLsmmmbLcbLgR
sRgbRhbRgbRoLsbLsbRjbLeLsbRhb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 14; Drug: OSU6162 1 然 Apo 50 然
bLsRobLjbLsLoRsbLiRsLsbRsbLoLsmbRgbRgbLobRsbLibLibRsbRsbLoLsmbLjLgbLiL
sLsmbRsbLebRsbRsbRsbRoRsmbRcbRobLgbsbsbsbLjbLcbRoRsmbRoLsbRsbsbRsbRsbR
cbLhbLebLobLsbsbLsRoRsmbRoRsLsRsmbRgbRgbRsbRsbRsbLsRsbRsbRsRgbRsbRgLsb
LsRsRsmbRhRsRsRsmmmbLibRjLsbRibLsRsbRsbLgRsbRcRsmbRgbRibsbLjbLjbLhbRob
RcbRiRsmbRsbLgbLcbLsbLsLsmbLcbLsbLobRgRsRsmmbLsLoLsmbLgbRsLcbRsbLsbLgL
sbLiRsbLgbRsbRgbLsbLgbLgbLsbLsbLsbLsLsmbLsRsLsbLsbRsbLsbLgbLiLsbRsbRib
RgRsmbLsbLsbsbRsbRgbRsbRsbRsbRsbRsRsmbRsbRsbRsLsbRsLsbRgbRgbRcbLgbLgbR
obLsRsbLhbLgbLjbRsbLoLsmbRibRhbRgbRgbRibRgbRgRsmbRjLsbRgbLsbRgbRibRgRs
mbRhbLsRsbLsbRibRibRcRsRsmmbRsRsRsmmbLibLcbLobRsbRjRsmbRsbRgbRsRsmbRgb
LsbRsbRsbRibRibRiRsLsmbRsLsbLibLiLsbLsbLsRsLsbRobRsbRibRsRsmbRsbRsbRsR
sLsmbRgbRsLsbRsbRsbRgbLsbRibRhRsmbRcbLibLsbRobRjLsbLsRgbRsbRsRsmbRhbRs
bLgbLsbRoLsbLsRsbRsLsbRsbLcbLiLsbLibLibLgLsbRgbRjbRibRhbRibRsbLsRsbLjb
LgLsbLsLsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 15; Drug: OSU6162 1 然 Apo 50 然
bLibLhbRsbRibLhbLjbLjbLjbRibRibRibRibRibRsLsbRsbLsbLeLsbLsbRibRsbRibLs
LsmbRibRsbRibLsRsbRibRsbRgbLsbLsbRsRsmbRibLsbRgbRgbRsbRsbRsbRsbRgbRsbR
sbRibRgbRsbRsbRgRsmbRibLsbLsbLsbRgbRibRgRsmbRsbRibLgbRsbLcbLebsbLgbLib
LsbLobLsbLcLsmbRsbLibsbLhbLiLsbRgbLgbLgLsbLsbLcbLsLsmbLiLsbLgbRsbRiRsm
bLibLgbLibRobRcbRibLsbRibLsbLjbLcbLsbRobRgbRgbRjbRcbLsbLgbLibLibLsbLcb
RibLsbLcRsbLsLsLsLimmbLgbLiLsbLsbLgbLgbLsbLgLsLsmbRsbsbLsbLgbLgbRsRsmb
LsbsbLgbsbLsbRsbLjbLibLsbLibLsbLgLsbLsbLsbLiRsbLcbLiLsbRjbLcbLsbRibRsb
RgbsbLsbRjbRjbRsbRibRjbRsbRgbRsRsmbRsbRgbLsbRibLcLsmbLsbRhbRgbRibRsRgb
RiRsRgRsmmbRgLsbRibRcRsLsmbLhRsbLibRsbLgbRsLiLsbLibsbsbLhbLsbLsbLiLsLg
bLgbLgLsbLibLsbLcbLgLsbLgbsbLsbLgbLsbLsbLeLsbLibRgbLiLsbLobRgbRibLsbLj
bLibLibLsbLiLsLsRsLsmbLgbLibLgLsbLgbLibLeLsbReRiRiRsRsmmbRgbRgbRsLsbRs
RsmbRgbsbLsbRsRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 16; Drug: OSU6162 1 然 Apo 50 然
bLebLgbLjbLjbRhbLibLcLsmbLibLibRcbRcbRobLgbLjbLobRhbLjbRibLiLsbLjbLjbL
sbRibLobLhbLsbLibLebRibLsbRcbLsbRebRcbLjbRibLcbRjbLsbRgbLgbLjbRobsbLgb
RebRgbRgbRgRsmbRiRsmbRobLsbRcbRsbRebRcRsmbRebRsbRebLcLsmbLsRsbLhbLiLsb
RibRsbRhbRiLsbLsRsbLjbLebRsbLhbLsbLcbRsbLibRsbRsRcRsRsRsmmmbLsbLibRebR
iLsbRibRhRsmbRibLoLsmbLgbLobLsbLebLoLsmbRsbLsbLobLobRsbRgbRhLsbLgLsbRe
bLsbLsRsLsbRsbRhRsmbLgbRobRcbRgLsbRsbRibRgbLgbLibLobRsbRgbRebRsbRgbLsb
LobLsbLjbLsbLibRebRsbRibRsbLsbLjbLsbLgbLsbLibLibLobLsbLsbLcbRsbLgbLibL
iLsbRhbRibRgbRgbRobLgbLibRsbLobsbLibRiRsmbRibRhbLibRcbRgLsbRgbRoLsbRgb
RhbRgRsRgmbRsbRsRsmbRgLsbLgbsbLjbLhLsbLgbLgLsbRjbsbRhbRebRcbRcbLcbsbRj
bRcbRsLsbRibRibRgbsbRgbRsRobLsbLiLsbLgbLgbLiRsbLibLoRsbLgbLobLcLsmbRsb
RcbRgLsbRobLsbLibLiLgLsbLibLibLcbRsbLcLsmbLiLiLsLsmbLgbLibLibLsbLiRsLs
bLibLebLhbLiRsbLibLobRiRsmbRibRibRiLsbRibRcbLgbLoLsmbLgbLobRgbRibRebRg
RsmbRcbRibRibRibRibRibRibRgbRsbLjbLibLgbLibLsLgbLgbLobRibRiLsbRibLgbLg
bRobRsbLiRsLsLhbLhbLoRsLsbLjLibRiRsmbRibRhbRibReRibRgbRibRibRibRibLsbR
ibRcLsbLsbRcbRgbRibReb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 17; Drug: OSU6162 1 然 Apo 50 然
bRgbRcLsbLgLsLsmbRsbRebRgbsbLsbRibRsRsmbLsbLsbRiRsmbRibLibRiRsmbRibLib
LobLgbLsbLgbRjbRiLsbRibLsbRibLsbRobRiLsbLgRsLsbRjbLcbRsbRhRsRsLsmmbLcb
LibLibLhbRsbLibLjbLibRibReRibLgLsbLibRsbLgbLgLsbLgbLgbLibLiLsbRsbRsbRc
bsbRhbRsbLcbRjbRibRsRsmbRsbRibRsbLsRsbRsbRgRsmbRibRiLsbLibRjbRibLgbRgR
smbRgbRhbLsbLgRsbLibsbsbRoRsmbRibRsbRgbRibRiRsmbRhLsbLsbLsbRjbRsRibRib
RcbLsbLhbRibLsbLcLsmbLsbRjbRcRsmbRebRsbLiLsbRcbRcLsbLsbRibLibLobLibLib
ReRsmbRebRgbsbReRsmbRhRsmbRgRsmbRgbRgRsmbRgbLgbRgbLcbRebRiLsbLsbRsbRiR
smbRsbLsbRgbRsRsmbRiRsmbsbRsbsbsbRiRsmbRgbRsbRgbRsRsRimbLsbRgbRibLsLsm
bRibLsbRgRsmbRsbRgRibLsbRcbRibLsbRibRsbRsbRgLsbRsbRsbRibRiRsmbLgRsbRcb
LsbRgLsbsbRgRsmbRcRsmbRgLsbReRsmbRgbRsRsmbRgLsbRsbRibRgbRiRsmbRiRsmbsb
RgbRsRsmbRgbRiLsbRhbRiRsmbRebRib

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 18; Drug: OSU6162 1 然 Apo 50 然
bLobRgbLoLsmbRcbRhbRhbRibRcbRhbRobRsRcbRhbRobLibRsLoLsmbRcbRhbRcbRcbRo
bLobLhbLobRobRobRobRobRcbRobRobRcLsRsbLcbLcbLobLcbLobLsbLobLobLobRsbLo
bRobRjbRhbRobRsRobRcbRsbRibRcbRiLsLsmbLcbLcbRsbLcbLsbRobRiRsmbLsLsmbRo
bRibRgbRgRsRgReRgmbRgbRgbRsRsmbRoRsmbLibRsbLsbRgbLobRgbLibLoLsmbLibLib
LibRobLsRsbRgbRsbRjLsbRobLsLgbRoLsbRgbLobLibLcbRsbLobRsbLoLsmbLsbLsLsm
bLobLcbLcbLsbLhbLsbLobRsbRobRhbLsbRebRibRgbRcLsbLhbLjbRcbRgRsRsmmbRebL
obRgbRobRobLsbRibRobLsbLgbLibRobRibRsbRobLsbRcbLiLiRsbLgLsLsmbLsbLeLsb
LhRsbLsLcLsmbLhbsbLibLcbLcLsmbsbLgLsbLsbRobRiLsRsbRsbRobLsbRjbRobRsbRo
bRsbRoLsbRgbRoRsmbsbLsbLobLibLcbLsRsbLjbLoRsbLcbLcbsbLcbLibLgbLgbLcLsm
bLsbLobRsbLcLsmbRcbRsbRobLsbLgbLcbLhbLsbRoRsmbRsbRgbRobLsbRib

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 19; Drug: Control Apo 50 然
bRgbRsbRsbsbRsRsLsmbRcRibRsbsbLobLobRcbRcbLgbRcbRiLsbRjRibRibRibLiLsbL
sLsLsmmbLsbsbRcbRibRcbRcbLibLgLsbLhLsLiRsbRibRsbLobLibRsbRjbRhbLgbRibR
sbRsRsmbRoRsmbRibRsbRibRgbLsbRsbRgbRsRoLsbRiRsmbRcbRibRsRgRsmbRcbRgbRs
bRjbRgbRibLjbRibRgRsmbRgbRgbRgbRsbRobRibRsRsmbRhRsmbRhbLobLibLsLsLsmmb
LibRebRibRsRsmbRsbRobRiLsbRibRgLsbRsbRsRsmbRgbRsbRgRsRsmmbRgbRgbRgRsmb
RgLsbLobLhbLgbLibLsbLsLgLsbLsLsmbLsLsmbLgbLsbLoLsmbLcbRibRcbRibRibsbLg
bsbLibRhLsbLhbRcbRgRsmbRcRsLsmbRcbRibLsbRcbRcbLsbRgbRcLsbRibLsRsbRibRg
LsbRsbRgbRgbRsbRgbRsbLoLsmbLibRsbRjbRcRhLsbLsRsRsmbLibRhbLsbRiRsRgmbRs
RsmbRibRcbRiRibRgbRgbRibRgRsRsmmbRgbsbRgbRibLcRsbLcLiRgbLgbLiLsbRjRibL
cbLgbLsLsmbLsbLsbRsbLsRsbLgbLoLsLsmmbLsbRibRcbLcbLsbRcbRcRgLsRibRcbReb
LibRcbRibRcbRcbRcRsmbRgbRgbRgRsmbRebRibRgbLobLiRsbLiLsRsbRsbLgbsbLibRi
RsmbRcRsmbRsLcbLiLsbLibRsLsbLibLgbRsbRgRcbRebLjLsLsmmbsbRcbRcRibRsbRcb
LsLjbRsbRibReRsmbLsbRsbRgRsmbLcLsLhmbRsLsbLibLibLgRsbRcRsmbRgRsmbRgbLs
bRiRgbLsLsmbRjbRibRcRiLgbLiLsLsmbLgLsbLgbRjRhRgbLsRsbRcbLhbRibRcbRiRsm
bRiRibRgRsmbRgbReRsmbRgbLoRsbLcbLcbLobRgbRiRsmbRgbLobLgLsbLgbLsbLgLsbL
gbLsbRcRsmbRcRiRsmbRsbRsbRcbsbLsbRcbRibLsbLgbLcbLgbRcbRibRibRibRgbRgbR
sbRiLsbRcbRcbRebRgbRgbRgRsRsmmbRgRsmbLsbRgRjbRiRebReRsmbLsRibLcbLcbRcR
cRsmbRibLsbRcbRibRsbRcLgbRibRgbRcbRcbRcbLsRsbLgLsbLjbsbRgbRsbLsbLcbLiL
sbLibRhbRsbRiRsmbRiRgbLsbRhbLsbRibRcRiLsbLgbLibRjbReRiRibRgbRhbLibLcbL
gbLgRsbRgbLiLsbLgbLgLsLsmbLsbLjRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 20; Drug: Control Apo 50 然
bLsbReRsmbRcbRgbRibRgbLsRsbLsRcRsmbLsRsbsbsbLcbLcbLsLsmbLibLibRsbRibRg
bRgbRhLsbLgbLgbRcbRcbRsRsmbLibLsbLjbLsbRibRibRgbLibRibRcLsbLgbLsbLsbRh
bRcbRgbLsbLibLgbRsbLsbLsbLgbLibRhbRobRjbRgbRsbRibLsbRsbRibLsbRsbLsRsbR
hbRcbLsbRibLibRobRjbRibRibRibRebRjRsRsmmbRiRsmbLsbRgbRsbRgbRgbLsbRsbRo
RsmbLiLsbLgbLgbLgbRjbRiLsRsbRsbRoLsRsRsmbRsRsmbRhbRcRsmbRsRsmbLsbRcbLi
bRgbLcLsmbLibLsLsmbLgLgbLsbLgRsbLgbRsbLsbLsbLgbLcbRoRsRgmbRebRhbLcbLib
RgbRhbRibRsbRibLsbRsbLgbLibLsbRsLcbLcbRjbRjLsbRsRiRsLsLsmmbLsRsbRebRiR
smbRsbsbLgbRcbRjbRibLsbRcbLcbLjbRcbRgRjbLibLcLgbLgbRiLsbRibLjbLjbRcbsb
sbLcbRjbRgRsmbRgbRgbRjbLsRsbLsRsbRsbLcbLibLgLgbsbLcbRcbRcbRgbLcbLibLib
LsbLsRsbLcbLgLsLebLsbLcLibLgbLibLgLsbRsbLgLsRsbsbRjbRcbRgbRibRoRsRsmmb
RhbLsbLibLsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 21; Drug: Control Apo 50 然
bRgbLjLsmbLcLsLiLsmbLsbLiLsLsmbLsbLgRsbReRsmbRsbLjbLgbRobReLgbLsbRhbRo
bRibRebRiRsmbRhbRsbRsLsbRsRsmbRgbLsbRoRsmbRhbRiRsmbRibLgbRibRsbRgbRsbR
sbRsRsLsmbRhRcLsRhbLhbLsbLgbLjbLsbLsbLhRsbRsbRcRsmbRcbRibRsbLsbRgbRibR
cbRibRebRgRsmbRgbRsbRsbRgbRibRcbRgRsmbRhbRgbLgLsbLcbLobLoLsmbLgbRebReb
RsbRgbRsbLsRcbLgbRoRgbLgLsbRiRsmbRgReRebRsbRibRoLsbRsLibLgbRsbLibRsLsb
RcbRcbRhbRsbLibLgbLibLibRibRcbRiRsmbLcbRcbLobLcbLgbLibRibRcbRibRsbRoLs
bRsbRcbLsbRibRibRsbRcbRgLsbLsbRcbRgbRsbRcbRgbLgbLibLgbLgbLgbLsbLcbLsbL
sLcbLibLjLsmbLjLibLibLgbsbLibsbRobRcRsmbLsbRcbRiRsmbRcbLsRebRsbRibRgbR
cRcbLiLiRsLsbLibRsbLibRcbRibRgbLgbRobRsRsmbRibRcRsLsmbRsLsbLjbLibLhbLg
bRhbRcbRiLsRsbLsbLsbLcbLcLsmbsbLcbLibLjbLiRsbLobLgbLgbLebLhbLsbRsLobRs
bRoRsRsLsmmbRgbRcbRcbRsbLobLibLiLsbLibLibRsbLsLsLsmmbRjbsbLibLcRsbRibL
jbRcbRibRibRobRhbRibRibRibReRcbRhbRiRsmbRiRsLsmbRgLsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 22; Drug: Control Apo 50 然
bRjbRibLsLsmbRoLsbRobLebLobRjbRiRsmbLsLsRsmbRcbRcLsbRibLobLobLcbRcbRhL
sbRibRibLsbRibRcbRibRiLsbLobLcbRjbRcbRhbLsbRobLsbLsbLgLsLsmbRjbRibRgRs
mbRgbLsRsLsbRsRsmbRgbRsbRgLsbRsbLsRjbRjbsbRhbRcbRobRcRsRsmmbRibRcbRibR
ibRobLsbLobRobReRsmbRcbLsbRcbLgbLjbLoLsLgRsmbLsbLibLgbRcbRiRjbRsbRjbLg
bRgbRgRsmbRiRsmbsbRhbLcbRcbLhLsbRcbLsbLiLsLsmbRhbRcLsbLcbLcbLhbsbRsbRc
bRibLcbRcbsbsbLcLobRebRgbRcRsmbLsRsLsbRiLsRsbRgbRjLsbRiLsLsmbLsbRcb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 23; Drug: Control Apo 50 然
bLsbLibLsRsbLsbLibLsLsmbLibRsbRsbLsbLsbRobRsbLebLibLsRjbLsbRobRsRsmbRc
bLsRsbRibRcbLsbRsRsmbRgbRgbLgbRibLsbRobLsbLiLsbLibLsbRiRsmbLsbRcbRgbRi
bRcbLgRsbLibLgbLhLsbLcbLgbRsbRibRcbLsbRsbRcbLsbLiLsbRibLjbRcbLsbLibLcb
LibLsbRsbLgbLobLsbLsbLobRsbLsbLibRcbRibRsLsbRiRsRsmmbLsRsbRsbRibLsbRgb
RibLgbLibLibRebRgbRsbLcbLebLsbLgbRjbRcRsmbRiLsbRsbRsbLcbLgbLibLgbLcbLs
bRgbLsbLhbLsbRgbLoLsmbRsbRgbLcbLibLgbRibLsbLibLsbLcbRsbLsbLobLsbRcRsmb
RsbRcbRsbRiLsbLgRsbLcbLibLsbLsbRsbLibLibLsbLhbsbLsRsbLsLsmbRibRibRibRi
bLsLsmbRsbRibLsbLsbRibRsbLcbsbLhbLsbLibRsbRcbRiRsmbRsbRiRsmbLgbRgbsbRh
RsmbRsRsmbRobLsbRsLsbLgbLibLsbLibLsbRcbRibRibLsbLebLibLgbLiLsbRsLsbLjb
LibLjbLsbLjbRjbLjbRcbLjbRjbLjbLhbLsbLsLsmbLsbLgbLibLcbRsbRibLgbLibsb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 24; Drug: Control Apo 50 然
bRcbRibLgbLobLgbLsbLgbLsbLgbLgbLsbLhbRsbLibRgbRsbRiRsmbRgbRgbLgbLebLhb
LsbLsbLsbLibRsbRcbRibRibRibRgbLsbLoRsbLsRsbLgbLcbLsbLgbLibRsbRgbLibRgR
smbLobLsbRsbLibLibLibLsbRjbRibRobRgRsmbRgbLsbLsbRobLsbRibRibRsbRcLsbLs
bRhbRsbLsLgbLcbLsRsbLibLsbLibLsbRsbLjLsmbRebRjbLsbRiLsbRgbRcbRsbLibLib
RsbLibRgRsmbRibRgbRsbRgbRsbRgbRsLsbRcLsRsbLsbLcbLgbRebRhbRsbRjLsbRsbRg
bRibRgRsLsLsmmbRsbRjRibsbRcbRibRgbRgbLjbLhbLibLgbRsbRjbLsbRcbLjbRgbRhb
RsbLsbRhbRiRsmbRgbRsbRibLsRibRgbRgbsbRsbLobsbLgbLhLsbRcbLeLsbLgbLsbLsb
RcbRgbRiRsmbRgbsbsbLsbsbsbLcbLhLsbLsbRsbRobRibRgbRgRibRgbRgbRgRsmbRibR
gbRgbRsbLjbLebLibLiLsbLgbLgbLcbLsbRsbLjbRjbRgbRibRsbRhbLgbLhbLgRsbLibL
gbLibLgbRsLgbLsLibRobLeLsbLcRsbLibLibLiLsbLgbLibLgbLob

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 25; Drug: OSU6162 10 然 Apo 50 然
bRobRobLgbsbRibLebLibRjbLobLibRsLsbLsRsbLibRcbLjbRcLsbRcbRcbRcbRjbRjRs
mbRibRcbLibLcbLibLobRjRsRsmmbRhbLhbRjbRcbRcbRhbRhbLcbRcbRcbRiLsbLsbLsb
sbLsbLsLsmbLsbsbLsbRsbRgbLjbLsbRibRsLgbLsbsbRjbsbLibsbsbsbRjbsbLsbLgbR
ibRibLsLsLombLgbsbRgLsbRsbsbLsbRsLsbsbsbLsbLgbsbRsbRjbRhbsbLsLsmbsbsbs
bsbRhbsbRsRhbRgbRsLsbLgRsbLgbLgbLcbRgbLibRcbLjbsbRcbRjRgbRiLsbLibLgRsb
RjRsRsmmbLsbLsbsbRsRsmbRebRjRsmbRgbRsbLcLsmbsbRjbRjbRsbRibRibsbRsbRibR
ibLsLsmbRoLsbLcLsmbRcbRiLsLsmbRgbRibRibLsbLiLsLsmbRoLsbLgLsbRcRsmbLcbL
jbLibLibLsbRgbLsbLsbRsbLcRsbLgbLiRsbRgbRcbRgLsbRibRgbsbLsbRgbLsbRgbRgb
RiLsLsmbRgLsbsbRiRsmbLsbRsbRsbRcb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 26; Drug: OSU6162 10 然 Apo 50 然
bRsbRsbRibRcLsbLibRgbRgbLsbRsbRobRibRsbLgbLobLgbRibRgbRibRebRibRhbLsbL
ibRibLiLsbLjbLobRgbRjbLibLobRibLoLsRsLsmbLobRebLobRebLjbLcbLcbLibRhbRc
RsmbLjbLjbLcbLsbRjbLibRoLsbRhbRcbsbLgbLsbRsRsmbRjRsmbRibLebLibsbRjRebR
hRsLsmbLsbLebRcRsmbLcLsmbLcLsmbRebReRsmbRgRsmbRgbRgLsRsbRsbsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 27; Drug: OSU6162 10 然 Apo 50 然
bsbLibsbRsbRjbRibRgRsmbRgLjbRgbLobLgLsLsmbLibRgbLsbLgbLgbLgbLsRsbLgbRs
LsRsbLobRsbRsbLhbRcRsmbRgbLgbRcbLgbLiLsbRjRsmbLsbRcbRhbRebRsbLhLsbRibR
obRiRsmbRiRsmbRsbLsbLcbLcLsRsmbRsLsbRibRsbLgbRobRibRsbRiRsmbRgRsmbRsbR
sRsmbRgbRibRibLsbRcbRhRsmbLhbLgLsbRobLsRibRsbLsbRsRhbRgbRsbLsbRsbRibRi
bRibLsbLcbLibLibRibRsbRsRsmbLsRoRsmbLibLcLsmbsbLibLgbsbLgbLgbRgbRibRcb
RiRsmbRjRsmbRcbRsbRjbRcbLhbLibLsRsbLsbLgbLsLsmbLsbLsbLcRsbRgbLgbLgbLsb
RcbRibRibRsbLsbLhbLgbLsbRsbLibLsbLsbLgbLobRgbRgLsbLsbLibLhbLsbLgLsbLgb
LgbLsbLgbLsbLibLibRsbRsbLsbLobLsbLibLsbLgbRcLsRsbsbsbsbsbsbsbLsbLsLsmb
LgbRcRsmbLibLcLsRsmbLibRsbLgbLgRsbLsbLibLibRsbLibLsbLiLsbLgbLiLgbLiLsL
gbLgbLgbLgLsbLgLsbLgbsbLgbLsbLgLsbLsbLsbLsbLgbLebRsbRgbRgbRgbRibRsbRgb
RgRsmbRgbRsRsmbRsRsmbRgbRsbLsbLcbLibLgLsbLgbLgLsbLgbLgbRsbsbLsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 28; Drug: OSU6162 10 然 Apo 50 然
bLsbLoLsmbRsbRgbLsbLcLsmbRsbLcLsmbRsbRsbLsbLcbRsbRsbRsbLobRibRobRsbLgb
RibReLsbLgbLsbLsbLibLsbLgbLgbLsbLgbLsbLobLsbRgbRibRsbRibRsRsmbRgbRgbRs
bRgLsbRibLibLgbLsLsmbRebRibLsbLibLcbLsbLsRsbRsbLhbRsLsbLcLsmbLsLsmbLcL
smbRgbRibLsRsbRiRsmbLsbRsLsbRgbRibLsbRibRgRsmbRgLsbRsRibLgbRsbRhbLjbRi
bRsbLobRcbRsbRgRsmbRsbRgbLoLsmbRsLsbRgbLcbRgbLsbLobLcbRsbRsbLsbRcRhLgL
gbLsLsmbLibsbLcbLsbLsbLjLsmbLcbRhLsbLhRsLsbRgRsmbsbLcbsbRiLsbLhLsbRsbL
hbLibLsLsmbRgbLibLibLhLsbLgbLibLsbLibLsbLgbLsbLsbLgbLcbRsbRsbLsbLcbLsb
LsbLhbLgLsRsLibLsbLgbRsbLcbLsbLsbLibRsbLibLsbRsbLcbRsbRcbRobLsbLsRsbLj
bLcbLsbLsbLgbRiRoRsmbRiRsmbLgbLsbLcbLgbLibLsbRgbRebLsbRhbLobLcbLcbsbLs
bRgLsRcRsmbLgbRcbRsbRiLsbRsRsmbRcbRgbRsbLgbLibLcRsbLsLsmbLsbLcbLiLsbRg
bLgbLcbRcbRcbRsbRsbRoRsLsmbLibLgbLsbLobLhbLgbRsbLsbRgbRobLsbRsbRobsbLs
bRsRsmbLcbLibLcbRcbRibRhLsbLebLcbRgbRibRhbLiRsbLobLgLsbLibLgbLcRsbLsRs
LsbLsLibLibRibLcbRgbLcbLgbRsbLibLibRgbRebRjbRsLsbLcLsmbLsLiLsbLgbRsRsm
bRsbLsbLiLsbLsRsbLsbRcbRsbRibRgLsLsmbLcLsmbLiLsbRsbLcbRgRsmbLsbLibLhbL
gbRgRsmbRsRibRsbRsRsRsmmbRjbRsbLsbRsbRsbRsRgbRibLgLsbRsbRhbLjbRoLsbReb
LsbLsbLhbLcbLcbLgbsbRgbRcbLsbRsbRjbLsbLsLsmbsbRibRgRsmbRsbLobLibLsbLib
LsbLsbLgRsbLgbLsbLgbLsbLgbLgbLsbLsbLcbLsLsmbLiRsbRsbLoLsmbLsLsLsmmbLcb
LibRsRsRsmmbRgbsbLcbRgbLobRgbLcbLcbRgbRibRcbRgbRjbRsRsmbsbLobRsbLsbLhb
LiRsbLsRsLsbLgbRcbRibRsbRgbRgbRsbRgbRgbRsbRgRsLsmbRsRsmbRsbRgbRsbRsRiR
iLsbLsbLhbLiRgbLsLsmbLsbLsbLsbRsLsbRsbLsbLibLsbRsbLhLsbLibRgbLcbRebsb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 29; Drug: OSU6162 10 然 Apo 50 然
bRobRjRsmbRibRsbRsbLsbRibRsbRhbRiRsmbRgbRgbRsbRsbRsbRsbRgbRgbRhbRsbLsb
RhbLgbLgRibRcbRibRgbRibRsbRsRsmbRsbRcbRibRgbRcbRsbRgbRsbRsbRsbRgbRsbRh
bRsbRibRgbRhbRsbRsbRgbLsbLsbRibRibRibRsbRgbLgbLgbLcbLobRsbRsbRsbRsbLsb
RibRgbRgRsmbRibRsbRcbRsbRsbRsbLsbRgbRibRsbRsbLsbLhbRibRgbRgbRgbRsbRsbR
sbRsRsmbRgbRsbRgbLsbRibLcbRobLsbRsbLibLobLhbRsbRgbRgbRibRsbRibRibLgbRs
bRsbRsbLsbRobRsbLgbRsbRsRsmbRgbRsbRgLsbRsbRgbRgRsmbRgRsmbRgbRgbRsbRgbR
sbRsbRgbLgbRsbLhbsbRoRcbRsbRsLsbRsbRiLsbRsbRgbLsLgbLsbLhRsLiLhRoLsbRcb
LsbsbRcbLsbRcbRgbRsbLsbRsbLsbLsbRcbRsbRibRibRsbLsbRsbRibRhbRsbLsbRsbRh
bLsbRgbRgbRsRgbRibLsbLsbRibLgbLsbRoRsmbRibsbLsbLsbLgbsbRgbLgbLibLsbRsb
RcbRiLsbRsbRgbRibRsbRgbRsbRobRcbRsLsbRsbRibRibRibLsbRsbRhbRsbRhbLsbRsb
RgbRsbRibRgbRibRsbRgbLibLobLibLsbRsbLibLgbLgbRgbRhbRibRibRgbRibReLsbLs
bRsbRsbLcbLibLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 30; Drug: OSU6162 10 然 Apo 50 然
bLgLsbLsbRibRobLgbLsbsbLebLgLsbLiLsbLgbLgbLobLsLsmbLcbLcbLsbLcbRcLsbRc
bLsbRiLsbRibRsbLoLsmbLibLiLsRsbsbLgbLibLsLsmbLsbLsbRjbRebRcbRhRsmbsbRo
bRobLhbLcbLibLiLsbLibLibLcbLsbLiRsbLibLhbLiLsbLcbLcbLcRsbLibLhbLhbLhbL
hbLibLjLsmbLibLibLhbLsbLiRsbLobLcbLcLsmbLsLsmbLcLsmbLibLhRsbRsbsbLcbLc
LsmbLhbLhbLcLsmbLcLsRsRsmmbLsbLsRsbLcRsbLgbLcLsmbsbLcbLcRsbRsRjbRhbLib
LhbRsLgbLibLgbLibLhbLibLsbRobRibRiRsmbLibLhbLibLiRsbRgbRhbRibRiRsmbRcb
RibLcRsbLhLsbLgLsbsbLobLgLsbLobRgbRhRsLsRsmbRiRsmbRgbRibRiRsmbRiRsmbRo
bRobLsbRgbRjRsmbRiLsRibLgLsRsbRobRibRgbRobLibLibLgRsbLgbLgbLsbLgbLgLsb
Lsb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 31; Drug: OSU6162 3 然 Apo 50 然
bRobRiLsbRobRjbRiRsmbLobLcbLsRsbRcbRibRibRobRjbRcbRcLsbRcbLobLsbLjbRgb
RsbRhbLsbLobLjbLibLsbLibLcbLiLsbRsRsmbRgbRobRjbRibLsbLibLsLsmbLobLcbRj
bRobLhbRcbRobLhbLcbLibLcbLgbLibLcbLibRcLsLsmbRhbLcbLibLibRcbRjbRibLsbR
ibRobLsLsmbRobRgRsmbRsbRibRcbLsbLobRsbLsbRsbLobLgbLibLiRsbLsbLgLsbLobR
sbLobRjbRjbLsbRebLgbLhbRsLsbRibRcbRhbRcbLcbLibLhbLsbRobRgbRsbRcbRgbRob
RhbRibRibLsLsmbRebLsbRebRgbRgRsmbRsbRgRsRgLsmbLcbLobLibRsbRsRsmbRhbRhR
sRsRgmmbRibRjLsbLcbLcLsLsmmbLobLgbLibLhbLhbLgbLobLgbRcRsmbRiRgbRibRgRs
mbRgRsmbRsbRhLsbLeLsbLibLcbLcbLobLhbLibLcbLsbLoLsmbLgbLcbLibLhLsbLebLe
bLibLoLsLgmbRobRgbLsLhLsbLiLsbLgbRcbsbLebLcbRcRsmbRibRsRibRibLsbRcbRsb
RiLsbRibRebRgbRcRsmbRhbRibRcbRibRebRcRsmbLsbsbsbRsbLcbLebRgRibRhbRgbRi
RsmbRebRebRgLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 32; Drug: OSU6162 3 然 Apo 50 然
bLhbLcLsmbLsbRgbRgbLobRcbLsbLsLibRsbRsbLgLsbLgbRobRibRgLsbRgbRgbRgRsmb
RgbRgbRgbRoRsRsmmbRhbRcbRiRsRsRgmmbRgbRgbRgbRsbRsbRgLsbRgbRgbRsbRcbRgL
sLsRsmbRhbRgbRobLsbRebRiRsmbRsbLoLsmbLobsbLcLsmbRibRhbRjbRcbRcbsbRcbRg
bRibRiLsbRgbLsbsbLebLcbLcRsbLhbRibRcbRhbReRsmbRjRsmbLcbLiLsbsbRsbLcbLc
bLcbLoLsLsmmbLcbLcLsLsmmbsbsbsbsbsbLebRebReLsbLcRsbLiLsbLiLsbLoLsLsmmb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 33; Drug: OSU6162 3 然 Apo 50 然
bRsRcbRcbRibRcbRsbRobLsbRhbRcbRsbRgbLjbRjbRcbRcbRibRsbRcRsmbRcbRgbRcbR
hbRgbRibRcbRgbRcbRgbRiRgbRibRhbLcbLcbLcbLibLcbLcbLgbLcbLebLibLhbRjbRsb
LjbLobRibRcbRjbRgbLibLcbRcbRebRhbRiRsRsmmbLgbRibsbLjbRcbRibRibLibLgbRh
bRsbRibRsbRsbRjRhbRgbRgbRebLsbLcRsbLhbLsbRcbRhbReRsmbRsRsLsmbLgRsbLcRs
RgbLgLsbLiLsbLcbLibLibLhbLcRsbLgbLcbLgbLibLcbRgbRiRsmbRibRiRsmbRsbRhbR
sRsmbRcRsmbLsRhbLsbLcLibLiLsbLiLsbLgLsbLgbLibLgbLhRsbLgLsbRjRgbRhbRhRg
bRgRsmbRgbRhRsmbRiRgbLcLsmbLhbLiLsbLgLsbLiRsRsmbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 34; Drug: OSU6162 3 然 Apo 50 然
bRibRcbLjbLjbLcRsbRibLobLjbLcbRebLcbLjbLcbRjbLebRjRsmbLcbLcbRcbRobRibR
cbRcbRcbRiRsmbRhbLibRobLjbLibRobRcbRcbRibLjbRcbLibLgbRobRcbRhbRcbLibLo
bRobRcbRhbLibLcbLibRgbRgbLsbLobRsbRjLsbRcbLsbLibRcbRiLsRsbLsbRiRsmbRsb
RjbRsbRibRcRsmbRcbRcbRcbRcbRcbRcbRcbRsbRcbRhbLibLiLsbLsbLiRsbLsRsbLibL
obRibRcbRiRsmbRcLsbRibRcbRibRibRsbRgbLgbRcLsbRibRibRsbLjbLobRsLsbLibLc
bLcbLgbLibLcbRgbRgbRhbRcbRsbRibRiRsmbRsbRibRsbRgbRgLsbsbsbsbRobRsbRebR
hRsmbLibLibLgLsbLsRsbLibRsbLibLobRgbRibLgbRobRibRibRcbRsbRcbLsbLsbLgbR
sLhbLsbLgbLgRsbLsLsLsmmbLgbRsbLibLgbLgbRsbLcbRibLcbRsbRjRsmbRcbRibRgRs
mbRcbRgRsLsmbReLsRsbRsbLgbRoRsmbRgRsmbRgbRiLsbLsbRjbRiRsmbLebRsbLebRsb
LsbLgbLoLgbLiLsbLsbLoLsmbLibLibRobRcbRibRhbRcbRibRibRcbRibRebRiRsmbRgR
ibRibLsbRobRibRgbLsLsmbRcbRgbRsbRcbRgbRgbRiRsmbRibRibRobLgLsbLcLsmbLsb
RsbLjLcbLiLsbLibLgbLibRsbLhbLsbRcbRiRsmbRcbRcbRgbRcbRibRgbRcbRsRsmbLsb
RcRsRsmmbRgRsRsRsmmmbRibLgbRoLsbLibLgLsbLgbLgbLsbLsLgLsbLsbLsRcbRcbRib
LobLgRsbLgbLibLsLgbLgbLibRsbRcbRoRsmbRcbRcbLcbLiLgbLibLsbRsbLiLsbLgbLg
LsbLgRsRsmbLsbRgRsmbRcbLjbLcbRobRcRsmbLcbRibRiRsmbRibRgRsmbRcRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 35; Drug: OSU6162 3 然 Apo 50 然
bRgbRsbLjbLcLsmbRgbLcbLsbLibLhbLsbLcbLhbLobLibLcbRcbRcbRhbRcbLiLsbLcbL
cLsmbLsbLjLhbLcbLsbLsbLgLsbLsbLgbLhbLcbLsbLcbLgbRjbRcbLcbLcbRsbLibRcbR
cbRsbRibRibRsbLsbRcbRgRsmbRcbRcbRcRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 36; Drug: OSU6162 3 然 Apo 50 然
bRibRiLsbsbRobRobRgRebRobRcRsmbLsbRsbRiRsmbRibsbsbRobRcbsbsbsbsbRcbRcb
RebRebRhbRcbRhbRcbRibRcbRhLsbRcRsmbRcbRcbRcbRjRibRcRsRsmmbRhbRsbRcbRob
RgLsLsmbLgbLcbLiRsbLsRsbLsbLhbRsbLcbRsbLgLcbLgbLgbLgLibLgLsbLiLsbLsRgb
LibLsRgbLsRsbLsbLibRsbRebRibRibRcbLcbLcbLibLibLibLiLsbLgbLibLiRsbLibLg
LiLsbLiLsbLibLsbLiLsbLjRsbRsbRobRhbRgbRgbRsbRibLsbLcbLibLiLsbLsbLgLsbL
gbLsbLcbLgbLsRsbLsbLcLsmbLgLcbLiLsLiLibRsLibRgbLsbLgbLibLibLibRgbRcbRc
bLsbRobRibRgbRiLsbRhbRsbRgbRoLgbLiRsbLgLgbLcbLibLhLibLgbRobLsbRcbRiRsm
bRcbLiLibRsLsLhbLgbLgbLgLgLcbLiLsbLgLgbLgLsbLgLgbRcbRcRsmbLsbLsbLsbRcb
RgRsmbRibRibRibLgbLhbLobLgLcbLiLsbLgbLebRgbRsbsbRsLsbLsbLobLeb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 37; Drug: OSU6162 1 然 Apo 50 然
bRgRsmbRgbRhLsLsLsRgmmbRhRsmbRcbLsRsbRsbRgbRsbRobLibRgbLcbRjbRhRsmbRiR
sLsRsmbRiLsLsmbLhbLobRsbLhbRibRjbLhbLgbLiLsLibLgbRgbLobLibRcbRibRibRhb
RhbLgbLibRsbsbLsbLgbLibRgbLsLsLsmmbLoRsRsmbRgbRgRsmbLibLibRibRibRgLsbL
gbRgRsmbRsRibRibLibRsbLsbRsbLsRobRobRgbLobLsbLiRsbRcbRgLsRibRiRsmbLsLs
mbRibRibLgbLjbLobLhbRcRsLsmbLjbRsbRiRsRsmmbRhbLsRcbRibLsbRgbRsbLibLsLs
mbLsLsmbLsbLgbLoRsRsmbLgLsbRsLsbLsbsbLgbLibRsbLibsbLhLsLsmbLibLcbLiLsb
LhbLibLsbLhRsbLibRjbRcbRsbsbRibLsbRsbRgLsbRsbRsRsmbRjbRsbRsRsmbLcbLhbL
cbLcbLhRsRsmbLjbLibLiRsbRgbLiRsbLsbRobRibRcbLsRsbRgRsmbRsbRgbRsbRsbRsb
RgbRsbRibLsbRgbRsLsbRgbLsbsbRgbRgRsmbRsbRsRsRsLsmmbRgbRsbRgbRsbRibsbLs
LgbRsbRsbRsbLgbLjbRiRsmbRibRcLsbRiRiRsmbRcbRsbRibRsRsRimbRgRgRgRsmbRgR
smbRgbRgRsmbRgbRgRsmbRsbRgbRgLsbRgbRgbLsRsRsmbsbsbRgRsmbsbLsbsbRsRsmbR
sbRgRsmbRsbRgbRsRsmbRsbRgbRsbLcbLhLiLibRjRgbRibRsRsmbRsLsbRibRsLsbRibL
sbRsRsRsRsRsmmmmbRsRsRsmmbRsbRiRsRsmmbRgbLsbsbRgbRsbRgbRsRgbLhLebLiLsb
LgbLgbLgbRjbRobRibsbRgRsmbRhRiRsmbRiRsmbRiRsmbLsbRsbLsbRsbsbsbRgbLsRsb
LsbRsbRgRsmbRsRsmbLsbRsbRgbRsbRsLsbRgRsmbRsLsbLsRsbsbsbsbsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 38; Drug: OSU6162 1 然 Apo 50 然
bLsbsbRsRsLsmbLoLsLsmmbRsbRsbRiRsmbRsbRiLgbLgLsbLibLsRsbLgbLsbLsbLgLsb
RsbLgbLsbLsbLibLibLibRobLobLcRsbLsbRsbRgRsmbRsbRgbLjbLibRsbLsRsbLoRsRs
mbLsRsbLgbRsbRsbsbLcbRobLoRsbLhbLgLsbsbLibLobRsbLsbRsRsmbLcbsbRiRsmbRi
RsmbLobLcbRibRcRsmbRsbRsbRgLjLhbLjbLgbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 39; Drug: OSU6162 1 然 Apo 50 然
bLibLgbLiRsbRsbLgbLiRsbLgLsbLsbLibRobRebRgbLsLsmbRgbRsbRcRsmbRcbRibRob
LibLobRobRhbLiLsbLobLsbRebRcbRcbRsbRcbLcbLibLcLsRsmbLcLsmbRcbRobRibLsR
sbLhLsbLsbRcbRsbRcbRgLsbRsRsmbLcbRsbLcLsmbRobRibRibRsbRcRsmbRjbRsbsbRc
bRibRhbRsbLsbLsbLibLgbRsbLcbLgbRibLsbLibRibLcbLobRcbRcbRibRgbRgbRgbRgR
iRiRgLsbRibLjbRiRsmbLgbRibRsRsmbLsbRgbLsbRiLiRsbRgbRsRgbRhLsbRibRsbRgb
RcbsbLsbsbRsbRgLgbRibLsbRsRsmbRsRgbLsbRgbLsbRiLibRcbLjbRiLsbRgLsbLsbRg
bsbRgRsRgmbRgRsRsmmbRsbRgLsbLsbRgRsmbRgLsbLgbRibLsbRgbLgbRgbRsbRsbRsRs
mbRgRgbRsbRsRsmbRsbRgbLsbRiRsmbRgbLgbLsbLgLhLgLsbLcRsRsmbLibRcbsbRcbRc
bRcbLcbRibLsLcbLgbRsbRjbRibsbRobRibLibRobLsLsmbRcLsRsRgbRibRgRsLsmbRsR
ebLeLsLsmbRhbLgbLibRcbRcbRgbLibRsbLcbLibRgbRcbRcLsLsLsmmbsbLibRebsbLgR
sbRibRsbsbRibLgbRibRsbLjbRcbRhbLgbLgbLcbLsbLsbLgLsbLiLsbRgLsbLcbRibLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 40; Drug: OSU6162 1 然 Apo 50 然
bLiLsbLgbLsbLgbLsLsmbLgLsbLsbLgbLsbLsbLgbLsbLgbLsbLgbLsbLgLsbLgbRibLcb
LibLsbLibLgbLebRoLsbRgbRgbRsbRibRgbRsRsmbLsbRgbRgbRibLobLcbLobRsbRobLo
bLgbLoLsmbRgbRgbRsbLhbLoLsLsmmbRobsbRiLsbLcLsmbRobRoLsbRibLoLsmbLcbLcb
LobLcbLsLhbLhbLcbLhbLcbRebLcbLobLcbLsbLsLsmbLiLsbLcbRhbsbLsLsmbLibLcLs
mbRiLgbLibLobRibRgbRgLsbLcbLcbLsLsmbLibLhLsbLcLsmbLcRsbLobRcbRobLibLgb
RibLcLsmbLsLcLhbLcbRgbLhLsbLibLgbLebLcLsmbRgbRhbRcbLibLgbLeLhLsbLgbLhb
LsbLsbLeLsbLcLsRsLimbLhbRibRgbRibLsbRobLgLsbRsbLibLiLsbsbRjbRcbLcbLsLc
bLibLsbLcLsmbLiLsbLgbLebLgbRibLibLjLsmbLgbLeLsbLgLsbLsbRibLsbRhbLcLsmb
LibLhLsbLibRiRsmbRgbRiRsmbRgLsbRibRcbLibLsbLiLgLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 41; Drug: OSU6162 1 然 Apo 50 然
bLobLibLcbRsbLjLobLibsbLsbRebRhbRhRsmbLcbLcbLgRsbRgRsmbsbRcbLibRcRsmbR
cbRcbRcbLebRcbRcbRsLsbRibRcbRibLibRcRcRsmbRcbRcbsbLjRsbRjbLobLobRcbRcb
RcbRibRcbRiRsmbRcbRibRobLsbLcbLoRsbLibRgbRiRsmbRcbLsRsbRjbRcbRcbLhbRoR
smbRiLsbLjbRhbRoRsmbRgbRobRgbRoRsLsmbRibLgbLibLgbLoLsmbLsLsmbRhbRcLsbL
ibsbLgLsbLgbLgbLsbLgbLgbLsLsmbLsbLgbLsbLgbRsRsmbLsbLsRsbRcbRibRhRsmbLi
bRobRhbRiLsbRibRcRsmbLibLcbLcRsbRibRcbLgbLgbLibRoLsbRibRebRcbLiLsbLsbR
obRcRsmbRobRhbLcbLsbLgbLgbLsbLgbRsbLibRjbRhbLcbLibLibLcbLiRsbLoLsmbLib
RobRhbRibRcbRsbRcbRiRsmbRiRsmbLebLobRcbRcbLsbRhbRcbRibRgbRobLgbRiRsmbR
gbRsRsmbRgbRsbRgRsmbRgbRgRsmbRgbRgRsmbRiLgbLobLcbLgbLgbLobRibRoRsmbRib
RcbLsbLibLgbRsbLgbRsbLibLsbLgbLgbRcbRhbRibRibRhRsmbRibLcLsmbLgbLgbLgLs
bLsbLibLibLcbRsbLcbLcbRgbLibLiLsLgbLibLgbLibRjbRcRsmbLjLsmbRcbRcbRsbRi
bRsRsmbRobLibRobRibRgRsmbRgbLsRsbRgbRiRsmbLebLoLsmbsbLcbRibLjbLibLibLh
bRgbRcbRcbRgRsmbRgRsRgRgLsRsRiRiRsmmbRgbRgRsmbRsbRgbRhbRcRsmbRiLsbRcRs
mbRibRsbRibRgbRhRsLsmbLgbRiLsRsbRibLsbRgRsmbRibRibRcbLiLsbLibReRsLsmbR
hbRcbRsbRcRsmbRiRsmbRgbRcbRgbLhbLgRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 42; Drug: OSU6162 1 然 Apo 50 然
bLobRobRibRoLsbRcbRsbLobRsbLjbLobRobRhbLobLoLsmbRgbRoRsmbRcbLoLsmbRobR
obLobLobRebRobRgbRobRsRsmbLhbLobRcbRobRoRsmbLobLcbRobRobLsbRsbRcbRcbRs
bRobLsbRobRiRsmbRgbRiRsLsmbRgbRgbRsRsmbRiRsmbRsbRobLibLsbRjbRiLcbRcbRo
bRcbRsRsmbLobLibRsbRebRcbRsbLsbLjbRcbRsbLsLsmbLsbLcbLjbRobRhbRsbLhbLcb
RsbRiRsLsmbRgbRcbLobLobRobRibRsRsmbRgbRsbRsbRgLsRsbRjbLcbLsbLjbLcbRobR
sbRebRcRsmbLsRsbRcRsRsmmbRebRcbRsbRgRebRhbRgRsLsmbLebLcbRsbLebRsbLgbRo
bRsbLsbRcRsmbRobRgbRobRsbRcbLsbRsbLsRhbLsRsbRobLsbLobRsbLcLsmbLibLsbRe
bLcLsmbLgbLgbLibLibLgbLebLibLebLhbRsbRebRgbRibRsbRcbRibLsbLhbLibLgbLib
LgLsbLgbLgRsbLibRsbLhbRgRsmbRjbRibRobLsbLibLibLsbLsbLiLsbRobRcLsLsmbLg
bLibLcLsmbLgbLcbRsbRsbRcbRibRgbRcbLsbRcbRgbRiLsbRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 43; Drug: Control Apo 50 然
bLsbRsRsmbRsbRgbRsbRsRsmbRoLgLsLsmbRcRsmbLibLcbRgRsmbLgbLsbLsbLjbLsRoR
smbLobRsbLsbRgbLibRgbLsbRjbRobsbRsbRsbLobRgbRsRsmbRsRsmbLcbLhbLiRsbRgb
LibRsbLobLhbLibLibRobRhbRoLsbRoLsbLibRobRcLsbRobRgbRhRsmbLibRcbRebLibL
cbLsbLiLsbLcbLoRsbLobLoRsRsmbLibLobLobLiLsbLibRobLsLsmbLsbLobLsbLobLgb
LgbRcbRgbRgbLsbRoLsbLsbLsbRhbRjRebLgbLgbLsbRjbLgLsbLobLcbLcbLcbLibLgbL
gbLiLsbLsLsmbLgbLsbLjbRgbRcbRebLobLiLsbRhbRibLgbRgRsmbRgbRsRsmbLsbRgbR
obLibRibRjRgbRjRgbRsbRsbRibRsbRgRsmbLhLhbLjbLgbLiLsbLcbLobLibLgbLgLsbL
sbLiLsbRsbLhLsbRebLcLsmbLobLobLsLsRsmbLgLsbLjbLcbLsRsLsbLjLcbLibLsbRhb
RcbsbLjLsmbLcbLsLibLgbLiLsRsbRsbLsbLsRsRsmbLsLsmbLiRsbRgbLiRsRsmbRsbLh
bLibRgbLobLgLsbRsRsRimbRgRsmbRsRsmbRgLsbRgRsmbLgbRgLjbLcLiLsLsRjmbLiLg
LeLiLsbLoRgbLobLebLebRsLsbLgbLibRibsbLcbRcbRsRcbRgbRibLsbLjRsbLhbLibLj
LsRsmbLcRsbLcbLgRsbLibLibLgbLgLsbLeb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 44; Drug: Control Apo 50 然
bRcbLibRcbRebRibLcbRibRoRcbRiLsbLebLibLibRgbRibRcbRcbRgbLsLsmbRcbRcbLs
bLebLiLsbRibLcbLcbLgbRjbLsRobRhRsLsLsmmbLgbLiRsbRsbRobRibLsbRibLsbRsRc
LsbRibLibRjbRhbLsLsmbLibRjbRjbRhbRsbLibRibRiRibRiRsmbLsbLibsbLgbRsbLib
LibLiRsRsmbLcbRsbRsbRgbRibLsbLsLsmbsbRcbLsbRgbRibRgbRibRgbRsRsmbRgLsbR
sbRsbRsbRgbRsbRsbRibRiLsbRibRgRsmbRibRgRsmbRsRsmbRibRsLsbRcbRibLsbRcbR
ibRsRsmbRgbRsbRsRsRsmmbRsRsmbRgbRgbRsRsmbRgbRsbRibRsbRibRsRgbRibRsRsmb
RsbRgbRsRsmbRibRibRsLsbLsbLsbRjbRibRsbRibRiRsmbRibRhbRhbRibRobRsbRibRs
bRibRibRobRhbRcRsmbRgbRsbsbRsbLsbsbLsbsbsbRsbsbsbRsbsbsbRoRsmbRibRgRob
RobLsbRobRjbRjRsmbRibRsbRcbLsbRibRgbRsRsmbRsbRibRjbRebRsbRgLsRgRsmbRib
LgbLibLgbLobLiLsbLgLsbLgLsbLjbLsbRibRcRsmbRsbRhbRibRhbRhbRgbReRsLsmbRi
bRibRgbRsbRgbRgbRhbRib

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 45; Drug: Control Apo 50 然
bLobRibRsLsbRgbRgbRgbLsRsbRsRsmbRsRsmbRgbRsRsLsmbRsbLcbLiLsbLibsbsbLib
LsRsRsmbRgbRcbRhRsmbsbRibLgLsLsmbLjbLjbLibRcbRcRcbRhbRsRsmbRcRsmbLjbLo
bRcRsmbLcbRjbLcLsmbLjbLibLibLgLcRsbLiRsbRgbLsbLgbLcLsmbLiLsLgRsRsLsmbL
cbLcbLsbLsRsbLcLsmbRjbRhbLjbLibLibLibLibReb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 46; Drug: Control Apo 50 然
bRibRcbRobRibRcRsmbRjLsbLoLgbLibRobRibLsLsmbLibLibRcbRiRsmbRibRhbLibRo
bRcbRcRsmbLjRsbLcbLsbLibLcbLibLcbLhbLcbLibLibLsbLgbLgbRebLcbLibLiLsbLg
bLibLhbLcbRcRsmbRebLebLcbLgbLjLsmbLhbLcbsbLibLgbLibLcbLiRsbRsLsLsLsmmb
LibsbLcbLsbLibLhLsbLgbLgbLibLcbLcbLibLiRsRsLsmbLsbLibLjbRobRebLibLhbLi
bLobRoRsmbRibRcbLgLsbLibLcbLhbLcbLoRsbLcbLsbLgbLibLiLsbLibLsLsmbLiLsbR
jbLcbLcbLcbLcbLsbLibLibLhbLcLsmbLobLibLgbLiLsbLgbLoRsbRsbLcbRcbRoRsLsm
bRsbLsLsmbRcRsmbRobLgbLgbLibRobRibRgbLsRsbRhbsbRibLiLsbRcbRcbRcbRibRoR
smbLsbLcbLgLgLsbLibLsbLibLgbLgbLgLsLsmbLsLgLsbLsRsbLoRsbLgbLcbLcbLhLsR
sbRsbRcbRcbLgbLibLcbLiLsbLibLhLsbLgbLibLgbLgbRsbLiLsbLibLcRsbLibLiLhbL
iLsLsLsRsmmbLeLsbRobRibRsRsmbRoRsRsmmbRibRcb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 47; Drug: Control Apo 50 然
bRiRsmbLsbRibRcbLsbLjLsRjmbLgbsbRobLcbLobLcbLcbLibLsLsmbLibRcbRiRsmbRs
bLobLiLsLsmbRjbRjbRoRsmbRcbLsbRhbRhRsmbRiRcLsLsRsmbRcLsbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 155812; End: 160312;
Recording: 1-1; Individual: 48; Drug: Control Apo 50 然
bLsbLgbLsRsbLsbLcbLhLsbLibLibRgRsmbRsRibRsbRsbRgbRcRcbRgRsmbLgbLiLsbLg
LsLibLsbLgLsLsmbLgLsbLgbLsbLsbRcbRhRgRsmbLcbRobRcbRibRobLsbLcbRsRobRhb
LjbRobRsbRcbRibRcbLsbRcbRhbRcLsbLibLgLsLsmbLebLobLcLibLcbRsLsbLibLcbLh
bRebLebLibRsbLgLsbLgbLsbRsbLcbLcbLcbLibLebLibLgbLgbLgbLgbLobLhbLebLibL
sbLgbLiLgbLibLibLgbRcbLhbLcbRhbLcbLhbLjbLhbLiRsbLgbLibLebLgbLgbLgbLgbR
sbRjbRcRibRibRgbLjLiRsbLcRsbRhbLhbLcbRhRsmbLjbLibLcbRgbRsRsmbRgbRibRib
RgLsbRgbRobRcLsbRcbRibRsbRiRebRsbLgLjbRsbRcLsbLcbLhbLsbLsbLjbRjbRhbRib
RsbRgbRgLsbRebRgbRsbRcbRiLsbRjbRibRgbRebRibLhbLiLsbLcRsRgbRibRebRiRsmb
RsbLobRobLsbRiRsmbRhbRcbRsRiRsmbRhbLgbLibLgLsRsbLiLsbRsbRsLsbRibRcRiRs
mbRibLiLsbLeLsbLgLgLgbLebRcbLcbLcbLiRgRsmbRgRsmbRsbLcbRebRebLibLcbRgbR
eRibRibRjbLcbRcbLcbLcbLibLgbLcRsbLsLsmbLcbLcbLhbLcbLibLsbLsbLhbLgLsLgL
sbLgbLgbLsRcRsmbRhbRibRibLhbLcbRgRsmbLcbLgLsbLgLsbLhLibLibLgbLgbLgLsbL
sbRjbRhbRibRhbRibRibRgbRcbRcbRgbLcLsmbLsbRiRsmbRebLsRsReRsmbRebRhbRjbR
cbRibRsbRgbRgbRibRibLibLiLsbLjbLiLsbLgLsbLcbLsRsbRgbLcbLhbLibRibRgbLcb
LgbLebLcbLcbRjbLjbLsbLsbLiLgLsbLsLgbRiLsbRsbsbLebLibRhbRiRibRhbRhbRibR
sRoRsLsmbLgbRebRgbLeLsbLhLsLsmbLebRcbLcbLebLibLibLhbLebLibLibLhLgbLibL
iLebLjbLeLsbRsbLsbRebLeLibLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 1; Drug: OSU6162 10 然 Apo 50 然
bsbsbsbLsbRjbRcRsmbRgbRibRsbRsbRcbRiRsmbLgbLibLibsbsbLsbLgbRsbLsbLgbRs
bLsbLgbRcLsRsbRgbRiRsmbRsbRjbLgRsbLcbLibLibLjLsmbLibRsbLgbLsbLsbLgbLib
LibLgbLsbsbLibLsbRcbRgbRgbLsbRgRsmbRgbRgRsmbLsbRsRibRgbRgbRsbRsRsmbRgb
RgRsmbRiLsbRgbLjLsmbRsRsmbRibRgbRsbLsRcbRgbRgbReLsbRgbLsRsRsmbRsbRsbRg
bRgbLobLibLibRsLsbLsbRcbRhLsbRiLsbRgbRsbRobLsbRgRsRgmbRsbLobLgLsbLgLsb
LsbLgbLgbLgbLgbLgbLibLsbLiLebLgbRjbLibLgRsLsbLibRsbRjbRiLsbRsRsmbRibLs
RsbLjbLibLibLgbLsbLsRsbLgLsbLgbLgbLsbLgbLsbLgbLgbLibLgbLgbLibLgLsbLgbL
gbLsbLsLibLgLsbLsRsbLsbLgbLsRsbLgbRsbLibLibRgbRcbRgRgRsmbRebRhLsbRhbRi
bRgRsmbLsbRgbRgbRsbRgbRiRibRsRgbRsbRebRebRiRsmbRcRsmbRgRsRembLiRsLsbLe
LsLsLembLsbLgbLgLsbRgLsbRgbRjbRgbRgRsmbRiRsmbsbRsbRibRiRsmbLibLcLhLebL
eRsbLebLebLgbLsbLgbLgbLgbLsLsLsmmbLibRsbLebLebLsbRsbLoRsbLhbLibLiRsbRs
bLgbLsbLgLsbLibLiLsbLgbLgbLeb

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 2; Drug: OSU6162 10 然 Apo 50 然
bLobLsLsmbLobRcbLsbRhbRsbRgbRiLgbRsbRsbRsbLjbLebRhbRcbRsbsbRcbLsbRgRsm
bLsRebRgRsLeRjLsRembRobRobLsbRgRsmbLobLcbLibLibLeLgLsLsRsmbLibLhbLiLsb
RcRsmbRgbRcRsmbRsbLjbRsRcbRgbRgRsmbRgbLsRsbRcRsmbRiRsmbRibLoLsmbLebLeb
sbsbLgRsbRsbRsbsbRsbLiRsbRiRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 3; Drug: OSU6162 10 然 Apo 50 然
bsbRhRsmbRoRsmbRgbRgRsmbLsRsbRibRsbRgbRobLsbLibLsbLiLsbLibLsLsmbLsLsmb
LsbLibRsLsRsbLibLsbLhbLebRsbRiRsmbRsbRcbRcbLgbLsLsmbLsLsmbLsRcRsmbRgbR
sbRiRsmbLsLsmbRsbRhLgbLeRsbRibLsRsbRcbLhbLibLgbLgRsbLsLsmbLsbLgRsbLibL
iLsbLsbLhLibLibLcbLsLsRembLoLsmbLibLobLibLsbLebRjLobRsbRsbLobLcbRjbRcb
sbLjbLsbRjbRsbLsbRjRsmbLgRsLgbLsbRsbLsbRsbRsbLjLsRgmbRiLibRjLsbRjbRsbR
ebRsbLjbLoLcbLobRobRcbLsbLsbLibRobsbLhbLsLoRsLibLcRsbLgbLsbLobLobLsbLs
bRgbRoReRibLibLsbRjbRgbLibLobLobRsbRcbRibLsbRhbRcRsmbRibRsLsbRsRsmbRsb
RjbLjbLobsbsbRobLgbsbsbLiLsbLsLsmbLsbRibLgLjbLebRsLsbsbsbLsbRgRsmbLsbL
jLsmbRgbRsbLsbLgbRsbRgbLebRobsbRsLebsbRsbRebLebLebRcbLsbRobRsbLobLobLg
bLobRobLibRibLebRhLsbLibRhbLsbLjbRebLeRhbLebLsLibLibLebRebLobLobRsbLjb
LjbRsbRebLjbRobLebRebRobRjbLhRibReRsRombLjbRobLcbLobRebLobLobRobLgbLob
sbLcbsbLobRjbRibLsRebRob

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 4; Drug: OSU6162 10 然 Apo 50 然
bLobLibLibLgbLgbRsbsbLibRgbLcLibLgbLcLsmbLgbLhbLiLsbLgbLsbLiLsbLgbLiLs
LsmbLibLgbLibRgbRcLsbRiRsmbsbRibRsbRgLsbRsbRhLsbRibRgLsbLebLibLgLsbLgb
LiLsbLgbLhbRsbLibLibLiRsLsbLgbLhLsLsmbLcLsmbRhLsRsbRcRsmbRgbRgbRiLsbRs
RsRsmmbRibRibRcbRibRsbLcbLgLsbLiLsbLsbRsbRsbLibLsbLiLsbLsbLgLgbLiRsLsL
sLimbLsbLhLsbLibsbLsLsmbLiLsbLgbLcbLeLsbLibLgRsbLibLgRsbLsLsmbLgbRcbLc
RsbLgLsbLibLibLgbLhLgbLhLsbLiLsbLgbLgbLcbRsbLgbLoRibLcLsmbLeLhbLibLgbL
ibLgLsRsbRjRsmbLcLsmbLibLhLsbLibLsbLiLsLsmbsbLibLsLcbLibRcLsRsbRcbLsbR
cRsmbReReRsmbRsbLjbLibRebReRsmbRobsbRsbRebRibRsRhbRhbRsReLsbRsbLgbRibR
ibRibLiLsbLeLsbLcbLibLebLeLsbLgLsLsmbRgbLcLeLsLsmbLhbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 5; Drug: OSU6162 10 然 Apo 50 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 6; Drug: OSU6162 10 然 Apo 50 然
bRobRobLcbLhbLhbLibLibRgbLgbsbLhLsLsmbLgbLibLiRsbLhbLibLsLsRsmbRiRsmbR
cbReRsmbRiLsbRgbRibRibRoLgbLibLgLsbLgbLgbLibLibLgLsbRibRcbLibRcbRsbRib
RgbRiRsmbRibRibRiLsLsRgmbRibRsRsmbRiRsmbRebRiRibLcbsbLcbLcLsmbRcRsmbRc
bRcbRhbLgbLiLsbLibLhbLeRsLiLibLhRsbLsbRhbRcbLobLibLibLgbLiLibLiLgRsbLg
bLcbLcLsmbLcbLibLoLsRsmbRsbRcbRhbRiRibRcbRibRiRsmbRcbRebLcbLcbLhbLsbLh
bLhbLibLgbLgbLhbRgbRoRsmbRibRibRsbRibRibRibRibRgRiLsbRoRebRgbRgbRgLsbR
cRsmbRcbRobRcbRibRibRgbRibRhRjRebRhbRcRsmbRgbRgRsmbRgbRsbRgLsLsmbRiRiR
ibRibRcRhReRsmbRebLoRsbLibLgbLibLibLhbLsLeLsbLibLiLsbLibLhbLiLsbRebLjb
RoRsmbRibRiRsmbRcbRcbRobLcbLibLebLibLibLgLsbLoLibLebLibReRiRsmbRebRiRs
mbRcbRhbRcRsmbRiRsmbRibRhbRibRibReRsmbRiRgbLsbLoLsmbLibLhRsLsbLcbLgbLc
bLibLibLsLebLhbLiLhLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 7; Drug: OSU6162 3 然 Apo 50 然
bLhLsbLibLjbLiLsbsbRsbRsbLibRibRcbRsbRcbRobLsbRhbLibLgbLgbLsbLsbLgbLib
LsbLsLsmbLgLsbLsbLibLebRibRiRsRsRsmmmbRgbRiRgRsmbRsbRgbRgbRsbRgRsRgRgR
smmbRibRgRsmbRsLsbRgbRsRgbRcbRiLsbLgbLibLobLibLhLiRsbLsLgbLgbLiLebLgbL
sLsmbLhLiLhbRcbRgLsbRgbRhRsRsmmbRgbRhRsLsmbRibRibLgbRsbRcbRhbRgbRibLob
LsbLibLgbLsLsLgLgRsLimbLsbLgbRjbRhbRgbRibLgbRoRsLsmbRibRgbRibRibRsRsmb
RsbRsbRgbRgbLsbRgbRgbRsbRgLgbRsRcbLgbsbRgbRibRibRsbLcbLhbLibLibLiRsLsb
LgbLibLgbLoRsbRgLsRgRsmbRiRgbRiRgRsRgRsmmbRgRsRimbRgbRsbRgbLsLsmbRsLsb
RcbLcbLsLhbLcLsmbLsbLiLsLsmbRsbLhbLsbLibLgbLiLsLgbLobLsbLsLgbLgbLgbLgb
LibRsbLgbRjbRibRcRsmbLsbRcRibLgLsbLsbRcRsmbRgbRibRgbRibRgRsmbRibRgbLsR
gRsmbRgbRgbRgRsRiRimbRgbRgbRebRibRgbRhbRibRsRsmbRgbRgbRgbRgbRgbRiLsbRg
bRgbRibRiLsbRsRsmbRibRgbRgbRgRiRgRiReRibRgLsbRgbRgbRgbRibRsbLsLsmbRcRs
LsRsmbRgbRibRgbRgbRhLsbLgbLsbRhbLcbRibRhbRiRsmbLsbLsbLhbRcbRiRgRsmbRgR
smbLsRsbRgbRgbRgbRgbRiLsbRsbLcbLiLsbLoLsmbLgbLgbLoLsLsLgmmbLibLgbLsLgb
LobLebLhLiLsbLgLiLeLgLsbLgbLsbLgbRsbLobLibLibLiLsbLibLoRgbRibRgbRiRgLs
RiReRiRsmbRiRsLsmbRgRgbRgbRgRsmbRgbRiLsbLsbRsbRibRgbRcbRibRibRebLsbRiR
smbReRiLsRsRgRsRiRgRgRsmmbRiRsmbRgbRgbLsRgbRgbRgbRgbRiLsbRgLsbRgbRiRib
RsRsLsmbReRsRgRiReRimbRgRgbRiRsmbRiRsRgmbRgbRgbRsbRcbLcbLibLibLobLibLi
bLiRsLsbLibLgbLsLsmbRsbLgbLsbLibRjRsRsmmbRjbRcbLobLcRsbRsLsbRgbRibRibR
gRsmbRgRsmbRsbRsbRgbRobLgbRoLsbRgbRiRsmbRibRgReReRsRiRgRsmmbRsbRibLcbL
obLhLgbLibLoLsLimbLibLiLsbLiRsbLiLsbLibLgbLibLiRgbLibLibLoRsRsRimbRibR
gRsmbRgRgReRiReRiRsRimbRgbRgLsbRibRiRsmbRiRsReRhReReRhRsmmbRgRgRsRsmmb
RgbRoLsbRibRcRsmbRgbRgLsbRibRgbRsRgbLcbLibLcbLcbLcRsbLsbLhLhLsRsbLiLhL
eLebLiRsbLgLsbLhLebLiRsbLiLeLeLeb

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 8; Drug: OSU6162 3 然 Apo 50 然
bRibRgbRibRgbRgRsmbRgbRgbRsbRhbLibLiLsbRibRibLsbRhbRsbRobRgbRibRgbRibR
gbRgbRgRsRgRsmmbRibRgbRgbRgRsmbLobLibLibLiLsbLgRsLgbLsLgbLgbLgbLcRsLsb
RhbRobRcbLcLsmbLibLsbLgLsbLobsbRsbLhbLgLsLsmbLibLgbLgLsbLsLsLsmmbLgbLo
LsmbLsbLjbLiLsbLgbLsbLgbLsLsmbLobRgbRibRsRsmbRgbRsbRgbRsbRibRibRebRiLs
bLhbLibRjbRcbRcbRsbRcbRsbLjLibLhLsbLgbLeRsbLcRsbLgbLeLibLibLobLsbLiLsb
LiLsbLibLiRsRsmbLgbLsbLcRsbLsbRibRcbRsbRcbRsbLsbRoRsmbRgbRobLsbRcbRibR
gbRgbRiRsmbRgbRgbRgRsLsmbRsbRhbRibRibRgbRgbRgRsmbRobLibLgbLgbLgbLgbLiL
gbLiLsbLgbLgbLsbLsbRgbRcbRhRsmbRiRsmbRsbRcbLgRsbRcbRgRhbRibLibLibLgbLg
bLsbsbRsbRjbsbRibLjbLobLgbLibLsbRobRhbRiRsmbRibRgbRgRsmbLsRsbRsbRgbRgb
LsbRcRibLgbLibLgLsbLobLiLsbLgbLcLsLsmmbLgLsbLiLsbLiLsbLiLsbLgRsbLgbLgb
LiRsbLibRsbsbsbLiLsLsmbLgLsbLgbLgbLgbLobRiRibRibRiRibReLsbRiRibRibRibR
ibRiLsRibRgLsbRibRibRgbRgbLobLiRsbLgbLsbLcbLiLsbLgbRhbRiLsbRgRsmbRgbRs
bRibRgbRibRsbRiRsmbRiRiRebRiLsbRiRsmbRiRsmbRgbRgbRiRsmbRibRiLgLsbLebLi
LsLsLiRsmbLsLibsbRsbLibLcbRgLsRsbLsbLobLgbLiRsbLibLhLiLsLeLsLhbLiLsbLi
LsbLgbLhRsbLgbLoLibLcbLhbLibLcbLhbLeLsbLibLebLibLibLgbReRsmbRiLsbRsLsb
RhLsbRgbRibRsbRgbRhbRibRibRibRibRibRibRiRsmbRhbRibRiRsRimbRibRhbRibRhL
sbRgRsRsmmbRgbsbRsbRgbRgbRgbRgRsmbRibRsbLgbRcbRiRsRiRsmmbRibRiRsRimbRi
bRibRibRgbRebRgbRsLsbRsRsRsmmbRsbRsRsmbRsbRibLgbLjbLhbLibLsbLhbLsbLobL
eLsbLsbLcbLiLibLcLhbLhLsRsLibLeLeLsbLgbRsLsbRsLsbLsbRhbRibRibRibRibRcb
RibRgbRibRibRgRgRsmbRibRibRcbRibRibRsRiRiRsmbRibRgbRoLsbRsLsbRebRiLsbR
iRsmbRibRgbRgbRgbRgRsmbRgbRgbLsbLcbRcbRebRibRsLsbRibRcbLgbLibLobLibLgb
LobLibRsRsmbLobLibLsbRebRibRsbRcbLgbLibLgbLobLibLhbLib

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 9; Drug: OSU6162 3 然 Apo 50 然
bRgRsRiLsmbLgLcbLsbLgbLobRgbLcbLibLgLsLsmbLsbLsbRobRibRobLsbRobLcLsmbL
cbsbRcbRhbRibRgRsRimbRsRsRsmmbRcbLsRsbLgbLgbLoLsmbRibsbRibRcbRcbRcbRgb
RibRsLsbRsRibRgbRsbRibLsLsmbRcLsbRsbLcbLiLgbLgbLsbLgbLsbLobLiRgbLobLib
LsbLiLsbLgLsbLibLiLsbLiLeLgbRcbRhbRcbRcbRgbRcbRiRsmbRgbRgbRibLsbRsbRcb
RsbRcRsmbReReRsRembLobLibLcbsbLcbLobLcbLcLsmbLibLeLsbLiLsbLcLeLsLebLib
LhbLsbLiRsbLibLcbLibLiLcLsmbLibRsbLgbLibRjRsmbRcbRhbRhLsbRiRibRcRsLsmb
RibRgbRsRgLsbRgbRibsbRibRcRsmbLcbLcbLibLsbLcLsLiLsmbLgLsbLiLsbLobRibRe
RibRiRsRembRhbRibRcRsRembRibRcbRebRhRsRhRembRibRgbRgbRcbRsbRgbRcRsmbRg
bRibRgbRibRcbRgbReLsRiReReRsmbRibLsbRobLsbLcLsmbLobLeLiLebLiRsbLibLsbR
jbRgbsbRcbRgbRcLsRsbRebRibRebRiRsRgRiRsmmbRgRsmbRsbRgbRobRgbLibLhLsLib
LcLhLsbLgLsLibLcLhbLiRsbRhbRgRsRsmmbRibLjbLobLcbLiLibLhbLebLebLebRsbsb
RibRcbRebRcbRhbRiRsmbRiRhbRiRgbReRebRebRobRobLoLsmbRiRsmbLcbLcbRibLcbR
sbRjRibRibRibRgRiRiRgRsRiRimbRgRsmbReRebRebRsRsmbRsRsRgRgRsmmbLsbLgbLc
bLhLsbRgbLobLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 10; Drug: OSU6162 3 然 Apo 50 然
bRibRcbRcRsmbRcRsmbLibRhRsmbRsRcbRibRibRibsbRibRibRibRibRsRsmbRibRcbRi
bRgbReRsmbRibRgbRsRsmbLobsbsbsbLjbRjbsbLhLsbsbsbsbRcRsmbRhbRibRgRsmbRh
bLsRsbRgbRcbRgbRibRibRibRibRgbRsbRebRiRsmbRgbLjLsmbLhbRjbLsbLebRsbLibs
bLibLgbRsRobRcbRibRhLsRsbRibRibRgRsmbRsbsbsbLsbLsLsmbsbRsbRsLsbRsRsLsR
smbRsRsmbRsbRsbRsbsbLsbRsLsRsbLsbLsRsbRsLsbRsRsLsLsmmbRsLsRsbsbLjbsbRi
bLhbLjb

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 11; Drug: OSU6162 3 然 Apo 50 然
bLgRsbLsbsbsbsbLsLsmbsbLcbsbRsbsbsbsbsbsbsbsbLhRsbRsbLsbLgLsbLebLiRiRs
mbRiLsbLsRiRebRiReRsRembLsLoLsmbLgbLcLsLsRsmmbLsbLiLsbRebRhRsRemb

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 12; Drug: OSU6162 3 然 Apo 50 然
bsbLsbsbRsbLsLsmbRsLsbsbRsbLibLhbLcbLibLgbsbLsLsmbLgbLiLgbRobRiRiRsmbR
gbRsbLsbsbsbRsbRgbLobLibLiLibLgbLgbLhbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 13; Drug: OSU6162 1 然 Apo 50 然
bRhbLcbLcLsmbLiLsbLgbLgLsRsbRsbLiLsbLcbRiRsRsmmbRebLsbRgLsbRcLsRsbRcLs
bRibRgbRcbLsbLobLjbRsbLjbLibLsLibLgLsbLcbLibLibLcbRgbLibLibRjbLobLibLs
bLiLsRsbRcbRebLeLibRhLhLsbLhbLcLsmbLeLsbLcRsLsRgbRibRsRebRsRsmbRibRoRi
bRibRiRibRibRibRibRsbRsLgLsLhbRobRgbRjbLebRebRoRhbRiLsbRoLsbRobRcbRebL
sRebRgRsmbRgbLsRsbReRibLgLsbLobLgLsLsmbRcRibRibRcbLcbRjbLgbLcbRibLobLe
bLgbLgbLgbLsLsmbLsbRebRgRsmbRcRibRiRsmbRibRsbRsbRcRgbRgRebRcLsbRiLsbRj
bLibLcbLsbLsLobLcLeLsbLcLsmbLibLibLiLsbLgLsbsbLsLsmbRebRgRsmbRgbLsbRoR
hbRiLsbRiRebRebRebRsbLeLsbLeLsbLobRobLebLgbLibLcbLjbLcLsmbLibLoRsbLgbR
iRgRsmbRhbRebRcRibRsRsmbRebRebLebLhbRgbLgbLibLibLsbLobRjbRebLcLsmbLcbL
cbRebRgbRgbRobRobRobReRibRcLsbRsbRebRhLsbRobRibRebRgbRobLjbLebRobLebRo
bLoLsmbRjbRgbLcbLgbLsbRiLsbRibRiRsmbRibRgbRcbRcbRibsbRgRsLsRsmbRgbRgRs
mbLebLibLsbLcbRebRibRiLsbRiRsmbLebLcbLgLsbLibLibRsbRibRgbRibRsbRsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 14; Drug: OSU6162 1 然 Apo 50 然
bRcRsmbLjbLcLsLombLgbRsRsmbRcbRsbRobRsbRibRibRgRsmbRgRsmbRibRgbRiRsmbR
gRiRsmbRsLsRsbRgbRgRsmbRgbRsbRibRsbRhbRsbRibRhbRebRibLsLsmbLiLsbLsLsmb
LgLsbLsbLgbRsLsbLoRobLcbLobLebLibLobRgbRhRsmbRhbLsbsbRobRhbRgbRcbRgbRg
RsRsmmbRiRsmbRgLsbRibLsbRibLjbLgbLibLsbLibLgbLsbLibLcbLsbRcbRibRibRibR
iRsmbRibRibLsLsmbLibLibLhbRsbRibLobLgLsbRsLsbRebLsRsbRgbsbRgRibRgbRgbR
gRgbReRiRsRgmbRgbLjLsmbLobLebLibLgRsbLoRsRibRibRhbLhbLsbsbRsbRcRsmbLsR
obRibRebRsbRsbRobLsbRibRebRibRsRsmbRsbRiRsmbRhRgbRcLsbLgbLobLcRsbRgbRi
bRebRgRsmbRiRebRgRsmbRiRiRgbRhRsReRsRsmmmbRebLcLiLsLebLeLibRobRsbLsbRs
RhbRebRebLiLsbRcbRgbRebRiRebRhbLjbRobLsbRebLcbRgbRjbRobRgbLjbLibLgLsbL
sbRsbRibRgbRibRebLhbLiRsbLobLhbLibLiLsbLgbLgLsbLhRsbLobLibRebRoLsbRsbL
sb

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 15; Drug: OSU6162 1 然 Apo 50 然
bRgbRcRsmbRibRiRsmbRiRsRimbRgbRiRsmbRgbRgbRsbLcbLcRsRsmbLibLibRsbRsbLg
bLsbLeLsbRobLgRsbLibLgLibRgbReRsmbRibRsbRsbLsbRibLsbRsbRsbRibLsRibRcbR
hbLgbLibLibLgLsbLsbLgbLsLsmbLsbRsbLsRsbRsLibLsLsmbLsbLgbRcbLsbRhbRgbLs
bRibRgbsbRsbLsbRsRsmbLsbRgbRsbLsbRgbRsbLgbRgbRsbRgbRibsbRiRsmbLibLcLsm
bLibLgbLgbLebLiLibLebLgbLibLgbLsbLiLsbRsbLgRsbRobRsLsbRjbRgbRibRgbRibR
ebRgRsmbRgbRcbRsbLsbRgbLgbLibRsbLsbLibLsbRgbRcbRgbRibRibRjbLsbRcbLiRsb
RhRsmbRcbLgbRebLcbLebLebLsLsmbLsbLsbLsLsmbRsLsbLgbLsLsmbLgRsbRsLsbLsbL
sbRsbRsbLcbRobRcbRibRgLsRsRibReRebRhbRiLsbRgbLsbLsbRsbLsLsmbRibRgbRsbL
sbRcbRibRibRibReRsmbRebRibRibLgbLobLiLsbLgLsbRcbLjbRibRibLsRsbLobLsbLo
bLhLsbLobRebReRsmbRgRgRsmbLobRebRibRgbRsbRgLsbRibLsLsmbRgRsRsmmbRsbRsb
LsbLsbRgbLsbRgbRgbRgbLsbLsLsmbRebRcbRhbsbRibRiRsRsmmbRibRibRibRibRhRsm
bLcLsmbLoRebRebRobLiLsbLsbLhbLibLibRgbRebLcbLiLsbLsbLibRsbLibLibRibRsL
ibRibRsbLsbRgbLgbRibRgbRsbRsbRjRgbRibRgbRibLhbLsbLsbLgbLgLsbRsbLsbLsbL
sLsmbLgLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 16; Drug: OSU6162 1 然 Apo 50 然
bLiLsbLgRsbRcRsRgmbRhbLebRibRoLsbRcbRcbLsbRsbRobRgbRcbRgbRebRgRsmbRcbR
ibRsbLiLsbLgbLibRsbRobRsbRgbLibLibLibLsRsbRebLjbLibLibRsbRjbRhbRibRsbL
gbLjbReRsRsmmbLgbLiLibRjbLcbLibLsbLgbRcbRibRibLsRsbLebRhbRebLsLsmbLsRs
bRhRsmbRsbLobLibLiRsbLsbLgbRiRsmbRoRsmbRsbRhLsbRgbLgbLsRsbLcbRcbRebRgb
RibRibLjLhbLgLsRsbRhbRcbLsbLcbLebRgbLcRsbLsbLibRiRsmbRjRsmbRhRsmbLgbLe
bLibLsLsmbRibLcRsLsbLsbLiRsbLgLsbLhbLcbRiRsmbLgLsbLhbLcbLiRsbLibLibRsb
RjbLhbLgbLgLsbRcbRhbRsbRibRgbRebRcbRsbRibRibRibRebLcbRebLjLcbRgbRcRsmb
sbRibRgbRjRsmbRjRgbRsbRsbLibRebRhRsmbRcbRiLsbRsbLcbLgbLgbLcbRgbLhbLibL
sbLjLgbLsbLhbLgbLgbLgbLjbLobRgbLgbLcbRsbRobRgLsbRgbRgRsmbRgbRgbRgLsRsb
sbRgbLcbLcbRsRsmbRsbRebRsLobLsbLgbLsLsRsmbLcbRhbRsRsmbRgbLjLsmbLibLgbL
ibLgbRibRcbLjbLcLsmbLiLsbLgbLoRsLsbRgbLcbLcbLsbRobRibRsbRibLsbLsLjbLib
LibRgbLobLgbRgbLcbRjRjbLsRcbRiLsbRsbRiRsmbLsbRgbRibRiLsbLsbLibLebLibLe
bLhbRebRibRibRsRibLcbLhbRebRibLsbRgbLsRsbRgRgLsbRsRsRsRsmmmbRsbRiRsmbR
sLsbRsbLebLibLgbLibLibRsRsmbLgLsLsmbLgLsbLsbLhbRsbRcbRibRsbRibRcbRgLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 17; Drug: OSU6162 1 然 Apo 50 然
bRcbRgbLsbLobLgbLgRcbRibRgbRsLsbLobRsLsbLibLsLsmbLibLsbLibLibLcbRjbRib
RcRsmbRiRsmbLsbRibRgbRgbRiRsRsRsmmmbRgRsmbRgbLjRsbRgbRsbsbRgRsmbRhRsmb
LgbRsbRgbRgbRsbRsRiLgbRibRgbLsbsbsbsbsbRibRsRsmbRibRibRgbRibRsRsmbRgbR
gbRiRsmbRsbRgbRsbRsbRgbRiRsRsmmbRgbRgbRsbRgbRsbRgbRgRsmbRgRsmbRgRsmbRg
bRsbRgbRsbRgLsbRibRiRhRsmbRibRhRsmbLebLibRsbLgbLiLsLsmbLgbLhbLgLsbLgbL
iLsbLgLsbLibLgbLgbLgLsbLiLsbLgbLgbRhbRsRiLsbLsbLobLgbLgbLgbLgbLgbLjRsb
LiLsbLjbLjbLib

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 18; Drug: OSU6162 1 然 Apo 50 然
bRobRsbLsLcLsmbLcbLcLsmbLcbLebRobLsbRhbRebRgRsmbsbsbsbsbLsbsbLcbLcbRob
RobLsbRcRsmbRgRibRsRsmbRibRibRiLsbRhRsmbRgbRgRsmbLcbLgbLobLsbLobLgRsbL
iLsLsLsmmbLhLsbLibLobLgLsbLcLsmbLiLiLiLsbLgbLibLobLgbRibRjbLsLsmbLcbLi
bLiLhLebRhRiRibRcbLgbRebRsLsRibRcbRebRebLoLsmbLsbReRjbRsbRebRebReRsRsm
mbRebLobRsbRebLgLsLgbRebRiRsmbRiLsLsmbRsbLoLsmbLibLibLibLoRsbLgbRobRiR
smbRiLsbRiRiRsmbRgLsbRibRiRibRhRebRobLoLsmbRsbRgbRjRsRiLsmbRibRobRcbRi
bLsbLibLsbLsbLcLsRsmbLgbRobLsbRibRobRiRsRiRsmmbRoLgbLibLiLcLobLhbLibLg
bLgbLibLobsbRgbRsbRgbRhbRibLsRoLsbRobLoLsmbLsbRibRiRsmbRsLsbRjbLobLgbR
sbLcbRobRgbRiLsbLsbRibLcbLobLibLgbLibLsbsbsbsbRobRobRgbRoLsbRgbRiRsLgm
bRobLsbLobLjLhbLgLsbRobLebLcLsRsmbRiRiRsmbRobRgbRcbLcbRcLsbRgbRoLibLib
LoRiRiRgbRiLsRsbRibLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 19; Drug: Control Apo 50 然
bRcbLhbLcbLiRsbRibLobRebRgbRgbLoRsbRoRsRsRcRiRsmmmbRibRgRhRsRsRsmmmbLi
bRsbRebLibLcLsmbLcbLcbLgRsbLsbLhbLjbRsbLgbRcbLsbRcbRobRgbRsbLsRibLcRsb
sbLjbLcbsbLiRsbLibsbRsbLjbLcbLiRsRgbRjbLjbLcbsbsbRcRsmbRebLgbRcRsmbReb
LcbLebRsbRibRebLhbRebRobRcbRebRebsbsbRhLsLsmbLcbLobLobLibLgbLibLgbRcbs
bsbLcbLiLsbLibRibRobsbRcbRcbRibRsbLsRsLsbRsbLobLiRsbRsRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 20; Drug: Control Apo 50 然
bRebRcbRjRsmbRgbRiRcbRibRiRgRsmbRgbRobLgRsbRgbRoRsmbRgbRsLsbLebLcbLgLg
bLhbLibLsLibLgbRjbRoLsRsbRhbRibRsRcbLgbLibLibLgbLgbLibLgLsRsbLgbLibRjb
RcbRgbRibRsbRoRebRhRsRiLsmbLhbLgbRsbsbRibRibRsbLcbLibLiLsbRsRsLsmbLsbL
sbLibRsRsmbsbsbsbsbRjRjbLebsbsbLibRcbLsRcRsmbRibRiLsRsbRiRsmbRsbRibLjb
LebLcbRobRsbLjbLhbLcbRsbsbRibRoRsmbRoLsRebRiRsmbRgRsmbLsbsbRsbsbsbsbRs
bLsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 21; Drug: Control Apo 50 然
bRhbRcbRcbRibRgRsmbRgRsmbRebRibRsRsRgRsmmbRobsbLgbRoRsmbRibRgbRibRiRib
RiRsmbRibRgRibRibRsRcbLsbLibLibLibLibsbLibsbLiRsbRcbRebRgbRiRiRsmbRgRs
RcmbReRebRgbLoLsmbLibLgbLgbLobRsbLobLibLiLsbLoLsmbLoLsmbLebLgbLgbLgLsb
LgLsbLgbLsbLibLcbLcbLebLgbLibLeLsbLgRsLsRsbRjbRcbRobRibRhbRibRhRsRsRsm
mmbRcRsRiRimbRiRsmbRiLsbRsbRsRgbRgbRgbRibRsbRiRsmbRcbRhbRcRsmbRgRiRebL
gbsbLsLobRcbLoLsmbLjbLobLobLibLibLgLcbLibLibLgbRcbsbsbRebRibLcbLibLhLg
bRsbLobLiLiLsbLibLebLeb

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 22; Drug: Control Apo 50 然
bLobsbsbsbsbLhbLibLibsbsbsbsbsbsbLjLsmbRsbRhbLsbRsbRsbRibRiRsLsmbRgRsm
bRiRsLsmbRsbRgbsbRiLsbRcbRoLsbRibRoLsbLsbRibRgbsbRsbRoRsLsmbLobLibsbsb
sbLibLsLsmbRsRsmbLibLgbRobRibRhbRgbRiLsbRgbLoRsbLobLgbLjLsmbLgRsRsmbRs
bLobLibLgbRibLsLsmbRibRgRcLsbRibRiRsmbRibLhbLhLsbLgbLgRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 23; Drug: Control Apo 50 然
bRsbRsbRgbRiLsbLgbLcRsbLgbLobLiLsbLibLgLsbLsbLgbLibRgbRibRcbRsbLibLebR
obRsbRiLsbLgbRsRsmbRcbLgbRhbLibRibLsbLibLcbLgLsbRebRhbLgbRibLgbRibRgbL
sRsLsbRgbRebsbLsbLsbRgbRjbLibRebLgbRgbRhbLibLcRsLsbLsbRsbLibLibLibRsLs
bRsbRhbRsbRjRsLsmbRgbRiLsbLjbRhbRsRsmbRibRgbLgbRgbRiRsmbRiRsmbRgRsRsmm
bRibRibRsRgRsmbRgbRgRsmbRgLsbLebRsbLsbLgbLsbLgLsbLgbRsbLgbLsbLsLgLsLgb
LgLsLsmbLsLsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 24; Drug: Control Apo 50 然
bRgbRibRgLsbRibRoRsmbRgbRsbLcLsmbLhbLibLibLgbLgRsbRcbRsLcLiLgLsbLgbLsb
LgbLgLsbLgbsbsbLiRsbLibLgbLibLgbLsbLiLgbLgbLsbLcbLgbRgbRcbLjbRsbRibRsb
RiRsmbRhLsbLsbRebRiRsmbRsbsbRibRgbRgbRgbRgbRsbRobRiRsmbRgbRibRibRgRgbL
sbRsbLsbRgbLgbRsbRsRsRsmmbRiLsbRsbRcbRsbRiLsLgbReRsmbRsbsbRsbLsbLsbLsR
sbLgbLsbLsLibRgbLgbLiRsbLsbLsbLiLsRsLsbLgbLibLgbLgbLsbLiRsbRsLgbLiLsbR
sRsmbLhbRgbRgLsbRgbRgbRoLsbLsbLibLibLgbLgbLgbLibLgbLgLgbLgbLhbRgbLibLs
bRjbRhbRiRgbRsbRgRgRsRgRsmmbRiRgbRsLsbRgbRsRsmbRsbRgRsmbRsLjbRcRsRsmmb
RhbRibLsbRibRsbRibLcLsmbLibLibLgbLgbLgbLgbLgLsbLgbLgbLsbLgbLgLsbLiLsLg
bLsbLgbLgbLsbLgLsbLgbLgRsbLgbLgRsbLgbLiRsbLsbLibLgbLgbLsbLgbLcbLsbLeLi
LsLsLsmmbRgbLibRgbRjbLebLiLsbLsbsbRcbRibRibRgbRgbRiRsmbRgbRiRibRibLsbR
ibLsLsmbLhbLibLhbLgbLibRibRgRsmbRhbRcLsbLsbRgbRcbRibRgRsmbRgbRsbLsbRsb
RibRgRsmbRsbRibRiRsRsLsmmbLebLsLsmbLibLgbLsLhLgbLgbsbRjbLhbsbRjbLiLsbL
cbLsLibLgLsbLsbLiRsbLgLsbLgbLgbLobLsLsmbLibLsbLiLsbLgbLgbRsbLgbLgbLsbL
gLsbLsbLgbLsbRcbRebRjbRgbRgbRsRibRjbRjbRiRibLhLsbLibLgbLiLgbLiLjbLiLib
LiLsbLebLhbLgbLeLsbLibLibLcLibRibRebRsRsmbRibRibRjbRibRhRibRgbRebRiLsb
LobRgbLgbLhbLhbLibLiLsRsRsmbLcbRgbLhbLebLiLsRsbRcbRibRgbRhbRobRibLibLg
RsbLgbLgbLgbLgbRgbLgLibLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 25; Drug: OSU6162 10 然 Apo 50 然
bLgLsbLsRsbRibsbsbRjRsRsmmbsbRcbRibLibRsbRjbRibRjRsRsmmbRsbRsbRcbRcRsR
smmbRibRiRsmbRgbRgbRibRsbRgbRgbRgLsbRsRsmbRiRsmbRiRsmbLsRsRsmbLsLiRsbR
sbLgbRibsbRebRcLsbRgbRgbLsbRcbLsbLebLebRgbLeLsbLsbLgbLsbLsLsLsmmbRgbRi
bLsbLsLsRjmbLcbLgbLjbRsbRcbRhbRibRibRjbRgLsbRgbRgbRsLsbRjbRgbRibRebRib
RhRsLsmbLgbLebsbLhbsbRsbRcbLsRsbRhRsmbLgbRibRibRibRsbsbRsRsmbRibRsLsbR
gbRhRsReLsmbRiRsRsmmbsbRsbsbRsbLsbLsbRsbRsLsRsbLhbLhbLibLsbLhbLsbLcbLi
bRibLsbLsbLsLsmbRjRsRsRsmmmbLgbLebRgbRsbRjbRibsbRibRoLsRgbRjbRjb

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 26; Drug: OSU6162 10 然 Apo 50 然
bRsbLhbRgbLgbRsbRobRgRsmbRibsbsbLgLsbRcbRcbsbRsbRobRsbLjLgLsbLcLsmbRjR
gbRcbRsRgbRgbRiLsbRibLsbRibRcbLsbLsbRibRcbLcbLcbLgbLcbLgbRjbLsRsbRcRsm
bRgbRibRibRcbRsbRebRiLsbRibRiRsmbLcRsbRoLsbRcbRsReRsmbRiRibRsbRebLgbRc
bLibLcbRgbRibLoLibLibLibLibRgbRcRsmbRgbRibLgbLibRjbRhRsmbRgbRsbRobRsRe
bRgbRibRgRsmbRibRsbRhRsRiLsmbRgbRgbRebRgRsmbRebRgbRgReRgRsmbRgbReLsbRg
bRsRsmbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 27; Drug: OSU6162 10 然 Apo 50 然
bLgbRsbLgbLsbLgbLgbLgbRsbRsbRjRibRgbRibLsbRoRsmbRsbRibRibRgRsRimbRsbLs
LsmbRibRgbLsbLcbLibLgbLgbLsLsmbLsbLgLsbsbLsbLsbLgbLgbLgLsRsbRsbRcbRgRs
mbRibLgbLcLsmbLibLibLgLsLsmbLsbLsbLgbLgLsbLgRsbLiLsbRhbRsbRgbRgbRibRgb
LsRiRsmbRebRibRsbRgbRgbRsbLsbRsbLibRebLobLgbLibsbRibRjbRhbRhbRsbRhbRgb
RgbRibRgbRgbRjbRcLsbLgbLibLiLsbLiRsbRsLiRsLsbLcbLiRsbLsbLgbLiLsbLgbLib
LcbRsbRgbRgbRobRsbLgbLhLgbLibLeLeLhLsbLibLibLgbLgbLgbLsbLgbLsbLiRsbLgb
LsbLsbLgbRsbLibLhbLibLibLsLhbLibLgbLgLsbsbRsbLsbRsbLjbLgbLsbRcbRgbRhbR
ibRgbRhLsbRiRsmbRebRgLsbRgbRsbLgbRsbLhbLibLsbLgbRsbRcbRhbRgbRiRsmbRgbR
sbLcbLgbLcbLsLeLibLiRsbLgbLsbLgbLcbRgbReRsmbRgbRoLsLgbLeLeLcLsLembLoRs
bRcRsmbRcRsRembRebRsRjbRhLsRiLsbReRcbReLsbRcRsmbRhRsRsmmbRgRsmbRgRsmbR
gRsRiRsRgLsmmbLsbLcbLcbRjbRcbRibRgRsmbRsbsbLsbLjbLsbLgLsbLeLsbLibLebLh
LibLiLebLeLeLeLsbRsLgbLgbLsbLsbLsbLgLsbLsLsmbRgbLibLcLsmbLibRsbReRsmbR
ebRhbReRebLibLgLsLsLsmmbLhbRsbLgRsbLgbLsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 28; Drug: OSU6162 10 然 Apo 50 然
bLsbRsbRsRsmbLobLhbLibRsbLgbLibRgbRgbRgbRsRsmbRjbRsbRsbRsbRsbRgbRcbRgb
RibLibRobRiRsmbRgbLcbLhbLsbLsLsRsmbLgbsbLsbLsbLibRsbLibLibRsbRcRgbRibR
gbRgbRgbRgbRsRsmbRsbRibRsbLcbRcbRgbLcbLiRsbRsbLebLoRsbLgbRiRsmbLcbRibR
ibLgbRgbRebLibLoLsRsmbLgbRsRsmbLgbLibLjbLgbLhbLibRcbRjbRhRsmbRjbLcbLjb
LibLgbLebLebLgbsbLjbRobLsbRibRgRsmbRgbRibRgbRsbRiRsmbRibRhbRsbRobRhbRi
bLgLsbLobRsbLsbRsLsbLcbLcbRibRcbRsbLgbLcbLibRsbLsbRsLsbsbRjbLibLcbRcbR
ebRhbRcbLgbRoRgRsmbRebLgbLgLsbLcbLgbLgbLgLsbRsRsmbLhbLobLgbLhLsLiLsbLg
LsbLibRgbLibRsbRsbRjbLgbLgLsbLgLsLsmbRcbRcRsmbRcbLgbRibRcRibRibRibRgbL
eLsbLibLgLebLsLsmbLobRsbLcbLiLgbLgLsbsbRgbRcbRibRibRsRsmbRgLsbRgbRgbRg
bRsLsbRhRsmbRibRgbRebRgRibRiLsbRgbRiRcRibRebRgbRgbRgbRgbRsbRsbLjbLcbLc
LgbRjbRgbRibRobLgLgbRibLhLsLsmbLgbLsbLsbLgbLsbLibRsbRcRsRsmmbRgbsbRgLs
LsmbRibRoLiLibLsLebLebLiLsbLibLgbLibLebLeLeLsbLibLibLsbLsbLobLcbLgbLoL
smbLhLeLsbLcbLebLgLsbLsbLgLsbLsbLsLsmbRsbLsbLsbLsbRsbLgbReRsmbRgbRhbRc
bRgbRebRibLgbRiRsmbLjbLobRsbLhbLiLsLebLebLgbLibLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 29; Drug: OSU6162 10 然 Apo 50 然
bLgRsbRhbRgbRgRsmbRibLgbLobLibLibLsbRsbRcbRibRsbRiRsmbRcbLsbLoRsbLsbLc
bRsRsLsmbRhbRibsbRgbRgRsmbLcbLcbRcbRcbRibRsbRiLsbRsbRibRgbRiRhbLebLoRs
bRoRsmbLsLgbLhbRsbLibRsbLsbLsLsmbRsbRobRibRhbLsbRcbRibRibRsLsbLobLoRsR
smbsbsbsbsbsbsbsbsbRibRjRsmbRiRsmbRibRiLsbRsbRiRsmbRcbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 30; Drug: OSU6162 10 然 Apo 50 然
bLsbRebRiLsbRibRibRibRibRobRgbRcbRibRibRhbLsbLcRsbLgbLgbLgbRsbLsbLsbLs
bLsbLgbLgbLsbLgbLcbRgbRcbRiLsbLsbLobLgbLibLsbLoRsbLiRsbLoRsbRsbRcbRibR
ibRibRiRsmbRibRhbRiRsmbRiRsRsmmbRebRebLsbRibRgbRebReLsbRgbRiRgbReRsRim
bLcbLsbLjbLobLobLibLiLsRsbsbLibLcLsmbRcbRibRebRiRsmbRiRsRsmmbRcbRcbRob
RcRsmbRobLeLsbLobLebLsbLibLsbLgRsLsbRsbRsbRsLsbRcbRibRhbRibRibRibRebRi
RibRibRobRcRobRebRebRebRgbRibRibRgbRebRebRibRcbRsbLibRgbRsbLsbLsLsmbLs
bRsbRsbRsbRgbRibRgbRgRsmbRiRsLsmbLhbLcbsbRgLeLsLibLibLiRsbLobRcRsmbRhb
RibRcbLsReLebLgbRobLebLeRsbLgbsbsbRcbRcbsbLsbLcLsmbLibLobLcLsmbLcbLibL
cLsmbLcRsbLeLsbLebLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 31; Drug: OSU6162 3 然 Apo 50 然
bRobRibRebRiRsmbRibRgRhbRebRiRsmbLsbLobLcbLeLeLibLjbLsbLgbLsLsmbLiLsbL
cRsbLjLhbLcbLgbLgLsbLibRhRebRgbRibRcbRibRebRibRgbRgbRcbRhbLcbRcRsmbRob
RcRsmbRebRebRibLibRibRebRhbRiRsRembLsbLjbLsLebLcbLsbLiLsbLiRsbLsLibLiL
sbLeLsbLibLcbLcbLiLsbLcRsbLhbLibLsbRcRibRsRsLsRsmbRebRobRcbLcLsmbLobRh
RgbsbRgbRebRsbLcbLcbLebLcbRibLcLiLebLcbLcbRhbRobRcRhbRhbRhRiRiRebRcbRc
RhRcbRobLoRsbRjbRibLobLiLiLgbLsbLcLsLsmmbLgbLibLibLibLsbReLcbRcbRcRsmb
RgbRiRsmbRobsbRobRgbRibRibRibRhRcbLgbLjbRcRsmbRhbRebRobRcRobRibLoLsmbL
cbRiLsbLcLsmbLcbLibLgLsbLobLsbLiRsbLibLhRsbLgRsbLcbLcbLibRcbRobRebRibR
iRsRembRibRobLibLcbRcbRhbRjbRcbRibLcbRcRebRobRgbRcbRibRoLsbRhbRibRcbRo
bRcbRebRhbRcbRjbRobRgbRebRibRcbLcRsbLcLsmbLibLiLsbLibLeLsbLhbLebLibLcb
LsRsbRsRsmbLjbLgbRsbLcbRsbRhbRsRhbRjbRcbRcbRjbRcbRcbRcbRcbRebRgbRjbRjL
sRsbRebLgbLibLobRsbLobRcbRsLoRsbLgbRjbRgbLgbRhbRobRcbRcbRgbLibLibLhbLe
LsbLcbReRsmbRcbRcbRcbRcbReRcbRhbRcbRcbRibRcbRsbLcbLhbLhbLcbLibLobLsbLe
bLobLsbRibRibRcbRibRhRsmbRiRsRsmmbRgRsmbRibRibRibLibRcb

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 32; Drug: OSU6162 3 然 Apo 50 然
bLcLsmbLibLobLcbRcbRibRoLsbsbLcbLcLsmbLcLsLsmmbRcbRcLsbRsbLibRsbLsbLib
LjLsmbsbsbsbLcbsbsbLcbLjbLhLsbLibLiLsbLibRcbLcLsmbLhbLibLhbLcbRhRsmbRe
bLib

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 33; Drug: OSU6162 3 然 Apo 50 然
bRcbRibRiRgbRibRgbRcbRgbRcbRoRsRgmbLibLhRsbLobReRgbRibRgRibLsbRgbRgLsb
RgRsmbRsbRgbRibRgbRsbRsbRhbRgbRcLsLgbLiRsbLgLsbsbRsRsRsmmbLcbLhRsLsRsb
LsRebRcRgbLibLiLsLsmbLibLgbsbLoLsLsmmbRsbLsbLoRsLiLeLibLgbLgLiLgLsbLgL
gbLcLsLgmbLcLeLeLsbsbLgRsbLibLiLiLibLgLoLsmbLhbLgLsbLibLhRsLcbLeLebLgL
sbLgbLgbLcbLhbLiLsLhLsbLiLibLibLgbLhRgRsmbRibRcbRhbRoRcRibRcbReRsmbRiR
hRsmbRibLhbRsbRibRiRgRsmbLjbRsbRibRiRibRobRgbLoLgLsbLgbLhRsRsmbLhbLsbL
ibLiLhbLebLebLebLebLebLebLobRiRsmbRhRsmbRsbRgbRsbRcbLcRgRsmbRsRsmbRsLs
bRibLgbRibLsLsmbRgbRgbRgRsmbRibRgbRiRhbLgbLibLibLobLgbLiRsbRcbLobLgbLg
bLgbLgbLsbLibLgbLhRsbLibLibLiRsbLobLgbRibRhbRgbRobLgbRibRsLobLibLibLgb
LsbLhbLgbLgbRjRibLibRgbRgbRgRsRgmbLibRcbLibRgbRobRsbLibLgbLjbLibLsbRib
LcbLob

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 34; Drug: OSU6162 3 然 Apo 50 然
bRibRibRcLsbRiRiRsmbRsbRhbRsRsmbRobRsbRsbRcbRibRgbRcbLsRsbRibRgbRiLsLg
bLibLgbLgbLiLsbLsbLiRsbLiRsbRibRgbRgRsRgmbRiLsbLgLsbRjbLibLjLsmbLebLeb
RcbRgRsmbRhbRibRcbRiLsbLgbLgbLibLebRebRibLebLibLibRgbRjbRibRibRiRsmbRs
bRibRiRsLsmbRgbRgbRhRiRibRibRgRsReLsmbRiRsmbRsbRibLsbRoRsmbRibRcbRebRe
RebRsbLcLsmbLcbLcbRibRcbRibRgbRibRibRiLsbRsbRsbRcLsRsbLcLsmbLcbRcbRhRs
mbRhLsbRiLsbLsbRhbRgbRgbRcLsbLgLsRsbRoRsmbRgbRiRgbLsRibRgRsRoLgmbLobRs
bLhbLhLgLibLsLibLebRsbLhbLsbLibRobRhb

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 35; Drug: OSU6162 3 然 Apo 50 然
bRibLjbRsbLgRsbRjbRobLobRjbLobLsLsmbLcbLsbLgbLcRsbLsLsLsmmbRsbsbRcRsmb
RiRsmbLsbRebRiLsRsLsLgbRjbRcbsbRcbLcbLcLsmbRcbLcLsmbLibReRsmbRgbLsbRcR
cbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 36; Drug: OSU6162 3 然 Apo 50 然
bLcbReRsmbsbLobRsbRhRsmbRiRsmbRobRcbRgbRsbRhRsLsmbLsbRoRsmbRsbRcbLobLc
LsmbLhRsbRcbRjRcRsmbRcbRgbRcbRgbRibLgbLobLhbLibRsbLhRsbLhbLgLsbLhLibsb
LsbLsbLsLsmbLgbsbLcbRcbLcbRoRsmbLsbLobLiLsbLibLhbLiLiLsLsmbLgbLsbLibsb
LsbRobRjRibLsRgRcLsRgRibLsLebLebLobRgbRiRsmbReRebReRsmbRebRebRebReLebR
obLsRsRsmbRhRsmbLhbRjbRgbRcbLjLsmbLibLcbLibLibLeLgLsLhbLgbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 37; Drug: OSU6162 1 然 Apo 50 然
bsbRgbRsbLsbRsbRsbRiRsLsmbLsbLobRiRsRiRgmbRibLsbLsbRibRgRiLsbRcbLibLsb
LiLiRsRsmbLhbLibRibRoRhRsmbRgbRgRsmbRgbRsRiRsRsLsmmbLsRsbRiRsmbRibRsbL
sRsbRiRsmbRgRiRsRgRsRiRsmmmbRibRgRsmbRsRsRsmmbRsbRsbRsbRsbRsbRsbRgLsbL
sb

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 38; Drug: OSU6162 1 然 Apo 50 然
bsbsbsbsbsbLsLsmbLoLsmbLoLsmbRcbRsbRcbRsbLcbLgbLsbLibRsbLobLsbRibRibRg
bLcbRjbsbRjbRgbRebLsbRsbLsbRsbRgbRsRsmbRcbRsbRgbLgbLsbRgbLsbLcbLsbLgbL
gLsLiLsbRjbLgbLhbRsbRoRsmbRgbRsRgbLsbLsLsmbLeRsbLsbLsbLsbLibRsbLibLsbR
sb

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 39; Drug: OSU6162 1 然 Apo 50 然
bLsbLgbRsbLsLibRibRcbRiLsbRcbRcRsmbRcRsmbRhbRibsbLsbRhbRiRsmbRsbRsbRsb
RsbRsRsRsmmbRsbRsbRsbRgLsbLsbRsbLcbLiLsbLsbLgbLgbLsbLeLeLgbLgbRsLsbLsb
LgbLgbsbLgbLibLibLiLsLsmbLcbRsbLgLsbLibsbLgbLgLsbLgbLgbRobRsbRcbRiLgRs
bRoLsRsbLjbsbsbsbsbRob

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 40; Drug: OSU6162 1 然 Apo 50 然
bLcLhbRgbRgLsbRibRgbRibRsRibRhbRiLsLsmbLeLeLebLebRgLcbRsLcbRibRcbLcLsm
bRoRsmbLsbLobLiLibRgbLsbLcbLibLgbLiRsbLgLsbLgbLibLsbLcLsmbLibRsbRibLoL
smbRsbLsRsbLgbRibLgbLgbLhbLiRsLhbLgbRebRgbRibRgbRgbRgbRsbRebLhbLoLsmbL
gbLibLhbRhbRibRiLsbRibRebRibRibRgbRibRibLibLcLsmbRsLiLsbLibRsbLhLsbRib
LcLsmbsbRibRebLgLsbLibLcLsmbLibLcbLebLsbLiLsbLiLsbLcbLgLsbLiLsbLcRsbsb
RcbLgbRgbRgbRhbRibLgbLcLsmbRibRobRibRgbRgRsmbRibRebRgRsmbRiLsbRebRgbRs
bRibRiLsbRiRsmbRibRibRgbRgbLsbLoLiLsbLibLgLsbLibLobLiLsbLsbLhbLhLsbLcb
LibLhbLiRsbLibRcLsbRebRibRiLsbRiRsmbRgbRgbRgbRgRsmbLjbRiLsbRhbRibRibRc
bRibRibRsRsmbsbRsbsbsbRgLsbLsbRibRiRsmbLcLsmbLcbLiRsbLibLcLebLcbLebLiL
sbLibRib

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 41; Drug: OSU6162 1 然 Apo 50 然
bLcLsmbRcbLcbLcbLcbRcbRcbRibRcbLgbLibLobRsbReRsmbRiLsbRgLsbRibRgRgRibR
sbRsbRgbRiRsmbRcbRibRoRsmbRiRsmbLjbLcbLibLcbLcbRibRoRsmbRgbRhRsmbRiLsR
sbRhbRiRsmbRhRsmbRibLcbRcbRibLgbRibRibRiRsRgmbRcbRibRibRibRcLsRsLgbRgb
RibRgRiRsmbRiRsmbRibRibLibLebLcbLibLibLebLiLsbLgbLiLsbLibLgbLgRsbLhRsb
RcRiRgbRsRibRhbRibRhRsmbRhbRgRsmbRibRgRsmbRgbRcRsmbLhLsbLcLsmbLcbLibRh
bRibRcRsmbRiLsbRsRsmbRcRsmbRgRsmbRcbRgbRcLsbLibLcbLibLcLibLiLeLebsbsbs
bLgbLebRcRsRsLsmmbLiLsbLibRsRcbRcbRibRibRibRibRiRsmbRhbRibRibRsRcbReRe
RsRhRsmmbRiReReRsmbLhbLhbLcbLcbLhbLjbLibLiRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 42; Drug: OSU6162 1 然 Apo 50 然
bLcLsmbLhbRgbRobRjbLsbLsbRiRgLsLsmbRgLsbRgbRgbRibRhbLhbLcbLeLsbRsRcRsm
bRcbRcLsbRsbRgbRoLsbRibRibRsbRgbRsRsmbLebLcbRibLoLsmbLhLsbLjbLiLsbLibL
hLsLsmbLjLsmbLibLcbLcLsmbLhbLiLgbLibLibLiLsbRobRgbRgbRibRiRsmbRibRgRsm
bLjbLcbLcbLibLebLibLgbLibRcbRebRcLsbLsbRoLsbRgLsbRibLobLibReLsbRhLsLsR
sRsRgmmbRgRsmbRgbRibRiRiRsmbRibRibRibRhbLjbLgbRsbLgLsbLiLsbLgbLoRsbRcb
LcbRsbLoLsmbLcbLsbLcbRjbRoLsbLjLgbLcbRoRsmbRobRebRgbRibRgbRibRgbRgLsbR
gbRoLsbReRsmbRibRsRsmbRobRgbRcbRgbRiRsmbRgbRgbRibRgbRiLsRsbLjbLcLsmbLc
bLebLhbLibLibLiRsbLhbLiLsbLhLsbLibLgbLsLsmbLsLsmbLsbLibRibRcbRhbsbRcbR
cbLebLebLibRsbRobRobRobRobRsbRibRhbRgbRgbRoLgbLibLgLeLsbLibLcbLcbLcRsb
LibLibLhLsbLiLsLgbLgbLgbLcLsmbLhbRibRcbRcbLgbLibLgbLgbLebRobLsbRiLsbRc
bRibRebRiRsmbRibLsbRhbsbLcLsmbLcbLibRebRebRebRebRhbRebRgbRgbLsRiLsbRgb
RgbRgLsbRiLgbLcbLgLsbLcbLiRsbLebLjLsLsmmbRobRibRiLsLsmbRgbRiLsbRibRibL
hbLcLsmbLhbLcLsmbLibLiLsbLiLsbLibLiLsbLibLsRoRsmbRoLsbRsbRoLsbRgbRgRsL
smbRgbLcLsmbLjLsLsmmbRcbRjReLsbRgbRibRgbRibRiRiRibRhLsbRhbRhLsLgbRjRsm
bRibRibRobLgbRobRebRiRsmbLgbLcLsmbLibLgRsbLibLsRsbRsbsbLibLsbRsLgbLiRs
bLibLibLcbLibRgbRcbRiLsRsbRgRsmbRhbRcbRobLsbRoLsbRhbLiLsbLibLiLsLeLsbL
obLebLibLsbRcbRcbRhLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 43; Drug: Control Apo 50 然
bLibLgbLgbRsbRgLsbsbRcbLobLhbRcbRibLobLobLsLsmbRibRoRsmbLobLcbRobRibRo
bRsRsLsmbLgbLibRsbRgbRobRsbLsRsbRobRobLcbLibRcLsRsbLcbRobRobRsRsmbRoLs
LsmbRsRcbRibRhReLsbLibLibLgbLhbLibLcbLgbLcRsbLibLgRsbRsbLibLsbLgbRsbLj
bLgbRsLcbLibLsLebLibLgRsbLsbLsLsmbRsLibLibLgbLhbRsbLcbLcbLibLjRsbLibRs
bRibsbRgRsmbRgLsbRoLsbLibLsLsmbRjRgbRibRibRgbLsLsmbRibRgbLsbRibLsbRgLs
bRobRsbRcbRibRcLiLsbLsRsbLsLobLiLsbLibLibLjbLibRsbRjRcbRoLsLsmbLgbLiLs
bLsLsmbLsbLgbLsbRjRhbRibRjbRcbRhbRibRibRjRgLsbRhbLsbLgbLibLcbLgbLgbLib
LibLsbLobLgbLgLsbLibLsbLibLsLsmbLiRsRsLsmbLgLsRsbLibLgRsbLsbLibLsLgLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 44; Drug: Control Apo 50 然
bRgbRibRhbRibRsbRcbRsRsmbRibRsbRgbLgbLcbLcbLibLgbRiRsmbRibRibRibRibLgb
RobRsbRhLsbLebLibLiLsLsLembLobLhbLibLhLsRsLgLgbLibLsbLiLiLgbLgbRcbRoRg
bRhbRiLsRsbRsRibLcLsmbLgbLcbLjLsLhRsmbLcbLibLsbLibRgbRcbRibRebRsbRgbRs
RgRsmbLsRsRsmbLsbLsbRsLsbsbLobLcbRcbLobRebLgbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 45; Drug: Control Apo 50 然
bLcbReRsmbLjbLjbLsbLibLibLibLibLgbRjbLibRcbRibRgbRgbLobRhbRjbLgbLjbLiL
sbLsbLibLibLsbLsbLibsbsbsbsbRsbLsLsmbLsLsRsmbLsLsmbLsbRsbRsLsRsRsLsmbR
sLsLsRsLsmbRsbRsbRsRsmbsbRsbRsbsbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 46; Drug: Control Apo 50 然
bRcRgRsRsReRsRiRsReRimmmmbLobLcbLebRcRsmbRcbRibRhLsRsLsLgLsbLibLsbRcLs
bRibRsbRgbRgbRgbRgbsbRsbLcbLcLsmbLcRsbLsLsmbRoLsbRcLsLsmbLsbRebRibRgRs
mbRsRiRsRimbLsLjbRsbRsbRsLsbLibLiLsbRcbRiLsbRobRsbRsbRobRibReRsRimbRgb
RgbLoLsmbLobLobRgbRhbRiRgRsRsmmbRgRsmbLsRsbRibRgRebRsbsbRcRsmbLcLsmbRo
bRcbRjRsmbRibRsRhLsbRsRgbRgRsRgRsmmbRebRgbRsbRgbRibLgRsLsbLiLhbLgbLhLi
LgLsLiLsLeLgLibLgbLgbLibLiLsbRcbRcbRcLsbLgbLcLsmbLiLgbLiLgLgLsLeLebLgL
sbLiRsRsRimbRhbRibRibRibReRiReRebReRsRembRibRobRsbRobLcbLsLcRsbLgbLebL
eLebLibLibLobRsbRhbRsbRebRhbRgbLhRsbLobLcbLibLebLeLsbLjLsmbRibRhbRibLs
RsbLgbLoLgbLcLiLsLeLsLeLeLibsbRcRsmbRcbRhbRcbRcbRhRsRgmbRcLebReRibRebR
eRsmbRsRsmbRebLsRsbLobRsbLsLsmbLibLiRsLsbLgLsbLgbRsbsbRjbLcbLobLibLibL
sbLhLsLebLeLebLebRobRebLsLsmbRsRsRsRemmbRobLjbRobRebRebRibRibRjLsbRebR
cLsbRgbRebLcbLibLcbLibLibLcbLhLibLcLsRembRhbLobLcbLibLgRsbRcbLobRhbLcb
RsbLcbLibRsLsbsbLgbLibLibLgLsLsmbLgbLebLjbLebLgRsbRcb

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 47; Drug: Control Apo 50 然
bRebRhbsbRjLsbRgbsbLhbLsbRibRjRsmbRsbRiLsRsbRgRsmbRcRsmbRsRsmbRjLsbRhb
RsbRsbRgbLsbRsRsRsmmbRhRibRiLsbRibLcLsmbRjRcRsmbRhLsbLiLsRsbRcbLgbLsbL
ibLhbLhRsbLiLsbLsbsbLgbRsRsRsmmbRsbRcbRibRiRsmbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 160314; End: 160814;
Recording: 2-1; Individual: 48; Drug: Control Apo 50 然
bLgRsbLgbRcbLhbLhLsbLcLsmbLcLsLsmmbLibLgLsbLgLsLeLsLgbLibLoLsmbLcbLcLs
mbLgbRibReRsmbLsbLsbRsbRibLgbRjbRebLebLcbLhbLibLcbLibLcbLeLsbRebRgbRib
LjbRsbRcbRjbLsLsmbRcLsbRcLsLsmbLibLgbLsLsLsmmbLebLibLibLcbLibLsbLsLsmb
LeLsbRibRcbRibRcbRgbRiRiRebRcbRibRjbRcRsRsmmbRsbLobLhbLibLhRsbLibLgbRc
bRibRibRiLsbLgbRibLjLcbLhbLebLibLcLsmbLibLgbLiLsbLsbLgbLcbLcbLebLibLib
LiLibLibLgLsbLsbLgLsbLobLcbLcbLibLeLsRsRgbRibRgRsRembRcbRoLsRsbRoLsbRc
LsbRibLoLsmbLoRgbLhLeLebRcbRcbRcbRhbRhLsbRibLsRcbRibRcRsmbRibReRsmbRgb
LsbRhbLibLcbLiLsLgbLhbLsbLsbLgLsbLibLsbLhbLhLsbLebLhbLiLeLsbLgLsbLgbLg
bLsbRjbRobRhbRibRiRsmbRhLsLsmbLsbRcbRibRibRgbRgbLjbLjbRsbLhLsbLcbLhbLi
bLsLsRgmbLebLibLiLebLcbLcbLcbLiLibLeLsbLgbLgLhbLebLcbLcbLiLsbLgLsbLsbR
hRsmbLibRhbRibRibRibRcbLsbRobRibRibRibRibRibRibRcRibReRiRsmbRibRhRiRsm
bRgbRhbLjbLibRcbRgbLjbLhbLcLsmbLhLsbLebLiLsLibLgbLiLebLgbLsbLgbRjbRcbR
ibRibRibLsbRibRibRgbRsbRibRcbRcbRibRibRgRsmbRibRibRgLsbRsbLjbLhbLjbLgb
LgbLcbRgLsbLcLsmbLibLiRsbsbLgbLcLsmbLcbLibLcbLibLebLgbLobLcbLobLibLcbL
cbLcRsbLebLsbsbLiRsbRibRjbRoLsRsbLsRjbRiLsbRhbRibRhbRiLsRiRebRhLsbRcbR
cbRcbRcbRibRgbRobRobRibLiRsbLcbLoRsbLjLobLiLsbLiLeLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 1; Drug: OSU6162 10 然 Apo 50 然
bLsRsbLgbLgbLsbRsbRibRiRsmbsbRobRgbRcRsmbRibRebRebRibRgbRgbRsbRoRibRsb
LiLsLsmbRgbRibRiReReRsRembLibLsbRobsbRebRcbRibRhRibRibRgbRibRebRoLsLsm
bRcbLcbRcRsmbRibRsbRsbLobLebLgbLgbRgbLcbRobLgRsRobRgbRebRebRsbRebLhLsb
RsLibLibLgbLiLsLsmbLgbLgbsbLibLiLibRebRgbRebRebsbRgbRgbRibLgbLsbRsbRib
RibRhbLibRhbLcbLebLgRsbLiLsbRjLsbLibLgLsbLgbLibLiRsbLgbLcLebLebLgbRgbL
gbsbLhLsbLibLsLsRsmbRgbRobRiRsRsmmbRiRsmbRsbLsLsmbLjbRcRsmbRsbRsbLhbLi
LsbLgbRjRsmbLgbLibLgbRsbRsbLcLsLsmmbLibLgbLibLcLebLcbLebLebLobRebRcLsb
RsRsmbRsbRibLiRsbLjbLebLsLibLsLsmbLsbLsbLgbLsRsbLgbLgbLsbLsbLsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 2; Drug: OSU6162 10 然 Apo 50 然
bRcbRhbLebLhbsbLgbRcRsmbRgLsbRgRsmbRhbRgbRibRsRsLsmbRgbRsbsbRhLsbLsbsb
LsbsbsbsbsbLsbLiLsbLgbRsRcbRsbsbsbLsbsbsbsbsbsbLjbLebLibLeLsbLgbLhLsbL
sLsmbsbsbsbsbsbLsRsbLsRsLsbsbRsLsRsbLsRsbsbsbsbLsbsbsbsbRsbsbsbsbsbsbs
bsbLsbRsbsbLsLsmbsbsbLsbsbsbLsbsbRsLsbLsbsbsbsbLsbLsbsbsbsbsbsbLsbsbsb
sbsbsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 3; Drug: OSU6162 10 然 Apo 50 然
bLobsbRibsbLsRsbRgRsmbLgbsbsbRsbsbLjbLobLsbLsLsmbLsRsbLsbsbsbLsbsbLsbR
sbRsbLsbLibRgbRjRibReRiLsLsLsmmbLgLgbLoRsRsRsmmbLsbRsRsmbLoLsLsLsmmmbR
cbsbRcbRjbLibLsRgbLsRsbRcbRjRobLsbRgbLjbRcLsbRsRsmbLibRiLsRsRsmbLgbRsb
RsLsbRebLiLsbLgbRobLebsbLebRgbRcRsmbLsRsbLebLebLhbLibLobRibsb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 4; Drug: OSU6162 10 然 Apo 50 然
bLgbLgbLgbLobRsLsbRcbRhbLeLsbLiLsbRsbLgbLgbLhbLcLebLiLhLibLgbLebLsbLgb
LibLhLeLsbLhbLibLhbRcRsmbLsRibRcRsmbRibRcLsbRibRsRiRebLsRsRsRsmmbLsbLe
bLcbLhLiRsbLeLsbLsbsbLsbLibRibRgReRgbLcLibLcbRhbLcLjbLebLebLebLsbLebLe
bLiLsbLibLebLsbsbRsRgRsmbsbLebLibRsbLgLsLsmbLibLhbLebLcbLiLhLsbLiRsbLe
bRobLcbLcbLiRsbLcbLgbLebLiRhbRibRgbRsbRsRibRhbRcLiRsbLiLsbLsLeLebRobRc
bsbsbsbLsbRibLcbLcLsmbRjbRhbRobLhbLsbLiLsbLhbReRiRsmbRiRibRibRhReRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 5; Drug: OSU6162 10 然 Apo 50 然
bsbRsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbLsbsbLsbsbLsbsbsbRsbsbsbsbsbLs
bsbsbRsbsbsbsbLsbsbsbLsbsbsbsbRsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbLsbLsbsbs
bsbsbsbsbRsbsbsbsbsbRsbsbsbsbsbsbsbRsbRsLsbRsbLjRsbsbsbLsbLsbLjbRsbLsb
RsbLibLibLsbLibLsLsLgmbRibLeLebLiLeLeLsbLib

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 6; Drug: OSU6162 10 然 Apo 50 然
bRebRsbReRsRsmmbLobsbLibLhRsRsmbLsbLhbLgbLoRgRsRsmmbLcLibLiLhbLibLjbRg
bRgbRcLebRobReRebRibRebRebRiReLjbLgbLeLsbLgbLsbsbsbLcLsmbRobRebRhbRibR
cRjbRgRhRgbRebLsbRobLjbLobLobRgRsmbRsbLhbLibLebLibLibsbRcbLobLcbRsbRsb
LgbLcbLcbLsbLibLsbRsLhbLhbRjbLgLsbLhbLebRgbLobLiRsbLhbLiRsbLcbRiRsRemb
RjbRgLsbRgbRcbRsRsmbRsbRhbLjbLibRjbRhbLjbRcbRiRsmbRibRebRibLcbLgLibRhb
RsRiRsReRembRgbLibLibLobLhbLhbLcbLibRsbRhbLoRsbRcbRobRiLsbLsRcbRibLjbR
obRobRcbLjbRjbRhbRibLcbLcbLjLgbLcLsmbLhLsbLhbRjbRcbRsRebRibRgbRhbRjRsm
bRgbLibLcLsmbLibLcbLeLsLsmbLebLibLebRcLsbLgbLiLsbLcLsmbLgbLhbLebLibLgR
sbLcbRibRcbRiRsmbRsbRiRsRsmmbLcbLcbLcbLibRcbLsLsLsmmbLibLgbRjbLcLsmbLi
LsbLsbReRsmbRobRhbRcbReLsbLibLcLsLsmmbLcbLibLeLsbLcRsLsRsbLcbRoRsmbRiL
sbRhRsmbRoLsbRobLebRcbRiRsLsmbRgRsmbLebLhbLcbLhbLhbReb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 7; Drug: OSU6162 3 然 Apo 50 然
bRcbRhbRsRgLhbRsbRibRiLgLsbRobReRsmbRibRiRcbRiRiRibRiRsmbRgbLobLibLcbR
hbRcbLgbRhLsbRgRgRsmbRibRiRgRsmbRsbRsLsbRsbRgbLsRsbLcbLsbRcRsmbRibRgbR
iRsmbRgbRgLsbRibRiRsRsmmbRgbRgbRibRebRiLsRiRsmbRoLsbLhLsLiLiLobReReRsm
bReReRsmbRebRiReRsmbRiRibRobLgbRcbRsbRcRsmbRhRsmbRiReRiRiRibRgRsmbRgbR
ibRcbRgbLgbRibRhbRgRsLsmbRgbLsbRsbsbLsbRsRsmbRsbRsbLsbRsbLsLsmbLsRsbLs
bLsRsbLsLsmbRsLsbLsRsRsmbLibLgLgLeLsLiLibLgbRsbRsbLsbLsbRsLgbLobLibLib
LhbLiRsbLiLsLgbLgbLibLibLibLoRsbRiRsmbRgbRiRiRibRgRgRebLsRsbLsbLsbsbRs
bRsbsbsbLsbLcLsmbLgbRebRgbRgbRiLsbRoRsmbRiRhLsRgbRgbRgRebRgRsmbRgbRgRs
mbRgbRgbRibLgbLhbLobLiRsbLiLiLsbLibLgbLibLhbLgbLgbRjbLobLcbLibLgbLibLg
LsbLibLiLiLibLibLiRsbLhbLgbLgbRhbLsbLebRobRgbRgbLebLibLsLeLgbRjbRsbRib
RibLjbLibRcbRibRobRobRibRjbRiRsmbRsbRobLhLsbRjbLjbLhbRjbsbLobRgbLcbLgb
LibLibLgbLgbLebLsbRhbRjbRobRjbLgbRibLcLsmbRsRsLsLembLebRobRjbRsbRibRgb
RgbRibRibRhbRgbRibRibRgRsmbRgbLsbRibRibRcbRcbRgbLsRjbRgbLebLgbLiRsbLgb
RgbLibLgRsbRjLsbLibLiLsbLgRsbRsbLcbLiRsbRsbRhRsmbRgbRibRgbLibLgbRibLib

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 8; Drug: OSU6162 3 然 Apo 50 然
bsbsbsbsbRgRsLsmbRibRsbRcLsbRgbLsRgbRibRiLsbRiRgbRibRgbRibRcLsbRsbLibL
gRsbRcLsbLibRcbRibRibRgbRgbRgRsmbRhbRsbLhbLobLgbLiLibRhbLebLibLcbLgbRi
bRgbRibRiRsmbLsbLgbRcbRiRsRsmmbRcbLcbLcbLgbLibLiRsbLgbLsLsRsmbRibRgbRh
bLsbRibRibRgbRgbRgbRibRgbLgbLibLgLsbLgbLibLgbLiRsbLibLhbRgRsmbRjbRcbRg
bRibRcbLgbLgbRjbRibLsbRebLsbLgbLiLsbLgbLeLsbLebRjbLibRsRsmbRibRgbRibRg
bLgbLiLsbRjRibLjbLhbRhbRhRsmbRjbLgbLsbRiRsmbLjbRcbRiRsmbLgbLcbLibLjbRi
bRhbLsbLjbLcbRibRsLcbRjbRibRibRgbLsbsbRjbRibLgbsbLsbRebLiLsbLgbLhbLcbR
ibRibRebLgbRebRcRsLsmbLiLsbLibRjRsmbLibLibLjbRibRcRsmbLsbLiLsbLcbRsbLj
bRibLjbRibLcbRibRiRsmbRibRibRsRsmbLhRsbRjbRjbLsLsmbRgbRibReRsmbRsbRibL
gbLjbRsbRibRibRgbRebLibLibLgbLjbRsbLibRiRgbRibRjbLcbLibRhbRibRibLcLsmb
RiRsmbRgbLobRibRibRsRibLsbRebLhbLibLjbLsbLjbLibsbLcbLibRcbLhbLibLibRcb
RhbRibRibLiRsbLibLcbRibLsbLobLgbLsbRjbRhRsLsmbRgLsbLebRcbRibRcRsmbRsLs
LsmbRibRcRsmbLhbRcbLebLhbRsbLcRsbLibLiRsbRgbRiRsmbRibRgLsbRibRiLsbRibR
cbLibLjLgbLibRsLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 9; Drug: OSU6162 3 然 Apo 50 然
bLiLsbLibRgbRgbRibRcbRsRibRcRsmbLgbLhLhLgbLoLsLsmmbLeLebLsbLsbRsLsRsLs
bLsRsRsLsLsLsmmmbsbLcLsmbLjLgbLhbLhbLibLibLsbLoLsRgRimbRhbRgRsRsmmbRib
RibRcbRhbRhRhbRiRsRhmbRiReRsmbReRsRsmmbRgLsbRsbRhbRcbRgLsbLibLebLibLcb
LibLibLgLebLsbLsbLsRsRsmbLsLsLsLsLiLsLsLsmmmmmbLhLsbLibLcbLoLiLsLeLibL
ebLhbLobRsbReRsmbRibRobReRgbLebRoLsbRobLgbRebReRgRsmbRibLsbRsRsRsRsRsm
mmmbRobLgbLeLsbLobLcbLiLiRsbRgbRgRsmbRgbRgbRcbRiLsbRgRsmbLebLhbLhLgLeb
LobLeLsLsmbLobReRsmbRibRgbRsRsRsRsmmmbRsLsRibRcbLhbLibLibLhLsbLibRsbRi
bLjbRgbLsRsRsRsRsRsRsmmmmmbLsbRsRsRsRgmmbRsRsRsRsRsRsRsRsRsRsmmmmmmmmm
bLebLibLibLgLcbLgbLgbLibLeLibLgbRibRcbLsbRsRsRembRgbRgbRgRgRgbRhbRgbRi
bRibRgbRcbLcbLsLhbLhbLcbLhbLoRsbRsLsbRibRobRibRcbRiRsmbRoRsmbRcbRobLib
LeLsbLobLebsbLcbLhLsbRjRibRibRibRgbRebLsbRibRhbRibRibRjbLgLsbLebLcbLoR
sbLibLcbLobRgbRgbRsbRibRsLsbRsRsRsRemmbRgRsmbRobRibRhbRibLsLsLsLsLsmmm
mbRsRsRsRsRgmmmbLsLebLiLsbLgbLoLsmbLcbLhbLiRsbLebRibRibRibRjRibRgbRsbR
cbRibRibRgbLebLoRsbRgbLcbLcbRsbLcLsLsmmbLibRibReRsmbRcbRibLgbLsLcbLhbR
gbLibsbLcbLcbLgRsbLobRibLsLibLsLiLsbRsRgRsLsmbLsLsmbLgLsbLsbLsbsbLebLs
LsLsmmbLhbRgLsbLsbLsLsmbLsLsLsLsRsmmmbLsLsLsmmbLibRibRhbRiLsbRibRhLsbR
ibRiLsbRgRsmbLhLsbLcbRiRsmbRcRsRsmmbRiRsmbRgRsLsmbLjbLcbLsLcbLibLibReb
RobLgbRhbRgRsmbRibRgbRgRsRsRsmmmbLjbLeLsbLibLsLibRcbLjbLcRsbRgbLsbLebL
ebLiLgLgLsbsbsbsbLgRsbRcbRhbRcbRiLsbRibRgbRcbRsLsbRhbRibRgbLcbLibLibLi
bRjbLsLobRibLgbLibRobRhbRiLsbRiRsRgmbRibLebLgbLibLgbRibRibLsLcbRhRsmbR
cbLgbRgRsRsmmb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 10; Drug: OSU6162 3 然 Apo 50 然
bRibsbsbLgbRsbsbRobLsbLjbLcbRcbRcRsmbRsbRiRcbRgRsRiRsmmbLsbLsbLjLsmbRs
bsbRsbLgbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbLsbLsbsbsbsbsbsbsbsbsbs
bsbsbsbsbLsbsbsbLsbRsLsbLsbsbsbRsbRsbRsRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 11; Drug: OSU6162 3 然 Apo 50 然
bReRsmbRebRhRsmbRibRibRsbRcLgbRoRsmbRiRsRsmmbLjbLhLsbLgbRobRebRebRobRi
bLgbLgRsbLjbLgbLgLsLsLsmmbRcbLsLsmbLsbLgbLiLsbLsLsLsLiLsmmbLsbLgLgbLiL
sLhRgbRibRsbReRsmbRoRsLsmbLsLsmbLibLsRsbLibLsRsbRsbsbLsbLsLsmbLiRsbLsL
smbRsbLsLsmbLibLgbLsLsmbLsbLsbLiLsbLgbLgLsLsmbLibLibLsLsmbsbLsbLiRsbRc
bLcbLcRsbRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 12; Drug: OSU6162 3 然 Apo 50 然
bLiLsbLsbLgbLiRsLiLsbLhbLgbLgLsbLibLibLgLsbLsLsmbLgbLiLgLsbLiLsbLgbLgb
LgbLgbLiRgbLhLsbRhbsbRiRsmbLsRgLsbRgbRgLsbRsbRhRgbRgbRgbRgbRgbRsbRsbRg
bLsLsmbRgRsmbRsbRgLsbRgRibRgRsmbRgbRsbRgbRgbRgbRgbRiRsLsRgmbLcbLiLsLsm
bLsbLgLsbLsLgLsbLgbLgbLhLgbLiLhLiLiLsbLgbLgbLgLsbLgbLgLsbLobRsRgLsbRiR
smbRiRsmbRsRsmbRgbLsbLsbRgbRiLsbRiRsmbRgbRsbRsRsLsLsmmbRiRsmbRgbRgRgbR
hLsbRibRgRsmbRgRsLsLsRsmmbRgRsmbRgbRibRgbsbRgbRibLsbLcbLgLsbLgbLgbLgLi
bLiLiLsbLebLgRsbLsLibLgLsLsmbLgbLebLgbRsbRibRibLcbLcRsbLhLsLsmbLsLsmbL
gbLgbRebLobRibRsbRiLsbRsRsmbRgRsmbRgbRiRsmbRgbRgbRgRiRsRgmbRiRhLibLhLs
LsmbLgLsLeLsLsmbLgbLiLiLgLsLibLgbLgbLsLsmbLiLsbRsbRcbRibLgbLcbLgbLibLi
LsRsbRhbRiLsbRibRgbRibRgLsbRgbRibRsbRgRsmbRsbRiRsmbRibRgbRibRgRgbRgbRi
RsLgmbLhbLibLiLsLibLeLebLiLsLeLsbLgbLgbLcLiLsbLibLeLeLebLgLsbLgbLibLiL
ibLgbLgLiLgLsbLebRsbLgbLiLsbLgbsbRsbRcbRibRiLsbRgbRgbRiLsbRgRsRimbRibR
ibRibRgRgbRiRsmbRgRsRsRimmbRiRsRsmmbRgbRiRsmbRgbRsbRiRsmbRibRsLsbLsRib
LgLiLsLsmbLiLsLsmbLiLebLibLgbLiLsbLeLhLibLibLiLibRsLgbLibLiLsbRebRibRi
RsmbLsLsmbRcbRiLsbRgbRhbRibRiRibRgRiRsRimbRgRsRiRimbRibRiRsRembRibRiRs
RsRsmmmbRgRsmbRsbRibRgRsRimbRgbRiRsRimbRgRsmbRibRgbRgbRgbReRebRibRgbRg
bRgbRibRgbLsLsmbLhbLibLiLsbLgbLgLsbLgbLiLiLhLiLeLeLiLsbRsLibLhbLiLsbLi
bLiLibLhLsLsLhLeLhLsmbLibLiLsLcbLeLebsb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 13; Drug: OSU6162 1 然 Apo 50 然
bRsRsRsRsRsRgmmmmbLsRsRsRgRsRsRsRsmmmmmbRsbRsRsmbRiRsmbRsRsmbRiRsmbLsb
sbRgbRibRhbRgbRhRsmbRgbRiRsRsmmbRiLsbRibRgbLobLibRobRiLsbRcbLoRsbLhbLe
LsbLhRsbLibLhbRsRsRsRgmmbRsbRsbRsRsRsRsmmmbRsRsmbRhRsLsmbRibLebLibLiRs
bLhbRsbRsbRebRibLsLsmbRiRsmbRibRibRibLgbRibRgbLebLsLsmbLsbLgbLsbLiRsbs
bLebLgbLhbLibLjLsmbRsRsmbLsLsmbRcbRhRgRsLsmbRiLsbRibRibRgbRgbRibRibLsb
LhbLhbLibLibLsbRsbRcbRhbRgbRgbRsRsRsmmbRsbLcbLgbLibLebLibLsbLsLsmbRcbR
ibRibRhbRibsbRgLsLsmbLhbLiLsRsLsbLeLsbLgLgbLebRiRsmbRibRhRsmbRhbRsbRib
RsRsmbRibRibRsbRiRsRsmmbRsRsRsRsmmmbsbRibLjbLhbLebLibLsbLgbLsRsbLsRcbR
cbRsbRsRgRsmbLjbLebLsLgLgbLsbLsLibLsLsLsLemmbLibLhLgLsbLiLsbRgRsRgmbRc
RsmbRibRibLhbLibLsbLsLsLsLsLiLsmmmbLsbLcLsmbRgbLgLsbsbLsbRibRhRgRsRsmm
bRsLsbRsRsmbRebRsbRsRsmbLgbLsbRhbRebRoLsbLsLsLsmmbLibLsbRebRgLsLsmbLgL
sLsmbLsLsRsmbRsRsRsmmbLiLsbLhRsbLgLsbsbLcRsRiLsbRhbLgbLobLsLsmbLsbLsLs
mbRjbsbRiLsbRgbRgRsmbLebLibRsRsLsLsLsmmmbLsbRcbRiRsmbRsbRsbRcbRsLsbRsb
RsbRibLgbLsbRsRsRsRsRsmmmmbLcRsbLgLsLsmbLgLsLsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 14; Drug: OSU6162 1 然 Apo 50 然
bRsRsmbsbsbLcRsbLcbRibRoLsLsmbRcbRhbRibRibRibRhbRsLgbLgbLiLgLsLsmbRhRe
bRebRiReRsmbRoLcbRgbRcRsmbsbLjbLebLibLgbRobRgbRoRsRoRiRcmbRiRsmbLcRsbL
ebLgLibLcbLgLsLibRibLibRebLsbLsbLsbRhbRobRcbRoLsLsRsmbLsbRjbRcbRgRiRgb
LebLoRsbReRsLsLembLsbLeRcLgbRebRobsbLobLhLsbLobLcbLhbLibLiRgbRsRebRiRj
bLeLsbRebRcbRebRibRibRcbRsbRhbRiLsRsbRibRiRibRcRgRsmbLgbRsbLcbLcbLcbLi
bRjbLoLsmbLgbRjLoLsmbLobLiLoLsmbRgbRsRsmbRsRsLsmbLsbLeRiRibRiRgbLsLibL
sbLsLgLsLsmbRebRobLobLibRgLsbLobLsbRibRibRibRibRsbRobRjbRcbLgbLhbLiLsb
LibLobLibLibLibLibLsLgbLibLgLcbRcbLjbRhbRibRibRjRsRsRsLsmmmbRcLsbRibRc
bLsLjbLebLgbLhbLgbLcbLgLsbLoLsmbRsbRebLcbLibsbRsbLhbRgbRobLgbRoLsbLibR
cbRebRgbRibRsRsmbLjbRibLhRsbLjbLibLibRgbRebRcbLjLsmbLgbRibRcbLjbRcbRgb
LgbLsLcbLibLgbLjLsmbsbRcbLjbLgLgbLibLgRsbRibRcLsbLgbRcbRebRibRibLibLcb
LibLibLibLgLsbRibRebLgbLjbLibRcbRobLgLsbRebRibRobRoRsmbLobLibRhbLcLsmb
LsRsbLibLiLsbRibLibRgbLibRhbLcLsmbRsbRhRsmbLhbRcbRibLjbLcRsbRsLsbRgRsm
bRjRsmbRgRsmbRiRsmbRcbRobRcbLsRhbLibLebLgbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 15; Drug: OSU6162 1 然 Apo 50 然
bLsbLsbRsbsbLgbLgLsbRgLsbRebRibRibRsbsbRsRgbRsbRsbRsRsmbRsRsRsRsmmmbRh
bRebRibRibLjLsmbLgbLibLsLsmbLsRsbsbLsLsLsLsmmmbLsLsLsmmbLsbLsRsbLsbLiR
sbRgbRgRsRsmmbRsbRgbRsRsmbRsRsmbRsbRibRgbRgRgbRibRibLgbLjbRjRsmbLsbRgR
smbRsbRsRsRsLsmmbRsbLsbLcbRjbLsLibLiLsbLsLsmbLsLsRsmbLsLsmbLsbLsbLsLsm
bLsLsmbLsLsLsmmbLsLsmbLgbRebRiRsLsRsmbRibLsLsmbRsbLcbLcbLgRsbLiLsbLjbR
hbRibRgbRgbRobLgbLsbLsbLgLsbLjbRibLoLsmbLibLibLibLiLsbLgbLgbLgbLgbLsbR
sRsmbLgLsbLsLsLsmmbLgbLgbLgLgbLgbLgbLgLgbLgLsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 16; Drug: OSU6162 1 然 Apo 50 然
bLsbLhbLibLibLiRsbLsbRjbRhbRiRsRsmmbRobRgbRcbRibRibRgLsLsmbLiLsbRjRsmb
RsbRsRsmbRsRgRsRsmmbRgbRgbRsbLsbRsbRhbRebRibsbLgRsbLcbLgLsbLibLibReRsm
bRibRobRgbLibLsbRgbRhbRgbRcbRcbLsbRcbLsRebRhbsbLibLjbLgbLgbLibLgLsbLjb
RsRsmbLsLsmbRsbLsbRsRsmbsbLiLsbLibLobRibRebRjbRcRsmbRjbLsbRjbRobRibLhb
LiLsbLsbLgLsbLobRibRebRcbRgbRgbRgbRsbRsRsRsmmbRcbRgLsbRjbRcLsbRsbLobLh
bLiRsbLjLgbLhbLibLhRsLsbLibRibLebRsRsmbLobLibLcbLgLsbLsbRsLsbRgbRgbRgb
RgbRjbRhbLibLjbLiRsRsmbLsbRhbRgbRiRsmbRsbLgbLsLhbLcbLsbLibRsbRcbRgbRjb
LsbRebRibsbLgRsRsmbLjbRibRsLsbRibRgbLsbLjbLiLsbLjbLsbRgRsmbRebRjbLsbRe
bRgbRsbLibRiRsRsmmbRgRsRsmmbRgbRgbRsbRjbLsbLgbLiLsLsmbLibLiRsLsbRgbRib
RsRsmbRhbLcbLibLgLibLgLsbLhbRsbLibLiRsbLobRsbLsbRhbRibReLsbRsbRgRsmbLe
bLiLsbLgbLgbRsLsbRebRibLsRsbRiRsRsmmbRsRsmbLebLibLgLgbLgbLgbLgLsbLeLsL
gbLobRsbRhRsmbRgRsmbRsbRgbRibRgbRgbLsRsbLcbLiLsbLgbLcLsmbLibLhLsLibLib

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 17; Drug: OSU6162 1 然 Apo 50 然
bLcRsbsbRsRsmbRsRsLsmbRgLsbRiRsmbRsRsmbRgRsmbRgRsmbRgbRgbRgbRgRsmbRgbR
sRgRsRimbRsLsbRsbRsRsmbsbLsRsRsRsmmbsbsbRsbLsbRibRsLsbsbLgbRcbRgbsbRsL
sbLsRsbRgbRgbRgbRgRsmbRibRgbRsbRsbRgbRsbRiRsmbRgRsmbRsRsmbRiRsRsmmbRsb
RgbRsRsmbRsbLsRsbRsLsbRsbRsbRgbRgRsmbRsbRsbRiRsmbRibRsbRgRsmbRgbRgLsbR
gRsmbRgbRgLsbRgbRiRibRgRebRsbRsbRiRsmbRsbRgbRsbRgRsmbRgbRgRsmbRgbRgbRi
bRsbRiRsmbRgRsmbRsbRsRgbRgbRgbRsbRsbRibRiRsmbsbRsbRhbRgbRgbRgbRsRiRiRs
LsmbRibRgbRgRsmbRgRsmbRsbRsRsmbRgbRgbRgbRgbRiRsmbRgRsmbRgbRgRsmbRsLsbR
gRsRsmmbRgRsLsmbRgRsmbRgbRgbRibRgbRgbRgbRibRhbRgbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 18; Drug: OSU6162 1 然 Apo 50 然
bLsbLgLgbRebRgbRibRibsbRgbRgbRgbLiLsbRcbRhbRsbLobLiRjbLsbLeLcbLobRgbRe
bRoRsmbRobRgbLobLcbLibLgbLibLobLsbRebRgbRhLsbLibLobRobRebLsRsbRgbLcbLc
bLcbLsbLoLsmbLgbLgbLobLobLobLiRsLhbLsbLebLobLobLibLibRcbRcbRgRsmbRgRhb
LsbRebRobRiLsbRoLsbRibRgbLsbLobLcbLhbLiLsbLsbLcbLgbLsLsmbLcbLibRhbRcbR
ibRhLsbRgLgbLsLobLsLsmbReRibRgbRibLsRsbRiLsbRebLibLobLobLibLhbLoLsmbRg
bRibRgbsbRobRsbRsRsmbLobLobRcbRhbRibRhbRibRoLsbRgbLsRsLcbLgbLsbsbLgbLo
LsRsmbLibLibLobLhbLobLgLsbLobLsbLgbLcbLgRsbLobLgbRoLsbRsbRobRgbRcbLgbL
cbRobRibRiLsbRibRsbLjRsbLcbLgLsbLobRsbLcbLobRsbRcRsRsmmbRgbRgbRibRibRi
bRibRibLgbLiLsbLcLsmbRgbRcbRhbRgbRibRgbLgbLhLsbReRsmbLobsbRibLeLsbLcbL
iLsbLibLobRsbLsRcbLgbLjbLobLiLsLsRsmbLobLcbLgbLjbLibRcbRibLobRgbLsRobR
obRibRgbRebRgbRibLsbRobRgRibRgLsbRobLgLsbLgbLgLsbLgRsbRcRgbRcbRiLsbLeL
sbRsbRcRsRsRsmmmbRobLhbRobRibRibRibLsbRibRgbLsbRhLsbRsRsmbRgbLobLibLib
LiLibLibLcbLiLsbLobLgLgbLibLgbLobRgbRgbRoLsbRiLsbRcbRiRsmbRiRobLsLsmbR
obLgbLcbLhbLhbLcbLhbLgLsLiLibLiLsbLgbRobRcbRibRgLsbRibRobRcRsmbLgbRobR
sLsRsbRobLgRcLsbRcLsbRibRiLsLsmbLgLsbLibLsLibLsRsbLoLsmbRhbRibRhRsmbRo
bsbRibRobRgbLcLsmbLcbLibLibLcbLibRhLsbRhbRiRobLsbRgbLsbRobRib

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 19; Drug: Control Apo 50 然
bsbsbRcbRibLobLcLsmbRgbLsbLgLibRcRsmbRcRsmbsbRhbRcbLcLsmbLcRsbLgbLcRgb
LhLsRsbLgbLgLebLobLebLebRjbRsLsbRcbRjRsRsmmbRgbRibRobRcbRibRibRibRgRsR
gmbsbRiRebLjRsRsmbRcLsbLobLhLsbLiLsbLhRgbRibRgRebRobRcRsmbRibRibRebReb
RebRibLjbRibRcRcbRcbRgRsmbRgRsReRimbRhLsbRibLobLoLibRsLeLsLhLgLhbLebLe
bLobLcbLobRebLcLsmbLcbLibLgbLgLsbLsLsmbsbLsRsbLibLibRoRsmbRebRcbRgbRjb
LobLiLsLsmbLebLgbLiRsRsmbLibRcbRobRcbRcbRiRsmbLcRsbLoLsRembLhRsbLibLhL
jbLsLgbLebLobLebsbLiRsbRhbRcbRiRsRimbRebRoRcbRebRsLsLsmbLebReRsmbRsRib
RcRsmbLsbRsLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 20; Drug: Control Apo 50 然
bsbRsbLcbLjbLsbLsLcLsmbLcRsbLiLsLiLgbLibRsRsmbRsbsbsbsbLsbRsLsbLsbLsbL
sbRsRsmbLebLoLsmbRobReRsRcmbRhbRibRibRsbRebRgLsRsbRobRibRgbRoLsbLsbLgb
LcbLiLgbLiRsbLgbLgLsbLobRgbLsbLobLebLebLebLjbRgRgbRiRibRebRgRibRcRoLib
RjbReRsmbLibLgbLibLgbLgbLgLsbLgbLgLsbLgbLgLsbLgRsbRibReRsmbReRsRsLsmmb
RgbRibRiRgbRhbRiRiRcbRsRsmbRsRobLsbLhLebLgbLiRsLsRsLhLibLeLebLebsbsbLs
RsbLibLgbLgLsbLhLiRsbLiLsbLibLibLiLgbRcbRhRgRsmbsbLsbRgbRibRcRsmbRgbRo
bRhbRgRibRgbRgLsbRgbRibLcLsmbRebRgLsbRhRsmbRiRiRsmbRiRsRiLsmbRsbRsbRsR
smb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 21; Drug: Control Apo 50 然
bsbsbsbsbsbsbRsbsbsbsbsbsbsbRsbsbsbsbsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 22; Drug: Control Apo 50 然
bRibRcbsbRibRiRsmbRsbLjbRcLsbRibRibRiLsbRgbRjRsmbRgLsRiRsmbRgbRhbLsbLc
bLhLsbLhbLgbLsLiRsbLhRsbRcbLjbLjbsbLsbRobRobRhbRibRhbRibRibRiRsmbRoLsb
LibLeLhRsbLebLcbRgbLebLebLgbReRsRsmmbRhbRobLobReRsmbLiRsbLiRsbRebRgRsR
smmbLsbLsbLsLsmbRsbRsRsmbRsbRsLsbLsbLsRsbLsbLsbLsLsmbsbLsbLsLsmbLsbLsb
LsbRsLsLsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 23; Drug: Control Apo 50 然
bLgLsLsmbRsLgbLgbLiLgLebLsbLibRgLsbLobLsLsRsRsmmbRebRgbRhLsLgbLgLsbLgb
LgLsbLgLgbLgbLsbRobRhbRgbRsbRgbLsbRgbRsbRsRsmbRsRsmbRgbLsbsbsbLsbLgLsb
LsLsmbLsbRebRoLgbLibRsbRibRsbRjbLsbLiRsbLebRsbLebLsbLiLsbLoRsbRsbRibLj
bRgRsmbRibRgbRgbRgbRjLsbRsbRsRsLsmbLebLsbLibLiLsLibLgbLgbLebLgbLsbLeLi
bLgbLsbRiLsbRgbRgRsRsRgmmbLjbRebLsLsmbRjbsbLjbRgbRgbRsRsmbRebLiLsbLebL
eLsbLgLsLgbLsLsmbLgLsLsmbRcbRsbRgRsmbRgRsmbRgRsmbRgbRsRgbRgRgbLgbRgRsm
bRgbRiRsmbRgRsmbRsbRgRsmbRgRgRsmbRsRgRsmbRibRibLsbRsRsmbRibRgRsRsmmbRs
bRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 24; Drug: Control Apo 50 然
bLsbRgbLsbsbRjRsmbLibRiRsmbLsbRsRsmbRsbLjLsmbLibLgbLibLgbLgbLgLsbLgbLg
bLiRsLsbLgbLsLgbRsbLibRibRgbRibRsbRjRibRibLsbRibRibRgbRgRsmbLjLsmbLebL
jLgbRgLsbLgbLibLgbLgbLsbRebRibRgRsmbRhbsbLgRsbLiLhbRsbLibRgbLhbLibRjRs
mbRsbRsbsbLhbLcbLgbRcbRibRsRsmbRgbLgbRiLsbLgbRibRgLsbRibsbRgbRgbRiLsbR
ibRgbRgbRsbLibLibLgbLiLsbLibLgLsbLibLibLsRcbRhbRibLgRsbRibRibRibRibLgb
LibRgbLhbLebLibLcbLsbLhbRsRsLsmbRsLgbLsbLgbLsbRjbRibRibRgbLsLsmbRgbRgb
RibRiLsbLgbLgbLibLgbRgbLgbRjRjbRebLsbRgbRgbRsRsmbLsRgbLsbRsbRibRgbRgbR
ibLgbLjbLibLgbRjbRiLsbRgLsbRgbLsRsbLsRsbRgRsmbRgbLsRibRsbRibRgbLgRsbLc
bLibLgbLgbLibRjRsmbRcbLsLsmbsbRiLsbLsLsmbRibRgbRgbRibRibRgbLsRsbRsbRib
RibLsRsRsmbRsRsmbLsbLsbsbRsRsmbRgLsbRibRgbRibRgbRsbLsRsbLcbLibLgLsbLsb
RebRibRibRgbRgbLsbRebLgbLeLsbLgbLebRibRhRsmbRibRsRsmbRiRsmbRgbLiLsbLsb
LibLiRsbRsbRsbLgRsbLibLgbLgbsbRebRcbRsbRiLsbLebLibLsbLibRgbLjbLibLgbLg
bLsLsLsLsmmmbLgbLgbLhbLsbLsLsmbLgLsbLgbLsbLgbRsbLibRsLsbLsLsmbLsLsmbLs
bLgbLgbLgbLib

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 25; Drug: OSU6162 10 然 Apo 50 然
bRhbsbLcbLcbRcRsmbRgbRjRsmbRibRibRsLsbRgbLgbsbsbLsbLsbLhbLsbLiRsbLiRsb
LgLsbLiRsbLiLgbLsbLsLsmbLibLibLgbLibLgbLgLsLiLsbLebLhbLebLhbLgRsbsbLib
LiRsbLgbsbLsRsbLjbLsbLsbLsbLgbRcRsmbRhRsLsmbRiLsRsbRgbLebLgLsbLibLsbLc
bLgbLgbLgLsbLiLibLsbRibLjbLsLsmbRoLsbLgbLgbLgbLgbRsbRjbRcLsbRcLsbRibLg
bLibLibLibLgLsbLibRhbRcbRiLsbRgbRgLsRsbRibRgbRcbRhRebRhbRebRibLebLsbRs
bRebLcbLibLibRgbRibRgbRgbRjbRcbRiRibRhbRebRebsbLsbRiLgbLcbLibLiLsLibLi
LsbLobRcbRgbLcbRsRsmbRiRsRsmmbRiRsmbsbRcbRsReRsRsmmbRebRibLsbLcbLcbLhb
LgbLibLgbLsbRsRsRsLsmmbsbRcbRibRcbReRebRgReLsbRibLibRgbLobLobLcLcbLibL
gbLcbLsbRcbRiRsmbRibRibRhRcbRibRgRebLcbRsLsbRcbRcRsmbRgRsmbRgbRsbLsbLs
bLsbRsbRsbLsbRsRsmbLcbLibLiRsRsLsmbLobLcbLibLhbRhRsmbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 26; Drug: OSU6162 10 然 Apo 50 然
bsbRiRsmbRjLsbLjbRcbRiRsmbRcbRibRcbRibRibLobsbRobRcbLcbRgbRcbRibRsbRib
RiLsbReReRsmbRebRiRsmbRsbLsbRcbRgLsRsbLsLsmbRebRcRsmbLsLsmbRcbsbLsbRhR
gb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 27; Drug: OSU6162 10 然 Apo 50 然
bLsbLsbLsbLgLsbRcRsmbRibRsbRgbLeLiLsbLhbLcbLebRgbLsbLsRsbLgbLgbLgbLgbL
hbLibLsbLibLiLsbLibLebLibsbLgbRsLsbLgbRebRebsbRgbRsRsmbRcRebRebReRsmbR
cbRebRibRibRebRibRibRgbRgbRsbRsbRsbRibRgbRsbRebRhbLgbRebRebLibLibRibLi
RsbLobRobLgbLsbLsbLsbLsbLsbLsbLsbLsbLgbLibLibLibLhbLgbLcbLcbLhbLibsbRg
RsmbRobRcRsmbRgbRjbLgbLiLsRsbLiLsbLgbLgbLsLsmbLgLsLsmbLsbLsbLsbLsbLsbL
sbRsLsbLsbLsLsmbLsbLsbLsLsLsmmbLgbLgbRsbRcbRibRhbRgbRibRibLebLibLcbLob
LcbRibLibRibRobRsRsmbRibRiRsmbRgRsmbRiRsmbRgbRgRsmbRgbLjbRgbRsbRsRsmbR
sbRsRsmbRsbRsbRsRsmbRgbRgbRgbRsRsmbRgbRgbRgbRibRgbLhbLsbLsbRsLsLsLsmmb
LsLsLgLsLsmmbLsbLsbLsLsmbLsLsLsLsmmmbLiLsbLsLsLsLsLsmmmmbLibLsLgbLgbLg
b

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 28; Drug: OSU6162 10 然 Apo 50 然
bLcbLcRsbLgbLgbLcbLibLcLsLcmbLibRsLibLibRobLobLcbLhbLcLeLebLeRsbRgbLsb
LgbLgRsbRsRsmbLobLobLcbLhbLibLeLsLeLebLibRhbLhbRoRsmbRoLibRibRgbRibRsb
RobRibRebRhRsLsRcRiRsmmbRiRsmbRhRebLsbLsRsbRebRcbRsbRsbRebRibRsbLsbRoL
sbRsbLcRsbLibLiLsLhbLeRsbRsRsRgmbRsbsbRibRsbLjbRibRhRgRsmbLsLeRsbLhbLe
bLsbRebLcbRobRcbRobLcbReRsmbRhLsbRsbRgRsmbRibRobRcRsmbReRsmbRibRibRiLe
bLcbLgbLebLsbLjbRsbLsbRsbRsLsbLsbLobLsbLsRsbsbRibRiRsmbLibLcLsmbRcbRcb
RiRsmbRgbRibLobLoLsmbLcbLcbLobRobRhRsmbLcbLsLgbLebRsbRgbLeb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 29; Drug: OSU6162 10 然 Apo 50 然
bRgbsbRcbRsbLeLsbRobRibRcRsmbRgRsmbRiRgLsbLsbRsLsbRsbLsbLsbLsbRsbLsLsR
smbRsRsRsmmbLsRsbRsRsLsLsLsLsRsLsRsLsRsmmmmbRsbLsRsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 30; Drug: OSU6162 10 然 Apo 50 然
bLcbLibLcbLoLibLcbLeLebRcbRcbLsbLsLsmbRsbLsbRsbRcbRsbRhbRcbReRobRoReRh
RsmbRobRiLsbRjbRoRsmbRibRiRsmbRsbLsbRsbLjbRhRsmbRibRjbLobLobRgbRobRgRs
RgLimbLhbRobLjbLobLhbLibLoLsmbRgbLcbLibRibRgbRebRibRcbLsbLsRsbLcbLcbLc
bLsbLhbLibLebLebLoRhRsmbRibRobRiRhbsbLeLsLsmbRcRcbRibRcbLsbLhbLobRiRsm
bRhbRobRcbRhRsmbLcbLhbsbLcbLhbLsLgLsbsbLsRsbLibLcbLcbLibLgLsbLibLibLhL
sbLgbLcbRgbLcbLcbLsbRjbRcRsmbLsbLsbLsRsbsbRebLibRsRsmbLibLsbRsbRsbRibL
gbRgRsmbRhbLjbRhRsmbRhRsmbRcbRsRsmbRcbLjbLgRsbRjbRobLgbLgbRebRhRsmbLsb
RobRibRcRsmbRibRgbsbRgbRsRsmbRsRsmbRsRsmbLcbLgRsbLiLsbLhbLeLgLiLgbLcbR
cbRcbRhbRcbReRsmbLsbRsbsbRsbLsRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 31; Drug: OSU6162 3 然 Apo 50 然
bRhbRiRsmbRcRsmbLebLibLibLeRsbLcbLgbRibLibLcbLobLgbRsRsmbLibLcbsbLhbLo
bLobLibLcbLcRsbLhbLiLsbLhbLoRsbRgbRibRhbRibRibRibLsbRsbRebLgbLcbLcbLgL
sbLhbLiLcbLcbLhbLobLibLobRcRsmbRoLsbRibRcRsRsmmbRibRgbRibRcbRibRcRsmbR
ibLsRsbLsbLsbRcbRsbRcbLgbLcbLhbLiLsbLobRhbRcbRjbRhbRiRsmbRgbLobLgbLibL
ibLjLgbLgLgRsbRcbRibRgbLcbLcbLgLsLsmbLcbRcbRhbRgbRebRiLsbLjbRcbRiRsmbR
jbLobLgLsbLibLjbLsbRobRibRibRibLsbLcbLcbRcbLjbLobLgbRebRibRhbRjbRsbRib
LcbLoRsbLibLobLobLsRibRcbRiRsRsmmbRibRibRibRoRsmbLibLhbLibLibLcRsbLgbR
oRsmbRiRsmbRiLsbRibRcbRibLgbLoRsbLgbLhbLcbLjLhLsbLibRibRcRgRsRsmmbRibL
ebRibLcbLgbLibRcbRhbReRsmbRgRgRsmbRibLjbRsbLoLsLsmmbLibLobLhbLiLsbLobR
hbRoRsmbLebLhLsbLibRiRsmbRcbRhbRgbRibRcbRibRibRcbRibRcbLsRsbLjbRcbLhbR
gRsRsRsmmmb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 32; Drug: OSU6162 3 然 Apo 50 然
bRobRiRiRebRsbLibsbLgbLibRcbRcbsbsbLcbLoLsmbRsRsmbRhbRcLsbRcbRcbRiRgbR
eLsbRibRoRsmbRsbRjbRsRhbReRsmbRgbLsRsRsmbRgbsbLgbRgbsbsbLsRsLsRsRsRsLs
LsmmmbLsLsmbRsLsRsbLsRsbLsRsRsLsmbRsbLsRsRsmbRsbRsbRsLsbRsbRsRsmbRsbLs
bLsbRsRsRsmmbLsbRsbRsbLsbsbsbRsbsbRibLoLsmbLcbRobLoLsmbsbRobRoLsbLobLh
LgbLgbLibLsbRcbLibLhbLcLsmbLhbLcbLcLgLebLoRsRgbRoLsLsLsLsmmmbLsbLgLgbL
gLgRsLsbLiLgbLibLgbLgLsbLobLibLcLsLiLsmbLobRsRgbReRgRiRsReRsmmbRiLsbRj
LsbRibRibLobRcRsmbRobRibRcRsmbRhbRsbRibRsRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 33; Drug: OSU6162 3 然 Apo 50 然
bLsbLjbRgbRsbLjbLiLsbLiLsbRsLsbLibLcLsmbLibLcbLhbLiRsRsmbLhbLgbLgbLgbL
gbRsLsLsmbLibLibRjbLhbLibRgRsmbRcbRgbRgbRibRgbRgbLsLsmbLjbLiRsbLiLsbLi
bLsLibLgbLsRebRibRgbRibLsbLebLibLgbLibRsbRcbRgbRcbLgbLcbLibLsLsLsmmbLi
bLibLibLibLibLhbRoLsbRgbLsLhbLhRsbLgbLhbLibRsbLgbRgbLcbLiLsbLcLsmbRsbL
hbLibLibRsbRgbRcbRiRsmbRgbRgbLhbLhbRiRsmbLcbLjLgLsRsbRgbLibLgbRjbRjRib
RibRgbLjbLibLgbLhbLsRsbRgbLiLsLgbLsLhbLibLgLsbLibLibRjRsRsmmbRjbRebRib
RsbLobLjbRsRsmbLsRsLsbRsbRibRibRibRsLsLsmbLcbLcbLsbLgLgLsLsmbLibLcRsbL
ibRgbRsRibRcbLgbLibLsLiLsbLsbLgbLiLsbRiLsbLsLsmbRcbLjbLiLsbLhbLhbLgbLc
bRibRobRgbLcbLibLhLsLsmbLibRjbRcbRibRgRsmbLsbRgbLgbLcbRjbRjRhbLibRjbRc
bRgRsmbRsbLjLsmbLcLsmbLcLsmbLibLsbLsLcLsmbLiLsbLsbRjRsmbRibRibLgLsLsRs
LsLsmmbLcLsmbLcbLsLsmbRebRcRsmbRibLebLcbLcbRgbRsRsmbLhbRjbRcRsmbRgbLjL
ibLiLsLsmbLgRsbLgbLibLsbLsLibLcbRiRsmbRgRsmbLcbLsbLsLhbRjbRcbRiRsmbLsb
RibRcRsmbRsbRhLsbLjbLsLsLsLgmmbLibLsbLiLsbLcbLsbLcbRcRsmbRcbRgRsmbLcbL
ibLobRsbLsbLgLsbLibRgbRhbRgRibRibLsbLhbLcbLsLsLsmmbLgbRsLsbRcRgbRibRiR
smbRgbRsRsmbLeb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 34; Drug: OSU6162 3 然 Apo 50 然
bRoRsmbRcbRgRsRgmbRiRiRibRibRoLjbLjbLoRsbLcLsLhLembLsLsmbLsLsLsLsmmmbL
ibLsbRobRiRsLsRiRiRsRemmbRiLgRcbRiRiReRebRgRsmbRgbLsbRcRsmbRhbRhbRiRsm
bRibRibRebRgRsmbRsbRibsbRiLsbRcbRgbRiRiRsmbReRgRsLsRgmbRgbRoLsLibRobRi
bRgbRgRgRibRoRsLgLsmbLeLsLeLsbLgbLhRsbLiLsbLobLiLsbLgbLeLebLobLobLobLc
bRibLgbLiLsLsmbRcbRebLsbRgRsRsRemmbRhLsRibRgRebRgReRsRsmmbRebRebRjbLsb
RibRhRgbReRibRiRsRcmbRgbRebRebRsRsmbRsbLcbLcbLjbLebLebLcbLcbLebLibRsRs
mbLibLcbRsbRjbRcbLibLcbLsbLcbLsbRibRjbRebRebRebRhbLibRobRibRsLsbRsbRsb
RsbReRsmbRibRiRibRgRsRombLsbRcRsRsRemmbRibRjbRcbRgbRcbRhRiRcbRoRobRobR
cbRobLcbLobLobLebLgbLoRsbsbLsbRhRsRimbRibRibRobRhRgbRhRsRhRsmmbLsbRibL
sLsmbLgbLjLiLsLsmbRcbRcbRgbRiRiRsmbLsRgRsRhRgRcReLsmbRibRebRebRgbRiRsm
bRhRsRombRobRobRobRgbRibRsbRsbRsbRsbRsbRsbLeLsbLsLsLsRsmmbLcbLibRebRib
RcRiRsRsmmbRcRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 35; Drug: OSU6162 3 然 Apo 50 然
bLsbRgbRcRsmbRgbLsbRobLsbRibRobsbLjbLobLoLsLiRsmbLgbLibLgbLgLsLsmbLsbL
ibLsbLgbLsbLgbLsbLibLhbLhbLsbLcbLcbRsbsbLjbRcbsbsbLsLsmbLsRsRsmbsbLsbR
cbRjbRcbLoRsbRcbRhbRcbRgRsLsmbRhbRgbRiRsmbRsbRibRjbRibRibRcRsmbRhRebRe
RsRhmbRiRsmbRibRhbRiRebRibRibRgRsmbRgbRsRsmbRgbRgRsmbRgLsbRgbRgRsmbRgR
smbRsbRgbLsbRgRsmbRiRsmbRsRsmbRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 36; Drug: OSU6162 3 然 Apo 50 然
bLgbLgbLibRcRsmbRhbRcbRcbRcRsmbRcRebRebRsbLcRsbLgbsbLcbLcbLcbLhbLibLiL
iLsLgLebLebLgbLgbRsRsmbRibRebLsbRebRcbReRsmbRiRsmbRsbsbRobRhbLhbLcbLiR
sbLsbLoLsLiLsLiLimbRjbsbLibRcRsmbRcRsmbLcbLoLsmbLiLsLsLsLiLiLimmbLobRi
ReRhbRibRobRgbRibRhbRgbLgbRgbRobsbLgLcbRgbRcRhbRebRibRibRhRcRsReRhRsRc
mmbRcbRgbReRsRhmbRhRsmbRobLeLsbLcLsLsmmbRsbLebLebLebLeLgbLebRhbLcbLjbL
ebLiLsbRjbRcbRhLsbLsbRjbRgRebRebLobLcbLhbLcbLgRsbLcLhLsLsmbLeb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 37; Drug: OSU6162 1 然 Apo 50 然
bRoLsLsLsmmbsbsbsbLibRsLoLsmbLibRiRiRsmbsbsbRibLsbRsbRsbRgbRsbRsbRsLsL
smbRsbRsLsbRgRsRsmmbRsbLeLsLsmbLhbRsRsmbLsLsmbsbLgLsbLibLsbLsLsLsmmbLs
bLsbsbLsbLsbLeRsbLsbsbRibRsbLcbLsLsLsmmbLibLhbsbLsLsLsmmbLsbRsLsbRsbsb
LgbsbLgbLgbRsbLsbsbLsbsbsbLcbLgbLsLsmbRib

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 38; Drug: OSU6162 1 然 Apo 50 然
bLcbRsbRsbRsRsmbLsbLsbLgLsbLcLgbLsLsmbRsbRcbLsbLsbLibRgbRsLsbsbsbsbRsb
sbLcbLhbLsbLsLsmbLibLibLibLsbLibLibLsLsmbLsbLsLsmbLobLiLsbRiRsmbRgbRsb
RsbRsbLgbLcbLhbLgbLjbLoRsbRibRgLsbRsbRsbRsbRgbRsbLsbLsbLjbRcbLsbRgbRgb
RcbLobLibLsbLibLsbLsbLsLsLsmmbLhbsbRsbRjbLobRsbRsbRsbLibLibRjRsmbRsbLg
bLsbLgbLibRsbLsbsbsbRsRsmbLsbLsbRsbRsbLsbLsbLsbLsbRsRsmbLsLsmbRsLsbLsb
RsbLsbLsLsmbLsbLsbsbsbsbRsRsmbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 39; Drug: OSU6162 1 然 Apo 50 然
bsbLobRcbLsLsmbRibRiRsmbRgLsLsmbLiLsbRobsbRibLgbRobRcbLsbLcbLsbLcbLgLs
bsbRsRcbsbRcRsmbLsbRjbRiLibLeRsbRgbRgbRsRsmbRibRiLsbRoLsbLiRsbRibLsbRj
LsbRibRgbRhbLcbLibRsRsmbRibRibLgbRoRsLsmbRgRsmbLibsbLcbsbRgbLcLsmbLgRs
LiRsbRgbRhbRsbRobRiLsbLsbLiLsbRsbsbsbRsbRsRibRhbRcbRibRibRgbRoLsbRibRc
bLibLgbRsbLgLsbRsbRibRsbRsbRsbsbLgbLsbRsbLsbRsbLsbsbsbsbsbRiRsmbLjbLcb
RsbLobLibRsbRgbLsRsbRsRsmbLsbLsbLsbsbRsbLobLgbLhbRgbLiRsLsRsbRgbLibLgb
LsbLibLebLoRsbsbRibRcbRgbRibLhbRsLgbRebRgRsmbRgbRgbRsLsbRsbRsbRibLiLsb
LsLgbLhLsRgbLibLgbRjbRsRsmbsbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 40; Drug: OSU6162 1 然 Apo 50 然
bRgbRgbLgbLcbLcLsmbLiRsbLcbLibLebLeLsLeLeLcbLebRgbRcbLsLsmbLhRsbLeLsbL
sbLiLsbsbLgbLsRsLsbLgbLsbsbRsbLiLsbLoLsmbRiRsmbRibRibRsbRhbLsbRobRcbRi
bRhbRgbRgbRobRhRibLgbLibRebRebsbRiRsmbRgbRibRjbRsLsbLgbLobRsbLcbLhbRhR
smbRebRgbLibLcLebLsbLsLsmbRgbRjbLobLcbRsbLcbLibLsbRibRgbLsbRobRebRebRe
bLebRebRsRsmbLsbRiLsbRgRsmbRcbLgRsbRebRcbLgbRcRsRsmmbRgbRhbRibRibLsbLj
bLibLhLsRsbLcbLebLcLsmbReRsmbRhbLgbLsRsRsmbRsbRjbRibLsbRhbRibRsbLobLib
LgbLsbLsbLsbLcbRsbRiLsbRgbRgbRsRsmbsbLsbRhbLsbRgLsbRibRgbRibRibRibRebR
ibsbRsRsRsmmbRibRibRibRibRibLjbRobLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 41; Drug: OSU6162 1 然 Apo 50 然
bLcbLcbRiRsmbRhRsmbRobsbsbsbsbsbRjb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 42; Drug: OSU6162 1 然 Apo 50 然
bRobRjbRebRgbLgLsLsmbLebsbLcLsmbLsbRiLsbLcLsmbLgbLgbRobRiRsmbRsbLebLib
RoRsmbRcbRebRhbRobRebLsbLcbLibRsbLjLsmbLiLsbLgLsbLebLcbLgbLhLsbLiRsbLs
bLcbLgbLcbLgbLibRjbRcbRibRhbRibRhbRebRcbRoLsbLebRsLsbLgLsLsmbLibRcbLcb
LhLsbLebRgRsmbRgRsRsRsmmmbRcbRebRgbRiRsmbRhbRibRoLsbRgbRcbRibRgRsmbLgL
sbLcbLiLsbLgLsbLcbLhbLibRibRcbRebRobLibLjLsRsRsmmbLebsbLibLibLeLsbLcbR
gbRhbLjbRobsbLsbLcbRebRibRgRsmbRcbRcRsmbRcRsmbRibRiRsRsmmbRibRgbLjbLob
LhLsLsmbLcLsmbRebRibRhbRhbRcbRibRibLcbLcLsmbLcLsmbRebLgbLcbRsLsbRsRebL
hbRcLsbLiLsbRcbRcbLiLsbLeLsbLcbLibRcbLebRcRsRsmmbRibRiLsbLeLsbLeLsbRiR
smbLcbLebLibRcbRibRcbLgLsbRcbLgbLeLsLsmbLjLgbLibRhRsmbLgbLcRsbLeLsLsmb
LebLcbRhbRhbRcbRebRgbRoLsbRiLsLgbRcbLcbLeLsbLcbRsRsmbLibRcRsmbRgbRiLsb
RcbRibLsLsLsmmbLobLsbLgbLcLsmbLoLsmbRhbRhbRcRsmbRcRsLsmbRhLsbLgbLcLsmb
RjbReLsbRsLsbRiLsLsmbLsbRcbRsbLhbLeLsLsLsmmbLhLsbLcbRsbRcbsbLiLsbLeLsb
LcLsRsmbRiRgRsmbRoLsbLgbRjbRiRsmbRiLsbRgbRhbLgbLibLiLsbLeLsbLsRsLsLsmb
RhRsmbRhbLcLsmbLibLcLsmbLcbRsbRebRcbLsbLiLsbRiRsmbRiLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 43; Drug: Control Apo 50 然
bRsbLgbLiLsbLgbLsLsLsLiLsmmbLibLgRsbLgbLobLcbLgbRebRibRebRsbRhbLgbRobR
sbRiRgRiRsmbRgbRobRsbRibRibRiLsRsbRiRsmbRebRgbRibRgbRoLsbRsbRobLsbLibL
ibLgLsRsbLiLsLsLiLsmbLibLgLibLgbRgbLiLebLgLibLhbLgLsRsbRsRgbLsLiLsbRcb
RgbRgbRsRcbRcbLibLsbLobLsbLcbRsbLgbLiRsRsmbLibLiRsbLsbLiLgbLibLgbLgLiL
ebLjbLsbLgLsbLsLsLsmmbsbLgbLebLebLjbsbLiRsbLcRsbRsbRiLsbRibReLsbRsbRsR
ebRibLeLsbRcbLhbRjbRcbRcbLcbLcbLiRsLgbLcbLiLebLobRsRsRsmmbRiRsmbRsLsbR
oLsLsmbLhbLjLgbLcbLhbLgbLiRsbRsLcbLgbLobRsbLcLiLsbLgLeLsLsLsmmbRcbLobR
obRhbLgbRobRsLsbLhbRsbRoRsmbRgRsmbRcRsRhRembLsbRobLgLsLsLhmbLibLiRsLiL
sbLcLsmbLcbRjLsbLebRsbLgbsbRsbRsbLhbRobRcbRobLobLhbLiLsbLebLiLgLsbLgbL
obLcbLsbRgbRcRsRimbRgLsbRoReRsmbRcRhRcbRoRsmbRcRsRsReRsmmmbRibRibRoLib
LobLgbRsRsmbLebLgbLgbLhbRebRgbRgbRoRsmbRobRhLsbRiRibRgbRiLsbRgbReLsbRi
bRebReb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 44; Drug: Control Apo 50 然
bLsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 45; Drug: Control Apo 50 然
bLibLcbRiRsmbRgbRiRsmbRgbRebLsbLebLcbRebRcbRobLsbRobLjbRebRobLobLsbLsb
RcbRobLebLoLjbRgLsbLgLobRsRsmbLgbRjbLgbLjLsmbLgbLgbRiLsbRgRsRsmmbRsbLs
bLsbsbLgLsbRsbRcbLjbRibRgbRsbRgbsbsbRsbLsRsLsbRsLsbRsbRsRsRsmmbLsLsmbs
bLsbLsRsLsRsRsmbLsbLsbLsbsbRsbsbsbLsLsmbRsbLsbLjbLgLsbsbLibLsbRebRsLgb
LsbLobRebRebRobRebRsRobRobRebsbRsbRsbLgLsbLibLsbLibLoRsRgbRebsb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 46; Drug: Control Apo 50 然
bRcbRiRsmbRjLsbRcbRsbLjbRcbRcbLgbRcbLsbLibLebLibLibLibLcbLebLjRsRsmbRe
bRcbRibRibRhbLcbLibLjbRcbLiLsbLibRhbRoLsbLjLibLgbLibLibRhbsbLcbLcbLibL
ibLgbRhbLhLsbLhbRsbRibLhbRhbsbLcbLibRcbRcbRcbLcbLibLcbLibLcbLibRgRgbLh
bRcbLcbLiLsbsbRcbLjbRcbLcbRcbLcbRjbLcbRcbLcbLibRebRcbLcbRcbLcbRcbLibRo
bLcbLcbRobLgbLcbLiLsbLibRibRiLsbLgbLibRjRgbRcbLebRhbLjbLcbsbRhRsmbLebL
cbRsbRsRcbLiLsbLobLoLsmbRjbRobRibLcbLcbLcbLcbLhbLibRcLsbLibRcbsbRobLgL
sLsmbLiLsbLibLobLibRobLsbRibRibLibLgbLiRsbRhbLcbLcbLibRcLsbLcbLgLsbLib
RsRcRsmbLgbRcbRcLsRsbLjLcbLgbLoLsmbLibLiLsLsmbLgbLiLsbLiLsLhLhLsbLiRsR
smbRibRibRobRsbRcbRcbLjbLebLibLibLibLibLiRsLsbLhbLgbLgbLibLhRsbRsbLcbR
cbRobRgbLhbLibLgbLibLhLsbLobLhbLcbLebLhbLibRibRibRcbReb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 47; Drug: Control Apo 50 然
bLcbRsbRsbsbsbLsbLcLibLcbLgLibLibRiRsmbRibRhbRgbRsbRiLsbRgbRhbRhRsmbRe
RsmbLsbRiRsmbRibsbRibRibRhLsbLibLibLhLgLsbLibLsbLgbLsLsmbRsbLgbRjbRebR
iRsRsmmbRgRsmbRsRgbLsbRgLsbLsLsmbRgLsbReRsmbRcbRsRebRiRsmbRsbRiRsmbRsR
smbRgRsmbRgbRsbRgbRgRsmbRiLibRcbRgReRiRiRsRhRiRembRiReReRibRebRgbRgbsb
RsRsmbRsRsRsmmbRgbRgRsmbRgbRgbRgRsRiLsmbRiLsLgLsbRhbRgbRgLsbRiLsLsmbRg
bRgbRgbRgbRgRsmbRgbRoLgLsbLibLgbLgLsLgRsbLhLsbLibLgbLsLsmbLsbLgbLgbLgb
LgbLgbLgbLgbLsbLibLgbLiLsLsmbRebLcbLgbLiLgbLiLeLeLgLsLeLsbLgbRsbLgbLgb
LgbRgbRjbRiRsmbRgRibRiRiRsRsmmbRibRsbRhbRsbRiRsmbLcbLibLsbLibsbRjbLibL
cbLibRsLsbLgbLibLiRsLsbLiLgbRhbRsbRhb

>ZF Recording 2016-08-17; tW: 300s; Start: 160816; End: 161316;
Recording: 3-1; Individual: 48; Drug: Control Apo 50 然
bLiLsbLsbLibRsbRgLsbLcbLhRsbLiLibLhbLibLibLiLiLsLcbLebRcbRcbRhbLsbLsbL
jbRsbLcLsmbRcbRcbRibRiRiRebRibRgbRcbRibLobRobRobRiRsRsmmbRibRsbsbRsbLs
RsRsmbLcbLibLhbLiLsbLebLgRsLebLgbRsbRsbRjbRcbRjbRiLsRsbRgRsmbRibRhbRgb
RhbRgbRgbRgbRcbRiRsmbRiLsbRcRsmbRsRibRgRsmbRgbLjbLhbLcLsmbLhbLcbLcbRsL
sLiLsbLiLsbLibLeLsbLiRsLsbRgbRcbRcbRcbRgbRibRgbRgbRibRgLsbRgbLcbLcbLhb
LibRsLcbLhbLibLiRsbRibRibLjbLsLsmbRsRsmbLjbLebLibLebLibLebLibLebLhbLcb
LcbLiLsbLgRsbRgbLjbLhRsbLcbLcbLhLsbLeRsbRgbRsRsRsLsmmbRsbLebRjbLebRiLs
bRibRibRibRibRibRgRsmbRibRgbRsbsbRsbRsbRsbLjLcbLcbLhbLebLebLibLiLsbLhL
sbLibLsbLcbLiLibLibRcbRcbRcbRgbRebReRsmbRibRobRoRsmbRcbRhbRhbRcbRcRsmb
RgbReRgbLsbRsRsmbLjbLcbLiLsbLhbLibLcbLiLiLsbLiLsbLcbLebLeLebRsbLiRsbRg
bRjbRhbRcbRibRibRhbRibRibRhRgLsbRiRsmbRebLsbLcbLibRgbLcbLcbLgbRjRsmbLe
bLiRsLebLgbLgbLhbLebLebLhbLibLiLsbLgbLsbRsbLsbLgbRgLsbLibLhbLiRsbRgbLe
bLsbLebLsbLsLebRiRiRibRobRibRcbRcbRiRsmbRibRcRsmbRiRsmbRibRgbRgbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 1; Drug: OSU6162 10 然 Apo 50 然
bRgRsmbRibRhbRhbLiRsbLibLoLsmbReRebLsbLebLebLcbLsbRebRhbRgbRgbRobRsbRi
bRibLsbRibLsbRsRsmbRsbLebLhLsRsbLgbLgbLgbLsLsmbLsbsbLsLsLsmmbLgbLiLsbL
ibLobsbLsLsmbLiLsbLsLsmbRsLsbLsLsmbRoRsmbRibRiRsmbRibRcRsLsmbLgbLibLib
LoRsbRibRgbRhbRjRoLsbRsbLiLsbLibLobLibLsbLobLibRsbLoRsbRjRsRsmmbRhbLsR
ibRibRgbRgbRgbRiRsmbLjbRgbRsRsRgmbRgbRsbRgbLoLsRsmbRcLsbLgbLsRsRsLsmbR
cbLsLsmbRiRsmbRibLsbRgbRiRgbRiRgbRgbRgbRibLgbLcbLibLibLibRsLgbLgbRjbRe
bLob

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 2; Drug: OSU6162 10 然 Apo 50 然
bLebLsbLhbLebLhRgbsbLsbsbsbsbRsbsbRsbsbLsbRsbLsbsbsbLsRsLsbRsbLsRsbRsb
LsLsmbRsLsbsbLsRsLsbRsRsRsmmbRsbRsbRsbRcbRcRobLibsbsbLcbRcbRebLebRgbLs
bRcRsmbReRsRsmmbLcbRgbRobLsbRjbRobRcbRebRsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 3; Drug: OSU6162 10 然 Apo 50 然
bLcLsmbLcbsbLcLgbLeLsbRebLsbLcLcbRibLebRcLobLobRsRebRsbRobRebLobLgbRsb
LoLobRebRcbRebLobRiLgLsRcbLebLeLibRcRsmbRiRsmbLjbLcbRsLsbRibLobLobRobL
sbRsbRcbLjbRsbRcLibRcRsmbLibLiLcLsmbLibLgLsbsbRsbLebLobRsbRsbLhbLobLhb
LgbLcbLhRsbLhbLiRebRiLsLgbRobLebLsbLsbRcbRjbLobRobRebLjbLobRobLobLibLc
bLibRjRsmbLebRjbRhbLjbRcbLebRsRsmbLjbRcbLgbRsbRsRjRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 4; Drug: OSU6162 10 然 Apo 50 然
bRjRgbRcbLcRsbRobRebRibRiLsbRibLgLsbLobRiRsmbRsbRcRsmbRhRsmbRgbRhbRibR
gbRebReRsmbLgbRsRsmbRgbLibLjbRgbLobLcbLcbLebRsbRoRsmbRebRobLebLibLobLs
LsLsLsLsLsLsLsLsmmmmmmmmbLibLebRgbLgbRcbRiLsbLebLcbLjbLibsbRcbRoLsbLgb
LiLsbRsRsmbRcRsmbRiRsmbLcbRiRsmbLsRsbRsRsRsRsmmmbRsbRgRsRsRsRsRsRsmmmm
mmbLebLsLsmbLsLsmbLsLsLgLgmbRsbRjbRiRsRsmmbRebReRsRsRsmmmbRsbLsRsRsRsR
sRsRgmmmmbLsbLsbLebRcbRgRsmbRiRsRsmmbRsbRcbRsRsmbRcRsRsmmbRgRsRsRsRsRs
RsRsmmmmmmmbLjbLsLobLiRsLsbLsLsLsmmbLsbsbRgRsRgRsRsRsRsmmmmmbRsRsRsmmb
RgRsmbRcRsmbRsRsRsRsRsLsmmmmbLeLsbRsRsRsLsmmbLsbLsbLsbRjbRcRsmbsbLibRs
Reb

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 5; Drug: OSU6162 10 然 Apo 50 然
bRiRsmbRgbRsbRibReLsbRgbRjbRibRgRhRsmbRibRiRsmbRiLsbRgRcbRiLsbRgbRgRsR
smmbRsRsRsmmbRgbRsRsRsmmbRsbLoLsLgmbRjbRibRibRgReRsmbRgLsbRsbRsRsmbRsR
ebRsbsbLhbsbsbRobRebRibRiRiRsmbRibLsLsmbLibLgbRhRgbRsbLibLgLsbLgbLcbLe
bLgbLibLgbLgbLeLsLibLebsbRgbRiRsmbRgRsmbRgbRgLibLeLsbLjbRobRibLeLjbLsR
sbLgbLibLgbLgbLeLibLiLsbLhbLhbLcLebLobsbLsLsmbLsRsbLgRsbRsbLsbLgbLsbRc
bRiRhRiRiRibRgbRoLsbLgRsLeLsbLcbLgbLgLsLsmbsbLsbLcbLhRibRcbRibRcRsmbRe
RsmbRibLsbRibRgbRsbRsbRsbRsbLsLsmbLsbLsbRsRsRsmmbRsbLsbLsbLsLsmbsbRsRs
mbsbsbRsbRsbsbRsbsbsbsbsbsbLsbRsbRgbRcbRiRsRsmmbRhbRsbRcRsRsReReRsmmmb
LobLcLsmbLibRebRiRsmbRebReRsRsmmbRgRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 6; Drug: OSU6162 10 然 Apo 50 然
bRcbLcLsmbsbLgLsbLebRjRhbRebLsbRcbLgLsbRcbLsLsmbLebLebLibLobLhbLcRsbLh
RsbRcbRiRsmbLsbLsLsmbRsRsmbRsbLcLsLsmmbLgLsbRcbRibLgbLobLjLsLsmmbLobLo
bLoRsbLcbRcbRcbRiRsmbRhbRoLsbRsRhbLebLeLsbLhbLobLcbLhbsbRobRiRsmbRhLsb
RibRcbRobLebRiRsLsmbRsbsbsbRsRsRsmmbLsLsmbRsbRiRsRsmmbLobLcbLibLcbLgLs
bLoRsbLcbReRsmbRibRsbRibRebLsLsmbRebLcbLebLjbLcLsmbLcbRsbLsbRibRibRcbL
gLsbLiLsbLcLsmbLcbRcbRcbRcbLgbLcbLcbLcbLibLhbRhbReRsmbRebRibsbRsbsbRgR
sRsLsmmbRebRobLebRobReRsmbLobRsbRobRibRebRhbRiLsbRibLcbLeLeLsbRjbRiRsR
smmbRgRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 7; Drug: OSU6162 3 然 Apo 50 然
bRjbLsbLcbLibLsLsmbLsLibLgbLhbRibRibReRsmbRgbRjRibRibLcbRjRsmbRjbRgLsb
LiLsbRhbLcbLsbLcLsmbRgbLsRsbRcbLgbRgRsmbRibRgbLjbRsbLcbLsbLgbLgLsbRsbL
gbRgbLeLsbRcbLeLsbLgbLsLsmbRjbLhbLsLsLembLsbRebRibRibRgbRibRgbRiLsbLjb
RoRsmbRibRibLjbLgbLgbLgbRgbRgbRhbLsbRsbRsbLsbLebLgbRsbLgbRsbLjbRsbRibR
sbLibRsbRsbLsbLsLgbRibLcbLoRsbLobRsbRcRsLsmbRgbRibLsLsmbRgbRgbLsRsbRsR
smbRibRjbLsLsmbRoRsmbLhbLhLsbLibLsbLobLjbLhbRgbRibRgRgRiRiRiRibRgbRsbR
ibRjRsLsmbRoLsbRebRcRsmbRhRiRsmbRibRgRsRiRiRsRemmbLgLsbLibLoRsbLcRsbLh
bLsLsmbLiLcbRgbLjbLiLiLsbLebLebLebRgLsLsmbLibLobRhbRibRhRsmbLobRcbRoLs
bRsRobRcbRibLibRcbLebLobRsbLibLgbLiLsbLgbLgbLiLsLeLsbLsRsbRcRsRsmmbLcb
LhLgbLibRjbLsRjbLibLibRibRebRibRibRgbLcbLibRjbLibLibRjbLibRgbRhbLcbLsL
gbLiRsbRsRgLsbLhbRgbRcLsbLibRjRsRsmmbRobRgbRjRjLsbLgbRgRsmbRsbRjRsmbLh
bLebRgbRsbLhbLsbLibLiRsbLgbRibRgbRibRibRgbRobLiLgbLibRsbLobRgbRgbLibsb
LibRobLgbRhbLjbLebLiLsbLgbRibLibLibRsbLgbLiRsbLiLebLibLibLgbLgLsbLhbLg
LsbLiLsRsLsbLibLgbLgRsbRsLsbLhbRhbLsLgbRjbLhbLsbLibRgbRjbRhbLcbLiLsbLi
LsbLgbLibRgbRjbRjbLebRcbRibRibRibRibLgRsRsmbRgbLjbLhbLsbLgbRib

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 8; Drug: OSU6162 3 然 Apo 50 然
bsbRebLibLhbRjbLibLgLsbLibLgbRibRcbRibLsbRiLsbRgbRsLsbLibRebLibLibRhbR
ibRgbRgRgbRibRgLsbLibLhbLibLsbLobLgbLibRibRcbRgbLsbsbRibLcbLcbLgLsLsmb
LgLsLsmbLgbLgbLibLsbRgbRcbRibRiRsLsmbRgbRgbLgbRgRsmbRibRsRsmbRibRibLgb
RsbLeLsbLgbLiLsbLibLibLgbRgbRibRiLsRsbRibRibRebLibLibLibRibRibRgRsmbRe
bLobRgbRsRgbRgRsmbRhbLgbLsbRgbLgbRoRsRsmmbLebRobRgLsLsRgmbRebLhLsbLobR
sbRgbRiRsmbLobRcbLsbLibLjbLsbLgLsbRgbLgbLsbsbLibRsLsbRgbRiLsbRgbRibRsR
smbRsbLebLcbRiLsbLcbRebRiRsLsmbLgLsbLgLsbLibLgbLjbLsbLibLibLobLibLibLg
LsLgLsbRebRibRhbRobRcbRgRsmbLebLsbRcRsmbRibLiLsbsbLiLsLgLsbLoRsbRgbRib
RobLibLebLgbLiLsbRsLsbRobRibRhRsmbRsbRsLsbRgbRiRsmbRgbRibRsRgbLsbRgbRc
bRgbReRgbRibLcbLobLibLibLiLsbLobRgbRobRobRoRsmbLjbLgbLiLgbLibLobRjbRgb
RibRebLsbLsbRjbLsbLiLsbLiRsRgbRjbRjbRibLjbLobLiLsbLgLsbLgLsbLcbRhbRibR
ebLiLsbLgbLiRsbRgLsbRebLgLsbRsLsbLsbRjbRhbRcbLgbLebRibLjbRebLoLsmbLcbs
bLhLsbRgbRibRiRsmbRibRgbRgRsRhmbRibsbRibLsbRgbRiLsLsmbRibRgRsRsRsmmmbL
sLsmbLjLsmbRhRsmbLobLsbLcLgbRsLsLsmbLsLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 9; Drug: OSU6162 3 然 Apo 50 然
bRsbRgLsbRibRcLsbLebLgLsLsLsLsLsRsLsLsLsLgRsmmmmmmbLsLsmbLsLsLsLsLsLem
mmmbLibRibLibLsRcbRiLsbRgbRibRcbLsLsLcmbLhbLhbRgbLibLhbLcLsmbLiRsbLibL
hRsbLgbRobRibLgbRcRsmbRgbRgLsbLobRsLsbRsbLsbLibLiRsbLgbLhbLibLiLsbLhbR
gRsmbRibRhbRgbRibRibLgbRcbRibRibLsLsmbLcLsmbLibLhbRgbLcLsmbRibLsbRcbRg
RsmbRiRsmbLcLsmbLibLsbLcbLibLibLibRibLsLgRsLsRsbLsLsRsmbRcbRibLsLjbLgL
gbLgbLiRsLsbRsbRobRhLsbRiLsLgbLsLhbRsLsLsLhmbRibRhbRiLsRsRsmbRibLjbLcb
LgbRsbLibRebRsbLjRebLoRsbLgRebLoRgbLgbRiLsbRibRsbRiRsmbRibRibRibLibsbR
jRsmbLiLsbLsbLsbRcRsLsmbLjbRiRsmbRsRsRimbRgRsmbRibsbLcbLcbLiRsbRsLsbLg
bRcbRibRsbsbRibLhbLcLsmbRjbLoLsmbLebRjbRiRsmbLcbRhRiRsRsmmbLibRjbRhbRh
RsLsmbRhbLgbLhbLibRoLsbRibRgLsRsbRiLsLsmbLjbRhRsLsmbRgRsmbRsRsmbRsbRsR
sRsmmbRsRsmbRjRgRsRsRsRsRsmmmmmbRsbRsRsRsRsRsRgmmmmbRgbRsbRgRgbRibRsRs
mbRobLibRibRiRsRsRemmbRgLsbLibLjLsmbLibRibLcLsLsLsmmmbRsbLibLiLsLsLimb
LibLobReLsbRgbReRsmbLsbRiLsbRcbLcbRgbRsRsmbLiRsbRjbLjLsLsmmbRjbRiLsbRi
bRcbRobRebLiLsLsmbLiLsLsmbRebRsLsbLgLhLsLebLobRjLsbRiLsbRiLsLsmbRjbLjb
LcLsmbLibRsLsLsmbLsLgLgbLebLgLebLgbLsbLgLgLsbLiLsbLsLgLibLiRsbRsbRjbRh
bRib

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 10; Drug: OSU6162 3 然 Apo 50 然
bLsbRgRsmbLcbsbRsbRjbRgRhbLjbLgbsbLcbRsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 11; Drug: OSU6162 3 然 Apo 50 然
bRsbLcRsbLsRibRsbLsbLobLgbRjRoRebRiRsmbRsbRgbRsbRgbRgbLsRibRsbRiLsbRcL
sbRsbRoRsmbRgbRgbRgbRobLiLsbLsbLcbLiRsLsLsmbLiLsbLibRgbLsbLgbLgbLiLiLe
LiLsbRsLsbLgLsbLgbLgbLsLsmbLibLiLsRsbLebLsbLgLsbLsbLsbLiLsbRjbRgbRjbRh
bRcbRhbRcbRgbLibRoRsmbLobLibLcRsbRsbLhbLiRsLsbLiLiLsLgLsLiLiLiLobLcLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 12; Drug: OSU6162 3 然 Apo 50 然
bsbsbsbsbRsbLsbLibLsbsbLsRsbRsbLobRobRibRcbRibLibLgbLobLsbRsbRgbRibRgb
RibRsbRibRiRibRibRgbRiRiRsmbRibRgRsmbRibRoLibLsRcRsmbRibRiRiLsbRibRsRg
bRoLsLsmbRcRsRsmmbRgbRgbRgbRgbRsbRiRibRgbRgRiRsReRsRsmmmbRebReRibRibRi
bRiRebRebRiRsmbRhLsbsbsbsbRsRsmbRsbLibLibLoLgbRgbLobLoLgbLeLeLiLsbLibR
sbRjbRgbRiRibRibRgbRgRibRgbRibRgReRsRsmmbRibRgbRgRsmbRgbRgbRgbLsbRgRsm
bRgbRgbRgbRiRsmbRiRhRsRembRibRgRsmbRgRsmbRgbRgbRgbRgbRgbRiLsbReRebReRs
mbRibRsRgbRgRsmbRibRgLsLobRibReRsRsmmbRibLoRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 13; Drug: OSU6162 1 然 Apo 50 然
bsbLiLsbLsbLibLcbLgbLgbLsbLhbLsbRsbRcLsbRgbRiRsLsmbRiLsbLibLiLsbLiRsbR
gbLibLibRgbRgbRgbLcLsLsLsLsmmmmbLgbReLsbRiLsbRsRsRsmmbLobLibRsbLibLiRs
RsRsmmbLibRsLsLsLsLsLgLsLsLgmmmmbLiLsRsLsRsbRsbLjLsmbLsLsLsmmbLibLsbRc
bRsbRgRsRsLsmmbRsRsmbRsRsmbsbRsRsmbRgRsmbRsbRsRsmbRsbRsbRgLsRsbLsbRsbR
sbRgLsbRhRsmbLebLhLsbLgbLsbLsbLiLsbRsbRsRsLsmbRsbRsbsbLgbLsbLsLebLsbLs
bLsLsmbLcbLgLsLsmbLsbLsLsLsmmbLgLsLsmbRsbLibLsbRsRsLsmbLsbRgLsbLsLsLsL
sLhmmmbLsLsRsmbRsLhRsbLgbLiLsRsbLcLsmbRgRsmbRsRsmbLgbLsbLsbLsbLgLiRsbL
ebLsbRibLsbLsbLgbRsRsmbLgbLiRsRsmbLsLsmbLsbLebLsbLgbRgRsRsRsLsmmmbLgLi
bLsLsLsmmbLsRsbLgbLsbLibRjRsmbRjRsRsmmbRsbRsbRsbRsRsRgmbRsRgRgbRgbRsbR
gbLgbRsRsmbRsbRgbRsbRsbLsbRgRsmbRsbRgRsmbRsbRsRsmbRsbRsbRsRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 14; Drug: OSU6162 1 然 Apo 50 然
bLsLsmbRcbRgbRibRgRcbRgbLhbLgbLibLsbLgLsbLgbLgbLibRsbRsRcbRoRsmbRgbRoL
sbLebLibLgbLcbsbRsRsRsmmbLibLebLibLiRsbRibRcbRiLsbRgbRibRoLsbLgbLobLib
LsLibLsLcLsmbLgbRobLcbLhRsbRsbLgbLibRebRobLibRgbRcbRgbRibRgbRgRsmbRgRs
mbRgRsmbRebRsRsmbLebRibRcbLjbLibRobLhbLcbLibLibRgbLebLcbRgbRjbRcbRgbRi
bLsRibRibRiRsmbLebRibRibRibLsLsmbRhbRgbLgbRibLsRgbRsLsLoLsmbLibLibLiLs
RsLsbLibLibLibRgbRjbRcbRgRsmbRhbRgbRgbRgRcbLgbRiRsmbRiLsLsmbRsLsbRobLh
bLibLiRsbLsbLhbLiLiLsbLjLsmbRgbRcbLobLiLsbsbLgbLobRgbRibRgbRiRsmbRibRi
bLobLibLgLsbLgbLgbLibLibRgbRibLcbRcbRgbRhbRsbRsRibRibRibRcbLebRibRibRi
bRgbRibRibRibRgbLibLcbsbRsbLibLiLsbRebLjbRhLsbRjLsbRhbRcbLibRgbRsRsRsL
sRimmbLjbLiRsbLsRsbLeLsLgLsbLgbLebRgbLebLgLibLibRobLsRibRgLsbRgRsmbRob
LcbLibLibLsRsbRgbRsRhbRhbRibRcbRgbRsRsRsmmbRsRgRsReRsRsRhmmmbRibRhbLib
LgLsbLibLgbLiLsLgLsLiLibRobLgbRibRgLsbLjbRhRsmbRebRgbLibLcLsmbLcbLibRh
bRgbsbLgLebLjbRsbRebRcRsmbRhbRibLoRsRsmbRjbRcbRibLhbLibRsLsbRoLsRsbRib
sbRsbRibRgbRsbRibLgbRhbRsRsmbLjbLoRsbLib

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 15; Drug: OSU6162 1 然 Apo 50 然
bRebRgbRibRgRsmbRgbsbsbsbsbRgRsLsRsmbRsbLeLgLsbLgbLibLgbLiLsRsbRsbLgLs
bLibLgLsbLsLsmbLsbLgLsbLgLsbLsLsLsLsmmmbLgbLsLsLsLsLgLsLsLgRsmmmmbLgLg
LsbLgbLgbLgLsLsmbLsbLgLsLsmbLiLibLibLgbLgbLgbLgbLsLsLsLgmmbLsbRsbLgLsb
LsLsmbLgbLibLebLgLgbLgbLeLsbLiLgbLibLsLsmbLsbLgLsbLsbLgbLsLsLgmbLgbLgb
LgLgLsbLsbLsbLgLgbLibLsLsmbLsLsmbLsLgbLsLgbLsLsRsmbLsbLsbLgbLgbLgbLsLs
LsLsLgmmmbLsbLgLsbLibRsbLgbLgbLsLsLsmmbRsbLhbLsLgbLsLsmbRobLgLgbLsLsmb
LsLgbLsbLgLsLsLsmmbLsbLgLsbLgLsbLibLgLsbLsbLibLgLiLgbLcLsmbRgbRsbReRiR
smbRhRsmbsbReLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 16; Drug: OSU6162 1 然 Apo 50 然
bLsbReRsmbRsbLjLiLsbLiLsLsmbLsbRsLsLsLsLsLgmmmbLibRgLsLsmbRebLsbRgRsmb
RgRgRsmbRsRsRsmmbRibRhLsbLebRsbLibLsbsbLibLgLsLhbLgbLobRhRsmbLcbRiRsRs
RsRiRsmmmmbRgbLsbRgRhbLsLsmbLcbLsbRibsbRsbRsRsRsmmbRgRsRgmbRsbRgLsLgbL
ibLiLgLsbLoRsbLgbRcRsmbRiRsmbRsbRsRsRsRsmmmbRsRsmbRsRsRsRgRsmmmbRgbRgR
smbRgbRibRgbRcbLsbLebLiLsbLsLibLgbLgbLhbRsbLobRgLsbRibRgRsmbRgbRgRsmbL
ebLibLsbLsLsLsmmbLgbLgLgLsbLsLsmbLgbRgRsmbLebLibRgLsbRhbRsRsmbRsRsRsRs
mmmbRgRgRsmbLsLsmbRsbRsRsRgmbRgRsRsmmbRsRsmbRibRgbRhbReRcbLgbLiLibLsbL
gbLsLebLgbLhbRhbRibRgRsmbRibRgRsmbRibRgRsRsRsmmmbRsRsRsRsmmmbRsRsmbRsb
RsbRsbRgRgRibRgbRibRsRgbRibRsRgRsRsmmbRgbRgRsRsRimmbRgRsRsRsmmmbRgbRsL
sbRoRsRgRsmmbsbRiRsRgmbRiRsmbRgRsmbRgRsmbRibRgbRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 17; Drug: OSU6162 1 然 Apo 50 然
bLsbRibLibRjbRiRsmbRebRgbRgLsbRgRsmbRibRgRsmbRgbRgbRgbReRsmbRgRsmbRibR
gbRgbRgbRgbRibRsRsmbRibRsRsmbRibReRsRsLsmmbRibRgbRgbRgbRibRgbRgbRgLsbR
gbRgbRibRgbRiRgbRhbRiRsmbRgRsmbRgbRgbRgbRgbLgbLcbLiLgbLiLsbLiLsbLgLsbL
gbLsbLgbLobLsbRiRiRsmbRiRsmbRibRibRibRibRgbRgbRsbRgbRsRsmbRgbRgbRibRgb
RiRsmbRsbRgbLgLsbRgLsbRiRsmbRgbRsRsRiRiLsmbReRsmbRgRgbRgRibRgbRgbRebRi
bRgRsmbRibRgRsRiRsRsmmmbRibRhRsRsLsmmbRgbRibRgLsbRsRgRsmbRgbRgbRgRsmbR
gbRsbRgbRgbRgbRgbRgbRsbRiRgbRiRsRhmbRiRsmbRgbRgbRgbRsbRgbRgRsmbRgbRgbR
sbRsbLjbLsbLcbLcbLgbRsLiLsbLsLgbLgbLgbLgbLgRsbLsbLgbLgbLibLsbLcLsmbLsR
sbLgbLgbLgRsbLebLhbLgLsLsmbLsRsbLgbLgRsbLgbLgbRsLgbLgbLgbLgLsbLibLsbRs
RoLsbRgbRebLsRiRsmbLsbLgbRsbRgRsmbRsbLjbLhbsbLjLgbRjbLsbLibRsbLgLsbLgL
sbLgRsbLgbRgbLhLsbLiLsbLsbLgbLgLsbLsbRgbRcbRiRsLsmbRsbRibRgRsmbLjbLjbR
jbRgbLhbLgbLgRsbRhbLcbLsbLgLsbLgbLgbLgbLgbLgbLgLsbLibLgLsbLgbLgbLgbLgb
LsbLgbLsbLgbLgRsbLgbLsLsmbLibLiLiLsLiLsbLgbRsLgbLgbLgbLgLsRsbLgLsbLgbL
gbLgbLgRsbLgLsbLgbLgLsbLgLsbLgRsLsbLibLoRsbLsbRibRiRsmbRgbRgbRsbRsbRgR
smbLgbsbRibLgbRgbRgRsmbRsbRiRhbRibRibRgbRgbRgbRgbRibRsLsbRgbRsbRsbLcbL
gbLgbRjbRibRibLsbRgbRebRgbRgbRibRgRsmbRibRibRibRcRsmbRgRsmbRgbRibRgbRs
bRsLsbRgRsmbRgbRgRsmbRgbRsbRgbRgbRiRsmbRsRsmbLcbLeLsLiLsbLibLibLgbLsLo
LibLcbLiLsbLibLgbLgbLgbLiLiLhbLebLeLsbLhbLibLgLsbLibLiLiLsLeLeLsbLebLe
LsbLibLhbLhbLibRsbRgReRsmbRebRgRsmbRsRsmbRhRsLsmbRgbLsbRgbLsRgLsbRgbRs
LsbRgbRgbLsbLjbLcbLibLgbLiLsLibLgbRsbRobRibRgbRibRibRgbRgbRgbLsbsbRsbL
jbRiLsbRgbRgRsmbLsbLibRhbsbRibRsRsmbRibRiRsmbRiLsbReRsRsmmbRibRibRibRg
bRibRibRsLsbRgRsmbRgRsmbLjbRiRsmbRhbRebRibRiRsmbRibRsbReRiRsRcmbLhbLhb
LiLsbRobRhRsRsmmbRgbRiRsmbRibLcLsmbLibRsbRcbRiRsmbRibRgbRgbRgbRgbRgbRg
bRgbRgbRgRsmbRgbRiRsmbLsbsbLob

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 18; Drug: OSU6162 1 然 Apo 50 然
bsbRgbRsLsbRgbRhLsbRiLgbRobLgbLhbLobRsbRgbRgbRiRebRiRsmbRgbRibLoRsbLib
LibLhbLibLhLsbLsbLcbLhbLgLsRsbLibLobLhbLsbRiRsmbLgbLibRcbRibRiRsmbLsbL
ebRsLoLsmbLobRcbRhbRhLsbRgbRibRcRsmbRhbLsbLcLsmbLibLcbLobLibLiLsbLibLh
bLcbLibLiLsbLobLibLsbLobLsRiLsbRobRgbRobRibRibRgbRgLsbRibRgLsbRgRobRgb
LsbLibLobLhbLgbLibLebLibLibLobLibLobLibRhbRcbRibLgRsbRcbLibRoLsbLgLsbs
bLobRobRiLsbRobRgbRcbRibRgLsbLcbLhbRcbLobLhbLebLhbLiLsbLibLibLobRgLsbR
cbRibLebLibRiRsmbRoRsmbRgbRobLoLsmbRsbRibRcbRiRsmbRgbRgbRgLsbRsbLcbRcb
RcbLhbRhbLibLgLhLsRsbLcbLibLibLhbRhbRobRiRsmbRgbLgbRsRjbLcbLeLsbLibLgb
LcbLibLibLgbRcbLjbLhbRjLsbRibLobRibsbRhbLjLjbLsLibRgRgbReRsmbLgLcbRgbL
obRebRhLsLsmbLjLobLibRcbRibRebLjLjLgbRibLsbRcbRobRcbLcbLhbLibLgbRhbRjb
RoRsmbLsLgbLobRoLsbLgbLsLcbRibRcbRibRsbRobLgbLobLhbLibLcbLcbLgbLoLsmbR
cbRiLsbRibRibRsLsbRobRobLeLsbLcbLcbLgbLibLgbLcbLibLibRiLsbRhbRgbRibRiR
ibLiLsbLgRsbLjbRcbRcbLgbLcbLibRgbLebRjbLcbLgbRgbRcLsbLgbRcbRgbRsbLsLob
LobRgRsmbRibRobLgLsbLcRsbRibLcbLebLibRiRsLsmbsbsbRibRibRibRsbRsbRsbRgR
smbLjLsmbLgbLibRibLiLsbLgLsbRobLebLsLsRsmbRhbRobLgbLoRsbLebLsbLhbRgbRi
bRcbRibLcbLcbRgbRjRsmbLcbLgLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 19; Drug: Control Apo 50 然
bRsbsbLebLiRsRsmbLsbRcRsmbLgRsbLsRhbRsbLhbLobsbLgbsbRebRobRgbRhRsmbRib
RiRsmbRsRsmbRoRsmbRibRcRsRhRimbRsbRebRibRgbRibLobLibLiLsbLibLebLebLsbR
sLsbLgLhbLobLhbLibLibLiLsbLibRcbRhRsmbRobRcLsLsmbRhbRcbRobReRsmbRibRgR
smbRgbRiRsRembReRgRsmbRgbRobsbRhbRcbRiRiRiRsmbRsbRgRsLsmbRiRsmbRsLobLc
bLibLgbLgRsRsmbRsbLsRsbLsRsbLsbsbLsRsbsbsbLsbsbsbsbLsbLsbsbsbsbsbsbsbs
bRsbsbsbLsbRcbLcbRsLibLcbLibLhbLiLsbLibLoRsbLgbLobLiLcbLebLgLsbLgbLgbL
gLsbLobLeLsbLiLiLsLiRsbLebLebRgbLgLsbRsRcbRoRsmbRcbLibLebLibLibLiLiLsb
LgbLibLgLsbLsRsbRcbRibLobLibLcLsRgmbLibLiLsbRjRsmbLibLcbLibLeLsLgLsLcb
LiLsbLebLebLeLsbLibRjRsmbRoRibRoRsRsRemmbLibRsRcRsmbRcbRcbLcRsbLobLiLs
bLgbLiLgLsbLibLgLsbLibLgbLcLsmbLobLgbLcbLibLsRsbLgLsbsbRsbLibRcbRobRcb
RibReRiRsRiRsmmbRgRibRoRcRsmbRsRsmbRobRibRhRsmbRcbRobRcbRhRsmbRibRiRsm
bReRsmbRcbLhbLobLobLibLiLiLjbLebsbLhbLcbLibLebRibLsbsbRcbRhbRsbRgbRcbR
ebRsRsmbRhbRgbRebRcbRebRebRebRebRcbRjbRiRsRgLsLsmmbLibLcbLhLsLsmbLibLs
bLsbLsbLsLsmbLsbRsRsmbLsbLcbLcLsmbRcbRoRsRsmmbRcbRhbRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 20; Drug: Control Apo 50 然
bRcbRibRobRebLjbLcLsmbRgbLobRgbRsbRjbLjbsbLibLhbLgbReLibRhbRgRiRsRsRim
mbRhLsbLgbLcLsmbLibLiLiLsbLebReLsbRhRsmbRjbLgbLcRsbLcbLebLebLsbLsLsRsm
bLgbRibLcbLiLsbLiLsbRsbLcbLsbLebLebLsbRebLiRsbRsRsRsRsmmmbLibLgbsbLjRs
bLibLjbLebLiLsRsbLiLsbLjbLibLhLibRhbRhbRebLsbRebLiLsRsbLsbLibLcbLibRcb
LibLibLebLebRcRsmbRiRsRembLeLhLeLsRsbLiRsbRsLsbRgbRoRsmbRibLsbLcbLcLsm
bLiLhbLhLsbLgbLgLsbLobsbRsbLcLsmbLgRsRsmbLsbLhbLgbLiRsLiLiLsbsbLhbRhbR
cbRcRsRgmbRcbRgRgbRgbRhRgbRhRhbRhbRhRsmbRibRhbRebLsLsLsmmbLjLsmbLsLsmb
RebRibRebRibRsbLjbRsbLsLsmbLcbLcLsmbLgbLcbRibRcbLibLibLhbLgbLgbRjbRhbR
obRhbRibRiRsmbsbRgbRgbRibRibLsbRibRsbLsRsbsbLjLsmbLibRjRsmbRcbRjRsmbRh
bLsbLsLgbRcRsmbRebRgbRcbRiRebRhbLsbRsRoRsmbRibRibRebRgbRgbLgLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 21; Drug: Control Apo 50 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 22; Drug: Control Apo 50 然
bsbLsbLsbLsbLsbLsLsRsLsmbLsbsbLsbLsLsLsmmbsbLeLsbLoRsbRcLsbRibRobRhbLc
bRibRoRsmbRibRobRibLoLsmbLhRsbLiLsbLgLsbLiLgRsbLcLsRsmbLsLcRsRsmbLibLe
bLiRsRsmbLiRsLoLsLeRsmbLebLebLibRsbLsbLsbLsLsLsmmbRsbLsbsbRsLsbLsLsLsL
sLsmmmmbRsLsbLsLsmbLsLsmbLsbLsbLsbLsLsmbLsbRsLsbRsLsLsmbLsLsmbLsbLsLsm
bRsbsbLsLsmbLsbLsbsbLsbsbLsbLsbLsbsbsbLsbLsbLsbLsbLsbLsbLsbLsbLsbLsbLs
LsmbLsLsmbLsLsmbLsLsmbLsLsLsRsmmbLsRsbLsLsmbLsbLsbLsLsLsmmbLsbLsLsLsLs
LsmmmmbLsLsLsLsLsLsmmmmmbLsbLsbLsbLsLsmbLsbLsbLgbLsbLsbLsbsbLsbLsbLsLs
mbLsbLsbLsLsmbsbRhbRcLsbRhLsbRobRobRobRibRobRibLibRhbLeRsbLcbLebLgbLsR
sLsbRsLsLsmbRhbLsbLgLsbLgLgLgLgbLsbLsLsmbLsbLsbLsLsmbLsLsRsmbLsbRsbLsb
LsbLsbLsbLsLsmbLsbLsLsmbLsbLsbLsbLsLsRsmbLsbLsbLsbLsbRsLsbLsbsbRsbLoLs
mbRiRsmbRoLsbRibRcRgbLsRsbLiLsLsmbRibLgRsbRgbRibRgbLobLoRsbRgbRjbRoRsm
bRcbRsbRibRibRhbLsLsmbLsbRoLsLsmbLgLsbLcLsmbLibLiRsbLsbLibsbRsbRsLsbLg
RsbRsRsmbLsLsmbLsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 23; Drug: Control Apo 50 然
bRgRsmbRibRsbRgRsmbRgbRiRsLsmbLebLiLsLsLsRsmmbLiRsbLibLsbLjbLgbLgLsbRs
LiLgbRgbLgbLgLsbLebLgbLsbRsbLibLsLsRsmbLsLsmbLgbLgLiLsLsmbLsbLibLgbLsb
LgbLgLsbLibRsbLgbLsLibRsbLsbLgbLhbLiLsbLgbLsbLgLgbLsbLsbLsbLgLibLibLgb
LsRibRibRsRsRsRsmmmbRgbRgbRibRsbLsRsRebLgLsbRgbRibRgRsmbRibRgRibRgRsmb
RsbLsbsbLsRsRsRgmbRsRibRebRgbRgbRiRsmbRsbRsRib

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 24; Drug: Control Apo 50 然
bRgbRjbRcbRsLsbLgbLjbsbLibRsLsbLsbLgLgLsbLgLsbLsbLsbRcbRibRsbLcbLiLsbL
sbLiLsbLiLsbLgbLibRgbRjbRhbLiRsbLgbLibLgLsbLiLsbLgbLgRsbLsbLsbRiLibLcb
LibLgbLjbRobRiLsbRsbLcLsmbLibLsbLibLsLsLsmmbLsRsbRsbLgLsbLgbLgLsbLgbLg
bLgbLsbLgbLgbLgbLgLsbLjbRjbRgbRgbRgbRgbRibLsbRgLsbRibRgRsmbLsLiLsbRjbR
ibRgbRsbRiLsbRgbRiRsmbRsbLcbLgbLebRiRsmbLsbsbsbRsRsmbRsbsbLsbLebLebLeb
LsbRsbLsRsbLgLsbLsLsLsmmbLgbLibLsbLibLsbLgbLsbRsLsbLgbRcbRiLsbRgbRsbRi
bRsbRsRsmbsbLjbLjLsmbsbLsbLgLsbLibLgbLsbLsbLsLsLsmmbLgLsbLgLsbLebLgbLs
bLgbLgRsLsbLsbRjbRobRgbRibRsLsbRgbRsRgbRgRsmbRsbRsLsRsbLjbLibLsbLgLsLs
mbLgbLgRsbLibLgbLgbLsLgbLgbLgbLgLsbLsbRjbRcbRiRsmbLsRgbRgRgRsLsmbsbRsR
smbRsbRsLsbsbRsbLsbRsbLsbRsbsbRsbRsLsbLsbRsRsmbRgbRgbRiRsmbRsRsRsmmbRg
bRiRsmbRibRsbRsbRsbsbsbRgbRgbRgRsmbRgRiRsmbRsbRsbRsbRsbRsRsmbRsRsmbRsb
RjbRsbRgRsmbRgbRgRsmbRgRsmbLsRsbRsLsbLjbLhLsbLiRsbLsbLgbLsbLsbLsbLsbLs
bLiLsLsmbLgbLibLibLsLsRsmbLhLsLsmbRibRhbRgbRibRgbRibRobRsbLibLgLgLsbLg
LsbsbLgbRsbsbLgLsbLgbRjbRcbRibRibRibRgbRibRgbLsbRsRsmbLebLsLibLgLsLsmb
LgbsbsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 25; Drug: OSU6162 10 然 Apo 50 然
bLsLsLgmbLobLiRsbLgbLsbLsbRjbRebRibLsbRsLsbRibRibRibRibRsbRsbLsbRgbReb
RsbLebRibRcRibRcRsmbRgbRgRsmbRibRgbRgbRgbLjbLsRebRhbRsbLcbLgLsLsmbLobL
ibLhbLhLsbLhRsbsbLibRgbRhbRibRiRsmbRgbRhbRibRcbLgLebLgbLsLsLgmbsbLgbLg
bLgbRsbLgbRsLsbRibRgRsmbRsbRsbLgbLcLsmbLibRoRsmbRobRibRibRibRgbRgbLsbR
cLsbRibRhbRebRibRgRsmbRgRsmbRgRsmbRsbRgbLsbRsbRsRsmbRhRsmbRebRibRgbRhb
RgbRoLgbLsLjbLibLsbLsLsLsmmbRsLibLsbLgbLsbLsLgLsbLgbRsLsLsmbRsLsbRsLsb
LsLsmbsbsbsbsbRsLsbRibRhbRcbRibRgRsmbRhbRgbRgbRsbRsRiRsmbRebRgbRcbRcRs
mbRebLsbReRsRsmmbRibRhbLibRsRsmbLhLsbLobRgbLibsbRsbsbRsbsbLsbsbLsbLsRs
bLsbRsbLsbLsbLsLsmbRsbLsbLgbRebRgRsmbLgbRsbRhbsbRjbRsbLibLsLsmbsbRobRo
bRiRsmbRibRgRsmbRgbRebRsbReRhbRibRiRsRimbRsbRgRsmbRgbRibRsRsmbLhbLhRsb
LgbLhRsbLcbLcbRgbRiRsmbLsbRcRsmbReRebRebsbRsbRiRsmbRibRgbRgbsbRgRsRsRh
mmbRgbRiRsmbRgbRiRgRsmbRcRsRsmmbLjbLgbLsbLsbRcbLsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 26; Drug: OSU6162 10 然 Apo 50 然
bsbsbsbsbsbsbRibRcbRcbRiRsmbLibLobLcRsbLhRsLsbLsbLobRsbRibRgbRobLsbRoR
sRiRembRcbRgbLsbLsbRsbsbsbsbsbRcbRiRsmbRcbRcbRibRhRibRibLgLsbRhbLcLsmb
LhbRgbLeLjbLhbLsLsmbLobLgbLibLsbLgbLibLgbLebLeLiLgLeLsbLgbLebLeLebLsbL
gbLiLcbLebLibsbsbsbsbsbsbsbRsbsbsbRsbLsLhbLibLebLobLcLsLsmmbLiLgbLobLo
bLcbLgbLoRgRebRgLsbRibRebRgbRhRsmbRibRgRsmbRobRcRsRgmbRiRsmbRibRgRibRs
bRsbsbsbRgbRiRsmbRiRsmbRcbRibLoLsmbLibLcLsmbLobLcLebLebLebLgbLgRsRsmbL
gbLsbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 27; Drug: OSU6162 10 然 Apo 50 然
bLgLgbsbLsbLsbRsLsbLgLsbLibLgbRsRsRsmmbRgbLiLsbRgbRibRiRsmbRsRsRsmmbRs
bRgRsmbRsbRgRsmbRibLjLsmbLcLsmbRebRsLsbRsbRsRsmbRsRsmbRibRsRgbRibRgbRi
LsbLibLiLsLsLsmmbLsLsmbLgLsbsbLsLsLsLsmmmbLsbLgLsLsmbLsLsLsmmbLsLgLsbL
gLsbLiLsLsLsmmbLsLsLsmmbLsLgbLsbRsLsbLgbLgLsLsmbLgLsbLgbRsLsLsLsLgmmbL
gbLsLgbLgbLsLsmbLibRgRsmbLebRsbRibsbRibRgRsmbRsRsmbRsRsmbLsRsbRsbRgRsm
bRgbRibRibRgbLgbRsbRsRsRhmbRhbRsbLsbRgbRebRgbRsRgbRibRibRsbLsbRgRsmbRe
bRsbRhbRsbRgbRgbLsRsbRgbRgbRgbRebRgbRiRsmbLgbRiRsmbRgbLsRsbRebLgbRgbRg
bLsRsbRgRgRgbRiRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 28; Drug: OSU6162 10 然 Apo 50 然
bsbsbRgbRsRsmbRsRsRsRsmmmbRsRsmbRsbRsbRsbRgbRhbLobLcRsLsRsbRjRoRsRsRcL
iLsLsmmmbLeLhbLsLebRcbsbsbsbRsbRcbRcbRibRsLsbLobLgbLibRsbLsbRjbRcbRebL
obRgbRiRsmbLcbLhbLhLsbRibRcbRsRsmbRsRsmbRsRsmbRsRsmbRgRsmbRsRsRsRsRsRs
RsmmmmmmbRsRsRsRsmmmbRsbsbRsbRsRsmbRjbLiLsbLgbLibLgbRcbLcbLsbLobLsbLsb
LibLgRsbsbsbRibRebRcRsmbRibRibRibRobLgbLibRsbLobLibLobRibsbRgRsmbRgbRg
bRsRsRsmmbRsRsRsmmbRsRsmbRgbRgRsmbRgRsmbRgbRsRsRsmmbRgRsmbRsRsRsRsRsmm
mmbRsbRsRsmbRsbRsbRsRsmbRsRsRsRsRsRsmmmmmbRsRsRsmmbRsRsRsRsmmmbRsRsmbR
sRsRsmmbRsbRsbRsbRsbRsbsbRgRsmbRsRsRsRsmmmbRsRsRsRsmmmbRsRsRsRsLsmmmbR
sRsRsRsRsRsmmmmmbRsbRsbRsbRsRsmbRsbRgRsmbLoRsbRobRobRobRcbRsRhbRjbRgbR
gRsmbRgbRcbRhRebRsbRgbLibLebLhbRobLsbLcbLsbLsRsLsbLsLsRsRsmmbLoLsLsLsm
mmbLobRibRebRgbRgbRsRsmbRsbRsbRsRsmbRgRsmbRgbRsRsmbLsRgbRsRsmbRsRsRsRs
RsmmmmbRsbRsbRsbRsRsRsmmbRsRsRsRsmmmbRsRsRsRsmmmbRsRsRsRsmmmbRgbRsRsRs
RsRsmmmmbRsbLsbLsbRsbLsbRgRsmbRsRsRsRsLsRsRsmmmmbRsRsRsRsmmmbRsRgbRsRs
RsLsRsmmbRsRsRsRsRsmmmmbRgRsRsmmbRsRsmbRgRsmbRsRsRsRsmmmbsbRsbRsRsRsRs
RsmmmmbRgbRsRsRsRsRsRsmmmmmbLsRsRsmbRsbRsbLsRsbRsLsRsRsmbRsRsRsRsRsmmm
mbLsbLobRcb

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 29; Drug: OSU6162 10 然 Apo 50 然
bsbRsbsbsbsbsbsbsbLgbRobRgRsmbRgbRhRsRsmmbRiRsmbsbsbsbsbRsbRsbsbLsbsbs
bsbsbsbsbsbsbsbsbsbsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 30; Drug: OSU6162 10 然 Apo 50 然
bLsRsbLsbsbsbsbsbsbsbLsbLsbRsbRsRsmbLcbLebLgLsRsbLobLhbLcLsLsmmbLiLiLs
LsLhLiLsmbLobLcLsmbRebRibRsbRcbRiRsmbRibRhRsmbRcbRcbRhbLjbLgbLhbLcbLiL
sLsmbLibLhbLiRsbLiLsbLobLibLcLsmbLibLsbLibLibLiLsbLebLhLsbRiRgbRgLsRiR
smbRiRsmbRgbLsbRcRsmbRiRsmbRhRsmbRibRcRsRsmmbRibRibRibRcbLobLibLcbLsbL
iRsbLibRsbRsLsbLsRsbLsLsLsLsmmmbLsLsmbRgRsmbRgbRhbRgbRsRcbLcRibRiRhbRi
RsmbRcbRgLsbLcLibLiLsRsbLhbLhbLoRsbLgLibLibLibLhLsLsLsmmbLgbLcRsbRibRj
bRobRgbRhbRobRgbRibRiRsmbRobRgbRibRhRsmbLgbLibLgbLibLgbLibRsRsmbRsbLeL
sLsLsmmbLgbLcbLcbLhLsbLsLsmbLgbLibLibLibLibRjbRhbRiRsRsmmbRibRebRgRsmb
RgbRibRgbRgRsmbRgbLjbLobLibLgbLibLibLibLgbLsRjbRobRibRibRiRsmbRgbRgRsm
bRiRsLsmbRiRsmbRobRibRoRsmbRobLobLibLgbLgbLsbLsLgLeLsbLiLsbLgbRcbRibRi
RsmbRibRgRsmbRibRibLjbLobLgRsbLibLibLgLsbLiLsbLobLgbRibRibLsbRcLsbRibR
iRsmbRsbRgbRibRgRsRsmmbRibRgRsmbRibRcLsbRiRsmbRhbRgRsmbLgLsbLcbLibLhbL
gLsbLcbLhbRibRgbRibRibRsbRjRsmbRsLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 31; Drug: OSU6162 3 然 Apo 50 然
bRhbRibRibRsRsmbRcbRobLhbLobLibLobLgLsbLhbLiLsbLhRsbLcbLsbRibRiRsRsmmb
RcbRiLsbRebLgbLobLobLcbLcbLobLobLiRsRsmbRcRsmbRiRsmbRgbRibRiLsbRgRsLsm
bRsbRcbRibLoLsLsRsmmbLsLsLsmmbLsRsbLsLsmbLibLibReRsmbLjbLsbLiLsLsLsmmb
LsbLibLcLsRsmbLgLgLsLsmbRjbRcbRiLsbLgLsbRiRsRsmmbRsbRhRsmbRibLibLoLsLs
LsmmmbLiLsLsmbLiRsbLgLsbLiLgLsLsLsmmbLgbsbsbLgLsLsLsLsLgmmmbLgbLibRjbR
cbRiRsRsmmbRhRsmbLibRcbRiRsmbLsbLcbRibLsLobRgbLcRsLsbLiLsLgLsbLcbRibRi
RsRsmmbRsLgRsRsRsRsRsmmmmbRsbRiRsmbRibLcbReRsRimbRsRgRsRgmbRsRgRsmbRgR
gRgRsLsmbRsRsmbRcbLobLebLiLsbLgLsLsLsmmbLgLsLiLgbLgLibLsbLsLsmbLhbLoRs
bLcbRiRsmbRobRiRsRsRsmmmbLebLobRhbRibRebRsRsRsmmbRsRsRsRsmmmbRiRsmbLgb
LeLsLsLsmmb

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 32; Drug: OSU6162 3 然 Apo 50 然
bsbRsbLibLgLsbLgbLibLgLsbRsRibLoLsmbRsLobLiLsbLoRsbRsbLoRsbLoLsLsmmbLc
bLobLiLhLibLebLgRsbLibLgbRsbLsLsLsmmbsbLiRsbLcLsmbRhbRoRebRiRsRhRsRemm
bsbRsRiRebRsLsbsbRiRsRsRsmmmbLobLobLibLiLsbRsbLhbLoRsLsbLobLgbLcbLiLiL
ebRhRsmbLoLiRsbRgbRebRebRgRsmbRobRsbRgbRcRibRiRsReRembRsLsbRsLsRsbRhbs
b

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 33; Drug: OSU6162 3 然 Apo 50 然
bLiLsbsbLibLibLsLsmbLhbRsLsbLhbRsbRgbRjbRsbLjbLjbLsLsmbLsLsmbLiLsLsRsL
gmbRcbRhLsbRgbLgbLcbLsLsLsLsLsLsmmmmmbLiLsbLsLsLsLsLsmmmmbLcbLcLsmbLgb
LcbRcbRibRibRgbRiRsmbRgRsRsmmbRhbRgbRibRibRibRobLhbLcbLcbRgbRcbRgbLebL
gbLibLgbLiRsbLobLsbRiLsbLgbLcLsmbLgLsLsLsLsmmmbLsLsLsmmbLsLsLhmbLibRgb
LsbReRsmbRibRibRibRgbRibLhLcbLiLibsbLgbLgLsLsLsLeLsmmbLiRsLeLsLeRsbLib
sbRsRcbRobRsbLibLjbLcbLgbRibRiRsmbRibRgbRibRgbRcRsmbRibRibRcbRhbRibRib
RsbLcbLiLsbLibLibLibLibLibLhbLsbLgbLobLiRsbLcbRhbLjLcbLiLsbLhbLcLsmbLj
bRgbRibRibRsLsbLhbLibLiLsbRjbLcbRibRjRsmbRibLibLsLsLsLsRsmmmbLsbLsLsmb
LsbLgLsLsmbLibRgbRjbRgbRibRgRsmbRgbLjbLgbsbLsLsLsmmbLiRsLsLgbLiRsRsmbR
gbRcRsRsmmbRibRibRgRsmbRgRsLsmbRsbLcbLibLgbLgLsbLgbLiRsbLhRsbLsLgbLiLs
bLsLsLsmmbLibRibLgbRhbLsbRibRibLibRsbLjbLsLsLsLsmmmbLgbLgLsLsRsLsLsLsR
sLgmmmbLibLiRsLsRsRsmbRgbLhbLsbLiLsLgbLibRibLibRgRsmbLiLsbLgLsbLsLsLsL
sLsLsLsLsmmmmmmmbLsLgbLsLeLsbLebLgLeLhbRobRjbRsRsmbLibRjbLibLsbLsLsmbL
jLsLsmmbLsbLsLsmbLeLebLsbLgbLgbLiLsbLibRgbRgbLgLsbLsLsmbLgbsbLcbLhbLiR
sbRgbRjRhbRsRsmbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 34; Drug: OSU6162 3 然 Apo 50 然
bRebRebLjbReRibRcbRibRhbRibRgbRibRibRgRcbRhRsRiLimbLiLgbLiLebsbReLsbRc
RsRsmmbRibRibRhRsmbRcbRibRhRsmbRcbLgbLiLsbLibLgbLgbLgbLsLsLsLemmbLiRsb
LibLhbLcbLibLeLsbLsbLsbLiLgbLebLhbRcbRhbRiLsbRcbRibRiRsmbRiRsRimbRiRhb
RgbRibRoLiLsbLhbRobRiRsLsmbLgbLebLgbLiLsbRgbLcLsmbRgbRjbRibRcbRjbLsbRc
LsbRebReRibRebRebReRsLsmbLcLsLsmmbLiLebLobLibLebLibLsLsmbLebLibRibRibR
ibRibRibLjRsRsmbLobLcbLobRhbRhbRhbLibLgbRcbRibRibRobRebLhbLiRsbLgRsbRi
RibRjbLgbLjbRsbRibRgRgbRgbRcbRhbRibRibRjbLhbLcbLsLsmbLibLebLsbRjbRsLsb
RibRibRebRebRibRebLsbLibLibLgbLgLsbLjbLhbLsbRebLgbLgRsbLgbLiLsbLgbRebR
hbLibRibRibLgbLebRebLcLsmbLsLgLsbLsLsLsRsmmbRiRsmbRsRsmbRibRebRcbRhbRi
bRgbRhbRgRsmbRgbLgbLibRcRsmbRgbRsRsmbRibRgbLsLhbLibLsbRsbRebRsbRcbRcbR
ibRebRhbRhbRsbRhbRcbRcbRgRebLebLoRsbLsbRcRsmbLgbRcbRcbRcbRhbRgbLsLebRc
bRcbRibRibRhbRibRiRsmbLjbLjLsmbLcbLgbLgbLjLsmbLgbRsbLhbLibLsbLebRibReb
RibRibRhRsmbRebRsbRsbRibRibRgbLibLhbLeRsbLsbLiLsLiLsbLcbLcbRibRcbRgbLc
bLcbRibRcbRhbLgbRhbRibRgbRsbRibLebLibRcRsmbLgbLebLjLibLebLsbLibLibRibR
gbLiLsbLhbLgbLgbRjRsmbLebLibLgRsbRsRebRebLgbLgLibLjLsmbRjb

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 35; Drug: OSU6162 3 然 Apo 50 然
bLsbLsRsbLsRibRgbRiRsmbRsbReRgRsRhRsRsRiRsmmmmbRgbRiRsmbRibRgRsmbRgbRg
bRgbRgRsmbRsbRgbRgbRsbRsRsLsmbRcbLhbRcbRcbsbReRsmbsbRgbRsbRgbRiRsmbRcb
RcbRcbLsbRibRibLsbRiRsmbsbRibRobRcbRibRibLsRgRsRiRiRsReRiLsmmbRiLsbRgR
smbRibRgbRiRsReRimbRsbRsbRgbRgbRsbRgRsRsRsmmmbRcRsRsmmbReRsRsRsmmmbRib
RiRsmbRgbRibRiRibRebRiRsmbRgbRiRsRgmbRgbRsbRgRsmbRgbRsbRgLsbRgbRsbRsRs
mbRiRsRgRcRembRiRsRimbRibRiRsmbRcReRsRhmbRibRebRsbRiRsmbRiRsmbRhRsRimb
RiRsmbRibRgRcbRebRebRiRsmbRgRsmbRgbLsLhbLhLiLsbLibLhLsbLiLsbsbLgLsbLgb
LsLsmbLgbLsbLgbLsRsbLiLsbLsbRgbsbRsbLgbRjbRgLsbLgRsbLgbLgbRgbRsbsbRcRs
mbLoLsLsmmbLgbsbLsbsbRsRsmbLsbsbLhbRcbRcbRibRcRsmbRiRhRsRhRsRiRsRgLsmm
mbRgbRiRsmbRgbReRsmbRgRsRsmmbRiRsmbRhbRibRhRiRsRsmmbRhbRiRsRiRsmmbRgbR
ibRibRibRgbRibRibRoLgbLgbLcRsRsmbLsbRebLsbRoLsLcLeLsLebLhbLiLsbLgLsLsm
bLsbLiLsbLsbLgbsbsbLgRsLsbLsbLeLsbLiLsbLiLsbLgbLsLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 36; Drug: OSU6162 3 然 Apo 50 然
bRjbRhRsRimbsbsbRsbsbsbRsRsmbLsbRsbLsRsLsbRsbRsRsLsmbLsLsLsmmbLsbRsLsR
sbRsRsmbRsbRsbRsbLsRsLsLsmbRsbLsbRsbLsRsbLsbRsbLsbLsbRsbRsbLsbLsbLsbsb
LsbRsbsbLsbsbLsbRsbRsLsbsbLsbsbsbRsbLsbLsbsbsbsbsbsbsbsbLsbsbsbsbsbsbs
bsbsbLsbRsbRsbLsRsbsbsbLsLsRsRsmmbRsRsmbLsLsmbRsRsLsmbsbLsbRsLsbLsbRsR
smbRsLsRsLsRsbRsLsRsLsLsLsmmbRsLsRsbRsRsRsLsmmbRsRsmbRsLsLsmbRsRsRsLsR
smmbRsbLsRsRsLsRsLsLsmmbsbRsLsRsbRsbRsbRsRsLsmbRsRsmbRsLsRsbsbLsRsbLsb
RsbRsbLsbRsbRsLsbRsbReLsbRsLsLsmbLsRsbRsbLsbLsbRsbsbsbsbsbsbsbLsRsbRsb
sbLsLsmbsbLsbRibLobRjRcbRgRsmbRhbLgbLcbLoLsmbLcLsLhmbLcLibLeLsbLsbLsRs
bRgbRoLsLsmbRsbRibLjbLoLsmbLibLibLhLibLcLhbLobRgbRobLebLsLsmbLsbLsLsLi
mbRobRibsbsbRgbRcRsmbRebLsLsmbLebLiLcbLcLeLsLjbLiRsbRsbRcbReb

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 37; Drug: OSU6162 1 然 Apo 50 然
bLcbsbsbsbsbLsbsbsbsbLsRsbsbsbLsbLhbRsRjRibRhRgLsbRcRsmbRhRsRhRhmbRiRi
bRgRhbRgRsmbRibRgbRsbRgbRsbRsbRgbsbRsbRsbsbLsbsbsbsbsbsbRsbLhLsbRibRsb
RibRcRgRibsbRsbRobRiRsmbRsRsmbRsRsmbRsbRcRibRhRiRsLsRsRgRsRsmmmbRgRgbR
gbRgbRgRsmbRgbRsbRsRsmbRgbRiRsRimbRibRibRgbRgRgRsmbRsRgbRsbRgbRsbRiRsR
iRgRsRgRimmbRsRsmbsbRsbRgbRgbRsbRsbsbsbsbLsbRsbRsbRsbRsbRsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 38; Drug: OSU6162 1 然 Apo 50 然
bLibRsbRsbRsbLsRsLsbsbLsbRsbRsbsbRsbLibRsbRsbLsbLsbLsbRsbsbsbLsbLgbRsb
RsLsbLgbLcRsbLsbLiLsbLsbLibRsbsbRsbsbsbsbRsbRsbLgbLiLsbLgbLgLgLsLibRsb
LebLibLsbLsLgbsbRsbLebLsbLsbLhbRsbLsbsbLgbLsbLsbLgbLsbsbsbLgbLgbLcbLsb
LcRsRsmbLeLsLsmbRsbLsRsbLgbLgbLcRsRsmbRcLsbRsbRsbRgbRgRsmbRsRsmbRgbRsb
RsbRgbsbRsbRsbRgbRhLgbRiRsRiRsmmbRgRsmbRgLsbRsLsbRgbRgRsmbRibRgbRhbLsb
LoRsbLsbLibLgbLiLsbLsLsmbLgLiLsLsLgLsLiLsLgLsmbLiLhLsLibLiLsbLgbLsbRsb
LsLsmbLsLsmbRsbLob

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 39; Drug: OSU6162 1 然 Apo 50 然
bLsbsbRjbLibRjbRibRjLsbLjRsbLsRsLsbRgbLcbLgbRsbRsRsmbLsbLsLsmbLsLsRsmb
sbRsbLsbsbRsbLsRsbLsRsLsbLsbLsbRsbLsbRjbRobRjRibRcLsbRcbRsRibRgbRgbsbs
bsbRgbLjbRiLsbLcbLgbRsbRsbsbRjbRcbLobRcbRibRcLsRsbLobRcb

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 40; Drug: OSU6162 1 然 Apo 50 然
bLgLsLeLsbsbLsLsLsLsLsmmmmbLsLsLsmmbLsRgbRibRibLsbRibLgLsbLeLsbLhbLibL
ibLibLebLebLibLhLsbLsbLsLsmbLgbLsbLsLsLsmmbLgLsLgbRsRcRsmbRgRsmbRibRhb
RgLsLsmbLebLgbLiLsbLsbLsbLsbRsbLsbsbRsbRsLsbRsbsbLsbLsbLsbLgbLgbRiRsmb
RsbRiRsmbRibRgRsmbLsbRgbsbRgbRgbLsbLobLobLobRjbRhRsmbRebReRsRembLibRcR
smbRebRsbRsRsRsRsmmmbLibLoLsmbLhbLibLibLcbLjbRcbLeLsbLsbsbLsLgLsbRhbLg
LsLsmbLibLsLsRsmbRibsbsbsbRsbsbsbLsbsbsbsbsbsbsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 41; Drug: OSU6162 1 然 Apo 50 然
bLsbRsbsbsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 42; Drug: OSU6162 1 然 Apo 50 然
bLebLgLsbLsLiLsbRsLsbLibRcbRcRsRgmbRcLsbRgRsRsRsRsmmmmbRobLgbLiLsbLibL
ibLebRsbLgLsLsmbRhbRebRiRsmbLibLhbLibRsbLeLsbLhLsLsmbLiLsLgbRhbRibRcLs
bLibLsLsmbLgbRcbRiLsbLeLgLsLgbLiLsLgbLibLiLsLsLsLsmmmbLhLsLsmbLebRgRsR
smmbLsbLiLsbLsLsmbRjbRhRsRsRsRsmmmmbLcLsmbLsLsLsmmbLsLsLsLsmmmbLgLgLsb
RgLsbLebRgbLhbRsbRoRsmbLsbRgLsRsbRiLsbLsbRgRsmbRsbRgRsmbRiLsRsRibsbLsR
gLsbRibLcLgbLibLibLgLsbLibLiLsbLsbLsbRsRsLsmbLiLsbLsbLsbLgLsbLiLsbLsLs
LgmbLhbLebLobRgRsmbRhbLgbLcLsmbRsRsmbLgbReRsmbRsRsmbsbLjLjbRcRsmbRibRc
bRgLsbLcLibLiLsbLibLebLgRsbLgbLcbLibReRsmbRibRsbRhbRibRcbRibLcbLsbLsLs
mbLgbLgLsLsmbLgbLibLibLebLhbLiLsbLsLsmbLgLsRsbLsbLcbLsLsLsmmbLgbLsbLib
RhRgbLebLsLsmbLhbLibRhbRgbRhbRhbRibRibLsbRsbRjbLebRsLsbRebRgbLjbLoRsbL
ibLibLibLgbLibLsbLibRgLsbLgRjbLsLsmbRcbRiRgbRsbLjRsbRjbRobLebLcRibLgbR
ebRsLsbRobLsbLsbLibLibLgbLhLsbRobLibRcbRibRoLsbRsbRcRibRsRsmbRibRibLsb
RebLgbRobLgRsbRgbRib

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 43; Drug: Control Apo 50 然
bRsbsbRhbLsLjbRjRsmbLcbLobLhbLsbLibLiRsbLsRsbLebLsbLibLgLsbLobRhbRgbRo
bRhbRibRcLsbRsbLcbLhbLiLiRsRsmbLibLiLsbLebLibLibLibLibRsbLcbLiLiRsbLoR
sRsmbLgbRebRebLgbsbLgbRobRjbRsbRgbRhbRebLgbRebLobLgbsbLjbLcbLibLjbLibL
ibLgbLjbLsbLhLcbLibLibLibLgbRibRgbLibLsbLibRjbRsbRibLcbLibLibLgbLhbLib
LibLgbLibLobLsbRcRsmbRjbLoLsmbLsLiLsbRjbRsRcbRibRibRcRsmbRibLibLobLsLh
bLcbLibLiLebLeLebLgLsRsbRcbRobsbLcbLhbLhbLgLsbLibRjbRebLcLsmbRcbRibReb
LcbLhbLhbLhbLiLsLsLiLsLgmbLgLsbLsLsmbsbsbsbLsbRjbLobRobRobLobLibLsbLhR
sbLiLibLibLibLiLsLsRsmbLgbLiRsLsbLgbLibLsbLibLiLsbLiRsbLgbLhbLgbLcbLeb
LibLibLgLsbLibLgbLoRsbLebLebLsRhbLibRsLsbLsLibRibsbRcRsmbLjbLcbRcbRgbR
ibRjbRibRobRebRcbRibRhbLsLsLimbLgbLcbLibLgbLebLobLibLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 44; Drug: Control Apo 50 然
bRgbLcbLobRsbLebRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 45; Drug: Control Apo 50 然
bRgbRsbRsbRhbLcbRebRgbRebRsbsbRsbRsbLhbLibRcbRhbRibRgRsmbRsbRgbLsbsbsb
LgbRgbRiRsmbRcRsmbRsRsmbRsbsbLsRsbRibRsbRibRiLsbRsbLsbRsbLjbRsbLebReLh
bLsbLgbLsLsmbLeRsbLibLoReRgbRiLsbsbRsbsbLjbRiRsmbRhLsbRibRsbRgLsbLsbsb
sbsbRsbRsbRsLsbLsbRsLsbLsLsRsRsmmbsbLsbLsbLsLsmbsbLsLsmbsbRsbsbsbsbsbR
sbLsLsRsRsmmbRsbRsbLsbLsbsbRibLiLsbLgRsbsbRsRsmbLgbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 46; Drug: Control Apo 50 然
bRjbRcbRgbLobLhbLcLsmbLibLibLgbLgbLibLiLsbsbRcbRhbLjbLgbRcbRcbLhbLebLi
bsbLibLibLibLibRsbLibRcbRcLsLsRsLsmbRgbRoLsbLgbLibLoLsmbLcbLcRsbLgRsbL
gbLobRobRiLsbLjLsmbLobRibLsbLibLibLiLsbLiRsbLcbLibsbRibLiLsbRjbLjbLsbL
ibLhbLsbLsbLibRcbRcbRibLcLsmbsbLibRobRgbLjbLcRsbRsRsmbLibRgbLhbLgbLhLs
bLibLibLibRcbRibLgbRcRsmbLgLsbLcbLhbLiLsbRsLsbRsbRobRhLsbLebLcbRsbLhbL
gbLhbLcbLsRsbLgbLgbLhbLsbLgbRcbRibRsbLjLgbRsbRibLsRsbLhLsRsbLibLgbRibR
cbRgbRiLsRsbLcLsmbLibLgbLhbLgRsbRsRsmbRibLsbLgbLcRsbLgLsLsLiLsLsLsLsLi
LsmmmmbLobRsbRgbRgbsbLibRcbRhbRibLjbLibLcbRcbLibLibLsbRcbRibRgRsmbRiLs
bLsLsRsmbLhbLibLibLibRsRsRsLsLsmmmbLgbLhLsbLgbLibRcbRibLsbLobLhbRibLsb
RcbRgbRiLsbRcRsmbLibLebLibLcLsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 47; Drug: Control Apo 50 然
bRgbsbRibRgbRgbRibRcRsmbRgLsRibRhLsRsLsbLsRsbRsbRhbRiRsLsmbRibRsReRgbR
ibRgbRibLsbRhRsmbRgbRsLsbLcbLgbLiLsLsmbLsbLibLsbLoLsLeLsLgmbLibLgLibLg
LsbLgbLgLsbLsLsmbLebLcbLsbLgbLgbLsbLgbLgbLgbLsbLoLsmbRjbRibRiRsmbLjLob
LhbLhRsbReRsmbRibRiRsRgRsmmbRgRsRsmmbRgbRibRsRsmbRibRgbRiRsmbRgbRgbRgb
RiRgRgbRiRebRcbRebRcbRibLsbRibRibRsbLiRsbLgbRebRgRsmbRgbRgbRgbRcRiRebR
eRebRsbRibsbsbRcbsbRcbLgbRcRsmbRcbLsbLcLeLsbRjLhLsbLcbLsLsmbLcLsmbLgLs
bLibLibLgbLiLsbLgbLgLsbLiLsbsbLeLiLebLiLsbLiLsLibLibLibLiLsbLhLsLcLsLs
mmbRebLgbLgbLiLsbRsbLcbLgRsbLgbReReRsmbRebReRsmbReb

>ZF Recording 2016-08-17; tW: 300s; Start: 161318; End: 161818;
Recording: 4-1; Individual: 48; Drug: Control Apo 50 然
bLsbLibLsbLiRsbLebLiLsbLgbRsbLgbLsbRcbRcbRgbRgbRibRhbRcbRcbRcbRibRiRib
RiLsbLsRiRsRcmbRibRgbRhRsmbLsRsbRibRibRibRcbRibRobReRiRsmbRiRsmbRebLsL
smbLsLsmbLjLsmbLebLcbLiLsbLcbLeLsbLgbLebLiLsbLhbLibLobLcbLibLgbsbLibLh
bLebLcbLjbLsbRibLhbLcbLiRsbLebLsbRsbLsbsbLsbsbReRsmbRiLsbRsLhbLcbLiLsb
LgLsbLiLsLsLembLgbLobLcbLeRsbLgbLibLibRhbsbLhbLibLsLsLsmmbRsbLibRcbRib
RiRsmbRhbRgRgbLsbRibRcbRibRjRiRsmbRibRibRcLsRsbRebLsRebRgbRsRsmbLebLeb
LhbRibRibRiRsmbRibRiRsmbRsReRsmbRgRsmbRgbRsbRibRcbRebReRsmbRibRebRhRsm
bRibLgRsbRsbRsRsmbRsRsmbLcbLcbLhbLhbLibLibLeLsbLibsbLsLhbLgbLibRsbRcbR
cbRiLsbRhbRibRgbRgbLcLsmbLhbLcbLibRsLcRsbLiRsbLsbLibLibLebLgbRgbRibRhb
LjbLcbLibLibLebLgLgRsbRjRjbRibRhbRcRsmbRcbReRsmbRibRhbRebRiRsRsmmbRiRs
mbRgbLsRsbLjbLcLsmbLebLhbLibLcLsLsmmbLiLsbLibLebRcRsmbLcbLhbLobRibRiRs
mbRibsbReRsmbRibRsbLebRebRcbRibRibRhbRgLsbRiRsmbRhbRibRgbRobRsbRhbRibL
gbLgLsbLibLsbLgLsbLsbLgbLibLiRsbLibLgbLibLibLsbLgRsbLobRgbRhbRebRgRhbR
cbRiLsbRiRsmbRobRcbRhbRiRsReRsmmbRsbRsRsRsmmbRgbRgbRgRgbLgLsbLebLiLsbL
hbLibLibLcbsbLcbLibLibLcbRsRsmbRsRibRhbRibRiLsbLsbRibsbLsbRsRsRsmmbLsR
sRsmbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 1; Drug: OSU6162 10 然 Apo 50 然
bRcbRibRgbRsRsLsmbRsbLsbLsbLjbLsbRiRsmbLsRsbRsbRcbLsbRgbRibRgbRgbRgbRg
bRgbLjbRgbLjbRiRsmbRobRsbRsbLsbRsbRsRsmbRsRsmbRibRgbRgbRsbRiRsmbLcbLiR
sbRobRiRsmbRgRsRsmmbRsRsmbRgRsmbRgRgbRsbRgRsmbsbRgbRsRsmbRsRsRsmmbLsRs
RsmbRsRsmbRgRgRgbRgbRcbRiRsmbRibRibRiRsLsmbLjRsRsmbLcbLebLgLsLsmbLsLsL
sLsmmmbRsLsRsbLsLsLsmmbLiLgbLhRsbLgLsbLgbLebLeLsLibRobLcbLsbRebRhRgRsm
bRgbReLsbRgLsbRsbRgbLgbRgbRgbRgbRgbRgRsRgmbRgbRsbRgRsRsmmbRsbRgRgbRibR
gbLsbRsRsRsRsmmmbRiRsmbLgbLibLibLhbLebLebLgbLgLsLsmbRsbLsLsmbLsLsmbLsb
RsbsbLibLsbRsbRsbRcbRcbRiRsmbRibRsRgbRebRsRsmbRsbRgbRgbRgRsRsmmbRgbRiR
smbReRsmbRiRsmbRgbRib

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 2; Drug: OSU6162 10 然 Apo 50 然
bLsbLsbLsLsRsLsmbLsbRsbRsLsbLsLsLsRsRsLsLsRsmmmmbRsbRobRebLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 3; Drug: OSU6162 10 然 Apo 50 然
bRebRcbLobsbLcbRebRsbLiRiRsmbLgbRibRgbLgbLobLsbRobRsbLebRobRobRebRgbLi
RjbRobReRgRsRsRsmmmbRsRsmbLjbRibLibRcbRgbRsbRibRebLjLsmbLgbLsbLgbLsbRe
bRsbRebLebRsbLsbLgRsbRebRhbLcbLsLsRsmbLgLsbLibLcbRiRiRsmbRsRsRgmbRsbRg
RibRebLsRjbRgRebRebLgbRgRebLsbLgbRibLgbRebLsbLoRsRsmbLibLjbRsRsmbRibLj
bRcRsmbLebLoLsLsLsmmmbRibRcbRibLjbLgbLsLiLhbLgbLibRiRgLcLhLebLcbRebRsb
RsbLsRgRsRsmmbRsLsbLjbLebRcbLobLobLsbLobLoRsRsLsmbLobLoLsLsmmbLcbRsbLe
bLebLgbRobLgbRebRobRibLebRobRgbLsbRsbRcbLobLcLibRobLoLgbRgbLibRebRgLgb
RibLoRsbRsbLebLebRgbLcbRcbRjbRjbRobRsbLobsbRsbLsbRsbLsbLjbRibLgbRgbRgR
sLsmbRsbRgbLsbRobLiRgbLsbLsbLsbRebRobRiLibRebLoRgbLibLeLebRsbLsbsbLobL
ebLjbRsbLibLhbLcbLhbLhbLoRsbLhbLoRsbLhbRoRsmbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 4; Drug: OSU6162 10 然 Apo 50 然
bRsRsRsmmbRsbRibRsRsRsRsRsRsRsRsmmmmmmmbRgRsRsRsRsmmmmbLsRsRsRsRsRsmmm
mbRibRibRibRsRgbRibLebLgLsLsmbRcRsmbLgbsbsbLsbLsbLsLsmbLgbLsLgLsLsLgmb
LgbLsLsLsmmbRsbLcLsLsmmbLibLgLsbRcbRcLsbLeLsLsmbLobRsbLibLsbLsbRebRiRs
mbRiRsmbRgbRiRsmbReRgbRgbsbLibRsbRgRsRembLjbRcRsmbsbLiLsLsmbsbRibRgbRg
bRgbRsRsRimbRgbRsRsRsRsmmmbRgbRgRsRsRsRsmmmmbsbLjbLcbRcbRiLsbRgRsRsmmb
RiRsmbLsLsmbLebLiLsLsLsLsLsLsLsLsLgLsmmmmmmmbRsbRebRebReRsRsRsmmmbReRs
LsmbRiRsRsmmbRsbRsRsRsRsRsRsRsRimmmmmmbLgRsLsbLoLsmbRjbRebRiRsmbRcbRsL
sbLibLgLsLsLsLsLsLsLsLsmmmmmmmbLsbLjbLebLsLsLsmmbLiLibLsLsLsLsLsLsLimm
mmmbLgLsbLsLsLgmbLsLsLsmmbLsLgbLsbRsbsbsbLsbLsbLiLsbLgLebLcLsmbRcRsmbR
sLsRsRsRsmmbLjbLobRebRibLsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 5; Drug: OSU6162 10 然 Apo 50 然
bLsRsLsbLsbLsbsbLsbsbLsbsbsbsbLsLsmbRsLsbLsbsbsbsbsbsbLcLsmbRgbLhLsbLc
LhbReRiRiRsmbLcRsbRiRsmbRebRsbLhbLcbLebLsbRsLsbLsbLjbRibRibRebRgbRibRi
RsmbRibReRsmbRsbRgbLgbRcbReRibsbRgbRoLsbLebLcbLebLsbRsbRsbRsRsmbRsRsmb
sbRsLsbRsbRsbRsRsmbRsbRsRsmbRsbRsbRsbRsbRsbRsbRsRsmbRsbRsbLsbRsRsmbRsR
smbRsbRsRsmbRsbRsRsmbsbRsbRsRsmbRsbRsbRsbsbRsbRsRsRsmmbRsRsmbRsRsmbRsb
RsRsmbsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 6; Drug: OSU6162 10 然 Apo 50 然
bLsRsbRsRsmbRsbRsRsRsRsRgRsRimmmmbRiRsmbRgRsmbRgRsRsRsmmmbRgRsmbRsRsRs
mmbsbLsbRsRsLsmbRgbRsRsRsLsRsLsRsRemmbLsLsmbLsbRsRsRgReRsmmbRgbRoLsbLi
LsbLebLsbLebLobLcbLcbLibLcRsbRsLibLobRgbRiRsmbRebRcbRiLsbReRsmbRibRibR
ibRgRsmbRiRsmbLcbLhLsLsmbLiLsbLhbLibLoRgbRhbRsRebRgRsmbRibLgbRcbRsbRcb
LgbLcbLebLgbLcbRcbRhbRibRcRsmbRhbRiRsmbRibLsLsLsmmbRibRsRsRsmmbRsRsRsR
emmbRsRsmbLsRsbRsRsRsRsRsRsRsRemmmmmmbRhbLiLsbLcbLibRsLsbLcbRhbLhbLibL
ebLhbLhbLcbRgbRcbRsRsmbRebRsRsRsRsmmmbRsRsRgRsmmbRsRsRsmmbRsRsRsmmbsbR
sRsRsmmbRsRgRsRsRsRemmmbRhbLcbLcbLhbLhbLoRsbRcbRibsbRgbRibLsRsLsLsmbRg
bsbsbsbsbsbsbsbsbsbLsbRsRsRsRsRsLsRimmmmbRsbLsbRsRgRsRsRsRsRsLsRemmmmm
bRebsbRiRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 7; Drug: OSU6162 3 然 Apo 50 然
bRcbRibLsbLsbLebLsbRsbLsbRgbLsbRcbLebRjbLsRibRsLgbRsRibRcbRcbRcbRgbRgb
RgbRiLsbRgbLibRgbRgbRsRsmbRsRsRgmbRsbRgLsRsRsmbLsbLeLsLeLgLsbLgLebLeLg
LsbLgLgbLsLsmbRjbRobRcbRiLsbRibRibRgbRgbLcLsmbLcRsbLiLsbRsbLhbLibLgbLc
bLibRsbRoLsbRgbRgRsmbRibRgRsRgmbRgbRsbLsbLiRsbRibRsbRibRsRsLsmbRibLjLg
bLsLibLsRsLsRsbLibLhRsbLobLoRsbRgbRiRsmbLibLcLsmbLibRgRgbRiRsmbRgbLsLg
RsbLiLsbLibLibLibLibLgbLsbLsbLgbLsbLibLgLeLgLsbLsRsbRjbLsLsLsmmbRibRib
RgbRsRsmbRiLsbLsLsmbsbLgbRgbRiLsbRsRsmbRgRsmbRibRcbRsbLibLiLsbLoRsbLcb
LgbRhRsmbRibRiLsbRgbRibLgbRibRiLsbRcbLsbRhbRiRsmbRibRhbLsbRiRsmbRiLsbR
sbRibRibLebLibLiRsbRsLsbLobLgbLgbLibLibRsbLcbRgbRobLjbRcbRgbRgRsmbRibL
gRsbRobRhbLgbLcbLibLibLibLsbLobsbRgbRsbRibRsRsmbLsRibRibRsbRhbLgbRgLgb
RjRsmbLsbsbRibRsbRsbRsRsmbLhbRibLgLgbRjbLhbLsLsmbLsbLsbRhRsmbRebReReRs
RsmmbLjbRgbLcbLgbRjbRjbLibRsLcbLgLsbLsbReRsmbLjbLibRjbLhbRgbLoRsbRibLh
bLgbLgbLsbRjbRibRsbRibRcLsRsbRibRsbRsbRibLsbLgbLobRiRibRjRsmbRibRgbRgb
sbLhbLhRsbLgLsbLgbLsbRjbRhLsbRsbRsbLgbRsbRgRsmbLjbRhbRgRsmbRiRsmbRibLs
RibRibLsbRibRsbLibRjLsbLjbRjRgbRibRgLsRsbRgbRcbRhbLibRibRiRsRsLsmmbRiL
sbLgbRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 8; Drug: OSU6162 3 然 Apo 50 然
bLebLibRcbReRsmbRibRibLgbLcbLibLgLgbLsbLgbRjbLgbLibLsLsLsmmbLiLsbLsRsb
LcbLibRhbRhbRibRgLsbRcbLebLebLibLebRsLsLsmbLgbLsbRjbRibRsLsRsbRiRsRsLs
mmbRgbRiLsRsbRiLsbLebLibLibLsbLiLsbLibRibRibRibRgbRsRsRsRsRsmmmmbRibLg
bLebLsLsmbRjbLiLsbRcbRgbRibLgRsRsmbLhbLsbLgbRjbRibRsbRibRibRsbLsRsbRiR
sRgmbRgbLsRsbRsRgRsRgRsmmbRgbRgbRsbRibRsRsRsmmbRcbRibLsbLebLiRsbLibLgb
RjbLiRsRsmbRobRgRsmbLjbsbLsbRibRibRgbRcbRsbLcLsRsmbLiLgbLgbLgbRsbLgLsL
smbLsLsLsLsLsLsmmmmmbLsbLsbLsbLgLgLgbLiLgLsbLibRsbLibRibRcbRiRsRsRsRsR
smmmmmbRibRiLsbRibRgbRsRsmbRibRsRsmbRsbLhbRcbRsRsmbRiRsmbRsbLsLsmbLjLh
bRgbLjbLsbLgbLgbLgbLgbLgbRgbLgLsbLobRgbRibRgbRgRsRsRsmmmbLsLsRsRsmmbRg
bRsRgbRgRsRsmmbRgRsmbRgbRgbLsbRibRgRgbRgRsmbRhRiLsRgRsmbLobLhLsbLsbLib
RsbRibRibLgbLcLsLimbLgLsbLgLsLsmbLgLsLsmbLiLhLgbRjbRcbRgbRgRgbRsbRsbRs
bLsbRgbRsbLsbRgbRiRsmbLgRsbRiRsmbRgbLjbRibRgbRgRsRsRsmmmb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 9; Drug: OSU6162 3 然 Apo 50 然
bRibRsRsmbLibRsRhbRgRsmbLjbLcLsmbLoLsLsmmbsbLebRibRcbRiRibLebLiRsLsLsm
bRgbLgRsbLebLiLeLsbLeLgbLgLsRsbRcbRhbRgbLobLeLsLibLobRibLjbRgbRibLibLc
LsmbLgbRsLebLsbLsbLsLsLsLsLimmmbRcbRsbRhbRgRgRsRsRsmmmbRibRgbRgbRsRsRs
mmbRsRsmbRsbRsRsRgRsRgRsmmmbRgRibRcbLsbLsRgbLgbLebRsbsbLsLsmbLgLsbLsLs
mbLgbLsbLsbLgbLeLsbLobRibRsbRibLobLgLsLsmbLgLsbLsbLibRcbRsbLsbLgbLgbLi
LsLgLgLgbLgbLgbLhbLsbLiLsbRsbRobLgbRsRsmbRebReRiRsmbRibLobLibLebLcbLgb
LebRsbLgbLgbLsLsmbLsbRjbRhbRgbLsLsLgmbRgbRebRsbRibRibRibRibLsRsbRgRgRs
mbRebLsbRgbRgRsmbRgbRiRsmbRsbRsbRgbRsLsRsRsRhLsmbRsRsmbReRgbRibLcbLibL
ibLibLsbLiRsbRibRibRibRgRsmbRsRebRibRsbRgRibRgRgbRgbLcbLibLeLibLgbLibL
ibRsbsbLsLsmbLgbRsbLgbLebLgbLsLibLibLebLebLeLsbLgLsLsmbLeLsLsmbLsbLsbL
gLsbLgbLsbLsLsmbLgbLsbLibRsbLgbLgbLsbLgLsbLsbLgbLibLibLgLsbRgbLsbRcbLs
bRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 10; Drug: OSU6162 3 然 Apo 50 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 11; Drug: OSU6162 3 然 Apo 50 然
bLgLeLsLiLibLiLiLsbLgbRhbRiLsReRebRsbsbLobsbsbLjbRobRobRibReRoLsLsmbLh
bLeLsLgLebLgLgLsbLibRobLsLibLoRsbLcbLiLsbLgLsbLiLeLeLeLeLcLsLembLebLeL
ebLgRsbRsLsbRsbRsbsbLgbLsbLsRsbLsbLgbLgbLgbLiLhLeLiLsbLiRsbLobReRebRcb
Rsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 12; Drug: OSU6162 3 然 Apo 50 然
bRjRsmbLcbLcbLcbRgbLoRsbLsRsbLcLsmbLiLsLsmbLibLiLsLibLhLeLsLeLebLgbLiL
sbLibLgbLgbLgbLibLgLsbLgbLoRsRibLcbLgbLibLibLhLebLhbRoLsbLjLsmbRcbRhbR
ibRibRsbLsbRsRoRgbRgbRebRgReRebRhbRsbsbsbRgbRgbRsbRsbRibRgbRiLsReRebRi
RsmbRiRsmbRgbRibRgbRibRiRsRhRembReRebReLsbRibRibRsbsbRibRoRsmbLcLsmbLo
bLeLibLiLebLibLibLibLibLiLsbLcLebLebLibLgLsbLiLhLsbLebLgbRgbRiRsRsmmbs
bRibRibRiRgbRibRgRsmbRebRebRiRsmbRibReRibRhbRiRibRibRiLebLgLsbLeLsbLeL
sbLibLiLsbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 13; Drug: OSU6162 1 然 Apo 50 然
bRsbRsbRsRsmbRsRsmbRsRsmbLsRsbRgbLsbLsRsRsmbRsbRgbRsbLsbLjbLebRsbLgLsb
LsLsmbLgRsbLibLsbLgbRsLsbLsbLsbsbRsRsmbRsRsmbRsRsmbRsbRsbRgbRsRsmbRsbR
sbRgbRsbRsRsmbRsbRsRsmbRsbLsRsRsmbRsRsRsmmbLsbLsRsRsmbRgbRgbRgbLsRsbsb
LsbRsbRsRsmbLsbRgLsbLsRsbRgLsbLsRsbRsbRsRsmbRsbRsbLsbRsbRsbRsbRgbRsRsm
bLsbRgbRsRgbRgbRsRsmbRsbsbRsbRgbRsbRsbLsbRsbRsRsmbRsbLsRsbLsbRgRsmbRsb
RsRsmbRsRsRsmmbRsRsRsRsmmmbRsRsLsmbRsbRsbRgRsRsmmbRgbRsRsmbsbLsbRsbRsb
RsbRsbRsbRsbRsbLsbRsbRsRsmbRsbRsbRsbRsbRgbRsbRsbLsbRsRsmbRsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 14; Drug: OSU6162 1 然 Apo 50 然
bRsbRhbRgbRibRgbRgbRiRsRsmmbLcbLhRsRsmbRgbLoLsmbLgbRgbLibRcbLhbRjRsRcm
bRcbLibRgbRcbLgbLcRoRsmbRibLebLsbLgbRcbRiRsmbRiRsmbRsbRibRoLsbRibLibLi
bLibLgbRgbLoRsbRgLsbLgLiLsbLiRsbRgbLcbRsbRgbRgbLeLsLebRsLsbLgLsRsbRjbR
ibRobLcbRgbLcbLjbRjbRjbRibRgbRibRiRsmbRibRgbRcbLhbRsbRsbRgbRhbRsbRgRsR
smmbRgRsRgmbRgbRgbRsbRcbRcbRebRcRsmbRhbLobLibLcbLibLcbLcbLibLgbRsRsmbR
hbRibRcbRibLsRobsbLsbLgbRcbLhbLsbLgLiLeLsbRcbLjbLcbLsbRobRibRibLgbLhbL
ebLibRjbLcLsmbRgbLgbLgLebLebLebRobLsbsbRgbRsRsmbRiRsmbRebReRgbRsbRiRhR
smbRsbRibRsbLiRjbRsbLiRsbLsbRobLcbsbLjbRjbRgbLsbLeLeLsbLsbLeLgRoRibLsb
RobLobLsbLibLsbLiLsbLobRhbRibRgRsmbLgbLcbRjbRcRsmbRcbLebLiLgbRcbRgbRgR
gbLsRsbRsbsbsbsbLjLjbRcRsmbLsLgbRobRsRsmbRiRsmbRsbRsRsmbRibRgRsmbRgbRs
bRgbRebRebRsbLgbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 15; Drug: OSU6162 1 然 Apo 50 然
bLibLgLgbLibLiLgbLsbLgRsbLsLgLiLgbLiLsbLebRsbRsRsmbRgbRgbRgRebRebRsbLs
LgLibLsbLibLsRsbLgLibLiLibLgbLgbLgbLgbLsbLgbLsbLgLgbLsbLgLibLsLsLgmbLs
bLgbLsbLgbLsbLsbLibLsbLgbLebLsbRsRsLsLsmmbLiLgbLsRcbRobLgbLsbLsbLsbLgb
Lsb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 16; Drug: OSU6162 1 然 Apo 50 然
bRibRsRgbRgbRsRgbRgRsmbRsbRgRsRgRsRgRgmmbRgbRgbRsRibRgRsmbRgRsmbLebLiL
sLsmbLgLgLgbLhbLeLsbLebLgbLiLiLgLgLiRsbLgbLebLgLsbLgbLeLsbLgbLsbLibLgL
sbLeLgLebLiLsbLebLebReRhRgbRobLoLgLgLsRebLsRsRsmbRgbRgRsmbRoLsbLgbLsbL
gbLsbLsbLsLsmbLgbLsLgRsbLebLgLsbLsLgbLgbLsbLsLsmbLsLgLsbLibLiLsbRsLgbL
gbLgbLgLsbLsbLeLsLgbLsbLgbLibLsbLsbLsbLgbLsLsmbLsLgbLgbLgbRsbLsbLgbLgb
LsLgbLsLsmbLgbLsLsmbLsbLgbLgbLsbLgbLobRsbRgbRgbRsbRoLibLgbLeLgLgLsLcRs
bRsbRsbRsbRsRsmbRsbRsbRgbRsRsmbRsbRsbRsbRsRsmbRsbRsbLsbRsbRsbLsbRsRsmb
RsbRsbRsbRgLsRsRsmbRgbRsRsmbRsbRgbRsbRsbRgbRsbLsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 17; Drug: OSU6162 1 然 Apo 50 然
bRgbRgRsmbRgRsmbRgRsmbRgbRgbRgbRiRsmbRsbRsbRsbRhRsmbRibRiLsbRhReRsmbRe
bsbRsbRgbLsbRibLjbRjRsmbRhRsmbRiLsbRibReReRebReRsmbRgbRgbRgbRsRsmbRgbR
gbRgbLsbLcbLhbLiLibLcbLcbLibLiLsbLhLgbLeLsLeLeLsbLsLcbLebLebLibRebRebR
ibLsReRsmbRgRsmbRsbLsbLhbLsbsbRcbRibRgRsLcmbRsbRoRsmbRibRcbRebRcbRcRsm
bRgbRsbRjRsmbRsbLjbRcRsmbLjbLcbLobLeLsLgbLgbRoLsbRebRebLgbLjLsmbRebLgb
RcRsmbRibRibRibsbRibRsbRiLsRsbRobRsbRiRobRebReRsRsmmbRiRsmbRgbRgbLjbLh
bLibLibsbLibLibLhLhLsbLobRiRsmbRiRsmbRiRsmbRiRsmbRibRgbRibRcbRebRgbRsR
smbLsbRsRsmbRsbRsRsRsRsmmmbRsRsRsLsRsLsmmbLsbLsbLsRsbLsbLjbRiRsmbRhRsm
bRibRiLsbRgbRiLgbLoLsLhLsLeRsmbLoRsbLobLobRoRsmbLoLsmbRsLsLsmbLsLgbsbL
sbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 18; Drug: OSU6162 1 然 Apo 50 然
bRsRsmbLsbRsRsmbLgLsbLiLsbRgLsLsmbRcbLjbLcbLcLsmbRgbRibRcbLsbLobRibLsb
RcLsbLeLsbLibRibLgLsbLhbRibLsLsmbLcLsmbRibLsLjLsLsmmbLgLsLsLsLsmmmbLgL
sLsmbLsbLsbLsbLsbLgbRgLsbLsbLibLobRsRsLsmbReLsbLsRsRgRsRsRsRgReRiRsLsm
mmmbRsRsmbRsRsmbRgbLgRsRsRsRsRsRsRsmmmmmmbRgRgRsmbRsbRsbRebsbRiLsbRebR
sRsmbRoRsmbRibLibLibLcbLcbLhbLgLsbRsbLcbLibLcLsmbRibLibLhLsbLhLsbRcbRi
bRibLsbRibRgbRiLsbRiLsbsbRsLsLoLsmbLhbLcbRgbLobsbLebRibLgbRebRsRhbLgbL
cbLibLiLsbLgbLibLibLcbLobRibLjLobRgLsbRebRibLsbLsLsmbLjbRsbRsbLsbLsLsm
bLsbLsLsLsLsLsmmmmbLgLiLgLsLsmbLgLsbLgbRcbRcLsbLgLsbLcbLhbLebLibLebRsb
LobLcbLiRsbRibRhbRibRibRibRiLsRsbRibRgbLhbLgbLibLibLebLjbLhbLibRsbLiRs
bLgbsbsbsbLsbLsLsLsmmbLsLsLsLsLimmmbLsLgbRcbRgbRgRsRsmmbRgRsRgmbRsbRsR
sRsRsmmmbRsRgRsLsmbRcbRibLcbLibLcbLoLsRsmbLiLsbLobLcbLcLsmbLhbRsbRibRj
LsbRiLsbRgbRobRobLibLgbsbLgbLsLsmbLibLcbRgbLjbRebLebLcLsmbLiLsbLsbLsLs
mbLsLsmbLsbLsLsLsLsLsLemmmmbRgbRgbLcLsmbLsbReb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 19; Drug: Control Apo 50 然
bLgbRsbLgbLgbRcbRcbRsbRcbRibRhbRcbRgbRhRsmbRiRgRsmbRibRgRobRcbRoRsmbRi
bRiRsmbRgRsmbRobLhLsbLibLibLobLibLcbLcbLobLhbLibLiRsbLgLsLsmbLgLsLgbRs
bsbLcbLsbRhRsmbRibRsbLcbLibLibLcLsmbLgbLgbLobLiLsLebLiLebRgbLcbLcbLibL
gbRcRgRsmbRibLobsbRjRsmbRcbRgbRobRcRsmbRibRcbRiRsmbRibRiRsmbRgLsbsbLjb
sbLibRcRsmbsbRcRsmbsbRcbRcRhRsmbRibRibRiRsmbReRibRsRsmbRhLsbLobLiLsbLi
bLobLsbLobLibLgLsbLgbLgLsbLoRsbRibRibRhRsRcmbRcbsbRcbRiRsmbRiRsRsmmbLs
bLobLgbLiLsbLibLobLhbLcLgLsLebLebLsbLhbLobLcbLeLsLebLcbLebLgLsbRgbsbRo
bRgbLobsbsbRiRsmbLcRsbLibRgbLhbLibLcLsmbRsLobLeLsbRsLoRsbRgRcbRcRibReR
smbRcRsmbRibLsbRibRjLsbLjbLibLjLsmbRhRsmbRibRcRsLsmbRcbRobReRiRsmbRibR
ibRiLsbRibRobRgbLobLcbLhLgLsLsmbLgbLgRsRsmbReRsRgmbRebLsbRsbRgRsmbRcbR
cbRcbRiRsmbLeLsbLhLeLebLoRsRsRsRsmmmbRhRsmbLebRcbRcbRibRebRgbRibRhbRcb
RhbLoLsmbLsbLibLcbLhbRgbLoLsmbLiLsbRsbLibLgbLcbLibLiLsbRhbLoRsbLibLgLs
bLoRsbRebReRcLsbRibLhRsbRebRibRebRcbsbRibRhbRgbLhbLibLibReRsmbsbsbRsLi
bRibRsLob

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 20; Drug: Control Apo 50 然
bRiRsRsmmbLjbLcLsmbLibLsbLibLgbLibLiLsRsbsbLobLiLsbLeRsbLiLsbLibLgRsbL
ibLiRsbLgLsbLibLibLiLiLiLcLibLebRcbRsbRcbLsbsbLsbRobRibRhbRcbRiRsReRsm
mbRgRsmbRcbRibRobLhbLobLiLsbLibLibLibLibLiLibLgbLiLcbLebRsLeLsbRjbRebR
cbRcbReRsmbRibRgbRsLsbRsbLsbRgbRibsbsbLjbRibRobRsbsbRibLsbRgRsmbsbRsbR
gbLjbRibLcbLiRsRsmbLcRsbRjbLcbRcbRcbRcbRhRjbRsbRoRibReRcRsmbRhbRibRiRs
mbRibRiRsmbRgbLgbLcbLibLiLsLiLiLsLgbLibLibRgbLibLiLsbLibLiLsbLgbLibsbL
jLsmbLjLgLsbLgbRcbRgbRebRibRgLsbLcLsmbLiLsbLibLgbLgbLiLsbLgLsbLcbRiRsm
bRhbRsLsbLsbRsbRiRsmbLjLsmbsbLibLhbLhbRgbRsRgbRsRsmbRsRsmbRjRgbLgLsbRg
RsmbRcbRsRsmbRsbRoLsbRgbLebLoLcRsbLgbLebLgbLibLgbLgRsbLibLgbRsbLsLsmbL
sbRsbRsbLibRsbLsbLgbRsbsbLjLsmbRsbRsbLgbLsLsLsmmbLgbRsRjRgbLeLsbLibLgb
LcbLgbLgbLiLgLsLsLiLsLsLiLsLeLsmmbLebLgbLgLsbLhbLgbRsbLcLsLimbLcLiLgbL
hRsbLgLsbLgbLibLsLsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 21; Drug: Control Apo 50 然
bsbsbRjbLobLoLsmbLhbLibLibLcLiLsbLoRsbLibLcbRsbRcRibsbRcbRgLsbRiRcbRsR
cRsRsmmbRgbRibLebLgbLsbLobLgbLcbLibLgbLibLiRsLsbLhbLiRsbLibLgbLgLsbLgL
sbLgbLibLeLibLgbLsbLsbRcbRibRibLsRsRebRgbRiRcLiLeLeLebLibLoRsbLcbLhRsb
RsRsRsmmbLgbLsbReRhbRcRsRsmmbRiRsmbRobLjbLobLsbLhLiLhLsbLgbLebLcLcbLib
LgbLoRsbLcLsLsLsmmmbLibLsbRibRobRcRsmbRiRsmbRgbRcLsRsbRgRsmbRsLsbRibRs
bRcbRiLhbLibLiLsbLgLsbLsLgbLsLsmbLobLsbRcRsmbRebLcLsmbsbRsbLcLsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 22; Drug: Control Apo 50 然
bLsbLsbLsbLsLsLsRsmmbLsbLsbLsLsmbLsLsmbLsLsRsmbLsLsLgLsLsLsLsLsRsmmmmm
bLsLsLsmmbLsLsmbLsbLsLsmbRsLsLsRsmbLsbLsbLsbLsLsmbLsLsLsLsLsLsLsLsLsLs
LsLsLsRsLgRsmmmmmmmmmmmmbLsbLsbRsbLsbLsbLsLsmbsbLsRsbLsLsmbLsbReLsbLsb
RobRcbRibRibRcRibLjbLeRebRibLcbLibLsbLsLebLoRsbLeLsbLgbLgbLsbLsbsbRsbR
sLsbLgbLsbLgLsbLsLsmbLsbLsbLsLsLsmmbLsbLsbLsbLsbLsbLsLsmbsbLsLsmbLsbLs
bRsbRgbLsbLgbLsbLsLsLgmbLsbLsbLsbLsLsRsmbLsLsmbLsLsmbLsbLsbsbsbsbRsbLs
bLsbLsbLsbRsLsbsbLsLsLsLgmmbLobRebRibRcbsbRcbRibRibRgbRhbRiRcReRebRgbR
oLsbRsbLsbLsbLibLsbsbLgLsbLsbLsLsmbLsLsmbLsLsmbLsLsRsmbLsLsLsmmbLgLsbL
sbLsbLsLsLsLsmmmbLsLgbLgbLsLsLsLsmmmbLsbLsRsbLsbLsbLsRsbRsbLsLsmbsbLsL
sLsLsRsLsLsRsLsRsLsmmmmbLsLsmbLobRibRibRcbRibRoLsbRsLsbRibRsRjbLeLsRgb
LhbLjbLgbLibLgbRsLgLsbLoRsRsmbRsRibRsbRjbLiLsbRiLobRsbLsbRsbLsbLsRsbLs
LsmbLsbsbsbsbLsLsmbLsbLsLsmbLsLsmbLsbLsRsbRsLsbRsbLsLgbLsbRsLsbLsLsmbL
sbRsLsbLsLsmbLsbRsbLsbLsLsmbLsLsmbLsbLsLsLsLsLsLsLsLsLsLgLsLgmmmmmmmmb
LsLsLgLsLsLsLsLsLsmmmmmmbLsbRsbLsbRsbLsbsbLsLsmbLhbRobRoLsbRobRhLsbLib
LobRsbLobRibRibLibLgbLiLsbRiRsmbRiRgbRgbLgbLeLsbRsRsmbRsbRoLsLsmbLsbLg
bLebLgLsbLeRsbRibRobRcRsmbRsbLibRebLjbRgLsbLgbRcbRcbRsbRgLsbLjbRebRebR
ebLhbLobRcRsmbRjbRibLsLsmbLobRibRgbRibLiLsLsmbRjbRjbRsbRibRiLsbRsRebLi
bLsLgbLgbLsbLsLsLsLsRsLsmmmbLgbLgbLsbLsbLsbLsLsmbRcbRcRsRsmmbLobLjRsbL
gbLcbLebRibRiLsbRibRsbRsbRobRhbRgbRibRobLgbRjRcbLgbLcbLcbLgbRgbRibLcbL
gbRjRcbRgbRibRibRib

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 23; Drug: Control Apo 50 然
bRiRsRsmmbRsRsRgmbRgRgbRgbRgbRsRsmbRgLsbRsRsRgmbRgbRobRobRiLsbRibLsbRg
RibRibRibRgbRgbRgbRgRsmbRgbRsbRhbRgbRibLsbRibRgRgbRsbRgbRsbRsLsbRsbRsR
gRsmbRsbRsbRsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 24; Drug: Control Apo 50 然
bLsbLsLeLsbLgbLsbLgLsLsLsLsmmmbLsbLsbLsbLsbLsbLsbLgbLsbLsbLgbLsLgLsbLi
LgbLibLgbLgbLiLsbLiLsbRgRsRsmmbRibRiRsRsmmbRsRsmbLsbRibRgbRgbLgbLebLiL
sbLgLsbLsLsLsmmbLgLsLibLgbLgbLgbLsbRjRcbRgbRgbRgbRsLsbRgbRebRsRebLcbLg
bLgbLsLsmbRjbLcLsmbRsRsmbRgLsbRgLsbRsbRgLsbRgLsRibRgbLsbLibLgLsLsmbLib
LgLgbLibRsbLgbLsbLsbLsbsbLsbLgRsbLgbLgLsbLsLsLsLsLsmmmmbLgLsbRsLsbLsbL
gbLsRsbRsbLgbLgLsbLsbRsLsbRgbLsbLsbLsbLgLsbLgbLebLsbRgRsmbLsbRebRgbRsb
RsbRsbRsRsRsLsmmbRsbRsLsbRiRsmbRibRgRsmbRgbRgbRiRsmbRgbRsbLiLsbLgbLsbL
hbLgbLgLsLsmbLgbsbRcbRgbRgbRgRsRgmbRsRsmbLsbRibLjbLsLsmbsbLgbLiLsbLgbL
sLsmbLsbLsLibLibLgbLgbLgbLgbLsLsLsLgmmbLgLebLgLsbRgbLgRsbRsbRsbLiLsbLg
LgbRcbRgRsRsmmbRgRsmbRsbRgbRsbLsReReRgRsmbRgRsmbRsRsRsRemmbRgbRgbRsRsR
sRhmmbLjbRibRsRibRsbRsRsRsmmbRhbRsbRgRgbRgRsmbLsbRsbRsbLobLgbLgbLgbLsL
sLgmbLsbLsLeLsbLiLgbLgbLgbRsbLiLsbLebLsLsLsLsmmmbLsbsbLgLgLsbLgLgLsLsm
bLsbLgRsbRgbRgRgRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 25; Drug: OSU6162 10 然 Apo 50 然
bLiRsbLiLsbLiRsbRhbRhbRibLsRsbRgbRibRebRgbRsRsmbRgbRsRsmbsbRsbRsbsbLhL
sLsmbLibLgLsbLibLibLgbRsbRsbRgbLsbRibRsbsbRsRsRsmmbRsLsbLsLsmbRjbReRsm
bRibLsLsLsLsLsmmmmbLhLsbLibLibLibLiLsbLgbLibLsLsmbLiLsRsbLiRsbLsbLsRsR
smbLsLsLsmmbLsRsbLsLsmbLsbRjbRcbRibRsLibLcbLsbRjbRsRsmbRsbRsbLsbRsbLsL
smbLgbLgbLsbLsbLsRsLsbRsbLsbLgbLsbRsbRsbLgbLgbLsbLgLsLsLsLsmmmbLsLsLsL
smmmbRsLsbLsLsLsLsLsLsLsmmmmmmbLgbRsbRhbRibRjbRhbRibRhbRibRsbRibRsbRsb
RibLcbLibReRsmbRhbRsbLhbReRsmbRiRsRsmmbRhRsmbRgLsLsLsmmbLeRsbLhbRjbRhR
smbRiRsRsmmbLcbLcbLibRjbsbReRsmbRcbLsbRgRsmbRiRsmbLiRsbLcbLsbLsbRsbsbR
gbsbLiRsbLsLsmbRjbLiRsbLgbsbsbRsbRsbRgRsmbRsbsbsbsbRjRibRibLcbLcbLgbLg
bLgbLgbLibLsbLsbRhbLebLibLiRsbLibLibLgbLobRibLebLsbsbLsbLsLsmbLgbRiRsm
bRibRibRiRsmbRibRibRhbRibRgbRgRsRsmmbRgRsmbRgRsRgmbRgbRgbLsLsmbLcbLcLs
mbsbRjbRhRsmbRibRgbRsbRsbsbsbRibLsLsmbLebRjbRiRsmbsbRiRsmbRibLgbLcLsmb
LibLgbLibLgbLibsbRsbRjbRgbRjbLgbRgbRsRiRsmbRhRsmbRsLsbRebRhRsmbRhRsmbR
iRsmbRsRsmbRsRsRsRsmmmbRsRsmbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 26; Drug: OSU6162 10 然 Apo 50 然
bLsLsLsmmbLgbLgLeLebLhbLibLeLsLibLebLobRebRgbLsbLobRibRgLsbRgRsmbLsLeR
sbLibRsRsRembRgbLsbsbsbRsbLsbsbLsRsbRsRsmbsbRsbRsRsmbLsbRsbsbLsbsbsbRs
bLsbLsbLebsbLsLsLgLsmbLsLsLsLsmmmbsbsbsbLsLcLsmbRibRobRgbRibRsbRsbRiRi
bLebLeLiLebLeLeLsLeLsbLebLgLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 27; Drug: OSU6162 10 然 Apo 50 然
bRsRsmbRsbRsbReRsmbLsbRebRsRebRibRgbRhRsLsmbRsRsRsmmbRhbLsbsbRsRsmbReb
LsRebRsbRebLsLibLsbLgbLgbLsbLgbLibLsRsbRsbsbLibLgLsRsbLgbLsLsmbLsLsLsm
mbLgbLsbLgbRsLsLgbLgbLsbLibLgbLgLsbLsLsmbLiLsbLsLsLsmmbLibLiLgLsbLgbLg
bRsbLgLsbLsLgbLgLsbLgLsLsLsmmbLgbLgLsLsmbLgbLsLsmbLsbLiLsbLsbLsbRsLsLs
mbLsLsmbLibLgLsbLsbLgbLsLsmbLsLsLsmmbLsbLsLgLsbLsLsLsmmbLgbLsbLgbLgbLi
bLsLsmbLsLsLsLsmmmbLibRsbLgLsbRsbLgLsbLsLsLsmmbLgbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 28; Drug: OSU6162 10 然 Apo 50 然
bsbLhbLgbLibLhbRebLobLsbRobRebRebRebRibReRsmbRhRsmbRibRgbsbRsRsmbRgbRj
bRgRsmbRgbRgbRsbRgbRgbRgRsLsmbRibRsLsbsbLjLibRsbsbLobRsRsmbRsbRgbRsbRg
bRgbRsbRsbLsbRsRsLsmbRsRsRsmmbsbRsRsRsRsmmmbRsRsmbRsRsRsRsmmmbRgbRsRsm
bRsLsbRsRsRsmmbRgRsmbRsRsRsmmbRsbRsbRsbRsRsRsmmbRsRsRsRsRsmmmmbRsRsRsR
sRsmmmmbRgRsmbRsRsmbsbRsbRsRsmbLsRsRsmbsbRsbLsbsbRgRsmbLsRibRgbRsRsRsR
sRsmmmmbRsRgRsmbRsbRsbRsRsmbRgRsRsRsRsmmmmbRsRsRsRsRsmmmmbRsRsRsmmbRsR
sRsRsmmmbRsRsRsRsRsRsRsmmmmmmbRsbRsbRsbLsbRsbRgbRsbRcLsbLcRsRsmbRsRebR
sRsmbRsbRibLebLibLhRsbLobLeLibLhLsbLcRsbLebLebsbLjLsRsmbRibRjbRcbRsLsb
RhRsLsmbRibLcbLcbRsbRobRsbRjbRsRsmbRsLsbRgRsmbRsRsRsLsmmbRsbRsbRsRsmbR
sRgbRsRsmbRsbRsRgbRsbRsLsbRsbLsRsbRsbsbRsRgRsmbRsRsRsmmbLsRsRsmbLsbRsR
sRsRsmmmbRsRsRsRsRsmmmmbRsRsmbRsRsmbRsbLsbLsLsmbLsbRebReRobRibRgbLobLg
bLiLsbLibLiLsLsLsLsLsLsmmmmmbLiRsbLiLsbLgRsbLsbLsLsmbRsbRsLsLsLsmmbLsb
LsRsbRsbRjbRibRsRgRsRsmmbRsbRsRsmbRsRsRsRsRsmmmmbRsRsRsRsRsRsRsRsmmmmm
mmbRgRsRsRsmmmbRsLsRsRsRsRsmmmbRsRsRsRsmmmbRgLsbReRsmbLibLcbsbLiRsbReb
RjbRgRsmbRoRsmbLibRcbRcbRhbRsbRcbRobRibLcbLeLsbLiLsbLibLgLsbLibLgbRsLs
bLjbLsLsRsmbRsbLgbRsLsbRsLsLsmbRsLsbLgRsLsRsLsbRsRsRsLsLsLsmmmmbLsLsmb
LsLsLsLsLsmmmmbsbRjbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 29; Drug: OSU6162 10 然 Apo 50 然
bsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbRsRsmbsbsbsbLjbLcLgLsLs
LsRsmmbsbsbsbLsbRsbLcLsmbRhLsbLebLcbLoLsLsRimmbRsbRcbRiRiRibRsRibRebRg
RgRsRimbRiRiReRsRsmmbRiRsmbRibLgRsbRibLcLgLibLeLsbLsbLhRsRsmbRib

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 30; Drug: OSU6162 10 然 Apo 50 然
bLhbLgLsLsmbLsLsLgLsmbLsLgbLsLgbLsbLgbLsbRjbRsRobsbLcRsbLcbRhbRcRsmbLs
bRibRibRcbRcbRibLcLsmbLiLsbLibLhLsbLiRsRsmbRhRsmbRhRsmbRebRcbRiLsbRibL
cbLcLsmbLibLjLhRsbLjLgbLjLebRiRsmbRibLhbRcRsmbRibsbRsbRsbRgbRibRsRsRsR
sRsRsRsRgRsmmmmmmmbRgbRgbRibLcLsmbLibLibLgbLgLsbRsRsLsRsmbLibLgbLsLsmb
sbLsRsbsbLcbLebRibsbRhbRsRsmbRgbLsbLebLebLcbLsRsbLcbRcRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 31; Drug: OSU6162 3 然 Apo 50 然
bLsLsLsLsLsLgLsLsmmmmmbLgLeLsLsmbRsbLgLsLsLsLsLsmmmmbLeLsbLgbLeLsbLibL
iLsLsmbLgLgbLsLgLsLgLebLoLsmbRibLibRhRsmbLgLebLhLsRsbLibLiLsbLsLgLeLsb
LsbRoRgbRsRsRsRsRsRsRsRsRsRsRsRsRsRsRgRgmmmmmmmmmmmmmbLsLsLsRsRsRsRgRs
RgRgRsmmmmmmbRibLsbLcbLgLiLgLgbLebLsLsLsLsLsmmmmbLcLsmbRgRsmbRsbRgRsRs
RsRsRsRiRsRsmmmmmmmbRiRsRsRsmmmbLsRgRsRgmbRsRsRsRsRsmmmmbRsRsRgRsRsRhR
sRsmmmmmbRebLsbRsRsRgRgRsmmbRiRsmbRsRsRsmmbRhbRgRsRsRsRemmmbRiRsRsmmbR
iRsRsmmbLebLoLsmbLhbLiLsRsbLeLsLibLgLgLsbRobRsRsRsRsRsmmmmbRsRgRsRgRsm
mbLsRsbRsRgRsRsRgmmbRgbRsRsRimbRgRsRgmbRibLsRsRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 32; Drug: OSU6162 3 然 Apo 50 然
bLsbRcbLoLsmbRiLsbLhRsbLoRsbLiLsbLibLcRsRgbRhbRibRoLsbRsLsbLcbRsbRiRhb
RgRsmbRgbRgbRsLsbRgRsmbRobRibRibRsbLibRoLsbRcRsmbRsRsRsRsRsmmmmbRsRsRs
RsmmmbRsRsRsmmbRsRsRsRsRsRgRsmmmmmbRsRsRsRgmmbRsRsRsRsRsRsRsRsRemmmmmm
mbLjbRsbRsRgRsmbRsRsRsRsLsmmmbRgbRsRsmbRsbRsRsRsRsmmmbRsbRsRsRsRsmmmbR
sRsRsRsRsRsRsRsRsRsmmmmmmmmmbRsRsRsRsRsRsRsRsRsRsRsRsRsRsRsLsRsRsmmmmm
mmmmmmmmmmbRsRgRsRsRsRsRsLsRsRsRsRsRsmmmmmmmmmbsbRibLgbLcbLgbLobLibRgb
RcbRgRiRebRsRsRsmmbLsbRsbRsRsRsmmbsbRjRsmbLsLsLgmbRsRsRsmmbRsRsRsLsmmb
RhbLcbRhbRcLsbRibLcbLcbLhLsbRsLhLebLsbRsbLcLsRsRsmmbRebLcbLebLsLsmbRsb
RjRibRcbRgbRcRsRembRsbRiLibLgLsLebLsRsbLhLsbLoLsmbLsLsLsmmbLobRsLsLsmb
LsbLsbLsLsRsLsmbLsLsmbLsLsmbLgLeLsbLsbLcbRebsbLoLsRsmbRebRibRiLsbRhbRc
bRsbRibRgbRcRsmbRiRsmbRiRiRsRiRgRembRsbLobLibLhRsbLeLsbLgbLibsbsbRsLgb
LibRsbLiLsbLsLsmbRcbRoLsbsbRiRsmbRgLsRsbRgbRsbRsbRhbRgRsmbRgbRobRsLsbR
sbRhLsLsmbRgLsbRgbRgbRgbLsRsbRsLsbLoLsmbLiRsbLibLhbLeLiLhbLibLiLsbLoLs
RsRsmmbRgRsmbLibLiLsbLgbLgbLsLeLsbLoRsbLsbRsRsRsmmbRsRhRsmbLsLsLsLsLsm
mmmbRhbRgLsbRibRgRgRiRsmbRibRgRsRsmmbRibRgRsRsmmbRgbRibRgbRgbRgLsbRibR
gbRiRgRsRhLiLcmbRsbLsbLsbsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 33; Drug: OSU6162 3 然 Apo 50 然
bLhbsbLhLsbLibLeLsbLsLibLsRsRhbRhRsmbRgbRgLsLsmbLjbLobLgbLibRgbLgbRobR
sbRiRsmbLsbRcLsbLsLsLombLhbLcbRibRgbLsbLsLsLsLsLgLsLemmmbLgbLibRgRsRsm
mbRsbLgbLsbLgbLibRgbRjRcbLhbRcbRcbRhbRgbLeRsbLibLjbLibLcbLjLsmbLgLsbLg
LsLsLsLsmmmbLgLsLebLeLebLibLhbRhRsLsRsmbRgbLgbLibLiLsbRsLsLsLsmmbLsbLg
bRjbRsbLjbRobRibRobRibsbLibLiLsLsLsLsmmmbLsLsLsLsLsLsLsLgLsmmmmmmbLsLg
LsRsbLgbLgRsLsLsmbLibLsLsLsLsLsLsLgLgLsmmmmmbLebLgLsbRsbLcLsmbRibRgbLg
bLibLsbLiLsLgLsLsmbLebLgRsbRsbLsbLiLsLsmbLsLsLsLsLgLsLsmmmmbLsLgbLgbRs
bLebRibLsLsLsmmbLsLsLsLgLsLgLsLgLgLemmbLgbLiLsLsLsLsLsLsmmmmmbLsRsbLsb
sbLsbLsLsLhLembLoRsbRibRibLibLjbRsbRsbRsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 34; Drug: OSU6162 3 然 Apo 50 然
bRibRgRsmbLsRsbLgLgbLcbLiRsbLeLsbRibRibRibRcbRibRibRgLsbRcbLsbLjbLsbLc
LsmbRibLebRcbRibRcRsmbRhbLebRcbRibRiRsmbRebLibRobRebRibRgbRebLcbLhLsLh
bLibLcbLoRsLsbRsbRcbRhbRiRsmbsbLiLsbRibLsLsmbLcbLibLibLcbLebRhbRibRibR
ibLgbRcbRgbRebLsLsLsmmbLcbRsRsRsRsmmmbRibRhRsmbRhbRgbRibRgbLsRsRsRsmmb
LsbLsRcbLcbLcbRebLcbLiRsbLibRcbRsbRiLsbRcbRiRebReRsRgmbRibLsbRhRsLsmbL
cbLgLgbLgbLiLsbLibLjLgbLhbRhRsmbRsbRsbRsRsmbRsRsRsRsRsLsRsRsRsmmmmmmbR
gRsRsRsRsRsmmmmmbLebLsbRhbRoRsmbRcRsmbRhbRgbRiRsmbRsbLsLebRgbLibRsbLhL
sbLobRhRsmbRsLsLsLsmmbRgRsRsRsRsRsRsRsmmmmmmmbRibRcbLibRhbReRsRsmmbRsL
sbRcbLcRsbRcbLcLsmbRsbLcbLhRsbLhRebRhbLgbLobLgLsbLcbsbRcbRcbLgRsbRsRsR
smmbRsRsRsRsRsRgRgmmmmbRsRsRsRsmmmbRsRsRsRsRsmmmmbRiRsmbReRsRsRsmmmbLj
LgLsbRiRsmbRsRsmbRhbLsLsLsLsLsmmmmbRebLsLsLsmmb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 35; Drug: OSU6162 3 然 Apo 50 然
bLibRibRcbRcRsmbRibRibLsbRibRibLsbRsbRiRsmbRcRsRsmmbRiRsRiReReRsRsLsRi
RsmmmmbRiRsmbRsbRgbRgLsbRsRsLsmbRgbRgbLsbRibRgLsbRcRsmbLobsbLhbLobLeRs
bLcbLcLsmbLibLiLsbLgbLibLgLsbRsbLsbLgLsbLibLiLsbLoLsLimbLcLsLeLsRsmbLi
LiLsbLibLibsbLsLsmbLgbLgLsbLgbLsLsLsmmbLgbLgbLibLcbRhbLoRsbLgLiLibLiLh
bLhLsLsmbLgLsbLgbLgbLgLsbLgbLgbLsbLibRsbRcbLsbLcLsLsmmbLsbLiLgLsbLcLsL
eLsmbLibLiLsbLiLsbLgbLgbLsbLibLgbLgbLgLsbLsbLgLgLsbLsbLsbLsbLsbsbsbsbs
bsbsbLsbLsbLsLsmbLsbLsLsLsmmbLsLsLsLsmmmbLsLsLsLsLsmmmmbsbRsbLsbLsbLsL
smbLsLsLsLsLsmmmmbLsLsLsLsLsmmmmbLsLsLsLsmmmbLsLsLsLsmmmbLsLsLsLsLsmmm
mbLsbRsLsLsLsLsLsLsLsLsLsLsLsLsRsLsmmmmmmmmmmmbLsbLsLsLsLsLsLsLsLsRsmm
mmmmmbLsLsLsLsRsLsLsLsLsLsLsLsmmmmmmmmmbLsLsLsLsmmmbLsLsLsLsLsLsLsLsmm
mmmmmbLsLsLsmmbLsLsLsmmbLsLsLsLsLsmmmmbLiLsbRcbRcRsmbRhbsbRcbRibRgRsRe
mbReLiLsLcLeLebLsbsbLibLiLsbLhbLgRsLeLeLsLhLsbLeLebLiLsbLsbLibLgLsbRsb
RsbRcbRcbRibLsbRhbRhbRiRsmbRiRhRebRebRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 36; Drug: OSU6162 3 然 Apo 50 然
bsbsbRsbRsbLsRsRsLsmbRsRsmbRsbRsRsmbLsRsLsbLsRsbRsbRsbRsbLsbRsRsRsLsmm
bLsbRsbsbLoLsmbLiLsbRgbLcbLibLibLcLsmbRhRsmbRibRgRsmbRcReRsmbRebRibRgR
ebLoRsbLsbRcbLebLsLeLsbLcLeLsbLgbRcbRiRsmbRobLgbLebLeLsbRsbLsbLgLhLsbL
sLsLembLsLsLsmmbRhbRcbsbRsbRsbRsRsRsRsRsRsRsRsRhmmmmmmmbRcbRcbRgbLiLsb
LiLhbLhbLcbLcbLibLhRjbLgLsbLcbLeLsbLebLcLsLsLsLsLsmmmmmbLeLsLsLsmmbRsL
sLsLembRsLsLsLsLsLsLsLsLsLsLimmmmmmmmbLsLsLsLgLsLsLsmmmmbLsLgLibLsLebR
jRcbRiRsmbRsRsmbRcRsmbRsbRcRsmbRcbRibLgbLcbLiLsLoRsbRgRsmbLeLsbLcbLeb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 37; Drug: OSU6162 1 然 Apo 50 然
bRoRsmbRcbsbLsRhbLjLgbLcbLibLibLcbLibLsbRgbLiLsLsmbLsbsbLibLhbRsbRgRsm
bRsbLiLsLsmbLiLcLsLhRsRsmmbLiLsbRgRsmbRsRsmbRgbRsbRsRsmbRsbRsbRsRsmbRs
bRsbRsbLsRsbRobRoLsbLoLsmbLiLsbLiRsbRebRsLsRsbRsbRsbRgbRgbRgbRsbRgRsmb
RsbRsbLsbRsbsbsbsbLsbRsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 38; Drug: OSU6162 1 然 Apo 50 然
bLsLsmbRhLsbLgbRhLsbRsbLcbLibLsLsmbLgLsLsmbLsbLgbLgbLhbRsbLsRsbLgbLeLs
LsmbLgbLsLsRsmbsbRoRsLsmbsbLobLgbRsbLobRsRibRgbRiLsbLsbRgbRhbRsbRiRsRe
mbRibsbLgbRgbRibRibRgbRsbRsbsbLsbLsbRsbRsRsmbRsbLsbRsbRcbLsbLgbRibLiLs
bLsLeLsbLibLsLsmbRjbLsbLsbLsLsmbLgbRobLcbLgLsLsmbLsLsmbLsbLgbLsLsmbLsb
LgbLgbLgLsbLgbLgbLibLcRgRsLsmbRibRgbRsbRsbsbRsbsbRsbsbLsbRsbRsbsbsbRgb
LjbLcbRobRgbRgbsbsbRsbRsbLcbsbRibLgbLcbLsbRibLcbLhLgbLiLsLsLsmmbLobRsb
LobLsbLobRobRsbLcLsmbLgLsbLgRsbLgbLiRsbLhLgbReRsmbRoLsLsLgmbRcRsRsmmbL
sRsRgbRiLsLsmbRibRcbLsbRebRsbRiRiRebRebRgbRgbRibRsbRgbLsLsmbLcLsmbLgbL
sbsbRsRsRsLsLsRsmmmbsbRsbLsRsLsbRsLsbsbRsLsbLsRsbsbsbsbsbRsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 39; Drug: OSU6162 1 然 Apo 50 然
bRgbsbLcbRsbRibRobRibRhLsbRcbRibRcbRhLsbRibLcbLibLsbRjbsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 40; Drug: OSU6162 1 然 Apo 50 然
bsbRsRsmbReRsmbRsRsmbRobsbRhLsbRsRhbLgbLcbLiLebRcbLibLebLiLsLsmbLsbLgb
LcbRcbRibRgbRgbRgbLsbLjbRibRiLsbLcbLobLiRsbLoLsmbLoRsbRhbRcbRibRhbLsRs
bLsbRibLsRsLsbLsbRjbLhbLhLsbLcbRibRcLsbLobLebLiLgbLsLsLsLsLsLsmmmmmbLs
bLsbLsLsLsLsRsLsLsmmmmbLebLobLiLsbLibLiLsbsbLsLgLsbRebRibRgbRsbRsbLgbs
bLebLeLsbLibLcbLobRgbRhbRhbRgbLhbLiLsbLobReRgbLebLgbLgbsbLibLgLsLsmbLi
bLgbLibRjbRcbRsRsmbLibLsbRibRgRsRsmmbRgbRibRsRsRsmmbLsLsLsmmbLgbRsbRiL
sbRsLsbLsLsmbRsRsLsmbsbRsbLsLsmbRsRsmbLsbRebRgLsLsmbLibLgbLsbLsbLsLsmb
LgLsbLgbLgLsLsmbLgLsbLsbLgbLgbLsbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 41; Drug: OSU6162 1 然 Apo 50 然
bRsbRebRgbLcbLebRobLobRebRibLjbRebRgbLobRgbLsbRsbLebLobRebLsbLebLsbRsb
RebRsbLebLsbRgbRebLgbLobLgbLobLcbRobLcbRebRebLebRobRobRsbRsLsbLebLgbLs
bRebRobRobRgbLobRobRobLobRebRjbRebRebLebLsbRsbRebRsbRebLsbLsbLsbLjbRsb
LsbLobLcbLsbLcbRsbLobLobLgbLobRebLobLcbRebLebRjbLobLsbRgbLobRcbLsbRjbL
obLebLebRjbLsbRsbLsbLebRebLsbLjbLjbLobRobRsbLebLebRsbRibLsbLebLsbLebRo
bRsbLebLgbLebRobRcbRsbRobLobLebLcbRobRebLgbLebRjbLjbLsbLsbRsbLobLobRsb
LsbRobLobRebRsbRjbRcbLobRsbLsbLsbLobLsbLebRebRjbLobRobLobRibLebLobRebR
sbLsbRsbLsbLsbRebLsbLsbRsbRobLebRgbRebRsbLsbRebRsbLebLsbRebLcbLebRebRg
bRobRsbRsbRsbRgbLjbRjbRjbLsbLebRobRibRibLgbRjbLebRebRobRobLobLsbRsbRgb
RobRgbLsbLebRgbRibRgbRjbLcbLebRsbRebLobLibLsbLobLgbLsbRobRebLcbLsbLsbR
sbRgbRibLebLobLjbLebLsbRobLobLsbLsbLsbLcbLcbLsbRobLgbLobRobRjbLebRsbRs
bLcbLjbLsbRsbLsbRobRjbRebRobRsbRsbLobLsbLobLebRjbRebLobRebRobLobRobLgb
RgbLobRebRebRebRsbLsbLsbLebRebRsbLebRebLebLebLobRobRhbLcbRobRsbRibLobL
ebRhbRobRebLibLjbLcbLebLobLebRebLobRsbRjbLcbLsbRgbLebLsbLgbLcbRobRebRo
bRobLebRobLebRebLebLibLibLcbRobRibLsbLcbLobRebRsbLsbLobLjbRobLjbLsbReb
RobRobLcbLobRobLobRobLgbRebLibRjbRobLobRebRhbLsbRibLebLcbLsbRibLcbLcbR
ebLobLobLobRebLgbLobLibLibRcbRsbRobRobLobLcbRobLobLebRsbLobRebLcbRobRe
bLebLobRebRebRcbLgbLcbRsbLobLebRobRobRobRebRebLobLobRobRjbRhbRcbRebLgb
LsbRobRhbLobRgbLobRcbLebRebLobRebRobLhbLebRobRcbRobLobLobLcbRebRebRjbR
jbLcbRobRibLgbLobLebLobRgbLebLobRcbRgbLobRobRebRobLobRgbRobLebLebLebRg
bLebLibRebLibRhbRobLobLobRgbRibRobRebLcbLobLcbLebRobLgbRobLgbRibLobLob
RebRcbLobRobLcbRobRobLebRobLobLcbLibLjbRobRobRibLebRebLebLebRobLobRsbL
obRsbLebRcbLobLgbLcbLcbLobRibRcbRobRobLebLebRobRobRibRcbRobRebLebLobLo
bLobLibLobLibRibLcbLobLobRibRsbRobRobLibLebRsbLgbRobRobRsbRobRjbLhbLgb
LebLebRgbRsbLebLgbLibLobLobLobRhbRgbLsbRobRobRibLobLcbLobLebRobLobLibL
obRebRebRobRobRebLobRgbLobRobLobRsbLgbRibLobRobLibLsbLibLobRsbRobRebRo
bRcbLobRobRobLebLobLcbLsbLobLcbLcbRobLcbRcbRobLobLcbRebLobLobLebLsbLsb
LobRebLsbLobLebLobLgbLgbLcbRobLebRcbLcbLibRebLobRcbLebRobLobLsbLjbRgbR
obRibRobLebLebLebLebLsbRobRobRobLebLgbLobRebLebLebRebLobRcbLobRibRhbLi
bLcbLobRobRsbRsbLsbLcbRebRibLebRobLcbRobLcbLebLebRobLcbRobRebLobLobRcb
LobLebLebLebRjbRebLobRebLhbRobRobLobLebRcbLebLcbLobRobRcbLobRebRobRobR
cbRcbLebLjbRcbRobRjbLobRcbLebLebLobRcbLebLobLobLjbRebRibRjbLobRebRcbLj
bRobRcbRcbLjbLsbRobRsbRjbRebLobLjbRebLobRjbRebRjbRobRcbRobLebRjbRsbLob
RsbRobRsbLcbLcbRjbRcbRebRebLjbLebRebRjbLcbRebLebRcbLebLcbLobLjbRsbRcbR
jbLobLebLobLjbRobRebLebLobRjbRcbLjbLebRobLobLebLjbLjbRebRcbLcbLebRobRc
bRobRebLjbRebRobRobLobLobLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 42; Drug: OSU6162 1 然 Apo 50 然
bLeLsbLsbLsLibLgbLgLsbLiLgbRjbRgbRsbRibRsRsRsRsmmmbRhbRiRgbLsbRgbRebRc
bLgLsLsmbLgLsLsmbLibRsLsbLsbLcLeLsbLsLsLsmmbRjbRgLsbLsbRiRsmbRsRsmbLsb
LcLsLgLembReRgRsmbRhRsmbRhbRiRgbReRgbRibRibLsLsLsmmbRsRsmbLibLsbLsLsLs
LsmmmbRjbRgbLibLibLsLeLsbLgLsLgbLibLgLsLsmbLgbLsbLsbLsbLgLsbLsLsLsmmbL
gbLsLsmbLsLsLsmmbLsLsLsLhLsmmbLgLibLebRsbRsLsbLgbLsbLhbLhLsbLgbLibLgbR
sLgbLsLsmbLsbLsbLhbLsLgLsbLgbLsbLgbLibLgLibLgbLebLobLibRiRsmbRsbRgbRsR
iLsbRibRgbRsbRsbRibRsbRsbRgbRgbRsbRsRsmbRgbRgbRsbRsbRsbRsbRgRibRgbRgbL
sLsmbRsbRgbLsbRebRgbRgbRsbRsbRsRsmbRgRsmbRebRgbRsbLsRsbLibLgbLibLsLsmb
LibLgbLsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 43; Drug: Control Apo 50 然
bLsbRibRcbRibLjbRibRebRhbRibLcbLsbLibLgbLibLibLiRsbLibLibLobRjbRebRcRs
mbRgbsbRibRgbRebLcbLgbRjbRcbRcbLcbLcbLhbRgbRoRsmbRhbRibLobLsLsLsmmbLib
RgbRibLibRibRgbRgLsbLjbRibRjRsmbRgbLjLsLgmbRgbRibLgLsbRjRsRsmmbLebRcRs
mbRiRsmbLjLsLgLsLsmmbLhLsbLebLgbLobLhbLiLsbLibLgbLibLgbLibLgbLibLiLsbL
oRsbRibRobRobRgbRobLgbLsLobRgRsRsmmbRiRsmbRgbRsRebRiRsmbRcbLcbLibLcLsm
bLibLgRsbLobLibLibLibLiLsbRsLgbLcRsbLibLibLhbLgbLhbLgbLibRjbRoRsmbRhbR
ebRibLibLibLibsbLgLiLsLibLobLgbLhRsbLgbRsbRhbRgLsbsbRcRsmbRcbRhbRibLcb
RhbRibRsbLsbRibsbRgbRcbLgLsbLsLsLsLsLsmmmmbLsLsLsmmbRsLsLsmbLsLsmbLsLs
LsmmbRsbsbsbsbsbRjbLeLsLsmbRiRsmbLcLsmbRcbRoRsRsmmbLsLsmbRgRsmbRibRibL
cbLcbLebLgRsbLgLsbLibLibLiLsbLibLgLiLgLsbLibRobRiRsmbRebRiRsmbRcbLebLc
bLibLibLhbLiRsbLibLgbLibLgRsLiLsbLgLsbLgbLoLsmbLibRebRiLsRsRibRobRsbLo
bLiLiLobLibLoRsbLeLsbLiLsLsmbLsbLgLsbLibRibRcRsmbLhbLoLsmbRsRsmbLgLsLs
mbLhbRobRhbRibRgbLgbRebRgbRibRebRibRcRiRibRcbRoLgbLibLcLcbLcRsLebLoRsb
RibLoLebLobLobLcRsbLeLgbLeLhLsbLoRsRibRiRsmbRebRhbRsRjbRcbLhbLjLibLobL
gbRhRsmbRgRsRsRsmmmbRiLsbRgLsbRgRsmbRgRsmbRsRgRsRsmmbRsRsRsRsRsmmmmbRs
RsRsRsmmmbRsRsLsmbRgLsbRcbRgLsbRjRsRsmmbLjLgbLgLsbLgLsbRsLsLsmbLiLsLsm
bLcbLsLibLhLsbLiLsbLhbLiLsbLgbLcbLgLsbLiRsbLibLibLhLhbLibLgbLgbLobLgbR
cLsbRgbRibRsRsmbRebRibLibRebRibRibRgbRibRsbRgLsbsbRiRsmbRebRhbLcbLsRhR
smbRcbRsbReRsmbRsRsmbRsRsLsRsmbRibRibRsbRsRsLhmbLcbLiLsLsmbLsLgLsLsmbL
ibLhbLiLsbLiLsLsLsmmbLgbLgLiRsbLhbLsbLobLibLibLgbLgbLibLgLiLsbLibLibRh
bRcbsbRiRsmbRgbRgbRgRsmbLobLiLsbRgRsLsmbRebReb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 44; Drug: Control Apo 50 然
bLgbRsbRebsbRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 45; Drug: Control Apo 50 然
bLsLsmbLgbLgbsbLgbRsbRibRcRsmbRibRgbLsRebLgbLcLcbLsbsbsbsbsbsbsbLgRsbL
gRsbLgbLsRsbLiRsLsbLhRjbRjbRibRhReRsmbRhLsRcLsbRcRebRcReReRsmbRebRsbRh
bReRsmbRebRcbRgLsbRobRebLobLgLgbRoRsmbRjbRsbRebRoRsmbRgbRebLoLsmbRiRsR
sRsRsRsmmmmmbRibRjbRcbRgbRjbRiRsmbRibRjRsRsRsRsmmmmbRhbRibLibLgbRsbRiR
smbRjRgRsmbRhbRgbLjbLsLsmbRibRhLsbLgLsbRgbLgbLibRsRgRsRsmmbLiLsbLobRiR
sLsmbRgbRsLsRsbRsRibRgbRibLsRsbRgbLgbLgbRibRsbRobLgbLgLsbRibLiLsbLgbRj
bRebRibRgLsbLgbRhbRgbsbLsLsLgmbLgbLsbLsLsmbLgbRgbLibLsbLgRsbLgRsRsmbLs
LsmbLgLsLsmbLsLsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 46; Drug: Control Apo 50 然
bLhbLcbLsbRsbRjRsmbLjbRgbLsbRgbRgbRgbLibLcLsmbRsbRcbRsbRgRsmbLjbLgbLib
LgbLgbLeLsLsmbLgbLebLobLhbLgbLgbRgLsbLsbRsRsmbRsRsRembRsbRgRebRebRsbRe
bRibLgbLibLibRgbLsbLebLebLebLcbLibRhbReRsmbLebLeRsbLibLeRsbLobRgbLgbRs
bRsbLgbLgbRhRsmbRibRcbLiLsbLgLsbLibRgRsmbLibLiLsbLgLsbLsLsLsmmbLeLsbLi
LcbRibsbLgbLibsbRhbLibLibRjbLgbRibRgbLcbLgbRebLjLsmbRcbRsbRsRsmbRsRsRs
mmbRsRsmbRsRsmbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 47; Drug: Control Apo 50 然
bRiRsmbRgLsLsmbRhRsmbRcbLiLsbLcRsLsbLgbLhbLgbsbLiLsbLcbRcRsmbRibRcbRgb
ReLsbRibRcbRebRibsbsbRibRsLsbRobRsbRcRsmbRebLebLsbLsbRsLsbLsLsLsLsLeLs
LimmmbLiLsbLibLsbLobLiLsbLgbLeLibRebRebRebRsLsLsmbLgbLsbLgbLsbLsbLsLsm
bLsLsmbLsbLsbLsLsLsLsLsLsLgLeLsLsmmmmmmbsbLsbLsLsmbLsLsmbsbLsbLsLsmbLs
bLsbsbLibRobRobRibRcbRibRhbReRsmbRgbRhbLcbLibLibLcLsmbLebLebsbRsbLsLsm
bsbLsLsmbLsbLsLgbLsLsmbLsLsmbLsLsLsLsLsLsLsmmmmmmbsbLsLsLsmmbLsLsLsmmb
LsLsLsmmbLsLsRsmbLcbLsbLsbLsbLsLsLsLsmmmbLsLsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 161820; End: 162320;
Recording: 5-1; Individual: 48; Drug: Control Apo 50 然
bRcbRcbLibLibLibLibsbLebLgbLhbLgbLgLsLsmbLgbRsbLgRsbRsRsmbLgbLgbLibLgb
LhbLiLsbRiRsmbRebRebRibRibRgbRhbRcbLibLcbLcbLibLcbLcbRgbRibRhbLjbLhbRe
bLsRjRgbLobRsbRcRsmbRibRsbRibLcbLcbRsbLgLsbLgbLsLsmbRsLibLgbLibLiLsbLh
LsbRsbLebLhLsRsbRgbLebLgLsLsmbLgLsbLsLsLsLsmmmbLsbLgbLgLsLsmbLibLebLgR
sbLebLgLsbLebsbsbLsbLsbLsbLsLsLsLsmmmbLsLsLsmmbLgbLsLsLsmmbLsLsLsmmbRs
bLibRjbLjbRhbReRsmbRibRibRgRiRsRsmmbRgbLgbLeLsbLibLibLibsbLibLcbRgbLsL
smbLgbLsbLsbLgbLgbLcbLibLcbLiLsbLeLsbLebRsbRsbRjRsmbsbLgLsbLgbLgLsbRsb
LiLsbLibRgbLebLiLsbRjbRcbRhbRhbLgbRibRibRibRibRhbRebLibLebLibLgbLibLib
LhbRibRjbRiRsmbRebRcbRebRcbRibRgbRibLibLebLebLibRebLibLcLsmbRibLibLibR
jbLebLibLcbRjRibLgbsbsbsbsbRsRsRsmmbsbRsbLsbRebLebLebLhLeLsLsmbLeb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 1; Drug: OSU6162 10 然 Apo 50 然
bRibRibRibLsRsbLjLsmbLibRsbRsbsbRsbRsLsbLeLsbLsLibLibLgLsLsLsLgmmbRsbR
sRsmbLsLgLgLibLeLsLgbLgLeLsbLeLgbRoRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 2; Drug: OSU6162 10 然 Apo 50 然
bLsbLcbsbsbRsbRsbsbLgbRsbRobRobRoRsmbRsRsmbRsLsbLsbLsbRsLsbsbsbLsLsLsm
mbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 3; Drug: OSU6162 10 然 Apo 50 然
bRibLcbLsRsbLsbLibLgRsbRjbLgbRiRsmbRobRjbRsbRebRoRsmbLgbRgLsRsbLcLobRe
LobLobLcbLoLsRsLsLsmmbLcbRobRgLsLiLsLsmbLeLibRsbRebLcbRoLsLcbLobLhbRib
LsRsbsbRhbLcbLsbsbLcbLibLcLsLsLiLsmmbRiRsmbRcbRsRsmbReRsmbLiLsbLgbLiLs
LsLsmmbLgbLibLgbLgbLgbLoLsmbLsbLgbLcLsmbLjbLcbLcbLibLebRibRibLcbLobLob
LsLsmbRhbRsRebLsLsLsmmbLiLsbRebRsbsbLsbLgbLebRgbRgbLcbLgLsbLibLgbLcbLc
bLcLsmbLsLgLsbLjbLebLiLeLsbRgbLoRsbRobRobRcRsmbRgbRhRsmbLobLobRiRsmbLs
LoLsmbLsbLibLobLobLsbLjbRebRebLsbLjbLobReRsRsmmbLiRebRgLjbLsLebLsbLsbL
cbLibRsRsLjmbRobRebLobLcbLobLebLebLcbLsbLgLsbLjbsbLobLobLibRgbRebLibLc
bLcRsbLobLiLcbLibLobRsLsRsbRjbRcRsLsmbRibRibRgLsbLsbLsLsmbsbRsLjbRebRi
bRcbRsRsmbLsbLeRsbLibLsRjbRiLibRiLibRoLoRsbsbLoLsmbLsRsbLobRhRsmbRebLg
LsbsbLebLjbLcbLjLgbLhbLgbLoLsmbLobLgLsbRiRebRoRebLibLsLsmbLgbRiRgLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 4; Drug: OSU6162 10 然 Apo 50 然
bsbLebLhbLsbsbRibRiRibRsRsRsRsmmmbRsRsmbRsRsRsRsRsLsmmmmbRsRsmbRgbRsRs
RsRsRsRsmmmmmbRgbRsRsmbRgRsmbRsRsmbRiRebLcLsmbLcbLhbsbLsbLibLiLsRsbLgb
LebsbLsRsbLsLsLgLsmbLgbLiLhbRsbLsLsmbLsbLsbLsbLsLgbLibLiLgLsbLgLsLsLsm
mbRsRsRsLsmmbLhbLeLsLsLsLsLsmmmmbsbRgbReRgRsRsmmbRgbRibRibLoLsmbLgbLsL
sLsLsLsLsmmmmmbLeLsbLibLsRsbLsbLsbLibLsLgbLsbLsLsmbLgbLsRsLgbLgbLibLgb
LibLsLsmbLgbLgRsbLgLsbLgbLgLsLsmbLsLsLsmmbLsbLgbLsLsLsLgLsLsmmmbLebLgL
sbLgLsLsmbLgLsLsmbLsLsRsmbLiLsbLsLsmbLgLsbLcbRobRebLgbRgbLibLhbRgbRsbL
sLsLgLsmbLgbLgLsbLsbLsLsmbLsbLsbLsbLsLsLsLsLsmmmmbLsbLsLgbLgLsRsbLgLsL
smbLgLsbLsRsLsLsLsmmbLgbLsbLgbLgbLgbLgLgbsbsbLsLsLsLsLsmmmmbLiLsLgbLeL
sbLhbLsLsmbLiLsbLsbLsbLsLsLsLsmmmbLgbRsRsmbLsLsLsmmbLsbLsLeLibLgbRcLsb
RhbLsbRsLsbsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 5; Drug: OSU6162 10 然 Apo 50 然
bRsbsbRsbRsRsmbRsRsmbRsRsmbRsbRsbRsbRsbRsbRsRsmbLsRsbRsRsmbRsbsbRsRsRs
mmbRsbRsbRsRsmbsbRsbRsbsbRsbRsbRsbRsLsbLsRsbRsLsbRsRsmbRsRsRsRsmmmbRsR
smbsbRsbRsbLsbsbRsbLsRsLsbsbLsRsRsmbsbLebLsbRsLsbRsRsmbLsbsbsbsbRsRsmb
RsbRsbRsRsLsmbRsRsRsmmbRsRsmbRsLsRsLsbsbRsRsmbLebRcbRsRsRsmmbLsRiLsReR
eReLsbRebRhbRiRsmbRcRsmbRebLsbLibLcbLcbRobRcbLjbLobsbLsbLsbLsLsLgLsLsL
smmmbLsLsmbLsLsmbLsLsLsmmbLsbLsbLsbLsbLsbLsbLsbRsLsLsmbLsbLsbLsbLsLsLs
LsLsLsLsLgmmmmmmbLsbLsLsLsLsLsLsmmmmmbsbLsLsLsmmbsbLsLsLsmmbLsbLsLsmbL
sbRsLsLsmbLsLsmbLsLsmbLsbLsbLsLsmbLsLgLsLsLembsbsbLsbRsbLsbLsbRsRsmbsb
RcbRobRgRebsbRibLsRsbsbRsRsmbRibRobRhbRebRibRebRjbRcbRebRebLoRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 6; Drug: OSU6162 10 然 Apo 50 然
bRsRsLsmbLsRsRsmbRsbLsbRsbRsbsbsbRsbsbsbsbRsRsRsmmbRsLsRsRsRsRsLsRsLsR
hmmmbRsRsRsLsmmbRebsbsbsbLsRsRsLsRsmbRsRsRsmmbRsRsRsmmbRsbRsRsRgRsRsmm
mbRsbsbsbLsbsbRsRsRsRsRsRsRsmmmmmmbLsRsLsbRhbLobLcbLibLsbsbRsbRsLsbRsR
smbsbsbsbsbLsbLsLsLsLsmmmbLsLsLsLemmbLebRobRcbRsbRsbRsbRgbRgbRsbLsbsbR
sbLsRsbLsbLgbsbLsbLsbRsRsRsmmbLsbRsRsRsLsRsRgmmbRsbRsRsmbLsLsmbsbsbsbR
sbsbsbsbsbLsbLsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbRsbRsbRsRsmbRsbRibRsbRibsb
RgbRsbRsbLsbsbsbRsbLsbLsbLsLsLsLsLgLemmmbsbRcbRiLsLsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 7; Drug: OSU6162 3 然 Apo 50 然
bRgRsRsRsRsRsmmmmmbRgbRsbRsRsmbLcbRsbRgbRiRgbRibRibRgLsbLsbRgRsmbRibRi
RsmbRibRoRsRsmmbLgbLibRjbLhbLobLobLsbRiRgbRiLsbLjbLcbLibLibLsRsbLiRsbR
jbLsLgLsbRjbRcRsmbRgRsmbRibLsbLsLsLsmmbLsLgLsLsLsLimmbLibLsLsLsmmbLsbL
sbLgLsLsLsmmbLsLgbLsLsmbLsbLsbLebLsbLiLsbLcbRgbRhbRgbRiRgLsbRsRoRsmbLi
RsbRhbRibLibLhbRjRsmbRsbLcbRebRgbRibRgbRiLsLsmbRhRsmbRiLsbLhbLibLhLsbR
sLsbRiRsmbRiRsmbRibRiRcbRsbLsbRibRgbRibRibRiRsmbRgbLibLoLsmbLsbLiRsRsm
bRibRiRsmbLsbRgbLebLsLsmbLgbLsbLgRsbLsbLiRgLsbRsRsmbRjRjbRgbLgbRjbRoLs
bRsRibLiLsbLgbLgbLgbLsbRjRibRibRgRsmbRsbRgbRibRjRsmbRiLsbRibLgbRobRsLh
bLcbLibLgbLobRhbRcLsbLibRgbRhLsbRiLsbRgbRibRsRsRsmmbRgRsLsmbRibLiLsbRc
bLgRsRsRsRsRgRsRsmmmmmbRiRgbRsRsmbRiLsLibLibLiLsbRibLobsbLibLgLsbRibRg
LsbRcbRsbRibRgbRgbLsRgRgbRiLsbRsbRsRsmbRgbRsRsRsmmbRiRsmbRibRsLsbRgRsL
smbRsRjRsmbLibRiLsbRgRsLsmbLjbRgbLibLhbLobLhRsbLobRibRcbLsRsbRibRiLsbR
cbRgbLsbLiLsLsLsLsmmmbLgLsbLhbRgbRgbLhRsbsbLsbRjbRgbRibRgLsbLcbRibRibR
sLsbRgRsmbRgbRgbRibRiRsmbRiRsmbRibRsbRgLsbRgLsLsmbRgbRiRsmbRgRsmbRgRsm
bLjLsmbLiLsbLgRsbLgbRibRgRsmbRgLsLsLsmmbRcbLcbRsbRibRhbRsLsLsLsLsmmmbR
gbLiLsbLibLhbLgbRobRsbLjbRhbRibRgbRiRsRgmbRebRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 8; Drug: OSU6162 3 然 Apo 50 然
bRgbRsRsmbRsRgRibRibLgbLjbReRsmbRsbRsRsmbRsRsmbRiRsmbLsbLcbRjbLibLiRsb
LsbLgbLiLgbLgbLhbRibRibLoLcLsmbLebRcbLjbLibLebRsbLgbLgLsbLebLeLgbLgbRj
bRjbRgbRsbRgbRsRgbRgRsRsmmbRsRsmbRsbRsRsmbRsbRgbRsbRsbRsbRsbRsbRgbRsbR
sbRsbRgbRsbRsRsRsmmbRsbRsbLsbRsbRsRsRsmmbRgbRgbRsbRsbRsbRhbLgbLsRsbRsb
RsbRebRhRsmbLsbRsbRsbRgbRgbRgbRsbRsbsbRibLsbLsbRsbRgbRgbRsbRsRsmbRgRib
RsbRgbLsbRibRsbRgbRhbRsbRsbRhbRgbRhbLibLcbRsbRsbRgbRsbRsbRsbRsbRgbRgbL
sbRgbRsRsmbRsbLsRsRsmbLsbRsbRsbLsbRsbRgbRsbLoLsmbLsbLsbRsbLgbLgbLsbLgb
LgbRsbLsbLsbRsbLsbRsbLsbLsbLgbLsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 9; Drug: OSU6162 3 然 Apo 50 然
bRgbLobLeLsbLobRgbRgbsbLebLiLsbLsRsbLibRsbLsbLebLsLsmbLgbsbRsbRsLsbLib
LgbLsbLgbLibLgbRsbsbLsbLsLeLsbLgbLsbLsbLgbLgLibLgbLsbLgbRsbLgLsbLgbLsL
sLsmmbLgbLgLsLsmbLgLgbLibLsLsLgmbLgbLgbLibLsbLibLsbLgbLsbLebLsLsLsLsmm
mbLiLgbLgLsbLsbLsbLsLsmbLsLsLimbLibLsLsmbLibLgbLgLgLgbLgbLgbLibLibLcbR
sbRgRgbRgbRsbRibRgLsbLsbRsbRgbRsRsRsmmbRgbRibLeLsbLgbLsbLgbRjbLsbRibLo
RsbRsbRibRsbRsbRibLsbRsbRsbRsbRsLsbRsbRsbRgbRsbLibLsbLgbLsLsmbLsbLjbLi
LsbLgbLsbLgbLsbLibLsbRsbLsbLsbLsbLsbsbLgRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 10; Drug: OSU6162 3 然 Apo 50 然
bRgbLsbLsbLgbLibRebLgbLiRsbRiLgbRcRsRsmmbReReLsRsbRsbRgReRebRsbRsbRgbR
obRcbRiRgRgbRsbLsbRsbRsbLsbLeLsbLhbLoLibLcbLibLiRsLibLgLiLsRsLsbLibLib
LcLibLgbLeLiLgLsLgLsRsLsbLhbLsbLgbLhRsbRhRibRhbRgbRiRiRibRgLsRsbRgRsRs
mmbRibLsLcbLcRsbLgLgRsLhLsLgLhLiLiLsbLhLiLgLsbLiRibLsbLiLeLsLsmbLgbRcb
RcbRiRiRsRimbRgLsbLcLsmbLgRsRsmbsbLcbLhbRgbLsbLsLoLiLiLsbLhRsLhLeb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 11; Drug: OSU6162 3 然 Apo 50 然
bRcLsRsbRobRiRsmbRcbRibRiLsRiRebRiRsReRcRembReRsmbRebReRsmbRhbRgbRcRsL
smbRobLibLsbRsbRsbRsbRsbRsbRsbRsbRjbRcbRobLsRsbLcbRcRcRebRibLjbLjbRsbL
oLsmbLibLcLsLhLsmbLiLcbLiLebLebLibLcLiLsbLcbLgbLgRsbLgbLgbRibLjbLcbLib
LoLsRsmbLsbLhbLgbLgbLsLgLsbRobRibRibRiRsmbRibRoLsbLibLibLsLsmbLgLsLsmb
LgbLsbLgbLsbLsLsmbLsLsmbRsbLsbsbLebRebRebLsbRsLsbLsbLsLsmbLsbLsLsmbLsb
LsLsmbLcLsLgmbLibLiRsbLiRsLsbRcbRoRiRjbRgLsbRgbRsbLcLsmbLiLsbLgLsLsmbL
gbLsbLsLsmbRsLsbLsbLsLsmbRsLsLsmbLsLsmbsbLsbLsbLsLsmbLsLsmbLsRsLsbLsRs
LsLsmbLsbLsbLsRsbLsbLsLsmbLsbLsbLsLsLsmmbLsbLsLsmbsbRjbRcbRcbRcLsbRobR
obRibRiLsbRibRibRobRsbLhLhLsbLobRiRsmbRsbRcbLebLgLiLhbLsRsbsbLsLsmbLsL
smbLsLsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 12; Drug: OSU6162 3 然 Apo 50 然
bsbLoLsLsmmbRsbRibRhRsmbRiRsmbRibRsRiRiRsmbRhRsRhRsmmbRgbRgRsmbRiLsbRh
bRibRgbRgbRiReRebRibRiRsmbRibRibRgbRgbRgbRgbRgbRgRsmbLgRsbRibRgRsmbRsR
smbRgRsmbRgbRiRsRgmbRiLsbLsbRiRiRiRiRhRsRimbRibRibRhbLsbRobLcbReRebRhR
smbRhbRhbRiRsmbRibRiRiRsmbRiLcbLhLebLeLebLsLsmbLsLsmbLsbLsLsmbLsbLsbLs
bLsbLsbLsbLsbLsLsmbLsbLgbRgLsbRgbRibLeLsbRibRhbsbsbsbsbsbRsbRhbRcbRib

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 13; Drug: OSU6162 1 然 Apo 50 然
bRsbRsbRsbRsbRsbRsbRsbRsRsRsmmbRsbRsbRsbRsbRsbRsbRsbLsbRsbRsbRsbRsbRsb
RsbRsbRsbRsbRsbRsbRsbRgRsmbRsbLsbLsbLsbLsLsmbLsbRsbLsbLsRsbLsbLsbRsbsb
LsbRsbRsbLsLsmbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 14; Drug: OSU6162 1 然 Apo 50 然
bLeLsbLsbLsbLgbLgbLibLhbLgbLgbLeRsbLsbLjbLcbRjbRjbRjRsmbRibRgbLjbRgbRg
RsmbRgbRgbRgbRsRsmbLhbLiLsbLsbLiRsbRgbRcbLsLsmbRibRgbRibRsbRgbRgbRsbsb
RsbRgRsmbRsbRgbRhRsRsmmbRsRsmbRsbRibLsbRgbRsbRibLsbLsRsbLibLgLeLsbLeLi
LsbLsLsmbLgLsRsbRgbRgbLobsbRgbLsbRcbRgLsbRgRsmbRhRsmbRiRsLsmbRgRsmbLsb
RibLjbLcbRebRibRgRsmbLebLsbRcRibRgbRsRsRsmmbsbRiRsmbRgRgbRgbRoLsLsmbLi
LsbLgbLoRsLsbRgbLsbsbsbsbLgbLebsbRebLgbLiLsbLebLebLibRsbRobRibLiLsbLsb
LiLsbLhbLgbLiRebRsbRsbRgbRibLibLsbRebRcLsLsRsmbRsLebLsbLobRgbRgRsmbRgR
ibLsbLgbLsbLebRibRibRoLsbLobRobRsbRgbRgRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 15; Drug: OSU6162 1 然 Apo 50 然
bLiLgbLsbRsbLgLsbLsLsmbLgbLsLsmbLgbLsLiRsLsbLeLsbRsRsmbsbLsLsmbLibLgLs
LsLsmmbLsLsmbLsLsLsmmbLsbLsbLgbLgbRsbLsbLsbLsbLsRsbLsbRsbLsbLcbLeLsLsm
bRcLsRsbLgbRsbRjbLob

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 16; Drug: OSU6162 1 然 Apo 50 然
bRgRgRsmbRsbRsbRsbRsbRsbLsRsbRgbRsbRgbLsRsbRgbRgbRsbRgbRgbRsRsRsmmbLsb
RgbsbRsbRsbRsbRsbRsbLsbRsbRsRsmbRsLsbLsbsbRsbRsbLsbRgbLsbRgRsRsmmbRsbR
sbRsRsmbRsbRgRsmbRsbRsbLsbRsbLsbRsbRsbRsbRsbRsbLsbRsRsmbRsbRsbsbRsbRsb
RsbRsbLcbLsbRsRsmbRsRsmbRsbRsRsmbRsRsLsmbRsbRsRsmbLsbRsRsmbRsbsbRsRsmb
LsbRsbLsbRsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 17; Drug: OSU6162 1 然 Apo 50 然
bLgbRgRsmbRcbRibLjbLsbsbRsRsmbLsbLsRsbRsbsbLsLsLgLsmbLsLsLsLsLsLgmmmmb
LibRebRibRebRcRsmbsbRcbReRsmbRgRsmbRibRebRibRobLgbRibRebRhbLibRiRsLsmb
LgbRobRjLsbRsRsRsRsRsRsmmmmmbRsRgbRsbRsRsRsRsRsRsRgRsRsRsRsmmmmmmmmmbR
sRsRsRsRsRsRsLsmmmmmmbLsRsRsmbRsRsRsmmbLjbLcbLcbRsbLcbLsLsRsmbLobLibLh
bLhLsbLgbLgbLgbLhbLibLibLcbLeLsbLcLsmbLsLsmbLsLsLsmmbLsbLsLsLgmbLsbLsb
LsLsmbLsLsLsmmbLsbLsRsbRjbRcRsmbRgbRibRgbRgbRsRgbRgRsRsRsRsRsmmmmmbLcL
smbLibLhbLebLibLibLgbRsbRebLsbRcbRgbRsbRjbRoLsbRhbRebRoLsbLgbRcbRsbRgR
smbRgbRgbRgRsmbRibLobRhbLoLsmbRibLibLibLibLebLcLsmbLgbRiRsmbRgRsmbRoRs
LsmbLgbLibLibLcbLibLcLsRsmbRcbRgRsmbLsLsRombLibLgbLgbLgbLibLgbLgbLgbRj
bLobRgRsmbRibRsbLsRsRsLsmbRibLsRsRsmbLhbLsLsmbLhbLsbRibLsRoRsLsmbRsbLo
RsbLhLsRsbLgbLebLsbRsbRibLjLsLsmmbLibLebRsLsbLgbLgLsbRgRsmbRebRgbRgbRs
RsmbRgRsmbRibLibLibLcbLsLsmbLsLsLsLsLsLsLsLsmmmmmmmbLgRsbLiRsbRsLsbLsL
gbLsLsmbLgLsLsmbLibsbLiLsbLsbLsbRsbLsLsmbRsRsmbLsbLsbLsbLsbRiRsmbRsLsb
LsbLibLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmbLsbLiLsLgbRjbLsLsmbsbLsLsLsLsLs
LsLsLsLsLsmmmmmmmmmbLhLsRsbLsLsmbLsLsLsmmbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 18; Drug: OSU6162 1 然 Apo 50 然
bRhbRibLsbLeLsbLhbLiLsbLcbRgbLcbRsbRcbRsbRcbRgLsbLsbLjLgLsbLebLgbLeLgb
RjbRcbsbLjbRcbRiLsbLcbLsLhbLibLiLsLsmbRibLsLsLsLsmmmbRsbLgbRibLgLgbLsL
sLsmmbLiLeLsLeLsLeLibLsbLhLsbLcbRjRsRimbRibRibsbLgbLsbLsLsLsLsLsLsLsLs
LsmmmmmmmmbLsbLiLsLsmbLsbLsLsRgmbLsLsmbLgLgLsLsLsLsLsLsLsLgLsLsLsLsmmm
mmmmmmbLgLsbRsRsRsLsLsmmmbLsbLsbLsbsbLgLgLsbLibLsbLsLsLsLsLsLsLsLgLsLg
mmmmmmbLgLsLsLsmmbLjLsmbRsLsbLsbLsLsmbLgbLsLsLsRsmmbLsLsLsmmbLsLsLsLsL
smmmmbLsRsbLgLsbLgbLsLsmbLsbLgbRgLsLsmbLsLsLsLgLsmmbLgLsLsLsLsRsmmmbLs
LsLsLsmmmbLgRsbLsLsLsLsmmmbsbsbLhbRibLebRgbRsbRsLsbLsbLsLsRsmbLgLsLsLs
LgmmbLiLsLsLsmmbLiLiLsbLibLgbLsLsmbLsLsLsLsmmmbLsLsmbLgLsLiLsbLsLgLsLg
LsLsLsmmbLsLsLsLsLsLsLsmmmmmmbLgbLsLsmbsbLgbLgLgbsbLsbRobLcbLsLgLsLibL
sRsbLsLsLsLsRsLgLsLgmmmbLgLsLsLsmmbLgbRsLsbRcbLcbLsRcbLebLebRsRsmbRsRs
RsmmbLgbLsLgLsLsLiLsmbLsbLgbLgLsLsLsmmbLsbLsLsLsmmbLsLsmbLhbRhbLibLgLs
bsbLsLsRsLsLsLsmmmbLsLsLsLsmmmbLgbLsLsmbLsRsLsLsLsLsLsmmmmbLsLsLsLsLsL
sLgmmmmmbRsbLgLsLsLsLsLsLsLsLsLgLsmmmmmmmbLsLgbLiLsLsLsLsmmmbLgbLsLsmb
LgLsLsLsLsLsLsLsmmmmmmbLsbLgLsLgLsbLiLsLsmbLgLsbLgLsbLgbLebLsRsbRsRsRs
RsRsRsRsRsRsRsLsRsRsRsmmmmmmmmmmmbRsRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 19; Drug: Control Apo 50 然
bRjRsmbLsbRobLsbLhLsbLgbRcRsmbRhbRsbRhbLgbLeLsbLjLibRibRjbRcRsmbLgbRjb
RcbLebLiLcbRiRsmbRoRibRebRibRibRsbLobRibRibLjLcbRcbReRsmbRhbRcbRibRhRs
mbLsLsmbLhbRebLebLcLsmbRgbRebRoLsLsmbLebRoRsmbLiLsbLsbRebLjbLcbLcLsmbR
sbLiLgbLsbRjbRjRsmbLcbRcbLeLgbsbsbLsbsbsbsbsbsbsbLjbLsRsLsbLsLsmbLeLib
RgRsmbRsLsbsbRgbRebReRibRsRsLembsbLsLeLsbReRsmbRoLsLebsbsbsbLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 20; Drug: Control Apo 50 然
bLsLsLsmmbLsLsmbLiLsbRiLsbRsbRgbLibsbLsLsRsmbRsbLsRsbsbLsbsbsbsbsbsbLg
LsbRgbRsbRcRsRsRsmmmbRhbLhLsbLjbLibLibLiLsbRsbLibLhRsbRcbRhbRibRebRgbR
sRcRsmbLsbRcbRcbRibLhbLibLgbLibLibLibLibLibLibReRsmbRcRsmbLsLsmbLebLcR
sbLgbLgbLibLibLibLiLsbLgbRsLibLibLgLsbLsLibLibLgbRcbRibRcRsmbReLsbRhRs
mbRibLsRibLgbReRsmbRhRsmbLeLsbLcbRsLiRsbRiRsmbRibLcbLjLibLgRsbLgbRjbsb
LjbLgbLsbLibRsbLhLsbLgbLibLsLgbLibRibLjbLibLhbLgbLgbLibLiLsbLgbLgLsbLe
RsbLebLibRcRsmbRhRsRsmmbRgbRibRibRhbRgbRibRibRibRgLsbRibRibLcbLebLibLg
bLibLibRgbRsRjbLcbLibLibLgbLibLhbLgbRiRsRsmmbRgbRiRsmbRhRsmbLgLsbLgLsL
sLsLsLsmmmmbLsLsmbRsbRsbRsbRsRsmbRsbLsbsbLsRsbLjLsLimbRibRsLsbLsLibsbL
gLsRgbsbLsbLebRsRsmbRsbRsLsbLsbRsbLsRsbLsbRsLsbLsRsbRsLsbsbsbsbRsbLsbR
sbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 21; Drug: Control Apo 50 然
bLgbsbLiLsbRcRcRsmbRiRsmbRgbRsbRgbRcbRgLsbRoRcbRcbReRsmbRgbRsRibRebLhL
sLsRombRiRsmbLgbRsbLobLiLsbLhbLcbLcbLgbReReRsRsmmbLobRibRcbsbRibRcRsmb
LibLcbLebRebRibRoLeLsbLgbLgRsbLobLjLsmbReRsmbRebReRsmbLcbLcbLibLibLiLs
RsbLiRsRsmbLobLhbLibLeLsLcbRgbLcbLibLibLgbRcRebLsbLibRsLsLsmbRebRiRsRs
mmbRiRiRsmbRjbLsbLobLsbLobLobLcbRsbLibLibLoLsmbLibLibLibLobRhbRiLsbRsb
LsbRcbRgbsbRobRcbRoRsRsmmbRibLebLibLibLibLgbLcbLgbLcLcbRcLsbReRsmbRcbL
sLsLsmmbRsbsbLsLgLsbLjLibLgLibRcbRcbRibRobRcRibLgbRhbRsRhbRoLsbLibLobR
sLibLoLibLiLibLeLsLgLhbLgLsbLebLebLgLibLiLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 22; Drug: Control Apo 50 然
bLobRgbLibRebsbRibRsRcbLsLsmbsbRsbRsLsLsmbRibRsLsLsLsRsmmbLsbsbsbRjRhR
smbLsbLsbLoRsbRsRsmbRgbRcRsmbLsRsbsbsbLsbLsbRcbRhbRibLcbLgLsbLsLsmbLsL
smbLsLsmbLsbLsbRjbRibRibsbLsbLsbRsbLsLsmbLsbLsLsmbLsLsmbLsLsLsmmbRhbLs
LsRsmbRsRcLsbRsbLgRsbLsbLsLsmbLsLsLsmmbRjbRiRsmbRsbRgRibLsLsLsmmbLsLsm
bLsLsmbLgLsbLsbLsLsLsmmbsbLsLsLsLsLsLsLsmmmmmmbLsbRjbRcbLsbRcbRsbRsRsR
smmbsbRsbRsLsbRsRsRsRsRsRsRsmmmmmmbRsbRsLsRsLsRsRsRsRsmmmbsbRgbRiLsLsm
bLgLibRibLsbLoRsbRgbLsLsmbLsLiRsbLsbLgLsLeLeLiLsbRsbRgbRibRsRgbRhReRsm
bRgbRgRiRiRsRsmmbRobLiRsLgRsbRsbRgbRiRsmbRhbRobLgLsLsmbLeLgLsbsbLeLiLs
LsLsmmbLsbLebRsbRjbLcbRebLebRibRjRsRsmmbRebRgbLibLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 23; Drug: Control Apo 50 然
bLsbRsbRsbLsRsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 24; Drug: Control Apo 50 然
bRgbRgRsmbRibRsbRhLsbRgRgRgbRgRgRgRsmbRibRgRsRsLsmmbRsRsmbRgRgbRgRsReR
smmbRgbRgbRgbRgRsmbReRsRimbsbsbRgbRsbRgbRhRiRiRiRgRsmbRsRsRsmmbRgbRsbR
gbRsRsmbRhRsRsRhRemmbsbLgbLsLgbLsbLsbLsbLsLsmbRsbLsbLsbLsbLsbLsbLsbLsb
LsbLsLsmbLgLsbLgbLsLsmbLgbRsbLgbLsbLsbLsbLsbLgbLsLsmbLsbRsbLsLsLsLsmmm
bLsbLsbLgbsbLsbLgbLgbLgbLgLsbLsbRsbLsbLsLsmbRsbRsbLsLsmbLsbsbLsLsmbLsb
LsbLsbLsLsLsmmbsbLgbLsLsLsmmbLsbLsbsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 25; Drug: OSU6162 10 然 Apo 50 然
bLjLsLsmmbLhLsbsbLgLsRsbRebRibRebRibRhbRhbRsRsmbsbRsRsmbsbLsRsRsRsRsRs
RsRsRsRsRgRsRsmmmmmmmmmmbRsbsbRsRgbRibRgbRiRsmbLibLcLsLsRsmmbLiLsbRsRj
bRhRsmbRiRsmbRsRsmbRgbRsLsbRebRsLsLsRsLsRsRsRgRsRsRsRsmmmmmmbsbRsbRsRe
bLsRsbLsRsRsLsmbRiRsmbRsbLcbReRsRsmmbRsbsbRsRsRsRsRsRiLsmmmmbRsRsmbRsR
sLsmbRsRsRsRsmmmbRsRsRsmmbRsRsRsRsRsmmmmbRiRsmbLibLcbLhbLsbRsbLsbLgbLs
bRsbLgbLsbLiLsLsmbRsbLsLsLsRsmmbsbLsbLsLsLsmmbLsLsLsLsLsLsLsLgLsLsLsmm
mmmmmmbLibLsRsLsbReRsmbsbRebLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 26; Drug: OSU6162 10 然 Apo 50 然
bsbLsLsRsmbsbsbsbReRsmbRcbRcbRhRsmbRcbRiRcRiLsbLcbLobLebRcRibLsbRgbRgb
RibLeLgbRcbRebRebRcRebRebsbRsRsRsmmbLgbsbRsbLob

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 27; Drug: OSU6162 10 然 Apo 50 然
bLgLsLsLsLsmmmbLsbLgbsbLgbLgbLsLsLsmmbLsLsLsmmbLsLsmbLgLgRsbLsLgLsbLsL
smbLgbLgbLsLsLsmmbLsLsmbLgbLsbLgLgbLgbLgbLsbLsbLsLsmbLgLsLsLsmmbRcbRgb
RgbRgbRibRsRgLsbRsRsmbRsbRsRsmbRibRgbRgbRgbLgRsRsmbLsbLgbRsLsLsmbLsLsm
bLsLsmbLsLsLgLsmbLsLsmbLgLsLsmbLgbLsbLsLsmbLgLsbLgbLgbLsLgbLgbLgbLsLsm
bLgbLsLsLsmmbLgLgbLibLibLgLgbLgbLgbLsRsLsLsmbLibLsbRsbLgbLgbLgbLsLsmbL
sbLsLsmbLgbLsLsmbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 28; Drug: OSU6162 10 然 Apo 50 然
bLsRsRsmbRsbRgRsmbLsRsRsRsRsmmmbRgRsRsRsmmmbLsRsRsmbLsbRgRsLsmbRgbRsbR
sbLebLibLcbLibRcbRiRsmbRoRsmbLibLhbLcbRiRsmbRcRsmbRhbRibRsRsRsRsmmmbRi
RsmbRgRsRsmmbRsbRsbRgRsmbRebRsRsRsRsmmmbRsbRsbRsRsRsRgRgmmbRsRsRsmmbRs
RgRsRsRsRsmmmmbRsbRsbRgRsRgRsmmbRsbRsRsmbRsRsRsmmbLsbRsbRsbRibRgbRcbLi
bLobLibLiRsbLgLsbLibRsLsbsbLsbLgbsbRsbLsbRsRsmbRsbRgRsRsmmbRgRsRsRgRgR
smmmbRgbRsbRsRsmbRibRgRsmbRibLsbRsRsmbRsbRibRjbRsbRibLjbLcbLiRsbLibRgR
smbRcbsbLibRsbRsRgLsbLhbReRsRembRsRsRsmmbRgbRgRsRsmmbRgRsRsRsRsRgmmmmb
RsLsbRebRgbLsbLsbRsbRsRsmbRsRsRsmmbRsbRsbRsRsRgRsmmbRgRsRsRsmmmbLgbRsb
RsbsbRsRiRsmbRgRsmbRgRsRsRsRsmmmmbRsbRsRsmbLsLsmbRsbRgbRsLsbRsRsRgmbRg
bRgRsRsmmbLsRsRsRsRsmmmbRsRsmbRsbRsRgbRgRsRgmbLobRsbLcbLgLsLsLsLsLsmmm
mbRsbLsRsRsmbRsbRsbRsbRgbsbsbRsLsbRsRgbRsRgRsRgmbRgRsRsRsLsmmmbLsRsRsm
bRibRsbRsbRsbRsbRsbRsRsmbLsRsRsRsRsRsRsRsRsRsLsmmmmmmmmbRsRsmbRsRsRsRs
RsRgLsmmmmbLobRebRgRsRsRsmmmbRsRsRsRsmmmbRsbRsRgRgRgRsRsmmbRgbRsLsbRsb
RgRsRsRsRsRsmmmmmbRsRsRgRsRsRsRsRsRsRsRgmmmmmmmmbLsRsbsbLsRsRsRsRsRgRs
RsRimmmmmbRgbRgRsmbRsbRsRiRgbRiRsmbRsbRsbRsbRsRsRsmmbRgRsRsRsRsRimmmmb
RsRgRgbRsbLsbRsbsbRsRgRsRgRsmmbRsbRgRsRsRsRsRsRsRsmmmmmmmbRsRsmbLsbLsR
gbRsbRgbRibRsRsRgRsmmbRsLsbRgbRsbLsbLsbRsRgRsRsmmbRsRgRsRsRsRsRsLsmmmm
mbRgRsRsRsmmmbRsRsmbRgbRsRsRgmbRsbRgRsRgmbRgRsRsRsmmmbRsRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 29; Drug: OSU6162 10 然 Apo 50 然
bRgbRiReRiRiRgRsRiRiRsRgRsmmmbRgbRgbsbRibRiRiReRiRiRiReReReReReReRebRh
bRebReRsLsRhReRsmmbLobLibLhbLibRgbRgRobRebRebReRgRsmbRgbLsbRgbRsbRgbRs
bRsbRsbsbsbsbsbsbRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 30; Drug: OSU6162 10 然 Apo 50 然
bRsbRsbsbRsbRsbRgRsmbRsbRsRsmbRsRsRgmbsbRsbRsRsmbRsRsmbRgRsRsmmbRsRsRs
RsRsmmmmbRsbsbRsbRsRsRgmbRsRsmbRgbRsLsbRsbRsbRgbRsRsRsRsmmmbRsRsmbRsbR
gRgbRsRsRsRsmmmbRgbRsRsmbRsRsmbRsRsRimbRsbRsRgRiLsbRsRsRimbLsbRsRgRsRs
RgmmbRgbLeLsbRsbsbsbLeLsLsLsmmbRcRibRibRsbLsbRibRgbRsbRgRsRsmmbRsRsmbR
sbRsbRgbRsRsRsLsmmbRsRsRsRsmmmbsbRsRebRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 31; Drug: OSU6162 3 然 Apo 50 然
bLsRsRsRsRgmmbRsbRsRsRsRsmmmbRiRgRebRhbRsbLsRsRsRsRsRsmmmmbRsRsRimbRsR
sRsmmbRsLsbRebRcbRsLsLsRsmbLsRsbLeLsLsmbLgLsLsLsmmbLsLgLsLsLsLsmmmbLhb
LsLsmbLgLsLsLiLsLsmmbLiLsbLsLsmbLsLsLsLsLsLsLimmmmmbLhbLgLgbLgbLgLiLsb
LsLsmbLsLsLeLsmbLgLsbLeLsLsLsLsLsLsmmmmmbLeLsbRsbRebRsRsRsmmbRsRsRsRsm
mmbRsRsRsRsmmmbRgRibLebLgLsbLebRgbLsbLgLsLgbsbsbsbsbLgLgLsLsLsLsLsLsLg
LsLsmmmmmmbLiLsbLibRgbRgRsmbRibRsbRsbRgbLsRgRsRsLsmmbRibRsRoRibRgRsRsR
smmmb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 32; Drug: OSU6162 3 然 Apo 50 然
bsbRsLsbRgbRcbLsLsLsLsmmmbRsRsRsmmbRoRsLsmbRcLsLsmbLcLsmbLcbLibLibLcbL
ibLibLibLgLsbLoLibLsbRjbLsLsLeRembLsbReRiRsRsmmbReRobLsLsmbLgbRibLobLo
RsbLobLeLsbLgbLibRjbRsRsRsmmbRsRsRsRsmmmbRsRgLsLsmbRcbRjRsmbRibLsRsbRg
RsRsRsRsRsRsRgmmmmmmbRjbRgRgRsRsmmbRsRsmbRsRsRgRsRsmmmbLsbRsRsRsRsLsRs
RsmmmmbRsRsLsmbRsbRibRcRsmbRjbLcbRebLsbRiRsmbLsRiLsbRjbRobRgbLobRibRoL
sbRgbLebLsLsLsmmbLibLoLsmbLcbLobLobRsRsmbLobLobLibRebRebRibRebRebRhbLs
bLsLsRsmbLgLsLsmbLgLsLsmbLgbRjbRhbLhRsbRsbLcbRsLjbRhRsmbRgbRebLgbRgbRs
RsRgRgRsmmbRiLsbLgbLcbLibLibLobRibRobLoRsbLjbRgbRsbRgbRgRsRsRsmmmbRjbL
gLgbRjbRgbsbRgbRsRsRsRsRsmmmmbRsbRgLsRsRsRsRsLsmmmbRsbRgRsRsRsRsmmmmbL
sbRgRsRsRsRsRsRsRsmmmmmmmbRsRsmbRgbLcbLcbLhbLobLhbLibLebRcbRibRibRiRsR
embRcRsmbLhRsbRgbRibRibLsbRibLcbLcbLcRsRsmbLobRoRsmbRgbRebRgRsRsmmbRoR
smbRebLhbRsRsLsRsLsmbRjbRebRebRebLjbLcbRibRcbLsLgbLcbLcbLobLoLsmbRcRsm
bRhRsmbLibRjRgbRcbRgbLcbLebRiRsmbLcLsmbLjbRibRhbLcbLhLsLsmbLcbLibLgbLi
LsbLiRsLsbLgbLcbRcbRibRgbRsRsRsRsmmmbRsbRsRsRsRsRsmmmmbRsbRsRsmbRsRsRs
RsRsRsRgRsLsmmmmmmbRsbRsRsRsRsmmmbRsRsRsRgmmbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 33; Drug: OSU6162 3 然 Apo 50 然
bLibLgLgLsbLsLsmbRsLsLsLsLsLsLsLgLsLsLsLsLgLsLsLemmmmmmmmmbLgbLsLsLsLs
LsLsmmmmmbLsLgLsbLeLsbLebLobReRsRsmmbRibLsbsbsbLgbLeLsLsmbLibRgRsmbRsb
RsRiLsbRgRsRsRsmmmbRiLsbLjbLiLsLsmbLgbLgbLsbLsbLsbLgLsbRgbLgLsLsmbLsLs
LsLsmmmbLgRsbLgLsRsbLgbLsbLgbLgLsbLgbLebLsLsmbLiRsRsRsLgmmbLgbRgbLgRsL
sbLiLsbRsRsmbRsbRibLgbLgLebLgbLibRsLsbRjbLcbLsbLsLsLsLsLsLsLsmmmmmmbLs
LsmbLgLsLgbLgbLsbLgRsLsRsRsmbRsbLcbRiRsmbLibLibLibLibLgbLiLsLsmbLgbLgb
LsLsLgmbRsLsbLsLsLsmmbLebLsLsmbLsbRsbRcbLsLsLsLsmmmbLsLsmbRibRsRsRsRsR
sLsmmmmbRsbRsbLgLsLsmbLgbRsLsbLgbLsLsLsmmbLsbsbLgLgLsbLsLsLsmmbLebLgbL
sLsmbLsbRsbLsLsmbRsbLsbLgbRgbLgLgLsLgbLsLsLsLsLimmmbLsLsLsLsLsmmmmbLgL
sLsLsmmbLeLhLsbLib

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 34; Drug: OSU6162 3 然 Apo 50 然
bRsRgRsRsRgRsRsRgRsRsRsRsRsRsRsmmmmmmmmmmmbRiRsLsRsmbRsbRgRsRsRsRsRgRg
RgmmmmbRsRsLsRsRsLsRsmmbRcbLhLsbLebRcRsRsmmbRhbRiRsLsLsmmbLsbRsRsmbRsR
smbRibLcbLebLiLsbRebLcbRjbRhbRsRsmbRcbLjbRebRibRcbRebLibLcLgbRgRsmbLgb
RibRgbRgbRhLgbRgbRgRsmbRgRsRgRsRgRsRsRsmmmmmbRsbRsbRiRsmbLjbRcbLibRiRe
LsbRiRsmbLibLiRsbLcbLebLcbRgbRcbRsbRhbRibRcRsmbRobLcbRibRobRcbRcbRibRi
bRibRibRibLiLsbLsbLeLsLsLsLsLsLsLsRsLsLsLsLsRsmmmmmmmmmbRibRibLsbLsLsm
bLobLibLibRebRgRebRcbLgbLibLiLsbLcbRgbRibRsRsRsmmbLsRgbRgbRgbRibLgbLeb
LcbLcbRebRoRsmbLsbLsbLebLeRsbLcbLobRcbRcbRibRibRibRgbRgRsmbLsLsmbRhbRi
bRsRgbRgbRhRsmbRibLhbRsbRibLgbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 35; Drug: OSU6162 3 然 Apo 50 然
bRoRsmbRibLobLhLeLiLgbLiLsbLiLebLeLsLsmbLgbLsbRgbRsLsbsbRjbRibRhRsmbRh
bRiReRhReLsbRiRebsbReRsmbLsRsRsmbRibLgbRhRsmbRibRcbLsbRiLsbRgRsmbRgLsb
RsbRiRsmbsbRgbRgRsmbLjbRhbRcRsmbRhbRiRcbRibsbRibRibRebLeLsbLgbLobRgRsm
bLobLgbLibRgbLcLsmbLcbLsbLgLsbLgLsbLsLsLsmmbLebRcbRiRsmbRsRsmbRsbRibRe
bLgLsLcbLibsbLsbRsbRibRcbRsRsmbRgbRiRsRsRimmbRjbLsLsmbLebLgLsbRsbsbLsL
smbLibLsbLsbLsbLsLsLsLsLsLsLsLsLsmmmmmmmmbLsLsLsmmbLiLsbLobLoLsmbLibLi
RsbLcLsmbLcbLebLibLibLibLgLsbLgbLgbLsLoLsRsmbRcRsmbRhbRiRsRhRiRhmbRgRs
mbRebReRcRsmbRgbRgbRebLcbRsLsbLsLsLsRsmmbRsbRsbLsRsbRsRsRsRsmmmbRsbsbL
sbRsRsmbRsRsRsRsRsRsRgmmmmmbRsRsmbRsRsmbRsRsRsRsRsRsRsRsRsmmmmmmmmbRsR
sRsmmbRibRsbRgbRcbRebRcbRibRiRsmbRgRsmbReRsmbRjbRcReLsbRibRcRhbLcLsmbR
ibLiLsbLoLsmbRoRsmbReRsmbReReRsmbReRsmbRsRsRsRsRsRgmmmmbRsRsmbRsRsRgmb
LsRsRsLsmbRsRsmbsbLsRsbRsRsRsRgRgmmbRsRsRgRgRsRiRsmmmbRcbRhbRhbRiLsbRs
bRsbRsRsLsmbRsRsRsRsmmmbLsRsbRsbRsbRgbRsRsmbRsRsmbRcbRsbLsbLsbRsbRsbRs
RsmbRsbRiRgbRgbsbRsRsRgmbRgbRibRibRhRiRsmbRebRhbRsLsbsbsbRsRgLsbRsbLcb
Lib

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 36; Drug: OSU6162 3 然 Apo 50 然
bLsbLjLsmbLcRsbLobLcbLcbLiLsbLoRsbRcbRibRjbRsRsRgRsRsmmmbRsRsRsRsmmmbR
cbRsRsmbsbsbRsRsRsRsRsRsmmmmmbRsRsmbRebLhLsbLsbLebRcRsmbRibsbRsRsRsRiR
sRsmmmmbRsRsRsRsRsRiRiRsRsRsReRgRsmmmmmmmmbReRsRsmmbRsRsRsRsRsRsRsmmmm
mmbRgRsmbRsRsRsRsRsRsRsRsRsRsRsRsRsRgRsmmmmmmmmmmmmmbRsRsRsmmbRsRsRsmm
bRsLsbLsRsRsRsRsRsRsRsmmmmmmbRsbRsRsRsmmbRsbRsRsRsRsRsmmmmbRsbRsRsRsmm
bRsbRsbRsRsRsmmbRsRsRsRsRsRsRsmmmmmmbRsbRsRsRgRsRsRgRsmmmmbLsRsRsmbsbR
sRsmbRsbsbRiRsRgRsRsRsmmmmbRsRsRsRsRsRsRsRsRsmmmmmmmmbRsRsRgRsRsRsmmmm
bRsRsRsRsRsRgRsRgmmmmmbRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmbRsbRsRsRsRsRsR
sRsRsRsRsRsmmmmmmmmmmbsbLsLsmbLcbLgLsLsLsmmbLgbRsbLeLsbRgRsmbRhRsmbRgR
smbLgbLsRsbsbLibRsbsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 37; Drug: OSU6162 1 然 Apo 50 然
bLsbRhbRhbRcbRcRiLsRsbRsRoLsbRcRsmbRibRibRsbRcRsmbRsbRobRgReRiRiLsbRhR
sRgmbRgbRsbRgbRgbRsRgRsLsmbRsRsmbRibLgLsLgbLgbLgbLcRsbLibRsbLsbLgRsbLs
RsbRjbRgbRjbLsbRgLsbLcLsmbLiLibLiLhbLsbLgLsbLiRsbLgbLibLeLsbLiLsbLgLsb
LebLiRsbLiLgLsbLebRhbRebLsRsbRibRsRsLsmbRsRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 38; Drug: OSU6162 1 然 Apo 50 然
bsbsbLibRsLsbRgbRgbLoRsbRsRsmbRgbLobLsbLsbLcbLsbRsbsbLsbLcbLoRsbRgbRiR
smbRgbRibLgbRobRhbRsbRoLgbLgbLcbLgbLhLsbLgbRsbLsLsmbLsbLgRsbRsbLsbLsbL
obLsbRiRsmbRcbRsbRibRibsbRsbRgbRgbRgbRibLsbLsbRiLsbsbLsbLjbRibLoLsmbLs
bRsbRsRsmbLgbLhbRsbRgbRobRgbRibRiLsbRibLsbLoLsmbLiLsbLiLsbLsRsLsbLcbLi
bLebLebLiLeLgbLsLsmbLcbRsRsmbRsLsLsmbLjbRibLcLsmbLsbLcbLibRebRcbLhbLeb
LgbsbsbsbRgbLsbLobsbLibLsbRsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 39; Drug: OSU6162 1 然 Apo 50 然
bRjbRcbRobRobsbRobRcbRibRsbRibRgbRibLjbLhbLiLsbLsbsbsbRjRsmbRibsbRobsb
RiLsLsmbLgLsbRcbRiRgRgRgRebsbsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 40; Drug: OSU6162 1 然 Apo 50 然
bLsLsmbLsbLsbLsLsLsmmbLsbLsLsLsmmbLsLsmbLsLsmbLsLsLsmmbLsbLsbLsLsmbLsb
LsLsLsmmbLgbsbLsbLsLsmbLsLsmbRsLsbRsRsRsmmbsbLsbLsbLsbLgLsbLgLsLsLsmmb
LiLsLsmbLsLgLsbLgbLgLsbLgbLiLibLsbLsbRsbLsbLiLgbLgLsLsLsmmbLgLsLsLsmmb
LsLsmbLgbLsLsmbsbLsLsmbLgbLgbLgbLsbLsbLgbLgbLsbLgbLsbLgbLsLgLsLsLsLsLs
LsLsmmmmmmbLsRsbLgbLsRsbLgbLgbLibLgbLsLsLsmmbLsLsLsmmbLhLsLsmbLsbLsbLg
bRsbLgbLgbLsbLsbLsbLgbLgbLsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 41; Drug: OSU6162 1 然 Apo 50 然
bLsRsbRsLsRsRsmbRsbLsRsRsRsmmbLsbRsbRsbRsbLsbLsbLsbLsbRsLsbRsLsbsbLsbR
sbLsbsbsbLsRsLsbLsbLsbLsLsRsRsmmbLsLsmbLsLsmbRsbRsRsLsmbRsbsbLsRsLsRsb
LsbRsbLsRsRsmbLsbLsbLsbLsLsmbLsRsLsbLsLsLsLsmmmbLsbRsbRsLsbRsbRsbRsRsL
smbRsbRsbRsLsbRsRsRsLsLsmmmbLsRsLsRsbLsLsmbLsbLsRsbLsbLsbRsLsbLsbRsLsb
LsbLsLsmbLsbRsbRsbRsbLsbRsbRsRsRsmmbLsbLsbRsbLsbRsbRsLsLsmbRsbRsbRsbRs
bRsbRsbLsbRsbRsbLsbRsbLsbRsRsmbRsbRsbRsRsmbRsbLsbRsbLsbLsbLsbRsbRsbRsR
smbRsbRsbsbLsbLsbsbRsLsbRsRsmbRsbLsbLsRsbRsLsbLsbRsbRsbRsRsLsmbLsbRsLs
bRsRsmbLsbLsbLsbLsbLsbRsbLsbLsbLsbRsbLsbLsRsbRsRsmbRoRsLsRsRsLsRsRsLsR
eLsLommmbRobRiLsRsLsRebRobLcbLsbRsbLsRsRsmbRsbLobRobLebLobRsbRsRsLsRem
bLebRoLsbLibLjbRobRsbLsbLobLsbLebLobRoLsbLsbRebRobRobLeLebLsbReLebLcbL
cbRobRebLsbRobRebLobLobLsbLobRobLobLebLobLsbLsbRobRebRebRobLobRebRobRo
bRibRobLobRobRobRsbLsbLobLebLobRcbLobRobRcbLsbLcbRsbRebLjbLobLsbRobRib
LsbRebLebLgbLsbRcbRibRobLobRebRobLgbLcbLhbRcbLebLsbRebRobRcbLcbLobLebL
cbRobLibRsbRobLebLcbLebRcbLcbLobLobLobLobRobRcbLobRibRibRcbLobRcbLebLg
bLebRgbLcbRgbRgbRebRibRebRobRcbRebRcbLobRjbRebLcbRobLobLcbRobRcbRgbLcb
RgbLobLcbLobLobRobRcbLgbLobRobRobRobLebRcbLebRsbLsbLobLobLcbRobRcbLcbR
obLebRebLebLobRibRobRobRebLcbLcbLcbRebRobLibLobLobRsbLobLebLgbLobLobRo
bLibLebRobLebRebLebRobRobRgbRcbRibLcbRobRgbLgbLebRgbRobRcbLhbLobRebLcb
LobLcbLgbRobLobLobRobLcbLebLobLobRibLcbRobLobRcbRobRobRcbLebLobRebRibL
obLcbLibLgbRobRhbLobLobLebLobRcbRgbLobRobLobLobRobRobLobRobRobRcbLobLe
bLobRobLcbRibRebRobLcbLebLebLebLcbLobLebLebLebLobLebLibRobLhbRobRgbRob
LobLobRgbLobRcbLobRobRobRobLebLsbLobRobLibLobLcbLgbRobRibLobRcbRcbLobR
hbRobRibRcbLcbRcbRobLobLobRgbLcbRobRobLgbLgbLebLobRobLebRcbRcbRebRgbRe
bRebLgbLobLobLebLgbRebLobRebLobLobRobRebLibRhbLobRebLcbLcbRebLgbLobLob
LcbLcbLibLcbRobRgbRcbLcbRhbLebLibRobLcbRobLebRebRobLebRobRgbLebLobLobL
obLibRgbRobLobLgbLebLebLebLobRibRobRobLobLebRobRebRobRebLebRobLobLebLc
bRibRobLobLebLobLcbLcbRobLobRobRobRgbRobRobLcbLobLibRcbLcbLobRebRibLib
LebLcbRobRobRobLobRobLobLcbRebLibRobLebLobRcbRobLhbLebLebRebRsbRcbLebR
obRobRgbRibLsbLobRobRebLobLebRobLcbLebRsbRibRibRgbLebLobRebRibRibRobLc
bRobLobLobRobLobRobLsbRebRobRobLebLobRobLobLebRcbLcbRcbRibRobLgbRobRgb
RibRebLhbRebRgbLebLgbLobLsbRobRcbRgbLibRhbRobRcbRobLgbRgbRobRebRibLcbR
cbRobRobRibLebRobLobRgbLcbLobLcbRobRgbLobRcbRhbLibLcbRobRcbLsbLobRobLc
bLobLebRobLebLobLebLobRcbLgbLobRibRebLobLebRobRobLobRebLcbRobRhbLebRob
RobLebRibLobRebLebLcbRsbRcbLcbLebLobLobLibRobLgbRobLebRebRobRebLjbRsbL
cbLebLebRebLobRobRobRebLobLobRobRhbLobLobRcbRebLjbLobLobRobLcbLebRobLo
bRcbLobLebLgbLobLibLobLobLobRobRobLibRgbLobRsbRobRibRcbRobRebLobLobLob
LobRobRhbLibLobRcbRobLobRsbRobLcbLcbRcbLobLgbLebRhbRibRcbRebLgbRcbLcbR
obLobLcbLobLebLcbRebRebRgbRobLibRebLcbRsbRgbRebRobRobLebLhbLobLobRebLo
bRibLobLobLhbRobLobRibRobRobLibLobRobRebLcbLgbRibRobRsbLcbRgbLobRobLhb
RobLcbLibLobLcbLcbRobLebLibLobLebRobLobLobLobRsbRobLobRobLsbRebLibRcbL
obLobLobRobRobLibRebRobRcbRgbRobRobLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 42; Drug: OSU6162 1 然 Apo 50 然
bLgbLsbLgbLsbLsLsmbsbLgbLgbLsbRsLsbLgLgbLsbLgbLgbLsLgbLgLsbLsLsmbLsbLg
bLgbLsbLsbLgbLgbLgLsbLgbLsbLsbLgbLsbLgbLgbLgLsbLsbLsbLsbLsbLgbLgbLsbLg
bLsbLsbLsLsmbLgbLgbLgbLsbLgbLsbLsLsmbLsbLsbLsbLsbLsbLsbLgbLgbLgbLsbLgb
LsbLsbLgbLgbLgbLsbLsbLgbLgbLgbLsbLsbLsbLsbLsLsmbLsbLsbLsbLsbLgbLsbLsbL
gbLgbLgbLgbLgbLsbLsbLsbLgbLgbLsbLsbLsbLgbLgbLgbLsbLsbLsbRsbLgbLsbLsbLs
bLsbLsbLsbLsbRsbLsbLsbLsbLsbLsbLsLsmbLsbLsbLsbLsbLsLsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 43; Drug: Control Apo 50 然
bRcRsRsmmbRcRsmbRsbRcbLgbLcLsmbLibLiLsbLsLsmbLiLsbLibLgRsbRcbRiRsmbRib
RgbRcLsbRgbRcbRibLgbReRsmbRgRsRsRsRimmmbRgbRgbLsLsLsmmbRcbRebRebRobLgb
LjbLebLcRsLsLibLhLsbLibLibLgLiLsLhbLibLgLsbLhLsbLhbLhRsbLgbLeRsbLgbLiL
sbLibLiRsbRhbLsbLibLibRsRsRiRsmmbRgRsRsRsmmmbLjbLibLsbLjLsmbLcLsmbLgLs
bLibLiLsbLiLibLebLgbLiLsbLiRsbLibLeLsbRibLcRsbRhbRibReRgbRibRobRhbRcbR
iRsmbRcbRibRibRgbRebRgRsmbRibRibRcbReRsmbLsbLcbLhbLcbLhbLibLgLsbsbLebL
sbLibLgLsbLibLgLsbRobRebRgRgbRibRcbRebRebRibRgbRhbRiRsRsmmbRgbRcRsRsmm
bLcbLcbLiLibLiLsbLibLhbLibRebLiLsbLcRsbLgLjLebLibLgbRsbRiRsmbRhbRcRsmb
RcRsRsmmbRiRsmbRibRcbRiRsmbLsLsLsmmbLcbLhRsbLiLsLibRobRgbRiLsbRiRsmbRg
RgbLsRsbRsRsmbRiLsRsbLsLiLsLsmbLiLsLsLsLsmmmbLhRsbLhbLgLsLsLsLsLsLcmmm
mbRibRcbRiLsRsbRhRgRsmbRibRcRsmbsbRibRiRsmbRibRhbRhbRebRebRebRiRsLsmbR
iLsRsbRiLsbRcbRsRsRsmmbRcbLsbRebLgRsbLhRsbLhbLibLsLsLsLsLsmmmmbLcLsmbL
eLgbLhLsLsLgLsLsmmbLibLiLsRsLsbLcLsmbLgbRgRsLsmbLsLsmbLgLsLsLsLsLsLsmm
mmmbRsLsLgLsLsLsLsLsLsmmmmmbLsbLsLsLsLsLsLsLsLsLsLsLsLiLsmmmmmmmmmmbLs
LsLsLsLsLsLsLsLsmmmmmmmmbLsLgLsbLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLgmmmm
mmmmmmmmmmmbsbLgbRjbRhRsRsmmbRsRebRebLebRsRsRsmmbRgRsRsRsRsRsRgRsRsRsR
sRsRsRsmmmmmmmmmmmmbRsRsRgmbRsRgRsRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmmmbR
gRsRsRsRsmmmmbRsRsRsRsRsmmmmbRsLsbRsRsRsRsmmmbRgbLcbLibLsbLsbRjRjbRcbL
cbLhLsLsmbRhbRebRiRsRsRsRsRsRsRgRsRsRsRsRsmmmmmmmmmmmbRsbRsRsRsRsRsRsR
sRsRsRsRsRsRsRsRsmmmmmmmmmmmmmmbRsRsRgRsRsRsRgRsRsRsRsmmmmmmmmbRsRsRsm
mbRsRsRiRsRsRgmmmbRgRsRsmmbRcRsmbLsLsLsLsmmmbLsbLsLsmbLsLsLsRsLsLsLsLs
mmmmmbLiLsbRcbReRsmbRebRsRcRsmbReRsRsmmbRgbRhRebRsbLcbLcbLhbLiLebLhLsL
smbLeLsbLhLsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 44; Drug: Control Apo 50 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 45; Drug: Control Apo 50 然
bLsbLgbLgbRibLgbRiLsbRsbRsbLjbLiLsbsbLsLsmbLsbLsLsmbsbLsLsLsmmbRsRsmbR
gbRoRsmbRibRibsbLgbsbsbRsLsRsRsmbLgRsbRsbRgbLjbsbLsLgbRsbLiRsRsmbRsbLs
LgbLgLsLsmbLsLsmbLgRgbLiRsbLsLsmbLsbLgbRsLsRsbLsLsLsmmbsbLsbLsLsLsLsmm
mbLsLsmbLsLsmbLsLsLsmmbLgbLgbLsRsbLsbRsRsmbRsbLgbLgbRsbsbsbLsbsbRsbLsb
RsbRsbLsbLsLsLsmmbLsbLsLsmbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 46; Drug: Control Apo 50 然
bRhbLsRsRibRiRsLsLeLembLebLgbLiLsbLgRsbLgbLsbLsbLiLebLgLsbLebLgbRhbRsR
ibRibLcbLibLibRebLsbRgbLjbLgbLibLibLgbRsRsmbLiLsbReRebRsbRsbRsRsmbLgbR
gRsRsRsRsRsRsmmmmmmbRgLsbLgbRsRsLsmbRebRibLiLsbLcbLibLeLsbLgbLebLebLsL
smbLgLsLsmbsbLsLsmbLsLsmbLgbLgbLgbLeLgbLgbRjbRoLsbRobRiRebLjbLcLsmbRjb
RgReRebRsbLsRgRgReRsmbRsbRibRsRsRsmmbRsbRsLsbRsRgRsRsRsRgmmmbRgbLsbLjb
LobsbRsLsRsbLeLsLsLembLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 47; Drug: Control Apo 50 然
bRcbLgbLjLsmbsbRobsbsbLsbRsbRcbRobRsRjbsbRoLsbLcbLcbLcbLibLsLibLeLcLeb
LiRsLsbRibLcbRsbLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmbLsLsLsmmbLgLsLsLgLsLs
LsLsmmmmbLsLsmbLsbLgbLsbLsbLsbLsbsbLsLsLsmmbRoRsmbRoRsmbLsbLgbLoLsmbLi
bLibLeLsLiLibLibReRsmbRiLsbRcRsmbRsbRcbRsRsmbRcRsmbRcbRjbLjbLobLsbLobL
ibRibRsbsbRsRsmbRgRsRsRgRsRsRsRsRsRsRsRsRsRsLsRsRsRsmmmmmmmmmmmmmmbRsR
smbRsRsRsRsRsRsRsRsmmmmmmmbRsRsRsRgLsmmbRsbRsRsRsRsRsRsRsRsRsRsRsRsRsR
sRsRsmmmmmmmmmmmmmmmbRsbRsbRsRgbRsRsmbsbsbRsbRsbRsRsRsmmbRsRsmbRsbsbRs
RsmbLobLsLsLsLsmmmbLgbLibLsbLsbLobLcLsLcRsmbLiLsbLcbLhLiLsbLgbReRsRsRi
RemmbRobRebRebLobRcLgbRibRcbRibsbRsLsLsmbRcbLjLsmbRibRcbRjbLcLsmbLhbLh
bLibLhLsbLcbLiLsbRgbLobLebsbLsLsLsLsLgRgmmmbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 162322; End: 162822;
Recording: 6-1; Individual: 48; Drug: Control Apo 50 然
bRibRgLsbRsbRebLsLsmbLebRsRsRsRsmmmbLsbRibRgbRgbRsRsmbRcbRgbLsRgRsRsRg
mmbRibLsbLebRgbLhbLsLsmbRsbLgbRibLjbLsbLcLsmbRibLsbLgLgLsLsmbLgbsbsbsb
LsLsmbLsbLsbLsLsmbLsbLgbLibRgbLebRsRsRsRsmmmbLibLsLsmbLiLsbLgLiLgbLsbL
ibLibRiRsmbLhLsbLebRebRgbLsbRgbRgbRebRobsb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 1; Drug: OSU6162 10 然 Apo 50 然
bRgRgRiRgbRgRsmbRsbRsRsRsRsRsRgmmmmbRsbRsRgbRgRsmbRgbRsbRsbLsRsbRsbRgb
RsbRgRsmbRsbRgbRgbRsbRsRgRsmbLsbRgRsmbRsbLsbRsRsmbRsbRsbRsbRsbRgbRsbRg
bRsbRsbRsbRgbLoLsmbLsbLebLgbLgbLsbLsbRsbLsbRgbRsbRjbLeb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 2; Drug: OSU6162 10 然 Apo 50 然
bRibLobLobLhbLebRjbLobLsbRiLsbLcbLhbLiLgbRibRiRsRimbRoLsLgLsbLgLsbLiLi
LhLeLsLgbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 3; Drug: OSU6162 10 然 Apo 50 然
bsbLjLiLhRgbRgbRiLsRsbLobLcbLgLsbLjbLsbLsbsbRsbLobLsbRgbLsbsbsbsbLjLsm
bRjRiRsmbRibRibLjLsmbRsRiRjbRibLcLsLsmmbLsbLhbLibLgLsLibLibLcLsLsLsmmm
bLcLsmbLoLsLsmmbRsbRsbRebRcbLsbLsbRiRsmbLobRcLsbRgbRgbRsbLgLgbRibRsbRg
bRobRjbLiLgbLiLsbLsLsLsLsmmmbLsRsbLcbRgbRhRsmbRcbRhbLsLsmbLjLsLsmmbLcb
LoLsmbsbRgbRiRsmbLobRhRsmbRjRsmbRoLsbLsLsmbLsLsmbLgbLjbLgbLcbLsLgbLcbL
gRsbsbLobLcbLsbRcRsLsmbRcbRiRsmbRhbRsbRibLsRibRoRsLsmbLgbLcbLgRsbRsRsm
bLoLsRgRsmmbLibLeLsbLcLsmbLcRsbLcRgLsbRsbLjbLhLsbLiLsbRibLjLsLsmmbLcRs
bRsRsmbRsbLjLobsbLjLsmbLgLgbLgbLoLsmbLiLsbRebRsRsmbLcbLiRsbLsbLebLoLsm
bLiLsbRsbLcRsLsLsmbLsbLsLsRsmbLibLsLsmbLsRsbRjRsRsmmbsbLcLsmbLgbLgLsRs
bRgbRcbRhbRcLsRsbLgLebLgbLsLsLsmmbLsLgbLgLsLsLsLsmmmbLgbLhbLgbLgLsbLiL
gbLcRsRsmbLgRsbLibLcbLjbRgRsRsLgLsmmbsbRsbLibLcbLgbRhbLsbsbLibLsRibLiL
cbLsbLsbLsbLsbLsLsLsLsLsmmmmbLibLjbLcbLiLsbLjbRsRsmbLeLcLsLsLimmbLgLsb
LgbLgbLhbRsbLiLgbLcbLcbLsbLeLsLsLiLsmbLgbRgRsmbLgbRgbRsRsmbRsbRiRsmbsb
LjLsLsmmbLsLsLsmmbRebRjRsmbLsbLsLsmbsbLsbLobLcbsbLcbRjRsmbLjLsLsmmbLib
RsLsbRsLsLsmbLsLsLsmmbLcLsLsmmbLgbLsbReRgbRibRhbLeLsLiRsbRsbRjbRjbLsbR
sbRiLsbLsRsRsmbRsLebRobLjbLhLsbLsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 4; Drug: OSU6162 10 然 Apo 50 然
bRiRsmbRsbRsRsRsmmbRgRsRsRgmmbLsRgbRgRsRsmmbRebRgRsmbRibRsRgbRgRsmbLgb
LibLcbLibLgbLsbLsLibLsbRcbLobRgbRsbRsbRgbReLsbRebLibLcbLebLcbRoLsLsmbR
ebRjbRgbReRsmbLsbRsbLibLgbRjbRsbRsbLebLsbLcbLgbRgbRsbRsbRsbRsbRsbLcbLc
bLebLsbLsbLsbRsbLobLibLsbRsbsbsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 5; Drug: OSU6162 10 然 Apo 50 然
bLsbLsbRsbLgLebLebLsbLsLsLsmmbLsbLgLsbLobLibLiLgbLsLsLsmmbLgbLsbLsLsLs
mmbLsLsLsmmbLsLsLsLsLgLsmmmbLgRsbLgbLgLsLsLsLemmbLsLgLsLsmbLsLsLsLsLsL
sLsLsmmmmmmmbLgbLsLsmbLgLsbLsLsLsmmbLsLsRsmbLgLgLsLsLimbLgbLgbLsLsLsLs
LsmmmmbLsLsLgLsLsmmbLsLsmbLsLsLsLsLsLsLgmmmmmbLgbLgLsbLsLsLgLsLgLsmbLs
LsLsLsLsLsLsLsLimmmmmmmbLsLsLsLsLsLsLgLsLsmmmmmmbLsbLsLsLsLsLsLsLsmmmm
mmbLsLsLsLsmmmbLsLsmbLibLibLibLgLsbLgLsbRsLsbLsbLsbLsRsbLsbLgLsLsLsLsL
smmmmbRobRcbReRsmbLjbLebLebLeLobRgbLeLsbLsbLsbLiLsbLsLsLsmmbLsLsmbsbLs
LsmbLsLsLsLsLgLgmmmbLebLsLsLsLsLsLsLsLsmmmmmmmbLsbLgRsbLsLsmbLsbRsLsLs
LsLsLsLsLsLsLsLgLsmmmmmmmmbLsLgbRebRebRcbRjbRsbRobReRsmbReRsmbRebLjLsm
bLebRjbRgRsmbRebRebRsbLoRsbRebLibLgbRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmbR
sRsRsRimmbRsRsRsmmbRsRsRsRsRsRsRsRsRsRsRgmmmmmmmmmbRsRsRsRsRsRsRsmmmmm
mbRsRsRsRsRsRsRgRgRsmmmmmmbRsRsRiRsmmbRsRsRsRsRsRgmmmmbRsRsRsLsmmbRsRs
RsRsRsRsRsRgmmmmmmbRsRsRsRsRsRiRsRgmmmmmbRsRsRsRgmmbRgRsRimbRsRsRsRsRs
RsRgRsmmmmmmbRsRsRsRsRsRsRgRsmmmmmmbRsRgRgRgLsbRsRsRgRgRiRsmmbRsRsRsmm
bRsRgRsRsRsRsRsmmmmmbRsRsRsRsRsRsRsRsRsRgRsRsRsRsRsRsRsRgmmmmmmmmmmmmm
mmbRsRsRgRiRgmbRgRsRsRsRsRsRgRsRsRsmmmmmmmmbRgRsRsRsmmmbRebsbRcbRhbRgR
smbRcLebLcbRobLgbReRsmbRgbRhLsbLobLcbRjbLibLcbLebLoLsmbRiRsmbRcbReLsbR
obReLsbRgbRcbRobRhbRgbRsRgbRcbRjRibLebLibLgbLgbRsLsLsLsmmbRsbLsLsLsLsL
sLsLiLgmmmmmbLcRsbRiRsmbRsRsmbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 6; Drug: OSU6162 10 然 Apo 50 然
bLsbLgLsbLgLsLiLsLebRobRsbRgbRsLsbsbsbsbsbsbsbsbsbLsRsRsRsmmbRsRsRsRsm
mmbRsRsRsRsRsmmmmbLsLsRsRsmmbRsbRhRsmbLoRsbRcLsbLsbLcbLoLsmbLobRgRhbRi
bRcRsmbRibRjRsLsmbRebLcbLibLibLibLhbReRiLsbRibRibRiRsmbRiLgbLiLsbLgLsb
LsbRsLsLsmbsbsbsbRsbLsLsmbLsLsmbLsLsLsLsLsLsLhLgmmmmmbLsLsLsLgLgmmbLgL
sLsLsmmbLsLsLgLsLsLsmmmbRcRsmbLeLsbLcbLeLsbLiLsbLhRgbRibRsRsmbRsbsbsbR
sbLsbRsbRsbRsLsbRsbRsRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 7; Drug: OSU6162 3 然 Apo 50 然
bLobRsRgbRsRsmbRibsbRsbRiLsbLgbRhbRibRsbLsRsbRgRsmbRsbLsRsbLcbLibLhLsb
LsbLiLsbLobLsLsLsmmbRgbRgbLsLsmbLsbLgbLgbLsLsmbLgLsbLgbLhLsLsLsLgmmbRc
LsbRoRsmbRiRhRsRsmmbRcbRgbRgbRsbRgbRibLibRiRgbRgRsmbRgbLgbLjbsbLcbRoLs
bLgbLiLgbLgbLsbLibRjbLgRsbLgbLsRsbLgbLibRhbRibRgbLsRibRibRgRsmbRsbRgbL
jbLibRcRsmbLsbRebReRsmbRsbRgRsmbRgbRgbRgbRsbReRsRsRhmmbRibRiRsmbRgbRcb
LibLjbLcbLgbLgRsbLgbRsbLiLsbLgRsbRjbRibLibRibLjRsbLibRibLibRsbReRsmbLs
bsbRgbLsRsbRgbRsbRgbRgLsbRgbRiRgbRgbRgRsmbRibLgbRsbLcbLgLsbLhbLsbLibLg
bLgbRsbLibLsbLsRsbLibRebRcRsmbRgRsmbRsbRebReLsbRcbLjbRobLjbRibRsLsbRgL
sbRgbRgRsRembLsbRsLibLgRsbRjbRhbLgRgbRebLjbRsbRcbRgbRgbRgbRebRsRgLsbRs
bRsRebRsbRgbRgbRiRgbRsbRsbLjbLjLjLsmbLcRsbRjbRgRgRgRgRiRebReRiRsmbReRg
bReRsmbRiRhRgRebRsbRgRsmbRgLsbLjbRsbRibRgbRgbRhbLibLibRjRsmbLobLibRsbR
gbRsbRgbLgbReRsRsmmbReRebLjbRibRibRgRsmbRgbLsbRsRsmbRibRgRsRiRsmmbRsRg
RsReReReRsRsmmmbRebLibLeb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 8; Drug: OSU6162 3 然 Apo 50 然
bLgbLsbLsLsmbLsbLibLsbLsbRsbLsbRsbLsbLgbLsbLsbLgbLsbLsbLsbLsbLsbLgbLgb
LgbLsLgbLibLsbLsLsmbLsbRsbLobRobLsbsbRsbLsbRsbRgLsbLsbRibRsbLsbLsbLobR
cRsmbRsbsbRcbRobRjbRobLcLsmbLsLgLsbLsbLgLsbLsbLgRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 9; Drug: OSU6162 3 然 Apo 50 然
bLsbRsbRsbLsbLsbLjbLsbRsbLsbLsbRsbRsRsRsmmbRiReLgbLobLsbLsbLsbRhbRobLg
bLsbLsbLsbLoLebRsRsmbLiLsLsmbLiRsbLgbsbLibLsRsbLgRsbLgLsLgLgbLgRsbLsbL
gbRsbLsRsbLsbRsbLsbLsbRsbLsbRsRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 10; Drug: OSU6162 3 然 Apo 50 然
bLjLsmbRgbRebRhbLsRsbRcbRiLgLsbRsRhLsRiRsRsmmbLgbLhbLcbLibLcbRsbLjLiLc
LsmbReRhRsRgReRsRgmmbLgbRiRsmbLcbLiLhLsLsmbLsbLiRsbRebRiLsbLcLhLsLiLsL
sLsLiLiLiRsLsmmbLcLgLcLsLimbLiLebRobLsLsLsRsLsLsmmmbLsLsLsLgmmbLgLsbLs
LsmbRebRiRsmbRcLsReReReRiRebRsLsbLobLcRsbLsLibRhbRiRsRsRsLsmmmbLsbLjbL
ebRjbRcbRcbRibLiLgLsbLsbLgbLsRsbLibRibLhbRcbRibRcLebLibRsLsbRhbRibRibR
jRsRsmmbLcbLcbLibLgbLiLiLiLiLsLsmbLiRgbRhbRoRcRiRsRembRsRiRiRibLgbLoRs
bLobLsRsbLcbRibLobLsbLcbLobRgbRiLsLgbLjbLgbRebsbRsbRsRsmbRsbRsbRsbsbsb
LsbRjbRebLgRsbRebRcbRibRsRsmbRebLsRsbRcRsmbRiLsbLjbLsbLebLibLhbLcbLgbR
gLibLgRsbLibLhbLgbLebLgbLcRsbRibLsbsbLsbLsbLgbRsLsRibLibLiRsbLibsbRsLs
bLgbLjbRobRebRcLsRgbRibRebRoRebRibLhbRoRibRoRsLsmbLgbRiRsmbRgbRcbRcbRc
bRhbRibRibRjRcRsmbRibRiRsmbRcLgbLgbLcbLsRsbLiRsbLiLiLsLiLibLibLiLebLsL
hRsbLobLobLibLjbLibLhLsbRsLsbLsLgRsbLgbLgbLsbLcbLcbRibRcbRsLsbRsRsmbLi
RsbRgRgbRgbRsRsLsmbRibLgLsbLcLobLibLibLgbLsbLibLiRsbLiRibLsRsbRjbLjbRi
bLibLsbRibRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 11; Drug: OSU6162 3 然 Apo 50 然
bLsLsLsLsmmmbLsLsmbRsLsLsLsmmbLsLsmbLsbLsbLsbLsbLsbLsLsmbLsLsmbLsbLsbL
sLsmbLsbLsLsmbLsbLsbLsLsLsLsmmmbLsbLsbLgRsbRsRsmbRibLoLsmbLsLsmbRjRsmb
RcbRcbRiRsmbRhbRibRiLsbRibRoLsLsmbRiReLsLeLhLeLsbRsbRcRebLsLsmbRsbRsLs
bRsLsbLsbRobRobRcRsmbRhbRcbRcLsbRibRibRhbRibRgbRhbRoLsLsLgmbLcbLeLebLh
LsbLibRjbRebLcbLibLibLgbLibLsLebLgbLgLsbsbLsRsRsLsLsLsLsmmmmbLsLsmbRsL
sbLsRsbLsLsmbLsbLsbLsLsmbLsLsLsmmbLsbLgLsbLsbLsLsmbLibRobRcLsbRibRcRsm
bRhLsbRibRhbRibRibRhbLgbLibLhLibLibLibLobLobLgbLiRsbLobLhbRsbLgbRsbLsb
RsLsbsbRjbLebLhLsbLcbLiRsbLcbLsbLibLebLibLiLsLsmbLibLgRsbLgbRsLsbLsLsm
bLsbLiLsbRoLsbRgbRobRebRibRobRiLsbLsbRcRsmbRiRsLsmbRiRsmbRibLsbRebLsbR
ibRibRibRhbRiRsmbRjRsmbRibRhbRcbRgbRibRibRjRsmbRobLsbLjbLobsbRobLgLsbL
gbLobLsbLcbLibLgLsbRgbLgbLibLcbLibRibRcbRibRgbRibRgRsRsmmbRibRgbRjRsmb
RibLibLcLsmbsbLibLgLsbLsLsmbLsbsbLgLsbLsbLsLgbLgLsbRsRsmbsbLsRsLsLsmbL
sRsLsLsLsmmbLgLsbLgLsLsLsmmbLsbLsbsbLsLsLsLsmmmbLgLsbLsbLsLsmbLsLsmbsb
LsbLsbLsbLsLsLsLsLsmmmmbsbLsbLsRsLsbLsbsbLsLsLsLsLsmmmmbLsLsLsLsLsmmmm
bLsLsLsRsLsmmbLsLsmbLsLsLsmmbLsbLsbLsbLsLsmbLsbLsbLsLsLsmmbsbsbsbLsbRs
LsLsmbLsbLsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 12; Drug: OSU6162 3 然 Apo 50 然
bRsRiRsmbLeLsLsRsmbLsLebLhbLebLhLsbLibLgbLhLgbLiLeLeLsbLiLsbLebRcbRoRs
mbRebRibReRsRsmmbRibRgbRgbRgRsmbRsbRgbRgbsbRgbRiRsmbRebRebRjbRgLsbRiRs
mbLjbRcbLcbLgbRsLsbLgbLgbLgLsbLibLhLiLsLiLsbLgRsbLgbLeLibLiLcbLebLeLsb
LeLsLsmbLebLeLsbLeLsbLebLeLebLcbRiRsmbRhLsbReRsmbRcbRsbRgbRsbRsRsmbRsR
smbLjbReRsmbRibRcbRhbRiRsmbRgRsmbRibRibLebLeLsRsbLibLibLhRsbLibLibLiLs
RsbLjbRobRobRiLsbRibRcLsbRhbRiRsmbRgbRgbRsRsmbLsbLjbRsbRjbLsRsbRsLsbLe
bLeLsLsmbLibLcbLgbLcbLibLibLiRsbLiLsbLebLeLsbLibLebLcbRgbLsRsLebLeLsbL
iRsbLsLsmbLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmmmmmbLsLsLsmmbLsLsmb
LsLsLsLsmmmbLgbRgbLsLsmbLgLsLsmbLgLsbLsLsLsLsmmmbLgLsbLgLsLsLgLsLsLsLs
LsLsmmmmmmbLsbLsLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmmbLgbLgLsLsLsmmbLgRsbL
gLsLsmbLgLsLsLsmmbLsbLsLsLsLsLsLsLsLsLsLsLsLsLsLgLsmmmmmmmmmmmmbLsbLsL
smbLsLsmbLgbLgLsbLgbLgbLgbLgbLsbLgbLgLsbLibLgLsbRsbLgbLsLgLsbLgLsbLgbL
sLsmbLgbLsLsLsLsLsmmmmbLgLsbLgbLgLsLsLsLsLsLsLsmmmmmmbLgLsLgLsLsLsmmbL
sb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 13; Drug: OSU6162 1 然 Apo 50 然
bsbsbsbsbsbRsbRjbRgLsRsbRsbLibLjb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 14; Drug: OSU6162 1 然 Apo 50 然
bsbRsRgbRsbRibRgbRsbRsRsmbRgbLoLeLsbRcbLhbLsbRiLsbRiRsmbRsbLsRsbLsbRsb
RsbRgbRsbsbRgbRsbRibRsbsbRgReReRgbRsRsmbRsRgbRobLibsbRjbRiLsbLobLibRiR
smbRsRobRgbRsbRebRgbRsbRsRsmbRgRsRsmmbRsRsmbRebLibLgbRibRsbsbLsbLsbReb
RgLsbLgbRgLsbRiLsRsbRsbLsLsLsmmbLsRsbLsbLgbLeLibRiLsbRgbRgLsbLgbRsbsbL
sbRsbLsbRgbRiRsmbRsRsmbRsRsRsmmbLsRgbRebRgRsmbReLsbRobRsbRsLsbsbsbsbsb
sbRgRebRibRgbRgbRsbRgbRsbRsbRgbRsbRgbRsbRsbRgRsmbLsRsRsmbRgbRgbRebRsRs
mbRsRsRgmbRsbRsbLsbRsbRibLsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 15; Drug: OSU6162 1 然 Apo 50 然
bLsbLjRsbRsbLjbRsbLcbRjbLobsb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 16; Drug: OSU6162 1 然 Apo 50 然
bRsbRsbRsbRsRsmbLsbRoLsbRebRsLgbRibRsbRgRsmbRgbRgbRgbRibRgbRsbRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 17; Drug: OSU6162 1 然 Apo 50 然
bLsLsLsLsmmmbLsbLsbLsLsLsmmbLiLsRsbLibRhbRibRiRsmbRgbRsRibRgbRsRgRsmbR
sRsRsmmbRibRiRsmbRhbLsLsLembRjbRcbRgRsRsmmbRibRgbRgRsRsRgRsmmmbRibRebR
sbRgRsRsmmbLsRsRgRsRsRsRsmmmmbRsRsmbRsRsmbsbRibRsRsmbRsRsLsmbRsRibRhbR
gbLhbLibLgbLsLgLsLsLsmmbLsLsLsLgLgLgmmbLgbLgbLsLgLsLsLsmmbRsRsmbLsLsmb
LsbLsLsLsLsmmmbLgLsLsRsmbLibRebRebRgbRibRsbRsbRgRsRsRsmmmbRsbRgbRiLsbL
gbRhbRiRsmbRgbRiLsbRgbLibLiLsbLsLsLsmmbLgbLsLgLsLsLsLsLsLsLsmmmmmmbLsL
sLsLgLsLsLsmmmmbLsLsLsLsLgLsmmmbLgbLgLsbLgbRsbsbLibLsLsLsLsLsLgLsLgLsm
mmmbLsLsLgLsLsLsLsLgmmmmbLgbLgLsLsLsmmbLiLsLsLsLsLsLsRsLsmmmmmbLiLsLsm
bLsbLgLgLsLsLsLsLsLsLgmmmmmbLgLgLsbLsLgLsLsLsLimmbLgLgLsLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 18; Drug: OSU6162 1 然 Apo 50 然
bLgLsLsLsmmbLgLsbLsbLsLobLsbLsLsmbLgLgLsLsLsLsLsmmmmbLsLsmbLsLsmbLsLib
LsLsLsLsLsmmmmbRibLsbLobLeRsbRsbLgbLsLiLiLsbRsbLsLsmbLgLsbLgbLsLgRsbLg
bLsLsLsLsmmmbLgbLsLsmbLsbLsLsmbLsbLsRsLsLsmbLsbLsLsLsLsLsLsLsLsLsLsLsm
mmmmmmmmmbLsLsmbLsLsLsLsmmmbLsLsmbLsLsmbLsLsmbLsLsLsLsmmmbLgbLgbLgLsLs
LsLsmmmbLgLsLgLsLsLsmmbLgLsLsLsLsLgLsLsLsLsLsLsmmmmmmmmbLgLsLsLsmmbLgL
sLsmbLsLsLsLsmmmbLgLsbRsLsLsLsLsmmmbLgRsbLsRsbLsLsmbLgLsLsLsmmbLsLsLsm
mbLsRsbLsLsmbLsLsLsLsLsmmmmbLgLsbLsLsLsLsmmmbLsLsLsLsLsLsLsLsLsLsmmmmm
mmmmbLsbLsLsLsmmbLsLsmbLsLsLsLsLsLsLsLsmmmmmmmbLsLsmbLsbLgbLsbLsLsmbLg
bRsbLsbLgbLibLsLsLsLsLsLsmmmmmbLgLsLsmbLsLsLsLsmmmbLsLsLsLsmmmbLsLsmbs
bLsLsmbLgLsbLsLsLsLsmmmbLsLsLsLsmmmbLsLsLsLsmmmbLsbLsRsbLgLsbLsLsLsmmb
LsLsmbLgLsLsmbLeRsbLobLgLsbRebRhbRobLgbRcbLsbRibRobRibLhbLgbLobLhLsbLc
bLiLsbRcbRcbRebRibLcLsmbLhbLibLibRiLsbRibRobRibLibLiLsbLibRgbRjRsRsmmb
RsbRsbLjbRcbRhLsbRibLebRobLcbRsLsbRjbLjbRsLiLsLsmbLebRsbRsRebLebLgLibR
ebLebLgLsLsmbLsLsLimbLhbRgbRcbRgRsRsRhmmbRiRsRgmbRgRiRebLsbRgbRiRsmbLo
bLsbRsbLjbLsbLsLsmbRgbLsbLsbLsLsmbLibRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 19; Drug: Control Apo 50 然
bLibRebRebRiRsRsRgRemmbRoLsLsLeLembsbLsbLsbRsbLsbsbsbRsbLsbsbLsRsbLebL
sbRsbsbLsLsmbRsReRhRgRsRsmmbRhRsRsmmbLebLsbRsbRsbRsLsbsbLsRsRsmbRiReRs
RsRgRsRsRsmmmmmbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 20; Drug: Control Apo 50 然
bLiLsLsmbRgbRibRcbRsbRebReRsmbRcbRhbsbReRsmbRcLsbRsbRcbLibLebLcLsmbLiR
sbLebLcLsmbLibRsbRebLcbRibRjbRsLsbLjbLebLhbRgbReRsmbLsLsRsmbRsRsRsRsRs
RsRsRsRsRsmmmmmmmmmbRsRsmbLsbRsbRsbRsRgRebLhbLcbLhbLibLcRsbRsbRebRibRe
bLgbLibLoRsbRebRibRsbRgRgRebLgRsbRiRsRimbLsbLsLhLsbRebRcbLcbRibRebRebR
ebReRsmbLibLebLcbLebLibLhLsbLgbLgbLgLsbLebLibLiLsbRgRsRsmmbRiRsmbRebRi
bRebLgbRiRsRsRsmmmbRhbRhRsRsLsmmbRibRcLsbLgbLcbLhbLhbLsbLebLibLgbLibLi
bRjbRcbRcbRibRibLcbLhbLibLibLiLsbLibLibLibRhLsbRcRsmbRhbReLsbRibRhbRsb
RibLsbLgbLjbRsbRgRsmbRibRsRsRsRsmmmbRsRsmbRsLsRsReReRibLcLsmbLhbLhbRsL
sLsLsLsLsLsLsLsmmmmmmmb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 21; Drug: Control Apo 50 然
bLiRsbRobRgbLibRsbRgbLoRgRsmbRobLcLsmbLjRsLsbLsbRebRgbRibRebRcbLiLsLsm
bLjbLobRcbRsRiRsmbRcbRjRhbRcbLebLebLcLsmbLcLsmbLibRcbRebRiLsbRsbRobLgb
LcLsmbLebRebRcbRcbRibRibRgbLsbLgbRsbRsbLgRsbRjbRiLsbLsbRcbRebLobLibLcR
sbLcbLsbRobRebRebRibRjbRobLobLsbLsLsmbLsLsmbLsLsmbLsLsmbRcRsmbRebRcbRc
bRcbLcbLiLsLsmbLgbLhbLcLsmbLhLsbLcbLiLobLibLeLsbLhbLiLsLibLobLgLsbLjbL
obLibRcbRcRsRembRobRibRobRgbLgbLcbRjbRobRebRoLsbLeLsbLcbLeLsRsbLgRsbLi
bRcbLcLsmbLcbLcbLhbLcLsmbLhLsLsmbLhbLobRsbLibLgbRjbRgbRoRsmbRebLibLibL
ibsbRsRsmbRjbRibRcbRibRhbRhbRiRsmbRcbRhbRgbLcbLhLsbLibLoLsmbLhbLhbLhbL
iLsbLcLsmbLcbLcLsmbLibRsbLcbRibRjRsmbRcbRjRsRgRsmmbRcbLsbLgbLobLibLibL
hbLibRcbLhLsbLcbLjRsbLcbRgbRobRcbRhb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 22; Drug: Control Apo 50 然
bsbRsRhRebReRsmbRsbReRebRiRiRgLsRibLebRjbRibRebLsRsRsRiRsRsmmmbRsRiRgR
gbRgbRgRsRsmmbRsRsReRgRgmbRsRgRebRsRsmbRiRgbRgRsmbRgRgbRsRgRsReRgReRgm
bRsRsmbReRgRsmbRebRobRsRsRiRgRembRgReRgbRsReRsRsRemmbsbReRgbsbReReLsbR
ebRebRgRsmbRgRsmbRsbRgRsmbLsbRsRsLsmbRiRsmbRgbRgbRgbRgRibRgRsRsmmbRsbL
sRsRsmbReRgbReRsRiLsmbRgRsmbReRebRsLsbRsLsbRsRsmbRsbRsRsRsmmbRsRsRsmmb
RsRibReRhbReRiRsRiRiRsmmbRsLsRsbRiReRhbLsbReRsRsRsRemmmbLsbsbRsReReRsm
bRgRhbRiRsmbRgRsRgRimbRgRiRsmbLsRsReRgRsmbReRsRsmmbReRibRgRsmbRsRsmbRs
bRgLsbsbLcbRsbsbsbsbLiLsLsLiLgmbRsbsbLsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 23; Drug: Control Apo 50 然
bsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 24; Drug: Control Apo 50 然
bLsbsbLsbLsbRsbLsLsmbRsLsbLgbLsbLsbLsbsbLsbLsbLsbLgbLsRsbLsLsmbRsbRibR
sbsbRibLsLsmbLsLsLsmmbLgLsbLsbLsbLsbRsLsbLsbLsLsmbsbRsbRebRoRsmbRibLsb
Rsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 25; Drug: OSU6162 10 然 Apo 50 然
bLhRgbRsbLsbRsbLsbsbsbsbRsLsbLsRsbLsbLsRsLsLsLsLsLsmmmmbLsLsLsLgLsmmbL
gLsLsLsLsLsLsLsmmmmmmbLsLsLsmmbRsLsLsmbLsbsbLiRsRibRsRsmbRsbRsRsRsRsRg
RsmmmmbRgRiRhbRsRgbRsbRgbRgRsmbLsRsRsRsRsRsmmmmbRgRsRsmmbsbReRgRgbRibR
sRebRcRsmbRcbRhbLcbRobRebLgLsbLebLiRsbLibRcRsmbRcRsmbRsRsmbLsbLebRebRc
LsRsbLcLsmbLiLsbLgbLsbLibLsbLgLsbLsbLhbRjbRebRibLsRsbRibLcbLgLgLsLsLsm
mbLsLsLgLgmbLgLsbRgbRebRcbLgbLcbLsLsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 26; Drug: OSU6162 10 然 Apo 50 然
bLsbLjbRsbRsbLsbRibRobRoRibRcLgbLcLsLsmmbRsbRsbRgbRgbRgbLibLiLhbLcLsmb
LibLcbRsbRsbRsbsbsbRsbsbsbLsbsbLsbRsbLsbsbsbLsbLgbLsLsLgmbLsLsmbLsbLob
LoLsmbRiRobRoLsbLcbRibLobLibLobLiLibLgbRsbRgbRgRsmbRgLibLgbLgbRsbLsbLs
LgLsLsmbLsLsmbLsbLgbLsLsmbLsbLsLsmbLsbLsLsmbLsLibLibsbLsbLoLsmbLobLgLe
bLgbRsbLibLibRsbLsbLsbLsbRhLsbLcbLibLsLcbLiLebLebLgbLebLhbLgbRsLgLsbLs
bRebRibRcbRhbRgbRiRsmbRiLsbRgLsbRibRibRgbLcbLobLebLgbLiLsbLebLeLsbLebL
gbLibLsbsbsbsbsbLebRebRsbRgRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 27; Drug: OSU6162 10 然 Apo 50 然
bLgLsbLsbLsbLsLsmbLsbLgbLsLsmbLsbLsLsmbLsbLgbLgbLsbLsbLsbLsbLsLsmbLsbL
sbLsbLsLsmbLsbLsbLsbLsbLsbsbLsbLsbRsbRobLsbRjbRebRsRsmbRsRsmbLobLgbRob
LebLsbRcbLobLjbRibRoRsmbRcbRiLsbRcLsbLgbRsbRgLgbLsbLiRsbRebRoLsLsmbLsR
sbLgbLsRsbLibLgbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 28; Drug: OSU6162 10 然 Apo 50 然
bRsRgRsRgRsRsRsRsRsRsRsRsLsmmmmmmmmmbRgbLgRsbRhbRsRsRsmmbRibRsbRsbRjbR
gRsRsRsmmmbRsRsRsRsRsRgRsRsRsRsmmmmmmmmbRsbRgbRgRsmbRgRgLsbRsbReRsmbsb
LibRiRsRsRsRsmmmmbRgRsmbRgbRibRsRsRsRsmmmbRgbLsRsRsmbRsRiRsmbRsbRsbRgb
RsbRsRsRsRsRsmmmmbRsRsRsRsRsRgRsmmmmmbRsRsmbRsbRgbRgRsmbRjbRsbLsRsRsmb
RsRsRsRsRgmmmbRsbLsbLsbRgRjbLobLhbLgbsbLgLcLsLsRsLsmmbReRsRgRgRsRsRsmm
mmbsbRsbRibRsRsmbRgRibRgRgRgbRsbRgbRgRsmbReRsmbLsRsRsRsmmbRsbRsbRsbRib
RgRgRgbRgbRsRsmbRsLsbRgRsRgmbRibRsRgRsRgRsRsLsmmmbRsbRgbRgbRibRiRsRsmm
bLjbLeLsbRoRsmbRgbRgbRgbRiRsRgmbRsRsmbRsbRhRsRsmmbLsRsbRgRgRsRsRsRsRsR
sRsRsmmmmmmmmbRsbRiRsRsmmbRiRgRsRsRsRsRgmmmmbRsbLsbRgbRsbRgRsRsRgRsRsm
mmmbRsRsRgRsRsRsRsRsRgmmmmmmbRsbRsRgRsRsRsRsRsmmmmmbRsRsRsRsRsRgmmmmbR
ebRcbLebLcbRsbRsbRgRgRsRgRsmmbRibRiRgRsRimbLsbLsbRiRsmbRgRgRsRsmmbRsLs
bRgRsRsRsRsmmmmbRsbRgRgbRgbRiRibRsbRhRsmbRgRsRsRsmmmbRgRsRsmmbRsbRiRsm
bRiRsRsRsRiLsmmmbLsRsbRebRgRsRsmmbRsRgbRgRcbRiRsmbRsRsRsRgRsRsReRsmmmm
mbLcbLcbRsLcbRsbLsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 29; Drug: OSU6162 10 然 Apo 50 然
bRcbRgbRobRgbRgRsRsmmbRgbRgbLsbRobRsRobRhbReRhRsRgmbReRsRsmmbLsbsbLsRo
bLiLiLjbLiLsbRgbRebRoLsbRcbRgbRiRsmbRibRiReRebReReRsmbRhRebLcbLiRsbRsR
cbRoLsLsmbRgbLeLgLebLeLsbLgLsbLcRsbRcbLcRgbLcbRiRsmbRebLcbLebLebLoRsbR
oLsbRebRobLebRibLobLsLsmbsbsbLsbLebRsRsLsmbLsLsmbsbRsLsLsmbRsLsbLsbLsb
LsLsLsLsLsmmmmbRsbRsbLsbLsbRgbRhbRobRibRibRibRgRhRcReRibLiLsbLiRsbRgbL
sbLobLobLsbLgbLeLsRsbLsbLsRsLsbsbsbLsbRsRsLsRsmbsbsbLsLsmbLsbLsLsmbLsb
LsLsmbRsbLsLsRsmbLsLsmbLsbLsLsLsRsmmbRhbRoLsbLgbLcLsmbLibLgbLibLgRcbLs
LgbRobLcbLsLsmbLobRebRobLebLibLgbRjbLibLgbLsRsbLsbLsbLsbLsLsLsLsLsmmmm
bLsLsLsmmbLsLsmbLsbRsLsbLsbRoRsmbRhbRebRiRsmbRibRiRsmbRsbRiLsbRgRsmbRg
bRsRsmbRebLgbLcRsRsmbLjbRebLibLobRhbLibLobRsRsmbLiLsLsmbLobRcbRgbRgbLs
bRsbRsRsmbsbRsRsmbRgbRgbsbsbRsbRsRsRsRsmmmbRsRsRsRsmmmbRsRgRsRgRsmmbRs
RsmbRsbRgbLgbLeLsbLebLibLgbLibLob

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 30; Drug: OSU6162 10 然 Apo 50 然
bRsRsRsmmbRsRsmbRsbRsRgRsRsRsRsmmmmbRibRgRsmbsbRebRhbRgRgRsmbRiRsmbLsR
sbRsbRsbRgRsRsmmbRsRsRsmmbRgbRgbRhbRibRsRsRsmmbRgbRsRsmbRsRgRsmbRsRsRh
mbRgRibRgbLebLcbLsRsRsLsLimbLobLobReRsmbRebLsbRsbRsbRsbsbRsRsRsRsRsmmm
mbRsRsmbRsRgbRgRsmbRebRgbRibRibRebRsbRsRsRhmbLsbRcbRgRsmbRsbRsbRebLgbL
ebLibLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 31; Drug: OSU6162 3 然 Apo 50 然
bRibRsbRsbRgRsRimbRgRsmbRsRsRsmmbRgRgbRibRsRsRsmmbRibRgRsRsmmbRebLgLsL
sLsLsmmmbLsbLibLeLsbRhbRgRsmbRgbRibRgbRsbRsbRsbRgbRsRgbRsRsmbRsbRsbRgR
smbRsbRsRgbRibRgbRsRibRgbRsbRsRsmbRgbLsbLsRsbRgRsmbRcbRsLhbLcbLebLibLh
bRsbLgbLgbLgbLibRsLsbRsLsLsmbLsLgbLsbLibRsbLibLsbLsRsbLgbLsbLgbLgbLgbL
hbLsbLsbLgbLgbLhbLhbLibRob

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 32; Drug: OSU6162 3 然 Apo 50 然
bRgRsmbRsRsRsRsRsRsmmmmmbRsbRiRsRsRsRsRsRsmmmmmmbRsRsmbRsRsRsRgRsRsRsm
mmmmbRsRsRsRsRsmmmmbRsRsRsRsmmmbRsRsRsRsRsRsmmmmmbRsLsRsLsbRsRsmbRgbLs
RsRsmbRsbRsRsmbRgbLjbRgbRjRsRgmbRsRsRsmmbRsRsRsmmbRsbRsRsRsRsRsRsRsRsR
sRsRsRsRsmmmmmmmmmmmmbRsRsRsRsmmmbRsLsRsRsRsLsmmbRsRsRsmmbRsRsRsRsmmmb
RsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmbRsRsmbRsRsRsRsRsRsRsRsRsRsmmmmmmmmmbR
sRsRsRgRgmmbRsRsRsRsRsRsRsRsmmmmmmmbRsRsRsRsmmmbRsRsRsRsRsRsRsmmmmmmbR
sRsRsRsmmmbRsRsRsRsRsRsRsLsRsmmmmmmbRsRsRsRsmmmbRsRsRgmbRibsbLcLsmbLsb
LsbLsLsLsLsmmmbLsLsmbLsLsLsmmbLsLsmbLsLsLsmmbLsLsLsmmbLsLsmbLsLsmbLsbL
sbLiLsRsRsRcmbRsbRhRsLsmbRsbRsRsRsmmbRsbRsRsLsmbRiRsLsLsRsRsmmmbRsRsmb
RiRsmbLcbLcLsLsmmbLcbRebRcLsbRiLsbRibRibRibRcbRiLsbLobLcbsbRhRsmbRhbRo
RsmbRibRoLsRgbLcRsLibLgbLgLsLsmbLoLsmbLhbLeLsbLiRsRsmbRgLsbLjLibRgbRjb
RcbRibRiRsmbRsRoLsbRcbRgbRhbRobRjbLobRobLcbLiLsbLiLsLsmbLiLsbLsLibLobR
jRsmbRjRibRiRsmbLsRsRiRgbRsRsmbRgRsLsmbRsRsRsmmbRsRsRsRsRsRsRsRsmmmmmm
mbRiRsLsRsRsRsmmmbRgRsRsRsRsRgmmmmbLcbLcbLhbLsLsmbLeLsbRgRsRsRsmmmbRcb
RsbRiLsRsRsRsRsRsmmmmbRgbRgRsmbLsRsRsRsRsRsRsRsRemmmmmmbRibRsRsRsRsRsR
smmmmmbRsbsbRgbLibLibRcbRiLsbLsbRiRsmbRgLsbLgbLcbLsLgLsLsLsLsLsmmmmbRj
bLcbRhLsbRibRibRibRgLsLsmbRsRjRgRsmbLgRsRsRsRsmmmbRsRsmbLcbRcRsmbLcbLo
bRibRcbRibRgbRhbRiLsLsmbRgLsbRcbRibRsLebRobLebLhbLiLsbRibRcbLhLsbRsbLh
RsbLhLsbLebRgbRcbRibRgRsmbRcbRiRsmbRibLcLsmbLsLcLsmbLiLsbLebRgRsLhmbLe
bLhbLibRcbRsRibRiRsmbLsLsmbLcbLcbLgLsRsLsLsmbLiRsbLiLsbRsbRjRsmbRgRiRs
mbRsRsmbRcbLeLsbLhbLiLsbRsbLsbsbsbLsRsbRsbsbLsLsmbLsbLsLsLsmmbLsLsmbRs
LsLsLsLsRsmmmbLsLsmbRsLsLsLsmmbRsLsLsmbLsRsbRjRjbRsbLsbLsLsmbLsLeb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 33; Drug: OSU6162 3 然 Apo 50 然
bRsbRjbLebLiLsbLsLsmbLsbLgLsLsRsLsLsmmbLsLsLsmmbLgLsbRsLsbLsLsLsLsLsLs
LgLgmmmmmbLsLebLiLsLibLsLsmbLsLsLsmmbLsLgLsLsLgLiLembLgLibLsLsLsLgmmbL
gbLsLsmbLgLsbLsLibLgLsbLsLsLsLsmmmbLsbLgbRsLsLsLsLsLsLsmmmmmbLhbLsLsLs
LsRsLsmmmbLsLsLsLsLsLemmmmbLibLebLgLgLsbLsbLsLsRsLgLiLsLsLemmbLgbLsLgL
sLsmbRsLsLsLsLsmmmbLsLsLsmmbLgLsLsmbRsbRsLsLeLsbLgLsLsLsLsLgLgLsLsmmmm
bLhbLsbLgbLsbLsLgbLgbLsLsLsmmbLsbLsLgLsbLsLsLsmmbLsLsLsLsLsLsmmmmmbLhb
LebLsLsmbLgbLsRsbLgbLebLgLsbLsLsmbLibLsbLgLsbLsbLsbLsLsmbLgbLsbLibLsLs
mbLgLsLsRsmbLsbLsLsLsmmbLsbLibLgRsbLsbLiLibRgbRsbRcbRebRebRsbReRgbRsRs
RsRsmmmbRsbRgRsmbRsLsbLsbLsbRsRsmbRsbRsRgbRgbRgbRsbRgbRiRsmbLobReb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 34; Drug: OSU6162 3 然 Apo 50 然
bLsLsmbLsLiLsLgLgLsbLsbRcRsmbRsRebRiRebsbRcbRoRsLsmbLsLsmbLsbLobLibRib
LobsbLcbLhbRobRsbLibLibRsbRsRsmbRsRsRgRembRebRgRsmbRsbLgbRcLsbLsbLsLiL
sbRsbRgbRsbLebLiLsbLhbRsbLibRebLoRsbLeRsbRobRcbRiRgRsmbRsRibRgRsmbReRs
mbRsRsRsRgmmbRebRibLcbRebLsbLebLgbLobLoLsmbRjbRiRsmbRsRsmbRebRiRsmbRgb
RcRsmbLcbLeLsbLgbLibLsLsLsLsmmmbRebRebRibLibRcbRibRgbLibRgReRhbRgbLebL
iLsbLgLiLsbLibLgLsRsbRsbRcbRcbRcbLsLibRibRsbLsbLsbLgbLcRsbLiLsbLebLoRs
bRcbRobLgbLjbReRgbRebRiRhLsbRgbLibLgbLgbRsbLeRsRsmbLoLsmbLebLgRsbRjbRj
bRibLsbReRebRibRsbRsbRgRsmbReb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 35; Drug: OSU6162 3 然 Apo 50 然
bRibRcbRcbLeLsbLsLsLsmmbLsbLsLsLgmbRcbRibRibRsRsmbRiLsbRsbRhbRhLsbRhbR
cbRhRsmbRhbRibRiRsRsmmbLsbRsbRsbRsbRsRsmbRibRibRgbReRsmbRiRsRimbRiRsmb
RiRsmbRiRhbRgbRobRebReRsmbRgRsmbLjbRcLsbLobRsbsbRsRsLsmbRgbsbLsbRsbRsb
sbsbRsRsmbRsRsLsmbRsRsmbRsRsRsRsRsRsRsRgmmmmmmbsbRsRsRsRsRsRsRsRimmmmm
mbRgRsRsmmbLsRsbRsRsRsRsmmmbRsbsbRsRsRsRsRsRsmmmmmbRsLsbRsRsmbRcbRcRsm
bRiRhbRibRsbRiRsmbRibRibRibRebRibRibRgbRiRsmbRiRsmbRibRgbRsRsmbRsRsmbR
sRsRgRsRsRsRsRsRsRsmmmmmmmmbRsbRhbRcbRibRcbRiRsmbRibRibRgbRibLsRsRgbRg
bRhbRibRebRibRibRhRsmbRebRebRcRebRsLsbLobLoRsbLiLsbRiRsmbLgbLebLcbLibL
ibLcRsRsmbRcLsbRibLiLsbRhbLibLeLsLsmbLcRsbLibLhbLcRsbLiRsbLgbLhbLiLsbL
ibLcRsbRibRgRsRsRsRsRsRsmmmmmmbRgbRiRsmbLhbLhbLhRsbLgLsLsmbLibLcbLibLh
bRibRsbsbRsRsRsRgRsmmmbRsRgRgbRsRsmbRsRsRgRsRsRsRsRsRsRsRsmmmmmmmmmbLs
RsRsRsmmbsbRsbRsRsRsRsRsRsRsmmmmmmbRsRsRsRsRsRsRsRsRsRsRsRsRsRsRsRimmm
mmmmmmmmmmmbRsRsReRsmmbRsRgRsRsmmbRsbRsRsRemb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 36; Drug: OSU6162 3 然 Apo 50 然
bsbsbLgLsbLsLsLsmmbLsLsLsLgLsmmbLsLsmbRsLsLsLgLsLsmmbLsLsLsmmbLgLsbLsL
sLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmmbLsLsmbLsLibLsbRsLsLsLsLhmmbRsLsLsLsLs
mmmbRsbLsLsLsLgLsmmbLsLsmbLiLsbLgLgLsbsbLsLibLibLsLgbLsLsLsLsLsLsLimmm
mmbRsLsLsLsLiLsLsmmmbLgLgbLsRsbLsbRgbLsLsmbLsLsLsmmbRsLsLsmbLsLsmbRsLs
RsbRgRjbsbLsRsRsmbLsbLsbRsRsmbRsbReRgRsmbRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 37; Drug: OSU6162 1 然 Apo 50 然
bRgLsbRhbRcbRobRobRgbRsbRhbsbRcbLoLsmbLoRsLsLcRsLsbLibLgLsbRsLsbLibsbL
ibLiRsbLiLsLsLhLsmbLgbLgbLsbLgbLsbRsLsbLsbLiLsbRjbReRsRsLsmmbRgbLsbRcb
RcbRhRcRsmbRibRibRgRsmbRgRgLsbRsbRsbRiLsRsbRgbRgbRsRsmbRibLsbRiRsmbRoL
sRsbReRiRsRsmmbRgbRgRsmbRsRsmbRgRsmbLobLiLsbLgLsLsmbRsbLgRsbLiRsbLhbLo
RibLobLibLibLcRsLsLgbLsbLibLiLebLibRcbRcRsLsRsmbRhRsRsmmbRgbLsbLcbLibR
cbRobRgbRibRibRgRgRsmbRiRsLsmbRcbRibRiRsmbRhbRgRsmbRibsbRsRsRgRsmmbRiR
smbsbRoRgLsRhRsReRsRgmmbRiRsmbRsReRsmbRgRsRsLsmmbRsbRhbRgRsmbRgbRgRsmb
RsbRiRsmbRcbLobLibsbLhbRjbRcLsRsbRsbRgbRiRsRsmmbRsRsmbRoRsmbLsbLibLoRs
RsmbLgLsLobLiLhLiLsLhbRsbLgRsbRcbRiRsmbRiRebReRsmbReRsmbRibRiRsLsmbRgb
RiRsLsmbRibLsRsbRgbRgRsmbRibRsbRsRibRsRsRsmmbRcLsbsbRsRobReRibRcbReRsm
bRgRsmbRhbRgLsbRgbRibRsLsLoLsmbLgLsRsbLgbLgLsbRcbRiRsmbRiRsmbRgbRgbLsb
LgbLobLhbLhbLiLsbLcbLiLsbLibLiLsbLsLhbLiRsLeLsbLeRsbLsLsmbRcRsmbRebLgb
LsbRjbRcbLibRebRgbRgRsRsmmbRsRsRsLsmmbRsbRebRibRiRsmbRebRcRsReReRembRe
ReRsRcRcRsRcRcRsmmmbLcbLeLeLebLsbLsbLgbRsbRjbLjbLhbRcbRoRsmbRibRcbRcbL
cRsbLoLsmbLgbLobLiLsLsmbLiLsbRsbLsLcbLibRcbRhLsLsmbsbRobRiLsRsbRgbRiRs
mbRibRsbLoRsbLhbRhbRgbsbRsbRgbLsRsbRibLjbRibRcRsmbRobRobRcbsbRibLsRsbL
cbRobRiRsmbRcbRgReReReRsRembRgbLsLebRcLsbRiLsRsRsmbLsbRiLsbLjbRcbRhbRj
RgbLcbRcbRjRsmbRcbsbLsRsLsbRibsbRibLcbLcbLiRsbLcbLcbLhRsbLiLsLsmbRjbRj
bRibRcbRibRibRcRgbRcbRgbRiRsRsmmbRcLobLhbRcbRhb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 38; Drug: OSU6162 1 然 Apo 50 然
bLobLoLsmbRsbLsbRsbRgbRibRsbLsRsbRiRsmbLobLgbRsRsmbLcLsmbLibLibLiRibRi
bRibRgRsmbRgbRsRsLsmbRobRsLsbRhbRsbLgbLiRiLhLeLsLeLebLeLsRsbLeLsRsbRsb
RsbLsbRobLobLgLsbRsbRgbLcLsmbLiLsbLcbLibRgbLsLsmbRibsbRsRcbRiLsbLeLsbL
gRsbLibRsbLiRsbRsbRebRsbLoLibLeRsbLeLsbLgbLibLsbLsLsLsLsLsRsRgmmmmbsbR
sLsbLoLsmbLibLcRsbLobRibRgbsbRsbsbLsbRsbLsbRsRsmbRsbsbLsbRsbsbsbLsRsbL
oRsbLcbLgbLibLebRgbRoLgbLgRsbRibsbLgbLcbLsbLhbLibLgbRgbLibRgbRsLsbRsbR
sRsRsRsRsRsmmmmmbRsRsRsRsRgRgRsmmmmbRsRsRsmmbRsRsRsRsRsRsRsRsRsRsLsmmm
mmmmmmbRsRsmbRsRsRsmmbRsRsRsmmbRsbRsRsmbRgbRsRsRsmmbRsRsRsRsRsRsRsRsmm
mmmmmbRsRsRsRsRsRsmmmmmbRgbRsRsRsRsmmmbRsRsRsmmbRsRsRsmmbRsbRsRsRsRsmm
mbRsbRsRsRsmmbRsRsRsRsmmmbRsbLjbLoLsLsmmbLgbRsbLiLsbLgbLgbLsLsmbLsbLsb
LsbLgLsbLibLobLobRcLsbLsLibLiRsbLobLibLsLsLsmmbRsLsbLsbLsbRsbLsbRsLsLs
LsmmbRsLsLsmbLsLsmbLsLsLsmmbLsLsLsLsLsLsLsLsmmmmmmmbLsbLsLsLsLsLsLsmmm
mmbRsLsLsLsLsLsmmmmbLsLsmbLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmbRsLsLsLsLsL
sLsLsLsLgLsLsLgmmmmmmmmb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 39; Drug: OSU6162 1 然 Apo 50 然
bRgLsbRgbLobLoRsbRobRobRibRcbRibRgbRibRhbRobRcbRebRiRsRsmmbRsbRgRsRsRs
mmmbRgLsLsmbRgbRgbLcbLoRsbLiLsbRcbRgbRhLsbLiLsbLcbLiLsbRsbLgbLgLsbLsbR
iRsmbLgbsbRsbRebRebRiRibRibRsbRgbRgLsbRgbLibLoRgLsbLcLsRsmbRebRsRsmbRs
bRsbLjbLjbLhbRjbRcbRiLsbRgbRibRgbRgbRibLcbRoLsbRcbRiRsmbLcbLiLgRsLgbLg
LsbLgbLgbRjbLibLiRsbLobRobRibRobRibLsbRoLsbRibLgbLobLhLsbsbLibRcbRibRi
ReReRebRiRsmbLsbsbRgbLobLsbLcbLcRsRsmbLhbLgbLcLibLebLebLoRsLsbRibLsbLo
bRgRgbLjbLibLoLgbLiLeLgbLebLibLsbRibLobRcbRobRcbLsbRoLsbRiLsbRibRgbRib
LgbRobRcLsRcReRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 40; Drug: OSU6162 1 然 Apo 50 然
bLiLsLsLsLsLsLsLsLsmmmmmmmbLgLsbLgLsLsLsLsmmmbLsbRsbLsbLsbRsbLsbLsbLgb
LsbLsbLsLsmbRsbLsbLsbLsbRsbLsbLgLgLsLsLsmmbRsbLsbLsLsmbLgbRsLsLsmbLgLs
bLsLsLsmmbLsbLsLsLsLsmmmbLsRsbLsbLsLsmbLsbLsbLsbLgbLgbLsbRsbLsbLgbLsLs
RsmbLsbLsbLsbLsbLsbLsbLsbRsbLsbLsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 41; Drug: OSU6162 1 然 Apo 50 然
bLhbRhbRhbRibRgRgbRoLsbLsbRsbLobLcLibLsbLgbLebRsbRibLgRsbLebLsLsmbLsLs
RsmbRcbRgRgReRsmbRobRhbLcbLcLebLiRsLeLeLgbLibLibRgRcReRsmbsbRhbRibRcRc
RcReRsReRsRsmmmbRiReRgRsmbRsbLsbRsbLebRgRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 42; Drug: OSU6162 1 然 Apo 50 然
bLibLgbLsbLsbLsbRsbRsbLsbsbsbRsLsbLsbLgbLsRsbLsbLsbRsbLobRiLoRsbLeLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 43; Drug: Control Apo 50 然
bRgbRsbRsRsRsRsRsRsRsRsRsRsLsRsRsRsRsmmmmmmmmmmmmbRsRsLsRsRsRsRsRsmmmm
mbRsRsRsRsRsRgRsRsmmmmmmbRsRsRsRsRsRsRsRsRsRsRsLsRsmmmmmmmmmmbRcbsbRjR
sRsmmbLsRsRsLsmbLsLhbLsLsmbLsRjbReRsmbRsRsRsmmbRsRsRsmmbRsRsRsRsRsRsRs
RsRsRsRgRsRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmmmmmmmmmmmmbRiRsmbRsRsRsmmbR
eRsmbRsRsmbLcLsmbLcbRcRsRsmmbLjbLeLsbLgLsLsLsLsmmmbLsbLgbLsLsLgLeLsmbL
iLsbLgLsbLiLsbRjbRsRcbRhbsbRhbLsbRebRcRsmbRibRhbRcRibRcbRgbRibRibLhbLc
bLebLibLcbLhbLiLsRsbLiLsbLsLeLsbRsLebLsLgbLeLsLsmbLibLibLeLsbLgbLebLjb
LcLsmbLibLcbLebLcbLhbLebRcbRibRebRcRsmbRgLsRsbLcLsmbRcRsmbRiRsmbRsRsLs
RgRsmmbRcbRiRsmbRcRgRsmbRebRebRgbRebRebLeLsbLibLcbLebLcLsmbLhbLebLcbLi
LsbRiRsRsmmbLeLsbLibLibReRsmbRibRibRgRsmbRcbRcRsmbLgbLeLsbRjbRhbRjRibR
eRsRsmmbRebRcbReRsmbRgbLhLsbLhLgLsLgbLibLsLsmbRsbRebRsbRcRsRsRsmmmbLcL
sLgLsmbLibRebLgRsbRjbRsRjRcbRhbLcLsmbLsbRebLsbRsbRibRgbRebLgRsRsRsRsmm
mbRsRsmbRsRgRsRsRsRsRsmmmmmbRsRsRgRsRsRsRgRsmmmmmbRsRgRsRsRsRsRsRsRsRs
mmmmmmmmbRgbRsbRsRsRsRsRgRsRsRsRsRsRgRgRsRsmmmmmmmmmmbRsRsRsRsRsRsmmmm
mbRebRgLsbRsRsmbLjbLsbLgLsLsLsmmbLsLsLsLsLgLsLsLsmmmmmbLsbRebRgRsRsRsR
smmmmbRsbRsRsmbRsRsmbRsbRsRsRsRsmmmbRsRsmbsbRgbRiRsmbLcLsLsmmbRebLcbLe
bLgbLiLsbRibRhRsRsRsRsmmmmbLgbLhLsLsLsLsLsLsLsLsLsLsmmmmmmmmmbLsLgLsLs
LgLsmbRibReRsRsRgRsmmmbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 44; Drug: Control Apo 50 然
bLebLobRobRcbRcRhbReRsRiReRembRsLsbRcRsRembReRgRebRgbRsLsbRibRibRiLsbL
iLebRgbRsbRcbLcbRsRsmbRibRsRsLsRimbLsbLsbRsbLsbRsRsRsRsmmmbRgbRsbLsbRs
bRobRcbRcRsmbReRebRibRiRgbRcbRgbRibRgbRiRsRsmmbRsbRcRsmbRhRebRibRobLib
LobLebLibLob

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 45; Drug: Control Apo 50 然
bLsLsLsmmbLsLsLsmmbLsbLsLsmbRsLsLsLsLsmmmbsbLsLibsbLsLsmbLsLsmbLsLsLsm
mbLsLsmbLsRsLsLsLsmmbLsbLsbsbRsLsLsLsmmbLsbLsLsLsmmbLsLsmbLsLsmbLsLsRs
LsLsmmbLsLsmbLsLsLsLsLsmmmmbsbsbLsLsmbLsbLsLsLsLsLsmmmmbsbsbLsbLsbRsbL
oRhbLiRgbLsbRebLsbLobLgbLsLsLsmmbLsbLsbLsLsmbLsbLgLsbLgbLsLsmbLgRsbsbR
sLsbLsLsmbLsLsLgmbLsbRsbRsbRsbLgLsbRsbsbRsLsbLgbLsbsbLsbLsLsmbLeLsLsLs
mmbLsLibLsLgLsbLgbLgLgLsbLsbsbLsbRsRsmbLsLsLsRsmmbsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 46; Drug: Control Apo 50 然
bLsLsmbLsbLsLsmbLgbLcbRoRsmbsbLgLsLsmbLsLsmbRcbRsRgRsRembRsRsRsLsmmbRs
RsmbLsbRibRobLcbLcRsbLeRsbRsbLibLgLebLgRsbRsRsRsmmbLebLibLeLsbLibLebLs
bLsLsmbLsbRoRsmbRibRgbLeLsbLcbLcbRiRsmbLcLsmbRsLgbLgLsbLsLebLgbRjbsbRi
bRcRsmbRhLsbLcbLsRhbRibRibLsbLcbLiLsbLsLsmbLsLsLsmmbLibLsbsbLsbRcbRgbL
cbLsRsbLhLsbRobLibRcRsmbRjRcbRiLsbRobLibLsLsmbLgLsbLgLsbLsLgbLgbRgRsmb
LhbRsRsmbLibLcbRsbLebLhLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 47; Drug: Control Apo 50 然
bLsbsbsbLsLsmbLsLeLebLgbLgbLobLsbRsbsbRsRsmbRsRsRsRsRsLsRsRgmmmmbRsbsb
RsbRsRsmbRsRsmbsbRsRsRsRiRsmmmbRsRsRsmmbRsRiRsRsmmbRsbRsRgRsRsRsRsRsRs
RsmmmmmmmbRsRsmbRsbRsRsRsmmbRsRsmbRsRsmbsbsbRcRsmbRcbLobLcLsLsLsmmmbLc
bLibLcbLcbLcbLhbLcbLjLsLsmmbLcLibLsbLibLiLebLcbLibLobRebLiLsbLgbLobRiR
sRsmmbLhbLobLgbRsbRebRhRsmbRsRgbRiRsmbReRsmbRiRsmbLibRsbRsbRcRsmbLsLsm
bLsLsLgLsLsLsmmmbLgLsLsLsLsLsLsmmmmmbLsLsmbLgbLgbLjLeLsbLcLgLsbRsLiLsb
RjbRibsbLsbRsLsRsLsLsLsmmbReLsbRcbRsbRcRsmbRebLebLebLeLgbLhbLgLsbLobRg
bLgbLgLsbLcbRibRsbRsbLsbLjLgLsbLsRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 162824; End: 163324;
Recording: 7-1; Individual: 48; Drug: Control Apo 50 然
bRsbRsRsRgmbLcbRsbLsbLgbLgbRsbLgbLgbLgbLiLsbRebLeLsbLgbRsRsmbRibRgRsmb
RsRgRsmbLsLcbLibLgbRsbRsbLsbLgLsbLsLebLsbLcLsLsmmbReRsmbRgbsbRgbRsbLgb
RebLibRcbLsLsmbRgbRsbLeLsbRsRsRsmmbLsLsmbLibLeLsLsmbRgbLcbRobRiRsRsmmb
LiLsbRsbRsbLsLebRgRsmbLebLibLgbLibLgbLgbLsLsmbLsbLgLsLsmbLibLsLsmbLsLs
mbLebRsbLobLebRcbRebRobLiLsLsmbRibLibLeb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 1; Drug: OSU6162 10 然 Apo 50 然
bLjbRobRobRcRsmbLsRsbLibRgRsmbRgRsRsLsmmbLiRsbRgRsmbLibLibRjbLiLsbLsbL
jbLcbRobLsbRjbRobLobLjbRjbLoLsmbLsbLgbRsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 2; Drug: OSU6162 10 然 Apo 50 然
bLsbLsLgLsbLcbRgbRhbRgbRiRsmbsbsbsbsbsbRsbsbLsbRsbsbsbsbsbsbsbsbRsbsbR
sRsmbRsLsbLsRsbsbLsLsmbLsRsbLsbLsbLsbLsRsbRsbsbsbRsbRsbRsbLsbsbLsLsmbs
bsbRsbLsbRsRsmbRsLsbLsbLsbsbLsbLsRsbLsLsmbsbRsbsbRsbRsbRsbLsbsbsbLsbsb
RsLsLsmbLsbLsRsbLsbsbLsbLsbRsbRsLsLsmbRsbsbLsbsbsbLsbLsbsbLsLsRsRsmmbL
sbRsbLsbLsbLsLsmbsbsbsbsbsbsbRsbsbsbLsbsbsbLsbsbRsbRsbsbLsbLsbsbLsbsbL
sbLsbsbsbsbsbRsbsbsbsbsbsbsbRsLsbsbsbsbLsLsRsmbLsRsbLsRsbRsbsbLsbsbsbs
bsbsbLsbLjbLhLibLsbLsbLsRsbLcbLcLsmbLiRsbLgbLibLibLsbLgbLcRsRsmbLcbLeR
sbLiLsLebLsbRcbRgbRgbRgRsmbRgbRcRsRiReRsRsRsmmmmbReRgbReRgLsbLcLsLiLsm
bsbRhbRsbRsbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 3; Drug: OSU6162 10 然 Apo 50 然
bLcbLsLsmbRsRsRsmmbLsbLgLsbLjbLhbRiRsmbsbLsLsmbsbLcbReRsmbLgLgbLgLsbLg
LsbLgbLebLgbLsLsLsmmbLeLsLsmbLibRsLgLsbRsLsbReRsRsmmbLsbLjLsLsmmbLsLsm
bRjRsmbLsbLsLsmbLobsbRhbLcbRjRsmbRcbRgLsLsmbLsbReRsmbRgRsLsmbRgbRsRsmb
RobLsbRobLjbLebLgLsbLibLibLibLjbRsbLsbRjLgRgbRsLgbLsbRibLebLsRsRsRsRsm
mmbsbLobRcbLebLebLsbLobLsbRcbLcbLcbRobLgLsLsmbLgbRgbLjbLcbLjbRebLebLcb
LebLsbLobRibReLgRsbRgLsbLcLsmbRibRjbRobRsRsmbsbRhLobRebRcbRcbLebLsbLeb
LgbLsbLgLibLgbLsLsmbLsbLsbLsbRsLsLsmbLsLsmbLjbRobLcbLjbRebLjbRjbLsbLcb
LibLobLobLsbRsbRsbRibLsbRgbRjbRebRebRjbReb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 4; Drug: OSU6162 10 然 Apo 50 然
bRsbLsbLsbsbLsbsbLibRsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 5; Drug: OSU6162 10 然 Apo 50 然
bRgRsRsRsRsmmmmbRiRsmbRiRsRsRsRsmmmmbRibRsbRsRsRsmmbRsRsRsmmbRsbRsRgbR
gbRsbRsbRsRsmbRsbRsbRsRsmbRgbRsRsmbRebReRsRsmmbRebLibsbRgbRibLibLibLib
LibLhRsbLibLsbRgbRebsbsbsbRhbRebLsRsbLsLsmbsbRsRsmbRsRsRsmmbRhbRibLsRs
bRgRibLcbLsbLebsbLsLebLsLsLsLsLsLsLsLsmmmmmmmbLsLibRiRsmbRsbRsbRebRsRe
bLebLsLsLsmmbLgbLsbLhbRsRsmbLeLgbLgbLebRhRsmbRsRiRsmbRebRgRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 6; Drug: OSU6162 10 然 Apo 50 然
bRsLsLsLsmmbLsRsbRsbLsbLsRsbRcbsbLobLcbLebLebLhbLcbLcbLgbLsLsLgLsLgLeL
smbRcbReRsmbRcbLsbLsbLgbLsLsmbLsLsLgLsLsLsmmmbRgRsmbsbLsRsLsbLsRsLsbsb
sbsbRcRsmbReRsmbRsRsmbRsbsbsbRgbRsbsbRsRsRsRsmmmbLsRsRsmbLebLcRsbLoRsb
RebRibRcLsbLcbLibLcLsLsmmbLobLcRsbRibRebRsRsmbsbRsLsLsmbRsbRsbsbsbsbRs
RsmbRhbRcLsbRcbRibRgLsbRiLsbRiRgbRibRgbRibRsbLcbLhLsbLibLiLgLsLebLibLg
LobRobLobLobLgbRobLibLibLgRsbRhbRiLsbRibLgbLhbLibLebLcbLsLgbLibRcbRebR
ibLhbLebRcRsmbRibRiRsmbRibRibRibLgbLgbRibLeLsbRcbRibRgLsbRhbLhbRcbRibR
gbRgbRsbLcLsLsmmbLgLsbLibLibRgbLobRibRiLsbRsbLhbRsbRcbRibRibRhbRgRsmbL
gbRsbRebLiLsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 7; Drug: OSU6162 3 然 Apo 50 然
bLibRibRjbRgbRsbRgRsmbRgRsmbRiRebRgbRebRibLgRsbReRsRsReRsmmmbRsbLsbLiR
sbRibRgRsmbRgRsmbRsbRebLsbRgbRgbReRsmbRebRgbLjbLjbLoRsbLsbLsbRsbLsbRsb
RsbRsbRsbRibLgRsbRgbRgRsmbRgRsRiRembRsRsRiReRgRsRemmbRsLsbLsLjbLjbRobL
sRsbRhbRgRsmbRiRsmbReReRsmbLjbLjbLcRsbRgRsRgRhRsmmbRgRgRsRsmmbRgbLgbRg
bRgRsmbRhRhReRsmbRgRsmbRibRsRsReReRimbRibsbRhRsmbsbRsbRsbLsbRsRsmbRhRi
bRsRebRebRebLsbRsbRsRgRgbRiRsmbRsLsbRsRsmbLsRsbRhbRebLsRsRsRsmmbRibRsb
LsRsRgbRiRsmbRsRsReRsmmbLsLjbLobLjbRebLsRsbRgbRsbLsbRgLsbLgLgbLgbLsbLs
RsLsbLsLsLhLgmbLsLsLsmmbLsbsbLsLsmbLsRsbLibLsLgbLsbLgLsbLsLsLsmmbLgbLs
bLsLsLsmmbLsbsbLsbLjbLobRobLsRsbRsRsmbRgbRsLsbRsbRsbRobRibLgbLgbsbLsLg
LsLsmbLsbLsbLsbLsLsLsmmbLsbLgbLiLgLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 8; Drug: OSU6162 3 然 Apo 50 然
bLsbLsbLsbLsbsbRsbLobRebLebRsbLobLobRsbLsbRiLsbRsbRsbLjbsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 9; Drug: OSU6162 3 然 Apo 50 然
bLjbLjbLsbRjbLjbLsbRsbRjbLsbLsbRsbLsbRsbRsbLsbLjbRsbRsbRsbRsbRsbRjbLsb
RsbLsbRsbLjbLsbRsbLjb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 10; Drug: OSU6162 3 然 Apo 50 然
bLcbLhbLjbLsLcbLcLibLibLiLsLsLgmbLibLibLibLobLjbLcbLibLgLgbLgReRsmbRib
RebRcbRibLibRcRsRsmmbRibRgbRcLsLgbRcbRcbLibLibLjLgbLhLhbLgbLiLsbRebRib
RiRcRibRebRsbRibRebRgbsbsbsbsbsbsbsbsbRsbLsLsmbLsRsbsbsbRsbsbRsbsbLsbL
obLcbLibLhRsbLeLibLcLsLsRsmmbLsbLibLsbRcLsbRgRiRibRsbRcbReRebRsbRiRiRs
mbRgLsbLsbRsRoLibLcLibRiRgbReRcRhRsRimbReRsmbsbRgLsbReRsRsRsmmmbRobRhb
RibRcRiLsRsbLgbLsLibLebRgbLsLobLgLhLiRsbLibLiRsLgbLgLsLebLgRsbLiLoLibL
cbLcbRcRebRibRgbRobRcbRcRsmbRibLsRsRsmbLsRsRsRsmmbRsRsRsmmbRsRsmbRsRsm
bRcbLcbLcbLibLibLibLhbLgLcbLgbLeRsRiRibReRebLgbLobLobLibRgbRcbRgbRsbRi
LsbLjLsLsmmbLhbRsbRcRgbRgbRhbRcbRebRcRsRimbRsRcbLsLibLcRsRsmbLibLcRsbL
oRsbLsbLebLgbLgbRjbRcLsbRgbRibRibRibLhbRcbRibRibRgbLgbRsLjbLoLgbLsbRjb
LsRsbRhbRsbRgbRjRjbRebLhLsbLcbLjLcbRibRibRjbRjRsmbRhbLjbLgbRsRhbRibRsR
gbRcbRibRibLhbRhbRiRsmbLcbLcRsbRjbLjbRcbLsLsmbLibRcbLgLsbLjbRcRsmbRib

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 11; Drug: OSU6162 3 然 Apo 50 然
bLsLsmbLsLsLsmmbLsbLsbLsbLsLsmbLsLsmbLsLsmbsbLsLsmbLsbLsbLsLsLsmmbLsLs
mbLsbLgRsbsbLsLsmbLcbLcbLcbLcLsmbLcbLcbLsLgbLcbLiLsLsmbLibLcbLibLibLhL
sbLiLsbRhLsbLcRsbLibLcbLiLsbLjbLebRsbsbsbLibLgbLgbLibLgbLiLcbLibLjbLhb
RjRebRhbRibRcbsbRibRibRebRiRsmbRibRgbLcLsmbLcLsmbLibLhbLcbLiLsbRjRsRsm
mbRjRsmbRibRibRgLsbRibRgRsmbRgRsmbRibRibRgbRiLsRsbLjLsLsmmbRcbLcbRhbRc
LsbRibRibRgbRibRibRgRsRsmmbRgRsRsmmbsbRgbRgbLgRsLsbRsbRsRsmbRgbRgRsLsm
bRjRsRsRsmmmbRsRsmbRsRsmbRgbRsbRibRjbRgbLibRgRsmbRibLibLibLeRsbLcbLiLs
LsmbRcRsmbLcLsmbRjRsRsmmbRgRsmbRgRsmbLgbRsbRsRsmbRsbLsbRsbRsRsmbRsRsmb
RgbRsRsmbRsRsmbRsRsmbRsRsmbRsRsRsmmbRgbRsRsmbRgbRgRsmbRsbsbRsRsmbsbsbs
bsbsbRsLsRsLsbRsLsbRsLsbsbRsLsbLsbRsbRgbLsbRsRsLsRsmbRebRjbLsbLsbRgRsL
smbsbsbRgRsmbsbRsRsmbRgbLjbLsRsbRsRebLgbLsLsLsLsmmmbsbsbsbsbsbsbLgRsLs
LsmbLsbLsLsLsmmbLsbLsbLsbLsLsmbRsLsbsbsbLsLsmbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 12; Drug: OSU6162 3 然 Apo 50 然
bLsRsRsmbRgbRibsbRibRiRsmbRibRgbRgbRsLsbRibRgbRgbRgRsmbRgbRgbRgbLsbLcL
smbLgbLsbRsLsLsLgLsLsLsmmmbLsLsLsLgLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsL
sLsLsmmmmmmmmmmmmmmmmmmmmmbLsLsmbLgRsbRhbRiRsmbRibRiRsmbRibRgbRibRgbLg
bLibLibLhbLgbLibLgbLibLiLsbLgbLiRsLsbLgbLibLgbLiLsbLcLgbLhbLibLebLgRsb
RibRcbRibRgRsmbRgbRgbRgbRgbRsbRgbRgbRibLibLibLhRsbLhbLiRsLsbLibLibLibR
cRsmbLibRjbsbLobLsbLgLsbRsLsRsbRcbRebRobRcbRhbRgbRibLgbRibRobLsLsLsLsm
mmbsbLiLsLsLsLsLsLsLsLsmmmmmmmbLsbLsLsmbsbRsLsLsLsLsLsLsLsLsLgLgLsmmmm
mmmbLsLibLgLsLsLsLsmmmbLsLsLsmmbLsLsmbLsbLsbLsbLsLsLsLsLsLsLsLsLsLsLsL
sLsLsLsRsLsLsmmmmmmmmmmmmmmmbLgbLgbLgbLgbLsLgbLgbLgbLsbLibLgRsLsbLsLsm
bsbLsbLsbLsbLgbsbLsLsmbLsLsmbLgbLsLsmbLsLsLsmmbLsbLsbLsLsLsRsmmbLsRsbL
sLsmbLgbLgbLsLsLsLsLsLsLgLsLgmmmmmbLsLsLsLsLsLsLsLsLsLsLsLgmmmmmmmmmmb
sbLsbLsbLsbsbLsbLsbLsLsmbLsLsmbLsbLsLsmbLgLsLsLsLsLsmmmmbLgRsLsLibLsLs
LsLsLsmmmmbLsLsLsLsmmmbLsLsLsmmbLsLsLsmmbLgbLgbLgbLsLsLsLsLsLsLsLsmmmm
mmmbLsLsLsmmbLsbLsLsmbLsLsmbLsLsLgLsmbLgLsbRsLsLsLsmmbLsLsLsLsLsLgLsmm
mmbLsLgbLsLsLsLsLsLsLsLsLsLsLsLsLsLsRsmmmmmmmmmmmmmbLsLsmbLsLsLsmmbLsL
sLsLsLsLgLsmmmmbLsLsLsLsLsmmmmbLgbLgLsLsmbRsRsmbLsLsLsmmbLsLsLsLsmmmbL
sLsLsLsLsLsLsLsLsLsLsLgLsLsLsmmmmmmmmmmmmbLsLsLsLsRsLsLsLsLsLsmmmmmmmb
LsLsLsLgmmbRjbsbsbsbsbsbsbLsbLsLsLsRsmmbLsLsRsLsLsLsLsLsLsLsLsLsLsLsLs
mmmmmmmmmmmmbsbRsLsbLgLgLsLsLsLsLsLsLsLsLsLsmmmmmmmmmbLsLsLsLsmmmbLsLs
LsLsLsLsLsLgLsmmmmmmbLsLsLgLsmbRsLsLsLsLsLsmmmmbRsLsbLsLsLsLsLsLsLgLsL
sLsLsLsmmmmmmmmmbRgbsbLhLsLsmbLcbRiRsmbRsRsRgRsRsRsRsRsRsRsRsRsRsRsmmm
mmmmmmmmmbRjReRsmbLobLcbLiLsbLgLsbLiLsLsLsLgLsLsLsLsmmmmmbLiLebsbRsbRs
bsbRsRsmbLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLgmmmmmmmmmmmmmmmmmmm
b

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 13; Drug: OSU6162 1 然 Apo 50 然
bRebLsLsmbLoLsRsmbLgRsbRcLsReLsbReLibLsRsbRsbRgbLebLiRsRsmbLgLsbRgbLgb
LsbLjb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 14; Drug: OSU6162 1 然 Apo 50 然
bsbRgbRsbRsbRhbRiRjbRsbRjbLeLsbsbLsbRsbRsbRsbLsbLibLcLcbLiLsLsmbsbLsbL
ibRsLsLsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 15; Drug: OSU6162 1 然 Apo 50 然
bsbsbsbRsbLsbRsbsbLsbLsbRsRsRsmmbRsbRsbRsbLsbLsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 16; Drug: OSU6162 1 然 Apo 50 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 17; Drug: OSU6162 1 然 Apo 50 然
bLeLgLebRsLgLgLsbLgbLgbLibLgLibLgbLsbLeLgbLsbLsLsmbLhLiLsbLgbLgbLgbLgL
sRsbLgbLgbLsLsLgLsLsLsLgmmmbLsbRsLsLgLsLiLsbRsbLgLsLgLsLsLgLsLsLgLgmmb
RsLsLsmbLsLsLembLgbLsLsLsmmbLiLgLsLgbLgLsbLgbLsLgLgbLsbLsLsmbLsLsLsLsR
sLsLsLsLsLimmmmmmbLsLsLsLsLgLsLsLsLgmmmmmbLgbLgLgbLgbLgbLiLsLsLsRimmbR
sbLsLsmbLgLsbLsLsLgLsmbLsRsbLsLsmbRsLsLsLsLgmmbLsLsLgLsLsLsLsmmmmbLiLg
bLgbLsLsLsLimmbLgbLgLsbLsbLsLsLgLgLsLgRsmbLibLsLsRsmbLsbLsLsLgLsmbLsLs
mbRsbRcbRsRsmbRgbRgRsRsRsRimmmbRhbRgRsLsmbLebLsLsLsLsmmmbLsbLgbLsLsmbL
sLsmbLsbLsbLsLsmbLgbLsbLsbLgLsLsLgLsmbLsbLgbRsLsbLgLsbRsLsLiLiRsbLiLsR
sbRsRcbRgbRgRsmbRgRsmbRsRsRsmmbRgbRgRsmbRgLsbRsbRsLsRsbRsRsmbRgbRsbRgb
RgbRgbRgbRgbRibLsRib

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 18; Drug: OSU6162 1 然 Apo 50 然
bLsbLgbLsLsmbLobLsLsRsmbRsLsLsmbRsbLibRgbLibRsbLsLsmbLsbLsLsmbLsbLsbRs
LsbLsLsmbLgbLgbLsLsmbLsbRsbLgLsbLgbLsLsmbLsbLcbLsbLsRsbLsLsRsmbLsbRgLs
bLjbLsbLsbLsbLsLiLgbLsLgbsbsbsbLsLsmbLsLsLsmmbRobRgbsbRsbLeLsbLgbLsLjb
RsbRsbRiRsmbRsbLsbRgbRhbRsbLsbLsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 19; Drug: Control Apo 50 然
bsbsbsbsbRsRsmbRsRsRgmbRsRebRiRsmbReRsmbLobLobRoLsRsbLcbLibReRsRembLob
LhLsLsmbsbsbsbLsLhLsbRcRsLsmbRcRsLcRsmbRcbRsbReRsRsmmbRcbsbRiRsmbLobLo
bRoRsmbReRsmbRibLgbRgbLcbsbRsRsmbReRsmbRebReLsbRsRoRsmbLobRebRcRsmbRsR
sRhmbRgRsmbLcbLhLsbLibLsbsbReRsLsmbRoRsLcmbLhbReRsmbRibRcbRoRsmbLoLgbL
obLibRibLobRebLobLiLsbRsbLgRsbLgbRebRcbLsbLoLsmbLibLobRsbRcbRobRhRsmbR
ebRoLsRhLsbRcbsbLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 20; Drug: Control Apo 50 然
bRsbLebRebLeLsLcbRobRsRsRsRsRsRsmmmmmbLiLsbRcbReLsbLebLsbLsLsLsLsLsLgL
sLsRgmmmmmbsbRsRgRsRsRsRsRsRsRemmmmmmbRobRsbRsRgRsRgRimbReRsmbLebReReR
sRsmmbRgRsRgRgmbReRsmbsbsbsbsbsbsbsbsbLsbLsbsbLsbLsbsbsbsbsbsbLsRsbRsL
sbLsbLsbRsbRgRsRsRgRimmbRibRsRsmbLsLsmbsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 21; Drug: Control Apo 50 然
bRibsbRsRsRsRsRsRgRsmmmmmbRebRibRgbLiLeLsbLsLgbRobRsbLibLiLsbRobRgbRcb
RoRsmbReRsmbRebRibRcbRebLobLsbRobRcbsbRobRcbRebRebLhLsbLcLsmbLibLhbLcL
smbLibLibLhbLibLibLjLsLsmmbLhbLcbLhLsbLhbLiLsbLhbLgbRcbRjbRsRebLjLsmbL
sbLiLsLsmbLsRsLsbRcbRibRgLsbLeLsLsLgLsLimbLgLsbLsbLsbLsbLjLiLsbRcbsbLs
LsLsLsLsLeLgmmmmbLibLcbLeLsLsLsmmbLhLsLsmbLobLhbLsLsLsLemmbLgLsLsmbLiL
sbLiLsLgbLiLsbLiLsLsmbLiLsbLebRcRsmbLsReLsbRgbLjbLjLsmbRjbRebRhbsbLgLg
LsLsLsLsmmmbLeLsLsLsmmbLsLsLsLsLsLgLsmmmmbLgLsLhbLsLsLeLgmbLebLgLsLebR
gbLobRcbsbRhbRcRsmbRcbLsLsLsmmbLsLsLiLhmbLsLsLiLsmbLsLeLsLsLsRsmmbLcbR
ibLsLsLsLsLsmmmmbLebLeLsLsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 22; Drug: Control Apo 50 然
bLeLiLiLsLsLgRsLimbLsLsLiLembRsLsbLsLsLsLiLemmbLibLsLeLsLsLsmmbLsLsmbL
sLsLsmmbLsbLsLiLiLsLeLsLsmbLsbLsLgLgLiLsLgLsbLgLgLsbLsLsmbLsLiLsLsLsLg
LsmmbRsbLgbLgLsLsmbLsLsLgLsmbLgLsLsLgLiLsLgmbLgLsbLgRsbLiLgbRsbLiLgbLs
LsmbLsLgLsbLsRsLibLiLsbLsbLsbRsRgRsRembRsRsmbRiRsRgmbRsRsmbRsRsRiRsRsR
eRiRsmmmmbRsbsbReReRsmbRgRsmbRiRsmbRgbLsbRgLsbsbsbRhReRsRgRiRiRsmmbRsR
smbRgRsmbReReRsmbReRsReRiRsmmbRsRsmbRgbRibRgLsbRgbRiRgRhbLsRsbRsbLsRsR
sRsmmbRsbRsLsbRsbRsRibRsRsRsmmbRoRsmbLoRsRsmbLsRhRsRsRiRgRsRgmmmbRsbRs
RgRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 23; Drug: Control Apo 50 然
bLibRebRebLgbLebLobRobLgbLobRobLobLibLebRobLobRobLcbRgbRobLcbLcbRebReb
RsbLobRgbLcbRcbRsbRobLcbLibLobRobLibRobLobLsbLobRobLsbLobLebLcbLsbRibL
obRobRebRobLebLibLobRebLcbRebRgbRobLcbLjbLobLobRebLobRobRobRobRjbRcbLc
bRhbLcbRcbRibLibRobRobRobRcbRcbLebLcbLcbRcbRobLobRcbLobRebRobRobLhbRob
RsbLebRcbLobLobLobLobLcbRobRgbRcbRgbLsbRcbRobLebLebLobRcbLebLsbRobLobL
ebLhbLebRhbLobRgbRobRsbRobRobLjbLebRebRobRcbLobRebLcbLobLobLebRebLcbRe
bLgbRobRcbRcbRobLobLobRobLobLcbLobLobLobRebLobRobLgbRobRgbLobRobRgbLcb
RobRobLibLcbLobRobRebLebLgbLibRebRobRobRibLobRcbRcbRobLebLobRobRobRebR
hbRobRcbLobLsbLobLobLebLobLobRcbRobRgbRhbLobRebRsbLebLhbLobRgbLobLcbLi
bRebRjbRobRhbRobLibLgbRcbRebLobRgbRcbRibLebLebLebLebLibRobLobLobRobReb
RibLobLebRibLobRibRobRgbRobLobLobRobLobRobLobLobLobRobLebRobRebLobRcbR
obRebLobRcbLhbRsbLcbLcbLobRebRobRebLjbLobRibRcbLsbLobLebRebLobRibRobRg
bRcbRobLgbRebLcbRobLobRibRobLebLobRebRebLobRcbRebRgbRhbLebLobRebRcbRob
LobRobRcbRobLobLobLobRcbRebLibRcbLobRebRebLcbLobRcbRebRobRobLobLhbLcbL
ibLobRobLebLebLebRobRobRebRobRsbRobLcbRebLobRobLibLobLebRebRibLobLcbRc
bLcbLobLebRsbLebRobRebLobRcbLebLobRjbLobRebRebRgbLobRsbLcbLcbRebRobLeb
RcbLsbLibLobLobLibLebLobRsbRcbRcbLobRsbLebLibRibRcbRobRibRcbLjbRobLjbR
obRcbRobRobLsbLobRcbRobRcbRgbRobLebLobLobRobLebLcbLebLobRcbLsbLgbLobLo
bRibLibLsbRgbRobRobRobRcbRobLsbLgbRcbRebLobRcbRcbRcbRebRobLjbRcbLobRgb
LibLibRobLgbLebRibRebRibLibRsbLobRobRebLebRobLobLebLebRobRebRcbRebRcbR
obRobLcbLebLebLcbLobLobLsbLebLebRobRcbLcbLobRsbLibLhbRobRobRobRibRebRc
bLobRsbLibLebLsbRebLobRhbLcbRobRibRobLobRobRobRobLcbRebRobRebLsbRobLeb
RibRibLobLobLobLsbLobRobLcbRobLebLobLobLobRebRhbLebRebRjbLgbLobLgbRcbR
obLebRibLebRebLobLcbRhbLobLibLobRgbRobRebRsbRobRobRcbLebRobRobRsbRhbRo
bRebLobLobRgbLobLobLobRobRibRebRibLcbRobLcbRibLsbLobRobLobLobLibLobLeb
RebLobRobLibRebRcbLobRobRcbLgbRgbRebRebRobLcbLobLobLibLobRobLebRebRcbR
obRobRebRobLjbLobRobRebLsbLobLcbRobLebLobLobLcbLebRcbRebLsbLobLobLebRe
bRcbLebRgbLobLobRobRjbLhbLebRebLcbRibRgbRgbLgbLobLsbLobLibLsbRobRibRob
RsbLcbRsbRhbRibLgbLobLobLsbRibRebLcbRobRebLcbLobLcbLcbLobLobLobLebRjbL
cbLgbLebRcbRebRibRgbRebLobRcbLhbRobRibLobRcbRobRobRibLobLjbLcbRobRobRe
bRhbLebRebRobLibLobRcbLgbRobRgbLgbRcbRobRobRcbLcbRcbRgbLobLobRobLobLcb
RobLibLobRobLjbRebRhbLobLobRobRcbRebRcbRgbRcbLobLsbLebLebRcbLobRobRebR
ibLgbLobRcbLcbRebRibLebLebLobLsbLobLobLobRobRcbLobLobLobRobRhbRibRjbRc
bLebRobLobRobRobRebRibLcbLgbLcbLjbLebRobRcbRibLibLobRebRgbLobRhbRcbRob
RobLebRebRebLsbLcbRobLcbLobRjbRobRibRobRobLebLobLebRibLgbRobRobLsbLhbL
obRobRobLebLobRcbLobLebLcbLcbRobLsbRebRobRobRobRobRebLobLobLcbLobRgbLc
bRsbRgbRebLebRobRibRibLcbLsbLibRgbRobLobRsbRobLobLgbLobLsbRobLobLobLeb
RebRebRsbLobLibRhbLcbRobRcbRcbRcbRobLcbLibLobLcbLobRcbRsbRebLcbLjbLcbL
gbLcbRobRhbRhbLobRobLsbRebLebLobLobLebRebLcbLebLebRcbRcbRebRobLebLobLo
bLobLcbLcbLebLobRebRcbRobLobLcbRcbLcbLobLibLcbLsbRebRobRebLcbLebRobLhb
LobLobLcbRibLcbRebLobLsbLebLebRebRebRcbRebLcbRobRhbRebRebLcbLobRebLsbL
cbRebLebRobRebRobLebLcbLcbLobRcbLhbRebLcbRgbRcbRobRcbRobRebLgbLobLobRo
bLobRobLcbLobLebRebLsbRibLgbLobLcbLob

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 24; Drug: Control Apo 50 然
bsbsbRgbRobLjbRgbRgbReLsbRibRiRgbsbsbLibLoLoLsLsmmbLcRgLsbRgbLoLobRobL
sb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 25; Drug: OSU6162 10 然 Apo 50 然
bLibLgbRsLsbLibRgLsbLibLsbRsbsbLiRsbLsLsLsmmbLsLsmbLgLgbLsbLibLsLsLsmm
bLsRsLsRsLsbLsbLsRsbLcbRsbRgbLgbLcLsmbLobRsbRsbRsbRjbLibLsbRebRsRsmbRs
bRgbRsbRsbLoLsmbLcRsRiRsmbRsbRhRsmbRsbLsbRcRsmbRsRibRcbRibRiLsbRsbRsRs
mbLsRsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 26; Drug: OSU6162 10 然 Apo 50 然
bLsbRsbRgbLsbRgbRsbRgbRibRoRsLsmbRobRiRsmbRgbRiRsmbRibRgbRobRiRhLsbLsb
RjbLgbLebLebLibLhbLibRsbLsbLsbsbsbLsbsbLsRsbsbLsLsmbLsbsbsbsbLiLsLsLsL
gmmbLiLsbsbRsRcbRsbRsRsmbRgRsmbLsRsbRsRsRsRsmmmbLsbRgbRcRsRsmmbLjbLcbL
ibLgbRgbRgbRibLiRgbLjbRgbRsbRcbRobLoRsLjbRcbLgLcbLgRsbReRsmbLibLjbRobL
sLsmbLhbLobLcbLibLgLibRgbRsLsbRsLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 27; Drug: OSU6162 10 然 Apo 50 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 28; Drug: OSU6162 10 然 Apo 50 然
bLsLsLsmmbLsLsmbLsLgLiLsbLsLsLgmbLsLgLsLsmbLebLgLsLsmbLsbLsbRgbLsbLgLg
LgbLgLsLsmbLgLsRsLsLsLsLsLsLsmmmmmbLsLgbLsLsmbLsbLsbLsLsLgLsmbRsbLsLsm
bLiLsLsmbLsbRsbsbLsLgbLgbLsLeLsbLgbLgbLiLgLsbLgLgbLsbLsLsLsmmbLibLgLsb
LgLsRsbLsbLsbLsbLsLsLimbLibLsLibLcLibLsbLsbLsbLgbLsLibLgLsLgbLgLgLibLs
bLgbLgLgLsLsLsLsRsLsLsLimmmmbLgLsLgbLsLsmbLeLsbLcRsbRibLjbsbLobRsRsmbR
sLsbsbRibRibRsRebRebLgbLgbLgLebLjbRibRoRsRembRibRsbRsbRcbRcbLcbRsbRjbL
sRsbLibLiRsbReRsRsRsmmmbRsbRsRsRgmbRsbLsRsbRsRsmbRiLsRsbRsbRibLsbRsRgR
gbRgbRgbRibRibLsbLsbLsLsLsLsmmmbLsLsmbLsbLsbLgbLsbLsLgbLsLsmbLsLsmbLsL
gbLsbLsRsbsbLsLsLsLsmmmbLsLsLsLsmmmbLsLsmbLsbLsLsLeLsLgLsmbLebLebLsRsb
LsLsLsRsLsmmb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 29; Drug: OSU6162 10 然 Apo 50 然
bRhbLsbRibLsbLcbRcRsmbRobLsRsbRsbLsbRgbRgRsRsRsRsRsRsRsRsRsRsRgRsmmmmm
mmmmmmbRsbRsRsRgRsRsmmmbRsbRsRsmbRsbRgbLibLobLhbLsLobLgbRobRebLobLiLsb
LhLobRebLcLsmbRibLgbRsbRgbsbRgRsRsRgRsmmmbRgRsmbRibRsRgbRgRsRsmmbRsRsR
sRgRsRsRsRsmmmmmmbRsRsRgRsRsmmmbRsbRsRsmbRsRsmbRsbLsRsbRsRsRsmmbRgRsmb
RibRibRgbLsbLsbLebRibRcRsmbRibLgbRoRsmbLgLsbLcLsmbLhbRgbLgbLibLjbLibLo
bRsLsbRibLsbRebRcbLcbRhbLebLcbRibRebLcbLcLsmbLgRsbRcbLsLsmbRjRebLsLsRs
LsRsmbLcbLgbLgRsRsmbLsLsmbLsLsLsmmbLsbLsLsLgLsLsmmbLsLsRsLsmbRsRsmbRsL
sLsLsRsmmbRsbRsbRsbRsbRsRsRgRsmmbRsRsmbRibLcbReRsmbLjLjbLcbLsbLsRsbLsL
hRsbLsLsLsLsLsmmmmbLgbLsLsmbRgbRsLsbLobsbRsbLobRsbRibRjbRhbLjbLsLsmbLh
bRgbLgbLcbRgRsLsLsmmbsbLibRcbRcbReRsmbRsRsmbRcbLsLsmbLgbLjLoLsmbsbRcbR
sbRcbLsLsmbLhbLsbRhbLjbLcbRgLsbRcbRcbRsRsRsmmbLcbRsbRcbLibLgbLiLsbLsLs
mbRsRjbLcbLgbLsRsbLsbsbRjbLhbRebLebsbLjLibRsbLsLsmbLhbRcbLgbRhbRsRsmbR
sRsmbRsRsRgRgRsRsRsRsRsRsmmmmmmmbRsRsmbRsbRsRgRgRiRgRsRsRsRsRsRsRsRiRs
mmmmmmmmbRgbRibRgRsmbRiRsRsLsmmbRsbLjbLgbRcbLjbLhbRcbRibLjbRcbLcbLhbLh
RsbRgbRsbRebLgbLhLsbRibLhbRibLcbLsLgbRhbLcbLsRsbLsLibRcRsmbRcbRhRsmbLs
bLiLsRsbLhbLibLsRsRsmbRhbRjRgbLibLhLsbLgLsLsLgLsmbLibRsbLsRsRsRsmmbLib
RcbRiRsmbRgRsRgRsRsRsRgRsRgRsRsmmmmmmmbRgLsbRsbsbRgRsmbRibRiRsmbRibRsR
sRsmmbRsRsRsRsRsRsRsRsmmmmmmmbRsRsRsRsRsRsRsRsmmmmmmmbRsRsRsRsRsmmmmbR
sRsRsmmbRsRsRsRsRsRsRsRsRsmmmmmmmmbRsRsLsRsmbRsRgRsRgRsRsRsRsRsRsRsRsR
sLsRsmmmmmmmmmmbRgbLebLibRsRsmbLsbRjbRcRsmbRebRcbRgbRjbRsRhbRgRsmbLsbR
iLsbRhbLgbLcbLgbLgbLibRsbRsbRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 30; Drug: OSU6162 10 然 Apo 50 然
bLebLsLhbRsbLgbRcbRsbRebLsbRsbLebLebLcbLsbRsbRcRsmbRcbLsbRsbLsbLsRsRsm
bLsLsmbsbRsbRsLsRsbLsbRibRsbRgbRgbRsbLsbsbRsbRgbRgbRsbLsbLsbLsbRsbRsbL
sbLsbRgbLsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 31; Drug: OSU6162 3 然 Apo 50 然
bRgbRibRgbRgbRsbLsbRsbRebRgbRsbRsbLsbRsbRsbRsRsmbRsbLsbRsbLsbRsRsmbRsL
sbRebLobRebLhLebLoRsRsRhLsLimbLcLsmbLibRiLsLsmbLjbRgLsbReRsmbLsRsbRsbR
sb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 32; Drug: OSU6162 3 然 Apo 50 然
bLsbLsbRsRjbRcbLcbLcbLsLsLsLsLsmmmmbLsLsmbRsRsRsLsmmbLsLsmbRsbRsRsmbRi
RsmbRiRsRsRsmmmbRsbLibRhRsmbLhbLsbRjbRsRsRsRsmmmbRsbLsLsRsLsRsRsRsmmmb
LobRjbsbRsbLsRsRsLsmbLsLsmbLsbLsbLsLsLsmmbLsLsLsLsLsLsLsLsLsmmmmmmmmbL
sbRsRsLsmbRsLsbLsbLsbLsbLsLsLsLsLsLsmmmmmbLsLsmbLsbLsLsLsLsLsLsRsLsLsR
sLsLsLsRsmmmmmmmmbLsLebLgbLgbLsLsLsmmbLsLsmbLsbLsLsLsLsmmmbLsLsLsLsmmm
bLgRsRsRsRimmbRsbRsRhRsLsRsmbLsLsLsLsLsLsLsRsLsmmmmmmbRsRsmbRsbRsRsmbR
sRsmbsbRsRsRsmmbRsRsRsmmbRsRsmbRsRsRsmmbRsbRsbRsRsRsRsRsmmmmbLsRsRsmbR
sRsmbRsbRsRsRsRsRsmmmmbRsRsmbRsRsRsRsRsRsRsRsRsmmmmmmmmbRsbRsRsRsmmbLs
RsLsbRsRsLsmbRsRgRsmbRsRsRsRsRsRsRsRsmmmmmmmbRsbRsRsRsmmbRsRsRsmmbRsRs
RsmmbRsbRsRsRsRsmmmbRsbRsRsRsRsRsRsRsRsRsRsRgmmmmmmmmmbRsRsmbRsRsRsmmb
sbRsRsRsRsRsLsRsmmmmbRsRsLsRsmbRsRsRsmmbRsRsRsRsRsmmmmbRsRsmbRsRsmbRsR
smbsbsbRsRsmbsbsbRsLsbRsbRsRsmbRsbRsbRsRsRsmmbLsRsRsRsmmbRsbRsbRjbLsRs
bRsbsbRsRsRsRsmmmbRsbRsbRsRsmbRsRgbRibRsRgbRgbRsbLsRsRsRsRsRhRemmmbRsR
sRsmmbRsRsRsRsmmmbRsRsmbRsRsRsmmbLsRsRsmbReRsmbRsbLjbLebLiRsbRsRsmbLiL
sbLcLsmbLsRsbRsLsLsLsLsRsLsRsmmmbLibLsLsLsmmbLsRsbLsbLsLsmbLsLsmbLgLsL
smbLsLebLsLsmbLsbLsbRsLsbLsbLsLsmbLsRsLsbLsbLsLsmbLsLsmbLsLsmbLsbLsbsb
LsbsbLsbRsbLsLsLsmmbLsbLsLsmbLsbLsLsLsLsLsLsmmmmmbLsLsLsLsLsLsmmmmmbLs
LsmbLsLsmbRsbLgbLgLgbLgLsLsmbLsbLsbLsLsLsmmbLsbLsLsmbLsLsmbLsLsmbLsRsb
LsbLsRsLsbsbLsbLsLsmbLsLsmbLsLsLsmmbLsbLsLsmbLsLsmbLsbsbLgLsbLsLsLsLsL
smmmmbLsLsmbLsbLsLsmbLsLsmbLsLsmbLsLsLgmbLgbsbLsbLsLsLsmmbLgLsLsLsRsmm
bLsLsLsLsmmmbLsLsmbLsbLsLsLsmmbLsLgbLsLsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 33; Drug: OSU6162 3 然 Apo 50 然
bLiRsbRibLibLsbLsbLsbRibRgbRsbRcRgbRibLebLhbLgbLgbRsbLsbLgbLebRcbLgbRg
bRgbRcbRobRgbRsbRgbRsbRsRgbLsLsmbRgbRsbRsbRsbRsbRgbLebRgbRgbRsbRgbRcRs
mbRobsbsbLsbLgbLgbLgbLibLgbLgbLhb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 34; Drug: OSU6162 3 然 Apo 50 然
bRsRgLsbRgbRgbLsbRsbRgbRsbRebRobLibLoRsbLibRjbLgbLsLsmbRsRsmbLeRgbLebL
eLsLsmbLebLsbRsRgbRcRsmbLgLebLgbRjbLsbRsbRsbRgRsmbRgRsmbRhbRgbRsbRsRib
RibRsRsmbRgRsmbLjbRcbRiRebRsbLsbRsbRobLsbRsbRgbLgbLgbRhbRhbRgbRgbLgbRh
bRibsbsbRgRsmbRiRgRsmbLebRcbRsbLobRebLcbLsbLsLeLgbLsbsbLsbLsbLeb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 35; Drug: OSU6162 3 然 Apo 50 然
bRibRsRsmbRsReRsmbRsRsLsmbRebRsRiRsmbRsRsLsReRsmmbRsRsRsRsRimmmbRsbReb
sbRsRgRsmbRsbRsReRsmbRsRsRsRemmbRsRgRebRsLsRsRibRsRsRimbRibRgRsmbRsReR
smbReRiRsmbReRsmbRsReRsmbRsbRsRsRsRsmmmbRiRibRsRsRsRemmbRibRibReRsmbRs
RsReRsmmbRebRebRsReRsRsmmbRsRsRsRemmbRgbsbReRsRsmmb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 36; Drug: OSU6162 3 然 Apo 50 然
bLsRsRsRsRsRsRsRsRsRsRsRsRsLsRsRsRsRsRsRgRsmmmmmmmmmmmmmmmmbRsRsRsRsRi
RsRsRsmmmmmmbRgbsbsbsbsbRsRsRsmmbRsRsRgRsRsRsRsmmmmmbRsbRgRsRsmmbRsRsm
bsbRsRsRsRsRsRsRsRgRsmmmmmmmbLsRgRsRsRsRgRsRgRsLsmmmmmbRsRsRembRibRsRs
RsmmbRiRsmbRebRsbRsRsmbRibRibRgbRsRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmmbRs
RsmbRsRsmbLsRsRsRsRsRsLsmmmmbRgRsmbRsRsRsRsRsRsRsRsmmmmmmmbRsRsRgLsRsL
smbsbRgbRsbRsbRsbRsRgbRgbsbRsbRsRsmbRsRsRsLsRsRsmmmbRsLsRsRsmbLsRsbRsR
gRsRsRsRsmmmmbRsbRibRcbRobLibLcbLobLcbRobsbRsbsbsbsbsbsbsbsbsbsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 37; Drug: OSU6162 1 然 Apo 50 然
bRibLgLsLsmbLobLcbRibsbsbRgbRgbRcRsmbLobLoLsRsmbLhLsbLcbLobLoLsmbLibLi
LibLcbLeLsLibLeRsLcbRgbLgRsbLcRsbRcbRoRsmbRobRobRibRebRhbRgbReRsRsmmbR
gbRiRsmbRgbRsbRgRsmbRsbRgbRgRsmbRsRsmbRibLhbLcbsbLobsbLobLcbLhbLibReRc
bRcRcbRcbRiRsmbRiRsmbRibRhRcbRsbRibRibRsbRsLsbRgbRsRsmbRsbRsbRgRgbRhRs
mbRobRcRsmbRiRsmbRcbLcLsmbLoLsmbLgbLhbLcbLiRsbLgbLhbLiLsbLgbLgLsbRsRsm
bLgbLsLsmbRjbRjRgbLjLsmbRibRsRsRsRsRsmmmmbLsbRsRsmbRgbRsRhbLiLgRsbLgLj
LsLsmmbLsbLibRcRsmbRhbsbRibLcbLhbLcLsmbLhLsbLcLsLsmmbLibRgbRebRcRsmbRc
bRibRhbRcbRcbRcLsbRibRibRoRsmbRgbRibRebLebLebLgLsbLiLsRsbRjbReRsmbLjLc
bRjRjRsmbRiRsmbRiRsmbRcRsmbLjLebLgLsLsLsmmbLcLsmbsbLsbLsRsbLsbLibRcbRi
RsRsmmbRgRsmbRebRobRobRcbRcbRibRsRsmbRgbRsRsRsRsLsRsmmmbRsRsRimbLcLsmb
sbLcbLiLsbRcbRhbRsRiRsmbLjbLcLsmbLcbLcLsmbRcbRobRhbRibRebRjRiRsmbRibRi
bRibRhbRibRiLsRsbRcRsmbRgbRiLsbRibRhbRibRiRsmbRcbRhLsbRibRiRsmbRibRgRg
RsmbRiRsmbRcbRgbRsRiRsmbRgbRgbRgRgbRgRsmbRgRsmbRgbRgbRibRibRsRsRsmmbRg
RsRsmmbRgRsLsmbLsbRgbRsbRibLsbRgRsRsmmbsbRsbRiRsRsmmbLgbRhRsmbRibRibsb
LsbRcbReRsmbRebRiRsmbRiRsmbRgRsRsRgmmbLebRhRsmbRcRsmbLcLsmbLobLgLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 38; Drug: OSU6162 1 然 Apo 50 然
bsbLsbLsLsmbLsbLsbLsbLsLsmbLsbLsbLsbLsbLsLsLsLsLsmmmmbLsLsLsLsmmmbLsbL
sbLsbLsbRsLsLsRsmbLsbLsLsLsmmbLsbLsLgLsbLsLsmbLsLsmbRsLsbLsLsLsLsLgLsL
smmmmbLgbLgbLiLgLsbLcbRibLebLiLeLsbLibLhbLhLsbLibLgLsLobLeLeRsbLebRoLs
bRcbRsLsbLsbRsRibRsRsRsRgmmbRsbLsbRgbRsRsmbRsRsmbRebLsbLgbRoRsmbRgbRhb
RsbsbsbRsRsLsRsmbRsRsRsmmbLsRsbsbLobLhbLiLsbLibLibRcbRcbRcbRsbRibRebLs
bLebLibReRgbLcbLsbRcbLoLsmbLibLibLgLsbLebLjbRsRsRsmmbRgRsRsmmbLsbRibRs
RsmbRsbRsRsRsRsRsRsmmmmmbRsRsRsRsmmmbRsbRsbLjbRgLsbRcbRcbRcRsmbRebLsRg
bRebRebRiLsbRcRsmbLebLebLcbLhbRgbLobLibLsbLgLgbLiLeLgLsLgLsbLsbLobLgbL
obLibRebRcbsbLjbRoRsmbRsRsRsmmbLcbLsLsmbRsbLgLsRsLhbLsLibLsbRsbLsbRibL
ibLebLibRobLcbLcbLobLoRsbLgbLibLcLsmbLhbLhLsbRcbRhbRibRobLeLsbRibLobRj
bRcRsmbRobLcbLibLobLsbLobLobRibRhbRhbRcRsmbRsRsRsRsmmmbLjLgLsLsLgLgmbR
sbRjRhbLcLsmbLsLsLsLsLgLsLsLsLgmmmmmbRgbLsLsLsLgLsmmbLsLsLsLgLgmmbLsLs
LsLsLsLsmmmmmbRsRsLsLsLsLgLsLsLgLimmmmbLgLsLsLsLimmbRsLsbLsbLsLsmbLsLs
LsLsLsLsmmmmmbLhbLiLgbLgLsbLgbRgbRjbReRsmbRsLsRsRsRsmmbRsRgbLiRsbLcLsL
smmbLebLiRsbRgbRhbRgbRibRgbLsLsmbRcbRibRobRobLjbLsRsbLhRsbLgLsLsLsRsmm
bLiLsbLiLsRsbLhb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 39; Drug: OSU6162 1 然 Apo 50 然
bRgbRsbRibLcbRobRgLsbRobRgLgLsbLiRsLibLiLsbLgLcLsLcmbRjbsbRcbLcbLobRcR
smbRcbRobLibLcbLibLgbLgbRhbLobRsRobLsLcbLobRcbRcRsmbRhLsLsmbLiLsbLobLs
bLgbLgbLgbLsbLgbLhRsRsLsmbLsbLgbLibLgbsbLoRsbLcbLcbLibLibLibRebRibLsRs
bRgbRiLsbRoLsRsbLsbRoLsbLsbRoLsbRcbRebRsbRsbRsbLsLsmbRgbsbLhbLoRsbLobs
bRobRcLsbLsbRobsbLoLsmbLobLgbLiRsbLiLsbLiLsbLiLgbLiRsbLoLsmbLobRoRsmbR
gbRoLsRgRsmbRcbRgRsLsmbRgRsmbLsbRhbRoLsLsmbLgLsbLoLsmbLobLcbRobRiRsmbR
ibRhbsbRgbRcbLibRebRibLobLobLcbLibLgbLgbLibLgbLibRobRebLsRsbRsbLoRgbRe
bLgbLibLiRsbLjbLoLsmbsbLsLsmbLjbRcbLcbRgbRibRsLiRsbLcbLgbLgbLcLsmbLsbL
ibRsbLobRiRsmbLsRsbLsbLjbLobRibRebRhRsmbLiLsbLjbLibLsLhLsbsbRcbRiRsmbR
ibLsbLibLobLiRsLsbLgbLgbLgbLgbRsbRjb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 40; Drug: OSU6162 1 然 Apo 50 然
bLsbRsbsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 41; Drug: OSU6162 1 然 Apo 50 然
bRgbLjbLsbLobRsbRibRebLsbRgRsmbRsbRsRsRcmbLsRsbRiRsmbRebLgLsLiLebLcbLs
bLibLgbsbRsbLobLcbLiRsRsRembLobRcbsbLsbRcRsRsmmbRcRsmbRcbRcbRibRcbRibL
obLiLgbLsbsbLsbLgbLgbLsbLsbLsbLgbLebLcbLibLebLgLhbLebLsbRebLoRgbsbsbRs
LsRsbLsbsbLibLgbLgbLgLgbLibLoRsbLhbLcbLebRebLcbLcbRsbLsLsLsRsRsLsLgLgL
smmmbLiRsbRhbLoLsmbLobReRsmbRobRobRobLcbLibRhbRibsbLsbRsbRsRsmbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 42; Drug: OSU6162 1 然 Apo 50 然
bRgRsmbLjbLsRsbRjbLgLsLsmbRsbRhbRsbRiRsRsmmbLsbLjbLebLobLgLsLsmbRsbLsb
RsbLcbReb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 43; Drug: Control Apo 50 然
bRgRgRsRsRsRsRsRsRsRsmmmmmmmmbLsbRiLsbLeLsbRcbRibLsbRhbRgbRgRsmbRgbLsR
sLsRsLsLsLsLsLsmmmmbsbLcbsbRcRsmbLsRsRsmbRsRsRsRsRgmmmbRgLsRsbRiRsmbRh
RsmbRsRsRsRsRsRsRsmmmmmmbRgRgRgRsmbRgLsLsRsmbLsRsbRsbLsbRebRgRsRsmmbRi
RsmbRsRsmbLsbsbRsRsRgRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmmbRsRsRsRsRsRsRsmmm
mmmbRgbRibLgbLsLsmbLsbLsbLsLsLsmmbLiLsLsLsLsLsLsmmmmmbLsbLhLsbRsRsRsmm
bLsbLsbLsbLsbLsbLsLsmbLsLsmbLgLsLebLsRsbRsbLsLgLsLsLsLsLsLsLsLsLsLsLgL
gmmmmmmmmmbLgbLgLsbLgbLibRibRgbRgbRsbRsbRsRsmbRsRsRsRsRsRsmmmmmbRsRsRs
RsRsRsRsRsRsRsRsRgRsRsRsRsRsmmmmmmmmmmmmmmmbRgRsRsRsmmmbRgRsRsRsmmmbRs
RsmbRsRsRsmmbRsRsRsRsRsRsRsRsRsRsRsRsRsRsRsRsRsRsRsRsRsRgRsRsRsmmmmmmm
mmmmmmmmmmmmmmmmbRsRsRsRsRsRsRsRsRsRgRgRsRsmmmmmmmmmmbRsRsRsRsRgRsRsmm
mmmbRgbReRsmbsbLibLebLsLeRsbLibRsLcbLobLcLsmbLeLsbLeLsbsbLiLiLsbRgbLhb
sbsbRibLsbLgbLebLsbLgLsLiLsbLgLsLsLsLsLsLsLsLsLsLsmmmmmmmmmbLsLgLsLsmb
RsLsbLsLsLsLgLsLsLsLsLsLsLsLsmmmmmmmmmbLsLsLsLsLsLgmmmmbLgLsLgLsbLeLsb
LgLsLsLsLsmmmbLsLgLgLsLsLembLgbLsLsmbLgLibLgRsLsbLsbRsbLsbLsbLgbLsLsmb
LsLsLsmmbLsbLjLsLsLsmmmbRjbRjbLibReRsmbLcbLibsbLeLsLsLembLibLobRiRsmbR
cb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 44; Drug: Control Apo 50 然
bLgbRcRsmbRgbLibRcbRiLsbLhbLibLiLgLebRjbRebRibRobRgbRibRcbRgbLsbRcbRgb
RhbRcbRobRhbRibRiLgbRcbRobRcbRcbRcbRiLsLsmbLgbRoLsbLgbLebLhbLcbLcbLcbL
gbRsbLibLgbRgRgRebLibLibRhbRibRhbRebRibLobRobRcbRcbRhbRibLgbRibReRsmbR
iRsmbRibRcbRibRebRibLjLsLsmmbLhbLibLsbRsbLcbLjLsmbRhbRjRhbRsRsRsRsmmmb
RhbLibLibRgbRsbLibRsbLgbRgbRjRsmbRibLcbLjLsLsmmbLcbRiRsmbRcRsmbRjRibRi
bLhbLjbRcbLjLsLsmmbLjLsmbLibRjbsbLjbRjbRcbRcbRiRsmbRibLjLsmbLjLjbLhLsL
smbLjLgLsbRibRjbRcbRhRsmbRsbLcLsmbLcbRibRibLgLsbLcbRjbRhRsRsmmbLcbLjLs
LsLsmmmbLiLsbRcRsRsmmbLjLsmbLcbLebRjbRsRcbRiRsmbRhbRibLjbLhbLhbRjRibLi
bRjRsmbRsLsbLsbLibRjRsmbsbLibLjLsLgmbRjRsReRsmmbLhbLjbRjRobRsbLeb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 45; Drug: Control Apo 50 然
bsbsbsbsbLsbRsbRebRiRgbReRsmbLsRsRsmbRhRsmbRebRgRsmbRsbRgbRsbsbsbLsbRs
bRsLsRsRsmbsbRgRgRgRsmbRgRsmbRgRgLsbRgbRgbRsRsmbRsbRsRsmbLsbLsbLsbRsbs
bsbsbsbsbLsbsbsbsbsbsbLsbLsbRsbsbRsbRsbRsbsbsbsbsbsbsbsbsbsbRsbsbLobsb
sbsbLsbsbsbsbsbRsbsbsbsbRsbsbLsbRsLsbLsbsbRsLsLsRsmbLsbLsbRsbRsLsbRsbR
sLsRsbLsbRsLsbRsbRsbsbLsbRsLsRsLsLsmbRsLsRsbRsbsbsbRsbLsbRsLsbsbRsbRsb
RsbsbsbsbRsRsLsmbRsLsbLsLsmbLsbsbsbsbsbLsbRsLsbLsRsbLsbRsbsbLsRsbsbLsR
sbRsLsRsbsbsbLsRsbRsbsbsbsbRsbsbLsbsbsbRsbLsRsbLsbRsLsRsbsbLsbRsRsLsRs
mbRsLsbsbLsbRsbsbLsbsbRsRsmbLsbsbRsbLsbsbsbRsbsbRsbsbLsbLsbsbLsRsbsbsb
RsbLsbsbRsbLsbsbRsbRsLsbsbLsbLsRsbRsbLsbLsbsbsbsbsbRsLsbsbsbsbRsbsbsbs
bLsbsbsbRsbsbRsbLsRsbLsRsbRsLsLsRsmbsbsbsbsbsbsbsbLsbRsbRsbRsRsLsmbsbs
bRsRsmbsbRsbRsLsbsbRsLsLsmbRsRsmbRsbLsRsLsbsbRsLsbRsbRsbLsbRsbRsbsbsbs
bRsbRsbsbRsbsbRsRsmbLsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 46; Drug: Control Apo 50 然
bLjLsmbRsbLgbLobRhbRibRcRsmbRgbRobLsbLgbLsbLsbLebRsbRgbRibRsRsmbRsbRsb
RobRgRibRsRsmbRgbLobRibRiRsRsmmbRebRsRsmbRcRsRsmmbLibLebRsbLhbLebLebLg
bLibLgbRjbRcbRhbLobLibRibRibRsbLeLsLsmbLiLsbLgbLgbRjbLsbLibRsbLgbRcbLs
bRibLgbRibRibRgbRsbRgbRsbRsRsmbRgRsmbRgRgbRiRsmbRsbRsRsmbRgbRsRsmbRsbR
gRsmbRsbRsReRebRgbRsbRgbRsbRsRsmbRsRsmbRgRibRebLgLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 47; Drug: Control Apo 50 然
bLsLsLsLsLiRsmmmbLsLsLsmmbRcbRsLsLsmbLsbRebRibLsLsmbLeRsbLibLiLsbRebsb
RjbRsRcbLsRsLsbLebLibLsbLsLsmbLsLsmbsbLsbLsbRsbLsLsmbLsLsLsLsLsmmmmbLg
bLsLibLsbLsbRgLsLsmbLsLsLsLsmmmbsbLsLsLsmmbRsbLsLgLsLsLsLgLgmmbRgbLsbL
sLsmbLsbLgbLsbsbRsLsLsLsmmb

>ZF Recording 2016-08-17; tW: 300s; Start: 163326; End: 163826;
Recording: 8-1; Individual: 48; Drug: Control Apo 50 然
bLiLsLgbLgbRebLsbLsbLgbLsbLsbRsbLsbLsbLsbLsbRsLsbLsbLgbRsRsmbLsbLgbLgb
LsbLgbLsRsbLsbLsbLsbLibLgLsLgbLsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 1; Drug: OSU6162 10 然 Apo 50 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 2; Drug: OSU6162 10 然 Apo 50 然
bsbsbRjbRibLcbLobLiLsbLiLsbLhLebLebLgbLiLsbLgRsRsmbLgbLgbLgLsbLibLiLeL
eLebLebLebLgLsbRsbLhbRgRsmbRoLsRcbLhbLgLibRsbRobLgbRhbLibLjLibLebRibRs
bLgbRibRgRsmbLsbsbsbsbsbsbsbLsbsbsbsbsbsbRsbRsbLsbLsRsRsLsmbRsbLsRsbRs
RsmbsbRsRsmbLsbsbLsLsmbLsbLsbRsRsRsRsmmmbRsLsRsbRsRsmbLsbRsRsmbRsRsmbR
sbLsbsbLsbRsRsmbsbsbRsbLsbRsbsbsbLsbLsbLsbLsLcbRcbRiLsReRebReRsmbRebLi
bRibsbLebRhbLcbRobRhbLsbRcbsbLoRsbRibRsLsbRgbLobLiLsbLgbRjbRibLsbRiLsb
LgLgbLiLsbLgbLhLsbLgbLiLsbRebLcRsbLgLsbRobLoRsbLibRcRsmbLcbLsbsbRsRsmb
RjRsRsRsmmmbRgRsRsmmbRjbLhLsbLiLsLsmbRjbLeLsbLjbRsbLsbRsbLjbRsbRsbRibL
sLebLgbLibLibLsbLgLsbRoRsRsmmbRjbLgbRibLoRsbRgRsRsmmbRgbLibLsLibLobRob
LsbLgbRsRsmbLsRjbRsRsmbLobLhbLcbLcbLiRsbLcbLibRcRsmbRibRibRibRgbRcbLsb
LsbRibRsRsmbRgRsRsRiRsRsRhRgRsmmmmmbRsbLsRsLsLsRsRsmmbRsbRgLsLsmbLsbLs
RsLsbLsbRsbRgRsRsRsRsRgRsRsRsmmmmmmmbRsbRsRsRsRsRsRsmmmmmb

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 3; Drug: OSU6162 10 然 Apo 50 然
bRibLibRebRebRibLiLsLsmbRsLsbLsLsmbLsbLsLgLsbLsRsbLsbLsLsmbRsbLsbLgbLg
bLsbLsbLsbLgbLsLgbLsLsLsLsLsmmmmbLibLcbLebReLsbRcbRsbRsbLgbLcbLcbRibLs
bLsLhLsLsRsmbLsLsmbLsbRsLsLsmbRsbLsLsmbLsbLsLsmbsbRgRsmbLgbLsbLobLobLo
bRcbsbLsbLsLsLimbLsLsmbLsLsLsmmbLiLsLsmbLsLsLsmmbLsbLsLsLsmmbsbLsLsLsL
sLsLsmmmmmbLsbLsLsLsLsLsRsmmmmbLsLgbLgLebLebRsRsmbLgLsLsLsmmbsbLsLsLgL
smbLsLsmbLjbLiLgLibLsRsbLgLgLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 4; Drug: OSU6162 10 然 Apo 50 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 5; Drug: OSU6162 10 然 Apo 50 然
bLsbRebLcbsbRgRsRsRsmmmbRsRsRimbLibRiLgbRobLgLsLsmbLsLsLsmmbLebRsbRsbR
gbLeLgLsbLsLsmbLgLibLhLgbLebLiLsLsRsmbLsLsLgLsmbLsLsmbLgbLgbLiLsbLibLe
LsbLibLsLsLgmbLeLeLsbLgLsLibLsLsLsLsLiLsmmmbRsLibLiLsLgRsbLgLsLsLgmbLg
LsLsmbLgLsLsLsmmbLsbLsLsLsLsLsmmmmbLsLsLsmmbLgbLebLebLiLgLgbLgbLgLsbLi
RsbLgbLibLibLsbLsbLsLsmbLsbRsLsbLsLsLsmmbsbLsLiLsbLsLsLsLsLsLsLiLsmmmm
mbLiLsLibLgbLgLsLsLsmmbLsLsLsLsLsLsLgmmmmmbLsLsLgLsmbLgLsLeRsbLcbLcLsm
bLgLsLsLgLsLgLsLsLimmbLsRsbLsbLgbLsLsLsLemmbLgLsLsmbLhbLebLibLibLsbsbR
ibLsRsbRsbRobRsbRibRibLibLsLsLsmmbLibLhbLsbLsLsLsLgLgmmbLgbLgbLgLsLsLs
LgLgmmbLiLsLsLsLemmbRgbLgbLiLsLgLebRgbRsRsmbLsbLibRsLhbLgbLgLgLsLgbLsL
sLgLsmbLiLsLib

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 6; Drug: OSU6162 10 然 Apo 50 然
bsbLgLsLsmbLsbLiLsbRcbLcLsmbLhLsLsmbLhbLebRjbRgbRgbRebRsRsLgmbRgbRsbLe
bLsLebLjbRsbsbRgLebLjbRsbRibRibRhbLibLgbRsbRgRibRgRiRsmbRsbRibsbsbsbsb
sbsbLsbRsbLsLsmbsbRsRsRsmmbRsRsRsRimmbLsbRsbLsbsbLsbsbsbsbsbsbsbsbRsRs
RsRsmmmbRgRsRsmmbRibLcLsmbLibLgbLibRgbRgbRibRebLsLsmbRhLsbRgbRebLcbReb
LjbRiLibLsbRiLsbLibLiLsbRibLibLgbLobRgbLsLsmbRsbRsRsmbsbLsbLsbsbRsbsbR
sRsRsmmbRebLebLcbRsbRsbRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 7; Drug: OSU6162 3 然 Apo 50 然
bLsbLgbLgLsLiLgLibLsbLgLgLgLibRsbLsbRsbLsbRsRsmbRsbRsbRsbRsbRgbLsbLjbL
sbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 8; Drug: OSU6162 3 然 Apo 50 然
bRsbRsbRsbLsbRsbLsbLsbRsbRsbRsbRsbRsbRebLjbRobRebRcbRobLcbRsbRobLjbLsb
RjbRjbRsbLebRobLsbRobLebLcbRobLobRebRobRobLebLibRjbRobLjbRobLjbLobLjb

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 9; Drug: OSU6162 3 然 Apo 50 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 10; Drug: OSU6162 3 然 Apo 50 然
bLibLgLsLsLsmmbRsLhbRsRsmbRjRsmbLjLsLsmmbLibLhbLebLgLhbLibRebRcRsmbLsb
LgbLcbLjbLibLgbLiLsbRjbLcbsbLjbLjLebRcbRjbReRsRsmmbRjRsmbRcRsmbRibLhbL
ebLibLhbLebLjLgbLcbLjLgLsbLjLsLembLhbLibLsLebRebLsbRcbRsRibRibRibRjRib
LsLgLsbLiLsbLcLibLibLhbLibLhbLhbLibLcbRibRobRgRsmbRcbRcbsbLibLibLcbLgb
LcbRebRcRsmbRebLgbLsbLsbLgbLhbLibRibRcbRcbRcRsmbLsbLgbLcbLebLebLibRsbL
cbRsbLcbLcLsmbLebLsLgLsLsLgmbRsbRgbRibReRebRiRsmbLoLsmbLgbLcLsmbRgbLcb
LiRsbRgRsmbRsbRjbLiRsbLebLhbLhbLibLibLiLsbLibRobRcRsmbLeLsLsmbLibRebRc
bRibLcbRsbLsbLcbLcbLiLsbLhbRebRebRcbLcbLibLjLcbRibLsRsbRsLsbRcbReRsmbR
sLsbLibRsbRsRsRsmmbRsReRsmbLjbLjLcbLcbLiLcbLcLsmbLibRcRsmbRibLobLibLib
LibLebRcbRcbRibLcbLibLcbRsbRhRsmbLhbRcRsmbLsbLgbLcLsmbLibLsbLgbLsbLjLs
mbsbRjbLeLsbRgRsmbRsRebRhbLgbReb

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 11; Drug: OSU6162 3 然 Apo 50 然
bLsLsLsLsmmmbsbsbLsbLgbLsbRsLsLsLsLsmmmbLsRsbLsbLsbsbLsLsmbRsbLsLsmbLs
bLsbsbLsRsbLsbsbLsbsbsbsbLsbLsbLsbsbLsbsbLsbLsbLsbLsbsbsbLsbLsbLsbLsLs
LsmmbsbRsLsbLsbLsbLsbLsLsmbLsRsbLsLsmbLsbLsbsbLsbLsbLsbLsbRsbsbLsbsbsb
sbLgbLcLsmbRobRebReRsmbRibRhRsmbRhbRebReRsmbRibRibLcLsLsmmbLhLsLsmbLib
RsLsbLsbLhbLsLsLsmmbLiRsLsbLibLgbLsbReRsmbRibRhLsbRiLsRsLsbLsbLgbsbLgb
sbLsbLsLsLsmmbLsLsLsLsLsmmmmbLsLsLsLsLsLsLsLsLsmmmmmmmmbRsLsLsLsmmb

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 12; Drug: OSU6162 3 然 Apo 50 然
bLgbLobRiRsmbRibLebLebLgLgLsLgbLgLsbLsLsLsLsLsLgLsLsLsLgLsLsLsLsLsmmmm
mmmmmmbLiLsLgLsbLsbLsbsbLsLsLsLsLsLgLsLsLsLsLsLsLsLsLsLsLsLsLgLsLgmmmm
mmmmmmmmmmmbRsLsRsbRebRhRsmbLebsbLhbLhbLibLsRsbLebLiLsbsbLsbLibLebLibL
ebLibLeLibLibLsbLsLgbLgbLiRsbLgbLgbRjLsbLcbRibRhbRebRgbRibRiRsmbRgbRgb
RgRsmbRgRsmbRebRgRsmbLebLibLiLgLsbLibLgLsLgbLgbLibLgbLibLibLibLgbLgLsL
ibLsbLgbLsbLgbLsLsmbLsbLsbLsbLsbLgbLibRsbLgLsRsbLsbLsbLgbLgbLebLgbLgbL
sLsmbLgbLsbLsbLsbLsbLsbLgbLsbLsbLsbLsbLsbLsLsmbLsbLsLsmbLsbLsbLsbLsbRs
bLsbLsbLsLsmbLsbLgbLsbLsLsmbLsbLsbLsbLsbLgbRsRgbRcbRibRibRgbRgbRgRsmbR
gbRgbRgbRgbRiLsbRgRgbRgbRgLsbLsbRgbRebRgbRiLsbLcbRjbRobLobRebLibLgbLib
LiLsbRibRibRibRsbRgRsmbsbLsRsbRsbRgbsbsbsbsbsbLsbLsbsbRsRsLsRsmbRjbLcb
LgLsbLcbLebRebRobLibLgLsbLgbLsbLsbLeLsbRobRebRgRsmbLsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 13; Drug: OSU6162 1 然 Apo 50 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 14; Drug: OSU6162 1 然 Apo 50 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 15; Drug: OSU6162 1 然 Apo 50 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 16; Drug: OSU6162 1 然 Apo 50 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 17; Drug: OSU6162 1 然 Apo 50 然
bRsRsRsRsRsReRsmmmmmbRibRsRgRsmbRibRiRsmbRsbReLsbRgRgbRibRgbRebRsbLobL
cbLeLgbLgbLgLsbLgbsbRsbRsRsmbLsbLgLsLsmbLsLsmbLgbLgLsbLsbRsbRsLsbLgRsb
LgbLibLibLgbLibLgRsbLibLgbLhbRebLibLhbLcLsmbRcbRcbLibLsbRgbLsbLibRibsb
sbRsRsRsLsmmbRsRsmbRgbRsRgbRibRsbRsRgbRibLsbRsbRsbRgbsbLsRebLsbRgbRgRs
mbRgbRcbLsLsmbLsbRebReReRsmbRebLibLsbLibLsbLsbLsbLsbLsbLgbLsLsLgmbLgbL
sbLgbLgbLsbLsbLgbLsLsmbLsLsmbRsbLsbLsLsmbLgbLsLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 18; Drug: OSU6162 1 然 Apo 50 然
bLsbRsbRsLsbRsbLgbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 19; Drug: Control Apo 50 然
bsbsbRsRebLsbsbRebRebRiRsRsmmbRcbRsbRsbReRiLsbLhbLoRsbLobLhbLobLcbLobL
hRsbLobRibRebRcRsmbRcRsLsmbLgbLsbLsRsLsbsbsbLsbsbLsbLhRsbsbRsbRsbsbsbs
bsbReLsbRgbRcbRgRsmbLeLsLsmbLoRsbLobLoRsbLhRsbLoRsbRhbRibRiRsmbRoRsmbR
hRhbsbRobRoRsLsmbRcbLgbRcbRiRgbRebRebRiRsLombLhLsbLhbsbRsLsbsbsbsbsbsb
sbsbRgbRjbRebRiRsmbRibLcLobLibRcbRibLcbRsbsbLsLsLsLimmbLsbsbLeLsLsLsmm
bRsLsLgbRjbReRsmbRebReRsmbRoLsLsmbLiLgbLcbLebLoLcbLebLcRsbReRgbRibRcRs
mbRebsbLoLsLsmmbLgLibsbLiRsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 20; Drug: Control Apo 50 然
bReRsmbLgbRsRsRsRsRsRgmmmmbReRsRsRsRsRsmmmmmbsbsbsbsbsbsbLsbRsbsbsbsbR
sLsbRsRgbRsRebsbLgRsbRobLsbRcRiRsRembLibsbLiLsbLsbLsbLsLsLsmmbLsbLsbsb
LsLsmbsbLsbRsLsbLsbsbsbsbsbRsRsmbRsbsbsbsbsbRsbRsbsbsbLhbLgbLgbLibLebL
hbLhbLgbLsbRsbRsRsmbLsbsbRsbLgbLsbsbLsbLsbLsbLsbLibLsbRsbLsbLgbRsbLsbR
sbLsbLsbLsbLsbLibLsbLsbLsbLsbLsbLsbLsbRsbLjb

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 21; Drug: Control Apo 50 然
bLsLeLebLsbLcbRibRcLsbRgLgbLebLgLiLsLeLeLsLsmbLobRebRibLsLsmbLsLsLsmmb
LsLsLgmbLcbLeLsbRcbLsbLebLcbLeLgLsLeLeLsbLebRjbLsRsbLsLsLsmmbsbLebLibR
ebRcbLcbLebLiLsbLsbReRsmbLsbLeLsbLgLsLsLsLsLemmmbLiLibLeLsbRcbLcLsmbRe
bsbLsLebLebLsLgbLsLgbLsLeLsbLiLsbLebLcLsmbRcRgLsbLibLsLiLsLsLsmmbsbsbs
bLeLsbLsLeLebLibLhLsLsmbRibLgbLgLsbLibLsLsLsmmbLsLsLsmmbLeLsLsmbLcLsLh
mbLebLcbRcRsmbLcbLebLob

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 22; Drug: Control Apo 50 然
bRsRgRgRhbRsRgbRgbLsRiRsmbRsRiRsRimbRsbRgRsRsmmbRsbRsRsmbRsRgbRsRibRsR
sLsRsmbRsRsmbRgRsmbRsRgRsmbRgbReRgbRgRgbRgbRgbRgbLcLsmbLibRibsbLhRsbLe
bLgbRgRsRsLsmmbRgbRgRibLjbRsbsbLgbRjbRgRsmbRsbRsRsmbRgbRgbRsbRsbRgRiRs
mbRiRsmbRgbRsbRsRgbRibRsbRgRsmbRgbRsbRibLsLsmbRebLsRsbLibRibRcbRiLsbRi
bRibLsbRibRibRgLsbLibLobLgbLgbRsLsRsbLgbLsLibLsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 23; Drug: Control Apo 50 然
bsbLsRsbsbsbsbLsbsbLsbRsbsbsbsbsbsbLsbsbsbsbsbsbsbsbsbRsbsbRsbRsbLsLsm
bLsRsRsmbRsbsbLsbsbsbsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 24; Drug: Control Apo 50 然
bLebRebLobLebRgbLsbLibRebLjbLobRibLcbRebRcbRjbRobLebLsbRobRibRobRobLjb
LebLgbLobRebRebRcbRobRebLjbLebRsbLobRobLibRobRjbLcbLobRobRcbLobRebRobR
ebRsbLobRcbRobRobRobRcbLebRobLjbLebLsbRjbLobLobRcbRebRebRobLsbLcbRjbLc
bLobRobRebRobLobLsbRjbLobLebLsbRcbRhbLobRobRobRebLebRebRcbLobLebRjbLeb
RobRobRjbRobRobLcbLebRobRebLobRjbLobLobLcbRgbRobRebRcbLjbRebRibRgbLobL
sbLcbRjbLsbRobLgbLsbRobLobLjbRobLjbLjbRgbLjbRobRobRjbLobRobLcbLobRobLo
bLobRobLjbRobRobLebRobRebLobLjbLsbLobRebLobRobRjbLcbRsbRobLcbRjbRsbRob
RebRobRobRcbLebLobRsbLobLebLebLobLcbLobLhbRobLobRobRobRobRjbRcbRobRobR
obLebRjbRobRjbRobLobRsbRjbLcbLobLobRcbLobLjbRebLobLobRebRobLjbLsbRcbLo
bRobRsbLjbLobLobRebRobRcbLobLjbRebLobLebRobLcbRjbRebLjbRebRcbRcbRibRob
RebRobLsbLobLobRjbRobRjbRobRebRebLjbRobRobLebLobRjbRobLjbRobLebLobRebL
hbRjbRjbRobRebRobRobLcbLjbRebLcbRobLjbLebRsbLobRobLebRobLobLjbRobLebLo
bRsbRebLobRebLobLjbRebRjbRobRebLjbLsbLobRgbRebRobRobLobRobRjbLjbRobReb
LobRjbRobLobRsbRcbRjbLsbRibRobLhbRobLebLjbLjbLcbRebLobLjbLobRgbRibLcbR
obRobLebLobRibLobLobRcbRcbLobRobRibLjbLobLobRobRobRobRjbRebLobLobLobRe
bRobRobLobLjbRebRcbLsbRebRjbLebRjbLobLobLebLobRobRobLobLobRobRobRobLob
RobRebRobRibRebLsbLgbLebLsbLebRibLobRjbRobLebRobLobRcbLobRobLobLcbLsbR
obRibLhbRobLobRcbLjbRcbLebRibRsbLebLobLjbLebRebRibRcbLobLobRobLebLgbLs
bLobLgbLsbLobLjbLobRebLobLibLobRebRcbLgbRobLsbLobLobLebLebRobRobRsbRgb
LobRobRjbRebLjbRobRobRsbRobLobRobRsbLjbLhbLibLobLebRobRsbRobRgbRobLobR
ibRcbRobRobRobLebLgbRebLobLobRebRebLobLebRebRobLebRobRobRjbLgbLobRgbRc
bRebRjbRjbLobLebLebRobRcbLebRcbRobLebLsbLobRcbLibRebRcbRobRebRibRebRjb
RcbRjbLobRsbRgbLjbRobRgbRsbRsbLjbRebRobRebRobLsbLsbLcbRobRobLobRebRobL
jbLebLcbRibLobLobLgbLebLcbLobRebLjbLsbRibLjbLjbLjbLebRjbLebRobRjbRcbRo
bLobLibRebRobLobRobRobLibRhbRebLobLobLjbRobRcbLobLibLobLobLobLcbLjbRob
LsbRobLebLebLobLobRebLobRobLobLjbLibLebLobRobRebLebLobLobLsbRcbRebLcbL
jbLebRgbRobLebRebRsbRobLjbRcbLobRobRobRobLobRsbRobLebLobLjbRebLobLebLo
bLobRcbRebRobLobRcbRobRjbLebRebRebRobLcbLobRobLcbRcbRebRebRobLjbLobLeb
LcbLobLebLobRobLebLjbRjbLobLsbRebRobRobLebRsbLjbRobRebLobRgbLobRobRobL
obLgbLsbRjbRjbRobRebLobLsbRobRobRsbLcbRsbLobLjbRobLsbLjbRobLjbLebLobLo
bRobLjbLcbRobRjbLcbRobRjbLobRgbLcbLjbRobLsbRjbRebRibLobRobLjbLebRcbRgb
LobLgbRobLobRobLcbRobLgbLibRobRebRgbRhbLobLobLobLobLibLebRobLobRcbLibR
cbLobRebLsbLibRobLobRgbLobLibLjbLobRjbLobRobRcbRcbRobRobLgbRobRobLjbLe
bLebLsbRebRsbRobRsbLebRebRebLobLebRobLgbLsbRebLobLobRobLcbRobRibRobLgb
RebRebRobRcbLgbRcbRcbRobLobRobLobLobRgbLcbRobRebLgbLjbRobLcbLobLcbRcbL
cbLgbLebLcbLobRebRobLebRcbRobLobLgbLibRobRobRibLobRobLebLobLobLcbLebRj
bRobRsbRobRibLebRibLibLobRobRcbLibLobRhbLjbLobLobLobRebRobRhbLobRobLob
LobLebRobRebLsbRibLebLcbLcbLobLcbRcbLgbLobRobLobLobRcbLebRjbRobLobRsbL
obLsbLobRobLobLjbLobLjbLobRebLebRjbRobLobRcbRobRsbRebLobRsbLebRjbLjbRc
bLobLobLobLcbRcbRsbLjbRsbLebLebRibLcbLobLebRgbLjbLobLjbRobRjbLjbRebLjb
RebRobRobLcbRjbLcbLobLobRcbRobLebRcbRobLjbLobRjbRobLjbRebRjbLobLobLebL
cbRobRobRjbLebRcbLobRcbLobLcbLjbLjbRebLobRebLebLjbRobLebLhbRebRhbLebRc
bLjbLobLobRobLebRobLobRjbLobLobLobRjbRjbLobRobRobRobRobLobLobRobLebLob
LjbLjbLcbRsbRcbRobLibLjbLobRebRobRobRjbRobRsbLcbRhbLjbLobRibLjbRjbRcbR
obRgbRobLobLcbLobLebRobRobLjbRebRobLebRobLebRebRebLobRjbLjbRobLcbLcbLc
bLibRobRsbLebLebRobRcbRobLebRcbRobLobRcbRebRobLcbRsbRobRobRebRcbRcbRcb
RcbLjbLcbLobLcbLgbLebRcbRcbRobRebRobLobLobRebRcbLobLobRobRebLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 25; Drug: OSU6162 10 然 Apo 50 然
bRsbsbsbRsbLsbLsbLcbRgbLsbRsbRsbRsbLsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 26; Drug: OSU6162 10 然 Apo 50 然
bLsbLjbLsbsbLgRsbsbLiRsbLsbRjbRjbRsbRiRsmbLebLgbLibLgbLobRobLsbLobLcbR
sLsRsLsbRsbRsRsRembRsbRsbRsLsLsRsmbLsbsbRsbReb

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 27; Drug: OSU6162 10 然 Apo 50 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 28; Drug: OSU6162 10 然 Apo 50 然
bLsLgbLibLsRsbRsbLsLsLsmmbLsbLsbLsbLsLsLsLsmmmbLsbLsLsmbLsLsLsmmbLsbLg
bLsLsmbLgbLgbRsbLsLsRsmbLsbLsbsbLsLsmbLsLsLsmmbLsbLsbLeRsbLgbRsbsbsbRs
LsbRsbLgLsbLgRsbLsbLsbLsbLsLsRsmbLsLsmbLsbLsbLsLsLsLsLsmmmmbLsbRsRsmbL
sLsmbLsLsLsLsmmmbLsbLibRsbLiLsRsbLibRsLsbLsbLsbLsbLsbLsbLsbLsbLsbLsbLs
bLsbLsbLsbLsbLsLsmbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 29; Drug: OSU6162 10 然 Apo 50 然
bRgRgRsRsmmbRgRsRsmmbRiRsRsRimmbRgbLsbRibLsbRsbRhbRiRsRsmmbRibRgRsRsmm
bRgRsmbRibRgRsmbRibLibLjbRcbRcbRibLgLsbLcbRgbLjbReRsRsmmbRgRsmbRsbRsRs
RsRsRsRsRsRsRsRgRsRsRimmmmmmmmmmbRgbRibRhRsmbRgRsRsRsRsRgRsRsmmmmmmbRs
RsRsRsRsRgRsRsmmmmmmbRgRgbRibRibRgbRgbRgbRgRsmbRibLcbLhbRjbRcbRibRibLj
bLhbRsRsmbRibLgRsRsmbRsRsmbRgbLsLjbRebLcbLeLsbRebRgbRsRgbRsbLsbRsbRsbR
hbLjLcbLsRsLsbLsLiLsbLsLsLsRsRsLsLsmmmmbLsLsLsLsLsLsLsLsLsLsLsLsLsLsLs
mmmmmmmmmmmmmmbLsLsLsLsLsLsLsLgLsLsLsLgLsmmmmmmmmbLgLsLgLsLsmbLsLsLsLs
LgLsLgLsLsmmmmbLsLsLsmmbRjRcbRsbRsbLsbLsbRsbRsRgRsmbRgbRgbRsRgbRgbRsbR
ibRgbRgbRgRsRsRsRsmmmmbRsRsRsRsRsRsRgLsmmmmmbRibRgbLsbRsRsmbLcbLsbLcbL
ibLcLsRsmbRibRcbReRsmbRebRibRhbLibsbLcLsmbLibLsbLsLsLsRsmmbLsLsmbLsRsL
sbRsbLsLsmbLgLsLsLsLiLsmmbLsbLgbLgbRsLgLsLgbLiLsbLiLsbLgbLgbRjbLibLgLs
LsLsmmbLsLsmbLsLsLsmmbLgLiLsLgLsLsmbLsbLsbLgbLsLsLsLsLsLsLsLsLsmmmmmmm
mbLiLsLsmbRcbLsbLsRsbLsbLsbLsbLsbLsbLsbLsbLsbLsRsbsbLsLsmbLsLsmbLsbLsb
LsbLsLgLsbLsRsLsLsLsmmbLsbLsbLiLsLsLsLsLsLsLsmmmmmmbLsLsmbRgLsbRsbLsLs
LsLsmmmbLsbLsbLsRsbLsLsLsLsLsmmmmbLsRsLsLsLsLgLsmmbLsLgLsLgLgRsbLgLgLs
LsLsmmbLsLsmbLsLsmbLsbLsLsLsLsLsLsLsLsLsmmmmmmmmbLsLsLsLsLsLgLsLsLsLsL
smmmmmmmmbLsLsmbRsbLsbRcRsmbLcbRsbRcbRsbsbRgRsRsRimmbRgRgRsRsRsRsLsmmm
mbRsbRsbLsRsRsRsRsRsRsRsmmmmmmbRgbRcbLcbRsLsbRcbLsbLsbRsRgRgRsRsRsRsRg
RgRsRsmmmmmmbLsRsbRgRgbRgRsRsRsRsRsRsmmmmmmbRsbReRsmbLcbLcLsmbLsLsmbLc
bRsbRebRsbRsbRsbRsRhbRsRsRgRsmmbRiRgbRgbRsRsRsRgRsRimmmbRibRgbRgbLcbsb
RcbLcbsbLcbRsLsbLsbLsbRsbLsbLsbLgbRsbLsbLgbLsLsmbLsLsmbLsbLibLsLsLsLsL
sLsLsLsmmmmmmmbLsbRibLsbsbRcRsmbRcbLgbLgbLgbLgbLgLsLsLsmmbRsbLsLgbLsLs
LsLsLsLgLsLsLsLgLsmmmmmmbLsLsLsLiRsmmbLgLsbLsLsmbLsLsLsLgLimmb

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 30; Drug: OSU6162 10 然 Apo 50 然
bRsbRsbRsbRsbRsbRsbLsbRsbLsbLsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 31; Drug: OSU6162 3 然 Apo 50 然
bLjbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 32; Drug: OSU6162 3 然 Apo 50 然
bLsLsmbLgLsbLsbLsLsmbLsLsmbLsLsmbLsbLsbLsLsmbLsLsLsmmbRsbLsRsLsRsbLsbL
sbLsbLsLsLembLsbLsbLsLsmbLsbLsLsmbLsbLsLsLsmmbLsbLebLsLsmbsbLsbsbLsLsm
bLsbsbLsLsmbsbLsLibLebLsbLsbLsbLsbLsbLgbLsbLebLhbLsLsmbLebLebRsbLiLsbR
gbLhbLhLsbLcbLibLibLgbRobRcbLjbLibLsRsbLgbLsbLgbLgbLibLibLebLjRsbLgbRg
bRcLsbRgbRibRgbReRgbLsbRsRsmbLsbRibRebReRhbRhbRsbRoRsLsmbLibLgbRgLsbLs
bRjbLibLibLgbLsbLsbLsbLsbLsbLgbLgbLsbLgbLgbLsbLsbLgbRsbLsbLgbLibRsbLib
RgbLibLsbLsbLsbLgbLgbRsbRsbLibRgbLgbLsbLgbLibRgbLgbLgbLgbRgbLgbLgbLsbL
sbLsbLjb

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 33; Drug: OSU6162 3 然 Apo 50 然
bRgbRsbRgbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 34; Drug: OSU6162 3 然 Apo 50 然
bLebLgLeLsbLibLsbLsbLsRsbLsbRsRobRobRobLobLsLgRsbRgbLjbRebRgbRibRsbLib
LebLgbRjbLsbLsbLebRsbRsbLsbRobReLsLsmbRgbLebRsLsbRjbLgbRoRsRsRsmmmbReR
sLsmbRsbLgbLibRsbRgbLgLsbLsRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 35; Drug: OSU6162 3 然 Apo 50 然
bReRsmbRsRsReLsmbReRsmbRgRgbRsbRebRgReRsmbRsRsRsRsRemmmbRsRsReRsmmbRgR
ebRsbRebsbRsRgbRsbRsbRibReRsmbRebRibRgbRgbRgbRsbRebRibRgbRebRsRsRsRemm
bRebRebRsbRebRibRebRsRhbRebRebRibRebRebRsRgRsmbRebRsbRibRsbReRsmbRgbRs
LsRebReb

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 36; Drug: OSU6162 3 然 Apo 50 然
bsbLsLgLsLsLsLsLgLsLsLsmmmmmbsbLgLsLsmbLsbLsbLsLgLsLsmbLsLsLsLsmmmbLsL
sLsLgLsLsmmmbLgbLsLgLgbLgLgbLsLsmbLsbLsbLsbLsLsmbLsbRsLsbLsLsmbRsbLgLg
bLgbLibLsbLsLsmbLsbsbLsRsbRsbRsbLsbLsbsbRsbLebLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 37; Drug: OSU6162 1 然 Apo 50 然
bLgbLgbsbsbRjRjbRjRcbLgLsbLcLsmbLsLsmbRjbRibRgbRebLcbLhLsbLcLsLsmmbLcL
sRsLsmbLsbsbLibLgLsbLibRebRhbLsRcRsRsmmbsbLhLsbLhbsbLibLsbLcbLcLsRsmbL
cLsLsmmbLiRsbRebRhbRhbRcRsmbRebsbRhRsmbRebReRsmbRiRsmbReRsmbLsLgLsbLob
sbLiLsbLibLhbLhbLibLiLsbRgbRiRsmbRcbLcbLcbLgLsbLibLgbReRsmbLsReRsmbRcR
sRsRsRsmmmmbsbRjRsReRsmmbReRsmbRcRsmbsbReRsmbRhbReRsmbRebRebRebRjRebLg
LsLebLcbLibLiLsLsmbLibLgbLiLsbLgbRjbRsbRibRsRsRsmmbRgbRsRsmbRibLcLsmbL
cbRjRjRsmbRebLcLsLsmmbLgLsbLgLsLsmbLsRsbRjRsLjLimbRhbRjRcbsbRcRsRsmmbR
eRsmbReRsmbLjLgbLcbLgLhbRgRsmbsbReLsbRjReRsmbRcbRebRjReRsRsLsmmbRcbReb
RsRhRgbLebLcLsmbRsRiRsmbRiRsRsRsRsmmmmbRsRgRsmbRsbRgRiRsmbLeLsbLcbLjLg
LsLsLsmmbLiLsbLibLoRsRsmbLjLcbLjLcbLcLsmbsbReRsmbReRsmbRebReRsmbRebLsb
sbRibLebLsRsLsbsbRsbRjRgRsRsmmbLjLsmbsbRsbRsLsRsbRsbLsLsmbsbRsbRsbRgRg
RsRsRsmmmbLcbRsRsmbsbsbRsbRsLjLjLebLeLsbLeLsRsbRsbRgRsRsmmbRgbRgRsmbRs
bReRsmbRcbLcbLebRgbsbsbsbsbsbRgRsRsRsmmmbRsbsbReRsmbRobRcb

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 38; Drug: OSU6162 1 然 Apo 50 然
bLiLsbLgLsLsLsmmbLiLsLsLsLsmmmbLgRsbRsbRsbLsbLsLsLgLsmbRsbLgbLsbLsbLgb
LsLsmbLsLsmbLsbLsbLsbLgLsbLsLsLsRsLsLsLsmmmmbLsbLsbLsbLsLsLgmbLsLsLsmm
bLsLsmbLgLgbsbLsbLsLsLsLiLsmmbRsbLsbLsLgbRsLsLsmbLsLsmbLsbLsLsmbLsbLgb
LgbLgbLiLebLsbLsbLsbLgbLgLsLsLsLsmmmbLsbLsbLsbLsbLsbLgbsbLgbsbRsRsLsLs
LeLimmbLsbLsbLgbLsLsmbRibLsbLgbLsbRsbRsbLsbLsbLibLsbLsLsLsmmbRsbLsbLgb
LiLsbLsbLgbLsbLeLibLgLsbLsbLgLsbLsbRsbLsbRsbRsbLsbLsLsmbLgbRsbLgRsbLsL
smbLsLsmbLebLsbLgbLsbLsbLsLsmbLsbLsbLebLsbLgbRsbLsbLsbRgbRsRsmbRsbRgbs
bRgRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 39; Drug: OSU6162 1 然 Apo 50 然
bLsbLsbLcbLcbLgbsbLsLsmbRsRsLsmbRibsbRsRsmbRsLsbRobLsLsLsLsmmmbLcbRcRs
mbRjRgbRhRsmbLsLsmbRcbRcbRibRebRebReRsRsmmbRebRcbRiRsmbRibsbRsbRhLsbLc
LsmbLsbsbLibsbRsbLsbsbsbLsRsbLsbRsbLsbLsLsmbLobRcbRibRhbRiLsbLsbRcbReb
RibRebRebsbLgbLibLsLsmbLsLsLsLsmmmbLsLsmbLsbLsbLsbLsLsmbLsbLsbLsLsLsLs
LsLsLgLsmmmmmbLsbLsbLsLsLsLsmmmbLsbLsLsmbLsLsmbLsLsLsmmbsbLsbLsLsLsLsL
sRsmmmmbLsLsLsRsLsLsLsmmmmbRsLsLsLsLgLsmmbLsLsLsmmbLsRsbLsLsLsmmbLsbLs
bLsLsRsLsLsLsLsLgRsLsLsmmmmmbLsLsLsLsLsLsmmmmmbLsLsLsmmbLsLsLsLsmmmbLs
LsmbLcbLsbRobLgbsbLsLsmbLsbLsLsmbLsLsLsLsLsmmmmbLsLsmbLsRsbLsLsLsLsmmm
bLsLsLsmmbLsbLsLsLsLsLsLsLsLsLsLsmmmmmmmmmbLcLsmbRebRcbRcRsmbRgbRsbRsb
RsbsbRsbsbRobLcbLgbRcbsbLjbsbRsRjRgbRhRsmbRhRsmbsbRoLsbRcRsmbLobLhbLiL
sbLgbLibLcbLcLsmbLgLsbLsLiLsbLsLsmbLgbLsbLsLsmbLgLsbRsbRcbRiLsbRsRsmbR
oLsbLebLibLgbLgbRsLsLsmbLsLsLsmmbLsLsmbLsLsmbLgbLsLsmbLsbLhbRcbRhbRiRs
mbLsbRobsbRobRcRiReLcLsmbRebRgbRgRsmbRsbRiLsRsbLhbRcbRsRsRsmmbsbRiLsbL
sLsLsLsLsmmmmbRiRsmbRsLsbRsbRsRcLsbLsRsbLsLcbsbLsbLsbRsRsmbLsLsLsRsLsL
sLsmmmmbRebRsRsmbRcRsmbRcbLsbLsbRsRsLsLgLsmbLsLsLsmmbLsLsLsmmbLgLsbLsb
LsLsLgmbLsLsmbLsLsLgLsLsLsmmmbLsbLsLsLsmmbLiRsbRobRibRsRsRsLsmmbRhLsRs
bLsbRcLsbLebLsLhLsbLiLsRsLsbRsbLsLibLebLjLiLsbLsbLsbLsbLsbLsLsmbLsLsmb
LsLsLsmmbLsbLsLsmbLsLsmbRsLsbLsLsLsmmbLsLgLgbRsLsLsLsLsmmmbRsLsLsLsLsL
sLsLsmmmmmmbLsLsRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 40; Drug: OSU6162 1 然 Apo 50 然
bRgbLgbRsbLsbLsLsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 41; Drug: OSU6162 1 然 Apo 50 然
bRsRgRsmbRsbRcRsmbRcbRcRsmbRcRsmbRobRobLibLcbLhbLebLcbLcbLobLcbLeLibLc
bLsbLsbLiLsbRgbsbLsbRsLsbLsbsbLsRsbsbsbsbsbsbsbsbLsbLsLsLsmmbLsLgLsbLs
LgLsbLgLiLsLibRjRsmbRjbRcRsmbRobRhbRobRibRcbRobRiLsbRiRhbRibReRsRsmmbR
gRsmbRcbLibRjbRobRobRcbRgRsmbRcbRhbRcbRibRgRsmbRgLsbRsbRjbRsLjbLjLsmbL
sbRsbLsRsLsbsbRsbsbsbsbsbLsLsLsmmbLsLsmbRsRsmbLsLsmbRjbRcbLcbRcRsmbRcR
smbRhbRhbRjRibLcbLcbLgbLgbLibLgbLgLsbLiRsbRjRsmbRhRsmbRsRibRcbRjRgbLcb
RcbRcbRhbRhbRhbRcbsbRebRhbRhbRcbRgbRoRsmbRjRsmbRhRsLsmbRcbRsRhbLiLsbRj
RsRsmmbRibRibLobLhbLcbRibLcbLsbLcbLibRibRibLhbLcbLhbRjRsmbLibLhbRebRsR
smbLhbLjbRsbRgbRcbLjLgbLcbRsRjbReRsmbLhbLgbLeRsbRhRsmbRsbRjRsRsmmbRcRs
mbLcbRcbRiRsmbRcbRibRcbLsbLcbLhbLsbLcbRcRsmbRcbLibLibLeLsbReRsRsmmbLhL
sbLcbRjRsRimbRgRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 42; Drug: OSU6162 1 然 Apo 50 然
bRsbLsLsmbLsbLsbLsLsmbLsbLsbRsbRsbRobRebLsLsmbRsbRsbRoLsbLsLsRsmbRobLo
bLsbRebRjLsbLebRsbRebLsbLsbLsbLsbRsLsbLsbLsbRsbLjbRsbRsbLsbLobLebLoLsm
bLsbLsbRebRsbLsbLebLsbLobLebLebRsbLsRobRoLsbLsbRobLsbLsbRsbRsbRsbLjbRs
LsbRsRsmbRobRsbLsbLsbLobLebLsbRsbRsRobRebLcbRsbLjbLebRobLobRebLjbRebLs
bLjbLsbLobRebRsbRibLsbRebRebRsbRebLobLsbLebRsbRjbLobRcbRobLobLobLsbRsb
LebLsbRsbRsbLibLebRebLobLobLjbRsbRjbLsbLebLebLobLsbLsbRebLsbRcbLobLebL
gbRobLebLebRsLsbRebLsbRhbRsbRebLebRsbLcbLebLjbRobLobRcbRsbLobRgbRcbRjb
LcbLcbRcbLobRibLsbRgbRcbRsbRsbRsbLcbRobRcbRsbLibRsbLobLobLsbLsbRsbRobR
cbRobRebLjbRsbRebRebRobLsbRcbRsbRebLobRjbLebLebRsbRobRjbLsbRebLcbLobLo
bRobRjbLebLobLebLebRcbLjbRebRsbRebLobRsbLebRobLsbLjbRobLsbLsbRgbLjbRsb
LjbLobLobRebRobLebLebRobRobLebLsbRebLobRebLjbRebRsbLebRcbLobRebRsbLobR
ebLcbRcbLjbRsbRebLobRebLibLebRibLobRjbRsbRebRebLebRsbRebLebRobLsbRebLs
bRebLobLobRobLcbLjbRebRjbLcbRebRebLhbRebLjbLobRsbLobLebRebLobRsbLjbRjb
LobLobLjbLebLebRobLibRebLobRcbLobLibRebLcbLgbRsbLcbRebRcbRjbLsbRebRebR
jbLebRebRebRebLgbLjbRobRebRobLcbLsbLobRobRobLobRobRebLebLobLebRobRobLo
bLebRgbLebRsbLsbLcbRcbRebLobRebRobRebRjbRobLobRobRcbLobLobRcbRebLebRsb
LebRobLobRobRjbRjbRobRcbLsbLebLsbRsbRobLebRobLcbRcbLebRobLebRsbLobLobL
ebLgbLsbRobLobRobLcbRebLobLebLebRcbRobRebRobLcbRebLsbRobRjbLobLobRcbLj
bLsbLcbRcbRobLjbRjbRobRobLsbRjbRobLobLobRsbLjbRobLjbRjbLsbRebRobRobRcb
LebRebRsbRsbLebRebRsbLebLebLcbLsbLibRebLebRsbLobRobLobRebRebRobRsbRebR
obLjbRsbLjbRebRjbLsbRsbLsbLcbLsbLsbRobRobLebLobLsbRebRebLebLcbRsbRjbLj
bRebLobLcbLobRobRobRjbLjbLsbLsbRebLsbLjbLsbLsbRjbRsbRebLsbRsbRebRebReb
RobRebRobLjbLjbLobRobRobLjbLobRsbLsbRcbRebRebRjbLebRsbLobLsbLebRebRjbR
ebRobLebLjLsRsmbRsbRebRsbLsbLsbLcbLjbRebLsbLebRsbRobRebLsbRebLebLjbLsb
LsbLcbLoRobRjbRsbLsbLebRebLsbRsbRobRcbLsbLgbLobRebLebRobLjbLebLsbRebLj
bRsbLsbLjbLebRebRobLebRebLjbRibLjbLebLsbLcbLcbRsbRobRjbLcbLsbLobLobRob
LobRsbLebLebRobRebLsbRjbLebLobLebRjbLsbLsbRebLebRobLebRsbRebLsbRebLjbR
ebLjbRobLjbLobLebRobLobLcbRobLsbRjbLcbRobRsbRebRjbLebLcbLebRcbLsbLsbRe
bLcbLsbRsbLsbLsbRjbRjbRebLobRsbRcbLebRebLjbRcbLcbRcbRcbRebLcbRebRsbReb
RcbLcbLebRcbLobRobLobLjbLebLsbLebRobLjbLsbLebRobLjbLobRjbLobLsbRjbRebR
ebRebLebRsbRjbLsbLobLcbLsbLsbRebRsbLebLsbLebLebLjbLcbLsLsmbRsbLibRebRs
bLebRebLjbRebRebRebRjbLjbRjbRsbRcbRobRjbLsbRjbRebRebLobRcbLsbRsbLebRob
RsbLsbRebRebLebLebLebLebLsbLcbRobRsbLebRjbLcbLcbLebLebRjbRsbLebLebRobR
jbRebRebRsbLebLebRobLebLobRcbRsbRobRobRobLebLebRjbLsbLcbLjbRobRebLebLj
bRcbLobLsbRebLcbLebRebLjbLebRobRobRjbRebLcbLebLobLobLobRsbRjbRebLobReb
RcbLebLebLsbLjbRcbLsbRjbLobRebRobRobRebLobRebLebLobRebRebLebLjbLobRobL
sbRjbRsbLjbRobLobLobRcbRsbRcbRobLobLebRobRebRcbRebRcbLjbRebLcbRjbLebRj
bRobRjbLebLjbLebLobRobLsbLobRebRcbRobLjbLebRjbRobLobLobRebRsbLcbLsbLob
LibRebLcbLsbLebRjbRibLobRjbRebRobRsbLsbLobLjbLcbLjbRobLebRebLebLebRjbL
ebRgbRsbLobLebLsbRsbLjbRebLgbLobRcbRcbRcbRebRebLsbLobRebLjbLobRjbLibRs
bLsbLsbRebRcbLsbRjbRcbRobLebRebLsbLobLjbRcbLcbRobRobRjbLgbRcbRjbRhbRob
LobRebRobRobRjbRobRcbLibLcbLcbLebLebLgbRcbRcbRcbLcbLcbLobLcbLhbRjbLebR
cbRobRobRgbRibLobRobRcbRebLobRobRcbRebLcbRcbLcbLobRebLobRsbLcbLobLjbRo
bLebLobLebRsbLobRcbRebLebRebRcbLebLsbLebRebRsbLobLsbLobRobLebLcbRobLcb
LsbRcbRobLebRebLebRebLobLjbRjbRsbRjbLobLsbRebLsbLebRcbLsbRgbLobLebLobR
ebRsbLobLjbRjbLsbLobRjbRsbLebRjbRsbRsbRjbRjbRsbRjbLsbLjbRsbLobLsbLsbRs
bLsbLjRsbLsbRsbLsbRebRsbLsbRsbRjbRsbLsbLsbLsbRsbLgbLsbRsLsbRjbLobRsbLs
bLebRobLsbRsbRsbRebRsbRebLsbLsbRebRsbLsbRgbRjbRsbRebRjbLgbLgbLsbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 43; Drug: Control Apo 50 然
bRiRsmbRgRsRsRsRsRsRsmmmmmmbRsbRsRsmbRsRsLsmbRsRsRsmmbRsRsmbRsbRsRsmbR
sbsbRsbRsRsmbRsbRsbRsLsbRsbRgRsRsRsmmmbRgbLsRsRsRsRsRsRgRsRgRsRsmmmmmm
mbRsRibLsbRgRebRsRsmbLcbLcLsLsmmbLobRgbRhbRebLcbLcbLgLsbRsbRjbLhbLibRs
bRjbRhbRgbRcRsmbLhLsbLebLgbLibLebLibLsRsbLobRiLsbRhbRsbRjReRsmbLobLsbL
gLsRsbLibRsbLgbLibLgbLsbRcbRgbReRsmbLgbLjbLibLsLsmbLgRsbRgbRsbLebLcbLh
LsbLiRsbLsbLsbLgLibRgbRcbRgbRiLsbRsLsbLjbLjbLgbLsbLgbLsLgbLgbLebRsbRgb
RgRsmbRebRjbRsbRebLgbRgRsmbLsbRgLsbLebRgRsmbLsbLsbLsRsbRebLcLsmbLgbLeb
LsLsmbLibRsbLibLgbLgbLsbLsLgbLgbLiRsbRibRebLjbLibLsbRgbRibRebRgRsmbLcb
sbLibLsbLibLgbRgbRsbLiLsbLibLsbRebRgRsmbLcbLibLgbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 44; Drug: Control Apo 50 然
bLibRebLgbRsLsbLhbRsLsbsbLsbRcbRcbLcLsmbLhLsbLgbLgLsbRjbsbRsbLobLcLsLs
mmbRjbRebsbRsbsbsbRsRsmbLsbRsbRsbLsLsmbsbsbRsbRsbsbLsLsLsLsmmmbLsLsmbL
sLsLsLsLsLsmmmmmbLsLsmbLsLsmbLsbLsbsbLsbLsbLsbLsLsmbRsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 45; Drug: Control Apo 50 然
bRsbsbLsRsRsmbRsbLsLsmbsbsbLsbsbLsbRsbRsbsbsbRsLsbRsLsbRsbLsbLsbLsbRsb
LsbRsbLsbsbsbsbsbsbsbLsbsbLsLsmbRsbsbLsbRsbLsbLsbLsRsbRsbLsbRsLsbsbsbR
sLsbLsLsmbsbRsbsbsbsbLsbLjbRobRobRobsbRsbRsLsbLsbLsRsbLsLsRsmbRsbRsLsR
sbLsbLsbLsRsbsbLsbLsbsbRsbsbRsRsmbRsbRsbsbLsbsbLsbRsbsbRsRsmbsbsbRsbsb
sbsbLsbRsLsRsbLsLsmbsbRsLsLsmbRsbsbsbLsbsbsbsbLsbLsbRsLsbRsbLsbRsbRsbR
sbsbsbRsRsRsmmbRsbLsbLsRsbsbRsbRsLsRsbLsbLsLsmbRsbLsbRsLsbRsLsbRsRsLsm
bRsbLsLsmbsbRsbLsbsbsbsbLsLsmbRsbRsRsmbsbsbLsbRsbLsLsmbLsbRsbsbLsbRsRs
RsmmbLsbRsRsmbsbRsRsmbRebRcRcbsbLjbLiRsbsbLiRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 46; Drug: Control Apo 50 然
bRibRgbRcbLgbRibLobLibRibRebRgbRsbRgbRsbRsbRsbRsRsmbRgbRsbRgbRsbRsbRgb
RgbRsRsmbRsRsmbRgbRsRsmbRgbRsRsmbRgRsmbRsbRibRibRsbRgbRiRsmbRsbRsRsmbR
sRsmbRsRsmbRsbRgbRgbRsbRgbRsbRsbRhbRebRsbLsRsbRibRsRsmbRsbRsbRgbRgbRgb
RsbRsbRgbRgbRsbRsbRsbRsbRsbRsRsmbRiRsmbRsbRsbRsbRsbRsRsmbLsbRgbRgbRsbR
sbRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 47; Drug: Control Apo 50 然
bLsLsLsLsLsLsmmmmmbLsLsmbLsbRsbLgRsbLgbLgLsLsmbLsLsmbRsbRsbLsbRsbLsbLs
bLsbLibLgbLgbLsbLsbRgbLsbRsbLsLebLsbLgbLgbLsbLgbLgbLgbLsbLsbLgbLgbLsbR
sbRgRgbRsbRgbRsbRgbRsbRsbRibRsbRcb

>ZF Recording 2016-08-17; tW: 300s; Start: 163828; End: 164328;
Recording: 9-1; Individual: 48; Drug: Control Apo 50 然
bLgbRgbLsbRsbLsbLsbRsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 1; Drug: OSU6162 10 然 Apo 50 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 2; Drug: OSU6162 10 然 Apo 50 然
bRsRsLsRgRgRsRsRgRsRsRgRsmmmmmmbRsbRgRsRsRsmmmbRgbRsbRsRsRsRsmmmbRgbLs
bRiRsRsRsRsRsRgRsRsmmmmmmmbLsRsbRgRsmbRsRsRsRsRsRsRsRsmmmmmmmbsbRsRgRi
bsbRsbRsRgRsRgRgRsRsRsmmmmbRsRsLsmbRgRsRsRgRgRgRsLsmmmbRgLsbLsbLcRsbRc
bRgbRsbLsbRsbLsbsbsbLsbRsRiLsbsbLsbRsRsRgRgRsRgmmbRsRsRiRembRgRsmbsbLs
bsbRsRgRgRebRsRhbRgRsRsRiRsmmmbRsRsRsRsRsRsRsRsRgRiRsmmmmmmmmbRsRsRsRs
RhmmmbRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmbRebRsRsRsRsRsRsRsRsRsReRsRsmmmm
mmmmmmbRebRgbLsLsRsRsRsRsmmmmbRsbRsRsmbRsRsRsRsRsRsRemmmmmbRebsbRsbReR
smbRsLsRsRsmbLsRsbRsbsbsbLsbsbRsLsbLsLsmbRsbLsLsmbLsbLsbLsRsLsLsRsmbLs
RsbRsLsbLsbsbRsRsRsRsRgRsRhmmmmbRibRsRsRsRsRimmmbRsbRgbRebsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 3; Drug: OSU6162 10 然 Apo 50 然
bLsLiLibLsbLeLsLgLsbLsbLsLsmbLsLgLsRsbLsLsLsLemmbsbLsLsLsLimmbLsbLsLhb
LsLgLgbLsLsLsLimmbLiLebLsLgLsLibsbLsLsLsLsLsLeLsmmmmbLgLebLsLsmbLsLsLs
LsLsLsLsLgmmmmmmbsbLsLsmbLsbLgLsLsLsLsLsLemmmmbLsbLsLsLsLsLsLsmmmmmbLo
bReRsmbsbLiLsbRsLgbRsbRsbLsbsbRhbLsbRgbLsbRibRoLgLsbLeLsLsmbLibRsbLhLs
LsmbRgbRsbRsLsbRjbRobLobLsRsbLsLgLibsbsbLgbLsLhb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 4; Drug: OSU6162 10 然 Apo 50 然
bRsLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 5; Drug: OSU6162 10 然 Apo 50 然
bLebLebLiLeLsbRgbRibLsbLgLiLgbLgbRsbLgLiLsbLsbLsRsbLsbsbLsLsLsmmbLgLsL
sLgmbLsLsmbLgbLsLsmbLgbLhbLsLgLiLsbLgLgLgLsLsmbLhLsbLgLsLsLsLimmbLsbLg
LsLibLsLgLsLgLibLhRobLgbRsRgbLgbLgLsbLgLsbLsLgbLgbLgbLgLsbLsRsbLobsbsb
RsbRsbLsbRobRibLgbLgbLsLsmbsbLsRsbLsbLsbRiRsmbRjbRsbRibRjbLsbLibRgbLsb
RcbLgRsbRhbLiRsbRhRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 6; Drug: OSU6162 10 然 Apo 50 然
bRsRsRsRsLsLsRsmmmmbLsRsLsbRsbRsRsmbRoRsmbLgbLgbLibRcbRcbRsbRsbRsRsRsm
mbRebRcbRibRsbLsbLsbsbsbRsbLsbLsbLiLsLsmbLgbLcbLgbLsRsbLsLebLsbLsbLsLs
LgmbLgbLsbReRsmbRibRsbRsbLsRsLsbLsbRsbRcbLsLsmbLsbLsbLgbRgbRsLsbLsLibs
bLsbLebRgbRsbRsbRsLsLebRgbRibRsbRoRsmbsbRsRsmbsbRsbRsbRsbLsLsmbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 7; Drug: OSU6162 3 然 Apo 50 然
bLsbLsbsbsbLsbsbLsbLsbsbRsbLsbRsbsbLsbsbLsbsbRsLsRsRsmbsbRsbsbRsbRsRsm
bLsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 8; Drug: OSU6162 3 然 Apo 50 然
bLobLibLhbLgbLobRebLebRgbRobRebLebLebRebRebRobRobLcbRobLibLobRobRobRib
LebLobLobLobLebLcbRobRobLcbLobRobLibRebRhbRcbLcbRobRobLibRobRobRcbRhbR
gbLobRibLibLgbRebLobLobRcbLgbLobRobRcbRebLgbRgbLobLgbLgbRebRgbLobLobLi
bRebLobRebLebLobRobLibRibLgbLebRebLibRobRibRibRobRgbRcbLibLcbRobLobRcb
LsbRcbLibRobRobLobRebLcbRebRcbLobRobRobLgbRebLobLobLsbRsbLebLobLibRibL
cbRobRebRobLcbRobLgbLebLobRobLebLibRebRobLsbLgbLcbLobRebRcbRsbLgbLobLi
bRsbRebLobRobRebRibLebLibLibLobLhbLgbLobRobRsbLobRobLobRobRobRebRgbLib
RobLobLcbLgbLgbRcbLobRobLjbRebLsbRjbRcbLebRibLobRebLebRgbRsbRcbLobLobR
ebLobRebRobLcbRobRobRgbLobLebRobLobLibRcbRobRhbRebLcbRsbRobLibRibLebLh
bLobLobRobRibRobRobLobRjbRsbLjbLebLobLebLebLobLebLjbRsbLjbRjbLcbRebRsb
RjbRebLsbRjbRsbRsbRebLgbRobRebLjbRgbRjbRjbRebLobLebLjbLjbRjbLjbRjbLebR
sbRebRjbLjbLsbRobRobLsbLjbRsbLsbRsbRsbLebRobRebRebRjbLebRobRebRebRsbRj
bRsbLebRsbRsbRjbLebRsbRjbRebRebRcbRobLebRebRobRjbLjbRobRobRjbLsbRjbReb
RjbRebLobLsbRjbLebRobRobLobRjbLsbRobRjbRcbLobLsbLjbRsbRobRobLjbLcbRobL
jbLebLjbRsbLebLebRebRjbLsbLsbLjbLobRebRebLjbLcbRsbRebRjbRjbLjbLjbLjbRo
bRsbLebRsbLobLcbRsbRjbLsbLjRsbLsbLjbRebLsbRsbLobLobLjbLjbLebLsRebRsbLe
bRsbLsbLsbLsbRebLsbRsbLoRsLsbRebRebLsbRsbLsbRsbRsLebRcbLsbRsbRsbLsbLsb
RsbRsbRsbRsbLsbRsbRsbLsbLsbRsbLsbRsbRsbLsbLobLsbRsbRsbRgbLsRsbLsbRsbRs
bRsbLsbLsbLsbRebLsbRsbLsbRsbLsbLsbLsbRsbRsbLsbRobRjbRsbLebLobRsbLsbLeb
LsbRobRsbLsbLsbLgbRebRebRsbLobLebLebLsbRsbLebLsbLsbLcbLobRsbLsbLebRsbR
sbRcbLsbRobLsbLsbRsbRsbRsbLsbRsbLebLjbLebRobLsbRjbRebLobRcbLsbRjbLjbLs
bLcbRsbLjbRobLsbLobRsbLsbRsbLobLcbLcbLebRjbRsbRsbLebLobRjbRobLsbRsbRob
LobRsbLobLsbRgbLsbRobLobLjbLsbRjbRobLsbRsbRsbRsbRsbLsbRcbLsbRobRsbRsbR
sbLebLsbRsbLsbRobRsbRjbLsbLobRsbRsbLsbLebRsbRsbLobLsbRobLsbLobRsLsLsmb
LsLsmbRobRobLsbLebRsbRsbLoRsbLsLobLsRsbLsbLsLobRgbRsbRjbRsbRsbLsbRsLsb
RsLsbLsbRsbRsRsmbLsLsmbRsbLsRobLsRsbRsbLsbRsLsbLsRsbRsRsmbRsbLsbLsbLsb
LsLsmbLsbRsbLobRsRsLsmbRsbRoLsbLoLsRsmbLsLsmbRsbLsbLsLsmbRsLsbRsbLsRsb
LsRsRsmbRsRsLsRsmbRsLsRsbRsbRsRsLsmbLsbRsLsLsmbRsbLsbLsbRsRsmbRsRsRsmm
bLsbRsLsbLsbLsbRsbRsbRsbLsLsmbRoLsbRsbRsRsmbLsbRsbLsbLsbLsRsRsRsmmbRsb
RsbLsLsmbRsLsLsRsRsmmbLsRsbLsLsmbRsRsmbLobRsbLgRsbRsLobLsbRsRsmbLsRsbR
sbLsbLsRsbLsRsbRsbRsbRsLsRsRsmbRsRsmbLsRsbRsbLsbRsLsbLsbLsRsbLsbLsRsRs
RsmmbRsLsbRsLsbRsbLobRsLsbRsLsbRsbLsRsRoRsLsLsmmbRsbRsRsmbRsRsmbLsbRsb
LsLoRsbLsbLsLobRsbRsbLsbRsbRsLsbLsbLsRsbRsbRsbLsLsLsmmbLsLsmbRsRsLeLsm
bRsbRsLsLsRsRsLsRsRommbRsLoLsRsRsRsmmmbRsLsRsRsmbLsRsbLsbRsLsRsLsbLobR
sLsLsLsRsLsmmbLsRsLsbLsRsRsLsmbLsRsbLsbLsbRsbRsbLsRsbLsLsmbLsRsRsLsmbR
sLsbRsbLsLsRsmbRsbLsRsbRsLsbLsLsmbLsbLsLsLsmmbRsLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 9; Drug: OSU6162 3 然 Apo 50 然
bRebLjbRsbRobLobRjbLjbRobRobLobLobRobRjbRcbRjbLebRjbLcbRcbRobRcbRjLsbL
ebRobLobLsbRjbRobLobRcbRjbRsbLcbRjbRjbRcbRobLebLebLebLebLebRobLebRcbRs
bRcbLebRobLobRebLcbRobRobRjbRjbLobLobRsLjbLobLebLsbRobRcbRobLobRobLebR
obLobRebLsbRcbLebRobRjbRjbLsbLjbLebRebLsbRcbRsbLjbRjbRjRsmbRjbRobLsbRo
bLebRsbLebRcbRsbRobRjbLsbLjbRobLsbRobLsbLsbLebLsbRsbRobLcbRobLobLobLsb
RsbRcbLsbRsRsmbRebRobLsbLobRobRobLobRsbLsbRobLebLebRsbLebLebLobLebLobL
sbLobLobRebRebLebLsbLebLobLjbLsbRobRcbRobLebRcbLebRcbLjbLebRebRsbLebRs
bLobLsbRsbRsbRobRebRjbLsbLsbLjbRcbLebRobRebRebLjbRsbRcbRjbLsbLobRibLeb
RobRebLsbRgbRsbLsbRobRsbLjbLcbRobLobLobLobLebLobLobRobLgbRebRebRobLebR
gbRjbRcbRobLobLjbLsbLsbLebRebLjbLebRobLjbLobLebRebRobRobLebLebRebRsRob
LobRebLobRsbRobLebRjbLjbLobRcbRobLebRobLobRsbRcbRcbLebRebRebRobRebRebR
jbRobLobRebLsbRsbLobRsLsbRcbLobLebLobLsbLsbLoLsmbLebLjbRobRjbLjbRobRjb
RjbLobRsbRobRebRsbRebLebRebRebRebLebRjbReRsRsmmbRebLsbRsbRobRebRobRsbR
cbRsbLobLcbRcbRebRobRobRjbRebRobRobRjbLcbLcbRobLobLsbLgbRjbRsbLjbRebLo
bLjbLebLobRebLsbLobLobLsbLobLcbLsbLobRobLjbRsbLsbLobLsbLebRjbRobRobLjb
LjbLebRjbLjbRobRebRsbRebRobRcbRcbLebRebRobLjbLjbRobLebLobRobLobRcbRobL
sbLobLobLobRjbRebLobRebRobLsbRobRobRebRebRebRcbLebLobLsbLobRebLjbRjbLo
bLebRcbLebRjbRobLobRobLjbLjbRsbLobRobRebLebLebLebRebRjbRcbLcbLebLobRob
LebLebRobRcbRsbRobLjbRobRjbLebLobRebLobRobRobRjbRjbLcbRobRobRsbLobLjbL
ebLcbLobLebLjbLjbRebRobLebLebLebRobRobLebLjbLebLsbLobRcbRobLobLebRebLo
bLsbRsbRobLobRobLebLsbRobRcbRebLcbLsbRsbLcbLjbRebLebLcbRebLobLsbRobReb
RobLobLsbRebLobLobRobLebLjbLebLobRjbLjbLebRebLebLsbLjbRcbLebLjbRobRebR
sbLebLebLobRjbRobRjbRebLsbLsbRebLcbLjbLsbLobRsbLebRobRobLebLjbLsbRsbLc
bLobLebLcbRobRebLebLebRobRjbLebRobLebRsbLsbLsbRjbLobLcbRjbLobLebLobRob
RsbLobLjbLobRebLsbRebRebLcbRsbRcbRebLebRobRjbRebRsbRobRebLcbRcbRjbRebL
ebLsbRobRebRcbRsbRjbLjbLobRcbLebLobRebRebLobLjbLebRebLsbLebLebRsbLobRe
bRobRcbRjbRsbLebLsbRebLsbLjbLobRcbRsbRobLsbRobRebRebRebLsbLebRobLobRcb
LebLobRjbRjbLebLobRobRobRebRjbLebRcbRjbLebLobRjbLebRobRebLjbLebRjbLsbR
jbLobLsbLcbRjbRjbLebRobRobRebLcbRobLebRebRjbRjbRsbRsbRjbLobRebRebLjbRj
bLsbLobRobLebRjbLjbLebLjbRebLjbLobLjbLsbRobRsbLjbLebLobRobRebRobRcbRob
LsbRebRobRjbRebRebLebLebRobLebLsbRobRobLobLebRebRcbRebRebRsbRjbLebRobL
ebLobRsbRsbLjbRsbRebLobRsbLobLsbLobLcbLcbLobLobLcbRsbLebRebRebLebRobRo
bLebRebLcbLjbLjbRebRjbLsbRjbLcbRobRebRebRobRjbLobLobLobLebRobRebLobLob
LobRsbLobLcbRobLobLsbLebRobRsbLjbRobLsbRebRsbRebLebLobLobLjbLcbLcbRebL
jbLobLebRobLobLcbLebLebRebRebLobLebRcbLcbLebRobLsbRobLebRebLobLsbLobRc
bLebRsbLsbRsbRobLobRjbLcbLjbLobRebLebRebRebLobRjbRsbLobRobLobLebLsbRcb
RobLjbRobRsbLsbLobLebLobLebLsbRebRobLcbLjbLcbRsbRcbRobLebRebLebLobLebL
ebLibRobRsbRcbRobLebLobRsbLobRjbRebRjbRsbLebLcbRjbLebLebLebLsbRebLsbRo
bRibLsbRobRsbLebRjbRebRebLibLebLobLobRjbRobLobLcbRobLobLobLobLibRsbRob
RebLcbLsbLibRebRcbRobRobLcbLebLebRobRcbRobLobLobRobLobRobLebRcbLebLebR
sbRobRgbRebLebRebRobLobRsbLjbRebRobLobRcbRibLcbLgbRcbRebRebLcbRobLgbRi
bLcbRebLgbLobRobLibLobRebLebRjbLobRobRjbRebRcbLobLsbLobLebLjbRgbLobReb
RcbRobLsbLebRcbLobRebRcbLjbRebRobLobLcbRcbLjbLcbRebRsbRibRcbLebLobLobL
sbRcbLcbRobLobRobLgbRobRsbLebRibRjbLgbRsbLjbLobLsbLjbRobRobLjbLebRsbRc
bLebLobRebRebRsbLobLobLsbRjbRcbRebRebLsbLebRsbRobLcbLjbRsbRsbRobLobLob
RebLsbRebLebLjbLobLobLobLsbLsbLsbLsbLobLsbLjbLsbRobLsLsmbLebLsbRsbRsRs
mbLsbLjbLsbLobRsbLobRjbLobRobRobLjbRsLsbLsLsmbRjbLebLsbRobRsbLjbLsbLsR
ebRobRebLebRsbRsbLobRobRebRsbRobRsbRjbRsLob

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 10; Drug: OSU6162 3 然 Apo 50 然
bLibRsLsbLjbLiLsbRebRsbLjbLeLsbLhbLhLsbLebLsRsbRibLcbLhbRgbsbLgbRsbLsL
smbRsRgRgbRsbLebLibRcbRcRsmbRcbRsRsRsRsmmmbRgRsRsmmbLebLgbLibLhbLcbsbL
jLsmbLhbRebLcbRcbRcbRibLsLsmbLsbLsbLsbLsLsLgLsLsLsRsmmmbLgLsbLsLsmbLiR
jbRhbRgbLgbRebRcbLibLebLsbLgbLgLsLsmbLibLsbLsbRgbsbRsRsmbsbsbsbsbRibLs
bLcbRibLibRsbRibLsbRibRebRcbRibRcbLgbRgbRgbLcLsmbLsbLibLibLsbLsbLsbLgb
LibLgbLibLsbLgbLgLsbLsbLsbLsbLoRebReRsmbRobLibRsLibLebLjLibRebLjLibLgb
RjbRgbLsbRhbLcbLibLgbLibLibRibRebRcbRibRgbRgbRibRhbLgbRibLsbLhbLeLsbRs
bRcbRcbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 11; Drug: OSU6162 3 然 Apo 50 然
bLsRsbLsLsmbLsbLsbLsRsbLsbLsRsbLsbLsLsLsLsLsmmmmbLsbLsbLsLsmbLgbLsLsmb
LsbsbLgbsbLsLsmbLsbLgbLgLsbLsLsLsmmbRsLsLsmbLsbLsbLsbLsLsLsmmbLsLsmbLs
LsmbLsbRcRsmbRiLsbReRgLsLsmbLeLsbLibLgRsbLeLsLsLsmmbLiLsbLjLsmbRibRgbR
iLsbRgLsLsmbLjbRjbLsbRgLsbLsLsmbLgbLgbLjLsmbLsRsRsmbLsbLsLsLsmmbLgLsbL
gLsbLsbLsbLgLsLsmbLsbLsLsmbLsRsbLsbLsRsbLsLsmbLsbLsLsLsLsLsLsmmmmmbLgb
RsbRsLsbLsLsRsLgLsLsLsLsmmmmbLgbRsbLsLsLsLsLsmmmmbLsbLsLsmbRsLsLsmbLsb
RsLsRsbLsbLsLsmbLsbLsLsmbRsLsLsLsmmbLgbLsbLsLsmbLsRsbRsLsLsmbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 12; Drug: OSU6162 3 然 Apo 50 然
bLsLsLsmmbLsRsRsmbRebLhbLoRsbLcbLebLhbRebRobLsRsbRcbRcbRsLgbLcbLcbLcLs
mbRibsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 13; Drug: OSU6162 1 然 Apo 50 然
bRsLsbLsbRsbLsbLsbRsbRsbLsbRsbRsbLsbRsbLsbRjbRsbRsbLjbRebLebLobLjbLobR
obLobLebLebLobLobRebLobLobRebRobRsbRobRcbRjbRebLsbLobRebRsbRsbLobLebLj
bLobLobLebRobRobRobRjbRobLobLjbLsbLjbRobLebLobRebLobLobLjbRebLsbLobLob
LjbRjbRhbRcbLobLibRobLobLebRcbRobRcbLobLobRobRjbRcbLobLcbRsbRgbLebLgbL
obLsbLcbRsbLebRebRobLebRcbRsbLobLebRobRsbRobLcbRobRjbRobLobRsbRebRcbRc
bRobLobRjbLobRobLjbLcbLobLobRobLjbLjbRsbLjbLgbLobRgbLibLjbLgbLebLcbLob
LobRcbRebRjbLebLobLhbRebRcbLobRobLgbRcbLebLebLebLobRebRibRobRgbLebLebL
cbRebLebLgbLgbLobRebLgbLcbRibLebRebLobLebRebRibLebLibRobRgbLebLebRobLs
bLebLibLhbLobLebRebLgbLobRibLobRebLsbRcbLgbRcbRgbLcbLebLibLobLcbRobLob
RibRebRebLsbLebRobRebRobRgbLcbLgbLobRobLjbRobRobLobLebLobLobRobRhbLebR
cbRibLobLjbLcbRjbRobRcbLgbLobRobLcbLobRcbLibRcbRcbRobLhbRobLobLebLsbLi
bRibRobRgbRsbLobRsbRebLsbLobLobLibRcbLobLobLebLibRebLcbLobRcbLcbLobRgb
LibRobLobRobRcbLebRebLebLobLobRobRebLebRcbRebRcbRebRobLobRsbLobLibLsbR
cbRsbLobRsbRgbLobLebLcbLobLobLobLsbRsbLobRsbRibLobLobLebRibLsbRobRobRi
bLcbLebRobRgbLobLhbLobLcbRobRcbRobRibLebRebLcbLobRobRobLcbLobLobRcbRob
LjbLcbRebRebRobLsbLsbRobLebRsbRjbRibLobRibLcbLobLobRobRjbLobRcbRgbRobR
ibRjbLibLobRebRebRobRebLsbRibRobRjbRsbRobLobLibLebRobRhbLobLjbLobLebRo
bLjbLobLsbRcbRebRcbLsbRcbLcbRsbRsbLsbRcbLobRsbRcbRobLobLcbRebLebLjbLeb
LebLobRsbRebRebLobRebLobLsbLobLcbRobLjbRcbLebLsbRebRsbRebLebLjbRobLebR
ibRebRebLsbRob

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 14; Drug: OSU6162 1 然 Apo 50 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 15; Drug: OSU6162 1 然 Apo 50 然
bRebLebLobRobRsbRobLobRcbRobRcbRebLcbRobLebLebLcbRebLcbLgbLobRsbRobRob
RsbLcbLebLebLobRobRebLcbRobLebLcbRebLjbRobLobRjbRobLobLebRebRcbRobRhbL
obLibLcbLjbLobRobLebLsbRebRgbRebRobRobLebRcbRibLobLcbLobRcbRobLobLobRo
bLebLobRobLgbRsbLobRobLebLebRobLibRebLcbLgbRebRobRcbRsbLjbLobLsbLcbReb
LcbLobRebRebLebLcbLcbLobLobRobRebLebLobLobLobRobRibRibLobRobLibRcbRgbL
cbLgbLebLgbLobLsbLobLobRebRsbLobLebRobRebRibRobLcbLobLobRcbLobLsbRebRj
bLgbRobRibRobLsbRobLobLsbRobRobRcbLhbRobRsbLcbLebLebLobLobRobRebRsbReb
LobRsbLobLcbLebRobRcbLebLobRcbLgbRsbRebRobRsbLjbRgbLobRebRobRcbRhbRcbL
ibLebLebRebRcbLebLobLgbRgbLobRobLgbLgbLobRobLhbRebLsbLobRobLobLcbLcbRh
bRhbLebRibRobLcbLsbLobRobRobRobLcbLcbLobLcbRobLebRebRobLebRcbRobLobLob
LebLebLibLgbRebLibLibRobRhbRobRobLebRobLcbRobLcbRobLebRgbRebLobRcbRcbL
gbRobLebRobLgbLobLobLobRobRobLcbLobRobRobLebLobLcbRibLcbRcbLebRobLebRo
bRibRobLsbLgbRobRcbLebLhbRebRcbLobRebLibRebRobLobLebRobLobRebLebRobLib
RobLebLsbRebRobLebRobRobLobLobLebLobLobRobLebLgbRcbLhbLobRcbLcbLcbRebR
obRebRobLcbLobLebLobRobLibLcbRcbRebLebRobRobRebLobLobLobLcbLobLobLobLo
bRebRcbLcbLebRcbLebRobRobLcbRibLobRjbLcbLobLobRgbLobLcbRibRcbLcbRebRob
RobRobRobRcbLibLjbLobRobLebRobRgbRobLibRobLebLobLobRobLcbRcbLibLobLcbL
ebRobRgbRcbRcbRobLcbRobLsbLebRhbRobRobRhbLobRobLobLebRhbLjbRebRsbRobLc
bLobLcbLibLobLobLobRibRcbRgbLobLobRcbLcbRcbLobRcbRibLobRebLebRobRsbLob
LibLobRcbLebRcbLobRcbLobLibRgbRebRcbLobRgbLebLebRobRobLobLgbLgbRcbLobL
obLebRibRhbRobLobRgbRgbRobRsbLebRobRcbRobRgbRobLebRebLcbRobLcbLobRgbRi
bRobRebRgbLcbLobLcbRcbLjbRsbLcbLobLobRobRebRgbLobRobLebLjbRcbRhbLcbRob
RgbRebRebLebLibRebRobRibRebLibRgbLhbLjbLcbLobLobRcbRebRebLobLcbRobRibL
obLobLobLcbRobRhbRobLgbRobRobRebLobRobLjbLobRobRebRebRebLcbRhbLgbRibLg
bLibRsbRcbRibRcbLebLobLobRebRibRobRebLcbRobRcbLebRibLobRobLcbRebRcbRcb
LobRhbLobRcbRobLobLcbRcbRobLebLobLobLebRobLibLebLgbRobRebRcbRobLcbRobL
gbLobLcbLcbRobRebRebRobRcbLobRgbRobRhbRebRobRibLobLsbRobLsbLibRebRcbLi
bLibRhbRebRebRebLibRebRobRibRobLobLcbRobRobRebLcbRobRcbLebRsbRobRibRob
LobRebRebRgbRebRobRobRgbLobRobRibLebRebRhbLibRsbLobRsbRcbRebLobLobLobR
gbRebRgbLcbRhbLobRebRebLcbLobLebRobLobLcbRebLobRebRgbLobRcbLobRobLobLo
bLcbLcbLobRobRcbRobLobLsbRcbLhbRobRcbRebLobLobLebLobLibLobLebLgbRobReb
LebLcbRobRcbLebLcbLcbLcbRibLobRobRobRgbRobRobLobLobRobLebLebRcbLobRobR
sbLsbRobLobLcbRebRcbLobRobRcbLobLcbLibLibLibLebRebLebLobRobLobLebLebLe
bRobRebLsbLobLobRhbLcbLgbLebLebLibRcbLgbLobLebRobRobLibRgbRcbRobLcbLob
LebRibLebLobLcbRebRobRobLobLobLobRibLebRibRibRibLobRcbRobRobRibRobRibL
cbLibRcbLobRebRobLibRobRobLsbLcbRebLobLobLibLsbRobLebRobRobRebRobRebRo
bRgbRobRebLcbRobLebRobRobLgbRebRibRobRcbRobLcbLebRobLcbRibLebRobRobRob
LcbLobLcbRobRobLobLcbLebLebLcbLobLobRebRobRobRebRcbLebLgbLibRsbLebLobL
ibRebRobLobLgbRobLgbRobLcbRobRgbRhbRobLcbLcbLebRobRobRebLebLobRebLcbLe
bRobRobRhbLibRebLcbLebLobLobLebRobRebRebLobRibRcbLebRobRcbLobLcbRibLob
RobRebRobLgbRobRobLcbLibLebLhbRibRobRobLobLebRobLcbRebRobRgbRobLgbLgbL
sbLebRsbRobRebRcbRebLobLebLobLobLobRcbRebRebLobLobRcbRgbLebLebLobLebLo
bLobLobRebLobRsbLebRebLcbLsbRgbRibLcbLobRcbLcbLibLcbLgbRcbLobRsbRobRcb
LebRgbRobRobLcbRibLgbLgbLebRobRobLebRhbLobLobRibRcbRobRcbRibLcbRcbLgbR
ebRcbRobLebLebRebRobRobRebLcbRcbRebLcbLhbRebLsbRgbLhbRcbRebRcbRibRobLg
bRibRobRobRobLebLebRsbRcbLcbRgbRobLobLcbRgbLobLobLobLcbRobRobRebLebLeb
LcbRibRebLobRcbLebRgbRobLibRhbLgbRobLebLobLobLibLgbLobRcbLibRcbRebRobL
obLobLcbRobLibLebRebLobLsbLobLebLebRcbLobRsbRobRob

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 16; Drug: OSU6162 1 然 Apo 50 然
bLobRobRibLobLebLcbLobRebRobLobLibLibLhbLobRgbLebRebLobLobLebRobRobLeb
LebLebLobRebLebLobLcbLgbRcbRobLibLobRebLobLobLibRebLibLobLebLhbLobLobL
obLobLebRobRobRgbRgbLobLebLobRebLebLobRobLobLebLobLcbLobRobLibRobLcbLg
bLgbRobRobRcbLobLobLcbLebLibLobLobRcbLgbLobLobLobLobLebLobRobRobLsbRsb
LebRobLobRibRobRobRebRcbLjbLebRcbLcbLcbRobLgbLebRcbLobLcbLobRobLhbRobR
ebRgbRcbLcbRobRobRgbRcbLobRobRibLobLcbRgbLobLobLobRobRobLebRebLobLcbRi
bRibLebRgbRsbRobLebRcbLobRgbRobRobRcbLobRgbLobLibLobLebLobRebLobLobLob
RibLobLobRobLobRebRgbLcbRibLebRebLobRsbLcbLebRobRhbRobRobLobLgbRcbRsbR
ebLcbLgbLcbRobRebRobRibRebLebLobRobLobRgbRsbRjbLibLobLcbLibRcbLsbLibRg
bLibLibLobRobRobRgbLobRobRobLobLobLcbRobRobRobLcbLsbLobRobLibLebLcbLib
LebRhbRcbLebRobLobLobLobLibLcbRebLebRobLcbRobLebRobRcbRebLobRcbLobRcbR
obRobLobRcbLobRobLobLobRobRebRibLobRebRibRebLebLobRobRsbLebRobRobLebLo
bRcbLgbLobRcbLebLebLobRobRebRsbLebRcbRobRobLebRebRcbLobRebLebRobRibLob
LibLcbLobLobLobRobLobRobRebRjbLcbRcbLhbRobRobRebLcbRibLcbLibRsbLebLebL
obRsbRebRebRebRobLcbLobLcbLobLebRobLibLebRobRgbLcbRibRobLibRobLhbRobLo
bLobLobLebRobLobRhbRcbLobRobLebRsbLebLibLsbRebRobLobRobLobRebLibLhbLcb
LcbLcbRgbLebRobLcbRebRobLebLebLibLobLobLsbLhbRobLcbRobLibRobRebRgbRobL
cbRobLobRobLsbLobLgbRebLobRgbLobLobRibRcbRobRobLobLhbRobLobLobLobLcbLi
bRsbLobLobRobRsbRobRebRobLobRobRobRobRgbLsbLcbRobLibLobLobRobLgbRcbLib
LobRcbLebRcbLobLebRcbLebLsbLcbRgbLobRebLobRobRobRcbRibLibLcbRobRgbRibR
cbLebLebLobRcbLobLobLobLebRcbLebLobRibLsbLebLobLcbLibRhbLobLobLgbLobRo
bRobRobRibLhbRgbLgbLebRibLsbLebRebRobRebLebLebRobLebRcbRebRhbRebRobRcb
RobLobLobLobRcbLebLsbRsbLebLjbLcbLsbLgbRibLebRebRebRobRobLcbLsbRobLobL
gbRebRsbRgbLobRobLobLsbRcbRcbRobRcbLcbRebLcbRebLobRobRobLebLobRobRsbRe
bRobLgbLobRobRobRebRebRgbRsbRebRhbLobLgbRobRobLobRobLobRgbRebLobLcbLeb
RobLcbRobRebLobLobRebLebLobLobLobLebLibLcbRobLcbLcbRobRibLobLebLebRobL
obLjbLebLgbLibLobRcbLgbRobLobRgbRhbRebLobRgbRobLebLobLcbLobLebRobLsbRo
bRobLebLobLcbRibRibLgbRgbLebLobLobRcbRebRebRobRcbRebLebRobLobLobLsbLcb
RebRgbRcbLibRobRebRibRcbRobLebRebLibLcbRobLobLebLibRcbRebLobLobRebLcbL
hbLobLobLebRebLcbRcbLobLcbRcbRcbRobLgbRobRgbRobLobRibRobRebLebLgbRhbRg
bRibLebLcbLobLibLebLobRobRobLebLgbLibRcbRhbRgbRobLebLebRobRgbLcbRobLob
LobRibLobRsbLobLobRcbLhbLsbLcbLobRebLobLebLibRobLibLobLobRobRobLhbLcbR
cbLebLobLsbLsbLcbRebRcbRgbLgbRobLsbRebRobLibRobRhbLcbLsbLebLgbRobLcbLh
bRsbLgbLobLobLobRgbRobRebRcbRebRcbLobLobRobRobLobRebRebRebLhbLobRobLob
LcbLibRobLcbRebLobLcbRcbLebRobRobLobLsbLebRobRobLibLobRobLibLobLebRebR
ebRobRcbRsbLcbRobLibRobRobRibRobLsbRebLgbRobRobRobLebRcbLobRobRhbLcbLg
bRebLcbLhbLebRobRebLobRcbRebLebRobLobRebLebRebLsbRebRcbRgbLobRobLobLeb
LsbRebRobLobRebRebRobRobLobLsbLobRgbLobRebRgbRsbRobRebLobLobRcbLobLcbR
ebLobRsbRobLibLebLjbRobRcbRcbRebLebLgbLobRebRobRobRebRobRobRgbRebRobLc
bLebLcbRobLebRobRebRebRobLcbLcbLobLobLobRebLibRobRcbLobRobLsbRobLobRcb
RcbRhbLebRhbLobRobRobRobRebRobRebLcbRgbRgbRobRobRobLebLibRobRibLobRobR
obLsbRibLobRgbLebRcbLobLobRebLebLibRobLhbLobRobRebRobRobRobRobLebLcbRe
bLcbRobLobLcbLsbLobLobLcbRcbLgbLcbLgbRebLebReb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 17; Drug: OSU6162 1 然 Apo 50 然
bLgbRjbRsbLsbRibLgRsbLiLsbLsLsmbLsbLibLgbLgRgRsmbRsbsbsbRjRjbLsbRsbRsb
LsbLsbRsbRsbLsbLsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 18; Drug: OSU6162 1 然 Apo 50 然
bsbLsbLsbsbsbLsbRsbLsbLsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 19; Drug: Control Apo 50 然
bsbLsbsbLsbLsbLsRsbRsRsRsmmbsbsbLsRsRebLsbLsRsbLgbLobLoLsmbLoRsbRibRcb
RcbReLsRhLsbLcLsmbLgbLcLsLsmmbLiRsbLoRsbRsbLsRsbRcbRibLcbLgbReLsbRebRc
bRcbLoLibLobLiRjLsbRcbRibLgbLgbLcLsmbLsbLsLsmbRsbRsLsbLsbLgLsbLsLsmbLs
LsmbLsRibLoLgbLoLsmbRebRhbLcbsbsbLsbLcLsmbRcbLcLsmbLcLsmbLhbRoRsmbRibR
cbRhbRibLcbLcbRibRobRiLsbLjbLoRsbLcbLgLsLsmbLsbLgbLgLsbsbsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 20; Drug: Control Apo 50 然
bLsbsbsbsbsbsbLsbLsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 21; Drug: Control Apo 50 然
bLgLgbLeLsbLsLsLembRsbLiLsLibLcLsLsmmbLgbLsLebLibRsbLsLsmbLebLeLsbLsRs
bLiLsbReRsmbRobRibRebRhRsmbLsbRcRsmbLsbRiRsmbLjbLoLsmbLcbRibRibRgbRibL
sRiRhRsmbRhbLsLsLsLsLsLsmmmmmbLgbLhLsbsbLcLsmbLebLibLsLibsbLsLsLsLsLsL
sLsLsLsLsLsLiLgLsLgmmmmmmmmmmbLsbLgbLsLgbLgbLsbLiLsbsbLhbLsLsLsLimmbLg
bLebLeLsLsmbLsLsLsLemmbLgbRjbLibLgbLebLsbLcbRebRcbLobLeLsbRoLsbLcLsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 22; Drug: Control Apo 50 然
bLsbRsLsbLsbLsbLsLsmbLsbLsRsbsbLgbLebLibRsLsbRgbRiLsbLsbLsbRiRsmbLobLo
bReRsmbRsbRiLsbRjbLibLsbRsbRcbRsbLsRsbLsbRsbRebLjbLhbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 23; Drug: Control Apo 50 然
bLcbRobLobRebRebLobLobRobRobRebLebLobLibLcbRibLcbLebRobRhbRgbLsbLobLgb
RibRobLebRebRobLcbRobRobLcbRcbLebRebLcbRebLcbLebLgbRcbRobRgbLebLibLebL
obRebRebRobLhbLcbLobRobLebLobLebLobRobLobRcbLcbRibLjbRebRobLgbRcbLebLo
bRebLobLobLobLobLibRhbRobRobRcbRebLobLobLobLcbLobRobRhbLobLibRobRobLob
RobRobRobLcbRjbLobRjbLebLsbLobLebLobLcbLcbRebRebLobRobLobLgbRobRsbLcbL
ebRebLcbRibLobLobRhbRobRobLobLcbRobRobRebLobLebRhbRobLcbRobLebRebRibRo
bRcbRebLsbRebLobLebLebLebLcbRobLcbRobLebLebLobLebLcbRobLcbLobRobLobLcb
LcbRobRobRobRcbLcbRebRebLcbRobRobRjbLobLibLebLibRhbLobLebLebRebRobRobL
ebLobRobLobRobLgbLobLobLobRibLobRcbRobLsbLobLobLebLobRobLebRgbLobRebLj
bRcbRgbRobLgbRobLgbRcbRebLobLobLobRobLcbLibLsbLgbLcbRhbLcbLobRsbRcbReb
LebRibLgbLcbRibRebLsbLsbLobRsbRibLcbRibRobLebLgbRebLebLebRobRebLebRobR
sbRobLobLobRobRebLobLobLebRobRobRcbLsbRobRebRebLsbRibLebRcbRsbRebRobLo
bLobRhbRcbLobLobLgbLebLebLobLhbRobRibRobLebRobRebRgbRebLobLcbLhbLebLsb
RobLobLobRebRsbRhbRcbLcbLobRcbRebLobLobLcbLobLgbRobRebRobRcbRebLcbRibL
obLobLcbLobLobRhbLsbRebRibRcbRebLcbRobRebLebRobLobLobLebRcbRcbRcbRobRi
bRobRobLobLobLobRhbLcbLebLobRobRobLsbLcbRcbLobRobLebLebRobRsbLobLobLeb
LibLobRebRobRhbRhbRebRgbRebLgbRobRebRcbRobLobRobLobLebRcbRobLebRibRobR
cbLobRobRobLhbLobRobLsbLebRobLibRcbRebLebLebRobLobLobRebLobRgbLobLcbLs
bLgbRgbRobRgbRobRobRebRibLobLebRcbRobLhbLcbRobRobLebLobLobRcbLibLobRib
RobRgbLsbLcbLobRebRcbLsbLcbRobLcbLhbLobRobRcbRhbLebLibRcbRebLebLebLobR
obLgbRcbLebRebLobRobLcbLobLibLgbRobLebLebLobRebLibRcbRebLebLobLgbLcbLi
bRobLgbLobRebRobLcbLobLibRobRibLcbLebLebLcbRobLobLebRibRobLcbRobLebLob
LibLebLcbRhbLobRobLsbRobLobLcbRibLcbRcbLobRobRcbRobLibRobLibRobRebRobR
cbRebRobLobLebRobLcbRhbLebLobRgbLsbLobLebRobRobLcbRsbLsbLobRobRcbRibRo
bRobLcbRobLebLcbLcbRsbRobRebLcbLobLobRsbLsbRcbLibLebRcbRobLobRobLobRgb
LobLibLobRcbLebRobLobLobLebRibRcbRgbRibLebLobRcbRobRgbLebLobLobRebLobR
obLgbRcbLobLebRcbRgbRobRobRebRobRcbLibRgbLcbLcbRcbLobLobRobLobRebRgbLo
bLebRhbLobRebRebRobLibRhbRobRobRebRobLobLibRcbRobLobLebRobLgbLobRhbLob
RgbLhbLibLobLgbRobRebLobLobLobRebLcbLebRhbLobLebRobRsbRobRebLobLebLsbR
ebLebRobLgbRebRebRgbLobRcbLobLcbRibRobLibRgbRobLhbRcbRcbRobRebRcbRebRg
bRebLobLobLjbRcbRobRhbLcbLobLjbLgbLcbRibRobLobRcbLobLcbLebRsbLcbLsbLob
RibRcbLcbLobLobLobLobRibRebRebRibRcbLebRobRobRebLcbRobRcbRobRebLcbRebL
gbLibLobLobRebLebLebRobLobRibLsbRjbLibRsbLgbRhbLcbLobRsbRobLgbRibLebRs
bRcbRebRobLibRebLhbRsbLcbRcbRobLhbRcbLobLebRebLobRobLebRibRobLobRibLeb
RcbRobLebLibLebRhbLcbLebLcbRobLobLobLibRsbLibRibRobLcbLebLsbRobRobLobR
ibLsbLobRobRibLcbRebRobLcbLgbLobLebRcbLibRibLobLobRebLobLcbLobLgbRibRo
bLsbLobLebRobRsbLcbLhbRobRibRobRobRobRsbLcbLcbLibLebLobRebRsbLobLhbLob
LobRebRobRobLobLobRobLobRcbRcbRibRebRhbRebLobRebLcbRobRcbLsbLobRcbRobL
cbRobRibRobLgbLsbLobRhbRobLobLgbLsbRebRobRobRibLibRobLobRebLobLobLobRe
bLibRebLcbRobRhbLebRobLgbLobLcbRcbRsbRhbLobLhbLobRobLcbLebRebRcbLibLcb
LobRsbRobLcbRobLobLobLobLgbLcbLobLobRcbRebRobRobLobLcbRebLobRobLobRobL
cbRebLsbLebRibRcbRsbLebLgbRibLcbLebLobLobLobRobLebRcbRhbRebLebLobRgbRs
bRobLcbRibRgbLgbLcbRibLebLobLgbLcbLobRsbRhbLobLcbRobLcbRcbLcbRebRibLib
RobRobRebRcbLcbLebRobLcbRobLobRebRobRibRcbLcbRobRgbLobRibRebRgbLobLobR
obLjbLcbLobRobLcbRgbLcbLcbRebLibLob

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 24; Drug: Control Apo 50 然
bsbRsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 25; Drug: OSU6162 10 然 Apo 50 然
bLsbRsLsbRsbRjbRjbLsbRsbLebRobRjbRsbLjbLjbRjbRcbLobRjbRsbRebLsRsbLsbLs
bLjbLsbRobLsbRobLsbLobLjbRsbLsbLjbRcbRebLsRsbRobLobLjbRsbLcbLjbLsbRjbL
obLjbRebRsbRjbRobLsbRsbRsbLcbLjbRjbRsRsmbRsbLebRebLebRsbRsbRjbLsbRsbLe
bRjbRsbRjbLsbRsRsmbRsbRsbRsbRebRobRsbLsbRsbLsbLebLcbLsbLobRsbRsbLsbLob
RsbRjbLebRjbLebLjbLjbRobLebRsbRjbLsbLjbRsbLjbRjbRebRebLebLebLjbRjbLebL
jbLebLcbRsbRjbRjbLebLebLebLjbRebRjbLobLsbRgbLsbLebLsbRjbLsbLebRsbLjbLo
bRsbRsbRjbRobLebLobRsbRobRcbLjbRobLobRsbLobRobLjbLcbLobLsbLjbRsbLjbLjb
RjbLebRjbRjbLjbRebRjbRibLjbRjbRsbLjbLjbRjbLebRobLjbRcbRebRebLsbLsbLsbR
jbLsbRebRsbRjbLebRebRcbRebLebLebLebRobRsbLcbRjbRobRsbLobRebRebLobRjbLe
bLjbRebLobLobRsbRobRjbLjbLjbRjbRsbLjbLjbRjbRebRobRebLobLebLjbRsbRobReb
RebRobLjbLebRsbLobRjbRebLebRjbLjbRjbRjbLebRobRjbRjbLjbLebRsbRobLebRjbL
sbRebLebLebLebRebRobLebLsbLcbRebLjbRjbLsbRobLebRebLsbLebRjbLobLcbRjbRs
bLcbLsbLobRsbLjbRsbLobLjbLcbRobLebLobRobLobRobLjbRsbRsbRobRebLjbRsbLob
LjbRjbRobRjbLobRsbLjbLsbLsbRjbLebLobRcbLsbRebLjbLebLcbLjbRebLobRsbLobL
jbRebRjbLobLjbRjbLebLobLjbRcbLjbRjbRjbLebRebRsbLjbLcbRebLjbRcbRebLsbRe
bRcbLsbLebRjbLobRebLebLcbLebRcbRebLobRsbLobRsbRebLobRcbLsbRjbLcbLobLob
LcbRsbLebLebRobLobRobLebRcbRcbLobRsbRsbRcbLebRsbLgbLsbLebRsbLjbLebLobL
gbLobRcbRgbRcbLjbLobRebRobLobRsbRebRobRebLcbLobRobRobLebLebLebRebRebLe
bRobRsbRcbRobLobLibRhbRobRcbLobLcbLobLcbRobLgbLobLcbLobLcbRcbRsbLcbRib
RobLgbRsbLhbRobLcbRcbRobRebLobRobRobLebLgbRobRsbRebLcbLcbLobRcbLebRebR
obRobRobLcbRobLobRebLebLibRcbLcbRcbRobLobLebRcbRcbRcbLcbLgbLebLobRebRo
bRobLobRcbRibLobLobRobLobRhbRebLcbLgbRobRobRobRebRgbLobLobRobLcbLobLob
RebLobLsbRobRobRibRjbLcbLebLibRebRcbRobRsbLobLcbLobRibLcbLgbRobRcbLebL
jbLobRcbLebRjbLsbLebLcbLobRcbLibLobLhbLobRobLobLsbLobLjbRebLobRobRobLj
bRcbRjbLobLobLobLebRjbLibRjbRjbLebLebLcbLcbLcbLobRsbLobRobRobLcbLjbLjb
LebLjbRobRobRebLcbLhbLobLobRobLsbLsbRobLebRobLebLjbLebRobRobRjbRebLebR
cbLobRebRjbRebRebRebLjbRobLobRobLobLobLjbRcbRcbLobRgbRcbRcbLjbRjbRobLo
bLcbLjbLebRebRjbLobLobLcbLsbLobRebRobLjbLcbRobRsbLjbRobRcbRobLobRjbReb
RobRgbLebRibLebRjbLcbRebLjbRebLobRebLebRcbRcbRcbRjbRjbLcbLjbLjbRjbRjbL
jbRobRebLobRobLobLcbRjbRebRcbRjbLcbLjbLjbLobRobRebLsbRjbRebLjbLebLsbRo
bLcbLebRobLebLjbRobLobRjbRobRcbRcbLobLjbLobLjbRjbRjbLobLebRobRjbLjbRsb
LsbRjbLsbLebLcbLcbRebLsbRjbRsbRcbRjbRjbLjbRebRobRobLebLobLebLsbLsbRsbL
obRobRobRebLsbLebRsbLsbLobLobRobLjbLsbRsbLjbRsbRebRebLsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 26; Drug: OSU6162 10 然 Apo 50 然
bRsRebLsRsRsRimbRsRsRsmmbRsRsmbRsRsmbRsRsmbRsbLsbLsRgRsmbLsbRgbRebRgbR
gbRsbRsbRgbRgbRsbRgbRebRibLsbLsRsLsRsbRsRsmbLsRsLsbsbsbLgbRibLsLiLhLiL
sbLebLsbLgbLsbLsbRsbLeLsbLsbLgLsLsLsLsLsmmmmbLsLsLgmbLsbLgbLsLsmbLsbLg
RsRsmbRsbRsbRgbRsRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 27; Drug: OSU6162 10 然 Apo 50 然
bRsRsLsmbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 28; Drug: OSU6162 10 然 Apo 50 然
bRgRsmbLsbRobRsbLobsbRibLgbLobRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 29; Drug: OSU6162 10 然 Apo 50 然
bLsLsmbLsLsLsLsLsmmmmbLsbLsLsmbLsLsLsLsmmmbLsLsLsLgLgLsLsLsmmmmbLsLsLs
LsmmmbsbRjbLsbRsLcbLibLgLebRcbRsLsLsLsLsmmmbLsLsLsRsmmbLgLsLgLsLsLgLiL
gLsmbRsLgbLhbLjbRsLsLsLsLsmmmbLsLsLsLgLsLsLsLsLsLsLsLsLsLgLgmmmmmmmmmm
bLsLsmbLsLsLsLsRsLsLsmmmmbLsLsmbLsLsLsLsmmmbLsLsmbLsbLsLsLsmmbLsbLsLsm
bRsLsLsLsmmbLsLgLsLsLsLsmmmbLgLgbLgbLgLsbLgbLgbLsLsLsLsmmmbLsbRjbLsbRc
bsbRsbRsbLsbRsbRgbLjbRsbsbRsbsbsbLcRsbLgbRgbRibRhbsbRsbRsbRgbRsbsbRibL
ibsbLcbLiLsbLgbLcbRibRsRsmbLebLibLsLsRsmbLgbLgbLgbLsLsmbLsLsmbLsLsmbRs
bLsLsLsLgLsLsmmmbRsbLhLsLsmbRgbLibLcbRibsbRsbLsbRsbRsbRsRsmbRsbRsbRsbs
bLsbsbRsRsmbRibRcbRibRsbRebReRsmbRsbLsLsmbRibRgRsmbRgbRibRgbRiRsRsmmbL
sbRebRgbLsbLjbLgbLiLsbLiLsbLgbLsbLgbsbLgbLgbLsbLsbLsbLsLsmbLiLsLsmbLgL
sbLibLiLgLsbLebRebRcRsmbRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 30; Drug: OSU6162 10 然 Apo 50 然
bRjbRebRobRjbRjbRsbLjbRjbLjbLsbLjbRsbLsbLobRebLebRobRobLobRcbLobLjbRcb
LebRgbLobLcbLobLsbLjbLjbLobLsbLjbLjbLsbLobLobRjbLcbRobLobLsbRebRobLjbL
obRsbLebLobRebLobRobLsbLcbLcbRsbLebRobLsbRebRebLobLsbRobRobRjbLobLjbLe
bRobLjbRsbRebLobRobRobRobLcbRjbRebRobRcbLebRjbLobLobRjbRgbLebLsbRsbLjb
LebRjbRobLobLobRsbLebLsbRobLebRebRcbLcbRgbRobLsbRebRcbRsbLebLsbLsbLobL
jbLobLobRcbLsbLjbLobLobRobLebRjbLebLebRcbLebRebLcbRebLjbRibRjbRebRcbRe
bRjbRcbRobRebRjbRobRobRobLobLebLsbRibLgbLebRjbRcbRebRjbRobLobLebLcbLcb
RobRsbRebRobRebRobLsbRhbLjbRjbRobRibLsbLhbLjbRcbLobRebRcbLobLebRjbRibL
obLobLobRjbRgbRjbRebRobLebLobLebRjbLsbRjbLobRobLobRebRsbRsbLcbLobRjbLe
bLcbRobRsbRobLsbLebLebRobLebRebRobLobLgbRgbRobLebLcbLobRibLebRobRobRsb
RjbRebRobRobRsbLsbRebLobLebRobLsbRsbRgbLsRsbLebLhbRsbRsbRobLsbLobLebRo
bRebLobRobRebRsbLobLsbRebLibLobRebLebLjbLobLebRcbRsbLobLobRibLebRobLjb
RcbLsbLsbLebLsbLsbLobLebLobRcbRsbRcbLsRjbRobRobLsbRebLobLoLsmbLsbRobRs
bLjbRobLsbLsbRjbLobLjbRobLjbLsbLsbLebLsbLobLsbLobLsbRsbLsLsmbLsbRsbLsb
LjbRsbRgbLebLobRebRsbLsbRebRobRebLsbRjbLobRsbLebRsbLsbLebRcbLobRsbRsRe
bRobLcbRobLebLebRebLjbLoRobRsbLsbRsbLobRebLsbRebLebRcRsmbLsbRoRsmbLobR
jbLsbLsbRsLsbLeRsbRobLoLsmbRsbRsLsLsLembRjbLsRsbRobRsbRsbLsbReLsRsbLsb
RebRebRoRsmbRsRsLsLoLsmmbRsRebRebRsbRsbLsbRsLobRsbRsLsbLsbRsbRsbRsbLsb
RobRsbRsLsbRsLobLsbLebRebLobRsbLsRsbRobLeLsRsbLsbLsbRsbRsLsbLsbLebLsLs
mbLsbRsRsmbRsLsbRsbLsbRsbLobRsRsmbLsRsbRobLsbRsbLsbRsbRobRebLobRsbLobL
ebLebRobRebLcbRebRobRcbRebLebRcbRsbRgbLobLobLobLobRebLebRobRebLebRcbLo
bLcbLgbRobLsbLobLgbRebLebRcbRobLibRibLsbLibLcbLcbRobLobRobLobRobRsbRob
LsbRebRibLobRcbLobRcbRebLobLobLobLibLgbLcbLcbRcbLcbLgbRobLobLsbRibLobL
cbRebRebLebLcbLobRebRcbRcbRebRobLebRjbLobRobLobRebRebRebRcbRobRibRebLg
bLobLobRcbRobLebRsbLcbRobLebRobRebLobLibRcbRibLebRobRobRobRcbLibRobRcb
RobLcbRibLgbRcbRgbLibLgbRibRsbRebLibRobRebLobLcbLibLcbLebLebLgbRobRcbL
cbRobRebLjbLcbRobLebLcbRgbLgbRebRobLjbLobRcbRobLibRobRgbRobRobLebRibLi
bRsbRobLobLobLobLobLobLcbRebLcbRobRebRgbRobRobRcbLhbLcbRobRgbRsbRobLhb
LobRobRibRcbLebRsbLobRobLcbLhbLobLcbLcbLobRcbLebRebRcbRgbLcbRobRobRobL
ebRobLcbLsbRebLobRsbLibRobRebRcbLebRebRebRobLcbLobLhbRobLhbRcbLebLcbRc
bLebRobLebRebLebLobRebLobRobRgbRobRcbRebRsbRobRobLcbLgbRgbRebRebLcbLob
LobRobLobRgbLgbLebLibLobLebRobRebRobLsbLcbLebLsbLobRebLebLobLebRibRebR
ebRobRibRobRobRjbLobRcbRgbRcbLebRgbLebRobRobLobLcbLobRobLcbLhbLobLobLc
bLebRobRebLebLobLebRebRobLebLobRcbLebRobRobRobRobLebLcbLcbRebLebLgbReb
RobLobRobRobLebRobLebRobRobLobRsbRsbLibRcbLebLobRebRobLcbLobLobRebLebR
obLebRhbLobLobRobLebRcbRhbLebLcbLobLebLobRcbLobRcbRobRebLobRobLobRibLo
bLebLibLgbLebLebLobLcbLebRobLebLebRgbLcbRebRcb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 31; Drug: OSU6162 3 然 Apo 50 然
bRjbRobRgbLibRsbRobRcbLebLobRobLibRcbLibRobRgbRobRebLgbRcbLebLobRcbRib
LcbLobRobRcbLjbLobLgbLcbRibLobLjbLebRebRobLobLobLgbRebRobLobRjbRgbRgbR
gbRebRcbLcbLcbLebRcbLgbRgbRebLgbRobRgbRebLobRsbLobRobLobLcbLcbRebRebLc
bRibLebLibLibLobLebRibRgbRcbLibLjbLobLibRibRhbRebLobLobRsbLcbRobLhbLeb
LsbRsbLcbLcbLebLcbRobRcbRebLcbRcbRobRjbLebRcbRebLebLebRobRhbRebRcbRcbL
obRebLcbRobLebRcbLebLobRebLobRjbLobRobRobRobLcbLobLebRebLobLobLcbRcbRe
bRibLobLcbLcbRhbRobRibLobRcbLobRobLgbRebLobLebRgbLobLobLebLcbRjbLobRob
RgbRobLobLcbRcbRebLobRsbLobRibRhbRobLobRibRobLgbRobRcbLebLcbLcbLobLobL
cbLobRobLobLebLebRebLebLobRgbRcbRibLebRjbRobLebLcbRobLsbRcbRobLobRobLg
bLcbLebLebRibRobLobLcbRobRobRobRcbLebLobRebLobLcbLebRobRobLgbRebLobRib
RobRebRobRobRcbLebLobRibRobRgbRsbLobLobLcbLcbRgbLobRobRobLsbRcbLobLhbL
cbLobRebRsbLobLebRcbRobLobLobRebRhbRobLcbRibLobRobRgbRcbRobLcbRcbRobRo
bRobRobLibRebRobLobLgbLcbRobLobRebLobLebRobLobRebRobLobLebLibLibRebLob
LibLobLcbLebLcbRobRebRcbRobRcbRebLobRgbRibRebRobLebRibLebRobRobRsbRsbL
ebRibLsbLibRobLebLibLebRobRobRibRebRcbLobRobLebRebLebRibRcbRebRebRobLc
bRebRobLibRibLebLobRobLebLebLebRobRebRsbLobRibRobRebRebRebLhbRobLobRcb
LebRobRobRgbRebLebRcbLebLibRcbLobLobLebLebRcbRcbLgbLobRobRobRobLobRobR
ibRobLobLebLebRebLobRobRhbRibLebLebLcbLobLobRobRobRobRhbRsbRcbLebRobRe
bLgbLcbRebLobRebRobLobLobRgbLobRobLobLobLobLobLebRobRcbRcbLobRcbRjbRob
LgbLobLgbRobRcbRebLobLebLebRobLsbRebRcbRobRcbRsbRobRibLobRibRebRebRobR
cbRibLgbRobLibRcbRibRobLebLsbLibRobLobRebLobRgbRebLcbRobRobLsbLobRcbLg
bLebLobLobLobLgbRobLcbLobLebLobLcbRobRgbRcbLobRgbRsbLsbRebLibLcbRsbRcb
RebLebRobLcbLobRebLcbLobRobLobRobRobRibLobRibLobLobLcbLobRjbLebLcbLobR
cbLobRcbRobLobLobLgbRobLebRobLebLcbLibRcbLgbLgbRebLibLsbLgbLebRebRobRe
bLsbLobLgbLebLobRobLhbRobRobLobLcbLgbRebRibRobLobLgbLebRebLgbRebLcbRob
LibRcbLebLibLcbLcbRebLobRobRgbRgbLcbRobRobLcbLgbRobRcbRcbRcbRobLobRebL
ibLibLibRcbLibRobLobLgbLobRsbLobRobRobRobRcbLebLobLgbLsbRobLebRcbRobRo
bRebLgbLcbRebLobRcbLebLcbLobRobLobRsbRobRcbLobRcbRobLcbLobLcbRcbLibReb
RcbRibLibRcbLibRibRgbLcbRobRobRobRgbRobRobLobLsbLibLobRhbRcbRcbRobLobR
ebLobRibRcbLjbLobLhbRobLcbLsbRebLobLobLobRobLobLobRobLobLcbLcbRobLgbLc
bRobLhbLobLcbRibLobRobRebRibRibRobRebLobLobLobRsbRebLebRebRobRgbLcbLob
LebLobLebLobLobLjbRcbRobRobRhbLgbRebLsbLobLobRebLobRebLgbLobRobLobRobL
jbRobRebLsbRobLebRobLebLgbRcbRebLcbLobLebLobRobLobLcbRobRobLgbRobRebRc
bLobRcbRobRcbLobLgbLobRobLobRebRcbRobLobLobLobLgbLibLcbLobLsbRebRibRob
RcbLobLsbLebLgbRcbLobRebLgbRobLebRibRcbRebRebLobRcbRibRobRibLobLobRgbR
obLobRebRsbLcbRebRobRebLobRebLgbLcbRebRobLibRgbRobLgbRibLebLebLebLobRg
bRcbLobRobLsbRcbLjbRgbRebRibLobRhbLobLebRobRcbLhbRobRobRibLobLobLcbLeb
RebLebLebRcbRcbLcbRebLobLebRcbLobLibLobRobLobRcbLobLobLobLebLsbLebLobL
obLsbRebRobLsbRobLgbRobRcbLebLhbRobRobLibRcbLcbLibLcbLsbRebRobRibRobLo
bLibRibRobRebLsbLobRsbLebRibLcbLcbRibRcbRobLcbLebLgbLobRcbRebLobLobLob
RobRobRgbLobRobLebLobRobLcbRgbRsbRobLcbRobRobRobLcbLsbRgbLibRebLobRebL
obLebLobRobLebLobLhbRgbRcbRobLcbRobRcbLgbRebLsbLobLobLobRebRgbLobLobRs
bLobLobRsbLebRcbRebLobRibRibLebRebRebRcbLobLobRobLebLcbLcbLobRebRobRob
RobLobLebRobLobLibRcbRgbLcbLcbLobLsbLebRebLebLcbRebLebRgbRobRobRebLcbL
cb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 32; Drug: OSU6162 3 然 Apo 50 然
bRsbLsbRebRgbRjbRgbLsbLcbLjbLsbLgbLsbLsbRgbLsbRsbRebRgbRcbRobRibRsbRsb
RsbsbRjbRgbRebRgbRgbLebRgbRgbLobLsbLibRjbRjbRoLcbRcbRjb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 33; Drug: OSU6162 3 然 Apo 50 然
bsbsbsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 34; Drug: OSU6162 3 然 Apo 50 然
bLsbsbsbsbsbsbLsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 35; Drug: OSU6162 3 然 Apo 50 然
bLebLobRhbRsRsmbRgbRebRibLjbLcbLsbLsbReRsmbRebRibLcbLcbLgbLebLsLebLebL
ebLebLebLebsbLebLebLsLebLibLgbLgLsbRsbLsbLiLsbLsLgbLsLgbLsbLsbRsLsbRsb
LsbRsbLgbLibLgbLebLsbLsLebLsbLsbLgbLibLebLsLsmbLibLgbLibLsbLebLgbLsbLs
bLgLsLsmbLsbLsRsbLsbLsbLsbLsbLsbLsRsbLgLsbRsbLgRsbsbLsbLsRsbLgRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 36; Drug: OSU6162 3 然 Apo 50 然
bLsbLgbLsbLgbLsbLsbLsbLsbLsbLgbLsbLsbLsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 37; Drug: OSU6162 1 然 Apo 50 然
bRgbRsRsRsRjRcmmbRsbRsbsbsbRsRsRsmmbRsRsRsRsmmmbRjRibLcbLcLsmbLcLsmbLc
LsmbLibLebsbLgbLgbLsLsLsmmbLsLsLsLsLsmmmmbLsLsLsLsLsLsmmmmmbLsLsmbLibL
ebRgRsRsRsmmmbRhRgRsmbRgRsRsRsRsmmmmbRjReRsRsmmbLcLsmbLoLsLsmmbRjbsbRs
LsbRsbRsRsRsRsRsRsRsRsRsRsmmmmmmmmmbReRsmbRcbRobLgLgbsbLsbLsbLsLsLsLsL
sLsmmmmmbLsbLsbLsLsLsLsLsLsLsLsmmmmmmmbLgbLcbRobRcbRsRsmbReRsmbLjbsbLj
LcbLcRsbRjRcRsmbRcbLsbRebLsbLebRsbRhbRibLsbsbsbRgRgRsmbRjRebLsRsLsbRsR
hbLsLcbRjRsmbRiRsmbsbLeLsbLgLsRsbRsRsLsmbLeLgbLibRsbsbRsRsmbLsbLsbLsbL
sbRsLsbsbLsLsmbsbRsbLsbLebLobRsbReRsmbLgbRjRsmbRebLcbLcLsLsmmbLcbLgbLs
LsmbLgLibLgbLgRsbLebRibsbRsLsbRsLsbLsbLsRsRsLsRsmbsbsbRsRsRsRgRiRsmmmb
RsRibLcRsbLcbRsbsbRsLsbsbLeLsbLsLsmbLgLsbLsLsmbLhbRoRsmbRsbRgbRgRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 38; Drug: OSU6162 1 然 Apo 50 然
bRsRsmbRsbRgbRsbRsbRsRgbRsbRsbRsbRibLsbRsbRsRsmbLsbRsbRsbRsbRsRsmbRsbR
sbRsbRsbRsbRsbRsbRsRsmbRsbRsRsmbsbsbRsbRsbRsbRsbRsbRsbsbRgbLgLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 39; Drug: OSU6162 1 然 Apo 50 然
bLsLsmbLsLsLsmmbLsLsLgLsmbLsLgbsbRebLcLsmbLgLsbLgLsRsbLsbLgbRsbLsLsmbL
sLsLsRsLsLsmmmbLsLsmbLsLsLsmmbRsLsLsLsLsLsLsLsRsLsLsLsLsmmmmmmmmmbLsLs
LsLgLgLsmmbLsLsmbLsLsLsLsLsLsLsmmmmmmbLgLsbLsRsbLsbLcbLcLsmbLcRsbLgLsb
LgbLsbsbLsbLsLsLsLsLsLsLsLgLsmmmmmmbLgbLgbLsLsLsLsmmmbLsLsmbLsLsLsLsLs
LsLsLsLsmmmmmmmmbLibRcbRobRobLcLsmbLjLgbRcbRgbLsbRgRgRsLsmbRiLsbRobRcb
RsRebRibRhRsmbRgbRgLsbLsbLsbLjbsbLebLhRsLsRsLsbLobRcLsbRcLsbLsRsbRcRsm
bRobRibRcRsmbRibLgbLcbLiLsbLsLsmbLcRsbLebLcbLibRobRgbRcLsLsmbLibLeRsbL
gbLibRjbRcRsmbLsLhbRobLgbLsbLsbLsLsLsLsLsmmmmbLsbLsLsmbLsbLsLsLsLsLsLs
LsLsmmmmmmmbLsLsLsRsLsLsLsmmmmbLsbLsLsLsLsLsLsmmmmmbLsbLsLsmbLsLsmbLsb
LsbRsLsLgLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmbLsLsLsLsLsmmmmbLsLsLsLsLsLsm
mmmmbLsbLgbLsLsLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmmmbLsLsLsmmbLsbRsLsLsLs
LsRsmmmbLsLsLsLsLsLsLsmmmmmmbRsLsbLsLsLsLgLgmmbLsLsLgLsLsLsLgmmmbLsLsm
bLsLsLsLsLsLsLsLsLsLsLgLsmmmmmmmmmbLsRsLsLsLsLsLsLsLsLsLsLsLsLsLsmmmmm
mmmmmmmbLsbLsLsLsLsLsLgLsLsLgmmmmmbLsLsLsLsLsLsLsLsLsLsLsLsLsLsLgLsLsL
sLsmmmmmmmmmmmmmmmmbLsRsLsLsLsLsLsLsLsLsLsmmmmmmmmbRsLsbLsLsLsLsLsLsmm
mmmbLsLsLsLsLsLsmmmmmbLgLsbsbsbsbsbsbsbsbLsLsmbLsbLsbLsbsbLsbLsLsLsLsL
sLsLsLsLsLsLgLsmmmmmmmmmbRsLsbLsLsmbLsLsLsLsLsLsLsmmmmmmbLsLsLsLsLsRsL
sLsLsLsmmmmmmmbLsLsLsLsLgLsLsmmmmbLsLsLsLsLgLgLsLsLsLsRsLsLsLsLsLsLsLg
LsLgLsLsmmmmmmmmmmmmbLgLsLsLsRsLsLsLsmmmmbLsLgLsLsLsLsLsmmmmbLsLsLsLsL
sLgmmmmbLgLsLgLsLsLsLimmbRsLsLsLgLsLsLgLgmmbLsLsLgLgLsmbLgLsLsLsLsLsLs
LsmmmmmmbLsLsLsLsLsLsLsLsLsLsLgLsLsLsLsLsLsLsLsmmmmmmmmmmmmmmmmbLsLsLs
LsLsLsmmmmmbLsLsLsmmbLsLsLsmmbLsLsLsLsLsmmmmbRjbLcbLoLsLsmmbsbLcbLhbLs
LsLsmmbLsbRsbLsbLgLsbRsLhbLgbLobLcbLsLsLembLoRsRsmbRobReRsmbRcbRobRhbR
ibRiLsbRsbLgbLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 40; Drug: OSU6162 1 然 Apo 50 然
bRsLsbsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 41; Drug: OSU6162 1 然 Apo 50 然
bLsLsLsmmbLgLsLsmbLgLsbRsbLsbRsLsbRgLsLsLsmmbLgbLiLsbLgLsbLiLsbLebRgRg
RsmbRgbLsbRsbRsbRsLsbRgbRsbRsRsRsRsRsRgRgmmmmbRsRsLsmbsbsbsbRsRsRsRsRs
mmmmbRsbRsRsRsRsRsmmmmbLsRsRsmbLsLsmbRsbRsRsRsmmbsbLsLsLsmmbsbsbsbsbsb
LsRsbLsbLsbRsRsLsmbRsbRsbLsbRsbLsbLsbLsRsbLsbRsbRsLsbsbsbsbLsLsmbRsbRs
bsbRsbsbsbsbsbsbLsbsbsbRsRsmbLsRsRsRsRsmmmbRsRsRsmmbRsbRsbLsbRsbLsRsbR
sRsRgmbLsLsmbRsRsRsRsRsRsRsmmmmmmbRsRsRsRsmmmbRgRsRsRsmmmbRsRsmbRsRsRg
mbLsRsRsRsmmb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 42; Drug: OSU6162 1 然 Apo 50 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 43; Drug: Control Apo 50 然
bRsbLgbLsbRsbLsbRsbLsLsmbLgbLebLibLhbRgbLsbLgbRsbRoLsbsbsbLsbLeLsRsbLs
bRsbRsbRsbLgRsbLsRsLsbRobRebLgLobLgbRcbLgRcRcbLsLsLsRsmmbLgbRsbRsbRsbR
obLibsbLsbLsbsbsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 44; Drug: Control Apo 50 然
bLsLsmbsbsbRsbLsbLsLsmbLsbLsLsmbLsLsmbRsLsbsbsbsbLsbLsbsbLsbLsLsmbLsbL
sbLsLsLsmmbLsLsmbLsLsmbsbLsbLsLsmbLsbLsLsmbLsLsmbLsbRsLsbLsLsLsmmbsbLs
LsmbLsLsLsLsLsLsLsmmmmmmbLsLsmbLsLsLsLsmmmbRsLsbLsLsLsLsLsmmmmbLsbLsbL
sLsLsmmbLsLsLsLsmmmbLsbsbLsLsmbLsbLsLsmbLebsbsbRsRsRsRsmmmbRsbRsRsLsmb
sbRsbRsbLsRsbRsRsmbRsRsmbRsRsRsmmbRsRsRgRsRsmmmbRsLsbLsRsRsmbRsbRsbRgb
RsRsmbLsRsRsRsmmbsbRibLsLsRsLsLsRsLsmmbRsRsmbRsRsmbRsRsmbRsbRgRgRsRsRs
RsmmmmbRjLsRsRsmbRsbRsLsbRsRsmbRgbRsRsmbRsRsRembRsRsLsRsmbRsbRgLsbRsRs
RsmmbRsRsmbRsRsRsmmbRsRsRsRsRsRsRsRsmmmmmmmbRgRsmbRgbRsRsRsRsRsRsRsRgR
smmmmmmmbsbRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 45; Drug: Control Apo 50 然
bRsbRsLsbRsbLgLsRsbsbsbLsLsLsRsmmbRgbsbsbsbLsLsLgRsmbRsLsbsbLiRibLsbRs
bRibRsRibLebsbsbRcRsRsRsmmmbLsRsRsmbRcbLoLebRebRsRsmbLsLsRgRsRsRimmmbR
ibRiRsRsRsmmmbRhbRsRsmbLcLsmbLcLsmbsbLsLsmbLgbRebRgbLjbRsLsbLhbLibRjbR
hbRiRsmbRgLsbRcRsmbLibLiLsLsmbRsRsmbLgbReRgRsRsRsmmmbLgRsbLobLsbLgbLeb
RsbRgbRgbRibLjbRsLsLsRsmbRcbLoRsbLcbRjRsmbsbLobsbLgbRsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 46; Drug: Control Apo 50 然
bRsRsmbRibLgbReRgRsmbRsRobLgLeLsbLebRgLsbRebRjbRjbLcbLsbLobLiRsLsRoLob
sbRgbLcbRcRsmbLcbLjbLiLsbLsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 47; Drug: Control Apo 50 然
bRibRebRsbRsbRsRsRsmmbRsbLsLsmbRgLsRsbsbRgbLgLsbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 164330; End: 164830;
Recording: 10-1; Individual: 48; Drug: Control Apo 50 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 1; Drug: OSU6162 10 然 Apo 50 然
bLsRsbLsRsLsbLsRsbRsbRsbLsbRsbLsbRsbsbRsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 2; Drug: OSU6162 10 然 Apo 50 然
bRsbRsLsbLsbLsbLebRcbRsbLsbsbRsRsRgRsRiRsmmmbRsRibLsbLsRsbRebRgRsRsmmb
sbsbsbRsRgRsRsRsmmmbRibRsRgRsRsRsRsRiRsRsmmmmmmbRibRsRsRgRsmmbsbsbLsbL
sRsRsRsLsRsRsRsmmmmbLsLsmbRsLsbsbRsbLsbRsbLsbsbsbsbsbsbsbRsRsRsRgRsRsR
sRsRsmmmmmmmbRsbRsbsbsbsbsbsbsbLsRsbRsbsbsbsbsbRsRsRsRsRsRgRsRsRgRsRsm
mmmmmmmbLsbRsLsbRsbLsRsbsbsbsbRsRsRsRsRsRsRsRsRsRsRgRsRsRsRsRsRsmmmmmm
mmmmmmmmmbRsRgRsRgmbRsbRiRsRsmmbLsbLibRcbRsbsbsbRsRsRsmmbRsbRsRsmbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 3; Drug: OSU6162 10 然 Apo 50 然
bRsLsLebLsLsmbLsLsmbsbLsbRebRsbLjLibRgLsLsRsRsmmbLsbsbLsRsbLsbLcbLebLg
LibLsRebRoLobRibLjbRsbLobLebLoLebRcbLebRoLibRebLebLibLgbLsLebLebLgLgbL
cRibLgLeLsbLobLoRebRebsbsbLsLeLsbsbsbLsbLibLibRgbLgbRsRcbLcbLjbRebRoLs
bReLsLsmbLsLsLgmbRjbLobLgbLobLebRjbLeRobLgbLcbRcbRjbLsRjbRiLsLsmbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 4; Drug: OSU6162 10 然 Apo 50 然
bsbLcbRobRobLjbLobRebLjbRobLjbRjbRgbRjbRjbLobRobRebLebLcbLjbLebRebRcbL
ebLobRjbLeb

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 5; Drug: OSU6162 10 然 Apo 50 然
bRgbRcbLiRsbLibRsLgbRsLsbLsbLgbLsbRsbsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 6; Drug: OSU6162 10 然 Apo 50 然
bLsRsbRgbsbsbsbsbLsbRsRebLsbRsbLsRsbLsbLsbRjLsbRsbRibRsRgRsmbRsbRiLsbR
gbRjbRibLcbRsbLsbRibRcbRcbLsbRjbRsbRobRcRsmbLcLsLsmmbLcRsbRobRcbRobLjb
LoLsmbLibLsbLiLsbRcRsmbLsLsmbsbsbsbRsbLsRsbRsbRsRsmbLsRsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 7; Drug: OSU6162 3 然 Apo 50 然
bsbsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 8; Drug: OSU6162 3 然 Apo 50 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 9; Drug: OSU6162 3 然 Apo 50 然
bLebRobLebRjbRobLobRjbLobRsbRebLebRjbLjbLobLcbLcbRebLebRobLcbRebLebLcb
LjbLobLebLcbLobRobRobRebRcbLebLsbLobLobRjbLcbLebRebLobRcbRcbRobRebRobR
obLobLebLjbLobRobLobRcbLobLebRjbLobRobLobRobRjbLobRjbRcbRobRjbLjbLjbRo
bRjbLobLebLebRobRobRobRjbLjbRcbLebLobLobRobRobLobRobLjbLcbLjbLjbRobLob
RcbRjbRebRobRebLebRebRjbRcbRobLebRebRjbRobLcbLcbRebRjbLebLcbLjbRjbLebL
ebLebLebLobLjbLebRcbRebLcbRgbRjbLebRebRebRebRobRcbRobRobRobLobRsbRsbLe
bRjbLsbRebLsbLebLebLobRobRsbLebLebLobRsbRhbRobRsbRobLebLebRcbRibRobRob
RobLcbRcbRjbRebRebLibRobLibRobLcbLebLobLebLgbLobLcbRobRebLebLebLibLobL
obRebRebLobRjbLebRebRobRebLibRcbLobLebLgbLcbRibRjbLobRobLgbRebRsbRjbRg
bLebLcbRobLobRcbRebLcbLobRsbLgbLebLebLcbRebLobRhbLcbRobLebRgbLebLobLeb
LibRibRobLcbLibRobLcbLobRebRobRobRobLobLcbRobRebLobLobRcbLgbLebRebLebR
obRcbRobRebRobLcbRobLcbLebLcbLebRebRhbRcbLgbLobLobLhbLobLobRhbLcbLcbLo
bRebLobRobRhbRebLhbLjbRebLobLobRibLobRcbRobRebRobLhbLsbLebRobRebLobLeb
RebLobLebLebLobLebRebRjbRobRobLobLsbLebRjbRebLibLjbLobRebRjbLcbRsbRcbR
cbRebRobRobLcbRobLobRebRobRjbLobRobLobLjbRobLsbLebLobRsbRcbLjbRebLebRe
bLebLobLsbRobLebRebRobLebRobRebRobLobLjbLobRebLobLebRobRebRobLebRobRob
LobLcbRebRcbRobRibLebRobRebRjbRjbRebRebLebRobRebLebRobLebLjbRcbRebLcbL
obLebRobLobRebRjbLobLebRcbRcbLjbLebLjbRjbRcbRobLobRcbLebLobRsbRobRebRo
bRcbRobLobLobRobRobLobLjbRobRobRobLebLobLebLebRobLebRjbRjbLobRebLobReb
LsbLebRjbLobLebRjbLsbRebLjbRobRebRcbRjbRjbLebLebLobRebRcbLjbRobLobRebR
ebRebRjbLebRjbRjbLebLebRobLobLjbRobLjbLjbLcbLjbLobLebRjbRobLjbLobLobRo
bRebLsbLobLjbRebLebLobLjbLobRjbLebLcbRjbRsbRobRjbLjbLjbLebRjbLebLobRjb
RobLebRobLcbLobRebRcbRjbLebRjbLobLsbRsbRobLobRobRobLsbRsbLebRobLjbLobL
obLebRsbRobLobLebLebLgbRobRobRjbRebLebLebLebLjbLjbLibLjbLsbRcbLebRobRj
bLjbRebLebRobRebLjbRebRobRobLsbRjbLobLebLjbLebRcbLobRobLjbLcbRgbRobReb
LsbRsbRebRobRebLobRcbRcbRgbLjbRcbLobRjbLcbRobRjbRebLjbRsbLobLobRebLebL
obLebRjbLebLobLsbRobRebLcbRobRobLcbRcbLobRjbRjbLcbRobRcbLobLjbLebRobLj
bLjbLcbLcbLcbRobRebRobRjbLobLjbRebRebLsbRobLobLobLobLjbLcbRjbRsbRjbLeb
RobRobLebRjbLcbLobRebLobRebRcbRobRsbRobLobLjbRjbLobLsbRcbRjbLobLobLcbL
jbLobRcbRjbLebLebRebLobRobRebRebRebLobRebRcbRobRobLjbRjbLobLjbRcbRebRe
bLobLobLibLobLobRjbRcbLjbRobLobLobLjbRjbLobRsbRobRobRjbLjbRobLsbLjbReb
LcbLjbLebRjbRcbLebLobRobRjbLobLobLebRcbLebRobLobRsbRobLjbRobRebRebRebL
obRobRjbRjbLcbRjbRobRebLebRcbLobRobLobLebRobLobLjbLobLobLjbRebRjbLjbRe
bLebRjbLjbRobLebRjbLobLobLsbRcbRcbLjbLobLjbLebLobRebLobRjbRebLobLobLob
LobRjbRobLobLjbLcbRebLobRebLsbLebRebRjbRebLobRebLebRebLjbRjbRebLcbLjbL
obLebRebRcbLjbRebRobRebLobLsbLebRcbLobLobLebLcbLjbRjbRobLobLobRcbLjbRe
bLcbLjbLjbLebRjbLobRebRebRebLsbLobLcbRobRebLsbLcbRobLjbLebRebRebRebRob
LjbRebRebRobLobLcbLjbLebLcbLjbLobRebLobRebRobLobLjbRobRobLobRjbRjbRebL
ebLobLjbRsbRobLjbRobRjbRebRjbRobRobLobLobLcbRjbRebRobLobLebRebLebLsbLe
bRobLebLjbLebRjbLsbLjbRjbLobRjbLebLobLobRebLebLobRobLobRjbLobLobLjbReb
RobRobLobLjbRjbLobLsbLebLebLobLjbLebLcbRobRebRobLebRobLebLobLobRcbRjbL
jbLobRebLebLjbRebRsbRebRebRsbLebRobLebRobLebRjbLobRebRobLebLebLjbLsbRj
bLobLebLjbRobRjbRjbLobRobLebRsbLebRebLjbRsbRebRjbRjbRebLjbLobLebRjbLsb
RobRobLobRebRcbLobRebRebLobLobRebRebRobRobLcbRcbLsbRjbRebRebRebRsbRsbR
ebLjbLobRcbLebLsbRobRcbLeb

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 10; Drug: OSU6162 3 然 Apo 50 然
bLcLsmbLibLibLgLibRgbRjbRsbRgbRibLgbsbLsbLsbLjbLhbLsbLibLsbLebLsbLsRsb
RsLebRgbRgbRebRebRsbRcbLsLgbLgbRebRsbRgbRebsbRsbsbsbsbsbsbsbsbLibLgbRs
bLsbLsbsbLsbLgbRsLsbLsbLsbRsbLsbLebLgLsbRsLsbRsbLebLebRjbRsbRebRibRgbL
sbRsbsbRgRibRhbRibRgbRsbRsbRgbsbRgRsRimbRgbRsbLsbLsbRsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 11; Drug: OSU6162 3 然 Apo 50 然
bLsLsmbsbLsbLsbLsbLsbLsLsmbLsbLsLsmbLsbLsbRsbRsbRsbRsbRsbLsbLgbLsbRiLs
bRibLsbLjbLibLgbRcbLobLsbRsLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 12; Drug: OSU6162 3 然 Apo 50 然
bLsbLsbLsbRsbLsbLsbRiLsbRjbRebRibLsbLibLcbLcLcbLcbLebLcbRobRibLcbsbsbR
gbRebLsbLibLcbLjbRgbLsbRibLgLsbLgbLgbLgbLibRjbRhbLsbsbRsRsmbLsbLsbLibL
gbLsbLsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 13; Drug: OSU6162 1 然 Apo 50 然
bRobRobRcbLhbLcbRobRjbLobRobRobLobLibLobLobRobLsbRobLibLjbLcbLobLjbReb
RjbRebRobRebLobLibRebLibLobRgbLobLobLebLibRcbRobRobRobRjbLobRobRsbLobL
obLobRibLobRebLobRobLobLobLobRebRobLgbLobRobRjbRcbLhbLjbLobLobRobRobRo
bLibLebLcbLibRobLibRgbRibLobRobRobLgbRcbRobLibRcbLobLgbLobLobLobLjbRob
LcbLebLgbLcbLobRobLebRcbRobRobLgbLobLebLobLebRgbRebRsbLobLobRebRebRibR
ibRebRsbRibRobLhbRobRobLjbRcbRcbRcbRsbRsbRgbRobLcbLobLgbLebRobRebLsbLc
bRibLobRebLcbRobLobLebRobRobRibRebLhbRcbRobRhbLobLhbLebLobLobLobLobLob
RebRcbLobLebLobLobLcbRsbRcbRgbRobLebRebLcbRobLcbRgbRibLcbRibLebRebLobL
cbRobLebLobRsbLobRobLcbLebRcbLcbRebRibRebLobLhbLcbRibLgbLobLobRobRhbLs
bRebRgbLobLobLobLsbLebRobLebRebRobRebLebLebLobLobLebLebRobRgbLcbRgbLeb
RgbRobLcbRhbLcbRgbLgbRobRsbRebLjbLebLibLobRobLobRcbLcbRgbRobLsbLobLcbR
gbLobLcbLibLgbRobRhbRsbRgbRobRebRjbLobLebLcbLobRcbLobLobRibRcbRibLhbRe
bLobLhbRgbRebLgbRobRhbLgbRsbLcbRcbRebRobRobLobRobRgbLobRobLgbRobRobLgb
RobRcbLebLobLibRcbRcbLobLebLobRobLebRobLebLobLcbRobLobLsbLgbRgbLcbRobL
obLebRjbRobRobRibLcbRcbLsbLobRebRibRobLebLobLobRobLebRebRobRobLobLobLo
bLobRhbLobRobRobRobRobLcbRobLibRebLgbLebLobLebRobRcbLebRobRobRobRobReb
RsbLebLsbLcbRcbRibRobRcbLgbLobLgbLsbLgbRebLgbRobLobRebLcbLebRebLobRgbL
ibLobRcbRcbLebLcbRsbLobLobLsbLobLobLgbRebLobRebRcbLebRobRcbRobLebRebLo
bLsbRcbLhbLhbRobLcbRcbRcbLobRobRhbRcbRebLgbRhbRebRebRcbRobLobLcbRobLob
RcbLobRebLgbLebLobLobLebRibLobLobLebLobLebRobLobLcbLebRibLobRebRebLibL
sbLsbRobLibLhbLobRebLebLsbRcbRsbLcbLebRebRebRebRhbLibRcbRobRebLobRibRo
bRobLebRcbLobRobLibLebLobRcbRcbLobLibLgbRibLebRobRibRebLobLobRebLgbLob
LibRobLibRcbRcbLobRebRobRcbLobRobLhbRebLobRebLobLobLsbRobLebRobRobLcbL
ibRobLobRobRsbLobLobRobLobRobLobRgbLobRobRsbRobLhbRibLsbRsbRobLobLcbLs
bRcbRebLobRobRsbRobRjbRobLsbLobLobLcbRcbRsbRobRobLobRobLcbRsbRobRobLob
RobLobRebRobRobLebRibRebRobRebLobRobRsbLcbLibRobRobRebRibLobLibRcbLobR
obLobLibLebRobLebLibRcbRsbLobLsbLcbLobLebRibRobLgbLebLebLsbLobRobLibLc
bLobRobRcbLobRobLobLebRobLebLobLsbRhbRibLebLobRobRsbRcbRibRebRsbLobLob
LobRebLhbRobLebRobRebRsbRsRebRobRobRobLsRsLsRsRsmbRobRebLoLebLsbLcLsmb
RebRoLsRsRebRsRebRoLcbRcLebRcbRsRsLsmbRoLebRsLsRsLsLebRoLsbRobLsbRoLsb
RebRsbLsbRebRsbRoRsmbLsbRsbRsbLoLsmbRgRsLsRsmbRsReLsbLsLsmbLoLsLombLsR
sRoLsbRsbRsRgLgbRsLsRobLsbLsRsRsmbLsRsbReLsLsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 14; Drug: OSU6162 1 然 Apo 50 然
bsbsbRsbRsLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 15; Drug: OSU6162 1 然 Apo 50 然
bLcbLobRobRibLcbRobLibRebRebRibRebRebLobRebLebRobRcbRebRobRibLobLobLob
LobLibRobLcbLcbRibRcbRobLebRcbLebLgbRobRgbRcbLebRcbLebRebRebRcbLebLsbR
ebLobRebRobLobRcbRebLebLebRcbRobRcbRibLebRobLobRcbLobRebLebLobRebLcbRe
bLebLebLobLebRcbRibLobRcbLobLcbRibRsbLobLobRsbLsbLcbLebLobLcbLgbLebRjb
LebLobLcbLobRebRcbRobLebLcbRebLebRebRgbLobLebLjbRobLebLcbLcbRobLobLcbR
ebLcbRobLcbRibLobLibLsbRhbLobLcbLobLobRcbRebRobRjbRcbLibRebRobLcbRobRi
bRibRobLobLebRjbRhbLibRobLsbRebLcbLobLgbLobRobLobRgbLobLcbLcbLobRebLcb
LobRsbRobLobRjbLobLcbLobLebLobRebRcbLobLebLobRobLebRcbLebLobLobLgbRebR
cbRcbRobRobRebLobRebRibRebLobLebLcbLibRebRebLibLobLobLgbRobLebLgbRobLi
bLobRibRobRebRibRobRobRobLobRsbRebRobLobRobRhbLcbLgbRobLcbLobRgbLebLeb
LobRgbRobLobLcbRobLobLobLcbRibRobRobRobRcbLobLibRsbLobRobRobLcbLibLobL
obRobLobLobRobRibRgbLobRobLsbRobRobLibRsbLibRebLobLobRobLobLebRobRobRc
bRcbRobRobRebLcbRcbRcbRgbLobLgbLobRebRcbRibRobLebLgbLgbLcbRibLobRobLsb
LebRebLcbRcbRgbRebRobRobRcbLgbRgbRobLibRobLobRobLebRsbRobLcbLobLebRhbR
cbRhbLebRcbRebLobRebRobLebRebRsbRhbLobLobLobLcbLobRobLobRcbLobLobRgbRo
bRsbRebRobLibRebRcbLsbRobLobRcbRobLobRobRebLebLsbLgbLebLobLobLobLjbRob
LobLobRebLobRgbLebRgbLobLebLobLcbRobLsbLgbRobRebLebRobRibRobLobRobRobL
obLobLebRibRobLebRebLobRobRobLhbRobRcbRgbRobLcbLebLebRobRebLebLcbLibRo
bLobLhbRobLebRcbLobRobLibLsbRobRebRebLobLebRobLobRcbLebLobLobLcbLobRgb
LobLgbRobRobRobLobRcbLebRebRobRobLobRibLobLobLobRibRobRgbRsbRobRobLebL
ebRsbLibLebLobLsbLobLobRcbLebRebLobRgbRibRobRcbRobRsbRebLibLebRcbLsbLg
bRcbRibRcbRobLsbRcbRsbLgbLsbLobLebRibRobRobLcbRsbRebRobLebLebRcbLobLeb
LobRobLgbLebLibRcbRgbLibRobRebLhbRhbLgbRebLgbRebLobLobRobLcbRcbLobLsbL
ebRsbRsbLobLobRsbRobLebLebLobRobRobLcbLebLobRobLcbRibLebRobLcbLebRcbRc
bRebLobRcbLebLobRgbRobLgbLobRebRebLebLebLebRobLobLobRebRibLebLcbLobLob
LhbLibRebLsbRobRebLobLgbRobLobRcbRebRebRobRobLebLhbRobLebLgbRobLobRebR
cbRobLobLobRobLebRcbRobLebRobLobLobLobLebRobLobRobRcbLebLcbRobLgbLgbLe
bRcbLcbLobRcbLobLebRobRebLebLebLobRcbRobRobRobRcbRcbRobLobRobLobRhbRob
LobRobLobLibLebLibRebLobLgbLobLcbRebLobLcbRobLcbLebRibRobLcbRcbRibLsbL
obLibLcbLgbRcbRobLobLsbLobLibLobLgbRobLobRobRobLobLobRhbLobLcbRobRobLi
bRobRsbRebLgbRcbLobLobRibLobLebLibRebRcbLobLibRobLobLibRibLgbLobLebLeb
RobRebLobLgbLibRgbLobLebRobLsbLebLobRobRcbLobRebLhbLobRobLobLobRebLobR
obRcbLobLgbLgbRebRcbLobRebRgbLebLobLgbLebRobLobLobLebRcbLgbRobRobLgbRe
bRobLobRebRebRhbLobRobRgbLobRebRsbRjbLhbLobRcbLobRobRcbLebLcbRhbLobRob
LobRobLhbRcbLobLobRebLobLibLobLobLhbRobRgbRebLcbLcbRobRebLibLobRebRhbR
obLibLibLobLebRebLebRibRobRobLibRcbRobLebRebRobLobRobRcbLobRcbLobRebRo
bLebLcbLcbLobLibRsbLobRobLgbLobLibRcbLebLcbRobLobLgbRobLobRebRebRobLeb
RebRebLobLibRcbLebLsbRibLcbRibLcbRgbRebLcbLobRobRebRebLebRsbLibLobLcbR
obRobRebLobLobRcbLobLsbRobRobLcbRobRebRibLobRobLobLobRsbLobRsbLobLebRo
bLcbLibRobLebRobLcbRobRobRobRcbLgbLobLobRobLebRebLebRgbRebLobLobRobLeb
LobLibLobRsbRobLcbRebRobRebLobRobLobRjbRibLebLcbRcbLobLebLobLobLebRebL
ebLcbLobLobLobRebRgbRebLebLcbRobRobRebRebLobLgbLsbRgbRsbLobLebLcbLobRo
bLcbRsbRobRebLibRobLibRobLobRcbRgbLobLobRcbRobRebLebLebRebRobRobRebRcb
RjbLebRebRebRobLcbLobLcbRcbRhbLobLebRobRebLcbLobLobRebRobLobLsbRibLcbL
ebLobRebRcbLobLobRobLebRibRibRgbRgbLebRjbLcbLcbRcbLcbLobRsbLebRebLebRs
bRcbLebRebRobRcbRobRebRobRebLcbLebRebLobLebLobLebRsbLsbRebRcbLebLsbLeb
RebLcbRebLgbRebLsbRcbLobLobRsbRjbRcbLsbLcbLcbRsbLcbRibRebRobLobRsbLobR
gbLobRebRcbRcbRebLcbRcbLsbRhbLebRcbLgbLobRcbRebLobLobRcbRjbLgbRobLebLi
bLcbRebRibLob

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 16; Drug: OSU6162 1 然 Apo 50 然
bLcbRcbRobLsbRibRgbRebRebLsbRcbRibLebLobRsbRsbLobLebLsbLobRebLcbRobRib
RobRebLgbLobRcbLcbRebLobLcbRebRgbLebRobRibLebRebLobRobRobRgbLibRobLobR
ibLobRibRobLibRobLcbRebRobLcbRebLgbLebLobLebLobRhbLobRcbRgbLobLobLibRo
bRobRobLcbRjbLibRobRibLobLebLsbLsbRobLcbRcbLebLebRgbLibRcbLobLobLibLeb
RcbRobRgbLobLgbRobRsbLcbRobLcbRcbRebLibLobLgbLgbLobLcbLibRjbRcbLobLcbR
ebRobRobLobRcbRobRobRobLobRcbLebRcbRobRebRobRebRebRgbLcbLobRgbLobLebLh
bLobLebRcbLobLebRibRobLobRebRobRebRobLobLebLebLebLobLebRibRcbRsbRobReb
LobRebRcbRobLjbRobRobLobRcbRcbLcbRcbRebRsbRebRebLebLibLcbLebLebLebRebR
cbRebLobRcbRcbLobRibLcbRsbLobRobRibLgbRebLobRebLobRobRibLibRebRebLobLc
bLobRobRcbRhbRobLsbRebLobLobLebRobRobLcbLebLobLebLebLobLobLobRobLebRob
LebRcbLobRobLibLcbLcbLobLebRobRcbLobRibLebRobLobRobLobRobLcbLgbRobRobR
ebLobRobRobLobLobRebRobLjbRgbLgbLebRobLobRgbRcbLobLebLobLebLobLibLobLs
bLobRebRobLebLobRcbLsbLebRobRobLobLebLobLebLibLobLobRobLcbLobLobRobRcb
RibRobLebRobRibLebLobRebRobRobLebRgbLobRobRobRobLobRobRobLobRcbRgbRebR
obRebRobRobLebRsbRobRgbRcbLobRgbRcbRcbRobLibRgbRgbRebRebRibLobLebRobRc
bLobRobLobLobLobRsbLcbLobRibRsbLsbRebRobRsbLsbRebLcbRgbLobLebLobRebReb
RobRsbLibLebRhbRebLobRcbLebRsbLobLsbRobLibRobLobRcbLobRgbRhbLobLobLebR
obRcbLebRobRobRobLobLibRebLibLcbLobRebRsbRobLebRobRibLobLibLibLebLebRe
bRcbRobRgbRobRebLobRcbLjbLobRcbLebRobRobRgbLobLebLgbLobRobLobLobLsbRob
RebLobRobRobLibLobLebRobLobRobLobRcbRebRcbRebLobLcbRebRsbLobLgbLobLobR
cbLobRibLebLobLobLebRobRcbRsbLcbRcbLebLcbRebLobLcbLebRobLcbRsbLobLcbLe
bLhbLobRhbLobLobLibLobRebRibLebRcbRebRgbRsbLobRibRibLobRobRebRobLcbLob
RebLsbLcbRobLobLsbLebLobRobLebLobLobLobLsbRobRobLebLobLcbRobLobLobLebR
ebRcbRgbLebLobRebRgbRebRobLhbLebRibLobLebRobRebLcbLibRcbRobLebRcbLobLo
bRebRobRebLebLebLobRebLcbLgbRobRobLobLobRgbLobLobRcbLobLcbRebLgbLobRcb
RcbRobRebRcbLebRobLobRebRcbLcbRcbLobRhbLebRgbRobRcbRobLobLebRgbRcbLobR
obLjbRobLcbLgbLobLebRebRobLobRobRobLhbLcbRebRebLcbLobRobRsbRebLcbLobRc
bLgbRebRebRsbRebRibRobLjbRcbRibRgbLebLcbRcbRebLebRobLobLgbRgbLebLebLeb
RebLgbLobLobRsbLebLobLcbRobRebRhbLebLobRobLobRgbRebRebRobRobRobLobRcbL
obRebLobRsbRobLcbLobRcbRgbRobLgbRebLcbLcbRobRcbLebLcbLibRibRcbRobRobRe
bLebLobLebRobLobRibLobLobRobLcbLebRebRibRcbRebLibLgbLobRebRobLobRgbRcb
LobRcbRobLobLebRobRibLobRebRebRgbRobLcbRgbLobLobLebLcbRobRgbRgbLebRobL
obRibRsbRobRhbRobRibRobRobRobRcbLcbRebRibRobLcbLgbRobRebLcbRobRibLobLc
bRgbLcbLebRobRobRobLobRhbLibRobLgbLsbLobRcbLibRcbLibLebRobLcbLobLcbRjb
LebRobRobRgbRsbRibLobRobRebLgbLobLgbRibLobRsbLcbRcbRcbLebLebRgbLobLobL
obLobRobRibLebLobLcbRgbLobLcbLobRobRhbRcbLobLebRgbRobRobLobLebLibLcbRo
bLsbRsbRobRobRobRebLebRcbLebLgbLcbLgbLebLobRcbLibLobLibRobRebLebRhbRcb
LibRebRhbRgbLobRcbRsbRobRobRibRgbRebRobLebLobLobRhbLcbLebLobRhbRebRobL
cbRcbRjbRcbRsbLobLcbRibRobLobRibRsbRibLsbLobRobLcbRibLebRsbRibLibLcbRe
bRcbLobLebRobLebLhbLibLobLebLobRibRobLobRebLobRgbLobLebLebLebLobLobLjb
LibRibRobLebLobRcbRcbRebRgbLcbLebRebRebRobRobLcbLcbLobRcbRgbRcbRgbLobR
obRobRobLibRobLobRobRhbLcbRcbRcb

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 17; Drug: OSU6162 1 然 Apo 50 然
bLsbLsbLsbRsRsmbRsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 18; Drug: OSU6162 1 然 Apo 50 然
bRsLsbRsRobRsbRsLobLsbRsbRsRsLsmbRsbLsbsbRsbLsbLsbRsbRsbLsbLsRsbLsbRsb
RsbRsRsmbRsRsmbRsbRsbLsbRsLsbsbsbRsRsRsmmbLsbLsLsRsmbLsbRsbLsbLsLsmbRs
bRsbLsRsbLsbLsbLsbRsLsbLsbsbRsLsbLsLsmbRsbRsLsbRsbLsbRsbLsbRsbLoLsmbRs
LsbRoLsRsbsbRsbLoRsRsmbLsLsmbLsRsRsmbLsRsRobLjbLobLsbLsbLsbLsLsmbLsRsb
LsbRsbLsLsmbLsbLsLsmbLsLsmbRsRsmbLsRobLsbRsLoRsRsmbLobRsbRobLsbRebRebR
cbRebRobLoRsbLsbRobRcbRobLsbRsbLgbRcbRobLsbLobLobLcbLobLebRsbLobRcbLeb
RobLebLobLobLjbLobLcbRobRgbRebRjbRobRebLebLobRjbLobRsbRobRobLcbRobRobR
obLobLsbLsbRobRoRcbLobRsbLsbLebLsbLobLebLobRobRobRsbRebRsbLhbLobRobLsb
LobRobLsbLebRobRobLjbLsbRsbRibLobLobRebRebLjbLcbLobLobRebRobLobLcbLobR
obRebRsbLibLobRebRobLcbRobRobRjbLobRebRobLebRobRobRgbRsbLobLobRobLobLo
bLebLobLsbRobLgbRobLobLjbLsbLibRobRobRgbLebRebLibRsbLgbLobRobRebRcbLob
RsbLebLobLobLsbRcbLebLobLobLobLebRgbRjbRsbRibLebRsbLobRobLebLobLsbLjbL
ebLobLebLcbLibRhbLcbLibLobRobRebRobRebRebLebLcbRebRobRebLsbRebLebRcbLe
bLibLobRobLsbLebRhbRobRebLsbRgbLobLsbLibRebLobRsbRobRsbLobRobLebLsbLob
RsbLobRobRebLebLcbLsbRebLobRobLsbRobRibLsbLobRobLobLobRebRobLebRobRcbR
gbRobRebRebLobRobRibRobRebRobLobRobRcbRobRobLcbLobLsbLibRebLobLebLebLe
bLibRobRibLebLcbRgbLebLobLobLcbLobRebRobRobLobLebRobLsbRebLcbRsbRobRsb
LcbLobLebLhbRebLsbLebLcbLgbLgbRhbRhbRobLebLebLebRobRobRobLcbLobRobLobL
obLsbLsbLobRebLobLebRobLobRobLcbRgbRobRebRebLebLgbLobLobLebLebRobRibRo
bRobRebRjbRcbRebRebLsbLebLobRsbLobRobRobLibRobRobRhbLsbLebRobRobRobReb
LgbRobRobLsbRebRobLibLgbRebLcbRhbRsbRobLsbRsbRebRibRobLobRobRebRcbLebL
ebLsbRebLgbRcbLobLsbRibLobRobRebLobRibRobRobLobRcbLgbRcbLhbLibLsbLebLo
bLebRobRobLsbLsbLobRobRobRobRsbRhbRebLobLibRobRobLobLobLcbLobRobLgbLob
LcbLobRsbRsbRebRebRcbLebRebLobLobRobLcbLebRebLobLobLebRibLebRcbRsbRebR
sbLcbLebLsbLobRcbRsbRsbRcbRebLebLibRibLobLobLebRsbRobRibRobLobLobLobRe
bLebRebLebLhbLsbLebLobLebRsbRobLgbRibRobLebLcbLebLsbRobRobRgbLsbRobLsb
RsbRebLobRobLsbLebRibRcbRobRjbLobRobLobRcbLobLebRobLibRobLebRobLebRobR
ebLebLobRobRebLobRobRsbLebRcbLebLsbLebRebRebLebLobLobLobRjRsmbLebLgbLe
bLsbLgbRsbRsLsbLsLebRobLobLsLsmbLsLsmbRobLsLsmbRobRgbRsbLebRsLsbLebRsL
ebRsLebLebLjbLebRsbRjbRebLsbRsRsmbLsbLsLebRobLsLsmbLsRoRsRsLsmmbRsbLsb
RjRsmbLsbRsbRsbRsRsmbRsbLebRobRsbLjbLobLgbLsbLsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 19; Drug: Control Apo 50 然
bReLsbLcbLcbsbLcbLcRibRebRcbLcbLiRsbLcLsmbLcRsbRebLcbRsbLibLcRsbRgbLsR
sbLgbRebLcbLibLsbRjbRiRsmbLibRibLgbsbLsLsmbRsbLcbRgbRebRibLcbLhbLeLsbL
gbRebRibRgbLsbRsRebLcbLcbReRsmbRgRsmbsbLgbRsRgRsmbRsLcbLgbLjbLobRsbRgb
RgbLsLsRsmbLsbRhbRsRibLiLsbsbsbLsLsmbLsRsbRsbRsLsRsbsbRsbRsbLsbsbLsRsb
LsLsmbsbRsLsbLsbLsbsbRsLsbsbsbLsLsLsmmbRsbRsbLsbLsLsmbsbRiRsmbLsbRsbRg
bsbLcbLibLgbRoLsLsmbsbLeLsbLcLgLsLsmbsbRsbLsbsbRsbLsLsmbRsbRsLsbsbRsLs
bLsRsbsbLsRsLsbRsbLsbRsRsmbRsbRsRsLsmbRsbsbsbRsLsRsLsLsmbLsbLsbLsbLsbR
sRsmbRsLsRsbLsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 20; Drug: Control Apo 50 然
bsbsbsbsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 21; Drug: Control Apo 50 然
bLsLgLsbLgLgLsbLgbLsbLsLsmbLcLsmbLgbLibRsbLgbsbLsbRsbLgLob

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 22; Drug: Control Apo 50 然
bLsbsbRsbRsbLsbRsbLsLgbsbLsbRsbLsbsbLsbLsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 23; Drug: Control Apo 50 然
bRobLcbRobRebLobRebRebRobRobRhbRcbLsbRibLgbRobLcbRobLobLjbLobRobRobLjb
LgbRebLebLebLebRobLobLebRobRebRcbRobLobRcbRjbRcbLhbRobRhbLgbLcbRsbLebR
obLobRobLobRsbRebRcbRobRebLjbRjbRebLebRobLgbLebLjbLebRjbRebLobRebRebLo
bRcbRobLcbRsbLcbLebRcbLebRobRebRobRgbLebLjbLobLcbRobRibRobLsbLjbRobLob
RobRobRcbRobRsbRobLcbRjbLjbRebRebRobLjbRobRsbRibLcbRjbRjbLebLobRjbLjbL
ebRjbLobLobLebRobRobLobLobLebRobLcbRobRobRjbLcbLobRobRobRobRobRobRsbRo
bRobRebLgbRjbRebLcbLobLcbRobRjbLebRobLobRebLobLjbLobRjbRobLebLobLcbReb
LcbLebLobRebRobLebRsbLcbRobRobRobLsbRjbRobRobLebRobRibLgbRjbRsbLobRcbR
obLjbRjbLsbLjbLsbLebLjbLgbRcbRibRobRebRobRcbRjbLgbRhbRebRobRgbRjbRsbRs
bLobRobRobLebRjbLebLobRibRsbLjbRebRebRcbLjbRjbRobLjbLebLcbLebLcbRjbLob
LjbRebRobLgbLjbRebRcbLjbRebLobLobRobLobLebRjbLcbRcbRobRobLcbLobLebLebR
obLobLjbRebRobRobLobRjbLobLsbRobLcbLsbLobRobRobLobLebLsbRobLobLebLjbRj
bLebRcbRebRsbRjbRcbRebLobRebRobRsbLobRebRobRobRobRobRhbRcbRcbRobRjbRjb
RobRgbLebRjbLjbRobLjbRebRobRsbLcbRjbLcbRibLjbRebRjbLebRebRcbRobRcbLgbL
jbLibLcbRgbRebRsbLobRcbRcbLobRebRcbRebRjbLcbLobLobRobLcbLcbRcbRobRobRi
bLobLjbRobRobLebRobLjbRjbLhbLobLebRjbRobLebLcbLebRobRobLcbLobRjbRobRob
RobRebLcbRebLjbLobLsbLcbRsbLobLobRjbLcbLebLobLobRebLebLibLebLobLobLebR
ibRebLebRobRhbRobLhbRgbRebRobRebLobLibLjbRobRobLibLobRebRobRjbLebLibRi
bRebLibLobLobRcbLcbLibRobRgbRobLcbRobLobLebRobLobRobLobLibLebRcbLobLib
LcbLobRebLebRobLobLebLebRobRebLibLcbLebLobLibLsbLcbLcbLibRebRebLgbLobL
obLebRobRebLcbRcbLobRsbLcbRcbLobRcbRibLebRobLobRobRebRebRcbRobRibLsbRe
bRobLobRobLebRcbLobRobRcbRobLobLebRibLebLobLobLcbLobRebRcbRobLobRcbLgb
RebRgbLobLibRcbRibLibLcbRgbLebRebLgbRebRobLobLibRebRobRcbRebRebRebLcbL
obRebLebLjbLobLobLobLobLobRgbLsbLobRobRebRebRobLobRobLcbLsbLibLgbRcbRs
bRcbLobRobLobRobLebLibRobRobRobRobRobLebRcbRobRobRcbLcbLobRobRobRcbRob
LobRobRcbLobRgbLebLobLobLobLhbLebLgbRebLobLibRobRcbLobRsbLibRebRobRobL
gbRsbLobLcbRobRobLebRcbLebLjbRcbRibLobLobRibRcbLcbRgbRobRobLibRebRobLo
bLibRobRobLobRcbRobRebRebLibLobRebLobRcbRcbLobRcbLibRibLebLobLobRcbRcb
RibLcbRcbLobLobRobRibLcbLobRobLibRebRhbRgbRgbRibRobLobLibRcbLibLobLcbR
ebLobLobLebRcbRobLobLcbLsbLcbRcbLebRebRgbLsbLebRsbRebRobRcbLgbRcbRobLe
bRebRebLebRgbLebLebRobLobRobRebLebLebRobLibLgbLibRsbLibLobLgbLobLcbRjb
LcbLobLgbRibLcbRebLobLibLebLcbRsbLibRcbRibLobRobLobLebRobRhbLcbRebLgbR
cbRebLobLobRjbLebRjbLcbLobLcbLebLebLibLibLibLebLsbLobLcbRobRcbLebRob

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 24; Drug: Control Apo 50 然
bsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 25; Drug: OSU6162 10 然 Apo 50 然
bLcbRsbRcbLibRebRibRibLebLcbRobRobLebRebRobLgbRebRobLobLgbRobRobRibLob
LgbLsbRebLgbRobLebRcbRcbLcbLebRebLobRebLobLebLebRibRobRobLobLebRebLgbL
gbLobLgbLobRcbLobRcbLobRobRebRobLebRgbLobLsbLgbRobRebLhbRgbRebLgbLhbRo
bRobLobLobLobRobRobRobLebLgbLobRobLobLebLobRobRobLobLsbLsbLjbRcbRobLgb
RebRcbLobLebRebRobRobRgbLibRobRobLobLibLgbLibLobRsbLgbRcbLibRobLobRebL
cbLsbLcbRebRgbRobRobLobLobLobRsbLcbLcbLobLobLobRibRobLobRobLcbRibRobRc
bLobRhbRcbLsbLebLsbLobLobRobRobLebLcbLcbRcbLobRebLsbLgbLebRebLobRcbRob
RebLebRgbLebRebLobRibRobRobRobRobRibRobLcbLobLibLebRsbRebRgbRobRibLobR
obRsbRobLibLebRobLcbRcbLobLebLobLobRebLcbRebRobRebLcbLobRebRgbRcbRobLc
bRobRgbLebLebLobRobRebRobRobRobLgbRcbLcbRgbLobRobLcbLobLibLibLobLcbRob
LobRibLobLobLobRobRebLebLobLobLobLcbLibRebLebLebRibRebLebRebRobRcbLobR
obLobLobRibRobLobRebLibRobLobLebRcbLcbRhbLcbLibRsbLcbRsbRebLibLobLebRs
bRibRebRebRobRsbLebLgbLibLibRobRebRibLibRibRebLobLcbRgbRobRebRgbRebLcb
RobLobLobLobLcbRobLobRsbLibRibLobRobRobLsbLhbRcbLobRcbRobRgbRobRobRibR
obLobLobLobLibRebRebLgbLobLgbLcbRcbRjbLobRobLebRhbRobLibRobLobLebRobLe
bRebLcbRhbLobLibLobRebLcbLobLobRibLobRgbLebRibLhbLcbLebRobLcbLobRobRcb
LobRhbRebRsbLebRcbRobLobLobRobRebRobRebLobLobRhbLibLsbRgbRgbRcbRibLebL
ibLobRebRibLcbRobRobLobRebRobLsbLcbLebLsbRobLobLcbLobLcbRobLebLcbRobRe
bRobRebLibRobRebLibLebLobLobRobRebRobLibRcbLobLcbLebRobLhbLcbRcbRobLob
RcbLobLebRobLebLcbLobRebRibLebRcbRsbLebLobLibLebRcbRebRcbLsbRcbLobRgbL
ebLobRobRobLobRibLgbLcbLobLobRcbRibLebRsbRgbLebRobLobLcbLgbLebRebRobRo
bRcbRobLobRcbLsbLobRsbRobLobLobRebLobLebRcbLebLobLobLobRobLobLsbLobRcb
RobLibLobLibLobRibRcbLobLhbLobLobLobLibLebRebLobLobLibLibRsbLcbRebLibR
obLsbRobLcbRebLobRobRobLhbLebRebLgbRebRobRobLebRobLcbLobRgbRebRsbLcbRc
bRebRgbRobRobRgbRcbRobRobRibLobRcbLgbRcbLebLebRgbRobLebLebRebLebLobRob
LsbLobLobLcbLgbRobLhbLibLsbRhbRebRgbLobRcbRebLibRebLebRobLobRebRebRibR
ebLgbLibLobLcbRobLebLebRebRcbLobRibRgbRcbRebRgbRebLibRebRcbLgbLebRgbLi
bRobRebLobLobLcbLebRebRebRobRobRebRcbRcbLebLgbLobLobRcbLcbRcbRcbRgbRob
RobLobRobRebLhbLobRobLcbLcbLobLebRibLibLobRobRibLobRobLobLcbRhbRebLobR
obRsbLcbRobRcbRobLcbLobRebLcbRobLobRebLobLobRcbRebRibLsbLcbRcbRobRcbRg
bRobRcbLgbLobLibRobLobLobLobLcbRgbLobRobRebRgbRobRcbRcbRsbLgbRebLobRob
RobRobRobLibRobLobLebRobLobLcbLcbRobLebLcbLobRobRobRobLobRhbLobLibRsbL
obRgbRobRibRobLgbLobLsbRobLebLobLebLsbLobRobLibLobLebRgbLobLobRcbRgbRs
bLibRebLobLobRgbLobRobLsbRobRebRgbRgbRobLobRobLebLobRebRobLobRebLobReb
RobRebLibRobLebLcbRobRobLobRcbLobLobRebRcbLebRcbLebRobLobLobLobRebRobL
obRobRobLobLebRobRobRebRobRgbLobRobLcbLobRebLobRobLcbLobRgbLibLobLsbLo
bRobLibLobRebLobRebLgbRobRobRhbRobRibRobLcbRgbRobRebLebRebLebLobLobRob
RobLebLebLobLebLebRebRcbRsbRobRobLobLebRobRibLobRebRobLcbLobRibRobRgbR
obLibRsbRsbLobRobLibLebRhbRobLebLobLebRebRobLobRobRhbLobRobRobLobLcbLe
bLebRobRobLobRcbRobLcbLebRobLobRebRsbRebRebLibLjbRsbLjbRobRobRebLebRob
RebLebLcbLobLsbLobLobLgbLcbRobLobLebLsbLobLobRebRibLsbLobLsbLebLebRobL
sbRsbRsbLjbLjbLobRobRobLjbLobLjbRebRobRsbLebRsbLobRobLjbLob

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 26; Drug: OSU6162 10 然 Apo 50 然
bRsbLsbRsbRsbRsbRsbRsbRgbRsbRsRsmbRsbRsbLsbRsbsbRsbRgRgbRsbLeb

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 27; Drug: OSU6162 10 然 Apo 50 然
bRsbsbRsbLsbRsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 28; Drug: OSU6162 10 然 Apo 50 然
bRsbRsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 29; Drug: OSU6162 10 然 Apo 50 然
bsbRsbLgLsbsbLeLsbLebRobLsbLgbRobRibReRsmbLgbLgbLgbLibLgbLgbLgbLgbLsLs
mbLsLsmbLibLiLsbLgbLgbLgLsbLgbLgbLibLgbLgbLgLebRsbsbLsbRsbLgbRsLsLsmbL
gbLibLsbLsbLgbLsbLgbLsbLgbLgbLgbRsRiLsbLsbsbsbRsRsLsmbRsRsmbLsLsLsmmbs
bLsbsbLsbRsbRsRsmbRsbRsbRgbRgbRebRsbRebRsbLgbRsbRsbLgbLgbRsbLsbLsbLibL
sbRsbLgbLsbLebLibRsbLgbRibsbsbsbRsbRsbRsbRsbLsbLsbRsLsbRsbLsbLsRsbsbLs
bsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 30; Drug: OSU6162 10 然 Apo 50 然
bRebRobLebLebRcbLsbLebLibLebLebRebLebRobLobRobRebLebLebRsbRobLibRobRgb
LobRobRibLebRsbRebLebRebLebRibRcbRebRgbRebRobRsbRobRgbLgbRebLobLhbLobL
cbRsbRgbLobLebLsbLebLcbLobLobLobLsbLobRobRobRebLobLobLobRobLobRebLebLo
bRobRobRsbRobLcbRobRobLebRobLobLgbLebRcbRobRebRgbLobRcbLgbRjbRobRcbRob
RobRobRgbRobRebRobRobLcbRgbRibLobLebRobLobLebRibLobLgbLcbRebRobRcbRebR
obLcbLobLcbRobRobLobRobLsbLebRobRebLibRobLcbRgbLobLibLebLcbLhbLebRebRi
bLobRcbLcbLobLsbLebRobLobLhbLobLcbLebLcbLobRobRcbLibLobLebRcbRebLobLeb
LgbRobLgbRebRcbLobRobRobRebRebLobLobRebRcbLgbLgbRgbLibLobLebLcbRcbLebL
obRobLobRobRobLobLobLobLgbRcbRjbLobLobRobRcbRobLcbRgbRibLobRibRebLebRo
bLobLcbRobRjbRibRobLebLebRibLebLibRebLcbLobLcbLobLgbLcbLjbLibRcbLobLob
RgbLebLcbLobLobLsbLobRobRgbRsbLobRgbLsbLsbRsbRibRcbLobLsbLcbLjbLsbLobL
obLobRebRjbLcbLjbLcbLebLobRobLjbRebLcbLebRsbLobLobRsbRebLjbLobRebRsbRo
bLebLebRebLsbLobLsRsbLsbLsRsbRsbLobLebRsLobRsbLsbRobRobLobLsbLsRsRsmbL
sbLsLsmbRsbRsLsbLsRsLsbRsbRsbRsbLsbRsbRsbLsbRsbLsbLsbLsbLsbLsbRsbLsbLs
bsbRsRsmbRsLsRsbRsbRsbLsbRsbRsbLsbLsbLsbLsbLsbRsRsRsmmbLsbsbRsbLsLsmbR
sbRsbLsbLsRsRsmbLsbLsRsbLsRsLsbRsbRsbRsLsbRsbLsRsbLsLsRsmbRsbRsLsRsLsR
sbRsLsRsbLsbLsRsbLsbRsLsRsLsRsRsmbLsbLsRsbRsbLsLsRsmbLsbRsLsRsLsRsLsLs
RsmbRsRsRsLsLsRsmmmbRsLsbLsLsmbLsLsLsmmbLsRsRsRsRsLsRsRsLsRsLsLsRsLsLs
RsLsRsRsLsLsmmmmmmmmbLsRsLsLsRsLsLsRsLsRsRsLsLsRsRsRsLsRsRsLsRsRsLsLsR
sLsRsRsLsLsmmmmmmmmmmmbLsLsRsLsRsLsLsRsLsRsRsRsRsRsLsLsLsRsRsLsLsRsLsR
sLsRsLsRsmmmmmmmmmmbRsRsLsRsLsLsmmbRsRsRsLsLsRsLsRsLsRsLsRsLsLsRsLsRsL
sRsLsLsRsLsLsRsLsRsLsRsLsRsmmmmmmbLsLsRsLsRsRsRsLsLsRsLsRsRsLsLsLsRsRs
LsRsLsRsLsRsLsRsLsLsRsLsLsRsLsRsRsLsLsLsRsLsRsLsLsRsRsLsRsLsRsRsLsRsRs
LsRsRsRsLsRsRsLsLsRsLsRsLsLsLsRsLsLsRsRsRsLsRsLsLsmmmmmmmmmmmmmmmmmmmm
mmmmmmmbRsRsLsRsRsRsLsLsRsLsmmmmbRsbRsLsRsLsRsRsmbRsLsRsRsLsRsLsRsRsLs
RsLsRsLsRsRsRsLsRsLsRsLsLsRsLsRsLsLsRsLsLsRsLsLsLsRsLsRsLsRsmmmmmmmmmb
LsRsRsLsLsLsLsRsLsRsLsLsLsRsLsRsLsRsRsLsLsLsRsRsLsRsLsRsLsLsRsLsRsRsLs
RsLsLsRsLsRsmmmmmmmmmmmmmbRsbLsLsRsLsLsRsmmbLsRsLsLsRsRsLsRsLsLsRsRsLs
RsRsRsLsRsLsRsLsRsRsLsRsLsRsRsRsRsLsLsRsLsRsLsRsLsLsRsmmmmmmmmmmmmbRsR
sLsLsLsRsRsRsLsRsLsRsLsLsRsLsRsLsLsRsLsLsmmmmmmmmbLsLsmbLsRsLsLsRsLsLs
RsmmbLsLsRsmbLsbsbLsLsRsmbRsRsmbRsLsLsLsmmbLsbLsbLsbLsbRsLsbLsLsmbLsbL
sbLsbLsRsbsbRsLsRsRsLsLsRsmmbRsbLsbRsLsLsRsRsRsmmmbRsbLsLsmbRsRsLsRsmb
LsbRsRsmbLsLsmbRsbLsbRsLsLsmbRsbLsRsbLsLsRsmbsbRsLsRsLsbRsbRsLsbsbRsbL
sLsmbRsLsbRsbLsbLsbRsbRsbRsbRsbLsbLsbLsbLsbsbsbRsbRsbRsbsbRsbLsRsbsbsb
RsLsRsbLsbsbRsLsbLsbRsbLsRsbRsbRsbLsbLsbLsbLsLsmbsbRsbsbRsbsbRsbRsRsmb
RsbRsbRsbRsRsRsmmbsbRsRsmbLsbRsbLsLsRsmbRsRsmbRsLsbsbsbsbsbsbRsbsbLsbR
sbsbRsbRsbRsbLsbsbRsbRsbLobRsbLsLsRsLsLsmmbRsRsmbLsbsbsbsbsbsbsbsbLsLs
mbsbLsbRsbsbRsbLsbsbRsbsbsbLsbLsbsbsbsbLsbRsbRsLsbsbLsbRsbLsbLsbRsbRsb
sbRsbRsLsbRsRsmbLsbsbLsRsbsbLsbLsbRsbLsRsbsbRsbRsLsLsLsmmbRsbLsbRsRsLs
RsmbsbLsbLsLsRsmbsbLsbLsbLsbLsbsbRsbsbRsbRsbsbLsbLsbsbRsLsbLsbLsLsmbRs
LsbLsbRsbLsbsbsbRsbsbLsLsmbsbLsRsRsmbRsbRsLsLsmbLsbsbsbsbsbRsRsmbLsRsL
sbRsbRsRsmbsbLsbLsbRsbsbRsLsRsRsmbsbRsbsbsbLsbLsbRsRsLsmbRsLsbRsbRsLsb
LsbsbLsRsbLsbRsRsRsmmbLsbsbsbRsbLsRsbsbLsbLsbRsbLsRsbRsbLsLsmbsbsbRsLs
bRsLsbsbRsbsbsbsbsbLsbRsbLsRsLsbLsbsbsbRsbLsbsbsbLsbsbsbsbsbRsbRsbLsRs
RsmbRsbsbRsRsLsmbLsbLsbsbRsLsbLsbLsLsRsmbsbRsbsbLsbRsbsbsbLsbRsbRsbLsb
LsLsRsmbsbLsLsmbLsbsbsbsbsbsbsbLsLsRsmbRsLsbLsbRsLsLsmbLsLsmbsbsbsbLob
sbRsbRsbsbsbRsLsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 31; Drug: OSU6162 3 然 Apo 50 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 32; Drug: OSU6162 3 然 Apo 50 然
bLibLebLebRcbRcbRsbLobRsbRsbRhbsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 33; Drug: OSU6162 3 然 Apo 50 然
bsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 34; Drug: OSU6162 3 然 Apo 50 然
bRsbRsbsbsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 35; Drug: OSU6162 3 然 Apo 50 然
bLsbLsbLsbLsbLgRsRsmbsbsbLgbRgbLsLsRsmbLebLcbLsbRsbLsbLebRsbRsbLcLsmbR
gbLsbRjbRsLsLsmbsbLcbRsbReRsLombLobRjbLcRjbRgbRsRgRsmbRibLoLsmbRibRibL
gLsbRsRebRgbRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 36; Drug: OSU6162 3 然 Apo 50 然
bLgbLsbRebLobRobRobLobLebLebLjbRobRjbRcbRgbRjbLsbRcbRcbRjbRjbLcbLobRob
LobRobLobLobLobLcbLebRobLcbLcbLjbLebLjbRebRobLobLebLobRebRebRjbLobLebL
obRebLobRcbLebRobLobLcbLobLsbLobLcbRcbRcbRebRobLobLobRebRcbRobRebRebRo
bRobLobRjbLobRobRobLjbRebRebLebLibLcbRibRebLebLebRcbLobLobRgbLobRibLib
LcbLobRebLebLcbRgbRibLobRgbLobLjbLjbRebRobRobRebLjbLobLobRobRobRebLobL
cbRcbLobLobRobLjbRcbRcbRebRebRcbLobRcbLobRebLsbLobLebLebLobRibRebLobRo
bRobRobLcbRobLcbLsbLjbLjbRobRobRobLobRjbRobRobLobLebLobRsbRcbRebRobReb
RjbRcbLjbLsbLibRobLebRobRebRobLgbLebLebRobLebLgbLobRebRcbRibRebLobLebL
sbRebRcbLgbRgbRcbLobLjbLcbLebRcbLebLjbLjbLobRcbLebLobLobRjbRobRobRjbRg
bLcbLcbRobLebRsbLjbLsbLobLjbRcbRobLjbLobLobRcbLgbRobLobLjbRobRobLjbLib
RobLobLjbLebRebLsbRhbLcbRobLobLgbLjbRhbRgbLcbLobRcbRobRobRjbRsbLsbRsbR
obRibLcbRobLebLobRsbLobRebLobRcbLcbLsbLobLcbRebLcbLobLobLobLcbLibLobLj
bRcbRobRebRebLjbLobRjbLibRcbRjbLobLcbRibLsbLobLobRebLobRsbRobRebRobLob
RebLebRobRobRgbLobRobLobLebRebRebRobLibRobRebLebLobRgbRobRcbLebLebLjbL
ebRgbLebLibRhbRgbRgbRobRsbLobRobLebRjbRobLcbRebRcbRcbRobLgbRebLcbRebRs
bLobRebRobLibRobLibLobRibRebRebRobLjbLobLebLebLebRebRobLcbLhbLcbRobRib
RcbLobLsbLobRjbLobLebRebLjbRjbLebRcbLebLobRebLebRebRebRibRgbLobRebLibL
obRjbRebRcbRobRobRcbRobLgbLcbRcbLebRobLcbLibLobLebLgbLcbRcbLobLobLobRo
bRobRobRsbRobRibLobLjbRibRobRibRcbLjbRobLobLebRibLcbLebRobRebLebLebLjb
LcbRobLobRebLcbRcbRebLebLobRgbLobLcbLebLobLcbRcbLebRebRobLebRjbLebRebR
cbRcbLobLsbLobRebRibLgbLcbRobLebLobRebLcbRebLebLobRibLobRcbLebLobLebRj
bRjbRsbLjbRcbRobRhbRsbRjbRobRebRcbRebLebRjbRobRebRobLjbLobRsbLobLobLjb
LebLibRebRobLcbRobRobLobRibRjbLcbRebRobRsbRsbRebLobLjbRobLcbLobRebRebR
ibRcbRobRobLcbLobLebLcbRobRobLibLcbLobLjbRgbRjbRebLjbLobLsbLobLobRebLg
bLjbRjbRobLsbLgbRebRobLobRibLibLsbLobRebLcbLobRebRobRebLobLobRebLhbLeb
LobLobRibRobLibLobRgbLibLobLobRobLebLobRebRobRjbLcbRjbLebLjbLobRobLobR
obRobRobRebLebLobLsbRcbRsbRjbRebLobLebLobRobLobRobRcbRibLobLcbRebLgbRo
bLobRobLebRobRobRobRcbRobLcbLobRobRgbRcbRebRibLcbLsbRcbRgbRobLebRebLcb
LobRgbLobLcbLhbRobLgbLibLcbLobLsbLcbLebRcbRobRobRobLobLobRebRcbLobRibL
gbRebRcbLobRgbLgbRobRgbRobLobRcbRobLobRjbLgbLcbRibLebLebRobLcbRobLobLe
bRobLjbRebRgbRgbLobLebLcbRebLobRobLjbRibLcbLebRobLsbLebLebLobRobLsbLob
LsbRebLsbRjbLebLobLebRgbLobRobRobRcbRobRcbLjbRobRobRibLsbLcbRobLebRebR
gbRebRobLcbLobRobRebLebRcbRobRjbLobLobRobLobRebRsbRibLebLjbRobLobLobLs
LebRobLobLcbLibRebRebRobLobLobRobRobLebRobLobRsbRjbRobLebRobRebRsbRobL
gbLebRobRcbLobRgbRobRebRgbLjbRebRebRsbRjbLebRhbRebRibRcbLebLobRobLobLo
bRebLcbRebRobRcbRobRsbRcbLobRcbRobLebLobRsbLobRobLobRobRjbLgbLhbRcbLob
RobLebLsbRobLcbLobRobRcbRebRsbLobRebLebLebLobLobRibLsbRobRsbRobLobRebR
ebLobLsbRjbRobRobRobLebRebLobLobRobLobRebLobLobLobLsbRebRsbRebLobRobRs
bLobRebRcbLobRgbLobLsbLobRcbRobRsbLobLgbLobRibLebLobRsbRobRobLibRgbRob
RcbLobRsbLebRsbLobLsbRebRebRebLcbLjbRsbRgbLobRcbLgRgbLgbLebRjbRebLobRo
bRebLsbLobLsbLebRobRebLobLobLsbLgbRobLsbRobLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 37; Drug: OSU6162 1 然 Apo 50 然
bRcbsbLebLebLsLsRsLsLeLsmbLsbLgLsbsbRcRsmbsbRebLobRjRjbLjbRgbLsLsmbRsR
smbsbLsbLsbRjbReRsmbLcLsLsmmbsbLcbRgbLjbLcbLsRsLsbLibLcRsbLcbsbLoLsmbs
bLcLsmbLcLsmbLgLsbLsbLcRsbRcRsmbReRsmbRcbReRsmbReRsmbRcRgbRhRsRsmmbReb
RcRsmbRebRebReRsRsmmbReLsRsbLibLebLcLsmbLibLjLsmbRgbRcRsmbLgLsbLsbRsRs
RsmmbRsRsmbRsRsmbRsbRsRsRsRsmmmbLsRsRsRgRsmmbLjbLjLsLsmmbRsbLebRcRsmbR
ebRcbRobsbLeLsbLcLsLsmmbRsbLsLsmbLgbLsLsLgLsLgLsmbLsLsLgRsLgLsmbLcbLoL
smbRoRsmbRebLebLhLsLsmbLsRsbsbsbsbsbsbsbRsbRsbLsRsbRsLsLsmbsbRsbRsbLsb
sbLsbLsLsmbLsLsLsLsLemmmbLebLsLsmbLsLsmbLgLsLsLsLiLemmbLhLsRsbRoRhRgbR
obLcLsmbLgLobRgRcRsmbRsRoLsLsmbRoRsmbRsbRcbRcbReRsmbLjbLcbsbLebLibLgbL
gbLibRsLsbLsbsbsbsbsbRcLsbRobsbRjbsbLsbRsbRsbRsbLsbRsLsbRsbLsLsmbRsbLs
bRsRsLsRsmbLsRsRsRsRsRemmmbRibLcLobLcbLoRsLsRsRsmbLcbRsRgbRoRsmbRoRsmb
RcRsLgmbRcRsmbLsRobRcRsmbLsbRiRsmbLcbLiLsbLiLsbLcbsbRcRsmbsbRiRsmbRsRs
RsRgRemmb

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 38; Drug: OSU6162 1 然 Apo 50 然
bLsRsbReRsRsmmbRsbRgbRgbLsbsbRibsbRsbRsbsbRobRhbRsRsmbRgbRgLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 39; Drug: OSU6162 1 然 Apo 50 然
bLiLsbLiLsbLsRebRobRhbLsbRibRsbLjbLobsbLibLgbRoLsRsbLcbRjbLcLsmbRobReb
LjLsmbRebLcLsmbLebLcLsmbLiLsbRsRcbLjLebLcbLcbRcRsmbRsRobLiLgRsbLibRebR
jLcRsbLibLcbLobRcbRobRibLiLsbLiLsbLgbLgbLibReRsmbLsbRjbRgRgRjRsmbRcbLi
bRsRsRsRsmmmbLsbRsbLsbsbsbLsLsLsLsmmmbLsbsbLsbsbRsbRsLsLsmbLsbLsLsLsmm
bLsLsmbLsLsLsmmbLsbRsLsLsmbLsLsLsLsmmmbsbLsbLsLsLsmmbLsbLsLsLsLsLsmmmm
bLsLsLsLsLsLsLsLsmmmmmmmbLsRsbsbLsLsmbLgbLsLsLsmmbLsLsLsLsmmmbLsbLsbLs
LsLsmmbLsLsmbLsLsLsmmbLsbLsLsLsLsLsmmmmbLsbLsLsLsmmbLsLsRsRsmmbLsbRsbL
sLsLsLsLsmmmmbsbsbLsLsLsLsmmmbLsLsLsmmbLsbLsbLsbRsbLsLsLsmmbLsLsmbLsLs
mbLgLsbRsLsLsLsmmbLsbLsLgLsLsLsLsLsLsLsLsLsmmmmmmmmbLsLsLsLsRsLsLsLsmm
mmmbLsLsLsLsmmmbLsbLsLsmbLsbLsLsmbRsLsLsLsLsLsmmmmbLsbLsLsmbLsbLsbLsbL
sLsLsmmbsbLsbLsLsLsmmbLsLsLsmmbLsLgbLsLsmbLsLsLsLsmmmbLgLsLsLsLsLsLsLs
LsmmmmmmmbLsLsLsRsLsLsLsmmmmbRsLsLsmbLsLsmbRsLsLsLsmmbLsLsmbsbLsbLsLsm
bLsbRsLsbRsbLsbLsbLsbLsbLsLsLsLsLsLgLsmmmmbLsLsLsLsLsmmmmbLsLsLsLsLsLs
LsLsLsLsLsLsLsLsLgLsLsLsLsLsRsLsLsLsLsLsLsmmmmmmmmmmmmmmmmmmmmmmbLsLsL
smmbLsbLsLgLgLsLsLsLsLsLsLsLsLgmmmmmmmbLsbLsLsLsLsLgLsLsLgLsLsLsLsmmmm
mmmbRjRcRoLsbRobRobLcLsmbLiLsbLgLsbLcbLcbLcLsmbRcbLobLgbsbRobRiRsLsmbR
ibRoRsmbLibLibLeRsbLeLsbRsRsmbRcbRobLgbLsLsmbRcbRhbLcbLcbLjbLibRsbRsRc
bRcbRsRsRsRsRgmmmbRsbsbRsRsmbRsRsRsRsRsRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmm
mmmmmmbRsRsRsRsRsRsmmmmmbRsRsRsLsRsRsmmmbRsbRsRsmbRjLgRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 40; Drug: OSU6162 1 然 Apo 50 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 41; Drug: OSU6162 1 然 Apo 50 然
bLsRsbLsRsRsLsRsmbLsRgbRsRsRsRsmmmbRibRsRsmbLsRsRsRsmmbRsRsRsLsRsRsRsR
sRsmmmmmmbRgbRsRsRsRsmmmbRsRsRsRsRsRsRsRsmmmmmmmbRsRsRsmmbRsRsRsRsmmmb
LsRsRsRsRsRsRsRsmmmmmmbRsRsRsRsRsRsmmmmmbRsRsmbRsRsRsmmbLsRsRsmbRsbRsR
sRsRsRsmmmmbRsRsRsRsmmmbLsRsRsRsmmbRsRgRsRsRsRsRsRsRsRsLsRsRsRsRsRsRsR
sRsRsmmmmmmmmmmmmmmmmbRgbRsbRsRsmbRsRsRsmmbRsRsRsRsRsRsRsmmmmmmbRsRcbR
cRsRsmmbRhbLeRsbRibLibLeLsbLebRcbRcRsRsmmbRcbRcbRcbRebRibRibLgbLjbLcRs
bRgRsmbReRsmbRsRgRsmbRsRsRsRsmmmbReRsmbRsRsRsRsmmmbRsRsRsRsRsRsRsRsRsR
sRsRsmmmmmmmmmmmbsbRsbRsRsRsRsmmmbRsRsmbRsRsmbRsRsRsRsRsmmmmbRsRsmbRgR
sLsmbRsRsRsRsLsmmmbRsRsRsRsRsRsmmmmmbLsRsRsRsmmbRsRsRsmmbRsRsmbRsRsmbR
sbsbLsbRsbLsbLsRsRsRsRsRsRsRsRsmmmmmmmbRsRsRsRsmmmbLgbLcbLibLcbLcRsbRe
RsmbRcbLjbLibLebLsbsbLibLgbsbLsbLgLsbLsbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 42; Drug: OSU6162 1 然 Apo 50 然
bRgbLibLobRobLobRebRibLcbLobRobRebRebLobRobLebLgbLebLhbRsbLobLcbLebLob
RcbRcbRobRobLcbLebRebRebRebRcbRobRobLcbLobLobLcbLobLibRsbLobRobLibRgbR
obRgbRsbLcbLgbLibRebLcbRobLcbLibRcbRibRibLobRgbLobRibLobRebRcbRibRobRo
bRobRobRobLebRobRobLjbLcbLebRgbLgbRebLsbRcbLebLobRobRibRebRhbLcbLebLeb
RobRsbRobLcbRobRcbRgbRobRcbLsbRobRobRebRgbRibLcbLobRebRgbRgbLhbLhbLobR
ebRcbLebLibRgbLobLebLibLibLobLobLebRobRgbRebLobRobRebLebRobLobRcbRebLo
bLebLebRcbRebRcbLobLcbRobRobRobLobRibRibLobRobLobLebLobLgbRobRobLebRob
LhbLobLobLcbLgbLgbRibRobRobRobLcbLebRibRobLgbLgbLobRebLobRobLebRobRibR
obRobRcbRgbRobRcbRgbRsbRibRobRgbLcbRobRsbLobLebRebLobRcbRobRhbRebRobRo
bLsbRebRobLibRobRebRcbRebRsbLobLobLobLebRcbRebRcbLobRibLobLibLobLobRob
LobLcbLjbRsbRsbRcbRobRobRgbRhbRcbLsbRebLhbRcbLobLobLebRebRobRobLsbLobL
obRebLebRebLebRobLebLcbLcbLobLcbRobLobLibRobLobLobLcbRcbLcbRibRebRsbRo
bLgbRobRobLobRsbRebRsbLobRobRobRibLobLobLebRjbRobLgbLcbLobLobLibLobReb
LobRcbLobLobLcbRobLobRobLobRobLebLebLebRsbRobLobRgbLcbLcbLobRobRsbRebL
sbLobRebRebLjbRebLobRebRcbRjbRobLobRobLebLebLibLcbLebLobLcbRobRjbRobLo
bRjbRjbRobLcbRcbLebRobLobLsbLjbLobRjbRcbRcbLobRebRobRsbLebLcbLebRsbRjb
RjbRcbLjbRgbRcbLobLjbRobRebLebLebLebRobRjbLcbLjbLobLebRebLcbRcbRebLobR
ebRobLebRcbLebLhbLobLebLjbLebRobLobLjbRebLebLjbLebRjbLobLjbRebRobRebRe
bLobLjbLobLebLebRjbLebLebRebRebLsbRcbRebLobRcbRobLjbLjbRebLcbRebLobLeb
RobLjbRobLobRjbRobLcbRcbRobLjbLobRobRebRobLebLobLebRsbRebRobLjbRsbRebR
ebRobRcbLebRcbRebRobLjbLjbRebLebRcbRcbLobRebRjbLebLibRcbLobLebLobLjbLc
bLjbLsbLjbLsbLsbRsbLsbRsbLsbRsRsmbRsbLsLsmbLsbRsbLsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 43; Drug: Control Apo 50 然
bsbsbsbRjRgbRsbsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 44; Drug: Control Apo 50 然
bRsRsRsmmbsbRsRsmbRsRsmbRsbRsRsRsRsRsmmmmbRsRsmbRgRsmbRsRsRsmmbRsRsmbR
ibLsLsRsmbLsLsRsmbLgbRsbRsRsmbRsbRsRsRsRsmmmbRsLsbRsRsRsmmbsbRsRsRsRsm
mmbRgRsmbRsRsRsmmbRsRsRsmmbsbRsRgbRsbRsRsRsmmbRsRsmbRgbRsRsRsmmbLsRsbR
sbRsRibRgbRgRsRsmmbRsRsmbLebLoRsbsbRsRsmbsbLsbsbRsbsbRsbRsbRsbRsbLsbRs
RsRsmmbRsbRsbRsbRgRsmbsbRsRsmbRgRsmbLsbLoLsmbLsbRsbRebLcRsbRsbLcbLsbRi
RsmbLebLeRsbLgbLibsbLsbLgbLgbLsbLsbLebLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 45; Drug: Control Apo 50 然
bLsRsLsbLsLsLsmmbLgbLgbsbLsLsmbLgLsLsLsmmbLsbLsLgbLsbLebLibLsLsRembLib
LsbRsbRcbRsbLgbsbRjbLsRsbRibLobsbLsbsbRsLsLsRsmbRhb

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 46; Drug: Control Apo 50 然
bsbRsbsbsbsbsbLsbLsbRsbsbLsLsmbsbsbRsbRsLsbsbLsbLsbRsbsbRsbLsLsmbRsbsb
LsbLsRsbRsRsmbsbRsLsRsbRsbLsLsmbRsRsmbRsbsbRsbRsLsbLsbRsbRsbLsbRsLsbLs
bLsbLsbLsbRsbRsLsbRsbRsRsLsLsmmbLsbRsbLsbRsbRsbRsbLsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 47; Drug: Control Apo 50 然
bsbLobRgbLoRsLsLsmbRsRcbRgRsRgRsRgLsmmbLjbRgbLgRsbRiLsbsbsbsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 164832; End: 165332;
Recording: 11-1; Individual: 48; Drug: Control Apo 50 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 1; Drug: OSU6162 10 然 Apo 50 然
bRebLibRgbLebLsRsbLebLjbRsRjbRebLsLsmbLobRobLsbRobLsbRebLsbLebRsLsRsbL
sbRobRebRjbLsbRsbLjLsmbRobRobRebLobRebRsLsLsmbLsbLsbRjbLjbRsbRsbLsbRjb
LsbRsbRobRebLebRsbRsbRjbLjbsbRsbRsbRsbLebLsRsbLsbLsbLjbLsbLjbLjRsbRsbL
sbRsbRsbRsRsmbLsbLobReLsbRsbRsRsmbRsbLjbLebLjRsbLebLsbRsRjbLsbLsbLsbLs
bLsbLsbLobRebLsbRjbLobLsbLsbLobRsLsbLjbLsbLebLsbLsbRjbLsLsmbLsbLsbRjbR
sbLsbLsbLjLsmbRsbRjbRsbLibRebRjbRsbRjbLsRsbRobRsbRjbRsbRebsbLsbLebRjbR
obRcbLsRsbRsbRsRsmbLsLsmbRsbLsbLsbLsbLsRjbRsbLsbLsbRsbRebRsbLsbRsbLsRs
RjbRobLsbRsbRjbRsbLjbRobRsLsbRsLsbLjRjbLsbLsbRsbLsbRsbRjbLjbRsLsbRobRo
bLsbLsbLsRsbRsbRjbLsbRjbLjRjbRjbLsbLsLsmbRsbRsbLsbRsbLjbRebRsbsbLsbLob
LebRsbLsbLjRsbLsbLsbLjbLsbRsLsbLsbLsLebRsbLsbRsbLsbLsbLjbLsbLebLsbLsbR
sbRjbRsbLsbLsbLsbRsbRsbRsLsRjbsbLjLsmbLsbLsbLsRobRsbRjbLsbLjLsmbLsbsbR
sbRsbLsLsmbLsbRsbLsbLsbLjLsLsmmbLjbRsbRsbsbRsbRsLobRsbLsbRsbRsbLsbRsbL
sRsbRsbLsbLsbRsbLsRsbLsbLjRsbRjbRsLsbLsbLebsbRsbLsbLsbRsbRobLsbRjbLsbR
sbLsbLsbLsLsmbRsbLsbRsbLsbLsbLsbRsbLsbLjLsmbLsbRjLjbLsbRsbRebRsbLsbLsL
smbLsLsmbRsbLsRjbRobRsLebRsRsmbRsbRsbLjbLsbRsRsmbLjbLsbLsLsmbRsbRsbRsb
LsbLsLsmbLsbRsLsbRsbRobLjRsbLsbsbLsbLjbLsbLsbRsbLsbLsbRsbLsbRjbRsbRjbR
cbRjbLsbRsbLsbLsbRsLsbRjbRsbRsbRobRebRobRjbLobRobLjbLebRjbRebLobRebLeb
RebRebRobLobLebLcbRgbLcbLebLcbRjbLsbLjbLjbLobLobLjbRjbRcbRcbRjbLjbRsbR
ebRobRcbLcbRsbRebRobRjbRsbRobRobRebRobLebLebRjbLobRobRobRobLobLobLobLo
bLjbRobLebLebLcbRebLobRjbRobLjbLjbRjbRebRebRjbLjbLcbRebRobLobRobLebRcb
LobLobRobLcbRcbRobLjbLobRobLobLjbLcbRobLjbLsbLobRjbLebLjbLcbRibLobLobR
obRobLobRobRobRjbRebLcbLjbRobRobRjbLebLobLobLebLobRobRobLobLebRcbRebLe
bRebLjbRebLobRobLcbLobRjbRjbRcbRobLebLsbRjbRcbLcbRcbRobRcbLsbRcbRobLob
LobRjbRebRobLobRobLobRjbRobRcbRobRsbRobLobRjbRobLobLobRjbLebRebRebLobL
ebLebLebLebLebLebRobRsbRebRgbRobRobLobRobRsbRebLcbRsbRcbRibLobLobRobLi
bLobRcbLgbRebRgbRcbRobRcbRobLcbLcbRobLsbLobLcbLebRobLcbRsbLgbLobRcbLob
LebRobLebLgbLcbRibLebRobLobRjbLobRcbRgbRebRobLebLobLcbRobLobRebRobLobL
obRhbLobRobRebRobLebLebLobLcbLobRobLcbRcbLobRobLebLebRibRgbRobLebLobLe
bLobLgbLobLebLobRobLobRibLobLebRebLobLcbLebRebLcbRobLhbLobRebRgbRibLcb
RebRebLgbRobLebLcbRebLsbLebLobRcbLgbRebLobLebRibLjbLobRobLebLobLobLobR
obRibRibRebRobRebRebLgbRcbRobLebLcbRebRobRibRgbLsbRobRcbLobRcbLebLcbRo
bRibRobRcbRsbLjbLcbRcbRobLcbLobLobLjbLebLobLebLobLcbLobRcbRcbRobRobRib
LobRobRobLcbLgbRgbLobLobRobLobLobRobLobRcbRebLobLobLobRebLobLgbRcbRgbR
cbLcbRebLgbLobRebRhbLebRobRebLobLobRebRebRobLobLebLjbRebRobRobLcbRobRc
bRcbLebRcbRebLgbRibRsbRobLjbLobLobRobLhbRebRebRebLgbLcbLibRobRobRebLcb
RsbRebLcbLcbLibLobRcbLebLobRebRhbLobLobLobLcbLobRebRsbRgbLobRibLobRobL
sb

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 2; Drug: OSU6162 10 然 Apo 50 然
bRsRsRsRsRsRsRsRsRimmmmmmmbReLsLsmbLsLsmbLsLsLsLsLsLsLsLsLsLsLsLsLsRsL
smmmmmmmmmmmmbRsLsLsLsLsLgmmmbLsLsmbsbLsRsbLsLsmbLsLsLsLsLsLsLsLsLsLgL
sLsLsLsLsLgLsLsLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmmmmmmmmmmmmmmmbLcbLsbLs
bLsbLgbLsbLsLsLsLsmmmbLsLsLsLsmmmbLgLsLsmbLsLsLsLsLsLsLsLsLsLsmmmmmmmm
mbRsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmmmmmmmbLgLsLsLsLsLsLsL
sLsLsLsLgLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmmmmmmmmmmmmmmmm
mbLsLsLsLsLsLsLsLsLsmmmmmmmmbLsLsLsLgLgLgLsLgLsLsLsLsLsmmmmmmbLsLsmbLg
LsLsLsLsLsLsLsLsLsLsmmmmmmmmmbLsLsmbLiLsbLsbRebRobLgLsbLibLcRsbLcbLgbL
ebsbLiLsbRiRgbRhLsbRsRsRsmmbRgLsbLsRsLsbRsbRsbRiRsRsmmbLsLsmbRsbRsbLeb
LcLsLsmmbLiLsbLgLsbLgLsRsbLiLsLgLsLsLsmmbLcbRebLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 3; Drug: OSU6162 10 然 Apo 50 然
bLgbsbRibsbLsRsbLgbLjRgbLibRobLibRsbRsbRebRobRibRibLobRgRsmbRibRobLsLs
RsRsmmbLsbLsbLgbRsLcbLcbLebsbReRcbLjbLcbRsRsmbRgLgbRsbLsbLgbLsbRsbRsLs
bLgbRibLgbRjbRsbRgbRsbsbsbLibRibLhLsbLsLsLsmmbLsbLgbLsRsbsbLsbLibLjbLi
bsbRsbRebLobRgLgbLibRibRsbRjbRebLebLobLobRobLibRoLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 4; Drug: OSU6162 10 然 Apo 50 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 5; Drug: OSU6162 10 然 Apo 50 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 6; Drug: OSU6162 10 然 Apo 50 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 7; Drug: OSU6162 3 然 Apo 50 然
bsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 8; Drug: OSU6162 3 然 Apo 50 然
bsbsbsbsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 9; Drug: OSU6162 3 然 Apo 50 然
bRjbLgbRcbLobLsbLcbRcbRebRebRibLebLobRobLobLobLgbRhbLobLcbLobRebLibLob
LcbLcbRobLebRgbLobLebRebRobRobRebRgbLobRobRebLcbLebLobLebRcbLgbRibLebL
cbLebRobRhbRobLibLgbRobLobLobRebLobLgbRobLebLhbLsbRcbLebLobRobRcbLobRo
bLobRobLobLobRebLobRobLibRcbRobRcbRebRebRebLhbLobLgbRobRebLsbRobLibLcb
LhbLobLibRcbLobLebRebRobRsbRebRebLobRebRibLebRobLsbLobRcbLebLcbLebLobL
cbLcbRcbRgbLobRcbRobLobRcbLcbLcbRcbRcbLobRobLgbLobRobRobLsbLobRebRebLe
bRobLobLebLcbLsbRebRgbLobRobRsbRcbLgbLobRobRebRcbRobRcbLebRcbLobRobLob
RcbLibLobRobRobRcbRibRobRcbRcbLobRobRcbRobLcbLibRobRebRcbRobLcbRsbRebR
cbRebRcbRobRobRobRobRcbRsbRgbRebLcbLcbLibRibLobRsbRebLgbLebRebRcbLebLo
bLobRobLebLgbLcbLcbLgbLebRobLgbLebRcbLcbRebLibLcbLebRobRebLebRgbLobLib
RobLebLebRsbLjbRcbLobLcbRgbRcbRobLobLobRcbRebRcbLcbLsbRgbRobRobRebRcbR
cbRebLobRobRebRcbRcbLobRobRebLcbLibLebRobLebLgbLebLobLobRebLobRcbLebLe
bLsbLhbRebLobLhbLobRobLgbLcbRebRhbRobLobRebLebLcbLibRebLobLebRobRebReb
RobLobLsbLgbLobRcbRcbLobLobRcbLhbLobLobRebRebRcbLobRebLcbRobLsbLobLobR
cbRcbRcbLobLebRibLobLcbLgbLgbRsbRobLebLebLebLgbRebRobRebLcbLgbRobRobLs
bLobLobLobLibRgbLobLebLobRebLebLebRebLcbRibLcbLgbLobRebLobRcbLobLobReb
RobLgbRobRibRobRebRebLsbRobLcbLcbLobRgbRgbLobRebLobRcbLebLebRobLibRcbL
obLobLsbLhbRobLobLobLebRobLebLebLebRobRcbLebLobRsbLobLobLobLobRobRebLh
bRobLebLcbLsbRobLsbRebRebLibLebLebLsbRsbLebRobRibRcbLebLcbRebRcbLcbRob
RebRebRibLebLebRgbLobLobRgbRibRcbLebRcbRebLebLcbLgbRcbLebLobRgbLhbRobR
obLobLibRcbRcbRobLhbRebLobLobLebLebLgbRobRcbRobLibLebRobLobLobLebRobRg
bLobRgbRebRebRobLsbLebLobRobLgbLcbRebLobRebLcbLobLobLebRgbLobLebRobLob
RobLobLebRibLcbRebRobRebLobLobRcbLibRcbRebRobLobLsbLibLebLibRjbLobLibL
hbLobLobRobLobRobLsbRebLebRobLobRobLebRobLebRebLibRobLobRobRobRebLobRo
bLebRobRobRobRobLhbRgbLobLhbLcbRcbRcbLcbLebRobRebRobLobRobLobLobLgbReb
RcbLobLobRgbLobLobLcbLcbRcbLobRobLebLcbRcbRebRcbLebLobRebLebRebRebRgbR
obRcbLcbRibLobLcbRjbLsbRibLsbRibLobRebRjbRobRobLsbRsbRobRebRobLobRobLj
bRebRobLobLcbRebRobLebRjbRjbLebLcbRgbLgbRobRobLebLebLjbRobLcbRebRsbLgb
RhbLebLobLjbLebLcbLobRcbRobRsbLobLebRjbRjbLobRebRebRebRobRebRjbRobRcbL
cbRcbLobRibLebLobLgbRebRgbRobLobLobRobRcbLibLsbRobRcbLobRcbRgbRgbRebRc
bLobRobRobLebLibRcbRcbRobRcbRebLibRebRobLebLcbRobLobRebRobRobLebRjbRsb
LebRebRcbLobLobLcbLobLobLsbRcbLcbRcbRjbRebRcbRobLebLebRobRcbRjbLebLjbR
ebRobRobLobLobRjbLebRjbLebLobLcbRobLsbLebRcbRobRcbRjbRebRcbLobLcbLsbLc
bRsbLcbRobLcbRobLobLjbRebRsbLebRcbRjbRcbLebRebRjbLebLjbLjbRcbRebLobLob
LobRobLobLobLobLobLsbLobRcbLebRjbLebRjbLobRobRobRobRcbLebLcbRobLebRebR
cbRobRjbRobRobLebRcbRebLobLobLsbRobRobRobRjbRobLobLebLobLobLjbLjbLsbRo
bRcbRsbRjbRobLebRebLebRjbLjbRobLjbLsbRobRsbLobLjbRjbRebRobLcbLebRobRjb
LcbLjbRobLobLobRobRobRobRjbLobLebLebLebLcbLobRebRobLcbRebLjbLebRjbRcbR
obRobRcbRobLcbRsbLjbLcbLobRsbRobLjbLebRobRobRcbLcbLjbLcbRobRcbLebLebLo
bLobLebRobLebLobRob

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 10; Drug: OSU6162 3 然 Apo 50 然
bRsbRsbRsbRsbRsbLsbLsLsmbLsLsmbsbsbsbRsbsbRsbRsbsbLsbsbLsbLsRsbsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 11; Drug: OSU6162 3 然 Apo 50 然
bRsbLobLsbLjRsbLsRsbRsLsbLsRsbLsbReRsmbLjbRobLobLsbLjLebRsbRsbRebRsbRj
bRsLsbLsbRcbRsbLsbRsbRobsbLsLsmbRsbRsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 12; Drug: OSU6162 3 然 Apo 50 然
bLsbRsbLhbLsbLsLiRsbRgbRsbRsbRjbLsbLsbLsbRsbRsbsbsbLgbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 13; Drug: OSU6162 1 然 Apo 50 然
bRobLobRcbLcbRcbLcbRcbRjbRebLobLjbRjbRsbLobRebLobLebRjbLjbRjbLsbRebLcb
LebLebLobRobLebLobLobRebRcbLibLebLobRhbLibRobLobLebLobLsbLobLebLebRcbL
obLobRcbLibLobLebRjbRobRgbLobLgbLobLobLobRebLobRobRobLcbRhbLcbRobLcbRc
bRgbLcbLobRebRobLobRebRebRcbLebLobRcbLebRebLibLebLebLobLobRcbRobRgbReb
LobLebLobRcbRsbLebLobLibRebLebLebRcbRobRobRebLebLebRebRobLobRgbRebRcbR
cbRsbRobRobRobLgbLsbLobLebRebLobRobLebLcbLebRobLobLebRobRobLibRcbRobLg
bLobLobRobRobLebLibLebLobLebRobRobLobLobRobRcbRobRcbLcbRobRobRebLobLib
LobLobRobLcbRobLebLebLgbLhbLebLebRobLebRcbLcbLobLgbLibRibRibLgbLobLebL
obRobRcbRobRjbLgbRebRobLebRobLcbRobLebRibLcbRebRibRobRsbRobRsbRobLobLo
bRobLibRobLobLebRibRebRebLobLobRcbRgbLsbRobLobRgbLgbLsbLibLobRobRobLcb
LobRebRobLebLobRsbLobLobRsbRebRcbLobLcbRobRhbRobRjbRobRobLobLebLsbRhbR
obRobLibLobLhbRebLibLobLobRobLebRobRgbLibLcbRobRobRhbLebRebRcbLsbLobLo
bRebLobRibRebLobRobLibLebLebLcbLsbRgbLsbRebRcbRobLsbRcbRgbRobLobLcbRcb
LobLobRcbLebLibLebLebRobLobLgbLibRcbRcbLcbRobRebRobLobRcbRobRobRebRobL
obLobLibRcbRcbRcbRobRebRebRcbRebRcbLjbRebLobRobLhbRobLobRcbRcbRebLcbLo
bRcbRobRobRcbRcbLobRobLcbRebRcbRobRgbLjbLobRobLebLcbLobLobLcbLcbRsbReb
LobRcbLsbLobRebRjbLebRgbLobRobLgbRcbRcbLebLebLjbRobRebLgbRibRebRcbLgbL
obRcbLobRobLibLcbLobRgbLebRebLgbLobRcbLsbRobRhbRsbRobRobRcbLcbRobLcbLo
bRjbLobLobRobRcbLebLobLcbLobLebLebLebRcbRebLcbRobRebLcbLebRobLjbRobRcb
LobLcbRcbLcbRebLobRobLobRibLobRebLebRobRobRobLibLjbRebRgbLebRobLcbLcbL
obRobRsbLobRebRobRcbLobLebLsbLebLhbLobRebRobRobLobRebRebRgbRhbLcbLobRg
bRobRcbLobRebRebRibRobRobRobLobRobLobRobRgbLobLobLebRcbRobRjbLobRobLob
LobLgbLobRcbLgbLibRcbLgbLobRsbLobRobLobRsbRobRobRobLobLcbRobRgbLjbRgbL
jbRcbRibRcbLobRjbLobRobLsbLobLebLcbRobLcbRhbRebRebLjbLcbLcbLobRgbRebRs
bRobLcbLcbRebRobRobLgbLobLibLcbLebLebLobLobRobRobRebLobRobRobLebLsbRsb
RobRsbLobLobLobLebLobRobRsbLgbLebLebRobRebRibRobLebLobLobLobRobLobRcbR
obLibLobRobLebRobRcbLobLobLgbRobLsbLobLcbRibLebLibLobLobLebRcbLcbLcbLo
bLebLobLibRobRjbLobRobRobRebRebLobLobRjbRobRcbRcbRcbLebLibLobRcbRcbLeb
LebLcbLobRebLobRebRobRebLibLcbLcbRibRobLebLebRebRsbRebLcbRhbLcbRobLgbL
obRcbRcbLgbRcbRebRcbRgbLobLobRobRobRgbLcbLcbLobLobRobLobLebRsbLibRebRc
bLhbRibRcbLebRibRobLebLobLebLobRebLobLcbRobLgbRobLgbLcbRobLobLhbLobRob
LebLobLgbLobRebLobRobLgbRobRhbLobLcbLebRcbRjbRsbLhbRobLebLobLobLobLcbL
cbLsbRgbLebLobRobRobRcbLobLibRebLcbRebLebLobLobLsbRjbLsbRjbLebLebLibRc
bRebLebLibLobRobRebRobLsbLebRebRcbLobRsbRobLebLgbRjbLebRebRobRebLobLcb
LcbLebRcbLebRcbRobRibRobLobRobLhbLobLcbRcbRebRobLcbRobRobRobRebRgbRebR
obLobLcbRobRebRibRebRsbRcbLobLibRebLgbRcbLhbRcbLobRobRebLcbRsbRcbLobRe
bRobLsbRobRebLcbLobRebRibLcbRcbLhbRobLgbLebLcbRhbRobRobRcbRcbRcbRobRob
LgbRebRsbLobLcbRibLobRebRobRobLobRebLjbRhbLsbRebLobLobLibLobLobLebLobL
ebLsbLcbLgbRcbRobRcbRobRobLibLibRobLcbRob

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 14; Drug: OSU6162 1 然 Apo 50 然
bsbsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 15; Drug: OSU6162 1 然 Apo 50 然
bRebRobRobRobLsbLebRobLobRobLsbLobLobRobRcbRobLsbLjbLebLebRebRobRsbLgb
RobRobLcbRobRebRcbRebLsbLcbLcbLgbLobRebLebRsbLebLobRobRebLsbRobRcbLcbR
obRobRjbLebLobRsbLobRobRobLobLobLebLcbLcbRsbRobLobRebRcbRobRobLobRcbLe
bRgbLjbLobLsbLebLobRjbLcbLebLobLibLobLgbRebLebRobRsbLebRobLsbLobRibRob
RebLebLebRjbLobLobLcbRcbLebRobLcbLgbLobRobRcbLebLobRcbRobLobRsbLebLobL
gbRsbLgbRsbRhbLebLobRobRgbLobRsbLobRcbLjbLebLobLobRebLebLhbLsbLobRebRg
bLsbRebRebRobLobRebRobRsbRobRebRsbRobRsbLebLgbRobLcbRcbLobLcbRobLobRob
RcbRjbRobLebRibLobRsbRcbRibRobRcbLjbLobLobLobRobRebLcbLcbLgbRsbRibRibR
obLibLobRobLobRgbLjbRebRcbLobRcbRobLobLsbRcbLsbRebRebLobRobRcbLobLsbLo
bRcbLobLjbRobRebLobLobLobRobRobRhbRgbRobRebRgbRobRobRcbLobLibLgbLsbLeb
LcbRobLibLobLebRobLebRobRcbLobRcbRjbRobRobRibRsbRobRebRobLobLobRsbRobR
ebRobRgbRobLcbRcbLibRobRcbLobLcbRebLgbRebLobLsbRobRcbLgbRobLebLobLobRo
bRobRebLgbLobRobRebLgbLebLebLobLhbLhbRebRobRcbRcbLobLcbRibRcbLgbRebRcb
LebLibLcbRobRebRobLgbLobRobRgbRcbRibRebRcbRibLobLobLobLobRobLibRobRcbR
obLcbRobRcbRobLobRebRcbLebLobLobRibLgbLcbLobLcbLobLcbLobLobRobRsbLcbLe
bRibLobLebLobLibRebLcbLgbRcbLobRobRgbLebRcbRgbRebLobRobRobRebLobRobRob
LcbRgbLcbRebRcbLgbLcbRcbLobRebRcbLobRebLobLcbLobLobLibLobRcbRebRibLebR
ebLebLebLcbLcbLsbLhbRobRobRobRcbLcbLebRebRobRobLobLebLobLjbRcbRobRobRe
bRebLcbRcbLcbRcbLebRobLcbLgbLobLobRobLjbLcbRebRebRobLebRcbRsbRobLsbReb
RcbLibRsbLcbRebRcbRsbLobRobRcbRcbLcbLebLcbRebRobLobLebLsbLebLobLebRobL
ebLgbRcbRobLcbLobLobRibLobRobRobLobRobLobRebRjbLcbLobLobLebLcbLobLgbRo
bLcbRjbLobRcbLcbLcbLobLgbRcbLobRebRobRhbRebLobRebRcbRebRobLobRcbRobLcb
LobRebRcbLobRibLobRcbLhbLobRebRsbLhbLsbRgbLibLibLobLobRibLgbRobRobRobR
cbLobRobLsbLobLobRibRibLcbLobRgbLobRobLgbLobRobRcbRobLsbLobLhbLobLobRo
bRibRebLobLibRgbRebLebRebLsbRobLjbRebLobRobRobRobLobLibRobLcbLsbLobLeb
LcbLobRobLcbRcbRobLobLebRsbRibLebLebRobRobLcbLobRobLsbRobLebRcbRibRcbL
sbRobLobLcbLobRebLhbRgbRibLcbRobLcbRhbRobRgbRobRebRcbRibLobLcbRcbLhbRo
bRgbRobRobLebRsbRobLobLebLibLobRobRsbRobLobLobLebLgbRsbRobLobRcbRgbRib
RobLcbRibRhbLobRebRcbRcbRebLebLcbLebRebRobLsbLobRobRsbRsbRcbRibRebLebL
cbLobLobLcbLobRebLgbRcbLebRobLobRobRcbLebRobRobRibRebLobRobLibRcbRebLo
bLcbRsbLebRobRobLebRobRcbRgbRobRgbLebRobLobRobRcbLibLobRebRobRobLgbRob
LebLobRgbLebRobRobLcbRsbLobLibRobRsbLsbRobRebRobLgbLebRebLsbLibLcbLobR
cbLgbLjbLobRsbRobLgbLcbRobRcbLcbRobRobRobLobLobRhbRcbLebLcbLobRcbLobRe
bLobLcbRobLobLcbLobRjbRobRsbLsbLebRebLibLobRobLebRebRcbLebLebLobRobRob
LebLobLcbLebLobRobRcbRobLobLobRobRobLsbRebRcbLsbRebLobRobLsbLobRcbRsbR
obRsbLgbRcbRebLsbRsbRebRsbLcbLobLgbRobRebRebRcbLobLobLebRebLebLsbRsbRs
bRobLebRebRobLhbRebLobRcbLebLobLobLcbRobLsbLebLebLsbLobRcbLsbRjbLjbRsb
LsbRobLobRebLsbRebRobLobLjbLcbLjbLebRsbLcbLjbRcbLobRsLsbRsbRsbLsbRobRs
bLsbRobRjbRjbLsbLsbRsbRobRcbLcbRsbLjbLsbLsbRebRsbRjbLsbRcbLobRsbLsbReb
RcbRsbLsbLsbLjbRobLobRsbLobLebLebLebRsbLcbLobRjbLsbRobLsbLebRsbRsbRsbL
sbRsbRobRebLsbRsbLsbLobRebLobLeb

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 16; Drug: OSU6162 1 然 Apo 50 然
bRjbRebLjbLobLebLcbLebRsbRcbLjbRebLebLobRebRobRjbRebRebLobRcbLobLebReb
LjbLobRjbLcbLobLobRcbLobRjbRjbRobRobRobRobRebLebLcbLcbRjbRcbLjbLobRgbL
obLobLhbRibLobLgbRobRobLgbLcbLcbLebRobRibRobLcbLobRcbLcbRebRcbRobLgbRo
bRcbRebLsbLebRebLobLobLebRcbRibRobLebLgbLobRcbLcbLobRebRebLhbRibRibReb
RebLobLcbLebLobLibRobRobLcbLhbLcbRebLobLgbLebRjbRobRobRobRcbRcbRobRsbR
cbRobLgbRebRebLebLobRebRobLobLebLcbLgbLcbRobRebLobRebLgbLobLibLsbLgbLc
bRebLcbRcbLibRobRcbLobRobRobRebLobRobLebRobRebRcbRobLjbLcbLsbRibRebRob
RebRobLobLibLibRebLibRcbLebRobLobRsbRibRobLgbRobRebRebLobLobRebRibRgbL
sbLobLcbRebLobLcbLebRhbRcbRibRobLcbRobRibRcbRcbLibRibLebRsbRobLibLcbLo
bRobLgbLibLebRobRcbLobLebRebLobLebLjbRobRobLcbLobLobRobRebRibRebRobRgb
RhbRgbLebLobLebRgbRebLgbLobRebLobLcbLcbLsbLebLobRebLebLcbLgbRobLcbLcbL
cbRsbLebRibLobLjbRobRobLebRebRobLebLcbLobRebLobLobLobLcbLobLobLobLobRe
bRebLebLibLobLobLcbLcbRibLcbLobRcbRgbLibLobLobRcbLobRcbRobRgbLebRcbLib
RobRgbLcbLebRibRcbLobLobRobLjbLgbRsbLibRibRobRcbRobLcbRcbLibLobRobLhbL
ebLcbLobRcbRebRobRsbLobRcbLcbLebLobLcbLobRgbRebRebLobLcbRcbRobLsbLebRc
bLobLcbRhbLsbLebLebLcbRebRobRjbRobLobLebRcbLcbRsbRobRebRebLsbLgbLebRcb
LebLebRebLebLcbLgbLibRgbLibRibLobLebRcbRebRobLibRebLcbRobRcbRgbLebLobR
obRobRcbLobLobRobLobLgbLobRobRibLobRibLhbRobRobLebRobLobLobLjbRcbLcbLi
bLobLibLebRibRobRobRcbRcbRobLibLebRcbLebRgbLsbLobRsbLcbRibLobRcbLobReb
LobLobLobLobLobLobLgbRsbRobLgbRebLobLibRgbRebLobRobLobLobLgbRsbLebLobR
obLjbLebLebRobLibRobRobLebRebLobLebLsbLcbRebLobRcbLgbRobLcbRebLjbRebRe
bLcbRobLibLebLjbRobRebLobRibLobLobRobRobLhbLobRobLobRobRcbRobLcbRobLob
LebRebRcbLobLebRcbRcbLcbRobRsbLobRobLobRhbLebRebRebLobLgbLcbRobRibRobL
ebLebRobRobLobRibLebRobLobLhbRobLcbLgbRcbRhbLobLobRobRcbRibLhbRcbRobLe
bRobLebLsbRcbLebLobLobLobLobLcbRgbRcbLsbRobRebLobRobLobRhbLibRobRebLcb
LobLebLebLobLebLibLebRobRobLebRcbRcbLobRcbRobRcbLcbLebRobLebLobLcbRcbL
obRobRcbRcbRobRcbLobLebRgbRcbRobLobRebLebLibRobLobRebRobLebLobRobRobRo
bRcbRebRebRobLsbRebLibRobRgbLebRobRcbLgbRobRobRebLcbRobRobLhbRebLebLob
LebLobLcbRobRobLebLobRibLcbLsbLcbRcbLebLsbRibRibRsbRobLobLebLobLebLgbR
ebLcbRibLcbLobLobRebLcbLcbRebLobRibRhbRobLobLobRcbRebLgbLobRobRobLobLo
bRobRcbRebLsbLobLgbRebRgbRgbRcbRobRebLobLobLibLgbRcbRebRobLobRebRobLeb
LobLobRibLsbRobLibRebRobLobLibLsbLebLhbRebRgbRsbRobLebRibRebRobRobLibL
obLebLibRobLobRebLobRobRibRobRhbLobRcbLebLcbRsbRobLebLobLcbLibLobLebLo
bRebRcbRcbLcbRsbLcbLobLobRebRebLobLibLobRobRobRobRebLobRobRcbRcbLibRib
RibLobLibRcbRebLcbRebRsbRibRebRcbRebLibRobRobRcbLobLobRcbRobLcbLebLebL
cbLcbLobRobLebLobLebLebRcbLobRobRgbLobLgbRcbRebLobLebLsbRcbLcbRcbLcbRh
bRibRobLhbLibRobLgbRobRobRgbRobLobRobLhbRobLobRcbRibRgbRobLgbLibLhbLgb
LobRcbRebRobRebRhbLcbLebRobRebRobLobRibRobLobLcbRebLobLebLgbRobRobLobL
gbLobRobRobLobRebLobRcbRcbLcbLobLobRobLobRobLobRebRobLebLobLobLobRcbLo
bRcbRsbLjbLcbLobRobRcbLebRgbLebRsbLgbRgbRibRebLibRobRobRobRsbLobRebReb
RsbLibRgbRobRcbLobRebRobLobRobLgbLobLgbLcbRcbRebLobRcbRgbLobLhbRobLebL
ebLobRcbLsbRobRgbLgbRobLibRibRcbRobRgbLcbRcbRobRebRebRibRobLgbRobLsbRc
bLcbLebLebLibRcbLgbRebLgbLibLjbRobLgbRcbLobLhbRebLcbRgbLebLcbLibRobLob
LgbRobLebRibRcbLcbLibLobRibRhbLibRobLib

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 17; Drug: OSU6162 1 然 Apo 50 然
bLjbRjbRibLobLobLsbRhbLcbRcbLhbLobLcbLobRjbLibRcbRobLobLsbLobRobRobLob
LjbLobLcbLebLjbLcbRgbLcbRsbRobRebRsbLsbLobRsbLibLibLsbLobRcbRcbLibRobL
obRcbLobLhbLcbRobLobLcbLebLgbLebRobRcbRcbLebRcbRobRjbRebRobRobRcbLcbRi
bLebLobRobLjbLobLobLobRjbRebRebLebRcbRsbLobRcbLebRcbLebLobRcbRhbLobLob
LhbRibLcbLobRobLobLebLcbRibLobLebRcbRobRobLcbRobRobLhbLcbRebLcbLebLcbL
cbLebLgbRcbRobRibRobRhbLebRgbLcbRobRcbRobLgbRobLcbLebRcbRobLebLebLjbLg
bLibRobLcbRcbRebRobRcbLobRebRcbLobRebRebLcbRobRobRobLobLobRebRobRgbReb
RibRebLibRebRsbLobLibLcbRcbLebLsbRebRobRcbRebRcbLebRcbRcbRobLibRobLobL
cbLobLcbLobLebLcbLcbRobLsbRobRebLebLebLcbLobRebLobLobRobRobLobLebLebLi
bLebRobRobRibRgbLsbLjbRobRsbRobRcbLibLebLibLsbRjbLobRebRobRjbRhbRibLeb
RcbLhbRobLobLebRobRebLebRibLhbRgbRcbLebLibLebLobRobRobLobRobRjbRcbRobL
obLcbLebLobRobRobLobRobRibRgbRobLobLcbRobLsbLobLsbLobLhbRebLgbRhbRobRc
bRhbLobRcbRcbLebLibLobLcbLobLebRcbRgbLsbLhbLhbRebLsbLebLebRcbLcbRgbLob
RobLebLebRcbRebRobLsbLsbLibRobLobLobRebLobLebLebRebLgbRgbRobRobRibLgbL
ebLobLcbLebLgbLibRobRobLcbLebLobLobRobRgbLebLobRobLobLobLebRebRgbLcbRi
bLcbRobLobLibLobRcbLibLobRibRobRobRgbRobLobLcbLobLibRobRcbLibRobLcbRob
LobRobRobRobLcbLobLebRsbLgbLcbLobLcbRcbLobRgbLebLcbLcbLobLibLsbRobRobL
obLebLcbLcbRgbRcbRobRebRgbRibLebRobRobRobRobRobLobLibRobLgbRebLobLgbLo
bRebRgbRobRhbLebRobLgbRebLgbLobLhbLobRobLibLobRebRobRobRobRobRebLobLcb
LobLobLsbRebLgbRobLcbRobRcbRobRgbRobRcbLcbRebLcbLcbLhbRobRebLebRobLobR
ebLsbRobRobLgbLebRobRgbLebLebLobLibRsbRsbRsbRobLcbRobRobRebRcbRibLcbLo
bLobRsbLebRobRobRebRobLobRobRebRobLobLebLcbRobRobLebLebRibRjbLjbLobLob
RcbRebLsbRjbRebLobRjbLsbLebRcbLobRobRebRsbRebLsbLjbLjbRebLjbLebRjbRobL
jbRsbLobLjbLobRcbLobRobLgbLobLobRsbLebRgbLobLobLgbLcbLobRobRobRebRebRo
bRobLobLobRebRobLobRhbLebRgbRibLcbRebLebRobLobRebLgbLebLebRobRebRsbLib
RebRsbRjbLsbRcbRobLobRibRgbRcbRobLcbLcbRobLsbRgbLobLibLjbLibRobLjbLsbR
obRebRebRebRobLobRobRsbLjbRjbRjLsbRcbRjbLobLebRsbRsbLsbLjbRebRibRebRsb
LsbLobLsbRsbLsbRobLebLobRjbLibLobLebLebLcbRsbLsbLjbLsbLsbRebRobLebLobL
sbLjbRobRsbRjbLsbRsbLsbRjbLobLebLobRobRobRjbLobRobRebRobLjbLobLcbLobLc
bRsbLebRebLebRsbRsbRebLebLsbRsbRebRebLjbRebRebLobLebRobLebLobRobRsbLeb
RobLjbLebRebRobLsbRcbLobLsbLebLobRjbRobRebLobLobRebRsbLcbLjbLebRebRebL
sbLjbRjbLcbRebLobRjbLhbLobLebLcbLobRebRjbLsbLebLobRobRsbRgbRcbRebRebRe
bRebRcbRobRebRobRebLobLobRebRjbLobRcbLobLcbLobLsbLgbLobRebLobLjbLobRjb
RobLsbRebLobLjbLjbLebLcbLjbLobRsbLjbRjbLjbRcbLobLibRcbRibRobRobRebLobR
ibLeb

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 18; Drug: OSU6162 1 然 Apo 50 然
bsbRsbsbsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 19; Drug: Control Apo 50 然
bsbRjbLsLsmbRobRebLsbRebRjbLebLsbRsbRjb

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 20; Drug: Control Apo 50 然
bsbsbsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 21; Drug: Control Apo 50 然
bRsLsbLsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 22; Drug: Control Apo 50 然
bLsbsbsbsbsbsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 23; Drug: Control Apo 50 然
bLjbRobLjbRobLebLjbRsbRebLeRobLobRebLeRsbRsbLibRobRhbRebRobLsbRoLobReb
LgbRobRhbLsRebLobLebRobLcbRobRobLcbLobRjbLebRobLobLcbRebRobRebLcbRsbLc
bRhbLobRobLebRsbRobRcbRcbLgbRobLsLobLcbLibRsbLobRcbRsbLcbLebLobLobRebL
sbRobLsbLobLcbLobRjbRobRcbLebRobRebLjbRobLhbLebRebLjbLsbLebLobLsbRobRo
bLjbLsRsbRobLobRibLebRobLcbRcbRhReRgbLcbLebRobLjbRgbRobLjbLoLcbRobLobL
obLsLebRebLcbRgbRobLoLobRsbRibLibRobLcbLcbRobLobLjbRsbLobRobLcbRobRobR
jbLobRibRjbRobLoLsmbRsbRcbLebLobLjbLiLsbRsbLsRsbLsbsbsbLsRsbsbsbLsbRsb
RsbRsLsbsbRsbsbLsbLsRsbRsLsbsbsbLsbRsbsbRsRsmbLsRsbsbLsbLsbRsbRsLsbsbs
bLsbRsbLjbsbsbsbsbsbLsRsbRsbRsbRsbLsRsbLsRsbLsbRsbsbsbRsbRsbRsbsbsbsbL
obRsbRsbLsLsmbRsbRsbsbsbLsLsmbRsbRsbsbLsbRsbLsbsbRsRjbLsbRsbRsbsbLsbRs
bsbsbRjbsbRsbRsLsbRsbLsbRebRsbLsbLsbLsbRsbRsbLsbsbLsRsbLsbsbRsbsbsbLsb
RsbRsbRsbLsbLsbLsbsbLsRsbLsbLsbRsbLsLsmbsbRsLsbLsbLjbRsbsbLjbsbRsbLsbL
sbLsbLsbRsbRsbRsbsbLsbRsbsbRsbsbLsLsmbRsLsbsbLsRsbLsbLsbRsLsbRsRsmbsbR
sbsbRebLsbsbLsbLsbRsbLsbsbsbLsbsbRsbsbsbLjLsmbRsLsbLsbsbRsbLsbLsbRsbLs
bLjbsbLsbRsbsbLsbRsbRsbsbRsbLebLjbLsbLibRsRsmbLsbsbLsbRsLsbRgbLebsbsbR
sbLsbRsbsbLsbRsRsmbRsLsbRjbRobLsRebLjbLsbRsbRsbLjbRebLsbRsRsmbRjbLsRsb
LebRsbsbLsbLoRobReRsmbLjbLsbLsbRsbLjbRsLsbLjLsmbLsbLebLsbLjbRobLsLsmbR
ibLobRebRebRjbLcbLebLsbLebRebLsbLjbLobRebLobRjbRjbLobRobRsbRsRsmbRobLg
bRibLhbRjbLobLibLobLgbRebRebRebLobLobRobLebLcbRhbRsbRebLebRgbRebLsbRsb
LobLibRsbRebLobRebLibRobLobRebRebLobRobRibRebRobRcbRobLobRobRobLobLebR
cbRobLgbLobRgbLobLgbLcbLebLgbRsbRobLcbLobLgbRebLebLobLobRobLobRgbRcbRe
bRhbRcbRebLobLebRebLobRobRebLobLgbLcbRobLobRobRgbLobLobRebLebRobRobLob
RobRobLebLebLobRobRcbRebRsbLcbRobRsbLebLobLobRobLcbLsbLebRsbRibLebLebR
obLcbLobRsbLjbRjbLobRobRjbRjbLibLobLebRobRebLibRgbLjbRobRobRjbLcbLebLo
bLsbRsbLobRebLobLsbRjbLebLjbRgbLcbLobRobLcbLobLobLebLsbRobLebLobLobLjb
LcbRobLebRebRebRsbLobRebLebRebRsbLsbLobRsbRobLobLjbLjbLjbRebLobLsbRobL
ebLobRjbRsbRsbRebRobRjbLcbLsbRsbLjbLebRsbRsbLjbLjbLsLsmbLsbRsbRjRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 24; Drug: Control Apo 50 然
bLsbRsLsbLsLsmbLsbLsbLsbsbsbLsbRsbLsRsbLsbRsbRsbLsbRsbLsbRsbRsbLsbsbLs
bLsRsbRsRsmbLsLsRsmbRsLsLsRsmbLsbRsbRsbLsRsLsRsbLsbRsbRsLsbLsbRsRsmbLs
bLsRsRsmbsbLsLsmbRsbLsbsbLsbRsbRsLsbRsLsLsmbRsLsbLsbRsbLsbsbRsbLsbRsRs
mbLsbLsbLsRsbLsRsbLsbRsbRsLsbRsLsbRsLsLsmbLsRsbLsLsmbLsLsmbLsbRsbLsLsm
bRsbRsRsmbLsbRsLsbLsbLsbRsLsRsbLsRsbLsLsmbLsbRsbLsbRsbLsbLsRsbRsLsRsbR
sbLsbLsLsmbRsbRsLsLsmbRsLsLsmbLsbRsLsbRsbLsbLsbLsbLsbLsbRsbLsbLsRsLsRs
bLsRsLsbLsbLsbRsbRsbRsbRsbLsbLsbRsbRsbRsLsbRsLsbLsLsLsmmbLsRsRsLsmbRsL
sRsbRsbRsLsbLsbRsbRsbRsLsRsbLsRsbRsbRsbRsbRsRsmbLsRsbRsRsLsRsmbLsRsRsm
bLsRsLsbLsRsbLsRsbRsbRsbLsbRsRsmbRsRsmbLsRsbRsRsLsmbLsLsmbRsLsRsbRsLsR
sRsmbRsbLsbLsRsbLsbRsbRsbLsbRsLsLsmbLsbLsbLsRsLsRsLsRsbRsRsRsRsLsmmmbL
sRsRsmbLsLsmbRsLsbLsLsRsLsmbLsLsRsRsmmbLsRsbRsRsRsmmbRsRsmbRsLsLsmbLsb
RsRsmbRobRsbLsbRsbRsbLsbLsbLsbRobRsRsLsmbLsRsbLsbLsRsbLsLobRsbLsRsLsRs
LoLsmbRsbRsRsmbLsbLsLsmbLsbRsLsbLsbRsbLsRsbRsbLgbLobRsLsbRsbRobLobLsbL
sbLsbRobLjbLsbRobLebRsbRobLobRsbRobRebRobRsbRjbRsbLebLsbRobRcbRsbLeRsR
cbLsbRsbRcbLsbRsbLobLsbLsRsRebLebRsbRebRebLeRebLebRsbLsRsbRebLcLsRsmbR
obRobLsRebRsbLsbLobLobRebRsbRsbRebLsbLsbRsRsmbRsbRebLsbLebLsbRebRsRobR
cLsbLebRsLsRobLobRobRebRobLobRobRsbLsbLsbLsLsRembRsbLsbRobRsbRobLsLsmb
LeLsRsbRjbLsbLsLsmbRobLeLsRsbLsbRsbLsbRsbLsbLobLobRobRsbLsbLebLjbRsbLo
bRsbRsbRsbRsbLsbLsbRsbLsbLsbRobRobRsbLsbLsbLsbLsbRsbRobRsbLsbRsbLgbLsb
RsbLgbLsRsbRobLeLsbRsbRobRebLobLjbRsbRobLsbLsbLobLobRoRsmbRsbLsbLsbRsR
smbRsbRsbRsbLsbRobRobRsbLsbRsbRsbRsbLsbLsbRsbRsbRsbLsbRobLsbLsbLsbLebL
sbRebRsbLsbLsbRsbLoLsmbLsbRjbRsbLsLsmbRsLsbLjRsbLsRsbsbRsbLsbRsbRsRsmb
RsbLsbLobRebLsbLsbRsbRsbRsbRjbLsbRobRsbRsbRsbRobLsRsbRobLsbLsbLsbLsbRs
bLsbRsbRsLsbRsbRsbLsbLsbLsbLsbRsbRsbLsbRsRsmbRobRobRsLoRsbRsbRebRsbLsb
RsbRsbRobLsbLsbLsRsbLsbRsLsbLsRsbRsbRsbLsbLsbRsbLsbLsbRsbRsbRsbLobRsbL
obLsLsmbLobRgbRsbRobLsbLobLsbRobLsbLobRebRobRsbLsLobRsbLsRsLsbLsLsmbRe
bRjbRsbLcbRsbLsbRsRsmbLsbLoLsmbLsRsbRsbRsbRsLobLsReLebRsbRsLsbLebRsLcb
RsLsbLsRsbLsbRsRsRsLsRsmmbLsbLsbRsbLobRsLebLsRebLobLsbRsbRebRgbLobRobL
sbLsbRsbRebRsbRebRobRsbRsbRobRjbLsbRsLobRjbLsbLsbLsbRcbLsbLsbRobLsbLob
RsbLsbLsbLsbLsbRsbLsbLsbRsbRsbRobLsbRsbRsbLsbRsbLobLsbRsbLsbLsbRsbRsbL
obLebLsbRsbRsbLsbLobRsbLsbRsbRsbRsbRsbRsbLsbLsbRsbRsbLsbRsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 25; Drug: OSU6162 10 然 Apo 50 然
bRobLebLhbLjbRcbLsbRebLebRgbLebLobLebLgbRcbRcbRsbLobRebRobLebRcbRsbLgb
LobRebLobLsbRgbLobRibRobRebLebLobLibLobLjbRhbRobLebLcbRhbRebLcbRobLibL
obLobRobLobLobLgbLibLobRobRobRcbLebLobRcbLebLobLjbRcbRgbRsbRebLebRcbRo
bLhbLebLobLobRobRgbLsbRebRebRgbRjbRobRobRhbLobLobLsbLobRcbLobLgbLobLob
LobRobRobRobRebLjbLcbLobLobLobRibLcbRcbRjbRebLibLebLibRsbRhbLjbLobRcbR
cbRebRobRobRobLgbRobRibLjbLebLebRjbRobLobLebLebRobLebLcbRgbLobRobLgbRh
bLsbLebRobLebLebRcbRgbRobRobLebLobLobLcbLebRobLjbLebRobRobLobRcbRobRob
LobRcbRcbLobRjbRobRobRobRcbLobLobLjbLobRebRsbRobRcbRibLobRobLebLobRebL
obRobLcbLcbLjbLhbRcbLobLobRibRobLcbLcbRcbRcbRcbRsbRjbLobLebRebRobLobLg
bRcbLobRebLsbLsbLobLebLsbRhbLobRcbLgbRgbLsbRjbRsbLibLobLobRobRobRebLhb
LcbRobRebLebLobRobLibRjbRebRobLebRobRobRhbRobRebRobLobLebRobRebRebRobR
cbRibLobRsbLibRjbRcbLebLgbRcbRibLobLebRhbRhbRcbRobLobLgbLebRobRebLobRo
bRobLcbRcbRhbRsbLcbLibLcbLgbLibRcbRgbLobLobLibLgbRobRebRsbRibRobLobRib
RgbLsbLobLsbLcbLjbRgbRobRobLobLhbLobLjbRcbLsbLobLebRcbLebRebLobRebRobR
sbRobLcbLjbLcbLobRobRobLobRibRobRsbRobRibRobLsbRibRsbRjbRgbLobRcbRobLo
bRebLobLobRjbRebLibLobLcbRobLebLobRgbLobRgbRcbLobLobRobRibRebLobLobLcb
LobRebLobLobRobRebLobLobRgbRobRhbRhbRsbRobRobLebLobLsbRgbRobRebLobLebL
cbRebLibLobLsbRebRobRebRcbLobLobRcbRobRcbLobLcbLgbRebRgbRsbRobRobLcbLo
bLobLhbLebLobRcbLgbRsbRobLobRibRobRcbRobLebLobLobLsbRhbLebLcbRebLobRob
LebRobRibRebLibRobLobRcbLjbLebRebRobLcbRobLobRebLobLobLebRobRebLgbLobR
cbLobLobLibLebLobLsbRobRobRobLibLobLobRgbLebRobLsbRobRobRsbLobLibRobRg
bLobRcbRcbLsbRebRebRobRcbLobLobLibLobRobRcbRobRjbRsbRobLobRcbLebRobRcb
RsbRcbRobRcbLsbRebRibLibLebRgbLobLobRobLgbRobLgbRgbRibRibRgbLibRibRobL
obLobRebLobLcbLgbLibLobLobLebLobLebRcbRobLibRcbRebRobRibRebLgbLhbRcbRo
bLcbLibLobRobRobRgbLebRcbLebLcbLobRebRgbLobLebLebRebRobLibRgbLobRobRob
RibRibLcbLcbRebRebLibRhbRebRibRgbLcbLebRebLebRebLobLebRcbRobLcbLobLobL
sbLebLgbLebRsbRobLobLobRebRobRobRobLebRobRobLcbRjbLibLobRobLebLobLobLo
bLebLcbLobRjbLibLgbRcbLebRibRebLobRebRebLobLobRibLobRobRebRgbRebLobLjb
RcbLebLgbLobRobRebLibLebRgbRhbRsbLsbRobRibRibLobLobRobLebRobLebRcbRobR
cbRebRgbRobLobLcbLobLebRebRibRibRobLobLsbLobLebRsbLebLcbLsbRcbLsbLebRo
bRhbRhbRebLibLobRobRgbRobLibRobLcbRgbRcbRgbRhbRebRibRobLobRhbRebLobLob
RobRcbRsbRgbRobRobRebLsbLobRebRgbLebLebRcbRobRibLobLebLobLebRibLobRsbL
ebRcbRobRebLsbRobLibLcbRobLobRebLobLcbRhbRebLgbRobRibLobLobRebRobLobRi
bLobLobLsbRobRobLobRebRsbRobLobLobRcbLibRobLobRobRebLibLsbLebRebRsbLob
LobRobRsbLobRebLobLebRobLhbLobRcbRobLcbLobLebLcbLobRsbLebLgbLgbLcbLobL
cbRcbLobLebLibRobLobRobLebRcbRcbRebRibRhbLebRcbRcbRobLebLobRebLobRcbLo
bRhbLibRobLobLobRobLobRobLobRebRebRebLcbRobLsbRibRebRobRobLebRebLobLob
LcbLebLcbRobLobLobLobLobLobRebLebLebRibRcbRobRibRobLebLobLcbLhbRibRebR
gbLobRobRibLgbLebLebLobRcbLhbRebLcbLobLgbRobLobLebLebRebLobLhbRibRcbLo
bRobRibRobRobRhbRobRgbRobLebLgbRebRobRobRibLobRebRhbLsbLobRebLgbRibReb
RobLobRgbRsbRcbRebRobRebLhbRebLibRebRobRebLobRsbRhbRebRebLobRebRcbRobR
cbRebLcbRobLebLcbRobRjbLobRibRebLebRcbLobLebLcbRobRcbRcbRcbLcbLcbLsbRc
bLobLobRebRibLebRhbRgbLobLcbLebLgbRobRobRobLgbLobRgbLobLebRobLgbRibRcb
RobLcbLsbRobLcbLcbRobLobLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 26; Drug: OSU6162 10 然 Apo 50 然
bsbRsLsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 27; Drug: OSU6162 10 然 Apo 50 然
bLsbRsbRsbRsbLsbLobRebRsbRsbLsbLobRsbRjbRebRjbLobRjbLebRjbRjbLsbLebRob
RobRebRsbLgbLebLsbRebLebLobRsbLebLsbLjbLsbLebLcbLobRebLebRjbRsbLsbLjbL
jbRobLebRobLjbLebLjbRcbRsbRcbRobRsbRsbLebLobLobRebLjbRobLjbRobRobLobLc
bLobLjbLobRebLobRebLjbRibLobLobLcbRobRebLjbLsbRcbLobLjbLebLobLobLjbRob
RebLcbLsbLsbLjbLebLob

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 28; Drug: OSU6162 10 然 Apo 50 然
bsbsbLsbsbRsRsmbLsLsmbRsLsRsLsbsbLsbsbsbsbsbsbRsbsbsbsbsbsbsbsbsbsbsbL
sbsbsbsbRsbLsbRsRsmbLsbRsbRsLsbLsbsbsbsbsbRsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 29; Drug: OSU6162 10 然 Apo 50 然
bLcLsmbLiRsbsbRsLsbRsLsRsbsbLgbLcbLcLsmbLgbsbLcLsmbLiRsbLsbLibLgbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 30; Drug: OSU6162 10 然 Apo 50 然
bLobRobRjbLsbRsbLobLjbRobRsbRebLebLjbRsbLebRobRgbLebRobRcbLsbRobRjbRsb
RobRibRebLobLobLobRobLgbRibLobLjbRebRobLobRcbLjbLsbRsbLebRebLobRsbRsbR
ebRjbLsbRjbLjbLsbRibRobLobRjbLsbLsbLebLobLebRobRebLobRcbLebRobRsbRobLi
bLoRsbLebRcbRobRcbLobRobLobLebRebLjbRobLebLjbReRsmbLebLebRobLobRobLsbR
jbLobLobLobRsbRobLobLebRgbRebRobLebRcbLebLcbRobLobRgbRebLebLobRebLsbLo
bRsbLebRsbLibLobLsbRobLobRobLobRjbRebLebLsbLgbRcbRebRebRobRebRobRsbLob
RobRobLobRobLsbRsbLjbLobLebLjbRjbRebRsbRibLjbLjbLobRsbRcbLebLibLobLobL
obRibLsbLebLcbLjbLobLhbRobLobLobRobLobRibLobLgbRebLobRsbLsbLebRsbLobRe
bRsbLjbRsbRobRobLebLjbRobRobRobLobRebRsbRhbLobRebLsbRobRobLobRebRobRob
LobLobRjbRobLsbLcbRobRjbRcbRibLcbLobLibLebLsbLibLobLobRebLebRebLjbRebL
obLibRebRcbRsbLsbLobLcbRsbLebRobRebRobLobRcbLcbLsbLebLobRibLobLcbRcbRe
bRebRjbRibRobRebRsbLsbRebRibLjbRobLcbRebRebLibRibRobLgbRsbRebRibLobLeb
RcbRobLibRcbRjbRsbRjbLobRebRcbRobRgbRebRgbRjbRebRobRcbLgbRcbLebLobLobL
obLjbRobRobRebRobRobRobRobLhbRcbLebRobRobRobLobRcbLebRsbRobLobRebLsbLo
bLcbLjbRsbLsbLebLebLsbRebLibLjbRebRebLebLobRobRcbLobLobRjbLibLebLsbLcb
LebLsbRhbRobRebRobRobRebRcbLobRobRobLjbLcbRobLibLcbLobRgbLcbRsbLjbRobR
ebLebRebRebLsbLobRobLobLsbRebLcbLjbLcbRobRgbRebRibRobLobLobLobLibLebLg
bLcbLcbRebLebLobRsbLobRobLebLjbLibRebRobRgbLobLobRebRibLcbRebRebRibRob
LebLebLsbLobRebLhbLcbRibRobRcbRibLebLebRibRobRobRibLebRsbRsbRobLobRobR
obLobLsbRcbLjbRebRjbRcbLobLobRcbLebLebRjbLobLcbLjbRobRhbRebRobRhbRobRo
bRibLibLobLebRobRobRebRibLcbLgbLobLobLebRcbLobRebLobRcbRibLebRebLobLob
LjbLebRgbLobRobRebLebRhbRgbRebLcbLebRsbRebLobLcbLibRobLobRebRebLebLibL
obLcbLebRobRebLgbRobRobLobLobLebRobLsbLebLebRebRebRobRebRobRobRgbRcbRs
bLobLsbLjbRebLoRsbRsbRebRobLobRebLcbLobRibLcbRsbRobRsbLgbRebRebLgbRcbL
hbRebLcbRobRsbRsbRibLcbLobRobRobRjbLobLobLobRebRsbLebRibRgbRjbRobLobLs
bLsbLcbLgbRsbLcbRebLsbRebLjbLcbRebLobRsbLebRsbRgbLobRebRebRgbLgbLobLsb
LobRobRobLobLobLsbLobLcbLsbRsLebRobLsbRobRobRjbRsbRobRebLebLjbLeLebLsb
RsbRsbLobLebLcbLebRobLsbRoRsmbRobRsbLsbRcbLobLebRebLebLobRjbLebLoRsbRg
bLoRsbRobLobLsLcbRsbLobRcbRsbLoRsbLsLobLoLsmbLsbLsLebLsLsmbLsLsmbLsRsR
smbRsLsbRsLsbRsbLsbRsbRsbRsbLsRsLsbLsbRsbLsRsbRsbLsLsmbRsbLsbRsbRsRsmb
RsbRsbLsbLsbLsLsLeLsmbRsLsLsmbRsbLsbRsRsmbLsRsRsLsmbRsbRsLsbLsLsLsmmbL
sLsmbRsRsLsmbRsbRsbRsbLsbRsLsbLsbRsLsbRsbRsbLsbLsbLsLsLsmmbRsbRsbLsbLs
bRsbRsLsLsmbLsbRsbLsbRsbLsbLsbLsLsmbLsbRsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 31; Drug: OSU6162 3 然 Apo 50 然
bRgbLobLobLgbRcbLobRobRcbRebRcbRebRobRebLcbLebRobLobLebLgbLebRibRobRob
LgbRebRobRcbLcbRcbRebRebLebLebLobLobRcbRgbLcbLgbRebRobRibRebRgbRobLsbR
obRcbRsbLobLcbLobRobLobRcbLebRebRcbLebLcbLobLobRsbLobRsbLebRcbRebLsbLg
bRobLebRjbLcbRobLebRjbLcbLgbRobRebLobLobRgbLibLobRobRcbRobLsbRebLebLeb
LobLebRobLobLibLebLebLibRibRcbRobLjbLobRobRebRsbLobRsbLobRebRcbRobRebL
obRibLhbRibRsbRobRobRobRebLgbRobRobLebRobLjbLobRcbRobRobRibRobRsbRcbRe
bRebLobLjbLobRobRobRobRgbRibLhbLhbRebLjbLebLobRcbLobLobRibRebLebRgbLob
LgbLibRobLebRcbRgbRobLebLcbLibRobRebLcbRgbLobRobLcbLebLebLebRebLgbLobL
obRcbRobRobLobLobLjbRobLcbRebLhbRobRobLobRobRebRcbLobRobRcbLibLobLebRo
bLibLgbRobLibLobLcbRgbRhbRibLobLebLcbLobLibRobRobRhbLgbLsbRebLobRebLeb
RhbLebRobRhbLebLjbRcbRebLibRobRobLcbRgbRobLobLsbLobLobRobLobRebLobRgbL
ebRebLobRobRcbLibRebLobRcbLebLebRibRibRcbRsbLibRcbLobRcbRebLobRcbRcbLg
bRobRobLobRobRsbRobLgbLgbRobLebRhbLobLgbLibLobRcbLebRobLobLobLibLgbLob
RebLobRobRsbLgbLcbLcbRobLobLcbLsbLobLobLcbLobLcbLobRobRobRsbLobLebLhbR
jbRobLobLebLibLebLcbLobRcbRobLebLobLobLobLobRobLebRsbLobLgbLobLebLcbRe
bRobRsbRobRobRebLcbLhbRcbLobRebRcbLhbLcbRsbLsbRebLibLsbRebLobRobRgbRob
LsbLobLobLsbRcbLsbLcbRobLibRibLobLobLobRgbLebRobLobRgbLobRobRobRibRgbR
obRibLobRobLibRebLebRgbLebRobRcbLobLobLebLobLobRobLebRebLgbLobRsbLobRo
bLsbRjbRobLsbLobLobLobRobLobLebRcbRobRebRcbLgbLcbLcbRobRobLobLobRcbLjb
LcbLobLibRobLobLibRobLibLhbRsbLebLobLibLcbLobLsbRibLhbRcbLobRobLobRibL
ibLgbRobRebRobRobLobRibLobLobLgbLobRcbRobLcbLibLebRhbRobRobLobRebRcbRo
bRobRcbLcbRgbRgbRebLebRebRobRcbRibRcbRebRobLebLobRcbLobLcbLobLgbRebRib
RcbLcbLhbLcbRobRcbLcbLobRcbLobRebRebRobRsbLobLsbRcbLibLebRobRebLcbRebR
ebRhbRcbLobLcbLcbRobRobLcbRcbLobLebLobRibLobRobRobRebRebRebRobLebLcbRe
bRibLsbLcbRobLebRobLobRebRcbRgbRobLcbLcbLgbLcbLobLebLhbLibLobLobRobLob
LobRgbLcbRgbRobRibRgbRebLobRebRebRobLebRcbRgbRobLobRebLebRobRcbRhbRobR
sbLsbLjbRebLebRsbRebRhbRobLcbLobLobRobRobLebLsbRebLsbRgbRibRobLobRobRc
bRobRobRobLsbLobRcbRebLebLobRgbLebRobRibLibRobRobRobRcbLebLgbLgbRebRob
LobRebLsbRebRhbLcbLebLobRobRebRebRebRsbRebLebLcbLibRebRobLobRobRobLcbL
obLcbLobLobRgbRebRobRcbRobRcbLebLgbLebLsbRebRjbRebRobLobRobRobRobLsbRe
bLsbLcbLobRjbRcbRcbLibLcbRhbLobRobRobLeRobLebRobLobRobLsbLebRobLcbLjbR
obLebLobLsbLsbLebLebLebLebLobLgbLibLobRsbLebRobRobRobLobRoRebLebLobRsb
RjbRobLobLsbRobLobLebRcbLcbRcbLobLobRibRobRobRobLibLcbLibLobLgbRebLobR
ebRebRcbLibLjbLsbRobLjbRobRebLcbRjbLsbRebRcbRgbRgbLcbLgbRebLobRebRgbLe
bLsbLobRebRobRobRsbLjbLsbRobLsbRcbLcbLjbRobLebRibRcbLebLobLgbRjbLgbLeb
LcbLcbLsbRobLibRibRobLobLjbLjbRobRibLebLebLjbRebRobLebRobRebRebLebRebL
obLobLjbRcbRobRobLibRebLebRobLebRebLobLebLobRcbRobRobRjbLcbLebRebRcbRo
bRjbLobLebRebLobLebRjbLebLjbLebRobRsbLsbLjbLjbRibLebLobLebLjbRebRibRob
RebRebLsbRobLcbLebRjbLjbLebLsbRobRcbRjbRobRebRsbRcbLebRobRgbRjbLobLjbR
obRibRobLjbLcbLcbRcbRebRjbRobRcbLsbLobLobLjbRebLjbLjbLebLebLjbRobRjbRs
bLobLobLsbRebRobLcbRebRebRobRcbLcbRebLobLebLcbRobLebLjbLebLsbLebRsbLsb
LjbLebLobRobRebLebRebLsbRjbLebLobRsbRsbRobRsbLsbLcbRebRobLjbLebLobRcbL
obRjbRjbLebLjbLobLobRsbRebLobRebLobRebRobLebLsbRcbLobRjbRsbRebLjbLjbLo
bRebLobLjbRebLobLsbLjRjbRcRjbLebLsbLsbRcbLobRcbRjbRobRebRobLobRsbLsbRs
bLsbRobRjb

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 32; Drug: OSU6162 3 然 Apo 50 然
bRjbLsbLsRsbLobRoRsmbRsbRcbRibRjbRebRcLsbRibRsbRibRgbsbRgRsmbsbLob

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 33; Drug: OSU6162 3 然 Apo 50 然
bsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 34; Drug: OSU6162 3 然 Apo 50 然
bRsbsbsbLsRsbsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 35; Drug: OSU6162 3 然 Apo 50 然
bRgbRhbRibRebRsbLiLsbLsbLsbRgbRoLsbLsbReb

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 36; Drug: OSU6162 3 然 Apo 50 然
bRobRgbLcbLgbLobLobRsbLebLcbRcbRobLibRobRobLsbLobRebRcbLobLjbRsbRobReb
LsbRjbLibRobLobRgbLobRgbLibRobRibLebRhbLgbLobRhbLsbLobLobRobRebLcbLobL
cbLobLobRobRebLobRobLobLebLobLebLobRcbLobLobRcbLobLobRcbRibLobRcbLcbRe
bLobLebRobRebLgbLebRebRgbRcbRobRobRobLobLobLobRobLobLcbRobLebRobLgbRob
RobRebLobRobLobLobRgbRobRgbLobLobLgbRobLebLsbRobLgbRobRobRobLobLsbLobR
ebLhbLsbRobRobLebRcbLebLobLibLobRebRjbLebLebRebRcbLobRibRobLibLobLgbRs
bRobRobRgbRebRobLobRobLgbLibRcbRobRgbLobRobRobLcbLobRebRebLebLsbLobRob
RcbLobLobLobLobLobRebLebRobLsbRcbRgbRobLobLobLobLgbRobRobRebRgbLhbRgbR
obLobLcbRcbRcbRebLgbRgbRibRcbLobLobLobRebRgbRcbRobRsbRebRebLgbRcbLsbLo
bRebLgbRcbRebLibLobLgbRobRebLibLobRibLobLibRobLcbLobRobRobLebLcbLobReb
RsbRobRobRobRobLcbLibRibRcbRcbLobRobLsbLsbLobRobLgbLobRobLcbLobLobLebR
obLobLebRobLgbRobLgbRsbLobRobLobLebRobLibRebLcbRobLibLcbLcbRibRibLobRg
bRcbRobLobLcbRobLhbRibLebRobLcbRibRebLibRobLgbLgbRobLjbLobRobRobRgbRcb
RebRgbLebRobRgbLibLcbRebRobRebLcbRhbRebRobLsbRobRobLcbRebLebRobRebRhbL
sbLobRobLcbRebRgbLebLobLobRobRobRebLebRobLobLcbLibLebLobRebLsbLobRgbRs
bLcbRobLgbRebLebRobRobLibLobLibLcbLobRebLobRobLcbRebRibLobLcbLobRobRib
LobRgbLobLibLebRebRobLobRhbRobLgbRcbRcbLobLibLobRobRobRibRobLebLobRobL
obRcbRgbRobRebRgbLebLcbLsbLcbLsbRobLobLebRsbLcbLobRcbRobRobLobLobRobRe
bRcbRobLhbRobRobRibRobLcbLobLobRobRobLgbRobLobLibRobLobLobRibLcbLobLcb
LhbLebLebRcbLsbLobLobRobRobRobLebRebRgbRgbLebRgbLobRibLobLebLhbRcbLgbL
obLobLobRobRcbRebLebRobRcbRobRcbLgbRobRobRsbLobRobLibLcbLgbRgbLebLibLi
bRgbLobRsbLobLsbLebLebLebLgbRebRobLobRcbRebLebLibLcbRgbRebLcbRebRobLob
RebRcbLobRcbLobRobLobRobRgbRobLobRibLobLjbRcbLebRobLibLobLobRobRobLjbR
hbRcbRobRobRcbRobRebRcbRgbLobLebRobRcbRibLgbLibRibLobLobRibRgbRobRebRo
bLcbRobLhbRsbLobRobLibLebLjbLcbLcbLobRobRobRobLobRobLebRobLebLsbRebLeb
LobRobLcbRobLcbLgbRobLgbLibLobRhbRebRobLebLebRibLobLobRebLobRobRcbRebL
ebRebLobRebRjbLobLebLcbRobLhbRgbRebLobRhbRebLobRobLebRcbRgbRobLobLebLi
bLibRobLebRebRhbRebRobLgbRobRibLobRcbRebLcbRcbRebRobRgbRobLobRobLhbLob
RebLcbLobRebRhbLobLobLcbRgbRebRobRebLgbLobRcbRcbRobLobRobLgbRebRebLebR
obLebRebLhbRobLobLcbLsbLcbRobRobRsbLebRebRobLgbLhbRobLibLebRgbRibLebLe
bLobLgbLgbRobLobRobRobLcbLebRebLebRcbLobLebLobRebLobRobLobRebRobLobLeb
LsbRobLobLibLcbRobRebRebRobRibRsbLobRobRibRobLcbRhbLobLobRobLobRebRcbL
ebRebLebRgbRobRebLobRobRcbRobLebRobLobLobRcbRobLgbRcbRobRebLsbLcbRcbRo
bRobLobRgbLsbRebRsbLgbRobLcbRcbLobRobRcbRcbLebRsbRibRgbRjbLobRobRobRob
LobLebLgbRobLobLebRobLcbRebRebLebLobLcbLebRobRobLobLobRjbLobLsbRcbLgbR
jbRobLobLgbRebLsbLgbLibLgbLobLgbLcbLebRebLobLebRcbRobRcbLebLsbLobRjbLo
bLsbLsbRcbRebLebRebRobRebRcbLsbRsbRjbLebLjbRibRsbLcbLsbLjbRebLsbRebRsb
RsbLobLjbLebLobRgbLjLsmbLebRibLjbLsbLgbLcbLsbRsbLoRsbLcbRobRsbRsbLsbLg
bLsbRobRgbLebLsbLsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 37; Drug: OSU6162 1 然 Apo 50 然
bRcbLcLsLsLsmmmbRjbsbRsbLsLsLsLsLsmmmmbRsLgLiLsbRobReLsbRobRgRibLjbLcb
sbsbLsLsLsmmbLgLgLsbLgbRsbRcbLjbRebRcbLcLsLsmmbLibLsbLgbLsbLsbLsLsmbLs
LsLsLsLsLsLsLsLsLsmmmmmmmmmbLsLsmbLsRsLsbRcRebReRsmbRcbRsbLsbRsbLsbRsR
sRsmmbRgRsmbLjbLcbLsbLsLsLsLgLimmbLgbRebRcLsbRobRhbLcRsLsbLcbLibLcbsbL
sbLebRcbRcbRebRobLibLjbLsbLsbLsLsmbLebLgbLsbRsbLsLsLsLsmmmbLibLsLsmbLs
bLcbRobsbLsbsbReRsmbsbRsbRgbLsbLebLsLsRsmbLcLsmbLsbsbRsbRsbRcbLsbRsRsR
smmbRgbRibLcbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 38; Drug: OSU6162 1 然 Apo 50 然
bRgbLsbLsRsbLsbLgbLobLgbsbRsbLsbLsLsmbLsbLsbLsbLsbsbsbsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 39; Drug: OSU6162 1 然 Apo 50 然
bRsbRoRsmbRcbRiRsmbRibRiRsRsmmbRibRsRsmbLcLsmbLibLiLsbLcbsbLsbRgbRjReb
LcbLeRsbLhbLibLsbLsbLsbRsLsbLsbLsbLsLsmbRsbLsLsmbLsLsmbLsbLsbLsRsbRsLs
bLsLsmbsbRsbRsLsLsmbLsbLsbRsLsbLsbLsLsmbsbLsLsmbLsRsbRsbLsLsLsLsLsmmmm
bLsbLsRsLsbLsbLsLsmbLsbLsLsLsmmbLsbLsLsmbsbLsbLsLsmbLsLsLsLsmmmbLgLsLs
mbLsLsLsmmbLsLsmbLsLsLsLsmmmbLsLsmbLsLsmbLsbLsLsLsLgLsmmbLsLgbLsbLsbRs
LsbLsbLsLsLsLsLsmmmmbLsbLgbLgLsbLsLsmbLsbLsbRsLsLsmbLsbLsbLgLsLsmbLsLs
LsLsmmmbLsRsbLsbLsbLsbLsbLsLsmbRsLsbLsLsmbLsLsmbRsLsbLsbLsLgbRsLsLsmbL
sbLsbLgbLeLsbRcRcbRcbRhbRebRcbRobRobLoLsRsmbsbRsbLsLsmbRsbLsLsmbLsbLsb
LsLsmbLsbLeLsbLcLsmbRcbRebRobRoRsmbRcbRhbRebRiRsmbLsbRebRcbLibLebLgbLg
bLhbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 40; Drug: OSU6162 1 然 Apo 50 然
bLobLobLcbLsbRibLebRobRebLobRcbLobRcbLobLibLebLcbRcbLobLobLcbLobRebReb
LcbRobLibLebRobRebLsbLobRsbRobLebLebRcbRhbLebRebLibLebRebLgbRebLcbRsbR
ebLjbRobLobLobRebLobRcbLcbLgbRgbRsbLcbLcbLcbLobRobLibRcbRobLobLcbLibLe
bLobLhbLgbRobLibRobRebRcbLsbLcbRsbLobLgbLobLebLebLobRobLebRebRobLebRob
LcbRcbRcbRobLhbRobRobLibRebLcbLibRebLsbRibRobLgbLebLebRobLibRobRobRebR
cbRobLobRobLobRebRobLcbRobLobRibLobLobLobLobRgbRcbRebLobRobLebLgbLcbLc
bRebRcbLhbRobRcbRobLobRobLobLcbLcbRobLobLebRebLebRobLcbRebLebLgbLcbReb
LgbLgbRebRobRcbLobLebRebLcbRcbLobRsbLobRebLebLobLhbLobRobRsbLebRsbRebR
obRobRgbLobLebRsbLobLebLebLcbLibLebLobLebLcbRobLobRebRibLebRobRobRcbRo
bLobRobRobRebRebRobLobRobLobRibLibRobRobLgbLcbRsbRcbRebRibLebRobLhbLob
RobLibLobRcbLibRobRebRebRebLcbLibLobRobRobLobLebLcbRobRebLobLobLcbRobL
obRebLobRebLebLcbLobRobLebRobRobRebRibLobLobRcbRibRobLobRobLibLebRcbLe
bRobLobLobLsbLobRgbLobRebRobRobLgbLobLibRibRobLgbRcbLobRgbLcbRcbLebRob
LibRobRobLobLobRibLobLobRcbRobRebLobRebLobRobRsbRcbRsbRobRobRsbLcbRgbL
obRebLcbLebLhbRibLcbLgbRebLobRjbRebLibRobLobLebLebLobRibLobLebLibRobLh
bRobRcbRebRobLobLibRobLebRobLobLobRibRgbRobRebLobRcbRcbLobRobLcbLobRob
RcbRsbLobRcbRobLcbRobLobRibRobLgbLibLcbLebLcbLobLcbRobLebRobLobLebLobR
obRobLhbRobLebRobRobLebRhbLobRebLobRobRebRobLhbRobLebRebLsbLcbLobRobRo
bLobLcbLobRcbRsbRebRobRebRobLgbLibRobLebLebRobLobRobLebLobLsbLebLobRob
LcbLcbRobRobLebRobRgbRsbRobLobRsbLebLcbLobRgbRobLgbRobRebRobRobRobRobR
ebRobRebRobRebLobLgbRgbRsbLobLobLebLebLhbLobRobRebLsbLobLebRobLibLebRe
bLebLobLcbRcbLobLobLcbLobLsbRibLobLobLebLebRobLobLebRobLobRibRgbLobRib
RibLebLebRjbRcbLgbRgbLobRobLobRhbRebLibLcbLobRobRobRcbLobLobLcbLebRcbL
cbRobRebLobRobLobLobRcbLgbRobLebRcbLobRebRobLobRgbRobLgbRebRcbLobLobRo
bLobLebLobRibLebLobRobLobLobLobLobRobRibRobLebRcbLebRebRobLebRibRobRob
LobRcbRibLebRebLcbLjbRcbRcbRebLebRcbLobRobLebRobRobRobRebRobRobLcbLsbR
ebLobLobLjbRebLsbRibLibLobRobRsbRsbRjbRebLcbLgbRgbRebRobLobRobLjbRebLo
bLebLobLobLobLibRobRcbRobLobLobRebLcbLcbLcbRobRobRobLibRsbRcbLhbRobLob
RebLgbLobRebRibRcbRebRjbRcbLebRobLobLebLobLebLobRobLcbRebLobLsbRebRebL
obLobLsbLgbRobRhbLebRcbRebLobRobLsbRobRobRobLebLobLobRebLcbLhbRcbRjbLo
bRobRobLebLobRcbRhbLobLobLobRobLsbLebLcbRgbLcbLobLcbLcbLsbRobRobRjbRob
RgbRobRebRhbLibLobLobLobLobRcbLebLobRcbLibLebLhbLobLobRsbRsbRebLebLobR
obLebRebLcbRebRgbLibLobRebRobRobLhbLcbRsbRebRebLebRobLcbRsbRobLgbRhbLe
bLibRebRebLobLobRcbRjbLobRobLobRobLobLobLcbRsbRobRsbLobRobRobLobRobLob
LcbRobLgbLebRcbRobLobLobLebLebLebRebLobRebRobRobLebLobLobLsbLcbLobRgbL
gbLobLobRobRjbLobRgbRobRobRebLebLebLsbLibLobRebLobLsbRjbLobRibRebLobLs
bLobLsbLobRebLobRobRebRebLebLobRhbLobLobRebRjbRsbRebLcbLobRobLobLsbRcb
RebLobRobRobRjbRjbLebLobRsbRebLebRobLcbLobLsbLobRcbRsbLobLobRsbRobRebR
obRcbLsbRgbRsbRjbRgbRebRobRobRcbLobLebRebLobLobRobRgbLebRobLsbLobRobRo
bRsbLobLobLobRsbRebLobRobRobLobRobLobRobLobRsbRjbRobRsbLobRebRebLjbRsb
LjbLgbRobLsbRsbRsbRsbLjbRobRsbLsbLsbLobRsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 41; Drug: OSU6162 1 然 Apo 50 然
bLeRsLsLsmbRsLsLebRcbRgRsRsmmbRsRsRsRsRsRsRsmmmmmmbLjbLcbRsbRsbsbLsRsL
sRsbLsRsRsmbRsRsRsmmbRsRsmbRsRsRsRcmmbLebLcbLibRsRsmbRsbRsRebLoRsbLgbR
ebRebLsRcbLsbLcbLsbLgbRsbLjbLibLsbsbLsbsbLsbRsLsbsbRsbLsLsmbLsbRsbsbsb
RsbsbsbsbsbLsbRobRgbsbsbsbRsRsmbsbsbsbRsbsbLsbsbLsbLsbLsbRsbRsLsbRsbLs
bLsbLsRsLsRsLsbLsRsbsbLsbLsRsbLsbLsbLsRsbRsbsbLsbRsbLsRsbRsbLsbRsbsbsb
sb

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 42; Drug: OSU6162 1 然 Apo 50 然
bRjbLsbRobLsbLsbLsbLsbLsbRsbRsbLsbRsbLsLsmbRsbRsbRsbRsbRsbLsRsbLsLsmbs
bLsbLsbLsRsbsbLsLsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 43; Drug: Control Apo 50 然
bRsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 44; Drug: Control Apo 50 然
bLgbLeLsbLsbLsbRsbLsbLebRsbLebLsbLsRsbLsbLibLebRsbRsbRsLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 45; Drug: Control Apo 50 然
bLgbRjbRobRcRsmbLsRsbLsbLsbRsbLgbLgbLsbLsbLsbRsbLsbLsbLsRsbLsbLsbRsbLs
bLsbLsbLsbLsbLsbRsbRsbLsbRobsbsbRhbLcbRsbLhbLobRsbRjbLebRebRobLobLobRo
bsbRobRobLsbLebRobRgbLjRebLoLsmbLoLobRebLebLobLoLgbLebLobLjbRjLsbRoLsR
obsbRoRsmbLobLibRobRsbLsbLsbRsbsbLebRsbRjbRobLebLebRobRjb

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 46; Drug: Control Apo 50 然
bLsbLsbLsbRsbLsbLsbLsbRsbRsbRsbRsbsbRsbRsbLsbLsbLsbRsbLsbRsbLsbRjRsmbR
sbLsbLsbRsbRsbRsbLsbRsbLjbRsbRsbLsbLsbLsbLsLsmbRsbRjbLsbRjbRjbRsbRsRsm
bLsbLsbRsbRsbRjbRsRsmbLsbRsbLsbRsbLsLsLsmmbRjbRjb

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 47; Drug: Control Apo 50 然
bsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165334; End: 165834;
Recording: 12-1; Individual: 48; Drug: Control Apo 50 然
bRebRebLebLobRobRhbRjbRobLobLobLebLgbLobLobLibRjbLobLobRebLobRcbLobRob
RibLebLobLjbLcbLobLebLcbRobLebLcbRsbLibRcbRebLebRibRsbLgbRcbLibLcbRebL
obRcbLobLobRobRhbLobRsbLebRobLebRcbRcbLcbLebRobLebRobRsbRsbRgbLobRobRc
bRcbRobRcbLobRebLobLcbLobRobLcbLebRobLebLebRibRjbRebRebRcbRobLobRcbRcb
LsbRcbRhbLebRcbLcbRsbRcbRebRobRobLobLebRobLcbLebLobLebRjbLcbLcbLobRcbL
obRibRcbRcbLgbLcbRebLobRjbLgbLobLobRobRebLobLebLebRebLjbRobLcbRobRobRj
bRobLebLebLebRobLebLebRobLobLcbRobLobLsbRobLhbRcbLobLsbRobRcbRjbLebLeb
LobRobLcbRobRobLebRibLcbRobLobRebLobRcbLebRibRobLobLhbRobLsbRobRobRobR
obLobLobRjbRebRebLjbRebLobRobLebLhbRibLgbRebRcbLobRebLobRcbLjbLebLebLg
bRcbLcbLobRebLibLobRibLhbRcbRobRcbRobRobRebRobLebRobLobRobLobRebRsbRgb
LobRebRcbRcbRobRobLobLebRobRcbLobRjbRobLcbLcbLebLobRobRcbLgbRibRcbLjbR
obLebRjbLcbRobLobRjbRcbLobRobRgbRobRobRcbLibRobRobRobLebLobRsbRsbLebRo
bRobLobLsbLcbRcbLebRgbLsbLobRobRebRebRcbRcbRobRjbLobLobLgbRjbRcbRebLjb
LcbRobLobRebRobLebLobRsbRebLsbLjbRobRobLcbLobRgbRebRsbRjbLebRobLobLebL
obLobRobLebRebLcbLcbLsbLjbLobLobLhbLcbRobLobRsbLobRobLobRcbRobRcbRebRe
bLobRobRobLobLobLebRobLobRebRobLobLsbRjbLebLhbRebLebLebRjbRcbLibRobReb
RebLsbRibLjbLcbRjbLobLobRobLebLcbLebRibLobLsbLjbRjbRebLobLobRobRebLebR
obRobLjbRcbLobLsbRjbRjbRobRsbLobRobLobRobLcbLebRebLobLebRsbRobRjbRobLo
bRcbRebLebLebLobLibLobLebRcbRobRsbLebRobRobLobLebRhbRebRcbRobRobRibLob
RcbLjbRebLjbRibRebRobRgbRcbRobRjbRobRebLjbLobRjbRobRebLobLcbLebLobLebL
obLsbLebRjbRobRobLobRgbLgbRobLobLcbRjbLhbRgbRgbLobLsbRhbRsbRobRobLibRi
bLjbLobRcbLebRobLebRcbRgbRcbRobLgbRobRebLobRobRobLobRgbLibRcbLjbLsbRib
LobRsbLebLebRobLebLhbRobLebRobLebRobRsbLebRobRobRobLcbLgbRcbLcbRebRobR
obLibLobLcbLjbLobRebLebLebRcbRcbLebLobRsbRobLjbLobRsbLebRobRobLcbLcbLo
bLsbLebLsbRsbLobLobLobRibRsbLsbRsbLebLobLcbRobLjbLobRjbRsbRsbLsbRsbRsb
RebRsbRsbRebLoRobRcbLsbRobLobLsbRebLebRcbRcbRsbRsbRsRsmbRsbLobLgbLjbLs
bRebRsRsmbRsbRsLsbLebRcbRobLeRsLebLobRsbLjRobLobLebLcbRobLsbRsbLsbRcbL
obRsbRsLsbRsbLsbLsRsbRsbLeRsbRsbLoRsbLsbRsbRsbRsLsbRobRsbRsbLsbLsLobLs
RsbLobRsbLsbLobRsRsmbLsbRsbRsbRsRsmbLsbRsbRsbLsbRsbLoLsmbRsbLsbRsbRsbL
sLsmbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 1; Drug: OSU6162 10 然 Apo 50 然
bRcbRcbLsbRsbRobRebLjbRebLobLcbRebRsbLebLcbLjbLebRobLobRcbLebLsbLebRcb
RobLobLcbLobLobRobRobLebRebRjbRebLcbRebRobLebLjbRobRsbLsbRobLsbRjbLobL
cbRebRcbRcbLobRobLjbLebLobLsbLobRjbLjbRjbLebRjbRobRobLsbRebLsbLcbLebLs
bRebLobRcbLsbLsbRebLjbRjbRcbRcbLsbLjbLcbLcbLobLjbLcbRebLobLobRobRjbLeb
LsbRobRjbLcbRcbLsbLobRcbRcbRobLobLobLebLjbRjbLsbLobLcbLsbRobLsbLebRcbL
sbRobRebLsbLjbLsbRsbLobLobLebRjbRcbRsbLjbRhbLcbRjbRebLobLjbRebRebLjbRo
bLjbRebLebLjbLobRobRobRebRsbRebRjbLcbLobLcbLcbRebRsbRobLobRebLobLcbLeb
LjbLobLcbLcbLebLebRjbRobRsbLobRsbLebRjbLobLobRebRjbLjbRsbRobLebLebRebR
cbLobLobLjbLebLcbLobRcbRebLobRobLobRjbLjbLsbRobRjbRcbRcbRcbLebLsbLjbLo
bRobLjbLobLobRobRjbRjbRcbLebLobRebRcbLebLjbRjbLjbRsbRobRebLjbLobRebLcb
LsbLjbRobLobRebLcbLobLsbLibLebLobRebRcbRsbRcbLebRcbRjbRsbLobLobLjbLcbR
cbLobRebRsbRjbLebLibRebLsbLcbRobLebLsbRobRjbRobRobRjbLjbLebRcbLobRobRo
bRcbRsbRebLebLebRobRobRobLcbRebRobLjbRcbRibRibLsbLebRebRebLsbLjbLjbRob
LebLsbLobRcbLobLebRjbLobLobLjbRebLobLjbRebRsbRebRebLobRebLebRobRobLobR
obLcbLjbRebLebRgbRsbRebLobRobLjbRobLjbRobRjbLobRobLjbLobLibLebLobLobLo
bRsbRgbRjbRebLobRsbLobLobLebLobRobRebRobLebRobRobLsbRcbRsbRibRobLebRob
RebRcbRobRibRobLebRobRebLsbLebRsbLibLebLobLebRebLebLebRobRcbRobRebLibR
obRobLcbRsbRgbRcbLgbRibLebLebLobLsbRebRcbRebLebLsbRebRcbLobLcbLobLobLo
bLobRobRcbLcbRobLobLjbRcbRgbLjbRobRebRobLebRobRibLebLjbLibLsbLcbLobLgb
LebRobLcbRobLcbRobLobLobRobRebRgbRebLobLcbRcbLcbLobRobRobLebLobLobLobL
ebLebLobRobRobRgbRebLgbLcbRcbRgbRhbLgbLcbRhbLebRebRsbRsbRobRebRcbRcbLo
bLebLebRcbLebLobLobLcbLobRobLebRebLcbRhbLjbLebRsbLobRobRibLsbRobLobRcb
LsbLebLobRebRebRobLjbLsbLobLebRebLobRobRjbLjbRobLgbLobLjbRobLobLobRebL
obLjbLobRjbRebLcbRobLobRebRobRjbRobLobRebLobRsbLobRobRobRebRobLjbRobLo
bRebRsbRebLebLjbLebLobLebRsbLsbRebLsbLebLobLsbRebLgbRebLjbLjbLebRjbRjb
LobLobLebLjbLsbRsbLebReb

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 2; Drug: OSU6162 10 然 Apo 50 然
bLhLsLsLsmmbLiLiLsLsLsLsLsLsLsLsLsmmmmmmmmbLsbLobLsLsRsRsmmbRsRsRgRsRg
mmbsbLsbLsbLsRsLsRsbRsRsLsRsLsmbLsRsbRsLsLsmbRsbRsLsbRsRsRsLsLsRsRsLsm
mmmb

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 3; Drug: OSU6162 10 然 Apo 50 然
bLsbRibRsLsbLsLebRiLgbLsLibRjLsbRebsbRsbLobsbLsbRsbLobRsRsmbLgbRgbsbLg
bLoRhbLsLobsbsbRebLoLebLjbLobLebRobRcbLgbLobRebRebLibRobRhbRebRobRobLi
bRebsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 4; Drug: OSU6162 10 然 Apo 50 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 5; Drug: OSU6162 10 然 Apo 50 然
bLebLobLebRobLjbRjbLsbLobRsbRobRcbRobRcbLobLibRibRibRobLgbLobLcbLobRob
LhbRebLobLgbLibRsbLcbRobLobLcbLebRobLebRcbLebLebRgbLobRobRgbRhbRcbRibR
ebRebRobRgbRcbLobRcbRebLibRibLcbRgbRobLebLcbRcbLebLcbRebLsbLebRebRcbLc
bRcbRebLcbRgbLobRibRgbLobLcbRibRcbRobRebRcbLobRcbRebLgbLobRgbLjbLebRcb
RobLebLcbLobLgbRobLobRgbRcbLobRobRgbLobRobLibLgbLobLgbLobRebLcbRcbRcbR
cbLhbRebRobRebRsbRobLebRsbLsbRebRsbRibRobLcbLgbLobLebRjbLcbLcbLobLebRh
bLobLsbRebRibRjbLobRobLibLebLibRcbRebLibLobRobRebLobRsbRebLobLibLgbRhb
LebLibRsbRebRobRobLsbRebLjbRobLobRebLsbRobLobRhbLebLobRgbLobLobRobRebR
ibRobRobLobLebRobLobRsbLobRobRebLebLebRobLebRobRcbLebLobLgbLobLcbLgbRs
bRebRebLebLebRobRsbLobRobRgbLobLebLcbLebRobRebRobLcbLibRobLgbRgbLgbRcb
RobRcbRebRcbLobRobLebLebLgbLobRobLcbRibLebRobLebLcbLcbLobRobLjbRobRebR
obRibLcbLcbRibLjbLibRobLcbRcbRebRhbLobLgbRgbRgbLhbLobRebLibRibLsbLobRo
bRobRgbLebLgbLgbLebLobLebRhbRebLobLcbRobRgbRjbRobLebRcbLobRibLebRsbLib
RcbLcbLebLobRobRebLcbLobLhbRobRebRobRebRobLebRebLebLcbLgbRsbRebRebRobR
jbLobRsbRobLobLobRcbLobRebRobRobLsbRobLcbRcbRgbRibLebLobRebLebRibRebLi
bLobRobLjbRsbLgbRjbLsbRgbLcbLebRobRibRobLebLibRcbRhbRcbLebRibRobLebLeb
RjbLhbRsbRobLjbRobRobRcbLcbLobLcbRebRebLebRibRjbRebLebRibRebLjbLjbLsbR
ebLjbLebLobRcbRobLebRobLsbRibRcbLcbLobLeb

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 6; Drug: OSU6162 10 然 Apo 50 然
bRsbLcbLobRobRcbLobLebRjbLobRsbLebRobLobLebLobRebRebLobRsbRcbLebLebRcb
LobRebLcbRcbLebRebLsbRjbLebRobRobLsbLsbLjbRcbRobRobRobLsbLjbLobLobLjbL
ebRjbRobRobRsbRsbLobRobLobRibLobRcbRebLobRsbLsbLobRcbRobRebRobRebLsbRs
bLebLcbRobRobLobLjbLcbLsbRebRsbLjbRsbRcbRcbRebLobLebLcbRcbRcbRjbRobRcb
RebRcbLebLjbLobLobRebLcbLcbRobRgbLebLobRcbRobRcbLobRcbRobLebLobLobLsbL
jbLibRjbRobRebRcbLebRebLobRobRobRobLibLsbLgbLebLcbLcbRjbLsbLjbLsbLebRj
bRobRobLebLobRobLjbLsbRobRjbRobLsbRcbRobRjbRsbLjbRcbLobLsbLjbLebLjbRsb
LobRebLjbLsbLebLobLobRobLobLsbRjbLobRjbLebRobLobLobRibRibLcbRobRobLcbL
cbLcbLebLibLobRibLobLobRobLebLsbRebLobRebLcbRgbRebLsbRobLibLcbRobRobLe
bRcbLobLgbLebRobLgbLibRobRebRebRebRobRobRgbLjbRebLobLgbLjbLcbRsbRobRob
RebRobRjbRcbLjbRobLobRobLsbRjbLsbRsbRobRsbLobLobLsbLcbRsbLsbRebRsbLebR
obRebLsbRobLobLebRobRobLobLjbRebLebLobRobLcbLsbRebRebLcbRobRcbLebRebRo
bRjbLebLobRobLobLhbLebRebLgbRobLsbLebRcbLebRobRebLebRsbRobLsbRobLebRob
RjbLebRcbLobLsbLobLebRjbLebRjbRsbRobLjbLjbLjbRobRebRsbLebRebRjbLsbLobR
sbRebRhbLebRobRjbRebLjbLobLebRobLobRebRjbRobRobRobRobRjbLobLobRobLjbRe
bLcbRjbLcbLcbLcbLsbLobLsbRebLobLobLobLsbRjbLebLjbRebLcbLobRjbRobLobRob
RobLjbLcbLobLcbLjbLebRsbLjbRobRebLobRsbLobLobRebLebLsbLcbLebRjbRjbRobR
obRobRobRebLjbLjbRsbLobRobLsbRjbRgbRcbLebRhbRcbRibRsbRobLebRobRobLebRe
bRebLebLobRobLcbLebLcbLcbLebRsbLobLebRebLebRobRsbLjbRsbRobLsbLcbLobLib
RobLebLcbRebRcbLobRcbRcbRebRcbRcbLobLjbRcbRobRjbRjbRjbRobRebLebLebLebL
sbLsbRjbRebLsbLjbRebRobRjbRibRobLcbRobLobLebLjbRcbRobRobRsbRcbLebLobLe
bLebLcbLobRsbLsbLsbRjbRcbRcbLjbRsbLsbRcbRobLjbRebRebRsbRcbRjbLjbLobLjb
LebLobRebLjbRebLebLsbLebLjbRjbLjbLjbLjbLjbRjbRobRjbLobRjbRobLobRjbRebR
jbLsbLebRjbLobRjbLsbRcbRebRebRsbLjbLobRebLebRobRobRjbRobLjbLsbRjbLsbRe
bRjbRebLobLjbLebRobLjbLsbRobLjbLjbRebLjbRobLsbLebLjbRebRcbLsbRsbRjbLjb
LsbRsbLebRebLcbLebRjbLebRobRjbLsbRebRobRebRjbLobLsbLsbLobRebRebLobRsbL
ebLebRjbLjbRobLobRcbLobRcbRsbRjbLobLebLebLobLcbRobRebRebRebLebRcbLebLe
bRjbRobLjbRcbLobLjbLibRobLobRgbRjbRobRobLebRobRibRcbLebRcbRebLobRebLcb
LebLebLobLobRebLobRebRebLebRobRjbLobLobRjbRobLobRobRibRsbLebLebRjbLobL
ebLobLgbRobLebLjbLobLjbRsbRobRsbRebLcbRebRsbRebRebRsbRsbRjbLobRjbLobLj
bRebLebRjbLjbRcbRsbLsbRjbLjbLsbRobRebRjbLobRobLcbLebLcbRebLcbLebRobLob
LcbLobRebRcbLobRcbRebRobRebLjbRsbLobLjbRobLebLebLobLjbLobLjbLebRobRobR
ebLobRjbRsbRobLjbRsbLobRebRebLebLobRebLgbRobRebRibRebLobRcbRibRobLobRe
bLcbRibRobRebRebLebRobLobRcbRobRsbLebRobRgbLsbLobLebRcbLobLsbRebLobReb
RhbRgbRcbLobRhbLcbRibRebLgbLobRobLobLjbRcbLibLebRibRsbLebLebLjbLobLobR
cbRcbLgbRsbLobRebLobRcbLebRobRcbRobLcbLsbLsbLebRobRebRsbRebLsbLibLobRs
bLcbRebRebRcbLebLobRcbRsbLcbRsbLobRsbRebLobRebRobRobRhbLjbLebLhbRjbReb
LsbLsLsmbRobRobLjbLsbRobRebLebRjbRjbLgbRobRobLsbLsbLcbRebRobRgbRgbRobR
ebLcbRebRjbRebLcbLcbLebRebLobLebLjbLebLobRsbRcbRobRjbLsbLobLebRebRcbLe
bRsbRobRsbRobLcbRobLgbRobLebLibRibLgbRobLebLhbRibRobRebRcbLebRobLjbReb
RgbLsbRcbLcbRebRobLcbRobRjbRgbLobLcbRjbRobLjbRebRjbLjbLobLsbLsbLsbRob

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 7; Drug: OSU6162 3 然 Apo 50 然
bsbsbsbLsbLsbLsbLsbsbRsbsbRsbRsbRsRsLsmbRsbsbsbLsbRsbsbRsbLsbRsbsbsbsb
sbRsRsmbsbRsbLsbsbRsbsbLsLsmbRsLsLsmbsbLsbsbRsbRsbsbsbRsbLsbLsRsbRsbsb
sbsbLsbLsbRjbLsbsbsbsbRsbLsbsbLsLsmbLsRsbLsbRsbRsbsbsbsbsbsbRsbLsRsbRs
bsbLsbsbRsLsbsbsbsbsbLsbRsbsbsbsbsbsbsbsbsbsbsbsbsbsbLsbLsbRsbLsRsbRsL
sRsbsbRsLsLsRsmbLsLsmbsbLsbLsbsbRsbRsbRsbLsbsbsbRsRsmbRsLsbsbLsbsbRsLs
bRsLsbLsbLsRsbLsLsRsLsmbRsRsmbLsLsmbLsbLsbsbsbLsbsbsbsbsbsbLsbsbsbsbsb
sbsbsbsbsbRsbsbsbsbsbsbLsbsbsbRsbsbsbsbsbsbsbRsbLsRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 8; Drug: OSU6162 3 然 Apo 50 然
bsbsbsbsbsbsbsbsbsbsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 9; Drug: OSU6162 3 然 Apo 50 然
bLibRcbLobRsbRhbLcbLibLobRobLcbLcbRcbRobRcbRobLobLcbRobRcbLobLcbRebLob
RobLsbRcbLobLgbRebRobRebLebRsbRsbRgbRobLcbRsbLcbRibLcbRebLgbRobRgbRobL
ebRobRibLobLcbLcbLebLibRebRsbLobLgbRobRcbLcbRobRobRsbRobLobLobRibLcbRs
bLgbRobRgbRcbLobLhbLobLobRobLcbLibRcbRobLebLobLebLebRcbLcbRobLcbLjbRib
LobLobRobRgbRcbLsbRebRobRebRobRcbRobRcbLobLebLcbLobLibLobRobLobRobRobR
cbLcbLcbRsbRibRobLobRsbRebLobRgbLibLebRebLebRebRebRebLsbLobLgbRibLgbRe
bLgbRebRobLobRsbRcbLcbLcbRebRcbLebRebRcbRobRcbLibLebRobLebRsbRebLobLeb
RcbLgbRobRebRobLgbRebRobLcbLibRobLobRobLsbLobRobRobLobLgbRobLobRcbRsbR
obRobLebRobRobLebRebRcbRobLobLebRobLobRgbRobLsbLebRebRcbLobRcbLsbRgbLo
bLobLhbRcbRebLobLibLebLobRsbRsbRebRebRobRhbRcbLobRobRebLebRebLibLgbRob
LobLobRsbRebRobLebRebLibRibLobRobRebRobLobLobLobRebLobRobRobLobLebRgbR
obRobRibRobRobLobLobLsbLcbRcbLcbLibRobRebRobLibRcbRobLobRebLobRibRebLi
bRcbLcbLhbLobRebRobRobRcbLobRobLgbRgbLobLobLobLebRobRcbLcbRobLebLobRcb
RobLgbLobLebRgbRobLgbRobLebRebLibRebLobLobRobLibLobRebLebLcbLobLcbRibL
gbRobRobLcbLobLhbLibLebRsbRhbRobLsbRibRebRibLobRebRebRebLibRgbLebLgbLo
bRobLobLibLobLobRcbLobLobLobLobRsbLcbRibLobLobLcbRebLebRobRobRgbRibLob
RsbRobRhbLcbLobRibLebLebRebRibRobLebLebRebRebLobRibLcbRgbLobLcbRsbLgbL
cbRcbLgbLcbLobLebLobRcbLcbRibRobLcbRebRcbLobLibRobLobLobLibRcbLebRebLe
bRebRebLobRebLebLebLhbLobRobRebLobLsbRebRobLebRobLebRcbRobLobLebLcbRob
LgbLibLibRobRibRebRcbLcbLobLobRgbLobRobLobRobLcbLcbLebLobRsbLobRobRobR
obLcbLobRobLobLobRobLebLebRcbRobLebLobRgbRebRobLsbRobLcbRobRobRebRobLc
bLibRebRebLebLibLebRobLobLobLobRsbRebRebRebLobLebLobRobRcbRobLsbLebReb
RibLebLhbLobLcbRebRobRebLcbLebLobRhbLebRebRobRobLebLebRobRobLsbLobLobR
obRobLebRobRcbRcbRebRgbLcbLobLcbRcbLebLebLebRobLebRibLobLobRobRobRcbLe
bLobLebRebLebLobRobLebRebRgbRobLobLobLcbRebRcbLibLobLobLobRgbRcbRebLeb
LebRcbLobLobRibLobLgbLcbRobLgbLcbLobLebLhbRhbLebLobLibRebRcbLibRebRcbL
ebLcbRobRsbRobLobLobRebLcbLibRgbRebRebLebRcbRobLgbRhbRobRobRobLsbLobRg
bRobLebLibLebLebRibLobRcbLobLobLobRobRobRhbRobLebLsbRobLebLcbLsbLobReb
LobLgbLibLebRgbLebLcbRebLcbRobLcbLebLobRobLobRobRebRebRhbRebLobRobRebR
obLebLsbLgbRcbLcbRebLobRebRobLebRobLobRobRobLobLibLcbRebRebRobLebLebLc
bRobRebLebLobRibLcbLebLobLobLobLsbRebRcbRsbRhbLobLcbLobLebLebRebRebRob
LebLebLebRobLsbLebRobRobLobRcbLibRobLgbRgbLebRobRcbRobRobLobRebRebRibR
obLibLobLcbLcbLcbRgbRebLhbRobLebRobRcbLibLobRjbRcbRebRsbRebRcbRobLcbRc
bLobLobLcbRobRcbRobRebRcbRobLebLgbRcbLobRcbRobRcbLibLebLebRebLhbRobLeb
LhbRobLobRcbRcbLebLebRgbRcbLgbLobRcbLibRcbLebLobLobLobLsbRibRobRibRebL
obLebRgbLcbLibRobLcbRibLgbLobLobLobRobRebRebLobRobRebLgbLcbRobLhbRebLg
bRcbRcbLcbRobLgbRcbRobRobRobLsbLebLobLobLebLebRebLobLebRobRsbRobRgbRib
LcbLcbLcbRebRibRcbRobRibLebLobLibRibLsbLsbLebRobRobRebLgbRebLebLebRebR
obLobLcbRobLsbRibLsbRebRobLobLgbRsbLobRcbLcbRobRobRobRcbLobLobRgbRgbRe
bRebRsbLobLobRobRcbLobLebLcbRobRcbRobRebRgbRobLebRobRobLob

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 10; Drug: OSU6162 3 然 Apo 50 然
bLhbRebRcbLobLsbLebLcbRhbLebRibLcbRobLobLebLcbRcbRcbRcbLebLobRobRebReb
RgbLcbRcbLcbRhbLobLobRebLebRibRobLebLibRebLobRobRgbLibLgbRobRebRsbLgbL
cbLebLgbRobLibLibLsbRobRebRebLgbRebLhbRcbRibLgbLgbRobLibLobRcbRebRebRi
bRebRebLibLobRobLobLobLcbLebRobLsbLebLobRcbRibLobRcbRcbLgbRgbRsbRobLeb
RebRgbRobRebLobLobRobRobLcbRibRsbLcbRebRhbLobLobLibLobLgbRsbRobLebRobR
cbRgbRobLcbRobLcbRobLcbRcbRobLcbRcbRobRhbLcbLcbLobLobLgbLobLobRobLibRo
bLgbLhbLebRobLsbLebRebLcbRcbRebLcbLibRobRsbRsbLcbRobLobRebLcbLjbLobLob
RobLjbRcbRibLsbLobLobRebRhbRobRobLobLcbLcbLobLobLobLebLebLibRebRgbRobR
obRobRebRebLcbRcbRcbLebRobLobRobLobLibRibRgbRebRcbLebLobRobLobRebLobLo
bRcbLobLebLebLcbRobRibLobRgbRcbLcbRebLsbRobLcbRcbRobLobLcbLcbRobRobLcb
RgbLibLobLibRcbLcbLobRebLsbLebRobRcbLcbLsbLobLobRcbRebRcbRobRobRobRobL
ebRobLcbLebLobLcbRobLcbRobLobLebLobRebLcbRcbLebRebLobLobLobRebLobLobRo
bRebRgbRobLcbRebRobLebRobRebLobRebRebRebLobRibLcbLibRsbLobLgbRebRobRhb
RibLobRsbRcbRobRobRcbLobRebLebRebRcbLebLibRhbRebRcbLibLgbRcbLebRobRsbR
ebLobRcbRobRebRobRebRsbLebRgbRobRibLebRobLobLebRobRobLobRobLcbRebRobLi
bRibLcbRsbRobLcbRobLobRobRibLebRcbRebRebLobLobLebLsbRebLobRobLcbLobReb
RobLgbRobRsbRibLobLebRcbRobLibRobRjbRobLobLobLobRebLjbLobLsbLcbLobLhbL
ibRebRibRebRgbLebLebLobLcbLobLebLobRebRebRibRobRobLebLobLobLobRobLebRc
bLebLebLebRobLcbRebLobRhbLsbRgbRobLobLobRebRebRcbLebRibRobLgbRjbLibLeb
LcbLobLebLebLibRcbLobRgbRobLcbLcbLebRobLobLobRebLebLibRobLebLibRcbLobL
cbLobRibRgbLebLebLobLobLcbLobLcbLobLebRcbRsbRobRhbLebLobLgbLobLibRcbLi
bLobLcbRcbRobLebLobLibLobLobLobLobLobLgbRcbRebLobLebRebRcbRobRebLobRgb
RsbLobLebRcbRobLebLibLcbLcbRobRobRobLobLobLsbLebRobLcbLebLibLsbRobRsbL
hbLgbLobRcbLgbLebRobRobLobLibLcbLsbRgbLcbLobRobLobLebLobRcbLobLcbRobLe
bLcbRcbRebRcbLebLobLobRobRhbRobLcbLebLobRebRobRobLibRgbLcbRcbRcbRobRob
RibLhbRcbRebRgbRgbLibLibRobLobLobLobLobLobRobRobRebLibRobRibLcbRobRobR
sbRibLebLobLobLcbLobLobLebLobLobRobLebRobRobRebLobLobRobLcbRobLobRcbRc
bRsbRebLobLibLobLebLobLcbLcbRobRobLebLobRobLgbRibLobLjbLebLebRebLobReb
RobLhbLsbLibLcbLcbRebLobLgbLcbLjbRobLobRebLsbRcbLobRebRobLebRobLobRobR
obRobLgbRcbRobLobLobLobLobRobLebLobRobLobRobRobLebLobRebLcbLsbLobLsbLe
bRsbLobLgbRobRsbLobLobLebRibLjbLcbRobLibLobLebRobLjbRobLobLibLibRebRob
LsbRebLobLobLobLcbLibLsbLobLhbRobLobLobRgbRcbLebRcbRcbLebLgbRsbRobRebR
obRcbLsbRebRebLebRcbLobLobRobRobLcbLgbLebLcbLsbRsbRcbRobLibRgbRebLobLe
bLcbLsbRobLhbLobRebRebLebLebRebRgbLsbRobRcbLgbLcbRobRobRobRobRebRobReb
RebLobLebLcbRibRobRobLcbLobRibLibLobRebRcbLgbLsbRobLgbLgbLcbRcbLobLcbR
obLcbLebLobRcbLcbLobLobRibLebLhbLcbLcbLibRobLebLebLobLobRhbRobLibLsbLh
bLcbRobLsbLibLibRgbLjbLgbLcbRobLcbRobRebRcbRobLebRcbRcbLobLebRebRcbLob
LibRobRobRebLcbRobRobLcbRebRcbRcbRobLobRobLcbLebRobRobLgbRobLcbLebRebR
obRcbLcbLcbRibRcbRobLobRibLebLcbLcbRcbRsbLobRebRobRobRobRobRobRebRobRi
bLebRibLebRobLobRobRobLjbLobLcbLebRebLebLebRebRobLobRebRobLebLobRobLhb
RebRcbLobRebLobLebRobLebRgbLobLobRebLsbRobRebRibLebRobLobRibRobRcbRcbL
ebLcbRebRobRebRebRebRebLcbRobRob

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 11; Drug: OSU6162 3 然 Apo 50 然
bLsbLebLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 12; Drug: OSU6162 3 然 Apo 50 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 13; Drug: OSU6162 1 然 Apo 50 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 14; Drug: OSU6162 1 然 Apo 50 然
bLsbsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 15; Drug: OSU6162 1 然 Apo 50 然
bLobRjbRobRobRcbLebLebRjbRobRobLcbRgbRebRjbLcbRebLobLebRobRobLcbLcbRib
LcbRibLcbLcbLsbLobRjbLobRebRobLebLobLobLebRebLobLobRsbLjbLcbLcbRobRebR
ibRebRcbRibLebLibRcbRobRobRebLobLobRobRobRobLebRobLobLobLobLobRebRebLe
bRobLgbLsbRhbLsbRcbRobRobLebLobLcbRebRobLcbRobLebRobRebLobRebLebLibLcb
LibRobRebLobLobRobLobRjbLebLebLcbRobLobLobLobRobRobLobLjbLebLcbLobRobR
obRobRebLobLebLobLobRebRobRsbLebLobRcbLcbRcbLobRebLibLcbRobLsbLobRobRo
bRsbRgbLobRsbLsbLebRebLebLobRobRcbRebRobLebRcbRcbRcbRobRobLcbLobRcbLob
RobRjbRobLebLgbRebRobRebLebLobRobRobRobRobRibLebLobLobRobLobRobLcbRibR
obLobLibLobRobLobLcbRobRjbRobLobRebRobRobRobLibRobRebLhbLsbRobLjbLebLo
bRebRcbRhbRibLobLobRobRobLebRibRobRebLobLebLobRobLobLgbLjbLebRobLobLeb
LobLebLcbRobLsbLjbLcbRobLobLobRobLebLcbRebRobLobRebRebRobLcbLcbRgbRobL
ebRobLibLhbLcbRibRcbRebRobRobRebLobRobRsbRobLcbLebRsbLobLobLobLobLobLc
bRcbRebLobLobLcbLcbRcbLcbLobLcbRjbRebRcbRibLobLobRibRsbLebLjbRobRcbRcb
RsbRobRobRcbLobRebRcbRobLebLobRobLibLsbRcbRgbRebLobRobRobLjbRcbRhbLobL
cbLebRgbLcbRobRebRhbLobLobLibLjbRibRebLcbRobRobRobLebLgbRobLobLcbRobRg
bRobLcbLebLebRebRsbRsbRebRjbLebRibRjbLobRgbLcbLebRgbLcbLebRobRgbLobRsb
LcbLjbRobRobLebLebLebRebRcbRebLsbLobRsbRcbRobRebLobRobRgbLobLobRebLobR
ibRjbLebRobRebLibLibRebLobLcbRebRibRhbLgbRgbRebRsbLobLobRobRebRobLobRo
bLsbRobLcbRobRobRebLobRobRsbRobRcbRcbRebRgbRsbRobLcbRcbRibRebLebRobRob
LebRsbLobRcbRcbRebLsbRobRobRobLobRjbLebRebRebRebRibLjbRsbLibLebRibLebL
ebRibRebLebRibLobRibRobLobRebRebRobRibRobRobLebRebLobLobLobRobLobRibLo
bLhbRobLcbRobRobRebRobRcbLcbLebLobLsbLibRobRobRobRgbRobRcbLcbLcbLsbRcb
LobLebRebLobRobLobRcbLgbLobLebLobLcbRcbLobLobLobLobRgbLsbLebLjbLobRobR
obRobLebLobLebRibLobRebRobRcbLibRobLcbLobRgbLobRobRobLibRobRobRobRebLc
bLebRobLobRgbLobRobLhbRebLobRcbLebRebRobLgbRebRebRhbLjbRebRobRebLobRgb
RobLgbLobRobLobLsbLjbLobLcbRcbLobLebLebRjbLsbLebLgbRebLcbRobLobRobLobL
ibLobRibRobLobRgbLibRobRobLjbRebLcbLobRebRobLobLcbLebRobLobRebLjbRobRo
bRibLsbRgbRebRjbRcbLobLobLobLobRcbLobLobRebRcbRgbLobRobRsbRibLebLobReb
RebRcbLcbLobLcbLebLobRobRebRebRibLobLgbRobRobLobLjbLobLobLcbLsbLebLobR
sbLibLobRcbRebRibLebRcbLobRgbLobLebRobRibRobRcbRsbRebLhbLcbLobRcbRebRi
bRjbRobLebLebLjbRebLobLjbLgbLcbRjbRcbRobLjbLebRobRobRcbRjbLobLebLsbLeb
RobRcbLebLobLebRobRgbRobLebRobRobLobLobLsbLibRjbRobLebLebRcbRjbRcbRcbL
ebRobRobRsbLobRcbRcbLobRobLgbLgbRobLobRobRebLjbLobRebRobRebRobLebRhbLi
bLobLjbRebRobLobRcbLobRebRebRebLcbLobLgbRobLebRobLobLjbRobRobRobRobRob
LhbLebRobLcbRibRobRcbLsbRebRobRebLobLgbLobRebLobLebRcbRcbRcbRobRebLjbL
obLjbLobLcbRsbRgbRobRobLebRjbRobLhbRobLebLsbLibRcbLobRobLobLobRcbLcbRe
bLobLebRgbLebLobLebLobRobLgbLgbLcbRobRobLobLcbLebRebLobRobRobLobLobRjb
RobRebRebRobRcbLobLcbLebRobLgbRobLcbRobRgbRebLobRcbLobLobLebRsbLobLobR
jbRcbRobLcbRebLobLobLobRobLcbLebRjbLcbLobLobLhbRsbLsbRibLobRobRibLobRc
bRobRebRobLcbRobLobLobLebLsbRcbRebRsbLsbLobLibRcbLcbRebLjbRgbLebLsbLsb
LobLebRjbLcbLobRcbRibRibRobRhbLebLobLibRobLjbLobRebRsbRobLcbLobRsbLobL
obLibRcbLobRebLibRhbLobLobLebLobLobLobRcbLobRgbLebLebRsbLibLebRobRibLc
bRobRobRibRjbLobLebRobRcbLebLsbLobRcbLobRobRobRhbLcbRobRcbLsbRebLebReb
LobRebLebRobLsbRebLebRibLebRobRibRcbLobRebRobLebLebRobRcbLobRobLebRsbL
gbRobRcbRebRsbRsbLebLobLobRobRobLobLobRcbRobLebLgbLebLebRjbLobRebRcbLg
bRobLcbLobRobRjbLobLobRcbLgbRcbRgbLjbRgbLebLjbLobLjbRebRsbRcbLobLobLob
LebLebRcbLsbLibLobLcbLobRobLobLebRebRhbLibRobRobRcbRcbLebLobLobRebLobL
obRibLobLibRebLgbLebRebRebRjbLibRobRcbLobLobLobRobLibLebLjbLobLobLebLc
bRebRibLebRcbLobLcbLebRebRhbRebLobRobLgbRobRobLebRcbRobRebRebRobRgbLob
RebRobRobLobRcbRobRobRobLebLobLobRobLobRcbRjbLobRebRgbLibLobRobLobLobR
ebRobRebRobRebLobLobLobRebRobRebRjbLebLobLjbRobLebLgbLsbRsbLobLebRcbLo
bRobRobLebLobLobLsbRebLobRebRebLob

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 16; Drug: OSU6162 1 然 Apo 50 然
bRobLobLcbRebRobLobRobLsbRcbRobLebLibRobRobLebLobLgbLobLobLcbRebLobLeb
RcbLebLebLobLibRebLcbRebLobRcbRobRcbLobLsbLibRobLobLcbRobLcbLobLgbLobR
sbRebRobLobRobLcbLcbLobLcbLobLebLebLibLebRibLcbRobRobRobLcbLhbLobRebRo
bRebLobRobRebLibLebRibLobLcbRobRebLcbLobRcbRobRsbLobRibRobRhbLcbRebRob
RebLobRobRobRobLobLebRobLobRebLobRebRibLobRobLobLgbRobLobLgbRobRgbLobR
obRobRibLebRcbLsbRobRcbLobRsbLobLibLcbRibLsbLobRebLebRibRibLebLobLobLg
bRobLobLibLobLsbLobRcbLebLcbRobLobLobRobLobLobRobLobLobLebRobLobLebLob
RsbRcbRhbLobLobRcbRcbRobRobLgbLebLibRobRobLobLibRobLobLgbLebRgbRebRebL
obLcbLobLgbLobLgbRobLcbLebRobRgbRcbLebLibLgbLibRcbRsbLobRebRobRcbRebLc
bRcbLhbLobLebRcbLebLobRobRcbRebLobLcbLcbLobLjbRsbLcbRebRgbLibRcbRcbRgb
RcbLobLebRobLebLobRobLobRobLobLobLibRibLebLobRebLebRcbLebLcbLobRobLobL
obRhbLebLobRcbRibLgbLgbLebLcbRibLobRgbRobLebLebRsbRebRobRobRgbRobLcbRc
bLobLebLgbLobLcbLcbRibLsbLobLcbLobLobLebRibRobRcbLebRibRobLebLebLsbReb
LobLebRgbRobLibRgbRobLobRebRobLobLebRobLgbLobRebRibLobRibRebRobRobRobR
cbLobLcbLgbLobLobLsbLgbRobLobLebRobRibRhbLobRebLobRobLibRobLobRobLebLe
bLcbLibLobRibLgbLgbLgbRhbLcbLebLobLhbRobLebLcbLobLobRcbLgbLobRcbLcbRob
RobRebRhbRobLebRcbRsbLebLibRebRobLebLgbLobLgbLobLobRobLobRebLobRobLobR
cbRobLobRobRcbLibLobRobRgbRebRobRobRobRobLibLebRsbRobLobLgbLgbLebLgbLe
bRibRhbRsbLebLcbRsbLgbRcbLobLobRcbLobRcbRcbRgbLobRcbRcbLebLebLobLgbReb
LobLebLibLgbRcbLebRebRsbLcbRibRobRcbRibLobLobLibRobLhbLobLobRebRobLgbR
cbLobRebRobLibRobRibRcbRibLebRobRobLibLebRcbRgbRcbLobLebLibLsbLibRebRg
bRobRebRebLcbLebRobRgbRgbLobRebLobLobLcbLobLcbRsbRobLgbLcbLobLgbRcbLib
RcbLebLobRebLobRibLobRebLebLobRobLobRcbLobLcbRebRibRsbRobRebLobLsbRobR
obRobLobLebRcbRobLibLcbLebRibLsbLgbLsbLsbLebRebLobRobLebRobRcbRebRebRo
bRgbRobLsbLcbRcbLibRobRebRebRebRebRibLcbLcbLobRobLobLobRobRcbRjbRobLcb
RgbRobRcbRgbRcbLcbRcbRcbLobLobLsbLcbLobRobRgbRebRebRebLobLibLobRibRobR
ebLcbRebLcbLsbLobLibLibRcbLobRebRebLsbRobRsbRobLobLsbLebRcbLgbLebRebLc
bLobRcbLgbLobLobLebLobRgbRebRobLibLobRobRobRobRebRsbRebRobLgbRebRobReb
RobLobRebRcbLcbRebLhbLibRobLibLhbRobLibRcbLobLebLgbRgbRsbRobRcbRsbLobR
obLebLebRobLcbLobRebLcbRobRcbRobRobRcbLcbLebRebRibLobRobRebLobLgbLebLo
bRobLobRobRobRobRobLebLibLobRcbLebRobLcbRebLgbLobRebRcbRjbLcbRibRebLob
RebRobLobLebRhbLcbLobLobRcbRobRebLcbRcbRcbRibRhbRobLobLobLobLsbRobLebL
obLebLibRibLobLebRobRebLgbLibRobLobLebRobRcbLsbLobRsbLobRobLebLobRobRc
bRobLibRobRobLobLcbLobRsbLcbLobLobLibLobLcbLobRobLobRobRobLobRgbLebLeb
LobRsbRobRobLobRibRcbLgbLibLebLebLsbLebRgbLsbLobRobRebLebLobLcbRgbLebR
obRibLjbLobLobLebLsbRobLebLibRobRobLobLcbRcbLobLgbRobRobRobRebLgbLibLo
bLhbRobRobLebLebLobRobLgbLgbLebRobRobLebLcbRebRobLibRibLibLcbRobRobLob
RobRebRibLcbLebLcbRcbRobRobRobLobRobRebLebLobRobLibRebLobRebRcbLebLobR
ebRebRebRgbRobLhbLcbLobLebLcbRcbRcbRgbLebLebLobLobRobLobRcbLibRcbLebRo
bRebLgbLebLgbLebRobLebLebLcbRobLcbLcbLebRcbLebLebRobRebRhbLibRobLebLgb
RibRcbRebLobLobLebRebLcbLobLibRobLebRobRibLebLobRebRcbLobRcbLobLebRobL
ebLobRebLobRobLobRobRibLhbRebLibRobRobLobRobRsbRcbRibRebLgbRcbRobLgbLe
bLsbRgbRobLobRcbLobRcbLobLibRcbRcbLobRobRobRgbLobRebRobLsbLobLcbLobRsb
RhbRibLibRebLobRebRobRibRsbLcbRobRebLobLobLobRgbLobLobLebLebRebRobRgbL
cbLcbRobLobRebLobLcbLobRobLgbLobRobRcbRibLibLobRobRobRibRcbRcbRobRebRe
bRobRobLcbLebRcbLobRibRsbLobRobLobLobLobRcbRcbLcbLebRibLobRsbLibLobLob
LgbLobRebLebRob

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 17; Drug: OSU6162 1 然 Apo 50 然
bRcbRobRobLcbRobLcbRobLobRsbRcbLobLjbRobRebLjbLcbLebLobLibRobLobRebRob
RibRcbLsbLobLobLobLobLebLobLcbLobRobRobLobLcbLobLjbLobLcbLobRsbRobLobL
ebLobLcbLobRebRebLobRebLibRebLobLobRjbRebLobLebLobRcbRjbRobRobLebRobRo
bLobLobLcbRebRsbLebLjbRebLcbRcbLcbLebRcbLibLsbRobRhbLobRobRsbLcbLgbLcb
LobLobLibRcbRobLobRebLobRobRobRibLibLebLobLobRjbRcbRobLobLobLebRobRcbL
jbRgbLebLobLibLobRsbRobRobLebRebRobLobRebLobRobLjbRobRebLcbLcbRebLobRs
bRobRcbRobLobLhbRibLsbRgbRibLsbLobLhbRhbLobRsbRobRobLobLcbLobRsbRsbLcb
LibRobLobLebLcbRobRobLibRobLobRjbLobRobLobLsbLebRobLobRobRobRobLobLebL
obRsbLobRobLobRobRobLcbLjbLibLobRobLhbLcbLcbLobRobLobRobRobRobLebLjbRj
bLebRobRjbLobLebRebLhbRobLobLobLcbRobRjbLcbRobLobRcbRebRebRjbRobRcbLob
RebRcbLobLcbRcbRobRobLebRebRobLcbLobLobLobRebLibLjbLibLjbLcbRcbLebLobR
ebLebRobRobLjbLcbRjbRobRjbRebRebRobRobLebLobRjbRobRsbRjbRobLebLcbLjbRe
bRjbRobRebRjbLobLjbRjbRebRjbLjbLebLobLsbRebRobRcbRsbLcbLebLobRobLobRcb
LcbLobLobRobLjbRebLcbRcbRcbLcbLjbRcbLjbLcbLcbLsbLobRebLobLebLcbRcbLjbR
obRobLobLebLobRobLjbRjbLcbRjbLsbLobLobRebLobLjbRobRebRobRobRobLebLjbLo
bRebLjbLcbLjbRcbRjbLobRobRebLobLobLcbRjbLjbLobLobLobRobLobLobLebRcbLeb
RcbLobRibRobRcbLgbRcbLebLebRebLobRobLobRjbLobLobLobRebLibRjbLjbLcbLobR
sbLsbLobLobRobRobLobLjbRcbRobLobLobRobRobLobLobLjbRjbRebLcbLcbRibRobRc
bLobLjbLobLobLebLobRobLsbLobLcbLobLibLcbRcbLsbLsbRebRsbRcbRcbRebRibRjb
RebRobRebRcbRobLebLobLcbRcbRebRhbLebRebRcbRobLobRcbRebRobRcbRcbRebRsbL
obRjbRebLebRobLebRibRobRebRjbRebLjbLobLjbRcbRjbRebLcbLobLcbLjbRcbRcbRj
bLcbRobLjbLjbLcbRobLobLobLebLobRobLebLjbRcbLcbLcbRjbLebRcbRsbLobLsbLib
RobRcbRobLebLobRgbRjbRobLsbRibLibLsbRebRobRobLobLsbRebRebRobRcbRcbLibR
obRcbRgbRgbRobLhbRcbLobLjbRjbLobLobRebLsbLebLobLsbLebRobRebLebRcbRobLe
bRobLobLebLcbRobRobRhbRibRsbRobRjbRsbLjbRobRcbRibLebLobLebLgbLebLjbLob
RobLebRcbRjbLebLjbLjbLsbLsbLjbLobRcbRobRobLobRjbRobLebLebLobRebLgbRebR
cbRcbLobRsbLhbLsbRebLobRsbLgbRebLjbRjbRobReb

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 18; Drug: OSU6162 1 然 Apo 50 然
bLsbsbsbsbsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 19; Drug: Control Apo 50 然
bLjbLebLobLcbRjbRobLjbRebLobLjbRjbLcbRobRobRobLjbLcbRjbRjbRsbRjbRebLob
RjbLobRjbLjbLobRobRjbRcbLcbRcbRobLobLsbLebRjbRobLebLobLebRebRobRebRebR
cbLjbRcbLjbRobLsbRebRobLebRibLebLobRcbRobLsbLjbRjbRebRjbLebLjbRebRcbRe
bRjbRobRobRebLebRcbRcbLebLgbRjbLcbLjbRebLebRobLebLobRcbLjbRcbRjbLobRsb
RebLcbRebLjbLebRcbRebRobRjbLebRobLebRcbLobLjbRobLsbLjbLebRcbLebRobLobR
obLobLsbLjbLobLobLjbLjbLobLobLcbLobLebRobLcbRsbRsbRobLcbLsbLcbLjbLobLo
bLjbRjbRebRcbLgbLjbRobLobLobRobRebRobRjbRcbRjbRsbRibRobLsbRobRebLsbReb
LcbLcbLjbLcbLebLobRsbRsbLobLebRobRebLebRobLgbLobRjbLobLgbRobLobLobRebR
jbLjbLobRcbLobRobLcbLcbRcbRobLebLebRsbRebRjbRsbRobRobRebRobRjbLebRobRo
bRobLobLsbLobRobLobRebRjbRebLjbLebLjbLjbRibLobRobLsbRebLobLebLsbLjbRob
LebRjbLebLobRebLjbRobRebLobRebLcbLsbLobLobLebRobLjbLobRsbRobLgbLobRobR
sbRcbRjbLebLjbRcbRebLsbLobLcbRobLjbLcbRobRgbLobRcbRobRebLjbLjbLebRcbLc
bLebRsbRobLebRjbRcbRsbLobLebLobLsbLsbRjbRsbRebRobRsbRebLobLcbRebRgbLcb
RjbLebRhbRobRebLebRebLjbLsbRsbLebLobRebRjbLcbRebLobLobLobRebRobLebLobR
obRsbLobLjbLebRobLebLobRobLobRobRobLobLobRsbRebRobRebRgbRcbLjbRcbRibLo
bRcbRsbLjbLsbLebLjbLebLobRcbRebLebRjbLcbRobRobLebRjbRobRobRebRobRebRib
RobLobLebRebLobLjbRjbRobLobRobRcbRcbRebRobRebRobRobLebRebRobLebLebRobR
jbRjbRsbRebRobLobLcbRebRibRsbLebLobLsbRjbRebRobRebRobRebLobRobRobLjbLe
bLobRebLsbRcbLjbRebLebRobLobLhbLebLebRcbLebRebRebRgbRjbRebLobRsbRobLjb
RcbLgbLobLobRsbLebLgbLibRjbRobRobRebLibLebRobRobRobRobLcbRibLibRebLebR
ibRebRobLobLsbLobLcbLcbLebLebLhbLcbRobRobLobRgbRobRebLcbRsbLibRobRobLo
bRobRsbRobRobLsbLcbLibLobRcbRobLebRjbLsbLobLobLobRobRobRcbRcbRsbLobLob
RobRsbRobRobLobRsbLobLjbRcbLcbRob

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 20; Drug: Control Apo 50 然
bLsLsmbRsbLsbRjbRsbLebLsbRsLsbLobLobRsbRsbLsbRsbLsbRibLebLcbRsLebLsLeb
RebLgbRebRebRibRebLobRsbRebRsbRebLsbRgbLebRcbRjbLobLobRgbLcbRobLebLebR
cbLobLgbLsbLobLebRobLebLobLsbRcbRcbRobRobLebRobLobRjbRebLobRobRobLhbRj
bRcbRhbRebLjbRgbLjbRjbLebLibLobRebLebRsbRobLebLibLobRcbLsbRobLgbLjbRcb
LobLebLebLebRcbLebLebLobRobLebRobRobRebLobRjbRebRobLobRebRobLebLebLebL
obLobRobLcbLobRobLobLebLobRobRcbRebRobLibRcbLebLebRcbRgbLobRebRobRcbLs
bRhbLobRebLgbLobLgbLobLobRjbLebLobLobLjbRobLobLebLjbRcbLebLobRobLjbLob
LobRebLjbRgbRcbLcbLobRobLebLcbLobLjbRebLjbRsbRobLcbLsbRibLobRjbLgbRebR
cbLjbRjbLobRcbLobLebRjbLebRcbRjbRjbLobLobLobRobLebLebRobRcbLcbRcbRcbRj
bLjbLobLebRobLobLobLcbRobLobLobRebLebLsbRobRobLsbLobLebLebRebRcbLsbRob
LobLebRobLobLjbRjbRcbLjbLjbLebRjbLcbLjbLobRebLebRobRobLobRobRjbRebRobL
obRobRjbLcbRsbLobRobRobRobLobLjbLcbLobLobRobRsbRebRcbRebLcbRsbRebRobLs
bRobRebRobRjbRcbRobRebLobLcbRjbRobRcbRjbRobLebLobLjbLobRjbRsbRobLebReb
RobRjbLebLsbRsbLjbLjbLjbLebLjbLobRebLjbRobLobLjbLjbLobLjbRcbRcbRcbRobR
obLjbRcbRobLobRjbLcbLobRsbLobRebLsbRebLobRjbRjbRebRobLobLjbRcbRebLsbLs
bLobLebLobLsbRebLebLobRsbRebLjbRsbLobRjbLjbRsbRjbLsbLsRsRjbLebLobRebRe
bRjLjLibLebRebRsRobLebLeLsbLsbRibLsbRobRgbRsbLibRsRsmbRsbLsbLobRjbRcbR
ibLobRsbLebLsbRsbRoLcbLjbRebLsbLsbRobRsbRsbRsbRebLobRsbLsRoRsmbLsLsRsR
embRobLoRebRsbRobLsbLsbRsbRsbLsbLsbLjbLoLsmbLsRsLsRsRsRsmmbLsRsLsLsmbR
sLsbLsLsmbRsRsmbLsbLsLsmbLsbLsbLsRsbRsbRsbRsLsbRsbRsbRjbRsLgbLsbRsbRsR
smbRsbRsRsmbRsbLsbRsbLsbLsbRsbLsRsbRsbLsbRsbLsbLsbLsRebRsbLobRcbLobReb
LsbRobRobRobRhbRgbLcbRobRibLebRjbRcbRsbRobRsbLsbLobRobLobLebLgbLobRobR
obLobRjbRobLobLobLobRobLcbLjbLobRobRjbRibLobRcbRobRobRobLcbLsbRebRobLe
bLjbLobRgbLjbLebRjbLobLobLobLjbRobLebRobLhbLjbLebRjbLobLebLsbLjbLobReb
RcbRobRhbLobRsbLobLobRebRjbRobLebLobLobLcbLobRcbRsbLibRjbRjbLjbRobLobL
jbLebRebLebRebRobRjbRhbRebRobLebLobLjbRebRobRobRobLjbRobLebLebRjbLjbRj
bRebLjbLobRobRobLobLcbLjbRobLobLebRgbLibRjbRobRibLobRjbRebLebLebRebLeb
RebLobRobLcbRebLobLobRobRebLsbLsbLobRcbRebRobRibLhbRhbRjbRcbLobRobRjbR
ebLjbRjbRobRebRebLjbRobLjbLobLjbRsbRjbRobRsbLebRobRebRsbRobLobRobRjbLe
bLobRebRhbLsbLebLebRgbLebLibLjbLobLsbRobLjbLcbLobLebLobRobLobRobRibRob
LobRcbLebRobLobRebLjbLjbLebLobRcbRobLobLjbRjbRobRibRebLebRobRjbRjbLcbL
obRcbLebRobRcbRjbLebRebLjbLsbLobLebRjb

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 21; Drug: Control Apo 50 然
bRcbLjbRebLobRjbLobRcbLobLebLibLjbRebRobRjbLgbLobRebRcbLobLcbRobLjbLjb
LobLebRobRcbRsbLobLsbRobLobRsbLjbLcbLobLjbLobRobLibLibLebLobLobRjbRebL
obRcbRjbRsbLobLjbLebRobRjbLebRibLebRebLsbLebRebRebLobLebRobRobRebLobRo
bLobLobRobRobLjbLebRobRobRcbRobLobLobRobLobRobLobRcbRjbLebRcbLebRsbLsb
RsbRsbLebLebRibLebRsbRsbRobRsbLebRobRsbLebLebLebLebRsbRgbRsbLsbLebRsbL
sbRebLsbLsbRobLjbLebRobRebRsbLsbLsbLsbRjbLjbRobLsbRsbRsbRsbRsbRsbLgbLs
bRsbLobRebRsLsbRsbLobLsbLgbLjbLsbRjbLsbRsbRgbLsbRsbRsbRgbLsbRsRsmbLsbR
sbRsRsmbLsbLsbRjbRsLsLsmbRsbLsbLsbRsRsmbLsbRsbLsbLjbLsbLsbRsbRsbLsRgbL
sbLsRjbRjbRsbLsbLjbLsbRsbRsbRjbRjbRsbLsbRsLsbRsbRjbRsbRjbRsbLsbRsbRsLs
bRjbLjbLjbLsbLjbLsbRjbRjbLjbLsbRebRsbLsbRjbRsbLsbLsbLebRsbLsbLsLsmbRsb
LsbRjbRsbRsLsbLsbLsbLsLsmbRsbLsbLsbRsLsbRsRsmbRsbRsbRsbRjbLsRsbLsbRsbL
sbLsbRjbRsbLsbRsbLsbRsbLsbRsbLsbRgbLsRsbLsbLsbLsbRsbLsbLsbRsbLsbRsbLsb
RsbRsbLsbRsbRsbLsbRsRsmbRsRsmbLsbRsbLsbRjbRsbLjbLsbRsbLsbLsbRsbRsLsLsm
bLsbLsbRsbLsbRsbLsbLsbLsbLsbRsbLjbLsbRsbLjbLsbLsbRjbLsRsbLsbLsLsmbLsbL
sbRjbLsbLsLsmbRsbRsbRsbRsbLsLsmbLsbLsbLsbRsbRsbLsbRsbLjbLsbLsbRobRsbLs
bLsbRsbLsbLsbRsbRsbLsLsmbLsbRsbRsbRsbLsbRsbRjbLsbRsbRsbLsbLsbRsbRsbLjb
RsbLsbRobLsbRsLsLsmbRsbLsbLsbRsbRsbRsbRsbLsRsbRsRjbRsRsmbLsbLjbRsbLjbR
obLsbRsbLsbRsbRjbLjbLobRsbLsbRobLjbRsRsmbRgbLobLjbRobLsbLjbRebRsbLsbLj
bLjbLsbRsbRjbRgbRobLsbRsbLobRsbLobRsbRjbLobRsbRsbRjbLsbRobRjbLsbLsbRjb
RsbLsbRsbRobLjbLebRsbRjbRsbRebLsbLsbRebLsbLobLsbLsbRsbRjbLsbLjbLsbRgbL
sbLobLsbRgbLebLebLsbRsbLsbLebLsbRsbLjbLsbLsbLsbLsbLjbRebRsbLcbRgbRjbLs
bLsbLjbLsbRobRsbRobRebLjbLsbLsbRsbRjbLsbLebRobLebRobLobRobRobRsbLebRsb
RobRebRsbRebRobLsbLebLobLobLebLjbLibRibRebRebRebRibLobLjbLobLobRjbLebR
cbLebLsbLsbRjbLsbLebLgbRebLjbRsbRebLebRobLsbLebLcbLsbRsbRebLcbLobRgbLs
bRebLgbRobRgbRjbLebLsbRsbLjbLsbLebRgbLsbRgbRjbRsbRsbLsbLgbRebLsbLebRob
LebLsbLebRsbRjbLebLjbRjbRsbLsbRsbLjbLgbRsbLsLsmbLsbRjLsbRsbLebLsbRsbLs
bLebRsbLobLebRsbRobLobLobLsbRsbRsbRsbRobLsbRsbLsbRjbLsbRjbLsbLjbLsbLob
RobRebRgbRgbLcbLsbLebLsbRsRsmbLjbLjbLsbLsbLsbLjbLsbLsbLsbLjbRsbRsbRsbR
sbLsLsmbLjbLebLsbLsbLsLsmbLjbRsbRebRsbRjbRsbLjbLsbRjbLsbLsbLjbRsbRobRs
bLsbLsbRsbLsbLjbLobRsbRsbLjbLsbRsbLobLsbLjbLjbLsRsbRjbRsbLsbLjbLsbLjbL
sbLebLsbRebLoLsmbLsbRsbLjbLsbLsbRjbRsbRsbLsbLsbRsbLobRjbLsbLsbLjbLobRj
bRsbLjbLsbRobRsbRjbLsbRobLebRsbRebLsbLjbLobRjbLobLjbLsbRsbLsbRsbRjbLsb
LsbLsRsbLobLsbRsbLjbRsbRsbLebRjbRsbRsbRobLebLsbLsbRsbRsbRsbRsbLobRjbRs
bLoRsbLjbRsbLsbLsbRsbRsbLebLobLsbLsbLsbRjbRsbLjbLsbRsbRsbLsbRsbLsbLsbL
sbRsbLjbLsbLsLsmbRsbLcbRsbLsbRobRsbLsbRob

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 22; Drug: Control Apo 50 然
bsbsbRsbsbRsbLsLsmbLsbsbsbLsLsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 23; Drug: Control Apo 50 然
bLebLebLobLjbLjbRsbLobLobLobRjbLibRobRobRobRobLobLobLobRgbRcbRobLobRob
LebRobLobLebLobLcbLobRcbLebLcbLobRebRsbLcbLebLobRebRobLgbLcbLobRebLibL
obRjbRcbRgbLobLibRibRobRobRcbLobRebLcbRjbRsbRcbRjbLobLibRjbRebLebLebLo
bLobRobRobRobLobRjbRcbLsbLsbRcbLebRobLobRobRgbRcbRobLibLobRobRobLebLcb
RebRsbRobRebRebLhbRcbRobRcbLobLgbLsbRcbRobRebRobLsbRebRjbRjbRobRebLobL
ebLcbLebLjbRcbLobLsbLebLobRebRobRjbRobRebLobRobLsbLgbLebRobLebRobRebRo
bLebRebRebLebRobRsbLobLcbRcbLobLebLebLcbRobRobRcbRhbRcbRobLebRebLobReb
RcbRobRebLobRsbLibRgbRcbRjbLobLobLcbLobLobRjbLobRebLgbRebRobLobLobRobR
ibLebRibRcbLobLgbRebRcbLobRsbLsbRobRobLobLibRibLebLgbLcbRjbRobLgbRobRo
bLebLebLobLobRebLebLobLobLjbLibLibLsbLobLebLobLobRcbRgbLcbLobLobRibLob
LgbRcbLebLebLebLebRobRobLcbRjbRebLobLobLobLebLobLobRebLsbLgbLgbLsbRcbL
obRobRcbRibLsbRobLobLibLobRibLobLcbRobRibLibRhbLobRcbLebRobLebLsbLobRc
bLebLebLcbLobRobRobRgbLibLobLjbLobRibRobRebLgbRebRobRebRobRebRjbLcbRob
LebRsbLobLibLcbRgbRobLcbRcbRobRcbRebLcbLebRebRobRcbLibRcbRsbLobLsbRibR
obRobLcbRobRsbLobRebLobRibRobRcbRcbLebRobRobRibRhbRobRhbRcbLcbLebLobRo
bRobLhbRgbLcbRsbRobLobRebRebRjbLibLobRjbRibLcbRobLobLebRobLebLcbRebLob
RcbRobLsbLcbRobRebLebLebLhbRobRebRebLebLobRobRobRebRsbRobRebLebLobLobR
cbLsbLebLibRebRebLobLobRobLobLsbLebRcbRobLebLcbLobRibLibRobLcbLebLcbRe
bRebLobRsbRibRobRsbLobLebRobLcbRobLcbRobLcbLebRcbLebRebLibRobLebLgbRhb
LcbRobRobLcbLobLebLobRgbLebRebLobRobLobRobLebLgbRebRebRsbLobLobRobLsbR
hbLobLcbLcbRcbLobRobLebLobLebRobRobLobRgbLgbLobRobLcbRebRobLibRebRibRo
bLebRebLobLgbRobRobRebLgbLobLobRebLgbLobLobLebRebRobRebRcbRcbLobRebLob
RibRgbLobLobLebRobLobLobRebLobRobRebLobLibRobLobRebRebRibRcbLcbLebRibR
ebLobLobLebRobRobRsbLibRcbRibRsbLobLobRobLsbRibLebRobRobRcbRobLebLobLi
bRsbRsbRcbLcbLebLebRebLobRobRcbRobRobLsbLobRobLcbRobLobRgbLebRobLebRob
RobLobRobLobRcbLsbRsbLebLcbRsbLibLobLebLobRebRibRebLsbLgbRobLebLobLobL
gbLibRobLobLebRobLobRobLobRcbRobRcbRgbRsbRobLobLebLsbRobRobRobLobRobLe
bRibRebLobLebLsbRcbLobRobLcbRsbLjbLebRobLebLgbRobLobRsbLgbRcbRebLebRob
RobLobLgbRobLgbRcbRebLebLebLobLobRsbLibLobLibRebRebLcbRgbRebRobRobLibR
gbRgbLebRcbLobLebLobRsbRcbLebLobLcbLebLobLobLcbRcbLebRcbLobLobLebLobLc
bRebLobRobRobLsbRobLebLobRebRobRcbRobLebRebLibLcbLibRobRebRobRobRcbLcb
LobRgbRsbRcbLibRobLibRobRebLibRobLsbLobLcbRibLobLjbRobLgbLobRgbLobRobL
obLobLobLebRibLibLhbRibLsbLebRhbRsbRcbRcbLobLcbLebRcbRcbLebRgbLobLhbRe
bLhbLebRobLibLcbRgbRobRobLcbLcbLsbLobLibRgbRebRcbLhbLobRobLgbRobRibRgb
LobRgbLcbLobLobLibRebRobRebRobRcbLobRobLibRcbRobLobLobRobRsbLobLobLebR
cbLebRibRebLcbLobRobLcbRobLebRhbRebLebLcbLhbRobRhbLobRobRebLebRsbRgbRe
bLcbRobRcbRobRobRgbRibLebLebRjbLibLobLebRcbRsbRobRhbLobLibLgbLobRobLeb
RobRebLobLsbLsbRgbRebRebRobRobLcbLobLobRobLobLebLgbLobRobRobRobRobRgbL
obRobLsbRobLobLebRobRsbRebLobLsbLobRobLobRibLcbRebRebRobRsbRsbRebLsbRo
bLgbLibLebLobLibLobRsbRobLsbRcbRobLcbRobRebRobLcbRhbRobRcbRgbRcbLobRsb
RobLobRebRebRobLsbRcbLsbRsbRsbRobLobLibLsbRcbRobLebLobLobLobRhbLobLobR
sbLgbRsbLibRsbLsbRcbLgbLebLeb

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 24; Drug: Control Apo 50 然
bsbsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 25; Drug: OSU6162 10 然 Apo 50 然
bLcbLjbRsbRsbRcbLebLjbRebLjbRibLsbRebRgbLobLobLgbLcbLcbLobRgbRebRibRib
LebRobRebLebLjbLjbLebLebRcbLibRebRsbRsbRebLobRobRgbLobRsbLebRobLobRobL
ebRibLjbLobLebLobRebRobRjbRibRebRsbLebLsbRibRibLobRobLebLibRcbRebRobLe
bLjbLcbLobLcbRobLcbLebRobLebRgbLobRcbRhbLobRobRobRibRobRebLcbLibRebLob
LobLebRobRgbRobLcbLobLebRobLhbLobRebLcbRcbLebLcbRcbLcbLibLobLcbLibLobR
ibLcbRobLgbLgbLsbRobLobRibLebRobRobRebLgbRobLobRibLebRobRsbLebRcbRibRo
bLebRobRobRebRobLobRobRebLebRsbRebRobRebLobRobLcbLobRobLobLcbLebLebLsb
LcbLibRibRebLobLsbLobLebRibLebRobLobRibRebLobRebLobRobLcbRobRobLebLobR
obRcbLobRebLobLgbRobRobRebRcbRebLobRobRibRobRobLsbRsbRobLebRobLebLsbRo
bLobRcbRibLebRebRobRobRibLebLebRibLcbRobRobRcbLobLsbRcbLobRibLcbRobRob
LobLobRsbLcbRobLcbRgbLebRhbRebRebLibRgbLobLibLcbLhbLobLobRobRebRobRebR
gbRobRobRsbRobLobRobRhbRobRgbLcbRebRcbLobLobRebRgbRobLgbRebRgbRobRibRs
bRebLobLobRobRobLobRobRobRebRobLsbLobLgbLgbLsbLibRobLsbLgbLobLcbRobRgb
LebLobLcbRebRebRebLsbRobRobRebRobRobLobRobLgbRobRibRebLcbRobRobRebLobL
ebRcbLebLobRebLobLibLobLjbLobLcbLibLobRobRcbLobLobRebRebLcbLebRibLobLo
bRgbLgbRgbLhbRebLobRebLebLobLhbLsbRcbLobLcbRobRobLobRibRobLobRobRebLcb
LhbLebLebLcbRebRobRsbRobRcbLsbLobRcbLcbLobRgbRobRobLibLebRibLebLsbLobR
obRobRobRobRebLobRobLobLhbLebLebLibRebLgbRobLobRcbRebRebRebLhbRsbLibLh
bLobRsbRobLcbLobRobLgbRcbRobLcbLcbRibRgbRebLobRobRobLsbRobRobLcbLibLeb
RebRebRobRebLebRibRsbLebRebLebRobLobLcbLobLobLobLobLebRhbLobLcbRcbLobL
cbRibRobLgbRobLobLobLcbRobRcbRobRobRebRobRebRcbLebRebLebRcbRibRobRobLs
bRobRibRebLgbRobLobRcbRebLgbRobRibRobLobRobRobLebLobRcbLobLobRgbLibLhb
RcbLebRcbRcbRebLebLebLsbLcbRhbLebLibRebRobLobRsbLcbRebLobLobLebRibRibL
obRobRebLobLcbRcbRobRhbRebLobRcbLcbRibRobLobRobRjbRebRcbLebRobRobRobRi
bLcbLebLobLobLcbLebRobLsbLebLhbLebRobRobRobLcbRgbRobRgbRebLobRobLhbRgb
LobLobLobLcbLsbLcbRcbRobLcbRgbLebRibLhbRobRobLobLobRobLobLobRcbLcbLhbR
obLcbRgbLebRobRebRobRobLebLgbLgbRebLobLcbLobRcbLcbLsbLobRebRobRibLobLe
bLsbRobLobRcbLobLobLobLcbLsbRcbRgbRgbRebLgbLobRhbRgbLebLcbRcbLebRcbLeb
LebLebLcbRobLsbRebRobRobLebRcbRebLcbRibRcbLgbLhbRibLebLobRcbLgbRhbRobR
ibRibRebRgbLcbLebLgbRebLebRobLcbRobLgbLobRibRebLebLcbLobLebLobRebLobLi
bLsbRobRobLsbRobRobLobLobRobRsbRobLebLobRobLcbRobLcbRgbRobRobLibLibRob
RibRibLebLobRebLobRebRgbRhbLebLebLhbRcbLebRobLobLebRibLebRebRobLgbRsbL
cbLobLobRgbLobRibLobLobLgbLebRhbRebRobRobRobLobRobLobLgbRebLobRgbLcbRi
bLgbLcbLobLcbRobLobLcbRobLobRhbLcbRobLibLebRobRcbLcbRobLebRcbLebLebLob
LobRcbRcbRobLebRebLgbRsbRobLobLobRobLobLgbLebLobLgbLcbRobLobRibRibLgbL
obLobLobLcbRcbLobRibRobLsbLgbLcbRcbLibRobRcbLjbLsbLibLobRcbRebLibLebLo
bRobLobLibLebRebRcbRcbRhbRjbLobRjbLebRebRobLibLsbLcbLgbLebRcbRcbLcbLcb
LobLobRcbRobRobLobLobLobRebRgbLsbLebRebLgbRebRjbRcbLobLibLobLobRebRobR
ebLsbRibRibLebRsbRhbRgbRsbLsbLobLobRebRcbLebLsbRcbRebLobLebLebRsbLobLo
bRobLobRcbRebLebLobRebRcbRebLjbRebRebLsbLobLcbLobRobLobLsbRebLebRebRcb
RobLebRjbRebLobRcbLebRjbLobRcbRibRgbLjbLebLobLjbLebLobLebLcbRjbLcbRobL
jbLebLobRobRebRebRobLebLobRgbRobRobRibRobRibRcbLebLgbLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 26; Drug: OSU6162 10 然 Apo 50 然
bsbsbsbsbsbLsbsbsbRsRsmbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 27; Drug: OSU6162 10 然 Apo 50 然
bLcbRobLobLgbLobLcbLcbRebRobRobLobRobRsbLebLcbLebLobLobRobRsbLcbLobLob
RobRobLebLobLebRebRobRjbLsbLgbRobLebLebLebRebRebLobLebLobLobLebLjbRcbL
cbLebRobLjbLsbLobLebLobRcbRobLobLcbLebLobRcbRjbRobLebLibLebRobRjbLobRo
bRobRcbRobRcbRcbRebRebRjbRebLjbRjbLobRebLobRcbRjbLobRobLgbRjbLebLjbLob
LhbRsbRobLjbRebRjbRobLobLobLsbRcbLobLcbLebRjbLobLcbRebLcbRcbRjbLobRibL
obLsbRobRcbLsbLobRebLobLibLcbRobLobLcbRjbRobRcbLibRcbLibLjbRobLcbLobRo
bLobRebLobLobRcbLobLebRsbRgbRgbLobRgbLobLobLobLibRgbLobLibRebRcbLobLeb
LobRobLsbLibLebLcbRcbRibLebLcbRhbRibRobRebRibLgbLobLebLgbRobLcbRebLebR
obLobRobLcbLobRgbRobLobRebRobRobLobRsbRebLcbLobLcbRobLebLebLebRgbLgbRo
bLobRobLobRobLebLebLobLobLibLibRebRcbRobRobLobRobRebLjbRobRjbRjbRsbRgb
RobRebRcbRobRcbRcbLebRobLsbLebRsbRebLebRebLibRcbLobRjbRsbLsbRebRobRsbL
sbRobRobRebLobRobRobLobRsbRsbLsbLibRsbRjbLjbRsbRsbLsbLsbLcbRebLobLsbLs
bRsbLcbRebRebLsbLsbRsbRsbLcbLobLcbRebRsbRsbRsRsmbLsbRcbRebRjbRobRjbReb
RobLsbRsbRsbLebLsbLjbRobLsbLebLjbLjbRsbRjbRebRcbRebLobRobLsbRebLsLsmbL
obRjbLebRsbLjbRsbLebLjbRjbRsbLsbRobRsbRsbLsbLebLobLobLsbRjbLobLsbRebRc
bRsbLobRobRebLjbRjbLobRsbRsbRsbRsLsbRsbLsbRebLsbRsbLsbRebLobLsbRsbLsbL
ebLsbRcbLjbRjbLcbLobRsbLebRjbRjRobRjbRjbRobRobRsbRsbRjbLobLsRsbRsRsmbL
sbLobRebRobLobLsbLobLsbRsbLsbRcbLsbRsbLsbRsbLsbRsbRsLsbRsLjbRsLjbRobLs
bRsbLobRobRjbLsbLebLsbRobLsbRsbRebLobLjbRobRjbRsbRsbRsbRsbRsbRobLsRsbR
sbLsbRobRsLsbRsLsbLobLsbLjbLobLsbLsbLsbRgbLsbRsbRjLsbRsbLsbLsbRsbRobRj
bRebRsbRsbLsbLeRsbLsbRsbLsbRsbRobLebRsbLsbLsbRebRobLsbRebLjbLsbLobLjbL
sbRsbLsbLjbLjbRsbRebRobRsRsmbRebLcbLsbRsbRsLsbLebLobLsLcbLsbLsbRsbRsbL
sbRsbLsbRsRsmbRsbRjbLsRsbRobRsbRebRsbRsRsmbRjbRjbRsbRobLsbRsbLsbLsbRsL
sbLsbRjbLsbRsbRsbRjbRsbLsbLsbLsbRjbRsbLsbLsbRsbLsbRsbLobLsbRsbLsbRsbRs
bLebRsbRsbLobLsbLsLsmbRsbLsbRsLjbLsbLsbRsbLsbLebRsbRsbLjbLsLsmbRsbRsbL
sbLsbLjbRsbLsbLcbLsbRsbRobLsbLjbLsLjbLsbLsbRjbLsbRsbRsRsmbLebLsbRebLob
RsLsbRsbLsbRsbLsbLsbRsbRsbLsbLsbLsbRsbRcbRsbLsbLsbRsbLsbRsbRsbLebRsbLs
LsmbRsbLjbLsbLjbRjbRjbRsbRsbRjbLsbLsbLsbLsbRsbLsbRsbRsLsbRsbLsbLjbLsbL
sbRjbRobLsbLsbLjbLebRobLsbRsbLsbLsbLsbLjbRsbLjbLjbRsbRsbRjbRebRsbRsbRs
bRsbLsbLobRsbLsbRobRsbLsbLsbLjbLjbLsbLsbRsbRsbRcbRobRsbRsbRjbRsbLsbLsb
LobLsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 28; Drug: OSU6162 10 然 Apo 50 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 29; Drug: OSU6162 10 然 Apo 50 然
bsbLsbsbsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 30; Drug: OSU6162 10 然 Apo 50 然
bRcbLebLebLjbLebLobLjbRobRebLjbLebLcbRobLcbLjbRsbLobRjbLjbRjbRebLebRob
LobLibRjbLobRsbRebLsbRobRobRobLobLobRobLobLjbRobLebRjbRobRobRobLebRsbR
jbRobLebLcbLgbLebLobRobLebRcbLobRjbRcbLjbRsbLebLcbLobLobRjbLebRobLsbRj
bRebLebLcbRebLebLebLjbLebRcbLebLobLgbRobRgbLjbLjbRobRebLjbRobRjbLobRjb
RebRsbLobLobRebRobLobRebRcbLobLebRobRcbRebLibLobRsbLcbRjbRobLobRobRebR
obLobLebLcbLebLjbRebRjbLebRobLjbRebRjbRobLebRcbRcbLjbLebRobLebLjbRobRs
bRobRjbRobLebLibRsbRobRobLobRcbLhbRobRsbLgbLcbLobLebLcbRobRebRebLebRob
RobLebRsbLebLobRgbRebRjbRcbLobLebLcbLobLobRebRjbLcbLobRsbLobRibLcbRcbL
obRobLebRcbRobRobLebRobRobLobRcbLobRebRobLobLobRobLsbRebLsbLobRobLibLo
bLcbRebLobLebLobRcbLebRobRjbLjbRcbRebLibRobRebRobRobLcbLebLobLebLgbRjb
LjbLobRobLibRsbRjbLobRobRcbRsbRjbRjbRobLobLobLjbRjbRobLobRjbLjbRobRgbR
sbLgbLobRgbRjbRcbLhbLobRobLsbLsbLobLcbLobLobLebLobLjbRobRobLjbLobRsbLo
bLjbRobLobRjbLobRobLobLibLcbRjbLsbRobLcbRebRjbRebLcbRsbRobRjbRobRebRob
RjbLoRebRcbRcbRobRobRobLjbLebLjbRsbRjbLobRobLobLebLobRsbLobLsbRsbLjbRs
bRjbRebRebLsbLsbRsbRjbRsbLobRebLjbLjbLsbRsbRsbLsLsmbRsbLsbRebLjbLjbLsb
RsbRobLebRsbRsbRobRsbRsLsbLebRsbLsbRebLebRsbLsbRobLobLsbRsbRobLobRobRs
bRebLsbRobRsbLsbLsbRsbLsbLsbRsbLsbLsbLsbLsbRsbRsbRsbRsbRsbRsbLsbRsbLsb
RsbRsbRsbRsbRsbRsbRsbLsbLsbLsbLobLsbRsLsLsRsLsLsmmbRsbRsLobLsRsLsbLsLs
RsRoLsmbRsbLsLsmbLsbRsbLsLsmbLsbRsbRsbLsLsRsmbLsbRsbRsbLsLsmbRsRsLsmbR
sLsbLsbRsRsmbRsLsbRsRsmbLsRsLsbRsbRsRsmbLsbLsbLsLsmbRsbRsLsbLsbRsbRsbL
sbRsbLsbLsbRsbLsbLsbLsLsmbRsbRsbRsbLsbRsbRsbLsbRsLsbRsbRsbLsbRsbRsbLsb
RsbLsbRsRsmbLsbLsbRsbLsbRsbLsbLsbLsLsRsmbLsLsmbLsbRsbLsLsmbLsbLsbLsbLs
bLsRsbLsbRsbRsRsmbLsbLsLsLsRsmmbRsbLsbLsbLsbLsbRsbRsbRsbRsbLsLsmbLsbLs
bRsbRsbRsbLsbRsRsmbRsbRsLsbRsbLsbLsbRsbLsbLsbRsLsbLsbLsbRsbRsbRsbLsbLs
bLsbRsRsmbRsbLsRsbLsbLsbRsbLsbRsbRsbRsLsRsbRsRsmbLsbRsbLsRsbLsbLsbLsbR
sbRsbRsbLsbRsbLsbLsbRsbLsbRsbRsbLsbRsbLsbLsbRsbLsbRsRsmbLsbLsbLsRsRsmb
LsbLsbLsbLsbLsbLsbLsbLsbRsRsmbLsbRsRsmbLsbLsbRsbRsbRsbRsbRsbRsbLsRsRsL
smbRsbLsbRsLsLsmbLsLsmbRsbRsbLsbRsLsbRsLsbLsbRsbRsbRsLsbRsbRsbRsLsLsmb
LsRsbLsRsbLsbRsLsRsbLsbRsbLsLsmbRsbRsbRsbRsbLsLsmbLsbLsbLsLsmbLsLsmbLs
RsbRsbLsLsmbRsbLsbLsbRsRsmbLsbLsbRsLsRsRsmbLsRsbRsLsLsLsmmbRsLsbLsbLsL
smbLsbRsbLsbLsbRsLsbLsRsLsbLsLsLsmmbLsbRsLsbRsRsmbRsbLsRsLsLsmbRsbLsbR
sbLsbLsRsRsRsLsmmbRsRsmbRsRsRsRsRsRsLsLsmmmmmmbRsLsLsRsLsRsLsRsLsLsRsR
sRsmmmmbLsRsbRsLsLsRsLsRsRsmmbRsLsbRsLsLsRsRsmmbLsRsRsLsLsmmbRsRsmbLsR
sRsLsLsLsRsRsRsRsLsRsLsRsLsLsLsRsmmmmmmmmbRsLsRsLsRsLsRsLsRsLsRsLsRsLs
RsRsmbLsRsLsRsRsLsRsLsLsRsLsRsRsLsLsRsRsLsLsRsLsLsRsLsLsRsLsRsLsRsRsmm
mmmmmmmb

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 31; Drug: OSU6162 3 然 Apo 50 然
bRobRsbLobRibRobRobRebRobRebRsbLobLebLcbLsbLsbLobLebLobLcbLcbLobRobLsb
RobLebLsbRcbLcbRebRobLibLobRobRobLebLobLebRebRebLhbRsbLobLobLobRebLebL
ibRgbRebLcbLibLobLobLobLebLgbRcbRebLobRobRobRebLcbRobLebRobLebRgbLcbLo
bLebRobLebRibLibLobLibLobLsbLcbLobRobLcbLhbLobLobRcbRgbRebLcbLobRobRsb
RobLcbLibLibRcbLgbRebRobLobRobRobLobLgbRebRobLebRobLobRibLsbRcbLobRobL
obLebLibLobLebRobRobRgbLgbLobRcbRibLobLobLobRobLibLgbLebLebLobLgbLobLo
bRobLcbRobRobRgbRebLcbRobRcbRcbRobLebRobRobLhbLobRcbRobLsbRebRebLebRcb
RobLobLobLobRobLobRcbLcbLobLobRebRgbRibRcbLcbRibLobRobLcbLhbRcbRobLobR
cbLobLcbRebLobRhbLobRobLebRobLobRobRobLibLobRsbLobRibLebRebLibRcbLebRo
bRibLobLebLcbRobRcbLobRobLobLebLebRobLebLgbLcbLobRibLobLobLebRobLobLcb
RebLebRobRobRobLsbRobRobRebRebRibRcbLcbRebRobLebLobLobRobLibLebLcbLobL
obRsbRebLsbRebRebLcbLibLobRebRebRobLobLebLobLebRobLobRgbRebRebLebRobRo
bLebRobRobLobLobRobLcbRebRcbLobLobRebLebLcbLgbRebRobLcbLgbRcbRcbLobLob
LcbRcbRobLobLobLibRsbLobLobRebRobLgbLcbRebRebRcbRgbRibLcbRebLebRhbLgbR
ebRibLobRcbLebRebLsbRobRobLgbLebRebLobLibLobRgbRobLebLebRobLobLobLibRo
bLcbRobLebRobRebLobRgbLcbLobLcbLobRebLobLcbLobLebLcbRebRobRgbRcbLibLib
RebLgbLobLobLebLebRobLsbRebLebRobLobRebLebLhbRgbRobRebLibRobRebRobLebL
obRebLobRobRobRibRobLcbRobLsbLebRobLobRibLobLibLebRobLobLgbRcbLobLhbLo
bLcbRebRebLebLgbLhbRibRebLobRsbRobRcbRebRobRobLebLobRobRebLobLebLobRsb
LhbLebLcbLobLibLibLcbLcbLobLcbLibLobLcbRebRebRibRebLebLcbLobRcbLobLcbL
cbLgbLobRobLcbLobRibRcbRgbLobLobLcbRobLebRobLebRcbLibLjbLobLcbLcbRhbRo
bLobRobRobLgbLobLjbRgbLjbLgbRobLebLobLobLibLibLobRcbRgbLgbRebRebRobLob
RcbRcbLobRobRebRobRobRebLobRibLebLhbLebLobRebRobRibLobLebRebRobRibRebL
ebLobLobLcbLobLcbLobRobLebRobLobRobLebLebLobRebRcbLebLobRobRobLcbRobLe
bRobLcbRjbLgbRcbRebRebRebRhbLgbLobRcbRebRcbRobRebLgbLebLebRobLebLcbLob
LobRobLibRebRobRobLobRebLcbLobLobLobRobLgbRebRhbRobLgbRobRobLobRebRgbL
ebLsbRobRobLgbRobRebRobRibLobRcbRebLebLebRobRobRobRobLibLebRcbLobRobLe
bRgbRobRobRcbLobLobLebRobLobLcbRcbRebRobRobRobLebLebRebRsbLcbLibLhbLob
RcbRebLobLsbRibLobLobLcbRcbRobRgbRobRobRebLobLebRcbLebRgbRobRobRobRgbL
sbRibRcbRhbRcbRobRcbRobLobLebLgbRebRebRcbLebRobLobRcbRebRgbRebLcbLibRo
bRebRgbRibRobRobRobRhbLebRcbLobRebRibLobLcbLebLebLobRobRobLebRsbRcbLcb
RebRcbLobRibRsbLgbLcbLobRobRibRebRobRobLobLgbRcbLsbLobRgbRebRobLsbRebR
cbLobRhbLobRcbLobRgbRcbLebRcbRobRebLobLcbRobRgbRobLobLibLcbLebLebLebLc
bLebLibRibRebRobRebLobRobRcbLobRebRobLebLjbLebLcbRsbRobRebLcbLgbLsbLcb
RobRobRibRobLibRibRsbRsbLebRcbLobRcbRobRebLobRjbLobLjbLobRcbLcbRebLobL
obLobLobLebLjbRobRebRcbLobLebRsbRobLebLebLgbRibLobLgbLsbRebRobRibRobLi
bRobRebRobLgbRsbLebRgbRobRebLibLobLobLobLobRobRobRobRhbLibRobRibRobRob
LebLcbRcbRjbLobRobLsbRcbRcbLobRcbRobLsbLebRcbLobRobRibRsbLobRobRgbRcbR
obRobLebLobLobLibLsbRjbLjbRebRgbLjbRebRobRebLsbLcbRobRgbLsbLobRcbLobLo
bRebLobLjbLobRibLebRebLobRobRebRobLhbLgbRgbRcbLhbLobRobLobRobLibLibRjb
LobRebRjbLebRgbRibRibLjbLebLsbRobLsbRcbLsbRobLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 32; Drug: OSU6162 3 然 Apo 50 然
bsbRsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 33; Drug: OSU6162 3 然 Apo 50 然
bsbLsLsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 34; Drug: OSU6162 3 然 Apo 50 然
bsbsbsbLsbsbRsLsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 35; Drug: OSU6162 3 然 Apo 50 然
bLobRsbRsbRsRsmbRsbRsRebRsbLsbRsbRsLsbLebLsbLsbRsbRebRobLobRsbRsbRsbLs
bLgbRebRsbRebLjbRebRobLsbLsbLebLobRebLobRsbLebRobRebRobLebRebLobRjbRob
RjbRsbLsbLobLsbLsbRgbRsbRobLebRsbLobRjbRsbLsbLsbLobLsbRsbRobLsbLsbRsbR
jbLsbLsbRsbRobLsbLsbRebRsbRjbLsbLsbLsbRobLobLcbReRobRobLjbLsbLcbLsbRsb
RebRcbLsbLsbRebRobRebRsbRsbLsbRsbRsbLsbLjbRjbRebRsbRsbLsbLebRobRjbRjbR
obRsbRebLsbRsbLgbRobLsbRobRsbLgbRobLsbLobRsLsbLsbLebRsbRsbLsbRjbRebReb
RobLobRsbRobLebRsRsmbRsbRsbLjbRsbRsbRsbLsbRsbLsbRobRsbLobRsbRsbRsbRsbR
sRsmbLsbRsbLsbLebRsbRsbLsbLsbRobRsbRsbLsbRobRsbRsbRsbRsbRsbRsbLsbLobLe
bRsbRsbRsbLebRobLsbLcbRobRebLsbRobRebRsbLobRobRsbRebLobRobRebLobLsbRjb
RebRobRsbRobLjbLebLjbLsbLsbRjbLebLobLobLobRsbRobRobLsbRcbRobLobRebRebL
sbLjbRsbRsbLebRsbLjbRsbLjbLsbRsbLsbLobLebLsbLcbLebLobLobLsbRsbRsbLebRs
bRsbLobLobRjbLjbLobRobRobLobLebLsbRobLsbLsbLsbLebLebLsbLebLsbRsbLebRsb
RebLjbLsbRobRobRjbLobLsbLsbRsbLsbLsbRsbLsbRobLebRobRobLobLcbRobLsLsmbR
ebLsbRsbLsbLsbRebRsbRobLsbRobLjbRsbLobLobLsbRsbLobRsbLebRebLsbLobRsbRs
bLobLebLobLebLsbLgbRebRsbRebLebLebLebLobLcbLebLcbLgbRobRobLsbRsbRsbRsb
LsbRobRobRsbLsbRsbRobRsbLsbLsbRobRobLsbLsbRsbLsbRebLsbLsbLobLgbRsbRobR
sbRobLcbRobRsbLsbLsbRsLsbLsbRobRsbRsbRobLebRsbRsbRsbLsbRsbRsbRgbRgbRob
LsbLsbLobRebLsbLsbRgbLsbLsbRebLsbRebLsbRebLjbLobLsbRsbLobRsbRsbRobRoRs
mbRgbRobLsbLsbRsbRgbRsbLobLsbLsbRjbRsbLsbRobRobLebRjbLsbLsbLobRebLgbRg
bLsbLjbRjbLobLjbLjbLgbLsbRgbLebLjbLebRsbLsbLobRsbLebRjbLsbLobLobRjbRsb
RsLgbLsbRsbLsbRsbLsbRsbLjbRsbRobRjbRsbRjbLsbLsbRebLcbRjbRjbLgbLsbRebLe
bRsbLgbRsbLcbLjbRjbRjbRjbRsbRsbLsbRsbLsbLebRsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 36; Drug: OSU6162 3 然 Apo 50 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 37; Drug: OSU6162 1 然 Apo 50 然
bLsbLeLsRcbLoLsmbLsbLsbLsbLgbRgbRsRsmbRibRsbRgbRcbLobRsbLgbLsbLebRsbLs
bLsbRsRsmbRsbLsbLgbLobLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 38; Drug: OSU6162 1 然 Apo 50 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 39; Drug: OSU6162 1 然 Apo 50 然
bLsbLsbRsLsbLsbLsbRsLsbLsbLsLsmbRsbRsbLsLsmbLgbLsbRsbRsbLsLsmbLsRsbRsb
RcRsmbRobLsbRobRibRibLsbRsRsmbLsRsbLsbRgbRiRsmbLcbLibLsbLsbRsbLsbLsbsb
sbLsbLsbLgbLiLsbLobLebRcbRoLsLgLsRsbRhbsbRsbsbsbLsbsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 40; Drug: OSU6162 1 然 Apo 50 然
bLobLobLsbLjbLeb

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 41; Drug: OSU6162 1 然 Apo 50 然
bRsbLsbRsbRsbLsLsmbRsbsbsbsbsbRsbsbsbsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 42; Drug: OSU6162 1 然 Apo 50 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 43; Drug: Control Apo 50 然
bsbsbsbLsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 44; Drug: Control Apo 50 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 45; Drug: Control Apo 50 然
bLebLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 46; Drug: Control Apo 50 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 47; Drug: Control Apo 50 然
bRsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 165836; End: 170336;
Recording: 13-1; Individual: 48; Drug: Control Apo 50 然
bRibLobLjbRsbRcbLgbLhbLibRebLgbRibLebRobLobRsbLobRobRsbRgbLgbLobLsbLeb
RcbLobRhbLibLobRgbLobRcbRobRgbLobLcbLobLobRobLobLobLobRebLobRobRcbRsbR
cbRebRobLcbRgbRgbRebRobRobLobRhbRobLjbLebLibRobRobRcbLobRebLobRgbRobLs
bLobRebLcbRibLcbLibLebRsbRobRobRobLcbRobLhbRhbRobLebRobLobRibRebLcbLeb
LebRcbLibRebLcbLsbRhbRjbRjbRebRgbRgbLcbLebRebRobLobLobRcbRebLcbLobLsbL
sbLobLebLjbRebRebRobLobRobRebLcbRobRgbRobRgbLebRcbRebLobLobRgbLibLcbRc
bLebLobRebLebLobRhbLobRgbRcbLgbRcbRibLobRebLcbRobRcbRebRobRobLobLhbRob
LcbRcbLobRobRebRobRobRebRobRebLobLobLjbLgbRibLobLobLcbRcbRobRebRobRobR
obRobRcbLebRobRebRhbLcbLobLcbLcbLsbRobRebLebRgbLebLobRcbRhbLibLsbRobRe
bLobRobLgbLebRebLgbRebRobLebLobLcbRcbRobRobLobLgbLcbLsbLebRebRcbLcbRgb
LcbLcbRebRobLobLebRobLebLjbLobLobRebLsbRebLibLobLebRebLobLcbLibRebRobR
sbLobRobRobRobLhbLobLhbRobRobRebRobLobRgbLcbRgbRebRobRcbRcbLebLibLsbLo
bRebRobLebLibLobRobLcbRobLobRebRibLobLobRobLobRgbRebRibRebLobLobRobLob
RobLebLsbLobLobLebLebRobRobLobLebLcbRobLobLhbLebLobLgbRobRibRebRhbLebL
obRsbLcbLcbLsbRobRsbRgbLgbLebRcbLebRebRobRobLcbLebLobLobRgbRobRibLobLc
bLobLgbLebLgbRebLobRobRobLcbRibRcbLcbLobLobRobRcbRebRibLebLobLobLobRgb
RobRobLobRobLobLcbRcbLhbRcbLebRobRobLcbLibRebLsbLebLobLsbLebLcbRcbLebL
obLobLebLgbRobRcbRobRhbRebLobRgbRobRcbLobLobLobRobRhbLobLebLcbLebRgbRo
bRcbLobRcbLgbRobLebRobLobLibLobRsbRcbRgbRcbRebLcbLgbRgbLebRebRsbRobRsb
RobLibLcbLibLebRebRsbRebLobLobLobRobLibRebLobRhbLebLibLebRobLebLcbLcbL
cbRsbRobLsbRobRobLobLebRsbLgbLgbLibRibLcbRobRebRobLobLibRobLebLobLgbRi
bRgbRebLobLgbLsbLcbLobLobRsbLcbLobRibRobLhbRjbRobRsbLebLhbRobRsbRobLcb
LcbRebLobRcbRgbRsbRcbRobLcbLebRhbLobRobRcbRebRobRebLobRgbRibLibRebRebL
obLibLobLcbLcbRgbLebLobLobLebLibLebRobLcbLobLebLebLhbLcbRobLcbRebRobRe
bRebRebLsbRcbRcbRjbRgbRebLsbRebRobLhbRobRebRsbLsbRcbRobLobLgbRobLjbLib
RobRebRsbLgbLgbRebLcbRebRobLgbRcbRsbLobLebLsbRobRobRgbRhbLobLgbRgbRobR
ebLobRobRobLebLobLcbLobLibRgbLhbLobLibLobRobLgbLsbRsbRebRobLebRobRibLe
bRcbLobRsbLsbRobRobLsbRebRcbLebRibLsbRgbLjbRobLobRebLsbRcbLebRobRcbReb
LjbLebLobRebLebLobLsbLebLobRobRgbRobRobLobLobLebLebLebRebLebLibLsbRsbL
sbRebLsbRsbLebRibRsbLgbLobLsbLsbRebRcbLjbLebRobLebLjbRebLgbLobRobRibLo
bRobRobLjbLebRsbLibLjbLcbLsbLobLjbLebLcbLobLobRebRsbLsbRsbRsbRebLebLeb
LobLsbRgbLsbRobRsbLebLsbLebLcbLsbLsbLobRsbLjbLjbRobRobLobLobRobRebLcbL
gbRibRobRsbRobLsbLcbLcbRobLebRgbRebRsbRibRebLebLobRebLobLcbLjbRobLoLeb
LsbRsbRsbLcbLebLsbLebRobRobRgbLsbRobRobLobLebRsbLebRsbLibRobRsbLjbRsbL
ebRsbLebRobRobLsbRsbLsbRcbRsbRsbLoLsmbRsbRsbRsLsbRsbRsbLsbRsbLobLoLobR
eRibRsbLjbRsbLsbRobLobLebRsbRobLobLsbLsbLobRsbLgbLsbRsbRobRsbLsbLgbRsb
RsbRsbRsbLobRsbRsbLsbRjbLsbRobRsbLsbRgbLjbRsbRsbLsbLoRobLsbRobRgbLsbRj
bRsbLsLoLsmbLsbRobRebLsbLgbRsbLsbRsbLsbLsbLsbRsbLsLsmbLsbRcbRsbRsb

